{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Dataset represents over 2000 clinical trials for Alzheimer's disease\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "import json"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "# set colors and labels for interventional and observational studies\n",
    "color_int = '#ff6961'\n",
    "color_obs = '#8bd6f2'\n",
    "colors = [color_int, color_obs]\n",
    "labels = ['Interventional', 'Observational']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "      <th>...</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "      <th>URL</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>NCT03880240</td>\n",
       "      <td>Gamma Induction for Alzheimer's Disease</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Alzheimer Disease</td>\n",
       "      <td>Device: Transcranial Alternating Current Stimu...</td>\n",
       "      <td>PET amyloid burden|PET tau deposition|Incidenc...</td>\n",
       "      <td>Beth Israel Deaconess Medical Center|Massachus...</td>\n",
       "      <td>...</td>\n",
       "      <td>2019P000092|R01AG060981</td>\n",
       "      <td>August 5, 2019</td>\n",
       "      <td>November 2023</td>\n",
       "      <td>November 2023</td>\n",
       "      <td>March 19, 2019</td>\n",
       "      <td>NaN</td>\n",
       "      <td>August 30, 2019</td>\n",
       "      <td>Beth Israel Deaconess Medical Center, Boston, ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03880240</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1 rows × 27 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   Rank   NCT Number                                    Title Acronym  \\\n",
       "0     1  NCT03880240  Gamma Induction for Alzheimer's Disease     NaN   \n",
       "\n",
       "       Status         Study Results         Conditions  \\\n",
       "0  Recruiting  No Results Available  Alzheimer Disease   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  Device: Transcranial Alternating Current Stimu...   \n",
       "\n",
       "                                    Outcome Measures  \\\n",
       "0  PET amyloid burden|PET tau deposition|Incidenc...   \n",
       "\n",
       "                               Sponsor/Collaborators  ...  \\\n",
       "0  Beth Israel Deaconess Medical Center|Massachus...  ...   \n",
       "\n",
       "                 Other IDs      Start Date Primary Completion Date  \\\n",
       "0  2019P000092|R01AG060981  August 5, 2019           November 2023   \n",
       "\n",
       "   Completion Date    First Posted Results First Posted Last Update Posted  \\\n",
       "0    November 2023  March 19, 2019                  NaN    August 30, 2019   \n",
       "\n",
       "                                           Locations Study Documents  \\\n",
       "0  Beth Israel Deaconess Medical Center, Boston, ...             NaN   \n",
       "\n",
       "                                           URL  \n",
       "0  https://ClinicalTrials.gov/show/NCT03880240  \n",
       "\n",
       "[1 rows x 27 columns]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# load alzheimer dataset\n",
    "alzheimer = pd.read_csv('alzheimer.csv')\n",
    "alzheimer.head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Rank', 'NCT Number', 'Title', 'Acronym', 'Status', 'Study Results',\n",
       "       'Conditions', 'Interventions', 'Outcome Measures',\n",
       "       'Sponsor/Collaborators', 'Gender', 'Age', 'Phases', 'Enrollment',\n",
       "       'Funded Bys', 'Study Type', 'Study Designs', 'Other IDs', 'Start Date',\n",
       "       'Primary Completion Date', 'Completion Date', 'First Posted',\n",
       "       'Results First Posted', 'Last Update Posted', 'Locations',\n",
       "       'Study Documents', 'URL'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# show all columns\n",
    "alzheimer.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>URL</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03880240</td>\n",
       "      <td>Gamma Induction for Alzheimer's Disease</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Alzheimer Disease</td>\n",
       "      <td>All</td>\n",
       "      <td>45 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 1|Phase 2</td>\n",
       "      <td>55.0</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>August 5, 2019</td>\n",
       "      <td>November 2023</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03880240</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                    Title      Status  \\\n",
       "0  NCT03880240  Gamma Induction for Alzheimer's Disease  Recruiting   \n",
       "\n",
       "          Conditions Gender                                        Age  \\\n",
       "0  Alzheimer Disease    All  45 Years and older   (Adult, Older Adult)   \n",
       "\n",
       "            Phases  Enrollment      Study Type      Start Date  \\\n",
       "0  Phase 1|Phase 2        55.0  Interventional  August 5, 2019   \n",
       "\n",
       "  Completion Date                                          URL  \n",
       "0   November 2023  https://ClinicalTrials.gov/show/NCT03880240  "
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# clear not needed data\n",
    "del alzheimer['Rank']\n",
    "del alzheimer['Acronym']\n",
    "del alzheimer['Study Results']\n",
    "del alzheimer['Interventions']\n",
    "del alzheimer['Outcome Measures']\n",
    "del alzheimer['Sponsor/Collaborators']\n",
    "del alzheimer['Funded Bys']\n",
    "del alzheimer['Study Designs']\n",
    "del alzheimer['Other IDs']\n",
    "del alzheimer['Primary Completion Date']\n",
    "del alzheimer['First Posted']\n",
    "del alzheimer['Results First Posted']\n",
    "del alzheimer['Last Update Posted']\n",
    "del alzheimer['Locations']\n",
    "del alzheimer['Study Documents']\n",
    "\n",
    "alzheimer.head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['45 Years and older \\xa0 (Adult, Older Adult)',\n",
       "       '40 Years to 65 Years \\xa0 (Adult, Older Adult)',\n",
       "       '60 Years and older \\xa0 (Adult, Older Adult)',\n",
       "       '50 Years and older \\xa0 (Adult, Older Adult)',\n",
       "       '50 Years to 80 Years \\xa0 (Adult, Older Adult)',\n",
       "       'Child, Adult, Older Adult',\n",
       "       '65 Years and older \\xa0 (Older Adult)',\n",
       "       '55 Years to 90 Years \\xa0 (Adult, Older Adult)',\n",
       "       '50 Years to 85 Years \\xa0 (Adult, Older Adult)',\n",
       "       '40 Years to 64 Years \\xa0 (Adult)',\n",
       "       '40 Years to 80 Years \\xa0 (Adult, Older Adult)',\n",
       "       '20 Years and older \\xa0 (Adult, Older Adult)',\n",
       "       '45 Years to 90 Years \\xa0 (Adult, Older Adult)',\n",
       "       '40 Years and older \\xa0 (Adult, Older Adult)',\n",
       "       '18 Years and older \\xa0 (Adult, Older Adult)',\n",
       "       '55 Years to 85 Years \\xa0 (Adult, Older Adult)',\n",
       "       '50 Years to 90 Years \\xa0 (Adult, Older Adult)',\n",
       "       '50 Years to 95 Years \\xa0 (Adult, Older Adult)',\n",
       "       '60 Years to 75 Years \\xa0 (Adult, Older Adult)',\n",
       "       '50 Years to 75 Years \\xa0 (Adult, Older Adult)',\n",
       "       '45 Years to 85 Years \\xa0 (Adult, Older Adult)',\n",
       "       '50 Years to 89 Years \\xa0 (Adult, Older Adult)',\n",
       "       'up to 100 Years \\xa0 (Child, Adult, Older Adult)',\n",
       "       '55 Years to 75 Years \\xa0 (Adult, Older Adult)',\n",
       "       '50 Years to 100 Years \\xa0 (Adult, Older Adult)',\n",
       "       '55 Years to 80 Years \\xa0 (Adult, Older Adult)',\n",
       "       '50 Years to 82 Years \\xa0 (Adult, Older Adult)',\n",
       "       '50 Years to 86 Years \\xa0 (Adult, Older Adult)',\n",
       "       '45 Years to 65 Years \\xa0 (Adult, Older Adult)',\n",
       "       '60 Years to 95 Years \\xa0 (Adult, Older Adult)',\n",
       "       '60 Years to 85 Years \\xa0 (Adult, Older Adult)',\n",
       "       '55 Years and older \\xa0 (Adult, Older Adult)',\n",
       "       '21 Years and older \\xa0 (Adult, Older Adult)',\n",
       "       '51 Years and older \\xa0 (Adult, Older Adult)',\n",
       "       '18 Years to 80 Years \\xa0 (Adult, Older Adult)',\n",
       "       '60 Years to 90 Years \\xa0 (Adult, Older Adult)',\n",
       "       '18 Years to 95 Years \\xa0 (Adult, Older Adult)',\n",
       "       '65 Years to 90 Years \\xa0 (Older Adult)',\n",
       "       '18 Years to 100 Years \\xa0 (Adult, Older Adult)',\n",
       "       '57 Years to 87 Years \\xa0 (Adult, Older Adult)',\n",
       "       '55 Years to 84 Years \\xa0 (Adult, Older Adult)',\n",
       "       '45 Years to 75 Years \\xa0 (Adult, Older Adult)',\n",
       "       '18 Years to 85 Years \\xa0 (Adult, Older Adult)',\n",
       "       '55 Years to 95 Years \\xa0 (Adult, Older Adult)',\n",
       "       '18 Years to 60 Years \\xa0 (Adult)',\n",
       "       '50 Years to 120 Years \\xa0 (Adult, Older Adult)',\n",
       "       '55 Years to 79 Years \\xa0 (Adult, Older Adult)',\n",
       "       '63 Years to 84 Years \\xa0 (Adult, Older Adult)',\n",
       "       '45 Years to 79 Years \\xa0 (Adult, Older Adult)',\n",
       "       'up to 90 Years \\xa0 (Child, Adult, Older Adult)',\n",
       "       '60 Years to 80 Years \\xa0 (Adult, Older Adult)',\n",
       "       '20 Years to 92 Years \\xa0 (Adult, Older Adult)',\n",
       "       '55 Years to 89 Years \\xa0 (Adult, Older Adult)',\n",
       "       '40 Years to 85 Years \\xa0 (Adult, Older Adult)',\n",
       "       '40 Years to 90 Years \\xa0 (Adult, Older Adult)',\n",
       "       '50 Years to 74 Years \\xa0 (Adult, Older Adult)',\n",
       "       '51 Years to 85 Years \\xa0 (Adult, Older Adult)',\n",
       "       '45 Years to 78 Years \\xa0 (Adult, Older Adult)',\n",
       "       '59 Years to 92 Years \\xa0 (Adult, Older Adult)',\n",
       "       '30 Years to 60 Years \\xa0 (Adult)',\n",
       "       '70 Years and older \\xa0 (Older Adult)',\n",
       "       '20 Years to 80 Years \\xa0 (Adult, Older Adult)',\n",
       "       'up to 89 Years \\xa0 (Child, Adult, Older Adult)',\n",
       "       '65 Years to 75 Years \\xa0 (Older Adult)',\n",
       "       '65 Years to 85 Years \\xa0 (Older Adult)',\n",
       "       '30 Years and older \\xa0 (Adult, Older Adult)',\n",
       "       '20 Years to 90 Years \\xa0 (Adult, Older Adult)',\n",
       "       '25 Years and older \\xa0 (Adult, Older Adult)',\n",
       "       '25 Years to 75 Years \\xa0 (Adult, Older Adult)',\n",
       "       '18 Years to 90 Years \\xa0 (Adult, Older Adult)',\n",
       "       '65 Years to 87 Years \\xa0 (Older Adult)',\n",
       "       '35 Years and older \\xa0 (Adult, Older Adult)',\n",
       "       '50 Years to 79 Years \\xa0 (Adult, Older Adult)',\n",
       "       '62 Years to 85 Years \\xa0 (Adult, Older Adult)',\n",
       "       '50 Years to 65 Years \\xa0 (Adult, Older Adult)',\n",
       "       '52 Years to 87 Years \\xa0 (Adult, Older Adult)',\n",
       "       '51 Years to 90 Years \\xa0 (Adult, Older Adult)',\n",
       "       '45 Years to 91 Years \\xa0 (Adult, Older Adult)',\n",
       "       '50 Years to 88 Years \\xa0 (Adult, Older Adult)',\n",
       "       '60 Years to 99 Years \\xa0 (Adult, Older Adult)',\n",
       "       '63 Years and older \\xa0 (Adult, Older Adult)',\n",
       "       '21 Years to 90 Years \\xa0 (Adult, Older Adult)',\n",
       "       '56 Years and older \\xa0 (Adult, Older Adult)',\n",
       "       '55 Years to 70 Years \\xa0 (Adult, Older Adult)',\n",
       "       '65 Years to 100 Years \\xa0 (Older Adult)',\n",
       "       '66 Years and older \\xa0 (Older Adult)',\n",
       "       '65 Years to 95 Years \\xa0 (Older Adult)',\n",
       "       '21 Years to 85 Years \\xa0 (Adult, Older Adult)',\n",
       "       '75 Years and older \\xa0 (Older Adult)',\n",
       "       '30 Years to 90 Years \\xa0 (Adult, Older Adult)',\n",
       "       '38 Years to 96 Years \\xa0 (Adult, Older Adult)',\n",
       "       '40 Years to 95 Years \\xa0 (Adult, Older Adult)',\n",
       "       '45 Years to 80 Years \\xa0 (Adult, Older Adult)',\n",
       "       '70 Years to 85 Years \\xa0 (Older Adult)',\n",
       "       '70 Years to 90 Years \\xa0 (Older Adult)',\n",
       "       '65 Years to 83 Years \\xa0 (Older Adult)',\n",
       "       '70 Years to 78 Years \\xa0 (Older Adult)',\n",
       "       '18 Years to 75 Years \\xa0 (Adult, Older Adult)',\n",
       "       '40 Years to 72 Years \\xa0 (Adult, Older Adult)',\n",
       "       '30 Years to 85 Years \\xa0 (Adult, Older Adult)',\n",
       "       '20 Years to 85 Years \\xa0 (Adult, Older Adult)',\n",
       "       '58 Years to 70 Years \\xa0 (Adult, Older Adult)',\n",
       "       '55 Years to 91 Years \\xa0 (Adult, Older Adult)',\n",
       "       '45 Years to 64 Years \\xa0 (Adult)',\n",
       "       '18 Years to 45 Years \\xa0 (Adult)',\n",
       "       '22 Years and older \\xa0 (Adult, Older Adult)',\n",
       "       '18 Years to 70 Years \\xa0 (Adult, Older Adult)',\n",
       "       'up to 85 Years \\xa0 (Child, Adult, Older Adult)',\n",
       "       '51 Years to 91 Years \\xa0 (Adult, Older Adult)',\n",
       "       '66 Years to 90 Years \\xa0 (Older Adult)',\n",
       "       '40 Years to 60 Years \\xa0 (Adult)',\n",
       "       '40 Years to 83 Years \\xa0 (Adult, Older Adult)',\n",
       "       '18 Years to 105 Years \\xa0 (Adult, Older Adult)',\n",
       "       '35 Years to 69 Years \\xa0 (Adult, Older Adult)',\n",
       "       '25 Years to 65 Years \\xa0 (Adult, Older Adult)',\n",
       "       '40 Years to 70 Years \\xa0 (Adult, Older Adult)',\n",
       "       '60 Years to 100 Years \\xa0 (Adult, Older Adult)',\n",
       "       '65 Years to 80 Years \\xa0 (Older Adult)',\n",
       "       '18 Years to 55 Years \\xa0 (Adult)',\n",
       "       '21 Years to 80 Years \\xa0 (Adult, Older Adult)',\n",
       "       '19 Years to 55 Years \\xa0 (Adult)',\n",
       "       '50 Years to 99 Years \\xa0 (Adult, Older Adult)',\n",
       "       '65 Years to 89 Years \\xa0 (Older Adult)',\n",
       "       '18 Years to 65 Years \\xa0 (Adult, Older Adult)',\n",
       "       '55 Years to 65 Years \\xa0 (Adult, Older Adult)',\n",
       "       '30 Years to 55 Years \\xa0 (Adult)',\n",
       "       '65 Years to 99 Years \\xa0 (Older Adult)',\n",
       "       '80 Years to 90 Years \\xa0 (Older Adult)',\n",
       "       '50 Years to 72 Years \\xa0 (Adult, Older Adult)',\n",
       "       '18 Years to 50 Years \\xa0 (Adult)',\n",
       "       '18 Years to 40 Years \\xa0 (Adult)',\n",
       "       '60 Years to 79 Years \\xa0 (Adult, Older Adult)',\n",
       "       '18 Years to 109 Years \\xa0 (Adult, Older Adult)',\n",
       "       '25 Years to 90 Years \\xa0 (Adult, Older Adult)',\n",
       "       '56 Years to 90 Years \\xa0 (Adult, Older Adult)',\n",
       "       '19 Years to 50 Years \\xa0 (Adult)',\n",
       "       '50 Years to 84 Years \\xa0 (Adult, Older Adult)',\n",
       "       '20 Years to 45 Years \\xa0 (Adult)',\n",
       "       '60 Years to 89 Years \\xa0 (Adult, Older Adult)',\n",
       "       '21 Years to 50 Years \\xa0 (Adult)',\n",
       "       '45 Years to 89 Years \\xa0 (Adult, Older Adult)',\n",
       "       '30 Years to 49 Years \\xa0 (Adult)',\n",
       "       '50 Years to 70 Years \\xa0 (Adult, Older Adult)',\n",
       "       '18 Years to 79 Years \\xa0 (Adult, Older Adult)',\n",
       "       '20 Years to 70 Years \\xa0 (Adult, Older Adult)',\n",
       "       '20 Years to 65 Years \\xa0 (Adult, Older Adult)',\n",
       "       '35 Years to 65 Years \\xa0 (Adult, Older Adult)',\n",
       "       '20 Years to 60 Years \\xa0 (Adult)',\n",
       "       '59 Years and older \\xa0 (Adult, Older Adult)',\n",
       "       '40 Years to 75 Years \\xa0 (Adult, Older Adult)',\n",
       "       '21 Years to 30 Years \\xa0 (Adult)',\n",
       "       '75 Years to 120 Years \\xa0 (Older Adult)',\n",
       "       '65 Years to 79 Years \\xa0 (Older Adult)',\n",
       "       '59 Years to 93 Years \\xa0 (Adult, Older Adult)',\n",
       "       '9 Years and older \\xa0 (Child, Adult, Older Adult)',\n",
       "       '30 Years to 80 Years \\xa0 (Adult, Older Adult)',\n",
       "       '45 Years to 95 Years \\xa0 (Adult, Older Adult)',\n",
       "       '45 Years to 76 Years \\xa0 (Adult, Older Adult)',\n",
       "       '18 Years to 115 Years \\xa0 (Adult, Older Adult)',\n",
       "       '70 Years to 89 Years \\xa0 (Older Adult)',\n",
       "       '65 Years to 101 Years \\xa0 (Older Adult)',\n",
       "       '55 Years to 100 Years \\xa0 (Adult, Older Adult)',\n",
       "       '18 Years to 30 Years \\xa0 (Adult)',\n",
       "       '18 Years to 110 Years \\xa0 (Adult, Older Adult)',\n",
       "       '21 Years to 125 Years \\xa0 (Adult, Older Adult)',\n",
       "       '55 Years to 99 Years \\xa0 (Adult, Older Adult)',\n",
       "       '18 Years to 99 Years \\xa0 (Adult, Older Adult)',\n",
       "       '76 Years and older \\xa0 (Older Adult)',\n",
       "       '19 Years to 89 Years \\xa0 (Adult, Older Adult)',\n",
       "       '61 Years and older \\xa0 (Adult, Older Adult)',\n",
       "       '30 Years to 75 Years \\xa0 (Adult, Older Adult)',\n",
       "       '65 Years to 84 Years \\xa0 (Older Adult)',\n",
       "       '20 Years to 100 Years \\xa0 (Adult, Older Adult)',\n",
       "       '30 Years to 50 Years \\xa0 (Adult)',\n",
       "       'up to 69 Years \\xa0 (Child, Adult, Older Adult)',\n",
       "       '62 Years and older \\xa0 (Adult, Older Adult)',\n",
       "       '30 Years to 70 Years \\xa0 (Adult, Older Adult)',\n",
       "       '20 Years to 95 Years \\xa0 (Adult, Older Adult)',\n",
       "       '70 Years to 75 Years \\xa0 (Older Adult)',\n",
       "       '16 Years and older \\xa0 (Child, Adult, Older Adult)',\n",
       "       '14 Years and older \\xa0 (Child, Adult, Older Adult)',\n",
       "       '60 Years to 70 Years \\xa0 (Adult, Older Adult)',\n",
       "       '18 Years to 88 Years \\xa0 (Adult, Older Adult)',\n",
       "       '45 Years to 70 Years \\xa0 (Adult, Older Adult)',\n",
       "       '32 Years to 87 Years \\xa0 (Adult, Older Adult)',\n",
       "       '35 Years to 55 Years \\xa0 (Adult)',\n",
       "       '19 Years and older \\xa0 (Adult, Older Adult)',\n",
       "       '15 Years to 90 Years \\xa0 (Child, Adult, Older Adult)',\n",
       "       '30 Years to 100 Years \\xa0 (Adult, Older Adult)',\n",
       "       '18 Years to 118 Years \\xa0 (Adult, Older Adult)',\n",
       "       '32 Years to 60 Years \\xa0 (Adult)',\n",
       "       '21 Years to 100 Years \\xa0 (Adult, Older Adult)',\n",
       "       '20 Years to 40 Years \\xa0 (Adult)',\n",
       "       '10 Years and older \\xa0 (Child, Adult, Older Adult)',\n",
       "       '14 Years to 29 Years \\xa0 (Child, Adult)',\n",
       "       '70 Years to 79 Years \\xa0 (Older Adult)',\n",
       "       '55 Years to 74 Years \\xa0 (Adult, Older Adult)',\n",
       "       '17 Years to 66 Years \\xa0 (Child, Adult, Older Adult)',\n",
       "       '18 Years to 35 Years \\xa0 (Adult)',\n",
       "       '12 Years to 20 Years \\xa0 (Child, Adult)'], dtype=object)"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# show unique values in Age column\n",
    "alzheimer.Age.unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "50 Years and older           246\n",
       "18 Years and older           174\n",
       "50 Years to 85 Years         142\n",
       "Child, Adult, Older Adult    139\n",
       "65 Years and older           126\n",
       "60 Years and older           123\n",
       "55 Years and older           110\n",
       "50 Years to 90 Years          94\n",
       "55 Years to 85 Years          91\n",
       "55 Years to 90 Years          57\n",
       "50 Years to 80 Years          50\n",
       "60 Years to 85 Years          45\n",
       "18 Years to 55 Years          38\n",
       "21 Years and older            34\n",
       "60 Years to 90 Years          29\n",
       "60 Years to 80 Years          26\n",
       "45 Years and older            25\n",
       "40 Years and older            24\n",
       "18 Years to 85 Years          24\n",
       "50 Years to 89 Years          20\n",
       "55 Years to 80 Years          20\n",
       "18 Years to 90 Years          17\n",
       "55 Years to 75 Years          16\n",
       "20 Years and older            15\n",
       "40 Years to 85 Years          15\n",
       "55 Years to 95 Years          14\n",
       "65 Years to 85 Years          13\n",
       "65 Years to 90 Years          13\n",
       "18 Years to 45 Years          13\n",
       "50 Years to 95 Years          13\n",
       "                            ... \n",
       "45 Years to 89 Years           1\n",
       "51 Years to 85 Years           1\n",
       "62 Years and older             1\n",
       "65 Years to 79 Years           1\n",
       "65 Years to 87 Years           1\n",
       "60 Years to 70 Years           1\n",
       "56 Years and older             1\n",
       "50 Years to 72 Years           1\n",
       "70 Years to 78 Years           1\n",
       "21 Years to 80 Years           1\n",
       "35 Years to 65 Years           1\n",
       "9 Years and older              1\n",
       "21 Years to 100 Years          1\n",
       "25 Years to 75 Years           1\n",
       "70 Years to 75 Years           1\n",
       "22 Years and older             1\n",
       "30 Years to 70 Years           1\n",
       "18 Years to 109 Years          1\n",
       "18 Years to 88 Years           1\n",
       "20 Years to 92 Years           1\n",
       "52 Years to 87 Years           1\n",
       "61 Years and older             1\n",
       "25 Years to 65 Years           1\n",
       "45 Years to 91 Years           1\n",
       "70 Years to 79 Years           1\n",
       "20 Years to 40 Years           1\n",
       "50 Years to 120 Years          1\n",
       "up to 69 Years                 1\n",
       "20 Years to 95 Years           1\n",
       "12 Years to 20 Years           1\n",
       "Name: clean_age, Length: 200, dtype: int64"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# create column clean_age which contains a clean string of the min and max age of study subjects\n",
    "\n",
    "alzheimer['clean_age'] = alzheimer.Age.str.split('\\xa0').str[0]\n",
    "alzheimer['clean_age'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>URL</th>\n",
       "      <th>clean_age</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03880240</td>\n",
       "      <td>Gamma Induction for Alzheimer's Disease</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Alzheimer Disease</td>\n",
       "      <td>All</td>\n",
       "      <td>45 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 1|Phase 2</td>\n",
       "      <td>55.0</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>August 5, 2019</td>\n",
       "      <td>November 2023</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03880240</td>\n",
       "      <td>45 Years and older</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                    Title      Status  \\\n",
       "0  NCT03880240  Gamma Induction for Alzheimer's Disease  Recruiting   \n",
       "\n",
       "          Conditions Gender                                        Age  \\\n",
       "0  Alzheimer Disease    All  45 Years and older   (Adult, Older Adult)   \n",
       "\n",
       "            Phases  Enrollment      Study Type      Start Date  \\\n",
       "0  Phase 1|Phase 2        55.0  Interventional  August 5, 2019   \n",
       "\n",
       "  Completion Date                                          URL  \\\n",
       "0   November 2023  https://ClinicalTrials.gov/show/NCT03880240   \n",
       "\n",
       "             clean_age  \n",
       "0  45 Years and older   "
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "alzheimer.head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "# create Age groups to subset dataset\n",
    "# 1. up to 18\n",
    "# 2. 18 to 40\n",
    "# 3. 40 to 65\n",
    "# 4. 65 to 85\n",
    "# 5. 85 and older"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>URL</th>\n",
       "      <th>clean_age</th>\n",
       "      <th>min_age</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03880240</td>\n",
       "      <td>Gamma Induction for Alzheimer's Disease</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Alzheimer Disease</td>\n",
       "      <td>All</td>\n",
       "      <td>45 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 1|Phase 2</td>\n",
       "      <td>55.0</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>August 5, 2019</td>\n",
       "      <td>November 2023</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03880240</td>\n",
       "      <td>45 Years and older</td>\n",
       "      <td>45</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                    Title      Status  \\\n",
       "0  NCT03880240  Gamma Induction for Alzheimer's Disease  Recruiting   \n",
       "\n",
       "          Conditions Gender                                        Age  \\\n",
       "0  Alzheimer Disease    All  45 Years and older   (Adult, Older Adult)   \n",
       "\n",
       "            Phases  Enrollment      Study Type      Start Date  \\\n",
       "0  Phase 1|Phase 2        55.0  Interventional  August 5, 2019   \n",
       "\n",
       "  Completion Date                                          URL  \\\n",
       "0   November 2023  https://ClinicalTrials.gov/show/NCT03880240   \n",
       "\n",
       "             clean_age min_age  \n",
       "0  45 Years and older       45  "
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# parse the Age column to extract the min age of each study\n",
    "alzheimer['min_age'] = alzheimer['clean_age'].str[:2]\n",
    "alzheimer.head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "50    608\n",
       "18    340\n",
       "55    329\n",
       "60    246\n",
       "65    173\n",
       "Ch    139\n",
       "40     77\n",
       "45     74\n",
       "21     45\n",
       "20     44\n",
       "30     31\n",
       "70     20\n",
       "75     12\n",
       "35      9\n",
       "25      9\n",
       "up      9\n",
       "51      8\n",
       "59      4\n",
       "19      4\n",
       "66      2\n",
       "14      2\n",
       "32      2\n",
       "63      2\n",
       "56      2\n",
       "62      2\n",
       "57      1\n",
       "12      1\n",
       "38      1\n",
       "10      1\n",
       "52      1\n",
       "17      1\n",
       "16      1\n",
       "9       1\n",
       "76      1\n",
       "61      1\n",
       "80      1\n",
       "15      1\n",
       "22      1\n",
       "58      1\n",
       "Name: min_age, dtype: int64"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# count unique values and their quantities in min_age column\n",
    "alzheimer['min_age'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "# parse the min_age column to conver 'ch' and 'up' to NaN\n",
    "alzheimer['min_age'] = alzheimer.min_age.str.extract('(\\d+)')\n",
    "# print(age_starting)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "# replace 'Child, Adult, Older Adult' with 0 in min_age column (as they include all ages)\n",
    "alzheimer['min_age'].fillna(0, inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "NCT Number          object\n",
       "Title               object\n",
       "Status              object\n",
       "Conditions          object\n",
       "Gender              object\n",
       "Age                 object\n",
       "Phases              object\n",
       "Enrollment         float64\n",
       "Study Type          object\n",
       "Start Date          object\n",
       "Completion Date     object\n",
       "URL                 object\n",
       "clean_age           object\n",
       "min_age              int32\n",
       "dtype: object"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# convert min_age column to int32\n",
    "alzheimer['min_age'] = alzheimer['min_age'].astype('int32')\n",
    "alzheimer.dtypes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>URL</th>\n",
       "      <th>clean_age</th>\n",
       "      <th>min_age</th>\n",
       "      <th>age_groups</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03880240</td>\n",
       "      <td>Gamma Induction for Alzheimer's Disease</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Alzheimer Disease</td>\n",
       "      <td>All</td>\n",
       "      <td>45 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 1|Phase 2</td>\n",
       "      <td>55.0</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>August 5, 2019</td>\n",
       "      <td>November 2023</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03880240</td>\n",
       "      <td>45 Years and older</td>\n",
       "      <td>45</td>\n",
       "      <td>40 to 65 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03645993</td>\n",
       "      <td>Early Onset Alzheimer's Disease Genomic Study</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Alzheimer Disease</td>\n",
       "      <td>All</td>\n",
       "      <td>40 Years to 65 Years   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.0</td>\n",
       "      <td>Observational</td>\n",
       "      <td>June 16, 2017</td>\n",
       "      <td>June 16, 2022</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03645993</td>\n",
       "      <td>40 Years to 65 Years</td>\n",
       "      <td>40</td>\n",
       "      <td>18 to 40 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT03827733</td>\n",
       "      <td>Gut Microbiota and Alzheimer's Diseases</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Alzheimer Disease</td>\n",
       "      <td>All</td>\n",
       "      <td>60 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>200.0</td>\n",
       "      <td>Observational</td>\n",
       "      <td>February 1, 2018</td>\n",
       "      <td>December 31, 2020</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03827733</td>\n",
       "      <td>60 Years and older</td>\n",
       "      <td>60</td>\n",
       "      <td>40 to 65 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT03168997</td>\n",
       "      <td>Memantine Treatment in Alzheimer's Disease Pat...</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Alzheimer Disease</td>\n",
       "      <td>All</td>\n",
       "      <td>50 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>222.0</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>July 15, 2017</td>\n",
       "      <td>December 31, 2018</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03168997</td>\n",
       "      <td>50 Years and older</td>\n",
       "      <td>50</td>\n",
       "      <td>40 to 65 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT03522129</td>\n",
       "      <td>Study to Evaluate the Effect of CT1812 Treatme...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Alzheimer Disease</td>\n",
       "      <td>All</td>\n",
       "      <td>50 Years to 80 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>18.0</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>May 16, 2018</td>\n",
       "      <td>December 31, 2019</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03522129</td>\n",
       "      <td>50 Years to 80 Years</td>\n",
       "      <td>50</td>\n",
       "      <td>40 to 65 years old</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                              Title  \\\n",
       "0  NCT03880240            Gamma Induction for Alzheimer's Disease   \n",
       "1  NCT03645993      Early Onset Alzheimer's Disease Genomic Study   \n",
       "2  NCT03827733            Gut Microbiota and Alzheimer's Diseases   \n",
       "3  NCT03168997  Memantine Treatment in Alzheimer's Disease Pat...   \n",
       "4  NCT03522129  Study to Evaluate the Effect of CT1812 Treatme...   \n",
       "\n",
       "           Status         Conditions Gender  \\\n",
       "0      Recruiting  Alzheimer Disease    All   \n",
       "1      Recruiting  Alzheimer Disease    All   \n",
       "2      Recruiting  Alzheimer Disease    All   \n",
       "3  Unknown status  Alzheimer Disease    All   \n",
       "4      Recruiting  Alzheimer Disease    All   \n",
       "\n",
       "                                           Age           Phases  Enrollment  \\\n",
       "0    45 Years and older   (Adult, Older Adult)  Phase 1|Phase 2        55.0   \n",
       "1  40 Years to 65 Years   (Adult, Older Adult)              NaN         2.0   \n",
       "2    60 Years and older   (Adult, Older Adult)              NaN       200.0   \n",
       "3    50 Years and older   (Adult, Older Adult)          Phase 4       222.0   \n",
       "4  50 Years to 80 Years   (Adult, Older Adult)          Phase 1        18.0   \n",
       "\n",
       "       Study Type        Start Date    Completion Date  \\\n",
       "0  Interventional    August 5, 2019      November 2023   \n",
       "1   Observational     June 16, 2017      June 16, 2022   \n",
       "2   Observational  February 1, 2018  December 31, 2020   \n",
       "3  Interventional     July 15, 2017  December 31, 2018   \n",
       "4  Interventional      May 16, 2018  December 31, 2019   \n",
       "\n",
       "                                           URL              clean_age  \\\n",
       "0  https://ClinicalTrials.gov/show/NCT03880240    45 Years and older    \n",
       "1  https://ClinicalTrials.gov/show/NCT03645993  40 Years to 65 Years    \n",
       "2  https://ClinicalTrials.gov/show/NCT03827733    60 Years and older    \n",
       "3  https://ClinicalTrials.gov/show/NCT03168997    50 Years and older    \n",
       "4  https://ClinicalTrials.gov/show/NCT03522129  50 Years to 80 Years    \n",
       "\n",
       "   min_age          age_groups  \n",
       "0       45  40 to 65 years old  \n",
       "1       40  18 to 40 years old  \n",
       "2       60  40 to 65 years old  \n",
       "3       50  40 to 65 years old  \n",
       "4       50  40 to 65 years old  "
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# create new column and group ages in it\n",
    "conditions = [\n",
    "    (alzheimer['min_age'] <= 18) & (alzheimer['min_age'] >= 1 ),\n",
    "    (alzheimer['min_age'] > 18) & (alzheimer['min_age'] <= 40),\n",
    "    (alzheimer['min_age'] > 40) & (alzheimer['min_age'] <= 65),\n",
    "    (alzheimer['min_age'] > 65),\n",
    "    (alzheimer['min_age'] == 0)\n",
    "]\n",
    "     \n",
    "choices = ['up to 18 years old',\n",
    "          '18 to 40 years old',\n",
    "          '40 to 65 years old',\n",
    "          '65 and older',\n",
    "          'Age not specified']\n",
    "alzheimer['age_groups'] = np.select(conditions, choices)\n",
    "alzheimer.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "40 to 65 years old    1452\n",
       "up to 18 years old     348\n",
       "18 to 40 years old     223\n",
       "Age not specified      148\n",
       "65 and older            36\n",
       "Name: age_groups, dtype: int64"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# count unique values and their quantities in age_groups column\n",
    "alzheimer['age_groups'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Completed                  1145\n",
       "Recruiting                  436\n",
       "Unknown status              181\n",
       "Terminated                  165\n",
       "Not yet recruiting          107\n",
       "Active, not recruiting       95\n",
       "Enrolling by invitation      37\n",
       "Withdrawn                    33\n",
       "Suspended                     4\n",
       "No longer available           2\n",
       "Available                     2\n",
       "Name: Status, dtype: int64"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# count unique values and their quantities in Status column\n",
    "alzheimer['Status'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 2207 entries, 0 to 2206\n",
      "Data columns (total 15 columns):\n",
      "NCT Number         2207 non-null object\n",
      "Title              2207 non-null object\n",
      "Status             2207 non-null object\n",
      "Conditions         2207 non-null object\n",
      "Gender             2205 non-null object\n",
      "Age                2207 non-null object\n",
      "Phases             1824 non-null object\n",
      "Enrollment         2171 non-null float64\n",
      "Study Type         2207 non-null object\n",
      "Start Date         2176 non-null object\n",
      "Completion Date    2107 non-null object\n",
      "URL                2207 non-null object\n",
      "clean_age          2207 non-null object\n",
      "min_age            2207 non-null int32\n",
      "age_groups         2207 non-null object\n",
      "dtypes: float64(1), int32(1), object(13)\n",
      "memory usage: 250.1+ KB\n"
     ]
    }
   ],
   "source": [
    "alzheimer.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Gender               2\n",
       "Phases             383\n",
       "Enrollment          36\n",
       "Start Date          31\n",
       "Completion Date    100\n",
       "dtype: int64"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# check for NaN values\n",
    "null_columns = alzheimer.columns[alzheimer.isnull().any()]\n",
    "alzheimer[null_columns].isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>URL</th>\n",
       "      <th>clean_age</th>\n",
       "      <th>min_age</th>\n",
       "      <th>age_groups</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03880240</td>\n",
       "      <td>Gamma Induction for Alzheimer's Disease</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Alzheimer Disease</td>\n",
       "      <td>All</td>\n",
       "      <td>45 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 1|Phase 2</td>\n",
       "      <td>55.0</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>August 5, 2019</td>\n",
       "      <td>November 2023</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03880240</td>\n",
       "      <td>45 Years and older</td>\n",
       "      <td>45</td>\n",
       "      <td>40 to 65 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03645993</td>\n",
       "      <td>Early Onset Alzheimer's Disease Genomic Study</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Alzheimer Disease</td>\n",
       "      <td>All</td>\n",
       "      <td>40 Years to 65 Years   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.0</td>\n",
       "      <td>Observational</td>\n",
       "      <td>June 16, 2017</td>\n",
       "      <td>June 16, 2022</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03645993</td>\n",
       "      <td>40 Years to 65 Years</td>\n",
       "      <td>40</td>\n",
       "      <td>18 to 40 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT03827733</td>\n",
       "      <td>Gut Microbiota and Alzheimer's Diseases</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Alzheimer Disease</td>\n",
       "      <td>All</td>\n",
       "      <td>60 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>200.0</td>\n",
       "      <td>Observational</td>\n",
       "      <td>February 1, 2018</td>\n",
       "      <td>December 31, 2020</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03827733</td>\n",
       "      <td>60 Years and older</td>\n",
       "      <td>60</td>\n",
       "      <td>40 to 65 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT03168997</td>\n",
       "      <td>Memantine Treatment in Alzheimer's Disease Pat...</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Alzheimer Disease</td>\n",
       "      <td>All</td>\n",
       "      <td>50 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>222.0</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>July 15, 2017</td>\n",
       "      <td>December 31, 2018</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03168997</td>\n",
       "      <td>50 Years and older</td>\n",
       "      <td>50</td>\n",
       "      <td>40 to 65 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT03522129</td>\n",
       "      <td>Study to Evaluate the Effect of CT1812 Treatme...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Alzheimer Disease</td>\n",
       "      <td>All</td>\n",
       "      <td>50 Years to 80 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>18.0</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>May 16, 2018</td>\n",
       "      <td>December 31, 2019</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03522129</td>\n",
       "      <td>50 Years to 80 Years</td>\n",
       "      <td>50</td>\n",
       "      <td>40 to 65 years old</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                              Title  \\\n",
       "0  NCT03880240            Gamma Induction for Alzheimer's Disease   \n",
       "1  NCT03645993      Early Onset Alzheimer's Disease Genomic Study   \n",
       "2  NCT03827733            Gut Microbiota and Alzheimer's Diseases   \n",
       "3  NCT03168997  Memantine Treatment in Alzheimer's Disease Pat...   \n",
       "4  NCT03522129  Study to Evaluate the Effect of CT1812 Treatme...   \n",
       "\n",
       "           Status         Conditions Gender  \\\n",
       "0      Recruiting  Alzheimer Disease    All   \n",
       "1      Recruiting  Alzheimer Disease    All   \n",
       "2      Recruiting  Alzheimer Disease    All   \n",
       "3  Unknown status  Alzheimer Disease    All   \n",
       "4      Recruiting  Alzheimer Disease    All   \n",
       "\n",
       "                                           Age           Phases  Enrollment  \\\n",
       "0    45 Years and older   (Adult, Older Adult)  Phase 1|Phase 2        55.0   \n",
       "1  40 Years to 65 Years   (Adult, Older Adult)              NaN         2.0   \n",
       "2    60 Years and older   (Adult, Older Adult)              NaN       200.0   \n",
       "3    50 Years and older   (Adult, Older Adult)          Phase 4       222.0   \n",
       "4  50 Years to 80 Years   (Adult, Older Adult)          Phase 1        18.0   \n",
       "\n",
       "       Study Type        Start Date    Completion Date  \\\n",
       "0  Interventional    August 5, 2019      November 2023   \n",
       "1   Observational     June 16, 2017      June 16, 2022   \n",
       "2   Observational  February 1, 2018  December 31, 2020   \n",
       "3  Interventional     July 15, 2017  December 31, 2018   \n",
       "4  Interventional      May 16, 2018  December 31, 2019   \n",
       "\n",
       "                                           URL              clean_age  \\\n",
       "0  https://ClinicalTrials.gov/show/NCT03880240    45 Years and older    \n",
       "1  https://ClinicalTrials.gov/show/NCT03645993  40 Years to 65 Years    \n",
       "2  https://ClinicalTrials.gov/show/NCT03827733    60 Years and older    \n",
       "3  https://ClinicalTrials.gov/show/NCT03168997    50 Years and older    \n",
       "4  https://ClinicalTrials.gov/show/NCT03522129  50 Years to 80 Years    \n",
       "\n",
       "   min_age          age_groups  \n",
       "0       45  40 to 65 years old  \n",
       "1       40  18 to 40 years old  \n",
       "2       60  40 to 65 years old  \n",
       "3       50  40 to 65 years old  \n",
       "4       50  40 to 65 years old  "
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# remove rows with NaN in columns 'Enrollment', 'Gender'\n",
    "alzheimer = alzheimer.dropna(subset=['Enrollment', 'Gender'])\n",
    "alzheimer.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "NCT Number         object\n",
       "Title              object\n",
       "Status             object\n",
       "Conditions         object\n",
       "Gender             object\n",
       "Age                object\n",
       "Phases             object\n",
       "Enrollment          int32\n",
       "Study Type         object\n",
       "Start Date         object\n",
       "Completion Date    object\n",
       "URL                object\n",
       "clean_age          object\n",
       "min_age             int32\n",
       "age_groups         object\n",
       "dtype: object"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# convert Enrollment type to int32\n",
    "alzheimer['Enrollment'] = alzheimer['Enrollment'].astype('int32')\n",
    "alzheimer.dtypes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 720x720 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "# bar chart showing the enrollment for each age group\n",
    "plt.rcParams['figure.figsize'] = [10, 10]\n",
    "alzheimer = alzheimer.sort_values(['clean_age'],ascending=True)\n",
    "plt.bar( alzheimer['age_groups'], alzheimer['Enrollment'], align='center', color='silver' )\n",
    "\n",
    "plt.ylabel('Enrolled patients (total)')\n",
    "plt.xticks(rotation=90)\n",
    "plt.title('Enrollment per age group')\n",
    "\n",
    "# plt.savefig('enrollment_per_group')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.collections.PathCollection at 0x1225a8780>"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1440x1080 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "# scatter plot showing the enrollment and age groups\n",
    "plt.rcParams['figure.figsize'] = [20, 15]\n",
    "\n",
    "plt.scatter( alzheimer['age_groups'], alzheimer['Enrollment'], alpha=0.5 )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "374\n"
     ]
    }
   ],
   "source": [
    "# get the amount of Observational studies\n",
    "count_obs = len(alzheimer[alzheimer['Study Type'] == 'Observational'])\n",
    "print(count_obs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1795\n"
     ]
    }
   ],
   "source": [
    "# get the amount of Interventional studies\n",
    "count_int = len(alzheimer[alzheimer['Study Type'] == 'Interventional'])\n",
    "print(count_int)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 360x360 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# create a pie chart showing Observational vs Interventional (amount of studies):\n",
    "plt.rcParams['figure.figsize'] = [5, 5]\n",
    "\n",
    "# Data to plot\n",
    "labels = ['Interventional', 'Observational']\n",
    "sizes = [count_obs, count_int]\n",
    "colors = [color_int, color_obs]\n",
    "explode = (0, 0)\n",
    "\n",
    "# Plot\n",
    "plt.pie(sizes, explode=explode, labels=labels, autopct='%1.1f%%', colors=colors, startangle=90)\n",
    "\n",
    "\n",
    "plt.title('Amount of studies')\n",
    "\n",
    "# plt.savefig('pie_amount_of_studies')\n",
    "print('')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>URL</th>\n",
       "      <th>clean_age</th>\n",
       "      <th>min_age</th>\n",
       "      <th>age_groups</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2049</th>\n",
       "      <td>NCT00006176</td>\n",
       "      <td>Clinical and Genetic Studies of Familial Prese...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Familial Dementia With Neuroserpin Inclusion B...</td>\n",
       "      <td>All</td>\n",
       "      <td>10 Years and older   (Child, Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>100</td>\n",
       "      <td>Observational</td>\n",
       "      <td>August 10, 2000</td>\n",
       "      <td>August 4, 2009</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT00006176</td>\n",
       "      <td>10 Years and older</td>\n",
       "      <td>10</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2206</th>\n",
       "      <td>NCT01682915</td>\n",
       "      <td>Structural and Functional Connectivity of Fron...</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Attention Deficit/Hyperactivity Disorder</td>\n",
       "      <td>All</td>\n",
       "      <td>12 Years to 20 Years   (Child, Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>240</td>\n",
       "      <td>Observational</td>\n",
       "      <td>August 2012</td>\n",
       "      <td>July 2015</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01682915</td>\n",
       "      <td>12 Years to 20 Years</td>\n",
       "      <td>12</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1124</th>\n",
       "      <td>NCT01095744</td>\n",
       "      <td>Influence of Age on Amyloid Load in Alzheimer'...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Alzheimer's Disease|Posterior Cortical Atrophy...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>60</td>\n",
       "      <td>Observational</td>\n",
       "      <td>March 2009</td>\n",
       "      <td>May 2012</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01095744</td>\n",
       "      <td>18 Years and older</td>\n",
       "      <td>18</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1780</th>\n",
       "      <td>NCT02333942</td>\n",
       "      <td>Dementia Signal Development Study of Nautilus ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Alzheimer Disease|Mild Cognitive Impairment|Fr...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>41</td>\n",
       "      <td>Observational</td>\n",
       "      <td>May 2014</td>\n",
       "      <td>February 2015</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT02333942</td>\n",
       "      <td>18 Years and older</td>\n",
       "      <td>18</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1125</th>\n",
       "      <td>NCT03942341</td>\n",
       "      <td>Sleep in Adults With Down Syndrome and Alzheim...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Alzheimer's Disease|Obstructive Sleep Apnea|Sl...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>90</td>\n",
       "      <td>Observational</td>\n",
       "      <td>May 8, 2019</td>\n",
       "      <td>December 2020</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03942341</td>\n",
       "      <td>18 Years and older</td>\n",
       "      <td>18</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       NCT Number                                              Title  \\\n",
       "2049  NCT00006176  Clinical and Genetic Studies of Familial Prese...   \n",
       "2206  NCT01682915  Structural and Functional Connectivity of Fron...   \n",
       "1124  NCT01095744  Influence of Age on Amyloid Load in Alzheimer'...   \n",
       "1780  NCT02333942  Dementia Signal Development Study of Nautilus ...   \n",
       "1125  NCT03942341  Sleep in Adults With Down Syndrome and Alzheim...   \n",
       "\n",
       "              Status                                         Conditions  \\\n",
       "2049       Completed  Familial Dementia With Neuroserpin Inclusion B...   \n",
       "2206  Unknown status           Attention Deficit/Hyperactivity Disorder   \n",
       "1124       Completed  Alzheimer's Disease|Posterior Cortical Atrophy...   \n",
       "1780       Completed  Alzheimer Disease|Mild Cognitive Impairment|Fr...   \n",
       "1125      Recruiting  Alzheimer's Disease|Obstructive Sleep Apnea|Sl...   \n",
       "\n",
       "     Gender                                               Age Phases  \\\n",
       "2049    All  10 Years and older   (Child, Adult, Older Adult)    NaN   \n",
       "2206    All             12 Years to 20 Years   (Child, Adult)    NaN   \n",
       "1124    All         18 Years and older   (Adult, Older Adult)    NaN   \n",
       "1780    All         18 Years and older   (Adult, Older Adult)    NaN   \n",
       "1125    All         18 Years and older   (Adult, Older Adult)    NaN   \n",
       "\n",
       "      Enrollment     Study Type       Start Date Completion Date  \\\n",
       "2049         100  Observational  August 10, 2000  August 4, 2009   \n",
       "2206         240  Observational      August 2012       July 2015   \n",
       "1124          60  Observational       March 2009        May 2012   \n",
       "1780          41  Observational         May 2014   February 2015   \n",
       "1125          90  Observational      May 8, 2019   December 2020   \n",
       "\n",
       "                                              URL              clean_age  \\\n",
       "2049  https://ClinicalTrials.gov/show/NCT00006176    10 Years and older    \n",
       "2206  https://ClinicalTrials.gov/show/NCT01682915  12 Years to 20 Years    \n",
       "1124  https://ClinicalTrials.gov/show/NCT01095744    18 Years and older    \n",
       "1780  https://ClinicalTrials.gov/show/NCT02333942    18 Years and older    \n",
       "1125  https://ClinicalTrials.gov/show/NCT03942341    18 Years and older    \n",
       "\n",
       "      min_age          age_groups  \n",
       "2049       10  up to 18 years old  \n",
       "2206       12  up to 18 years old  \n",
       "1124       18  up to 18 years old  \n",
       "1780       18  up to 18 years old  \n",
       "1125       18  up to 18 years old  "
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# subset observational studies only\n",
    "observational = alzheimer.loc[alzheimer['Study Type'] == 'Observational']\n",
    "observational.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2340160\n"
     ]
    }
   ],
   "source": [
    "# calculate total amount of subjects enrolled in observational studies\n",
    "total_obs = observational['Enrollment'].sum()\n",
    "print(total_obs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>URL</th>\n",
       "      <th>clean_age</th>\n",
       "      <th>min_age</th>\n",
       "      <th>age_groups</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1845</th>\n",
       "      <td>NCT03149380</td>\n",
       "      <td>Effectiveness of Alzheimer's Universe (Www.Alz...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Alzheimer Disease|Alzheimer Disease, Late Onse...</td>\n",
       "      <td>All</td>\n",
       "      <td>14 Years and older   (Child, Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>10000</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>January 2017</td>\n",
       "      <td>October 2024</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03149380</td>\n",
       "      <td>14 Years and older</td>\n",
       "      <td>14</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2065</th>\n",
       "      <td>NCT01699711</td>\n",
       "      <td>Normalization of dyrk1A and APP Function as an...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Down Syndrome (DS)</td>\n",
       "      <td>All</td>\n",
       "      <td>14 Years to 29 Years   (Child, Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>87</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>February 2012</td>\n",
       "      <td>March 2015</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01699711</td>\n",
       "      <td>14 Years to 29 Years</td>\n",
       "      <td>14</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1937</th>\n",
       "      <td>NCT01476228</td>\n",
       "      <td>EEG Objectification in Neuropsychiatry</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Personality Disorder|Depression|Neurodegenerat...</td>\n",
       "      <td>All</td>\n",
       "      <td>15 Years to 90 Years   (Child, Adult, Older Ad...</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>100</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>November 2011</td>\n",
       "      <td>December 2015</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01476228</td>\n",
       "      <td>15 Years to 90 Years</td>\n",
       "      <td>15</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1843</th>\n",
       "      <td>NCT00165100</td>\n",
       "      <td>Dynamic Area Telethermometry (DAT) as an Imagi...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Malignant Tumors|Subcutaneous Tumors|Lymph Nod...</td>\n",
       "      <td>All</td>\n",
       "      <td>16 Years and older   (Child, Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>50</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>January 2000</td>\n",
       "      <td>October 2002</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT00165100</td>\n",
       "      <td>16 Years and older</td>\n",
       "      <td>16</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2152</th>\n",
       "      <td>NCT00978536</td>\n",
       "      <td>A Monocenter, Cross-sectional Study to Compare...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Disseminated Sclerosis</td>\n",
       "      <td>All</td>\n",
       "      <td>17 Years to 66 Years   (Child, Adult, Older Ad...</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>29</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>February 2009</td>\n",
       "      <td>November 2011</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT00978536</td>\n",
       "      <td>17 Years to 66 Years</td>\n",
       "      <td>17</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       NCT Number                                              Title  \\\n",
       "1845  NCT03149380  Effectiveness of Alzheimer's Universe (Www.Alz...   \n",
       "2065  NCT01699711  Normalization of dyrk1A and APP Function as an...   \n",
       "1937  NCT01476228             EEG Objectification in Neuropsychiatry   \n",
       "1843  NCT00165100  Dynamic Area Telethermometry (DAT) as an Imagi...   \n",
       "2152  NCT00978536  A Monocenter, Cross-sectional Study to Compare...   \n",
       "\n",
       "              Status                                         Conditions  \\\n",
       "1845      Recruiting  Alzheimer Disease|Alzheimer Disease, Late Onse...   \n",
       "2065       Completed                                 Down Syndrome (DS)   \n",
       "1937  Unknown status  Personality Disorder|Depression|Neurodegenerat...   \n",
       "1843       Completed  Malignant Tumors|Subcutaneous Tumors|Lymph Nod...   \n",
       "2152      Terminated                             Disseminated Sclerosis   \n",
       "\n",
       "     Gender                                                Age  \\\n",
       "1845    All   14 Years and older   (Child, Adult, Older Adult)   \n",
       "2065    All              14 Years to 29 Years   (Child, Adult)   \n",
       "1937    All  15 Years to 90 Years   (Child, Adult, Older Ad...   \n",
       "1843    All   16 Years and older   (Child, Adult, Older Adult)   \n",
       "2152    All  17 Years to 66 Years   (Child, Adult, Older Ad...   \n",
       "\n",
       "              Phases  Enrollment      Study Type     Start Date  \\\n",
       "1845  Not Applicable       10000  Interventional   January 2017   \n",
       "2065         Phase 2          87  Interventional  February 2012   \n",
       "1937  Not Applicable         100  Interventional  November 2011   \n",
       "1843  Not Applicable          50  Interventional   January 2000   \n",
       "2152  Not Applicable          29  Interventional  February 2009   \n",
       "\n",
       "     Completion Date                                          URL  \\\n",
       "1845    October 2024  https://ClinicalTrials.gov/show/NCT03149380   \n",
       "2065      March 2015  https://ClinicalTrials.gov/show/NCT01699711   \n",
       "1937   December 2015  https://ClinicalTrials.gov/show/NCT01476228   \n",
       "1843    October 2002  https://ClinicalTrials.gov/show/NCT00165100   \n",
       "2152   November 2011  https://ClinicalTrials.gov/show/NCT00978536   \n",
       "\n",
       "                  clean_age  min_age          age_groups  \n",
       "1845    14 Years and older        14  up to 18 years old  \n",
       "2065  14 Years to 29 Years        14  up to 18 years old  \n",
       "1937  15 Years to 90 Years        15  up to 18 years old  \n",
       "1843    16 Years and older        16  up to 18 years old  \n",
       "2152  17 Years to 66 Years        17  up to 18 years old  "
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# subset interventional studies only\n",
    "interventional = alzheimer[alzheimer['Study Type'] == 'Interventional']\n",
    "interventional.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "622980\n"
     ]
    }
   ],
   "source": [
    "# calculate total amount of subjects enrolled in interventional studies\n",
    "total_int = interventional['Enrollment'].sum()\n",
    "print(total_int)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 360x360 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# create a pie chart showing Observational vs Interventional (amount of patients enrolled):\n",
    "plt.rcParams['figure.figsize'] = [5, 5]\n",
    "\n",
    "# Data to plot\n",
    "labels = ['Interventional', 'Observational']\n",
    "sizes = [total_obs, total_int]\n",
    "colors = [color_int, color_obs]\n",
    "explode = (0, 0)\n",
    "\n",
    "# Plot\n",
    "plt.pie(sizes, explode=explode, labels=labels, autopct='%1.1f%%', colors=colors, startangle=90)\n",
    "\n",
    "plt.title('Patients Enrolled')\n",
    "\n",
    "# plt.savefig('pie_patients_enrolled')\n",
    "print('')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.legend.Legend at 0x124666a58>"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAABN8AAANOCAYAAAAh8qrVAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjAsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+17YcXAAAgAElEQVR4nOzde5iddX3v/c+XHIgKwYJSoYihVA7RQIBplBALFMETRXYEolI10v2wtUXcPqJ4Kihqt6daan2qpa0gSiVC0aJtbYRyMIBiApFgBDw0VApPOWkCIkkGf/uPtRKGOEkmITeThNfruuaae/3u02+tCc41b+97rWqtBQAAAADY9LYZ7QkAAAAAwNZKfAMAAACAjohvAAAAANAR8Q0AAAAAOiK+AQAAAEBHxo72BHhiPeMZz2iTJk0a7WkAAAAAbDUWLFhwb2vtmcOtE9+eZCZNmpT58+eP9jQAAAAAthpVdfva1rntFAAAAAA6Ir4BAAAAQEfENwAAAADoiPd8AwAAANgMrFy5MnfccUcefvjh0Z4KazFhwoTstttuGTdu3Ij3Ed8AAAAANgN33HFHtt9++0yaNClVNdrTYQ2ttdx333254447sscee4x4P7edAgAAAGwGHn744ey0007C22aqqrLTTjtt8JWJ4hsAAADAZkJ427xtzM9HfAMAAACAjohvAAAAACRJtttuu/Vuc/bZZ+ehhx56AmYzvIULF+Zf/uVfVj++9NJL85GPfGSTn2ckr8VIiG8AAAAAjNjGxLdHHnlkk51/zfh2zDHH5F3vetcmO/6mJr4BAAAAbImuvy553zuSPz6p9/366zbZoa+88socdthhOe6447LPPvvkxBNPTGstn/rUp3LnnXfm8MMPz+GHH54kmTt3bg4++OAceOCBOf744/Pggw8mSSZNmpSzzjorM2bMyMc+9rFMmzZt9fGXLFmS/fbbL0myYMGCHHrooTnooIPykpe8JHfddVeS5LDDDsvpp5+eadOmZa+99sq3vvWtrFixImeccUbmzJmTqVOnZs6cOTnvvPNyyimnJEluv/32HHHEEdlvv/1yxBFH5D//8z+TJLNnz86pp56a6dOn57d/+7dz8cUXJ0kefPDBHHHEETnwwAMzZcqU/NM//dMmew1XEd8AAAAAtjTXX5f8w+eT++/rPb7/vt7jTRjgbrzxxpx99tlZvHhxfvKTn+Saa67Jqaeeml133TVXXHFFrrjiitx777350Ic+lMsuuyw33HBDBgYG8slPfnL1MSZMmJB58+bl3e9+d1asWJGf/OQnSZI5c+bkhBNOyMqVK/OWt7wlF198cRYsWJCTTjop733ve1fvPzg4mOuvvz5nn312PvCBD2T8+PE566yzMmvWrCxcuDCzZs16zJxPOeWUvP71r89NN92UE088MaeeeurqdXfddVfmzZuXr3/966uvlJswYUK+8pWv5IYbbsgVV1yRt7/97WmtbbLXMEnGbtKjAQAAANC9Sy9JVqx47NiKFb3xaQdvklNMmzYtu+22W5Jk6tSpWbJkSWbMmPGYbb797W9n8eLFOeSQQ/pTWJGDD370/EPj2AknnJAvf/nLede73pU5c+Zkzpw5ufXWW3PzzTfnyCOPTNK7PXWXXXZZvc/MmTOTJAcddFCWLFmy3jlfd911ueSSS5Ikr3vd6/LOd75z9bpjjz0222yzTSZPnpz//u//TpK01vKe97wnV199dbbZZpv813/9V/77v/87z3rWs0b8Oq2P+AYAAACwpVl1xdtIxzfCtttuu3p5zJgxGRwc/LVtWms58sgj86UvfWnYYzztaU9bvTxr1qwcf/zxmTlzZqoqz33uc7No0aI873nPy3XXDX/F3qo5rO3861NVwz6fVVe3XXDBBbnnnnuyYMGCjBs3LpMmTcrDDz+8wedZF7edAgAAAGxpdtxpw8Y3oe233z4PPPBAkuSFL3xhrrnmmvzoRz9Kkjz00EO57bbbht1vzz33zJgxY/LBD35w9RVxe++9d+65557V8W3lypX5/ve/P+Lzr2n69Om58MILk/TC2ppX6q1p6dKl2XnnnTNu3LhcccUVuf3229e5/cYQ3wAAAAC2NMfMTMaPf+zY+PG98Y6dfPLJednLXpbDDz88z3zmM3PeeeflNa95Tfbbb7+88IUvzC233LLWfWfNmpUvfvGLOeGEE/pTHp+LL744p59+evbff/9MnTo111577TrPf/jhh2fx4sWrP3BhqE996lM599xzs99+++ULX/hC/vIv/3KdxzrxxBMzf/78DAwM5IILLsg+++wzwldh5GpTv4kcm7eBgYE2f/780Z4GAAAAsIYf/OAH2XfffUe+w/XX9d7j7f77ele8HTNzk73fG2s33M+pqha01gaG2957vgEAAABsiaYdLLZtAdx2CgAAAAAdEd8AAAAAoCPiGwAAAAB0RHwDAAAAgI6IbwAAAADQEfENAAAAgCTJHXfckVe+8pV57nOfmz333DNvfetbs2LFipx33nk55ZRTRnt6+epXv5rFixevfnzGGWfksssu26TnuPLKK3P00UdvsuOJbwAAAACktZaZM2fm2GOPzQ9/+MPcdtttefDBB/Pe9763k/MNDg5u8D5rxrezzjorL37xizfltDY58Q0AAABgC7R46Yqc88MH84kfPJBzfvhgFi9d8biO9+///u+ZMGFC3vjGNyZJxowZk7/4i7/I5z73uTz00EP56U9/mpe+9KXZe++984EPfCBJ8otf/CKveMUrsv/+++f5z39+5syZkyRZsGBBDj300Bx00EF5yUtekrvuuitJcthhh+U973lPDj300Hz4wx/OpEmT8qtf/SpJ8tBDD+XZz352Vq5cmb/927/N7/7u72b//ffPq171qjz00EO59tprc+mll+Yd73hHpk6dmh//+MeZPXt2Lr744iTJ5ZdfngMOOCBTpkzJSSedlOXLlydJJk2alDPPPDMHHnhgpkyZkltuuSVJcv3112f69Ok54IADMn369Nx6662P6/VbG/ENAAAAYAuzeOmKzL1reZYNtiTJssGWuXctf1wB7vvf/34OOuigx4xNnDgxu+++ewYHB3P99dfnggsuyMKFC3PRRRdl/vz5+cY3vpFdd9013/ve93LzzTfnpS99aVauXJm3vOUtufjii7NgwYKcdNJJj7l67uc//3muuuqqnHnmmdl///1z1VVXJUm+9rWv5SUveUnGjRuXmTNn5rvf/W6+973vZd99983f//3fZ/r06TnmmGPy8Y9/PAsXLsyee+65+pgPP/xwZs+enTlz5mTRokUZHBzMZz7zmdXrn/GMZ+SGG27Im9/85nziE59Ikuyzzz65+uqrc+ONN+ass87Ke97zno1+7dZFfAMAAADYwsy7e0X63W21wdYb31ittVTVWsePPPLI7LTTTnnKU56SmTNnZt68eZkyZUouu+yynH766fnWt76VHXbYIbfeemtuvvnmHHnkkZk6dWo+9KEP5Y477lh9vFmzZj1medXVchdeeOHqdTfffHNe9KIXZcqUKbngggvy/e9/f51zv/XWW7PHHntkr732SpK84Q1vyNVXX716/cyZM5MkBx10UJYsWZIkWbp0aY4//vg8//nPz9ve9rb1nmNjiW8AAAAAW5hla5a39YyPxPOe97zMnz//scdbtiw//elPM2bMmF8Lc1WVvfbaKwsWLMiUKVPy7ne/O2eddVZaa3ne856XhQsXZuHChVm0aFHmzp27er+nPe1pq5ePOeaY/Ou//mvuv//+LFiwIL//+7+fJJk9e3Y+/elPZ9GiRTnzzDPz8MMPr3Pura37eW+77bZJerfSrnqvuT/90z/N4Ycfnptvvjlf+9rX1nuOjSW+AQAAAGxhJo799SvU1jU+EkcccUQeeuihnH/++UmSRx55JG9/+9sze/bsPPWpT803v/nN3H///fnlL3+Zr371qznkkENy55135qlPfWr+8A//MKeddlpuuOGG7L333rnnnnty3XXXJUlWrly51qvKtttuu0ybNi1vfetbc/TRR2fMmDFJkgceeCC77LJLVq5cmQsuuGD19ttvv30eeOCBXzvOPvvskyVLluRHP/pRkuQLX/hCDj300HU+36VLl+a3fuu3kiTnnXfehr1YG0B8AwAAANjCzNh5fNbsbGOrN76xqipf+cpXctFFF+W5z31u9tprr0yYMCF/9md/1jvnjBl53etel6lTp+ZVr3pVBgYGsmjRokybNi1Tp07Nhz/84bzvfe/L+PHjc/HFF+f000/P/vvvn6lTp+baa69d63lnzZqVL37xi4+5HfWDH/xgXvCCF+TII4/MPvvss3r81a9+dT7+8Y/ngAMOyI9//OPV4xMmTMi5556b448/PlOmTMk222yTN73pTet8vu985zvz7ne/O4ccckgeeeSRjX3Z1qvWd1keW5eBgYG25iWkAAAAwOj7wQ9+kH333XfE2y9euiLz7l6RZYMtE8dWZuw8PpN32Pj4xsgM93OqqgWttYHhth/7hMwKAAAAgE1q8g5i25bgSR3fquq9SV6b5JEkv0ryv1pr3xndWfVU1ZIkA621e0e4/ez+9qd0Oa/NxlnvS/7/Ox99/KxdkzM+NHrzAQAAABjGk/Y936rq4CRHJzmwtbZfkhcn+enozooRWTO8Jb3HZ71vdOYDAAAAm4i3B9u8bczP50kb35LskuTe1tryJGmt3dtau7OqllTVM5Kkqgaq6sr+8qFVtbD/dWNVbV9Vh1XV1VX1lapaXFWfrapt+tsfVVXXVdUNVXVRVW3XH19SVR/ojy+qqn364ztV1dz+sf8myeq3TayqP6yq6/vn/puqGtMff2NV3VZVVyU55Il76UbZmuFtfeMAAACwBZgwYULuu+8+AW4z1VrLfffdlwkTJmzQfk/m207nJjmjqm5LclmSOa21q9ax/WlJ/qS1dk0/pD3cH5+WZHKS25N8I8nMfrB7X5IXt9Z+UVWnJ/l/k5zV3+fe1tqBVfXH/eP+zyRnJpnXWjurql6R5OQkqap9k8xKckhrbWVV/XWSE6vqm0k+kOSgJEuTXJHkxuEmXlUnrzre7rvvvkEvEgAAAPDE2G233XLHHXfknnvuGe2psBYTJkzIbrvttkH7PGnjW2vtwao6KMmLkhyeZE5VvWsdu1yT5JNVdUGSS1prd1RVklzfWvtJklTVl5LMSC/MTU5yTX+b8UmuG3KsS/rfFySZ2V/+vVXLrbV/rqqf9cePSC+wfbd/rKckuTvJC5Jc2Vq7p3/uOUn2WstzPSfJOUnv007X/coAAAAAo2HcuHHZY489RnsabGJP2viWJK21R5JcmeTKqlqU5A1JBvPo7bgThmz7kar65yQvT/LtqnrxqlVrHja9W0a/2Vp7zVpOvbz//ZE89mcwXBirJJ9vrb37MYNVx65l+63fs3Yd/hbTZ+36xM8FAAAAYB2etO/5VlV7V9VzhwxNTe/W0SXpXWmWJK8asv2erbVFrbWPJpmfZJ/+qmlVtUf/vd5mJZmX5NtJDqmq3+nv+9SqGvaqtCGuTnJif/uXJfmN/vjlSY6rqp3763asquck+U6Sw/rvFTcuyfEb/CJsqc740K+HNp92CgAAAGyGnsxXvm2X5K+q6unpXe32o/TeF23fJH9fVe9JL3Ct8r+r6vD0rlZbnORfkxyc3u2kH0kyJb2A9pXW2q+qanaSL1XVtv3935fktnXM5wP97W9IclWS/0yS1triqnpfkrn9wLcyvfee+3ZVvb9//ruS3JBkzON4PbYsQhsAAACwBSifoLHxquqwJKe11o4e7bmM1MDAQJs/f/5oTwMAAABgq1FVC1prA8Ote9LedgoAAAAAXXsy33b6uLXWrkzvAxsAAAAA4Ne48g0AAAAAOiK+AQAAAEBHxDcAAAAA6Ij4BgAAAAAdEd8AAAAAoCPiGwAAAAB0RHwDAAAAgI6IbwAAAADQEfENAAAAADoivgEAAABAR8Q3AAAAAOiI+AYAAAAAHRHfAAAAAKAj4hsAAAAAdER8AwAAAICOiG8AAAAA0BHxDQAAAAA6Ir4BAAAAQEfENwAAAADoiPgGAAAAAB0R3wAAAACgI+IbAAAAAHREfAMAAACAjohvAAAAANAR8Q0AAAAAOiK+AQAAAEBHxDcAAAAA6Ij4BgAAAAAdEd8AAAAAoCPiGwAAAAB0RHwDAAAAgI6IbwAAAADQEfENAAAAADoivgEAAABAR8Q3AAAAAOiI+AYAAAAAHRHfAAAAAKAj4hsAAAAAdER8AwAAAICOiG8AAAAA0BHxDQAAAAA6Ir4BAAAAQEfENwAAAADoiPgGAAAAAB0R3wAAAACgI+IbAAAAAHREfAMAAACAjohvAAAAANAR8Q0AAAAAOiK+AQAAAEBHxDcAAAAA6Ij4BgAAAAAdEd8AAAAAoCPiGwAAAAB0RHwDAAAAgI6IbwAAAADQEfENAAAAADoivgEAAABAR8Q3AAAAAOiI+AYAAAAAHRHfAAAAAKAj4hsAAAAAdER8AwAAAICOiG8AAAAA0BHxDQAAAAA6Ir4BAAAAQEfENwAAAADoiPgGAAAAAB0R3wAAAACgI+IbAAAAAHREfAMAAACAjohvAAAAANAR8Q0AAAAAOiK+AQAAAEBHxDcAAAAA6Ij4BgAAAAAdEd8AAAAAoCPiGwAAAAB0RHwDAAAAgI6IbwAAAADQEfENAAAAADoydrQnMJqq6i+S3N5aO7v/+N+S/LS19j/7j/88yX1JDmytHVdVU5Ps2lr7l/769yd5sLX2ifWcZ0TbMXKfu/qW3P+MXVc/3vHeO3PS7+0zijMCAAAA+HVP9ivfrk0yPUmqapskz0jyvCHrpye5vLV2XP/x1CQv31Qnr6ondfzcWKvDW9Xqr/ufsWs+d/Utoz01AAAAgMd4sse3a9KPb+lFt5uTPFBVv1FV2ybZN8nPqurmqhqf5Kwks6pqYVXN6u83uaqurKqfVNWpqw5cVe+tqlur6rIkew8Zv7Kq/qyqrkry1qr6g6r6TlXdWFWXVdVv9rdbVFVPr577qur1/fEvVNWLq2p2VV1SVd+oqh9W1cc6fq02G6vD21D9AAcAAACwOXlSx7fW2p1JBqtq9/Qi3HVJvpPk4CQDSW5KsqK/7YokZySZ01qb2lqb0z/MPklekmRakjOralxVHZTk1UkOSDIzye+uceqnt9YOba39eZJ5SV7YWjsgyYVJ3tnf5pokh6QXBX+S5EX98Rcm+XZ/eWqSWUmmpBcFnz3c86yqk6tqflXNv+eeezb0ZQIAAABgI7nt8dGr36Yn+WSS3+ovL03vttT1+efW2vIky6vq7iS/mV4o+0pr7aEkqapL19hnzpDl3ZLMqapdkoxP8h/98W8l+b0ktyf5TJKTq+q3ktzfWnuweld+Xd5aW9o/x+Ikz0ny0zUn2Fo7J8k5STIwMNBG8JwAAAAA2ASe1Fe+9a1637cp6d12+u30rnybnl6YW5/lQ5YfyaNBc12R6xdDlv8qyadba1OS/K8kE/rjV6cX8V6U5Mok9yQ5Lr0ot75zb9V2vPfOpK3x8rbWGwcAAADYjIhvvcB2dHpXlD3SWrs/ydPTC3DXrbHtA0m2H8Exr07yP6rqKVW1fZI/WMe2OyT5r/7yG1YNttZ+mt4HQDy3tfaT9G5PPS2PjW9PSif93j6PBrj+l087BQAAADZHT4orpdZjUXqR6x/WGNuutXZvVW03ZPyKJO+qqoVJ/s/aDthau6Gq5iRZmN5to+sKZu9PclFV/Vd6V93tMWTdd5KM6S9/q3/OeSN5Ulu7Xw9tE0dlHgAAAADrUm3N2/fYqg0MDLT58+eP9jQAAAAAthpVtaC1NjDcOredAgAAAEBHxDcAAAAA6Ij4BgAAAAAdEd8AAAAAoCPiGwAAAAB0RHwDAAAAgI6IbwAAAADQEfENAAAAADoivgEAAABAR8Q3AAAAAOiI+AYAAAAAHRHfAAAAAKAj4hsAAAAAdER8AwAAAICOiG8AAAAA0BHxDQAAAAA6Ir4BAAAAQEfENwAAAADoiPgGAAAAAB0R3wAAAACgI+IbAAAAAHREfAMAAACAjohvAAAAANAR8Q0AAAAAOiK+AQAAAEBHxDcAAAAA6Ij4BgAAAAAdEd8AAAAAoCPiGwAAAAB0RHwDAAAAgI6IbwAAAADQEfENAAAAADoivgEAAABAR8Q3AAAAAOiI+AYAAAAAHRHfAAAAAKAj4hsAAAAAdER8AwAAAICOiG8AAAAA0BHxDQAAAAA6Ir4BAAAAQEfENwAAAADoiPgGAAAAAB0R3wAAAACgI+IbAAAAAHREfAMAAACAjohvAAAAANAR8Q0AAAAAOiK+AQAAAEBHxDcAAAAA6Ij4BgAAAAAdEd8AAAAAoCPiGwAAAAB0RHwDAAAAgI6IbwAAAADQEfENAAAAADoivgEAAABAR8Q3AAAAAOiI+AYAAAAAHRHfAAAAAKAj4hsAAAAAdER8AwAAAICOiG8AAAAA0BHxDQAAAAA6Ir4BAAAAQEfENwAAAADoiPgGAAAAAB0R3wAAAACgI+IbAAAAAHREfAMAAACAjohvAAAAANAR8Q0AAAAAOiK+AQAAAEBHxDcAAAAA6Ij4BgAAAAAdEd8AAAAAoCPiGwAAAAB0RHwDAAAAgI6IbwAAAADQEfENAAAAADoivgEAAABAR8Q3AAAAAOiI+AYAAAAAHRm7vg2q6pEki4YMXdha+8jjPXFVHZbktNba0VU1O8lAa+2UqnpTkodaa+dvgnMs6R/33o3Yd6PnUVXHJJncWvtIVR2b5LbW2uL17POY7arqrCRXt9Yu29DzPxl85ju35xfb/8aw6yY+8LPMuPbrmXznrcnxr0mmHfwEzw5GZvHSFZl394osG2yZOLYyY+fxmbzD+NGeFgAAAJvQeuNbkl+21qZuzMGramxrbXBD9mmtfXZjzrWpPZ55tNYuTXJp/+GxSb6eZJ3xbc3tWmtnbOz5t3arw1vVsOuXTdwxc494dXL5hZn8hXN7gwIcm5nFS1dk7l3LM9h6j5cNtsy9a3mSCHAAAABbkY2+7bSqllTVB6rqhqpaVFX79MffX1XnVNXcJOdX1YSqOre/zY1Vdfh6jvv+qjqtv3xlVX20qq6vqtuq6kX98adW1Zer6qaqmlNV36mqgbUc8h39/a+vqt+pqu2r6j+qalz/WBP7z2XcRszjO1X1vCH7XFlVB1XV7Kr6dFVNT3JMko9X1cKq2rOq/p+q+m5Vfa+q/rH/XIbb7ryqOq5/3CP6r92iqvpcVW27rp/B1m5d4W2VwXHjM2/60ckjg8mllzxBM4ORm3f3itXhbZXB1hsHAABg6zGS+PaUfhBa9TVryLp7W2sHJvlMktOGjB+U5JWttdcm+ZMkaa1NSfKaJJ+vqgkbMMexrbVpSf53kjP7Y3+c5Gettf2SfLB/vrVZ1t//00nObq09kOTKJK/or391kn9sra3ciHlcmOSEJKmqXZLs2lpbsGqH1tq16V0B947W2tTW2o+TXNJa+93W2v5JfpDkj9ayXfrHnZDkvCSz+q/h2CRvHjKvtf0MVquqk6tqflXNv+eee9bzNLcey1bdlnr/faM7ERjGsjXL23rGAQAA2DKNJL79sh+EVn3NGbJu1SVFC5JMGjJ+aWvtl/3lGUm+kCSttVuS3J5krw2Y43DnmJFe+Epr7eYkN61j/y8N+b7q3sO/S/LG/vIbk5y7kfP4cpLj+8snJLloBMd5flV9q6oWJTkxyfPWs/3eSf6jtXZb//Hnk/zeeub1GK21c1prA621gWc+85kjmOLWYeIDP+st7LjT6E4EhjFx7PBXb65tHAAAgC3T4/200+X974/kse8f94shy4/3L8nhzrEhx2xrLrfWrkkyqaoOTTKmH/A2eB6ttf9Kcl9V7ZdkVvpBcD3OS3JK/yq2DyRZ31WA63uua/sZbLWe9sDPkrbuq4PGrlyRGdd+PRkzNjlm5hM0Mxi5GTuPz5qdbWz1xgEAANh6PN74NhJXp3eFV6pqryS7J7n1cR5zXh693XNykinr2HbWkO/XDRk/P72r4UZy1du6XJjknUl2aK0tGmb9A0m2H/J4+yR39d9j7sR1bLfKLemFwt/pP35dkqse55y3aG9+wXMeDXDDfE1cdn+OuvzC3qedvu6NPmyBzdLkHcbnqF22XX2l28SxlaN22daHLQAAAGxlRnKl1FOqauGQx99orb1rA87x10k+27/NcjDJ7Nba8lrPG+aP4Jifr6qbktyY3m2nS9ey7bZV9Z30QuNrhoxfkORDefS21I11cZK/TO+954ZzYZK/rapTkxyX5E+TfCe9228X5dHgtuZ2SZLW2sNV9cYkF1XV2CTfTbJZfCLsaHrzC56zjrUTkxf8yRM2F9hYk3cYL7YBAABs5aqt5/a9zVFVjUkyrh+m9kxyeZK9Wmsj/pjA/ieJvrK19rqu5rk5GhgYaPPnzx/taQAAAABsNapqQWttYLh1W+p7hD01yRX9WzcryZs3MLz9VZKXJXl5R/MDAAAAgC0zvrXWHkgybE0c4f5v2YTTAQAAAIBhPREfuAAAAAAAT0riGwAAAAB0RHwDAAAAgI6IbwAAAADQEfENAAAAADoivgEAAABAR8Q3AAAAAOiI+AYAAAAAHRHfAAAAAKAj4hsAAAAAdER8AwAAAICOiG8AAAAA0BHxDQAAAAA6Ir4BAAAAQEfENwAAAADoiPgGAAAAAB0R3wAAAACgI+IbAAAAAHREfAMAAACAjohvAAAAANAR8Q0AAAAAOiK+AQAAAEBHxDcAAAAA6Ij4BgAAAAAdEd8AAAAAoCPiGwAAAAB0RHwDAAAAgI6IbwAAAADQEfENAAAAADoivgEAAABAR8Q3AAAAAOiI+AYAAAAAHRHfAAAAAKAj4hsAAAAAdER8AwAAAICOiG8AAAAA0BHxDQAAAAA6Ir4BAAAAQEfENwAAAADoiPgGAAAAAB0R3wAAAACgI+IbAAAAAHREfAMAAACAjohvAAAAANAR8Q0AAAAAOiK+AQAAAEBHxDcAAAAA6Ij4BgAAAAAdEd8AAAAAoCPiGwAAAAB0RHwDAAAAgI6IbwAAAADQEfENAAAAADoivgEAAABAR8Q3AKX9oJAAACAASURBVAAAAOiI+AYAAAAAHRHfAAAAAKAj4hsAAAAAdER8AwAAAICOiG8AAAAA0BHxDQAAAAA6Ir4BAAAAQEfENwAAAADoiPgGAAAAAB0R3wAAAACgI+IbAAAAAHREfAMAAACAjohvAAAAANAR8Q0AAAAAOiK+AQAAAEBHxDcAAAAA6Ij4BgAAAAAdEd8AAAAAoCPiGwAAAAB0RHwDAAAAgI6IbwAAAADQEfENAAAAADoivgEAAABAR8Q3AAAAAOiI+AYAAAAAHRHfAAAAAKAjGxXfqup/VFWrqn1GsO3sqtp1yOO/q6rJG3PeTaWqplbVy0dzDv15XNv/PqmqXjtkfKCqPjV6MwMAAABgUxi7kfu9Jsm8JK9O8v71bDs7yc1J7kyS1tr/3MhzbkpTkwwk+Zd1bVRVY1trgxt7kvXt31qb3l+clOS1Sf6hPz4/yfyNPe+TwZ/fdF/a2HFrXT/2V4M56tnbZfIO45/AWQEAAADrsnjpisy7e0WWDbZMHFuZsfP4rf5v9w2+8q2qtktySJI/Si++DV33zqpaVFXfq6qPVNVx6UWuC6pqYVU9paqu7F/Z9eaq+tiQfWdX1V/1l/+wqq7v7/M3VTVmPXO6sqo+2t/ntqp6UX98QlWd25/TjVV1eFWNT3JWkln9489a41izq+qiqvpakrn9sXdU1Xer6qaq+sCQbV/fH/teVX2hP3ZeVX2yqq5I8tGqen9VnTZkn5uralJ/+cH+8EeSvKg/n7dV1WFV9fX+Nu+vqs/1n+NPqurUIcf606q6paq+WVVfGnqerdnq8Fa11q/BMePyL3f8MouXrhjt6QIAAADphbe5dy3PssGWJFk22DL3ruVb/d/uG3Pl27FJvtFau62q7q+qA1trN1TVy/rrXtBae6iqdmyt3V9VpyQ5rX81V6pq1XEuTnJdknf2H89K8uGq2re/fEhrbWVV/XWSE5Ocv77n0lqb1r+d9MwkL07yJ0nSWpvSv0V2bpK9kpyRZKC1dspajnVwkv368z8qyXOTTEtSSS6tqt9Lcl+S9/bneW9V7Thk/72SvLi19khVvX89806Sd6X3Gh2dJFV12Brr90lyeJLtk9xaVZ9Jsn+SVyU5IL2f4w1JFozgXFu81eFtfbbZJvPuXrHVF3QAAADYEsy7e0X63W21wZat/m/3jYlvr0lydn/5wv7jG9KLXee21h5Kktba/es6SGvtnv6VXC9M8sMkeye5Jr1gdlCS7/ZD3VOS3D2CeV3S/74gvds4k2RGkr/qn++Wqro9vTC2Pt8cMv+j+l839h9vl16M2z/Jxa21e/vHH/p8L2qtPTKC84zUP7fWlidZXlV3J/nN9J7bP7XWfpkk/Sv1hlVVJyc5OUl23333TTitzd+yNf+rBgAAAEbF2v5G39r/dt+g+FZVOyX5/STPr6qWZEySVlXvTO+qsA19teYkOSHJLUm+0lpr1Stun2+tvXsDj7W8//2RPPq8RnB51LB+MWS5kvyf1trfDN2gf/vn2p7v0P0H89jbeydsxHyWD1le9fxG/Nxaa+ckOSdJBgYGtu5/0WuYOHZj/wkAAAAAm9LEsTVsaNva/3bf0Pd8Oy7J+a2157TWJrXWnp3kP9K7CmtukpOq6qlJMuQ2zAfSu11yOJekd6vqa9ILcUlyeZLjqmrnVcepquf0l8+vqmkbMN+r07tlNVW1V5Ldk9y6njmt6d/6z2u7/nF+qz+3y5Oc0A+SWeO206GWJDmwv82BSfYYZpsNmc8q85L8Qf997bZL8ooN3H+LVYMrkzaChvirX2XGzlvvZasAAACwJZmx8/is2dnGVrb6v903NL69JslX1hj7xySvba19I8mlSeZX1cIkq978/7wkn131gQtDd2yt/SzJ4iTPaa1d3x9bnOR9SeZW1U1Jvplkl/4u+yW5awPm+9dJxlTVovTi3uz+7ZtXJJk83AcurKm1Nje9TyG9rn+ci5Ns31r7fpIPJ7mqqr6X5JNrOcQ/Jtmx/5q8Ocltw2xzU5LB/gc3vG0kT6y19t30Xu/vpRcx5ydZOpJ9t3Rv32+nRwPcWr7GPrIyL9/tKVv1PeMAAACwJZm8w/gctcu2q690mzi2ctQu2271f7tXG8kVRJuBqpqY5O9ba8eP9lw2F1W1XWvtwf7VhlcnObm1dsO69hkYGGjz589/YiYIAAAA8CRQVQtaawPDrduYD1wYFa21ZUmEt8c6p6omp/c+cp9fX3gDAAAA4Im1xcQ3fl1r7bWjPQcAAAAA1m5D3/MNAAAAABgh8Q0AAAAAOiK+AQAAAEBHxDcAAAAA6Ij4BgAAAAAdEd8AAAAAoCPiGwAAAAB0RHwDAAAAgI6IbwAAAADQEfENAAAAADoivgEAAABAR8Q3AAAAAOiI+AYAAAAAHRHfAAAAAKAj4hsAAAAAdER8AwAAAICOiG8AAAAA0BHxDQAAAAA6Ir4BAAAAQEfENwAAAADoiPgGAAAAAB0R3wAAAACgI+IbAAAAAHREfAMAAACAjohvAAAAANAR8Q0AAAAAOiK+AQAAAEBHxDcAAAAA6Ij4BgAAAAAdEd8AAAAAoCPiGwAAAAB0RHwDAAAAgI6IbwAAAADQEfENAAAAADoivgEAAABAR8Q3AAAAAOiI+AYAAAAAHRHfAAAAAKAj4hsAAAAAdER8AwAAAICOiG8AAAAA0BHxDQAAAAA6Ir4BAAAAQEfENwAAAADoiPgGAAAAAB0R3wAAAACgI+IbAAAAAHREfAMAAACAjohvAAAAANAR8Q0AAAAAOiK+AQAAAEBHxDcAAAAA6Ij4BgAAAAAdEd8AAAAAoCPiGwAAAAB0RHwDAAAAgI6IbwAAAADQEfENAAAAADoivgEAAABAR8Q3AAAAAOiI+AYAAAAAHRHfAAAAAKAj4hsAAAAAdER8AwAAAICOiG8AAAAA0BHxDQAAAAA6Ir4BAAAAQEfENwAAAADoiPgGAAAAAB0R3wAAAACgI+IbAAAAAHREfAMAAACAjohvAAAAANAR8Q0AAAAAOiK+AQAAAEBHxDcAAAAA6Ij4BgAAAAAdEd8AAAAAoCPiGwAAAAB0RHwDAAAAgI6IbwAAAADQEfENAAAAADoydrROXFUtySdba2/vPz4tyXattfevY59jk9zWWlu8Cc6/yY71OOYwkOT1rbVTq+qwJCtaa9f2170pyUOttfNHa36bs0/c/PNkm8e247Erlmdw/LaZ+IufZ8a8r2XyfUuSZ+6c/PDW5Fe/6m1/yKHJa143OpNOkuuvSy69JLn/vmTHnZJjZibTDh69+QCQxUtXZN7dK7JssGXi2MqMncdn8g7jR3taAGxh/D4B1mY0r3xbnmRmVT1jA/Y5NsnkTXT+ER2rqh5XoKyqMWtb11qb31o7tf/wsCTTh6z7rPA2vNXhreoxX4PbTkiqsmy738jcI16dxTtNSm79QS+8Jb3v37oi+dIXRmfi11+X/MPne+Et6X3/h8/3xgEYFYuXrsjcu5Zn2WBLkiwbbJl71/IsXrpilGcGwJbE7xNgXUYzvg0mOSfJ29ZcUVXPqarLq+qm/vfdq2p6kmOSfLyqFlbVnkO2376q/qOqxvUfT6yqJVU1rqr2rKpvVNWCqvpWVe2zrmP19z+vqj5ZVVck+WhVPa2qPldV362qG6vqlf3txlTVJ6pqUX+ub+mPL6mqM6pqXpLjq+rK/lVuqapnVNWS/vJhVfX1qpqU5E1J3tafz4uq6v39qwHT3/+jVXV9Vd1WVS/qjz+1qr7cP/ecqvrOqvNs1VaFt3UYHDc+86YfPfzKa67qYFIjcOklyYo1fvmuWNEbB2BUzLt7Rfp/J6022HrjADBSfp8A6zJqt532/X9Jbqqqj60x/ukk57fWPl9VJyX5VGvt2Kq6NMnXW2sXD924tfZAVV2Z5BVJvprk1Un+sbW2sqrOSfKm1toPq+oFSf66tfb7azvWEHsleXFr7ZGq+rMk/95aO6mqnp7k+qq6LMnrk+yR5IDW2mBV7Thk/4dbazOS1beQrlVrbUlVfTbJg621T/T3OWKNzca21qZV1cuTnJnkxUn+OMnPWmv7VdXzkywc7vhVdXKSk5Nk9913X9dUtirLtv+N4VesuhLuibbqireRjgPQuWVr/qW0nnEAGI7fJ8C6jOoHLrTWliU5P8mpa6w6OMk/9Je/kGTGCA73d0ne2F9+Y5Jzq2q79G7lvKiqFib5myS7jHB6F7XWHukvH5XkXf1jXJlkQpLd0wtgn22tDfafz/1D9p8zwvOM1KrLoxYkmdRfnpHkwv65b05y03A7ttbOaa0NtNYGnvnMZ27iaW2+Jj7ws+FXbDNK/+x33GnDxgHo3MSxw19JvbZxABiO3yfAumwOn3Z6dpI/SvK0dWyz3v+7oLV2TZJJVXVokjH9GLVNkp+31qYO+dp3hPP6xZDlSvKqIcfYvbX2g/742uY2dP/BPPpaTxjh+de0vP/9kTx6xeKT83/Jf/WrpK37n8TYlSsy49qvD7/ykEM7mNQIHDMzGb/GG66OH98bB2BUzNh5fNb8u2hs9cYBYKT8PgHWZdTjW/9qsS+nF+BWuTa9W0eT5MQk8/rLDyTZfh2HOz/Jl5Kc2z/2siT/UVXHJ0n17D/CYw31b0neUtV7o7GqOqA/PjfJm1Z9KMMat50OtSTJQf3l49ayzYbMZ5V5SU7on3tykikbuP8W6bTnP/3RADfka+zyh5PWMvHBn+Woyy/sfdrp3vs+eqXbNtskLzp89D7tdNrByWvf8OiVbjvu1Hvs004BRs3kHcbnqF22XX1lwsSxlaN22dan0wGwQfw+Adal/m979x9v113X+f79adI05UcCKS2WX1NUUFMGKh4qYHAQsCJgUURBZMCBK9d5KOJ4Ow6jMwgqw6jc8T6cUe6tY4eqg+AgjL0dkfJT6FAtKZT+wlKKKEiHlqb0h9iGJJ/5Y6+kJ6fnpCch35zknOfz8TiPs9d3rb3W2mefley8svZefS9nEA3bcNUd3X2/6faDk/x1kl/r7tdOFyA4L8mDktyU5J91999W1Xck+Z3MzgJ7fndfv2CdXzet59Tu/vI09sgkb8rs7abHJ3lrd//SgdZVVW/OvM+Dq6oTMztD78mZnW322e5+zhTdfi3JM5N8NcnvdPd/mi6oMNfdX5ru/82ZBcY7krw/yYu7+7SqemqSc6Z1PTrJ25PsSfLKJE/P9Blw0+fZndPd26erw26f7n/fJOdn9vl0H0/ymCQv7O7rlvq5z83N9fbt2+/1+QEAAABgearqsu5e9CKYKxbfRqiq5yd5bnev0KlNR1ZVrUtyfHffOV2x9X1JHt3dS15SR3wDAAAAOLwOFN9W+mqnh01V/cck35vkWSu9L0fQfZJ8oKqOz+yMvH9+oPAGAAAAwJG1auJbd79ypffhSOvu25MsWlUBAAAAWHkrfsEFAAAAAFitxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBB1q/0DhxJVXVSkvdNk1+XZHeSm6bpM7t752HazsOTvLG7X3CI9//ZJL/d3XcexH2ekeSnuvv7D2Wbx5o3Xn1rUnX3QHeeddEfZOt1l82mj1uX7NmdbDkpOft5yZlPWpkdBQAAANa0NRXfuvvmJGckSVW9Nskd3f3G5d6/qtZ19+5lbOdzSQ4pvE1+Nsl5SZYd39aSfeFtfnyryp+e9eIkmQW4PdPTtOPm5C3nz24LcAAAAMAR5m2nk6p6aVVdWlWXV9VvV9VxVbW+qr5cVb9SVZcmObOqPl9Vr6+qv6iqj1bV46vqoqq6vqp+fFrXN1bV5dPt/6Oq3l5V766q66rqDfO2eW5Vba+qq6vqNdPYv0hySpIPV9V7p7HvrapLqupjVfW2qrrvNP7sqrq2qi5O8twj+xNbQQvD217HHZeLn/yce47v3Jlc8I7x+wUAAACwgPiWpKoek+QHkjy5u8/I7IzAF06zNyf5WHef2d2XTGOf7e4nJvmLJL+7975JfnmJTTwuyfOTPDbJi6vqIdP4q7t7bpr/3VW1tbt/I8mNSZ7S3c+oqlOSvDrJ07v78UmuSPKqqrpPkv8vybOSPCXJQ7KEqnrFFPm233TTTUsttircdv8HLj5jx81HdkcAAAAAssbednoAz0jyhCTba3ZG1YlJPjfN25nknQuWv2D6fmWS9d3990n+vqr2VNX9Fln/e7v79iSpqr9K8ogkX0jyI1X18syeh4ck2ZrkmgX3ffI0/pFp3zYkuXga+1R3Xz+t978mecliD667z01ybpLMzc31AX8Sx7hNt9+y+IwtJx3ZHQEAAACI+LZXJTmvu//tfoNV65P8Q3cvDFZ3Td/3zLu9d3qxn+n8ZXYnWV9Vj0ryqswu9PDlqvqDJBuX2Lc/6+5/umDf5pKs6pC2pL1Px8K3nu7Zk20fufCey2/YMLvoAgAAAMAR5m2nM+9N8sNV9aBkdlXUqnrE4G1uSnJ7ktuq6tQk3zNv3u1J7j/d/kiSf1JVXz/t232ncHdNkkdX1SNrdkrcjwze36PGOadvngW4+V979tzzaqfJ7Iy3F73UxRYAAACAFeHMtyTdfWVVvS7Je6vquCRfTfITmb01dJSPZRbQrkrymST/c968c6d9+dz0uW8vT/K2qtowzf/57r6uqn4iybuSfGm6/zcN3N+jyjmnb77n4Ok/eeR3BAAAAOAA6p7vqGQ1m5ub6+3bt6/0bgAAAACsGlV12XRRzXvwtlMAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGER8AwAAAIBBxDcAAAAAGGT9Su/AYqrqtCQXdvdj5o29Nskd3f3GA9zvx5LMdfdPDd7FQ1ZVZyR5SHf/6eFYbq1649W3JlWLzOmkjsvGdUn2JHd2UrPRbFpf2XbKhmzdvGHMTl16SXLBO5IdNydbTkrOfl5y5pPGbAsAAAA4Jjjz7cg7I8mzDuNya86+8Lbo1+xX+s7ds/CWzMJbkty2q3PRDXflmlt3Hv6duvSS5C3nz8JbMvv+lvNn4wAAAMCadUzGt6r6YFX9alVdWlWfqqqnLLLMs6vqkqp6UFW9uap+s6o+UlWfqarnT8tUVf16VV1VVVdW1Qum8d+uqrOn2++sqvOm2y+vql+pqtOq6pNV9TtVdXVVXVRVJy6yDz80rfsTVfWhqtqQ5JeSvKCqLq+qF1TVmdN+fXz6/k1LLPfaqjpn3rqvmvbjvlX1P6ZtXLX3Maxqe0PbIdjVycU3DohvF7wj2blgvTt3zsYBAACANeuYjG+T9d19ZpKfSfKL82dU1Q8keXWSZ3X3l6bhU5NsS/KcJP9+GnteZmeYPS7JM5L8elWdmuRDSfYGvYcm2Trd3pbkw9PtRyX5re4+PcmXk/zgIvv4miTf092PS3J2d++cxt7W3Wd099uS/FWS7+zub53m/bslllvKM5N8obsfN71N988WLlBVr6iq7VW1/aabbjrAqtaG23b1vS90sPae8bbccQAAAGBNOFrj21J1ZP743lOKLkty2rzx70ryr5I8u7tvmTf+37t7T3dfk+TB09i2JH/Y3bu7+4tJ/jzJEzILbE+pqq1JrknyxSnKPSnJR6b7/nV3X77EPuz1P5O8uap+PMm6JR7T5iT/raquSvIbSU5fYrmlXJnkGdOZgE/p7lsXLtDd53b3XHfPnXzyyQe5+tVn0/pDO2vugLacdHDjAAAAwJpwtMa3m5M8cMHYliRfmjd91/R9d/a/cMRnktw/yaMX3P+uebdrwff9dPffTdt/ZmZnwX04yQ9ndsGH2xdZ38J92Luen0jyb5I8PMnlVbVYifnlJB+Yzlr7viQbF9unJLuy//O1cdrGp5J8W2YR7g1V9Zol7r96dM++DsH6SradMuCCC2c/L9mwYL0bNszGAQAAgDXrqIxv3X1Hkhuq6ulJUlVbMgthFy/j7n+T2dtJf6+q7u0ssg9l9rlq66rq5CTfmeTSad4lmb2ldW98Oyd3v+V0WarqG7r7L7v7NZmFw4cnuT2zOLjX5iR/N93+sXnjC5f7bJLHT+t9fJJHTrcfkuQr3f0HSd64d5nV7JzTN98d4O7xtSdJsnFdsnFKq3sL66b1lbNOPWHM1U7PfFLyopfefabblpNm0652CgAAAGvaPc7WOoq8JMlvVdX/PU2/rruvX84du/vaqvrRzN7O+X0HWPSdmb2V9BOZvaX157r7f03zPpzkrO7+dFX9TWZn3h1UfMvsM+QelVn/ed+0nb9N8uqqujzJG5L8WpLzq+pnk7x/3n0/sGC5P07ykmn6o0k+NS33j6ft7Eny1ST//CD38Zh0zumbV3oX7unMJ4ltAAAAwH6qD/Htexyb5ubmevv27Su9GwAAAACrRlVd1t1zi807Kt92CgAAAACrgfgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwiPgGAAAAAIOIbwAAAAAwyJqPb1X1dVX11qq6vqquqao/rapHD9rWU6vqwntZ5oyqetYhrPuDVTV36HsHAAAAwOG2fqV3YCVVVSV5Z5Lzu/uF09gZSR6c5FMrtFtnJJlL8qcrtP1jwhuvvjWpWt7C3bNlq7JxXfK0B5+QrZs35Jpbd+biG3fmtl2djeuS7Enu7GTT+sq2UzZk6+YNB7VP89d3qOsAYLBLL0kueEey4+Zky0nJ2c9LHYkGbwAAEi5JREFUznzSSu8VAACr2JqOb0m+K8lXu/v/3TvQ3ZfXzK8n+d4kneRXuvttVfXUJK9L8sXMItk7klyZ5FVJTkzy/d19fVW9OcmdSU7PLOT9bHfvd8ZbVd03yX9M8o8zex5em+RdSX4pyYlVtS3JG5JcuHC57v6TqjoxyX9JsjXJJ6ftrwn7wtty49u85e7cnfzZDXfl776yK1ffuju7+u7xvW7b1bnohruSZNnx7Jpbd+aiG+7at75DWQcAg116SfKW85OdO2fTO26eTScCHAAAw6z1+PaYJJctMv68zOLa45I8KMlHq+pD07zHJfmWJDuSfCbJf+7uM6vqVUlemeRnpuVOS/JPknxDkg9U1Tcu2MYvJHl/d7+sqh6Q5NIk703ymiRz3f1TSVJV/27hclX13iT/Z5KvdPdjq+qxST72Nf4sjh0HE94WsaeTK768O32AZXZ1cvGNO5cdzi6+cee+8Hao6wBgsAvecXd422vnztm4+AYAwCBr/jPflrAtyR929+7u/mKSP0/yhGneR7v7hu6+K8n1SS6axq/MLLjt9Ufdvae7r8ss0n3zgm2cleTVVXV5kg8m2ZjkEYvsy1LLfWeSP0iS7r4iyRVLPZiqekVVba+q7TfddNMyHv7qd6DwttdtC2vaISx7MOsAYLAdNx/cOAAAHAZr/cy3q5M8f5HxA51Wdde823vmTe/J/j/PhdVl4XQl+cHuvna/wapvX+Zyi61zUd19bpJzk2Rubk4NyuyHem8/iE3rl3923ab1tWhoO5h1ADDYlpMWD21bTjry+wIAwJqx1s98e3+SE6rqx/cOVNUTktyS5AVVta6qTs7sLLNLD3LdP1RVx1XVNyT5+iTXLpj/7iSvnC76kKr61mn89iT3X8ZyH0ryo9PYY5I89iD379jVPfs6RMdV8tgHrMuButj6Sradsvy3i247ZcM91new6wBgsLOfl2xY8Ofyhg2zcQAAGGRNx7fu7iQ/kOS7q+r6qro6swsfvCWzt3F+IrNA93Pd/b8OcvXXZvZ21Xcl+YnuvnPB/F9OcnySK6rqqmk6ST6QZGtVXV5VLzjAcm9Kcr+quiLJz+Xg4+Ax65zTN98d4JbztWfPvli3cV3yzFNPyHefep+cdeoJ+85M27gu2TjFs03rK2edesJBfVbb1s0b9lvfoawDgMHOfFLyopfefabblpNm0z7vDQCAgaq/hjOIWNx0tdMLu/vtK70vC83NzfX27dtXejcAAAAAVo2quqy75xabt6bPfAMAAACAkdb6BReG6O4fW+l9AAAAAGDlOfMNAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgEPENAAAAAAYR3wAAAABgkPUrvQNHi6raneTKzH4mf53kn3b3lwdv8yPd/eSqOi3Jk7v7LdP4XJKXdPdPj9z+seyNV9+aVB1wmeo9edjnr8utX/eI3Hb8ianek67jsun2W7LtIxdm63WXJVtOSs5+Xs67zzdkx3Eb9933vv3VrNtwQm7b1dm0vrLtlA3ZunnDvvnX3LozF9+4c8n5y3W41nM0WE2PZbXwnMDyOFYAAI6ctfjay5lvd/uH7j6jux+TZEeSn/xaV1hVB4yb3f3k6eZpSV40b3y78La0feHtXr76uHX53MO/KbdtuM++6VTltk1bctHTX5hrHvVtyY6bc95dD5yFt3n3/fs6Prft6iTJbbs6F91wV665dWeS2R8UF91w15Lzl+twredosJoey2rhOYHlcawAABw5a/W1l/i2uEuSPHTvRFX9y6r6aFVdUVWvmzf+kmnsE1X1+9PYm6vqP1TVB5L8alW9tqrOmXefq6Yz3VJVd0zD/z7JU6rq8qr6F1X11Kq6cFrmtVV1XlV9sKo+U1U/PW9d/7aq/qqq3lNVfzh/O6va3ki23GUXsev4Dbn4yc9Jkuw46SH3XG7B9K5OLr5x9ofBxTfuzPTnxKLzl+twredosJoey2rhOYHlcawAABw5a/W1l7edLlBV65I8PcnvTtNnJXlUkjOTVJILquo7k9yc5BeSfEd3f6mqtsxbzaOTPKO7d1fVa5ex2VcnOae7nzNt86kL5n9zku9Kcv8k11bVm5I8LskPJvnWzJ7HjyW5bInH9Iokr0iSRzziEcvYnbXhtvs/8OCWn1fmDzT/YNf3ta7naLCaHstq4TmB5XGsAAAcOWv1tZcz3+52YlVdnllU25LkPdP4WdPXxzMLXN+cWYx7WpK3d/eXkqS7d8xb13/r7t2Hcd/+R3ffNW3rxiQPTrItyZ909z909+1J/v+l7tzd53b3XHfPnXzyyYdxt45tm26/5eCWX1/7fV9q/sGu72tdz9FgNT2W1cJzAsvjWAEAOHLW6msv8e1u/9DdZyT5R0k25O7PfKskb5g+D+6M7v7G7v7daXypNPv3827vyv4/5405eHfNu707szPdVvdv5oF0z76Wu+wi1n91Z7Z95MIkyZabv3DP5RZMr69k2ymzD4DcdsqGLPxzYf785Tpc6zkarKbHslp4TmB5HCsAAEfOWn3tJb4t0N23JvnpJOdU1fFJ3p3kZVV1vySpqodW1SlJ3pfkh6vqpGl8yxKr/GySx0/LPD7JIxdZ5vbM3lJ6MC5O8n1VtXHat2cf5P2PWeecvvnuAHeAr9qzOw//3LXZtPMr+6bTnU237chZ73vrvqudvuyEW7Jlz5373fe+/dX9znQ769QT9l19ZevmDTnr1BOWnL9ch2s9R4PV9FhWC88JLI9jBQDgyFmrr7185tsiuvvjVfWJJC/s7t+vqm9JcknNPoT/jiQv7u6rq+r1Sf68qnZn9rbUH1tkdX+c5CXTW1o/muRTiyxzRZJd0zbfPK3r3vbxo1V1QZJPJPmbJNuT3Hpwj/TYdc7pm5e34OlPWGRwU/Lt+1/M9mUHuf2tmw/PpZAP13qOBqvpsawWnhNYHscKAMCRsxZfe1Uv9+17HHWq6n7dfUdV3SfJh5K8ors/dqD7zM3N9fbt24/MDgIAAACsAVV1WXfPLTbPmW/HtnOramtmnyN3/r2FNwAAAACOLPHtGNbdL1rpfQAAAABgaS64AAAAAACDiG8AAAAAMIj4BgAAAACDiG8AAAAAMIj4BgAAAACDiG8AAAAAMIj4BgAAAACDiG8AAAAAMIj4BgAAAACDiG8AAAAAMIj4BgAAAACDiG8AAAAAMIj4BgAAAACDiG8AAAAAMIj4BgAAAACDiG8AAAAAMIj4BgAAAACDiG8AAAAAMIj4BgAAAACDiG8AAAAAMIj4BgAAAACDiG8AAAAAMIj4BgAAAACDiG8AAAAAMIj4BgAAAACDiG8AAAAAMIj4BgAAAACDiG8AAAAAMIj4BgAAAACDiG8AAAAAMIj4BgAAAACDiG8AAAAAMEh190rvA0dQVd2U5G9Wej8Oowcl+dJK7wQc5RwnsDyOFbh3jhO4d44TWJ7Vdqz8o+4+ebEZ4hvHtKra3t1zK70fcDRznMDyOFbg3jlO4N45TmB51tKx4m2nAAAAADCI+AYAAAAAg4hvHOvOXekdgGOA4wSWx7EC985xAvfOcQLLs2aOFZ/5BgAAAACDOPMNAAAAAAYR3wAAAABgEPGNY1JVPbOqrq2qT1fVq1d6f2CEqjqvqm6sqqvmjW2pqvdU1XXT9wdO41VVvzkdE1dU1ePn3eel0/LXVdVL541/W1VdOd3nN6uqDrQNOFpV1cOr6gNV9cmqurqqXjWNO15gUlUbq+rSqvrEdJy8bhp/ZFX95fQ7/Laq2jCNnzBNf3qaf9q8df3rafzaqvqeeeOLvj5bahtwtKqqdVX18aq6cJp2nMACVfXZ6bXR5VW1fRrz2msJ4hvHnKpal+S3knxvkq1JfqSqtq7sXsEQb07yzAVjr07yvu5+VJL3TdPJ7Hh41PT1iiRvSmZ/OSX5xSTfnuTMJL847y+oN03L7r3fM+9lG3C02pXk/+rub0nyxCQ/Of294HiBu92V5Gnd/bgkZyR5ZlU9McmvJvmN6Xf4liQvn5Z/eZJbuvsbk/zGtFymY+uFSU7P7Dj47SlUHOj12VLbgKPVq5J8ct604wQW913dfUZ3z03TXnstQXzjWHRmkk9392e6e2eStyZ57grvExx23f2hJDsWDD83yfnT7fOTfP+88d/rmb9I8oCqOjXJ9yR5T3fv6O5bkrwns39wnZpkU3df0rMr7/zegnUttg04KnX3Dd39sen27Zn9g+mhcbzAPtPv+x3T5PHTVyd5WpK3T+MLj5O9v9tvT/L06ayD5yZ5a3ff1d1/neTTmb02W/T12XSfpbYBR52qeliSZyf5z9P0gX6HHSewP6+9liC+cSx6aJLPzZv+/DQGa8GDu/uGZBYckpwyjS91XBxo/POLjB9oG3DUm97y861J/jKOF9jPdObN5UluzOwfONcn+XJ375oWmf+7ve94mObfmuSkHPzxc9IBtgFHo/8nyc8l2TNNH+h32HHCWtZJLqqqy6rqFdOY115LWL/SOwCHoBYZ6yO+F3B0Weq4ONhxOGZV1f2S/HGSn+nu26aPBll00UXGHC+set29O8kZVfWAJO9M8i2LLTZ9P9jjYbH/1Hf8cEypquckubG7L6uqp+4dXmRRxwkk39HdX6iqU5K8p6r+6gDLrvnXXs5841j0+SQPnzf9sCRfWKF9gSPti9Np2Jm+3ziNL3VcHGj8YYuMH2gbcNSqquMzC2//tbvfMQ07XmAR3f3lJB/M7DMSH1BVe/9Dfv7v9r7jYZq/ObOPQjjY4+dLB9gGHG2+I8nZVfXZzN4S+rTMzoRznMAC3f2F6fuNmf2Hzpnx2mtJ4hvHoo8medR0RaANmX2Y6QUrvE9wpFyQZO9VgF6a5E/mjb9kupLQE5PcOp2G/e4kZ1XVA6cPLz0rybunebdX1ROnzxl5yYJ1LbYNOCpNv8O/m+ST3f0f5s1yvMCkqk6eznhLVZ2Y5BmZfT7iB5I8f1ps4XGy93f7+UneP33uzgVJXlizqzw+MrMPwb40S7w+m+6z1DbgqNLd/7q7H9bdp2X2O/z+7v7ROE5gP1V136q6/97bmb1muipeey2pZsc5HFuq6lmZ/S/UuiTndffrV3iX4LCrqj9M8tQkD0ryxcyuBPTfk/xRkkck+dskP9TdO6a/lP5TZlcB+kqSf9bdey/5/bIkPz+t9vXd/V+m8bnMrqh6YpJ3JXlld3dVnbTYNoY/YDhEVbUtyYeTXJm7P6Pn5zP73DfHCySpqsdm9sHU6zL7D/g/6u5fqqqvz+wMny1JPp7kxd19V1VtTPL7mX2G4o4kL+zuz0zr+oUkL8vsSsM/093vmsYXfX221DaOzCOHQzO97fSc7n6O4wT2N/2+vnOaXJ/kLd39+qVeF3ntJb4BAAAAwDDedgoAAAAAg4hvAAAAADCI+AYAAAAAg4hvAAAAADCI+AYAAAAAg4hvAAAAADCI+AYAAAAAg/xv9D42SnGzUwwAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<Figure size 1440x1080 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "# scatter plot of enrollment, color coded by type of study\n",
    "colors = [color_int, color_obs]\n",
    "labels = ['Interventional', 'Observational']\n",
    "\n",
    "plt.rcParams['figure.figsize'] = [20, 15]\n",
    "\n",
    "plt.scatter(interventional['Enrollment'], interventional['Status'], color=colors[0], label=labels[0])\n",
    "plt.scatter(observational['Enrollment'], observational['Status'], color=colors[1], label=labels[1])\n",
    "\n",
    "plt.legend()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>URL</th>\n",
       "      <th>clean_age</th>\n",
       "      <th>min_age</th>\n",
       "      <th>age_groups</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1909</th>\n",
       "      <td>NCT03653156</td>\n",
       "      <td>China Cognition and Aging Study</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Mild Cognitive Impairment|Alzheimer Disease, L...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>25000</td>\n",
       "      <td>Observational</td>\n",
       "      <td>January 10, 2008</td>\n",
       "      <td>January 1, 2028</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03653156</td>\n",
       "      <td>18 Years and older</td>\n",
       "      <td>18</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1598</th>\n",
       "      <td>NCT03323502</td>\n",
       "      <td>Aligning Patient Preferences: a Role Offering ...</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>Alzheimer Disease|Dementia</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>22650</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>September 1, 2019</td>\n",
       "      <td>September 29, 2022</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03323502</td>\n",
       "      <td>18 Years and older</td>\n",
       "      <td>18</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2174</th>\n",
       "      <td>NCT02402426</td>\n",
       "      <td>Brain Health Registry</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Healthy|Neurodegenerative Disease</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>100000</td>\n",
       "      <td>Observational</td>\n",
       "      <td>September 2013</td>\n",
       "      <td>September 2028</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT02402426</td>\n",
       "      <td>18 Years and older</td>\n",
       "      <td>18</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1574</th>\n",
       "      <td>NCT02022943</td>\n",
       "      <td>Alzheimer's Prevention Registry: A Program to ...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Alzheimer's Disease|Dementia</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 110 Years   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>500000</td>\n",
       "      <td>Observational</td>\n",
       "      <td>May 2012</td>\n",
       "      <td>January 2030</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT02022943</td>\n",
       "      <td>18 Years to 110 Years</td>\n",
       "      <td>18</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1925</th>\n",
       "      <td>NCT03631069</td>\n",
       "      <td>Detecting Dementia in the Retina Using Optical...</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>Dementia Alzheimers|Dementia|Dementia, Vascula...</td>\n",
       "      <td>All</td>\n",
       "      <td>40 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>200000</td>\n",
       "      <td>Observational</td>\n",
       "      <td>September 2019</td>\n",
       "      <td>August 2022</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03631069</td>\n",
       "      <td>40 Years and older</td>\n",
       "      <td>40</td>\n",
       "      <td>18 to 40 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1548</th>\n",
       "      <td>NCT03638583</td>\n",
       "      <td>Alzheimer Prevention Trials Webstudy</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Alzheimer Disease|Dementia</td>\n",
       "      <td>All</td>\n",
       "      <td>50 Years to 85 Years   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>200000</td>\n",
       "      <td>Observational</td>\n",
       "      <td>December 20, 2017</td>\n",
       "      <td>April 30, 2022</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03638583</td>\n",
       "      <td>50 Years to 85 Years</td>\n",
       "      <td>50</td>\n",
       "      <td>40 to 65 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1270</th>\n",
       "      <td>NCT02564692</td>\n",
       "      <td>GeneMatch: A Program of the Alzheimer's Preven...</td>\n",
       "      <td>Active, not recruiting</td>\n",
       "      <td>Alzheimer Disease</td>\n",
       "      <td>All</td>\n",
       "      <td>55 Years to 75 Years   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>500000</td>\n",
       "      <td>Observational</td>\n",
       "      <td>November 2015</td>\n",
       "      <td>December 2030</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT02564692</td>\n",
       "      <td>55 Years to 75 Years</td>\n",
       "      <td>55</td>\n",
       "      <td>40 to 65 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1727</th>\n",
       "      <td>NCT03943641</td>\n",
       "      <td>Dementia Risk Prediction Model: Development an...</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>Dementia Alzheimers</td>\n",
       "      <td>All</td>\n",
       "      <td>60 Years to 79 Years   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>400000</td>\n",
       "      <td>Observational</td>\n",
       "      <td>May 8, 2019</td>\n",
       "      <td>May 1, 2020</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03943641</td>\n",
       "      <td>60 Years to 79 Years</td>\n",
       "      <td>60</td>\n",
       "      <td>40 to 65 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1927</th>\n",
       "      <td>NCT02612688</td>\n",
       "      <td>Pragmatic Trial of Video Education in Nursing ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Alzheimer Disease|Dementia|Heart Failure|Pulmo...</td>\n",
       "      <td>All</td>\n",
       "      <td>65 Years and older   (Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>197692</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>March 1, 2016</td>\n",
       "      <td>May 31, 2019</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT02612688</td>\n",
       "      <td>65 Years and older</td>\n",
       "      <td>65</td>\n",
       "      <td>40 to 65 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1156</th>\n",
       "      <td>NCT03565809</td>\n",
       "      <td>Quality of the Management of Diabetes in Elder...</td>\n",
       "      <td>Enrolling by invitation</td>\n",
       "      <td>Alzheimer Disease</td>\n",
       "      <td>All</td>\n",
       "      <td>65 Years and older   (Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>87816</td>\n",
       "      <td>Observational</td>\n",
       "      <td>May 2, 2017</td>\n",
       "      <td>December 2019</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03565809</td>\n",
       "      <td>65 Years and older</td>\n",
       "      <td>65</td>\n",
       "      <td>40 to 65 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1097</th>\n",
       "      <td>NCT03621839</td>\n",
       "      <td>New CSF Biomarkers for Alzheimer's Disease</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Alzheimer Disease|Dementia|Neurodegenerative D...</td>\n",
       "      <td>All</td>\n",
       "      <td>Child, Adult, Older Adult</td>\n",
       "      <td>NaN</td>\n",
       "      <td>50000</td>\n",
       "      <td>Observational</td>\n",
       "      <td>July 12, 2013</td>\n",
       "      <td>December 31, 2050</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03621839</td>\n",
       "      <td>Child, Adult, Older Adult</td>\n",
       "      <td>0</td>\n",
       "      <td>Age not specified</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       NCT Number                                              Title  \\\n",
       "1909  NCT03653156                    China Cognition and Aging Study   \n",
       "1598  NCT03323502  Aligning Patient Preferences: a Role Offering ...   \n",
       "2174  NCT02402426                              Brain Health Registry   \n",
       "1574  NCT02022943  Alzheimer's Prevention Registry: A Program to ...   \n",
       "1925  NCT03631069  Detecting Dementia in the Retina Using Optical...   \n",
       "1548  NCT03638583               Alzheimer Prevention Trials Webstudy   \n",
       "1270  NCT02564692  GeneMatch: A Program of the Alzheimer's Preven...   \n",
       "1727  NCT03943641  Dementia Risk Prediction Model: Development an...   \n",
       "1927  NCT02612688  Pragmatic Trial of Video Education in Nursing ...   \n",
       "1156  NCT03565809  Quality of the Management of Diabetes in Elder...   \n",
       "1097  NCT03621839         New CSF Biomarkers for Alzheimer's Disease   \n",
       "\n",
       "                       Status  \\\n",
       "1909               Recruiting   \n",
       "1598       Not yet recruiting   \n",
       "2174               Recruiting   \n",
       "1574               Recruiting   \n",
       "1925       Not yet recruiting   \n",
       "1548               Recruiting   \n",
       "1270   Active, not recruiting   \n",
       "1727       Not yet recruiting   \n",
       "1927                Completed   \n",
       "1156  Enrolling by invitation   \n",
       "1097               Recruiting   \n",
       "\n",
       "                                             Conditions Gender  \\\n",
       "1909  Mild Cognitive Impairment|Alzheimer Disease, L...    All   \n",
       "1598                         Alzheimer Disease|Dementia    All   \n",
       "2174                  Healthy|Neurodegenerative Disease    All   \n",
       "1574                       Alzheimer's Disease|Dementia    All   \n",
       "1925  Dementia Alzheimers|Dementia|Dementia, Vascula...    All   \n",
       "1548                         Alzheimer Disease|Dementia    All   \n",
       "1270                                  Alzheimer Disease    All   \n",
       "1727                                Dementia Alzheimers    All   \n",
       "1927  Alzheimer Disease|Dementia|Heart Failure|Pulmo...    All   \n",
       "1156                                  Alzheimer Disease    All   \n",
       "1097  Alzheimer Disease|Dementia|Neurodegenerative D...    All   \n",
       "\n",
       "                                               Age          Phases  \\\n",
       "1909     18 Years and older   (Adult, Older Adult)             NaN   \n",
       "1598     18 Years and older   (Adult, Older Adult)  Not Applicable   \n",
       "2174     18 Years and older   (Adult, Older Adult)             NaN   \n",
       "1574  18 Years to 110 Years   (Adult, Older Adult)             NaN   \n",
       "1925     40 Years and older   (Adult, Older Adult)             NaN   \n",
       "1548   50 Years to 85 Years   (Adult, Older Adult)             NaN   \n",
       "1270   55 Years to 75 Years   (Adult, Older Adult)             NaN   \n",
       "1727   60 Years to 79 Years   (Adult, Older Adult)             NaN   \n",
       "1927            65 Years and older   (Older Adult)  Not Applicable   \n",
       "1156            65 Years and older   (Older Adult)             NaN   \n",
       "1097                     Child, Adult, Older Adult             NaN   \n",
       "\n",
       "      Enrollment      Study Type         Start Date     Completion Date  \\\n",
       "1909       25000   Observational   January 10, 2008     January 1, 2028   \n",
       "1598       22650  Interventional  September 1, 2019  September 29, 2022   \n",
       "2174      100000   Observational     September 2013      September 2028   \n",
       "1574      500000   Observational           May 2012        January 2030   \n",
       "1925      200000   Observational     September 2019         August 2022   \n",
       "1548      200000   Observational  December 20, 2017      April 30, 2022   \n",
       "1270      500000   Observational      November 2015       December 2030   \n",
       "1727      400000   Observational        May 8, 2019         May 1, 2020   \n",
       "1927      197692  Interventional      March 1, 2016        May 31, 2019   \n",
       "1156       87816   Observational        May 2, 2017       December 2019   \n",
       "1097       50000   Observational      July 12, 2013   December 31, 2050   \n",
       "\n",
       "                                              URL                  clean_age  \\\n",
       "1909  https://ClinicalTrials.gov/show/NCT03653156        18 Years and older    \n",
       "1598  https://ClinicalTrials.gov/show/NCT03323502        18 Years and older    \n",
       "2174  https://ClinicalTrials.gov/show/NCT02402426        18 Years and older    \n",
       "1574  https://ClinicalTrials.gov/show/NCT02022943     18 Years to 110 Years    \n",
       "1925  https://ClinicalTrials.gov/show/NCT03631069        40 Years and older    \n",
       "1548  https://ClinicalTrials.gov/show/NCT03638583      50 Years to 85 Years    \n",
       "1270  https://ClinicalTrials.gov/show/NCT02564692      55 Years to 75 Years    \n",
       "1727  https://ClinicalTrials.gov/show/NCT03943641      60 Years to 79 Years    \n",
       "1927  https://ClinicalTrials.gov/show/NCT02612688        65 Years and older    \n",
       "1156  https://ClinicalTrials.gov/show/NCT03565809        65 Years and older    \n",
       "1097  https://ClinicalTrials.gov/show/NCT03621839  Child, Adult, Older Adult   \n",
       "\n",
       "      min_age          age_groups  \n",
       "1909       18  up to 18 years old  \n",
       "1598       18  up to 18 years old  \n",
       "2174       18  up to 18 years old  \n",
       "1574       18  up to 18 years old  \n",
       "1925       40  18 to 40 years old  \n",
       "1548       50  40 to 65 years old  \n",
       "1270       55  40 to 65 years old  \n",
       "1727       60  40 to 65 years old  \n",
       "1927       65  40 to 65 years old  \n",
       "1156       65  40 to 65 years old  \n",
       "1097        0   Age not specified  "
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# subset outliers in a separate dataset:\n",
    "alzheimer_over_20000 = alzheimer[alzheimer['Enrollment'] >= 20000]\n",
    "alzheimer_over_20000.head(11)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1080x1080 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "# grouped bar chart showing enrollment by study status, grouped and colored by study type\n",
    "plt.rcParams['figure.figsize'] = [15, 15]\n",
    "\n",
    "alzheimer.groupby(['Status', 'Study Type']).sum()[['Enrollment']].unstack('Study Type').plot.bar(color=colors, \n",
    "                                                                                                 label=labels)\n",
    "\n",
    "plt.title('Enrollment by study status, grouped by study type')\n",
    "# plt.savefig('grouped_bar_study_status')\n",
    "print('')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([[<matplotlib.axes._subplots.AxesSubplot object at 0x1243bd748>]],\n",
       "      dtype=object)"
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1080x1080 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "# histogram of enrollment - all studies\n",
    "alzheimer.hist('Enrollment', bins=20)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>min_age</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>count</th>\n",
       "      <td>2169.000000</td>\n",
       "      <td>2169.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>mean</th>\n",
       "      <td>1366.131858</td>\n",
       "      <td>42.940987</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>std</th>\n",
       "      <td>19197.413670</td>\n",
       "      <td>19.079539</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>min</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25%</th>\n",
       "      <td>31.000000</td>\n",
       "      <td>21.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50%</th>\n",
       "      <td>80.000000</td>\n",
       "      <td>50.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75%</th>\n",
       "      <td>240.000000</td>\n",
       "      <td>55.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>max</th>\n",
       "      <td>500000.000000</td>\n",
       "      <td>80.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          Enrollment      min_age\n",
       "count    2169.000000  2169.000000\n",
       "mean     1366.131858    42.940987\n",
       "std     19197.413670    19.079539\n",
       "min         0.000000     0.000000\n",
       "25%        31.000000    21.000000\n",
       "50%        80.000000    50.000000\n",
       "75%       240.000000    55.000000\n",
       "max    500000.000000    80.000000"
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "alzheimer.describe()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>URL</th>\n",
       "      <th>clean_age</th>\n",
       "      <th>min_age</th>\n",
       "      <th>age_groups</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1574</th>\n",
       "      <td>NCT02022943</td>\n",
       "      <td>Alzheimer's Prevention Registry: A Program to ...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Alzheimer's Disease|Dementia</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 110 Years   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>500000</td>\n",
       "      <td>Observational</td>\n",
       "      <td>May 2012</td>\n",
       "      <td>January 2030</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT02022943</td>\n",
       "      <td>18 Years to 110 Years</td>\n",
       "      <td>18</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1270</th>\n",
       "      <td>NCT02564692</td>\n",
       "      <td>GeneMatch: A Program of the Alzheimer's Preven...</td>\n",
       "      <td>Active, not recruiting</td>\n",
       "      <td>Alzheimer Disease</td>\n",
       "      <td>All</td>\n",
       "      <td>55 Years to 75 Years   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>500000</td>\n",
       "      <td>Observational</td>\n",
       "      <td>November 2015</td>\n",
       "      <td>December 2030</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT02564692</td>\n",
       "      <td>55 Years to 75 Years</td>\n",
       "      <td>55</td>\n",
       "      <td>40 to 65 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1727</th>\n",
       "      <td>NCT03943641</td>\n",
       "      <td>Dementia Risk Prediction Model: Development an...</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>Dementia Alzheimers</td>\n",
       "      <td>All</td>\n",
       "      <td>60 Years to 79 Years   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>400000</td>\n",
       "      <td>Observational</td>\n",
       "      <td>May 8, 2019</td>\n",
       "      <td>May 1, 2020</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03943641</td>\n",
       "      <td>60 Years to 79 Years</td>\n",
       "      <td>60</td>\n",
       "      <td>40 to 65 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1925</th>\n",
       "      <td>NCT03631069</td>\n",
       "      <td>Detecting Dementia in the Retina Using Optical...</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>Dementia Alzheimers|Dementia|Dementia, Vascula...</td>\n",
       "      <td>All</td>\n",
       "      <td>40 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>200000</td>\n",
       "      <td>Observational</td>\n",
       "      <td>September 2019</td>\n",
       "      <td>August 2022</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03631069</td>\n",
       "      <td>40 Years and older</td>\n",
       "      <td>40</td>\n",
       "      <td>18 to 40 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1548</th>\n",
       "      <td>NCT03638583</td>\n",
       "      <td>Alzheimer Prevention Trials Webstudy</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Alzheimer Disease|Dementia</td>\n",
       "      <td>All</td>\n",
       "      <td>50 Years to 85 Years   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>200000</td>\n",
       "      <td>Observational</td>\n",
       "      <td>December 20, 2017</td>\n",
       "      <td>April 30, 2022</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03638583</td>\n",
       "      <td>50 Years to 85 Years</td>\n",
       "      <td>50</td>\n",
       "      <td>40 to 65 years old</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       NCT Number                                              Title  \\\n",
       "1574  NCT02022943  Alzheimer's Prevention Registry: A Program to ...   \n",
       "1270  NCT02564692  GeneMatch: A Program of the Alzheimer's Preven...   \n",
       "1727  NCT03943641  Dementia Risk Prediction Model: Development an...   \n",
       "1925  NCT03631069  Detecting Dementia in the Retina Using Optical...   \n",
       "1548  NCT03638583               Alzheimer Prevention Trials Webstudy   \n",
       "\n",
       "                      Status  \\\n",
       "1574              Recruiting   \n",
       "1270  Active, not recruiting   \n",
       "1727      Not yet recruiting   \n",
       "1925      Not yet recruiting   \n",
       "1548              Recruiting   \n",
       "\n",
       "                                             Conditions Gender  \\\n",
       "1574                       Alzheimer's Disease|Dementia    All   \n",
       "1270                                  Alzheimer Disease    All   \n",
       "1727                                Dementia Alzheimers    All   \n",
       "1925  Dementia Alzheimers|Dementia|Dementia, Vascula...    All   \n",
       "1548                         Alzheimer Disease|Dementia    All   \n",
       "\n",
       "                                               Age Phases  Enrollment  \\\n",
       "1574  18 Years to 110 Years   (Adult, Older Adult)    NaN      500000   \n",
       "1270   55 Years to 75 Years   (Adult, Older Adult)    NaN      500000   \n",
       "1727   60 Years to 79 Years   (Adult, Older Adult)    NaN      400000   \n",
       "1925     40 Years and older   (Adult, Older Adult)    NaN      200000   \n",
       "1548   50 Years to 85 Years   (Adult, Older Adult)    NaN      200000   \n",
       "\n",
       "         Study Type         Start Date Completion Date  \\\n",
       "1574  Observational           May 2012    January 2030   \n",
       "1270  Observational      November 2015   December 2030   \n",
       "1727  Observational        May 8, 2019     May 1, 2020   \n",
       "1925  Observational     September 2019     August 2022   \n",
       "1548  Observational  December 20, 2017  April 30, 2022   \n",
       "\n",
       "                                              URL               clean_age  \\\n",
       "1574  https://ClinicalTrials.gov/show/NCT02022943  18 Years to 110 Years    \n",
       "1270  https://ClinicalTrials.gov/show/NCT02564692   55 Years to 75 Years    \n",
       "1727  https://ClinicalTrials.gov/show/NCT03943641   60 Years to 79 Years    \n",
       "1925  https://ClinicalTrials.gov/show/NCT03631069     40 Years and older    \n",
       "1548  https://ClinicalTrials.gov/show/NCT03638583   50 Years to 85 Years    \n",
       "\n",
       "      min_age          age_groups  \n",
       "1574       18  up to 18 years old  \n",
       "1270       55  40 to 65 years old  \n",
       "1727       60  40 to 65 years old  \n",
       "1925       40  18 to 40 years old  \n",
       "1548       50  40 to 65 years old  "
      ]
     },
     "execution_count": 44,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# subset the outliers - Enrollment >= 5000\n",
    "alzheimer_over_5000 = alzheimer[alzheimer['Enrollment'] >= 5000]\n",
    "alzheimer_over_5000 = alzheimer_over_5000.sort_values(['Enrollment'],ascending=False)\n",
    "alzheimer_over_5000.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Int64Index: 32 entries, 1574 to 2056\n",
      "Data columns (total 15 columns):\n",
      "NCT Number         32 non-null object\n",
      "Title              32 non-null object\n",
      "Status             32 non-null object\n",
      "Conditions         32 non-null object\n",
      "Gender             32 non-null object\n",
      "Age                32 non-null object\n",
      "Phases             9 non-null object\n",
      "Enrollment         32 non-null int32\n",
      "Study Type         32 non-null object\n",
      "Start Date         32 non-null object\n",
      "Completion Date    32 non-null object\n",
      "URL                32 non-null object\n",
      "clean_age          32 non-null object\n",
      "min_age            32 non-null int32\n",
      "age_groups         32 non-null object\n",
      "dtypes: int32(2), object(13)\n",
      "memory usage: 3.8+ KB\n"
     ]
    }
   ],
   "source": [
    "alzheimer_over_5000.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x1243da6d8>"
      ]
     },
     "execution_count": 46,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1080x1080 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "# grouped bar chart showing enrollment by study status, grouped and colored by study type\n",
    "# only studies with enrollment over 5000 patients\n",
    "\n",
    "alzheimer_over_5000.groupby(['Status', 'Study Type']).sum()[['Enrollment']].unstack('Study Type').plot.bar(color=colors, label=labels)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>URL</th>\n",
       "      <th>clean_age</th>\n",
       "      <th>min_age</th>\n",
       "      <th>age_groups</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1845</th>\n",
       "      <td>NCT03149380</td>\n",
       "      <td>Effectiveness of Alzheimer's Universe (Www.Alz...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Alzheimer Disease|Alzheimer Disease, Late Onse...</td>\n",
       "      <td>All</td>\n",
       "      <td>14 Years and older   (Child, Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>10000</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>January 2017</td>\n",
       "      <td>October 2024</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03149380</td>\n",
       "      <td>14 Years and older</td>\n",
       "      <td>14</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2065</th>\n",
       "      <td>NCT01699711</td>\n",
       "      <td>Normalization of dyrk1A and APP Function as an...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Down Syndrome (DS)</td>\n",
       "      <td>All</td>\n",
       "      <td>14 Years to 29 Years   (Child, Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>87</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>February 2012</td>\n",
       "      <td>March 2015</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01699711</td>\n",
       "      <td>14 Years to 29 Years</td>\n",
       "      <td>14</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1937</th>\n",
       "      <td>NCT01476228</td>\n",
       "      <td>EEG Objectification in Neuropsychiatry</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Personality Disorder|Depression|Neurodegenerat...</td>\n",
       "      <td>All</td>\n",
       "      <td>15 Years to 90 Years   (Child, Adult, Older Ad...</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>100</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>November 2011</td>\n",
       "      <td>December 2015</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01476228</td>\n",
       "      <td>15 Years to 90 Years</td>\n",
       "      <td>15</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1843</th>\n",
       "      <td>NCT00165100</td>\n",
       "      <td>Dynamic Area Telethermometry (DAT) as an Imagi...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Malignant Tumors|Subcutaneous Tumors|Lymph Nod...</td>\n",
       "      <td>All</td>\n",
       "      <td>16 Years and older   (Child, Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>50</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>January 2000</td>\n",
       "      <td>October 2002</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT00165100</td>\n",
       "      <td>16 Years and older</td>\n",
       "      <td>16</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2152</th>\n",
       "      <td>NCT00978536</td>\n",
       "      <td>A Monocenter, Cross-sectional Study to Compare...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Disseminated Sclerosis</td>\n",
       "      <td>All</td>\n",
       "      <td>17 Years to 66 Years   (Child, Adult, Older Ad...</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>29</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>February 2009</td>\n",
       "      <td>November 2011</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT00978536</td>\n",
       "      <td>17 Years to 66 Years</td>\n",
       "      <td>17</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       NCT Number                                              Title  \\\n",
       "1845  NCT03149380  Effectiveness of Alzheimer's Universe (Www.Alz...   \n",
       "2065  NCT01699711  Normalization of dyrk1A and APP Function as an...   \n",
       "1937  NCT01476228             EEG Objectification in Neuropsychiatry   \n",
       "1843  NCT00165100  Dynamic Area Telethermometry (DAT) as an Imagi...   \n",
       "2152  NCT00978536  A Monocenter, Cross-sectional Study to Compare...   \n",
       "\n",
       "              Status                                         Conditions  \\\n",
       "1845      Recruiting  Alzheimer Disease|Alzheimer Disease, Late Onse...   \n",
       "2065       Completed                                 Down Syndrome (DS)   \n",
       "1937  Unknown status  Personality Disorder|Depression|Neurodegenerat...   \n",
       "1843       Completed  Malignant Tumors|Subcutaneous Tumors|Lymph Nod...   \n",
       "2152      Terminated                             Disseminated Sclerosis   \n",
       "\n",
       "     Gender                                                Age  \\\n",
       "1845    All   14 Years and older   (Child, Adult, Older Adult)   \n",
       "2065    All              14 Years to 29 Years   (Child, Adult)   \n",
       "1937    All  15 Years to 90 Years   (Child, Adult, Older Ad...   \n",
       "1843    All   16 Years and older   (Child, Adult, Older Adult)   \n",
       "2152    All  17 Years to 66 Years   (Child, Adult, Older Ad...   \n",
       "\n",
       "              Phases  Enrollment      Study Type     Start Date  \\\n",
       "1845  Not Applicable       10000  Interventional   January 2017   \n",
       "2065         Phase 2          87  Interventional  February 2012   \n",
       "1937  Not Applicable         100  Interventional  November 2011   \n",
       "1843  Not Applicable          50  Interventional   January 2000   \n",
       "2152  Not Applicable          29  Interventional  February 2009   \n",
       "\n",
       "     Completion Date                                          URL  \\\n",
       "1845    October 2024  https://ClinicalTrials.gov/show/NCT03149380   \n",
       "2065      March 2015  https://ClinicalTrials.gov/show/NCT01699711   \n",
       "1937   December 2015  https://ClinicalTrials.gov/show/NCT01476228   \n",
       "1843    October 2002  https://ClinicalTrials.gov/show/NCT00165100   \n",
       "2152   November 2011  https://ClinicalTrials.gov/show/NCT00978536   \n",
       "\n",
       "                  clean_age  min_age          age_groups  \n",
       "1845    14 Years and older        14  up to 18 years old  \n",
       "2065  14 Years to 29 Years        14  up to 18 years old  \n",
       "1937  15 Years to 90 Years        15  up to 18 years old  \n",
       "1843    16 Years and older        16  up to 18 years old  \n",
       "2152  17 Years to 66 Years        17  up to 18 years old  "
      ]
     },
     "execution_count": 47,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "interventional.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<BarContainer object of 1795 artists>"
      ]
     },
     "execution_count": 48,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA4AAAANOCAYAAABA1mKTAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjAsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+17YcXAAAgAElEQVR4nOzdf8yuBX3f8c93nGrcOgfq0RGgg3anTanZUE+UpGnj6qoHshS66AZL5NSxPNVB0qZdInZ/YGxN7JbWhMzSHCcRmlZ0WgNrcJQwV7NMLcfKELSOI7VyCoGjWGtiZ4P97o/nOuvN4Tm/nuccz4Hv65Xcee77e/24r/vmrzfXdV+nujsAAAA8+/2tU30AAAAAfHcIQAAAgCEEIAAAwBACEAAAYAgBCAAAMMS2U30AJ9qLXvSiPv/880/1YQAAAJwSn/nMZ77a3ds3WvasC8Dzzz8/e/fuPdWHAQAAcEpU1Z8ebplLQAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIY4agBW1XlV9fGq+kJVPVBVP7fMX1BVd1XVg8vfs5Z5VdUNVbWvqu6rqpev7Gv3sv6DVbV7Zf6Kqvrcss0NVVVHeg8AAACO37GcAXwyyS929w8nuTjJNVV1YZLrktzd3TuS3L28TpJLkuxYHmtJbkzWYy7J9UleleSVSa5fCbobl3UPbrdrmR/uPQAAADhORw3A7n60u/9oef7NJF9Ick6Sy5LcvKx2c5LLl+eXJbml130qyZlVdXaS1yW5q7uf6O6vJ7krya5l2fO7+5Pd3UluOWRfG70HAAAAx+m4fgNYVecneVmSTyd5SXc/mqxHYpIXL6udk+Thlc32L7MjzfdvMM8R3uPQ41qrqr1VtffAgQPH85EAAADGOOYArKrvTfKRJD/f3X9xpFU3mPUm5sesu/d0987u3rl9+/bj2RQAAGCMYwrAqvqerMffb3f37y7jx5bLN7P8fXyZ709y3srm5yZ55CjzczeYH+k9AAAAOE7HchfQSvK+JF/o7l9fWXR7koN38tyd5LaV+VXL3UAvTvKN5fLNO5O8tqrOWm7+8tokdy7LvllVFy/vddUh+9roPQAAADhO245hnR9N8sYkn6uqe5fZLyV5V5IPVdXVSb6S5A3LsjuSXJpkX5JvJXlTknT3E1X1y0nuWdZ7R3c/sTx/S5L3J3leko8tjxzhPQAAADhOtX7jzWePnTt39t69e0/1YQAAAJwSVfWZ7t650bLjugsoAAAAz1wCEAAAYAgBCAAAMMSx3AQGTmt79uw51Ydw2llbWzvVhwAAwGnIGUAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGOKoAVhVN1XV41V1/8rsg1V17/L4clXdu8zPr6q/XFn2myvbvKKqPldV+6rqhqqqZf6Cqrqrqh5c/p61zGtZb19V3VdVLz/xHx8AAGCOYzkD+P4ku1YH3f0vu/ui7r4oyUeS/O7K4i8dXNbdb16Z35hkLcmO5XFwn9clubu7dyS5e3mdJJesrLu2bA8AAMAmHTUAu/sTSZ7YaNlyFu9fJPnAkfZRVWcneX53f7K7O8ktSS5fFl+W5Obl+c2HzG/pdZ9KcuayHwAAADZhq78B/LEkj3X3gyuzC6rqs1X1B1X1Y8vsnCT7V9bZv8yS5CXd/WiSLH9fvLLNw4fZ5imqaq2q9lbV3gMHDmztEwEAADxLbTUAr8xTz/49muT7uvtlSX4hye9U1fOT1Abb9lH2fczbdPee7t7Z3Tu3b99+DIcNAAAwz7bNblhV25L88ySvODjr7m8n+fby/DNV9aUkP5j1s3fnrmx+bpJHluePVdXZ3f3oconn48t8f5LzDrMNAAAAx2krZwD/aZI/7u7/f2lnVW2vqjOW59+f9Ru4PLRc2vnNqrp4+d3gVUluWza7Pcnu5fnuQ+ZXLXcDvTjJNw5eKgoAAMDxO5Z/BuIDST6Z5Ieqan9VXb0suiJPv/nLjye5r6r+d5IPJ3lzdx+8gcxbkvznJPuSfCnJx5b5u5L8ZFU9mOQnl9dJckeSh5b135vk3x7/xwMAAOCgo14C2t1XHmb+MxvMPpL1fxZio/X3JnnpBvOvJXnNBvNOcs3Rjg8AAIBjs9WbwAAAAPAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADHHUAKyqm6rq8aq6f2X29qr6s6q6d3lcurLsbVW1r6q+WFWvW5nvWmb7quq6lfkFVfXpqnqwqj5YVc9Z5s9dXu9blp9/oj40AADARMdyBvD9SXZtMH93d1+0PO5Ikqq6MMkVSX5k2eY3quqMqjojyXuSXJLkwiRXLusmya8u+9qR5OtJrl7mVyf5enf/wyTvXtYDAABgk44agN39iSRPHOP+Lktya3d/u7v/JMm+JK9cHvu6+6Hu/qsktya5rKoqyU8k+fCy/c1JLl/Z183L8w8nec2yPgAAAJuwld8AXltV9y2XiJ61zM5J8vDKOvuX2eHmL0zy59395CHzp+xrWf6NZX0AAAA2YbMBeGOSH0hyUZJHk/zaMt/oDF1vYn6kfT1NVa1V1d6q2nvgwIEjHTcAAMBYmwrA7n6su7/T3X+d5L1Zv8QzWT+Dd97KqucmeeQI868mObOqth0yf8q+luV/L4e5FLW793T3zu7euX379s18JAAAgGe9TQVgVZ298vKnkxy8Q+jtSa5Y7uB5QZIdSf4wyT1Jdix3/HxO1m8Uc3t3d5KPJ3n9sv3uJLet7Gv38vz1Sf77sj4AAACbsO1oK1TVB5K8OsmLqmp/kuuTvLqqLsr6JZlfTvKzSdLdD1TVh5J8PsmTSa7p7u8s+7k2yZ1JzkhyU3c/sLzFW5PcWlW/kuSzSd63zN+X5Leqal/Wz/xdseVPCwAAMNhRA7C7r9xg/L4NZgfXf2eSd24wvyPJHRvMH8rfXEK6Ov+/Sd5wtOMDAADg2GzlLqAAAAA8gwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCGOGoBVdVNVPV5V96/M/mNV/XFV3VdVH62qM5f5+VX1l1V17/L4zZVtXlFVn6uqfVV1Q1XVMn9BVd1VVQ8uf89a5rWst295n5ef+I8PAAAwx7GcAXx/kl2HzO5K8tLu/kdJ/k+St60s+1J3X7Q83rwyvzHJWpIdy+PgPq9Lcnd370hy9/I6SS5ZWXdt2R4AAIBNOmoAdvcnkjxxyOz3u/vJ5eWnkpx7pH1U1dlJnt/dn+zuTnJLksuXxZcluXl5fvMh81t63aeSnLnsBwAAgE04Eb8B/NdJPrby+oKq+mxV/UFV/dgyOyfJ/pV19i+zJHlJdz+aJMvfF69s8/BhtnmKqlqrqr1VtffAgQNb+zQAAADPUlsKwKr690meTPLby+jRJN/X3S9L8gtJfqeqnp+kNti8j7b7Y92mu/d0987u3rl9+/ZjO3gAAIBhtm12w6raneSfJXnNcllnuvvbSb69PP9MVX0pyQ9m/ezd6mWi5yZ5ZHn+WFWd3d2PLpd4Pr7M9yc57zDbAAAAcJw2dQawqnYleWuSn+rub63Mt1fVGcvz78/6DVweWi7t/GZVXbzc/fOqJLctm92eZPfyfPch86uWu4FenOQbBy8VBQAA4Pgd9QxgVX0gyauTvKiq9ie5Put3/XxukruWf83hU8sdP388yTuq6skk30ny5u4+eAOZt2T9jqLPy/pvBg/+bvBdST5UVVcn+UqSNyzzO5JcmmRfkm8ledNWPigAAMB0Rw3A7r5yg/H7DrPuR5J85DDL9iZ56QbzryV5zQbzTnLN0Y4PAACAY3Mi7gIKAADAM4AABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADDEMQVgVd1UVY9X1f0rsxdU1V1V9eDy96xlXlV1Q1Xtq6r7qurlK9vsXtZ/sKp2r8xfUVWfW7a5oarqSO8BAADA8TvWM4DvT7LrkNl1Se7u7h1J7l5eJ8klSXYsj7UkNybrMZfk+iSvSvLKJNevBN2Ny7oHt9t1lPcAAADgOB1TAHb3J5I8ccj4siQ3L89vTnL5yvyWXvepJGdW1dlJXpfkru5+oru/nuSuJLuWZc/v7k92dye55ZB9bfQeAAAAHKet/AbwJd39aJIsf1+8zM9J8vDKevuX2ZHm+zeYH+k9nqKq1qpqb1XtPXDgwBY+EgAAwLPXybgJTG0w603Mj1l37+nund29c/v27cezKQAAwBhbCcDHlss3s/x9fJnvT3LeynrnJnnkKPNzN5gf6T0AAAA4TlsJwNuTHLyT5+4kt63Mr1ruBnpxkm8sl2/emeS1VXXWcvOX1ya5c1n2zaq6eLn751WH7Guj9wAAAOA4bTuWlarqA0leneRFVbU/63fzfFeSD1XV1Um+kuQNy+p3JLk0yb4k30rypiTp7ieq6peT3LOs947uPnhjmbdk/U6jz0vyseWRI7wHAAAAx+mYArC7rzzMotdssG4nueYw+7kpyU0bzPcmeekG869t9B4AAAAcv5NxExgAAABOQwIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBCbDsCq+qGqunfl8RdV9fNV9faq+rOV+aUr27ytqvZV1Rer6nUr813LbF9VXbcyv6CqPl1VD1bVB6vqOZv/qAAAALNtOgC7+4vdfVF3X5TkFUm+leSjy+J3H1zW3XckSVVdmOSKJD+SZFeS36iqM6rqjCTvSXJJkguTXLmsmyS/uuxrR5KvJ7l6s8cLAAAw3Ym6BPQ1Sb7U3X96hHUuS3Jrd3+7u/8kyb4kr1we+7r7oe7+qyS3JrmsqirJTyT58LL9zUkuP0HHCwAAMM6JCsArknxg5fW1VXVfVd1UVWcts3OSPLyyzv5ldrj5C5P8eXc/ecj8aapqrar2VtXeAwcObP3TAAAAPAttOQCX3+X9VJL/soxuTPIDSS5K8miSXzu46gab9ybmTx927+nund29c/v27cdx9AAAAHNsOwH7uCTJH3X3Y0ly8G+SVNV7k/ze8nJ/kvNWtjs3ySPL843mX01yZlVtW84Crq4PAADAcToRl4BemZXLP6vq7JVlP53k/uX57UmuqKrnVtUFSXYk+cMk9yTZsdzx8zlZv5z09u7uJB9P8vpl+91JbjsBxwsAADDSls4AVtXfTvKTSX52ZfwfquqirF+u+eWDy7r7gar6UJLPJ3kyyTXd/Z1lP9cmuTPJGUlu6u4Hln29NcmtVfUrST6b5H1bOV4AAIDJthSA3f2trN+sZXX2xiOs/84k79xgfkeSOzaYP5T1u4QCAACwRSfqLqAAAACc5gQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCG2HIBV9eWq+lxV3VtVe5fZC6rqrqp6cPl71jKvqrqhqvZV1X1V9fKV/exe1n+wqnavzF+x7H/fsm1t9ZgBAAAmOlFnAP9Jd1/U3TuX19clubu7dyS5e3mdJJck2bE81pLcmKwHY5Lrk7wqySuTXH8wGpd11la223WCjhkAAGCUk3UJ6GVJbl6e35zk8pX5Lb3uU0nOrKqzk7wuyV3d/UR3fz3JXUl2Lcue392f7O5OcsvKvgAAADgOJyIAO8nvV9Vnqmptmb2kux9NkuXvi5f5OUkeXtl2/zI70nz/BvOnqKq1qtpbVXsPHDhwAj4SAADAs8+2E7CPH+3uR6rqxUnuqqo/PsK6G/1+rzcxf+qge0+SPUmyc+fOpy0HAADgBJwB7O5Hlr+PJ/lo1n/D99hy+WaWv48vq+9Pct7K5ucmeeQo83M3mAMAAHCcthSAVfV3qurvHnye5LVJ7k9ye5KDd/LcneS25fntSa5a7gZ6cZJvLJeI3pnktVV11nLzl9cmuXNZ9s2quni5++dVK/sCAADgOGz1EtCXJPno8i8zbEvyO93936rqniQfqqqrk3wlyRuW9e9IcmmSfUm+leRNSdLdT1TVLye5Z1nvHd39xPL8LUnen+R5ST62PAAAADhOWwrA7n4oyT/eYP61JK/ZYN5JrjnMvm5KctMG871JXrqV4wQAAODk/TMQAAAAnGYEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhNh2AVXVeVX28qr5QVQ9U1c8t87dX1Z9V1b3L49KVbd5WVfuq6otV9bqV+a5ltq+qrluZX1BVn66qB6vqg1X1nM0eLwAAwHRbOQP4ZJJf7O4fTnJxkmuq6sJl2bu7+6LlcUeSLMuuSPIjSXYl+Y2qOqOqzkjyniSXJLkwyZUr+/nVZV87knw9ydVbOF4AAIDRNh2A3f1od//R8vybSb6Q5JwjbHJZklu7+9vd/SdJ9iV55fLY190PdfdfJbk1yWVVVUl+IsmHl+1vTnL5Zo8XAABguhPyG8CqOj/Jy5J8ehldW1X3VdVNVXXWMjsnycMrm+1fZoebvwFPhN8AABgcSURBVDDJn3f3k4fMAQAA2IQtB2BVfW+SjyT5+e7+iyQ3JvmBJBcleTTJrx1cdYPNexPzjY5hrar2VtXeAwcOHOcnAAAAmGFLAVhV35P1+Pvt7v7dJOnux7r7O93910nem/VLPJP1M3jnrWx+bpJHjjD/apIzq2rbIfOn6e493b2zu3du3759Kx8JAADgWWsrdwGtJO9L8oXu/vWV+dkrq/10kvuX57cnuaKqnltVFyTZkeQPk9yTZMdyx8/nZP1GMbd3dyf5eJLXL9vvTnLbZo8XAABgum1HX+WwfjTJG5N8rqruXWa/lPW7eF6U9cs1v5zkZ5Okux+oqg8l+XzW7yB6TXd/J0mq6tokdyY5I8lN3f3Asr+3Jrm1qn4lyWezHpwAAABswqYDsLv/Zzb+nd4dR9jmnUneucH8jo226+6H8jeXkAIAALAFJ+QuoAAAAJz+BCAAAMAQAhAAAGAIAQgAADDEVu4CCgCnjT179pzqQzjtrK2tnepDAOA04wwgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCG2neoDAE5Pe/bsOdWHcNpZW1s71YcAALAlzgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQAhAAAGAIAQgAADCEAAQAABhi26k+gCn27Nlzqg/htLO2tnaqDwEAAEZxBhAAAGAIAQgAADCEAAQAABhCAAIAAAwhAAEAAIYQgAAAAEMIQAAAgCEEIAAAwBACEAAAYAgBCAAAMIQABAAAGEIAAgAADCEAAQAAhhCAAAAAQwhAAACAIQQgAADAEAIQAABgCAEIAAAwhAAEAAAYQgACAAAMIQABAACGEIAAAABDCEAAAIAhBCAAAMAQ2071AQBMs2fPnlN9CKedtbW1U30IADCCM4AAAABDOAMIAHAKuBrg6VwNACefM4AAAABDCEAAAIAhBCAAAMAQfgMIAByW36ltzG/VgGcqZwABAACGEIAAAABDCEAAAIAhBCAAAMAQp30AVtWuqvpiVe2rqutO9fEAAAA8U53WAVhVZyR5T5JLklyY5MqquvDUHhUAAMAz0+n+z0C8Msm+7n4oSarq1iSXJfn8KT0qAAAYxj8L83TPxH8Sprr7VB/DYVXV65Ps6u5/s7x+Y5JXdfe1h6y3luTgt/9DSb74XT3QZ54XJfnqqT6IZyHf68njuz05fK8nj+/25PC9njy+25PD93py+F6P7h909/aNFpzuZwBrg9nTirW79yTxvySOUVXt7e6dp/o4nm18ryeP7/bk8L2ePL7bk8P3evL4bk8O3+vJ4XvdmtP6N4BJ9ic5b+X1uUkeOUXHAgAA8Ix2ugfgPUl2VNUFVfWcJFckuf0UHxMAAMAz0ml9CWh3P1lV1ya5M8kZSW7q7gdO8WE9G7hc9uTwvZ48vtuTw/d68vhuTw7f68njuz05fK8nh+91C07rm8AAAABw4pzul4ACAABwgghAAACAIQTgaaaqvlNV91bV/VX1X6vqzO/Ce/6v5e/5VfWvVuY7q+qGk/3+3w1V9fer6taq+lJVfb6q7qiqHzxJ7/Xqqvq9o6xzUVVduol9/4+qOuG3PV7+299/yOztVfXvjrLdz1TVfzrRx3MiHet3vdn/JidKVb3w/7V35uF6T9ce/3wR8xjTo66hjakx3BSl5qhU66o5GmqKopfrkeKG9lIeQ1szveWJGC4xNWau4SISQuZQGc3EacOlJWpIBTex7h9rvTn7/PL7nfOeKTmS/X2e93n3b797WHvtvdbaw9q/N2R/sqT3JL2TPC/bgfVsIOmuduQ/XdLyrczTR9KDba0zKcckXZE8D5R0Xgt5DpTUs711d3RZ7aBhvl4OXbNz8tuJko4uyXNQ8G6LOsrvL+kbyfONXaDNi1Q2EzpqtnKepIZEPq/uCFuZ2o5Ut1b1axvraJC0VhvztpkOSftL+lWE65KjYjpJF0jq05b6S8q+StKpyfMTkm5Mnq+QdJake+O5yRisxz62Jt3iBElnS3pR0tSQjx0XNU01tHb8fx3mOG1FXgB2Pcwxs15mthXwIXByewuU1OzLfsysNoHYGPhpEv+8mQ1ob/2LGpIEPACMNLMeZtYTOAtYdxGS1QtY5BOaJQT18nqR9omZzQrZ7wUMBq6qPZvZly3ll7R0nfXMNLN+7SD1dKBVC8AOxBfAwa2cwB4IdNQCpq6yWtK5deSv7MuCXu4N7Jz8NtjMbi3JdjgwGn+TdkvoD8xfAJrZ8Wb2Uh35OhN1yWYH8L1eW/klMD2Rz1PqtZVtobGZfl2oaA8dZvaQmV0cj/XKZJN0ZnaumQ1vS/0lGEvIjqSl8D8V3zL5fWdghJn1jecOtQ/tHatdFZJ2An4MbGtm2wB9gJmLlqqMMuQFYNfGOGD92oOkMyQ9F7sq5yfxR0fcFEm3RdwQSVdKehq4pLgLJT9h3DjCsyP6YmC32LE5rbAbeZ6km+QnUDMkDUjKOkfSK5KelDS0C+527Qn8n5kNrkWY2WRgtKTLghfTJPWD+buwz0i6W9Jrki6WdISkiZGuR6QbImmwpFGR7sfFiiWtFHx7TtIkSQfIT3MuAPoFr/uVpYv8K8hPLqfKT21WWAj8WgDR75cED16TtFtJmn0ljZO0VvDmD5LGxnjpG2lUwfNBkvaP8AOSborwcZJ+Iz+hfFnSDbGzOEzSAryQdGiUPUXSsxW83iHomhTfm1ekK5WZ6KtHo47ptTZ0JiQdE7yfHLxaStIykj4K/kwEdpD0tqTfShofY2nb4NWbkk6IsjaRNDnCx0u6V777/bqki5I6r5f0fPD73Ig7DVgHGCVpeMTtE/3+gqS7JK0U8ftKelXSaOCADmLFXPzNb6eV8GgjSSNCVkZI2lB+OrY/cFnwrkeSfhVJb0nqFs+ryneHu0nqIelxSX+Sy/cWzZUV+Ys6t0qml5Z0eYz/qZJOifgGSecGvw5VctofMtUQ4d6SHpHr7xOB04Ke3dIxq0aZfR44CBgEHCZpRbluq9mMz9So5/oC2wN3RJkr1OiQdJKkS5P29pd0dYSPTMbndWphM0IV+kTS8pJuDt5MkrSnSmSzUFZ/SfdIehgYFnGdbSuXpcRWRh+OlPSBpNmSZkoaEGVeL+kNYFaMzxmS3q21swV+lfVrkXdpv94laYKqvUXOiPwT5fqgUhbaQMcESVsmeUZK2i766RqVyJGkE6K/pki6L9pSlm6IGm3JXsG7aXI5Wy7iGySdL9dH01R96j2Gxs2TLYHpwKeS1oiyvg38Pfq/agz2VPmc6Gy57hsObF7gxe8kPQP8QtJ+wa9JkoZLWjfSTZO0uhyzFKeukm6Te1P0l3S/XEe9rkQuuwDWAz4wsy8AzOwDM/tfJSdvcn0yMsJ7qPEkfVKMxd5y+/2A3GNrsHyRjqS91Whv7pG0csSX9rvcs2ZYlH0doBqhqtBbko6NMf0MsMvCY91ChpnlTxf6ALPje2ngHuBH8bw3PvERvnB/BNgdV1yvAmtFuu7xPSTSLB3P5wEDk3qmAxsX6uwNPJKkmf8c+ccCy+E7ZbOAbvhkYTK+MFkFeD2tpyt8gAH4aUox/hDgyeD1usBfcOXVG/gowssB7wDnR55fAL9PePx49MemwNv4yUjKt98BR0Z4deA1YCV8l/2ahJaqdKfjf38CsA0+Ad6+E3i0Mb6jncbNHzPASOCKCP8LMDzC/YFr8AnmKGCNhDf3BG96Am+0wPPDgMsizURgfIRvBn4Y9M0FekX83TV+FWieBqxf42NKY5JmVWCZCPcB7qtIN7/9qcxEG25I4lfrhP5Ieb8V8GBC8/X4Sf0ygAEHJ/neBk6I8NXApBhH6wLvRfwmwOQIH4/L7Cq4DM8EvhG/1XTJMtG3PZM6arxdB3gGWDGez8ZP11eMdD1wnXUf8GAH8GV29F8DsBowEDgvfnsYOCbCP6vVh4/FvhXl3QwcGOGf0zjGRwCbRnhH4Kk6yhpCU51bJdMnBT9q/VnjcwNwZlLeSELWcZ3bEOHeNNXL6RhNx81I4ArgSPyvlIbjOvwq4Dpgnxgfc3E93r1Yb/oMrE3IccQ/BuyKT5QfBrpF/CDg6Bb6cSTl+uTfgZsjvAWuH5anIJuFsvrjY61G/8KwlfOAj3HbNxk4P8poAP4n+DwAuA23lRcALwNTcDk7K/IPLLQz7dv5bS7r1xLeDQSuS3RGqa0IGs+O8NFJfaWy0IxeqqLjNBrt5XrAayXtGUIiR8CaSfg3wCkV6YYAfYNXM4HNIv5W4NSkfbX8/wbc2Mw4bAA2BP4V30y5MNqyC/AsiV2k3D6UzYm2w+3QiriueqPAs0FJGWvA/LfxH5/wczCwb/Tjc4S9wXX1ykHLDFwHLg/8Gdigvfq1Iz5B32Rc3w0C9kh4XZO97XGPLHDdsUuSdxlcDj4HvoXPFZ6Mfl8r+mWlSP9L4Nzm+h34Q5JmX9xmrkWF3sLH7F9wfbcsvlFQqnu+7p98Atj1sIJ8d34W0B0f+OBGbW/cYL+AG41Nge8D95rZBwBm9mFS1j1mNq8DaXvUzL6Iuv6GTyp3Bf7bzOaY2ae4QH1dsCsw1Mzmmdlf8Ynsd+O358zsXfNdrDeJnWVcsW+clHG3mX1lZq/jCrm427g38Kvo05G4st6whJaqdLsDtwOY2VRgaptb2zysjvj74/tPNOXBnrgi3tfM/p7EPxi8eYlGd9sqno/Cd9R7Ai8Bf5W0HrATbmQB3jI/uS2joYYxwBD5aVfVKcRqwD3yO49X0dTtpx5MA/rE7vduZvZxK/O3Fn1wHj0f42MPfGEF7or2QCH9Qwmd483sH8Hrr2q7pQUMN7NPzWwO8AqN4/NwSS/g+ubblLts7RzxY4O2I/B+6YlP/N40t653tLbRVTCzT/AJX9HlbifgjxG+DR9rLeFG4NgIHwvcHDzaGR8jk/HF0np1kpfq3CqZ7gMMNrO50Z5UZ7f5bmYF7sfdP2/E++VO3D3rzqBjEKFTCnQsADN7H5gh6XuS1sRPNsYAe+GT3ueirXvhE7d6aIOmsrwr3neY2Sv4xLaeu9pPJvQvDFv5JTDKGl22n05+exl4FJiAj5u/4RPbBlwnzsHleVgb2llDFe/ujDKn07ytGJp87xThBWShjXTcDRwa4Z/gG4EtYSv5Sfs0XIe0pJM3x+3Ba/F8C24rm6OrDLVTwJ1xj6txyfPYZvLVUDYn2g14wMw+C131UCFPKuP/BDwR7T6DxnaPivbsDlwLbC1pfeBDM6udQo8ws4/N7HPcZm5UB72djqBvO3wT4X3gLkn9m8kyBrgyTlBXr+lFYKKZzQi5HIqP7+/htmVM6JpjaNrusn5P51CPArU5SpXe2hFfnL5vfvWio3Vyl8Fi6YP8NcccM+slaTV8R/FkfAdDwEVmdl2aOISmavL+jyQ8l6Yuv225w/NFEp6Hjx9VpO1KeBHfPSqiOdrTtn6VPH9FU7kp8r74LOAQM3u1SeSCl6Kr0pWV2RmYhe9GpugOvJU813hQ6/saZuCKczPg+ZL00MjrUp6b2TuS1gB+hO/wdccnD7PN7NOYcBbH3wIuoGZ2YvB2X2CypF4l1V0IPG1mB8ldu0aW0USFzJjZa5K2w3eKL5I0zMwuqCijIyD8FPicJpF+h2ROLLBSpGO1OI7LdP4Cci1pU/y0ewcz+0jS7ZTrDAGPm9lRBdq2p3PH7e/xyX1zk9QW6zezMXK33j3wE6DpklYFPoqJfWuR6twqmVYztFXp7LbeuVweX/hsgy9GzgDWTOhrbR/dhcvlK/gk16I9t5jZf7SyrDJ90lZ7UuT7orSV8/C21do1L8pL7/G21262l3dWDJfJQlvoCF0+S9I2QD/8dK0lDMFPH6fEYqF3C+lbamuVrSqidg9wa/ykdyZ+Cv0JcFMLdaT1FOtqTq7SsXY1cKWZPSSpN36qCG4DT8Y3jM7GPWz64gvDlupe5IhF20hgZCxuj6FCn5nZxZIexe3peDW+5KdsbiV8s+fwiqqr+r2sP0r1lqQDK9IvdsgngF0UcaowABgo98N/AvhZ4u+8vqR1cFeln8QEGUndK4psALaNNNsC3yxJ8ynuCtYajAb2k9/dWBmfeHc1PAUsF6dCAEj6Lr4T1E9+J2dtfKdoYivLPlR+H6sHvgh6tfD7E8ApMUlC0ncivsjrqnTP4juiSNoKn8h1OGLX7l1Je0Vd3fHF2Og6sv8ZOBi4Vcndjwo8SzXPxwGnRppRuEvTqNJSKiCph5lNMLNzgQ+ADViQ16vhbr3grjQ1FNM1UCIz8jckfmZmtwOX19J0IobjMl67P7GmpLJT5I7Eqjg/PomT2B8mv6V8GgvsIelbQdtKsXh8CdhM0jdjTFcZ7DYhTm/uBo5LosfS+JKTI2gcuy3ptVvxHeabo+xPgLckHQrz763+c51lpaiS6WHAibGAb0lnbxfhsg2seujZC2/fd4C3zWwD4F18cT8Mn2RuXaCjuTLvx1/McTiNO+MjgL5hj5DUXdJGEb5V0g7N0FdEqu82wyfAr9bRzhQLw1ZaK+ip4S3CVgLjgR9EHWk724PR+OKc8KTYupm0/ZLvcUl8E1loB+4EzsTd46eV/F7sz1Vw+9ON6P+KdDW8AmwsaZN4Pgr3JmktxuAn4h+GV8qHuLv2TjTlS3O0FPEscJD8/uwqwH7NpE1t0TG1SDObibspbmpmM/C+bbU9XBSQ36nfNInqhc8RGmjUZ4ck6XuY2TQzuwTfQK55Ue0Q9mMpfJyOxuVml1q/y++KtnRynuqUfWjc6K7SWxOA3mFnu9F4mr3YIS8AuzDMbBJ+Z+AwMxuGuzeNix2Ve4FVzOxF4LfAM5KmAFdWFHcf0D2Ouk/C/bOLmArMlV/EXuAlCxU0Poe7OEzBJwfP43cbugzihOQg4Afyl2G8iO+0/RFv8xR8kXimmb3XyuJfxQ3PY8CJ4Y6R4kL8XsBUucvhhRH/NH6BvHahvCrdtcDKkqbiBrW1C9TW4Gjg1zFGnsLvcbxZT8Y45TgCd5vr0UzSB6jm+Sj8XtQb+OlOd1pv8C6TXwCfjiv+KSzI60vxk7sxNHUTLaarkpmtgYkRfzZ+Z6XTEBOo84HhMQ6G0flvsH0BX8RNB27AJ0o1XB+0DA/X0uNwN58p+CJsMzP7DL9T8xjehzM6gcYr8ElSDQOAY4NHR+GLHPDJ6BnylwCUjc078EnB0CTuCOC4aNOLNL7EpqWyUlTJ9I34HZOpUf5PK/JfDpwk/+uBqreePoxPNier5MVM+MK96CJ8LT6GL8VPhefiE//ai0+GAIOjzCan7OHi/RKwkZlNjLiXgF8Dw4L3T9LoMrsNvuCsF4OApcPG3QX0Dzf8omxWYiHZyuWAbSXNkfQO7u7WEt6m0Vb2wb0uTi20sz0YBKwdffBLXM9W2eLlJE3AZSS19WWy0Bbci2/G3F3xe1GOzsEn3k/ii7uqdACEnT0WtzfT8HE8mNZjGi5b4wtxH9dchRPUNQbN7AW8TyfjY6k5G3Ye3oZR+IZligk0jr1R+AsB69mQXdRYGbhF/vKWqbjL5nm4DfvPaGvqbn2q4sVtwBzcZoAvwC/GbdBbuMfB+/im7dAoezwLXrsp4nxgd/l1hr1x3Vupt8zs3aB3HL75+kIb+dDlUbt8mpHRZkha2cxmS1oRn3T/PJTgYg1JQ/AL9PcualoyMjLaBvlbBQ8ourEurpC/6a6bmX0ek+oR+KK9xb8aaWU9qwL/ZWaL7Q56a9GZtrIj+nVJk4WMrgm5O+xAM1vgzeoZHYcu4zOc8bXG9eFysjzuU73YL/4yMjK+/pD/jcE+LFn/ybki8HS4Nwk4qaMXfzDflTYv/pqiM21lu/p1CZWFjIwlFvkEMCMjIyMjIyMjIyMjYwlBvgOYkZGRkZGRkZGRkZGxhCAvADMyMjIyMjIyMjIyMpYQ5AVgRkZGRkZGRkZGRkbGEoK8AMzIyMjIyMjIyMjIyFhCkBeAGRkZGRkZGRkZGRkZSwj+HxI1/BU39/ACAAAAAElFTkSuQmCC\n",
      "text/plain": [
       "<Figure size 1080x1080 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "# bar chart (interventional studies only) showing enrollment by study status\n",
    "plt.bar( interventional['Status'], interventional['Enrollment'], align='center', color='#999999', alpha=1 )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>URL</th>\n",
       "      <th>clean_age</th>\n",
       "      <th>min_age</th>\n",
       "      <th>age_groups</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2049</th>\n",
       "      <td>NCT00006176</td>\n",
       "      <td>Clinical and Genetic Studies of Familial Prese...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Familial Dementia With Neuroserpin Inclusion B...</td>\n",
       "      <td>All</td>\n",
       "      <td>10 Years and older   (Child, Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>100</td>\n",
       "      <td>Observational</td>\n",
       "      <td>August 10, 2000</td>\n",
       "      <td>August 4, 2009</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT00006176</td>\n",
       "      <td>10 Years and older</td>\n",
       "      <td>10</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2206</th>\n",
       "      <td>NCT01682915</td>\n",
       "      <td>Structural and Functional Connectivity of Fron...</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Attention Deficit/Hyperactivity Disorder</td>\n",
       "      <td>All</td>\n",
       "      <td>12 Years to 20 Years   (Child, Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>240</td>\n",
       "      <td>Observational</td>\n",
       "      <td>August 2012</td>\n",
       "      <td>July 2015</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01682915</td>\n",
       "      <td>12 Years to 20 Years</td>\n",
       "      <td>12</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1845</th>\n",
       "      <td>NCT03149380</td>\n",
       "      <td>Effectiveness of Alzheimer's Universe (Www.Alz...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Alzheimer Disease|Alzheimer Disease, Late Onse...</td>\n",
       "      <td>All</td>\n",
       "      <td>14 Years and older   (Child, Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>10000</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>January 2017</td>\n",
       "      <td>October 2024</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03149380</td>\n",
       "      <td>14 Years and older</td>\n",
       "      <td>14</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2065</th>\n",
       "      <td>NCT01699711</td>\n",
       "      <td>Normalization of dyrk1A and APP Function as an...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Down Syndrome (DS)</td>\n",
       "      <td>All</td>\n",
       "      <td>14 Years to 29 Years   (Child, Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>87</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>February 2012</td>\n",
       "      <td>March 2015</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01699711</td>\n",
       "      <td>14 Years to 29 Years</td>\n",
       "      <td>14</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1937</th>\n",
       "      <td>NCT01476228</td>\n",
       "      <td>EEG Objectification in Neuropsychiatry</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Personality Disorder|Depression|Neurodegenerat...</td>\n",
       "      <td>All</td>\n",
       "      <td>15 Years to 90 Years   (Child, Adult, Older Ad...</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>100</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>November 2011</td>\n",
       "      <td>December 2015</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01476228</td>\n",
       "      <td>15 Years to 90 Years</td>\n",
       "      <td>15</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       NCT Number                                              Title  \\\n",
       "2049  NCT00006176  Clinical and Genetic Studies of Familial Prese...   \n",
       "2206  NCT01682915  Structural and Functional Connectivity of Fron...   \n",
       "1845  NCT03149380  Effectiveness of Alzheimer's Universe (Www.Alz...   \n",
       "2065  NCT01699711  Normalization of dyrk1A and APP Function as an...   \n",
       "1937  NCT01476228             EEG Objectification in Neuropsychiatry   \n",
       "\n",
       "              Status                                         Conditions  \\\n",
       "2049       Completed  Familial Dementia With Neuroserpin Inclusion B...   \n",
       "2206  Unknown status           Attention Deficit/Hyperactivity Disorder   \n",
       "1845      Recruiting  Alzheimer Disease|Alzheimer Disease, Late Onse...   \n",
       "2065       Completed                                 Down Syndrome (DS)   \n",
       "1937  Unknown status  Personality Disorder|Depression|Neurodegenerat...   \n",
       "\n",
       "     Gender                                                Age  \\\n",
       "2049    All   10 Years and older   (Child, Adult, Older Adult)   \n",
       "2206    All              12 Years to 20 Years   (Child, Adult)   \n",
       "1845    All   14 Years and older   (Child, Adult, Older Adult)   \n",
       "2065    All              14 Years to 29 Years   (Child, Adult)   \n",
       "1937    All  15 Years to 90 Years   (Child, Adult, Older Ad...   \n",
       "\n",
       "              Phases  Enrollment      Study Type       Start Date  \\\n",
       "2049             NaN         100   Observational  August 10, 2000   \n",
       "2206             NaN         240   Observational      August 2012   \n",
       "1845  Not Applicable       10000  Interventional     January 2017   \n",
       "2065         Phase 2          87  Interventional    February 2012   \n",
       "1937  Not Applicable         100  Interventional    November 2011   \n",
       "\n",
       "     Completion Date                                          URL  \\\n",
       "2049  August 4, 2009  https://ClinicalTrials.gov/show/NCT00006176   \n",
       "2206       July 2015  https://ClinicalTrials.gov/show/NCT01682915   \n",
       "1845    October 2024  https://ClinicalTrials.gov/show/NCT03149380   \n",
       "2065      March 2015  https://ClinicalTrials.gov/show/NCT01699711   \n",
       "1937   December 2015  https://ClinicalTrials.gov/show/NCT01476228   \n",
       "\n",
       "                  clean_age  min_age          age_groups  \n",
       "2049    10 Years and older        10  up to 18 years old  \n",
       "2206  12 Years to 20 Years        12  up to 18 years old  \n",
       "1845    14 Years and older        14  up to 18 years old  \n",
       "2065  14 Years to 29 Years        14  up to 18 years old  \n",
       "1937  15 Years to 90 Years        15  up to 18 years old  "
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "alzheimer.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>URL</th>\n",
       "      <th>clean_age</th>\n",
       "      <th>min_age</th>\n",
       "      <th>age_groups</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2049</th>\n",
       "      <td>NCT00006176</td>\n",
       "      <td>Clinical and Genetic Studies of Familial Prese...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Familial Dementia With Neuroserpin Inclusion B...</td>\n",
       "      <td>All</td>\n",
       "      <td>10 Years and older   (Child, Adult, Older Adult)</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>100</td>\n",
       "      <td>Observational</td>\n",
       "      <td>August 10, 2000</td>\n",
       "      <td>August 4, 2009</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT00006176</td>\n",
       "      <td>10 Years and older</td>\n",
       "      <td>10</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2206</th>\n",
       "      <td>NCT01682915</td>\n",
       "      <td>Structural and Functional Connectivity of Fron...</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Attention Deficit/Hyperactivity Disorder</td>\n",
       "      <td>All</td>\n",
       "      <td>12 Years to 20 Years   (Child, Adult)</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>240</td>\n",
       "      <td>Observational</td>\n",
       "      <td>August 2012</td>\n",
       "      <td>July 2015</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01682915</td>\n",
       "      <td>12 Years to 20 Years</td>\n",
       "      <td>12</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1845</th>\n",
       "      <td>NCT03149380</td>\n",
       "      <td>Effectiveness of Alzheimer's Universe (Www.Alz...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Alzheimer Disease|Alzheimer Disease, Late Onse...</td>\n",
       "      <td>All</td>\n",
       "      <td>14 Years and older   (Child, Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>10000</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>January 2017</td>\n",
       "      <td>October 2024</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03149380</td>\n",
       "      <td>14 Years and older</td>\n",
       "      <td>14</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2065</th>\n",
       "      <td>NCT01699711</td>\n",
       "      <td>Normalization of dyrk1A and APP Function as an...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Down Syndrome (DS)</td>\n",
       "      <td>All</td>\n",
       "      <td>14 Years to 29 Years   (Child, Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>87</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>February 2012</td>\n",
       "      <td>March 2015</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01699711</td>\n",
       "      <td>14 Years to 29 Years</td>\n",
       "      <td>14</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1937</th>\n",
       "      <td>NCT01476228</td>\n",
       "      <td>EEG Objectification in Neuropsychiatry</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Personality Disorder|Depression|Neurodegenerat...</td>\n",
       "      <td>All</td>\n",
       "      <td>15 Years to 90 Years   (Child, Adult, Older Ad...</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>100</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>November 2011</td>\n",
       "      <td>December 2015</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01476228</td>\n",
       "      <td>15 Years to 90 Years</td>\n",
       "      <td>15</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       NCT Number                                              Title  \\\n",
       "2049  NCT00006176  Clinical and Genetic Studies of Familial Prese...   \n",
       "2206  NCT01682915  Structural and Functional Connectivity of Fron...   \n",
       "1845  NCT03149380  Effectiveness of Alzheimer's Universe (Www.Alz...   \n",
       "2065  NCT01699711  Normalization of dyrk1A and APP Function as an...   \n",
       "1937  NCT01476228             EEG Objectification in Neuropsychiatry   \n",
       "\n",
       "              Status                                         Conditions  \\\n",
       "2049       Completed  Familial Dementia With Neuroserpin Inclusion B...   \n",
       "2206  Unknown status           Attention Deficit/Hyperactivity Disorder   \n",
       "1845      Recruiting  Alzheimer Disease|Alzheimer Disease, Late Onse...   \n",
       "2065       Completed                                 Down Syndrome (DS)   \n",
       "1937  Unknown status  Personality Disorder|Depression|Neurodegenerat...   \n",
       "\n",
       "     Gender                                                Age  \\\n",
       "2049    All   10 Years and older   (Child, Adult, Older Adult)   \n",
       "2206    All              12 Years to 20 Years   (Child, Adult)   \n",
       "1845    All   14 Years and older   (Child, Adult, Older Adult)   \n",
       "2065    All              14 Years to 29 Years   (Child, Adult)   \n",
       "1937    All  15 Years to 90 Years   (Child, Adult, Older Ad...   \n",
       "\n",
       "              Phases  Enrollment      Study Type       Start Date  \\\n",
       "2049         Phase 4         100   Observational  August 10, 2000   \n",
       "2206         Phase 4         240   Observational      August 2012   \n",
       "1845  Not Applicable       10000  Interventional     January 2017   \n",
       "2065         Phase 2          87  Interventional    February 2012   \n",
       "1937  Not Applicable         100  Interventional    November 2011   \n",
       "\n",
       "     Completion Date                                          URL  \\\n",
       "2049  August 4, 2009  https://ClinicalTrials.gov/show/NCT00006176   \n",
       "2206       July 2015  https://ClinicalTrials.gov/show/NCT01682915   \n",
       "1845    October 2024  https://ClinicalTrials.gov/show/NCT03149380   \n",
       "2065      March 2015  https://ClinicalTrials.gov/show/NCT01699711   \n",
       "1937   December 2015  https://ClinicalTrials.gov/show/NCT01476228   \n",
       "\n",
       "                  clean_age  min_age          age_groups  \n",
       "2049    10 Years and older        10  up to 18 years old  \n",
       "2206  12 Years to 20 Years        12  up to 18 years old  \n",
       "1845    14 Years and older        14  up to 18 years old  \n",
       "2065  14 Years to 29 Years        14  up to 18 years old  \n",
       "1937  15 Years to 90 Years        15  up to 18 years old  "
      ]
     },
     "execution_count": 50,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# replace all NaN values from column Phases (observational studies) with 'Phase 4'\n",
    "alzheimer['Phases'].fillna('Phase 4', inplace=True)\n",
    "alzheimer.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [],
   "source": [
    "# create a clean dataset with the columns which are going to be used\n",
    "alzheimer_clean = alzheimer.loc[:, ['NCT Number', 'Title', 'Status', 'clean_age', 'Phases', 'Enrollment', \n",
    "                                    'Study Type', 'URL', 'age_groups']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nct_number</th>\n",
       "      <th>title</th>\n",
       "      <th>status</th>\n",
       "      <th>clean_age</th>\n",
       "      <th>phases</th>\n",
       "      <th>enrollment</th>\n",
       "      <th>study_type</th>\n",
       "      <th>url</th>\n",
       "      <th>age_groups</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2049</th>\n",
       "      <td>NCT00006176</td>\n",
       "      <td>Clinical and Genetic Studies of Familial Prese...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>10 Years and older</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>100</td>\n",
       "      <td>Observational</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT00006176</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2206</th>\n",
       "      <td>NCT01682915</td>\n",
       "      <td>Structural and Functional Connectivity of Fron...</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>12 Years to 20 Years</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>240</td>\n",
       "      <td>Observational</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01682915</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1845</th>\n",
       "      <td>NCT03149380</td>\n",
       "      <td>Effectiveness of Alzheimer's Universe (Www.Alz...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>14 Years and older</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>10000</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03149380</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2065</th>\n",
       "      <td>NCT01699711</td>\n",
       "      <td>Normalization of dyrk1A and APP Function as an...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>14 Years to 29 Years</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>87</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01699711</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1937</th>\n",
       "      <td>NCT01476228</td>\n",
       "      <td>EEG Objectification in Neuropsychiatry</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>15 Years to 90 Years</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>100</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01476228</td>\n",
       "      <td>up to 18 years old</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       nct_number                                              title  \\\n",
       "2049  NCT00006176  Clinical and Genetic Studies of Familial Prese...   \n",
       "2206  NCT01682915  Structural and Functional Connectivity of Fron...   \n",
       "1845  NCT03149380  Effectiveness of Alzheimer's Universe (Www.Alz...   \n",
       "2065  NCT01699711  Normalization of dyrk1A and APP Function as an...   \n",
       "1937  NCT01476228             EEG Objectification in Neuropsychiatry   \n",
       "\n",
       "              status              clean_age          phases  enrollment  \\\n",
       "2049       Completed    10 Years and older          Phase 4         100   \n",
       "2206  Unknown status  12 Years to 20 Years          Phase 4         240   \n",
       "1845      Recruiting    14 Years and older   Not Applicable       10000   \n",
       "2065       Completed  14 Years to 29 Years          Phase 2          87   \n",
       "1937  Unknown status  15 Years to 90 Years   Not Applicable         100   \n",
       "\n",
       "          study_type                                          url  \\\n",
       "2049   Observational  https://ClinicalTrials.gov/show/NCT00006176   \n",
       "2206   Observational  https://ClinicalTrials.gov/show/NCT01682915   \n",
       "1845  Interventional  https://ClinicalTrials.gov/show/NCT03149380   \n",
       "2065  Interventional  https://ClinicalTrials.gov/show/NCT01699711   \n",
       "1937  Interventional  https://ClinicalTrials.gov/show/NCT01476228   \n",
       "\n",
       "              age_groups  \n",
       "2049  up to 18 years old  \n",
       "2206  up to 18 years old  \n",
       "1845  up to 18 years old  \n",
       "2065  up to 18 years old  \n",
       "1937  up to 18 years old  "
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# get clean dataset with the columns needed for visualizations\n",
    "alzheimer_clean.columns = ['nct_number', 'title', 'status', 'clean_age', 'phases', 'enrollment', 'study_type', \n",
    "                                   'url', 'age_groups']\n",
    "alzheimer_clean.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'nct_number': 'NCT00006176', 'title': 'Clinical and Genetic Studies of Familial Presenile Dementia With Neuronal Inclusion Bodies', 'status': 'Completed', 'clean_age': '10 Years and older ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00006176', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01682915', 'title': 'Structural and Functional Connectivity of Frontostriatal and Frontoparietal Networks as Endophenotypes of ADHD', 'status': 'Unknown status', 'clean_age': '12 Years to 20 Years ', 'phases': 'Phase 4', 'enrollment': 240, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01682915', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03149380', 'title': \"Effectiveness of Alzheimer's Universe (Www.AlzU.Org) on Knowledge and Behavior\", 'status': 'Recruiting', 'clean_age': '14 Years and older ', 'phases': 'Not Applicable', 'enrollment': 10000, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03149380', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01699711', 'title': 'Normalization of dyrk1A and APP Function as an Approach to Improve Cognitive Performance and Decelerate AD Progression in DS Subjects: Epigallocatechin Gallate as Therapeutic Tool', 'status': 'Completed', 'clean_age': '14 Years to 29 Years ', 'phases': 'Phase 2', 'enrollment': 87, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01699711', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01476228', 'title': 'EEG Objectification in Neuropsychiatry', 'status': 'Unknown status', 'clean_age': '15 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01476228', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00165100', 'title': 'Dynamic Area Telethermometry (DAT) as an Imaging Modality in Patients With Cancer', 'status': 'Completed', 'clean_age': '16 Years and older ', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00165100', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00978536', 'title': 'A Monocenter, Cross-sectional Study to Compare Different Type of Cognitive Impairment in Multiple Sclerosis Patients and Cerebrospinal Fluid Biomarkers (Beta Amyloid, Total Tau Protein and Tau-phosphorylated Protein).', 'status': 'Terminated', 'clean_age': '17 Years to 66 Years ', 'phases': 'Not Applicable', 'enrollment': 29, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00978536', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT04117178', 'title': 'Monitoring Anti-Dementia Drugs by Serum Levels', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 110, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04117178', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03902548', 'title': \"Initial Investigation of [18F]P16-129 in Alzheimer's Disease Patients and Healthy Volunteers\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03902548', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01095744', 'title': \"Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01095744', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03602391', 'title': 'The Senior Companion Program Plus', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03602391', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02291783', 'title': 'Phase I, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of an M1 Agonist to Treat Cognitive Impairment', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 108, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02291783', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02333942', 'title': 'Dementia Signal Development Study of Nautilus NeuroWave TM for the Detection of Dementia', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 41, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02333942', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03942341', 'title': \"Sleep in Adults With Down Syndrome and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 90, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03942341', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02134041', 'title': 'Amyloid Accumulation After Mild Traumatic Brain Injury', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02134041', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03858283', 'title': 'Mindfulness for Alzheimer Caregivers', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 145, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03858283', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02697721', 'title': 'Powerful Tools for Caregivers of Dementia Patients', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02697721', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01901263', 'title': 'Patients With Behavioural Symptoms and Hospitalized in Cognitive and Behavioural Units', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 306, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01901263', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01982578', 'title': \"Genistein as a Possible Treatment for Alzheimer's Disease.\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01982578', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01128725', 'title': \"Truncated and Extended Forms of Amyloid Beta Peptides in Alzheimer's Disease: Genesis, Toxicity and Identification as Biological Markers\", 'status': 'Unknown status', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01128725', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03687710', 'title': \"The Comparative Effectiveness Dementia & Alzheimer's Registry\", 'status': 'Active, not recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 1000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03687710', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03444181', 'title': 'ALzheimer and MUsic THerapy: Effects of Music Lessons on Brain Plasticity, Mood, and Quality of Life in Alzheimer Patients', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 135, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03444181', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03019757', 'title': \"Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 76, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03019757', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00291161', 'title': \"Partners in Dementia Care: A Telephone Care Consultation Intervention Provided to Veterans in Partnership With Local Alzheimer's Association Chapters\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 994, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00291161', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03288363', 'title': \"Transcranial Direct Current Stimulation and Early Alzheimer's Disease (tDCS-AD)\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03288363', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00585572', 'title': 'Wisconsin Brain Donor Program', 'status': 'Enrolling by invitation', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 500, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00585572', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02576821', 'title': \"Hippocampal Sclerosis and Amnesia Not Due to Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 140, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02576821', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00908492', 'title': 'Supporting Caregivers of Persons With Dementia: A Pilot Study', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00908492', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01652222', 'title': 'Experimental Study to Validate the \"Therapeutic Game\" CONEM-BETA', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 101, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01652222', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02690896', 'title': 'Caregiver Burden and Depression: Caring for Those Who Care for Others', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02690896', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02299154', 'title': 'Memory Problems Perceptions Among Patients and Accompaniers During Diagnosis Process :', 'status': 'Unknown status', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02299154', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT04058886', 'title': 'Telephone-delivered Mindfulness Intervention for African American Dementia Caregivers', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04058886', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01554202', 'title': \"Multi-modal Neuroimaging in Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 295, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01554202', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03144921', 'title': 'EPIC: An Intervention for Early-stage AD Dyads', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 320, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03144921', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03923517', 'title': 'RHAPSODY-plus: Online Counseling for Family Caregivers of Patients With Young Onset Dementia', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03923517', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01209156', 'title': 'Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological Conditions', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 11, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01209156', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02951559', 'title': 'SOLFAMU Study of Nasal Brushing Collected OLFActory MUcosa Samples in the Diagnosis of Human Encephalopathies', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02951559', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01723553', 'title': 'Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 27, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01723553', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03119259', 'title': 'iCare-AD: A Mobile Health Application for Caregivers of Patients With Dementia.', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 448, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03119259', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00479219', 'title': \"Study Evaluating GSI-953 in Healthy Young and Alzheimer's Patients\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00479219', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03828383', 'title': 'In-Home Technology for Dementia Caregivers', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03828383', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00795730', 'title': 'Multiple Dose Study Evaluating the Safety and Tolerability of NSA-789', 'status': 'Terminated', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 56, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00795730', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03342326', 'title': \"Lexical Priming by Music in Alzheimer's Disease and Healthy Aging\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 78, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03342326', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01926249', 'title': \"A Cohort of Outpatients From French Research Memory Centers in Order to Improve Knowledge on Alzheimer's Disease and Related Disorders\", 'status': 'Active, not recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 2300, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01926249', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03715855', 'title': 'Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03715855', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03721042', 'title': 'Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03721042', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00001178', 'title': 'Brain Study of Patients With Frontal Lobe Dementia and Parkinsonian Disorders', 'status': 'Terminated', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 597, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00001178', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03653156', 'title': 'China Cognition and Aging Study', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 25000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03653156', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03031184', 'title': 'Study of Mirtazapine for Agitation in Dementia', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 3', 'enrollment': 222, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03031184', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01028209', 'title': 'Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions', 'status': 'Terminated', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01028209', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01518374', 'title': 'Clinical Evaluation of Florbetapir F 18 (18F-AV-45)', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 1768, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01518374', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01550549', 'title': 'Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 151, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01550549', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02278367', 'title': 'Clinical Evaluation of 18F-AV-1451', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02278367', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02108769', 'title': 'Yogic Breathing Changes Salivary Components', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02108769', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01190800', 'title': \"Capacity Assessment in Persons With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 400, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01190800', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00970333', 'title': 'Evaluation of [18F] FEPPA and PET Imaging as a Marker of Inflammation in Subjects With Neurological Conditions', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 3, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00970333', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00654563', 'title': 'Memory Disorders Registry', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 12, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00654563', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02612376', 'title': \"Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 800, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02612376', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02205424', 'title': 'Cognition And Neocortical Volume After Stroke', 'status': 'Active, not recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 175, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02205424', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03047694', 'title': \"A Lexico-semantic Program on Tactile Tablet for Patients With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03047694', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02063308', 'title': 'Oxaloacetate Pharmacokinetics and Safety', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02063308', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT04099823', 'title': 'MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04099823', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00857415', 'title': 'Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 3', 'enrollment': 226, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00857415', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT04077450', 'title': \"HRVB on Alzheimer's Disease Caregivers\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04077450', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01819714', 'title': \"Sensory Support Care for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 31, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01819714', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00362284', 'title': \"Comprehensive Support for Alzheimer's Disease Caregivers\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 161, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00362284', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02968719', 'title': 'A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 107, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02968719', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02414178', 'title': \"F 18 T807 Tau PET Imaging in Dominantly Inherited Alzheimer's Network (DIAN Project)\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 130, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02414178', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00366288', 'title': 'Study Evaluating PAZ-417 in Healthy Young/Elderly', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 56, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00366288', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01745198', 'title': 'Effect of Cerefolin®/CerefolinNAC® on Biomarker Measurements', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 121, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01745198', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00474552', 'title': 'Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315', 'status': 'Terminated', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 56, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00474552', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00480818', 'title': 'Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Young and Elderly Subjects', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00480818', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02418806', 'title': \"Group Therapy for Caregivers of Alzheimer's Disease Patients in Spanish Elderly Persons Centres\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 231, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02418806', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01837641', 'title': \"A Study of LY3002813 in Participants With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01837641', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02563483', 'title': 'Yoga for Family Caregivers of Alzheimers Disease Patient', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 46, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02563483', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01640275', 'title': 'Markers of Alzheimers Disease After Propofol or Isoflurane Anesthesia', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 105, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01640275', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02362880', 'title': \"Study of Genetic Alzheimer's Disease Mutation Carriers in Preclinical Stages of the Disease 18F-Florbetaben Positron Emission Tomography Study\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02362880', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02506374', 'title': 'Development of Therapeutic Intervention for Sleep in Alzheimer/Caregiver Dyads', 'status': 'Withdrawn', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 0, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02506374', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00718731', 'title': 'Study GSI-136 in Healthy Young and Healthy Elderly Subjects', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00718731', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00089882', 'title': \"Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 360, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00089882', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01079819', 'title': 'Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-708163', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01079819', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01181921', 'title': \"The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 1, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01181921', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01447719', 'title': 'Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 3', 'enrollment': 110, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01447719', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01454115', 'title': 'Study to Evaluate the Safety, Pharmacokinetics and Tolerability of BMS-708163', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 116, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01454115', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01268020', 'title': 'Evaluation of [18F] FMH3 and PET as a Marker of Histamine-3 Receptor Activity in Subjects With AD Compared w/ HC', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01268020', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01565369', 'title': 'Evaluation of Physician Training Methods to Read Florbetapir-PET Scans', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 35, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01565369', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00366483', 'title': 'Study Evaluating the Safety of Lecozotan SR in Healthy Young and Elderly Subjects', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00366483', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT04111211', 'title': 'Long-term Follow-up of Cognitive and Functional Evolutions of Persons With Isolated Cognitive Complaints or Mild Cognitive Deficits', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 2000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04111211', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT04123314', 'title': \"Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04123314', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01089582', 'title': \"Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 628, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01089582', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03049501', 'title': 'Caring for the Caregiver Network', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 244, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03049501', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03770182', 'title': 'Brain Stimulation for Neurological Patients', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03770182', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03033875', 'title': 'Testing Tele-Savvy, an On-line Psychoeducation Program for Dementia Family Caregivers', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 270, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03033875', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03667924', 'title': 'Utilizing Senior Companions to Enhance Dementia Care', 'status': 'Enrolling by invitation', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03667924', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01117181', 'title': 'Apathy in Dementia Methylphenidate Trial (ADMET)', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01117181', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03654911', 'title': \"Sustainable Method for Alzheimer's Prediction\", 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03654911', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02164643', 'title': 'Longitudinal Study of Brain Amyloid imaGing in MEMENTO', 'status': 'Active, not recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 3', 'enrollment': 448, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02164643', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01978327', 'title': 'GSK2647544 RD, DDI in Healthy Young and Elderly Volunteers', 'status': 'Terminated', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01978327', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00869817', 'title': 'Dominantly Inherited Alzheimer Network (DIAN)', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 700, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00869817', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03233646', 'title': \"OCTA in Mild Cognitive Impairment and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 1000, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03233646', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03994237', 'title': 'Accompanying ALZHEIMER CAREGIVER', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 45, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03994237', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02489110', 'title': 'Webnovela for Hispanic Dementia Family Caregivers', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02489110', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02752750', 'title': \"Longitudinal Quantitative Susceptibility Mapping (QSM) in Alzheimer 's Disease\", 'status': 'Enrolling by invitation', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02752750', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02707978', 'title': 'F 18 T807 Tau PET Imaging of Frontotemporal Dementia (FTD)', 'status': 'Withdrawn', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02707978', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01450891', 'title': \"Health Technology Assessment of Diagnostic Approaches in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 304, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01450891', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00192998', 'title': 'The Serotonergic Transmitter System in Dementia and Affective Disorders', 'status': 'Unknown status', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00192998', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02319681', 'title': \"Reminiscence, Anxiety and Early Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02319681', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02414347', 'title': \"F 18 T807 Tau PET Imaging of Alzheimer's Disease\", 'status': 'Enrolling by invitation', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02414347', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT04100889', 'title': \"A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04100889', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02271685', 'title': 'Sound Estimation and Accuracy Task', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 600, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02271685', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01672827', 'title': 'Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]Flutemetamol Positron Emission Tomography (PET) Images', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 3', 'enrollment': 276, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01672827', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03938870', 'title': \"CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03938870', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03308032', 'title': 'Self-Directed Online Training for Chinese Caregivers', 'status': 'Unknown status', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03308032', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02556502', 'title': \"18F-Florbetaben PET Amyloid Imaging in Case of Intermediate CSF Biology for the Diagnosis of Alzheimer's Disease : a Pilot Study\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02556502', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03816228', 'title': 'Imaging of Brain Structural/Functional Connectivity and Amyloid and Tau Lesions in APOE4 Carriers.', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03816228', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00407576', 'title': 'PET Imaging of Brain Amyloid Using [11C]MeS-IMPY', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00407576', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02403752', 'title': 'Paired Integrative Home Exercise for Seniors With Dementia and Their Caregivers (PairedPLIE)', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02403752', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01434667', 'title': \"Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IV\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 146, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01434667', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03323502', 'title': \"Aligning Patient Preferences: a Role Offering Alzheimer's Patients, Caregivers, and Healthcare Providers Education and Support\", 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 22650, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03323502', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03786471', 'title': 'D-CARE - The Dementia Care Study: A Pragmatic Clinical Trial of Health System-Based Versus Community-Based Dementia Care', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 2150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03786471', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02278354', 'title': 'Tau Imaging in Professional Fighters', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02278354', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03311711', 'title': 'Two-Phased Study of SPIRIT in Mild Dementia', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 264, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03311711', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02221661', 'title': 'Performance of AclarusDx® a Blood-Based Transcriptomic Test for AD, in French Patients Newly Referred to a Memory Center', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 606, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02221661', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01638949', 'title': \"Multi-modal Neuroimaging in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 295, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01638949', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03987464', 'title': 'Platform-based Mild Cognitive Impairment (MCI) Trial', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03987464', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02392468', 'title': \"Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 61, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02392468', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03387267', 'title': 'Videofluoroscopic Swallowing Study (VFSS)', 'status': 'Terminated', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 442, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03387267', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT04104659', 'title': 'Study of Tau Imaging With the Use of [18F]MK-6240 Tracer', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04104659', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03076307', 'title': \"DAT SPECT and Procedural Motor Skills in Parkinson's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 9, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03076307', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01700556', 'title': 'A Trial to Support Caregivers of Patients With Dementia in Italy: the UP-TECH Project', 'status': 'Unknown status', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 900, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01700556', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02014246', 'title': 'Genetic Characterization of Movement Disorders and Dementias', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 12000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02014246', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT04055532', 'title': 'Biomarkers in Neurodegenerative Diseases', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 200, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04055532', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00253227', 'title': \"A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 3', 'enrollment': 387, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00253227', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03909347', 'title': 'PLAN: Dementia Literacy Education and Navigation for Korean Elders With Probable Dementia and Their Caregivers', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 288, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03909347', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT04048759', 'title': \"The Promotion of Physical Activity for the Prevention of Alzheimer's Disease in Adults With Down Syndrome\", 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04048759', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03945968', 'title': 'The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 16000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03945968', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02522091', 'title': \"Cerebral Substrates of Prospective Memory in Young and Its Disruption in Normal Aging and in Alzheimer's Disease: A Study in Anatomical MRI, Diffusion Tensor MRI and Functional MRI\", 'status': 'Unknown status', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 178, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02522091', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03724136', 'title': \"Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03724136', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03899298', 'title': 'Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 5000, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03899298', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02750982', 'title': 'Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02750982', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00253188', 'title': \"A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 3', 'enrollment': 653, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00253188', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT04037501', 'title': 'Effectiveness of a Care Management System to Reduce Unmet Needs of Informal Caregivers of People With Dementia', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 504, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04037501', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01565434', 'title': 'Erythrocyte Complement Receptor 1 and Alzheimer Disease', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01565434', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00253201', 'title': \"A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 3', 'enrollment': 636, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00253201', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01366027', 'title': 'PRISM Registry: Pseudobulbar Affect Registry Series', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 5290, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01366027', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03734289', 'title': 'Improving Family Quality of Life Through Training to Reduce Care-Resistant Behaviors by People With AD and TBI', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03734289', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02494531', 'title': \"Illiteracy and Vulnerability to Alzheimer's Disease: Evaluation of Amyloid Pathology by PET Imaging\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02494531', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03592563', 'title': 'CUHK Brain Health Longitudinal Study', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 5000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03592563', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00145132', 'title': 'Beta-CIT-SPECT and Neurophysiology in Depression', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00145132', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03506672', 'title': 'Assessing the Effectiveness of an Approach for Vocal Behaviors in Older People Living in Nursing Homes', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 324, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03506672', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03907748', 'title': 'Home-based Family Caregiver-delivered Music and Reading Interventions for People With Dementia', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 990, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03907748', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03623542', 'title': 'Adverse Drug Reactions in Older Subjects', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 293, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03623542', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01867359', 'title': 'The Genetic Characterization of Dementia', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 87, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01867359', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03657732', 'title': \"The Chinese Familial Alzheimer's Network\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 10000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03657732', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00321971', 'title': 'Prevention of Depression in Spouses of People With Cognitive Impairment', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 73, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00321971', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03628404', 'title': \"Defining the Genetic Etiology of Alzheimer's Disease in the Faroe Islands\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 1000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03628404', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00874783', 'title': 'Development of iPS From Donated Somatic Cells of Patients With Neurological Diseases', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00874783', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00878059', 'title': \"Alzheimer's Family Research\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 165, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00878059', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00249080', 'title': 'Magnetic Resonance Imaging (MRI) of Brain Iron in Neurodegenerative Disease', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 182, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00249080', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03650816', 'title': \"Cerebrovascular Reactivity in Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 48, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03650816', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03098459', 'title': 'Illuminating Neuropsychological Dysfunction and Systemic Inflammatory Mechanisms Gleaned After Hospitalization in Trauma-ICU Study', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 900, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03098459', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02402426', 'title': 'Brain Health Registry', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 100000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02402426', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01807026', 'title': \"A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01807026', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01334749', 'title': 'Observational Study on Determinants of Dementia After Stroke', 'status': 'Active, not recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 736, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01334749', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01078168', 'title': 'Alzheimer`s Disease Acitretin Medication', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01078168', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00086138', 'title': \"Depression in Alzheimer's Disease-2\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 131, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00086138', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01550718', 'title': 'Two Interventions for Early Stage Dementia: A Comparative Efficacy Trial', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 152, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01550718', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT04113577', 'title': 'COgilus Remediation in Alzheimer Patients (CORA)', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04113577', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01639586', 'title': 'Comparison for the Patient With Alzheimer Disease the Impact of Three Different Groups of Patient Care', 'status': 'Unknown status', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 360, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01639586', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01353430', 'title': \"Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01353430', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03417219', 'title': 'Mobile Tablet Education to Advance Caregiver Health', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03417219', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03894254', 'title': 'Predictive Factors of Autonomy Loss in Real-life Cohort', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 5250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03894254', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03610698', 'title': 'Life Enhancing Activities for Family Caregivers (LEAF 2.0)', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 500, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03610698', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT04044131', 'title': \"Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients\", 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04044131', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01430286', 'title': \"Web-based Psycho-Educational Program to Support Carers of Alzheimer's Patients\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 49, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01430286', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02428387', 'title': 'Evaluation of \"My Tools 4 Care\" for Family Caregivers of Persons With Dementia', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 199, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02428387', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01513967', 'title': \"A Randomized SAD and MAD Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01513967', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00459355', 'title': \"Home Safety Clinical Trial for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 254, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00459355', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02868905', 'title': \"Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in Women\", 'status': 'Unknown status', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02868905', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01638884', 'title': 'Prospective Memory Imaging', 'status': 'Unknown status', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 118, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01638884', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03185182', 'title': 'Diagnostic Imaging for Clear Cell Renal Cell Carcinoma', 'status': 'Terminated', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03185182', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03864965', 'title': 'Advance Care Planning in Cognitive Disorders Clinic', 'status': 'Recruiting', 'clean_age': '18 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03864965', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02309723', 'title': 'Influence of Beta Amyloid Imaging on Care of Patients Cognitive Complaints.', 'status': 'Completed', 'clean_age': '18 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 315, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02309723', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02650843', 'title': 'Non-motor Symptoms and Brain Dopamine Transporter Binding', 'status': 'Enrolling by invitation', 'clean_age': '18 Years to 100 Years ', 'phases': 'Phase 4', 'enrollment': 1000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02650843', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01592552', 'title': \"A Biospecimen and Clinical Data Study on Patients With Alzheimer's, Multiple Sclerosis, Parkinson's, and Huntington's, for Drug & Biomarker Discovery\", 'status': 'Completed', 'clean_age': '18 Years to 100 Years ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01592552', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03448601', 'title': \"Alzheimer's Disease and Precision Medicine Research With American Indian and Alaska Native People\", 'status': 'Not yet recruiting', 'clean_age': '18 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 3000, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03448601', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02685787', 'title': \"Early Counseling and Support for Alzheimer's Disease Caregivers\", 'status': 'Unknown status', 'clean_age': '18 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 230, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02685787', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03134963', 'title': 'Cerebral Haemodynamic Changes During Cognitive Testing: A fTCD Study', 'status': 'Completed', 'clean_age': '18 Years to 100 Years ', 'phases': 'Phase 4', 'enrollment': 51, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03134963', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03282916', 'title': \"Anti-viral Therapy in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years to 105 Years ', 'phases': 'Phase 2', 'enrollment': 130, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03282916', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03108846', 'title': \"Escitalopram for Agitation in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years to 109 Years ', 'phases': 'Phase 3', 'enrollment': 392, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03108846', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03932812', 'title': 'Building a Bridge (BAB) Between Clinical and Community Care', 'status': 'Not yet recruiting', 'clean_age': '18 Years to 110 Years ', 'phases': 'Not Applicable', 'enrollment': 106, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03932812', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03682185', 'title': 'The Healthy Patterns Study', 'status': 'Recruiting', 'clean_age': '18 Years to 110 Years ', 'phases': 'Phase 3', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03682185', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02022943', 'title': \"Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies\", 'status': 'Recruiting', 'clean_age': '18 Years to 110 Years ', 'phases': 'Phase 4', 'enrollment': 500000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02022943', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03896711', 'title': 'MEMORI Corps: Activity-based Companion Care for Dementia', 'status': 'Not yet recruiting', 'clean_age': '18 Years to 115 Years ', 'phases': 'Not Applicable', 'enrollment': 560, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03896711', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03653871', 'title': 'Caregiver Study Dr. Phillips', 'status': 'Recruiting', 'clean_age': '18 Years to 115 Years ', 'phases': 'Not Applicable', 'enrollment': 210, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03653871', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01498263', 'title': 'Inherited Diseases, Caregiving, and Social Networks', 'status': 'Recruiting', 'clean_age': '18 Years to 118 Years ', 'phases': 'Phase 4', 'enrollment': 3300, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01498263', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02681822', 'title': 'Multi-center Imaging Genetics Studies in China', 'status': 'Recruiting', 'clean_age': '18 Years to 30 Years ', 'phases': 'Phase 4', 'enrollment': 10000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02681822', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02899403', 'title': 'Neurophysiological Correlates of Cognitive Tasks in Healthy Volunteers -WP3 P003', 'status': 'Recruiting', 'clean_age': '18 Years to 30 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02899403', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02288000', 'title': 'Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases', 'status': 'Recruiting', 'clean_age': '18 Years to 30 Years ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02288000', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02891343', 'title': 'Effect of Hypoxia on Cognitive Assessment and Cerebral Activity in Healthy Volunteers', 'status': 'Recruiting', 'clean_age': '18 Years to 30 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02891343', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02453763', 'title': 'In Vivo Imaging of Therapeutic Electric Current Flow', 'status': 'Completed', 'clean_age': '18 Years to 30 Years ', 'phases': 'Phase 4', 'enrollment': 17, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02453763', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01487395', 'title': 'Prediction of Cognitive Properties of New Drug Candidates for Neurodegenerative Diseases in Early Clinical Development', 'status': 'Completed', 'clean_age': '18 Years to 30 Years ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01487395', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00592943', 'title': 'PET Study Examining the Dopaminergic Activity of Armodafinil in Adults', 'status': 'Completed', 'clean_age': '18 Years to 35 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00592943', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03711825', 'title': 'Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules Containing Memantine Hydrochloride in Healthy Adults', 'status': 'Completed', 'clean_age': '18 Years to 40 Years ', 'phases': 'Early Phase 1', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03711825', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT04023994', 'title': 'A Single Ascending Dose Study to Investigate the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Intravenously Administered RO7126209 in Healthy Participants', 'status': 'Recruiting', 'clean_age': '18 Years to 40 Years ', 'phases': 'Phase 1', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04023994', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01325662', 'title': 'A Study to Evaluate the Use of an Indwelling Catheter to Obtain Cerebrospinal Fluid (CSF) by Low-rate Continuous Sampling (MK-0000-211)', 'status': 'Completed', 'clean_age': '18 Years to 40 Years ', 'phases': 'Phase 4', 'enrollment': 11, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01325662', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03698695', 'title': 'A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers', 'status': 'Active, not recruiting', 'clean_age': '18 Years to 40 Years ', 'phases': 'Phase 1', 'enrollment': 152, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03698695', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01258452', 'title': 'Study to Evaluate the Effects of Food Ingestion on the Pharmacokinetics of CHF 5074 in Healthy Young Male Subjects', 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01258452', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00954252', 'title': 'Safety, Pharmacokinetics and Pharmacodynamics Study of Treatment With CHF 5074 in Healthy Young Male Subjects', 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 84, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00954252', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00479700', 'title': 'Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00479700', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01203384', 'title': 'Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of CHF5074 in Healthy Young Male Subjects', 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01203384', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00726726', 'title': \"Drug Interaction Study With a Potential Alzheimer's Disease Compound\", 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00726726', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00689637', 'title': 'Drug Interaction Study Between AZD3480 and Warfarin', 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 26, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00689637', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00901498', 'title': \"Relative Bioavailability Study of Four Experimental Formulations for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00901498', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00689559', 'title': 'Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 52, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00689559', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02051335', 'title': 'Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults', 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 27, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02051335', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00884533', 'title': 'QTc Study of Rosi XR in Healthy Volunteers', 'status': 'Withdrawn', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00884533', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03944460', 'title': 'SAD Phase I Study (First-in-human) to Investigate Contraloid Acetate', 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03944460', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03955380', 'title': 'MAD Phase I Study to Investigate Contraloid Acetate', 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03955380', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00479440', 'title': 'Study Evaluating the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-315 in Healthy Adults', 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 56, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00479440', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00906191', 'title': 'Study Evaluating How Quickly And To What Extent The 14-Carbon-SAM-531 Is Absorbed/Converted/Eliminated In Male Subjects', 'status': 'Completed', 'clean_age': '18 Years to 50 Years ', 'phases': 'Phase 1', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00906191', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03971123', 'title': 'Study to Compare the Pharmacokinetics of Two Formulations of Tricaprilin and a Placebo on Ketone Body Production', 'status': 'Recruiting', 'clean_age': '18 Years to 50 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03971123', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00452504', 'title': 'Single Ascending Dose Study of SRA-444 in Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 50 Years ', 'phases': 'Phase 1', 'enrollment': 64, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00452504', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00519298', 'title': 'Study Evaluating Effects of SAM-531 on Sleep Electroencephalogram (EEG) and Quantitative Wake EEG in Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 50 Years ', 'phases': 'Phase 1', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00519298', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00959881', 'title': 'Study Evaluating The Coadministration of Begacestat And Donepezil', 'status': 'Completed', 'clean_age': '18 Years to 50 Years ', 'phases': 'Phase 1', 'enrollment': 47, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00959881', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00459693', 'title': 'PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)', 'status': 'Terminated', 'clean_age': '18 Years to 50 Years ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00459693', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00494962', 'title': 'Study Comparing Lecozotan SR Two 5-mg Tablets Vs. Lecozotan SR One 10-mg Tablet in Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 50 Years ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00494962', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02126514', 'title': 'A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02126514', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03030105', 'title': 'Study to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy Volunteers', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03030105', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02197884', 'title': 'A Study to Assess Effects of Clarithromycin on Pharmacokinetics of JNJ-54861911 in Healthy Male Participants', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 13, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02197884', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03587649', 'title': 'Evaluation of [18F]MNI-1126 as an Imaging Marker for Synaptic Density Loss', 'status': 'Recruiting', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03587649', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03551769', 'title': 'Pharmacokinetics of Tricaprilin Including Food Effect on Ketone Body Production', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03551769', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00692510', 'title': 'Drug Interaction Study Between AZD3480 and Cytochrome P450', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00692510', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00745576', 'title': 'Study Evaluating The Potential Interaction Between Verapamil Immediate Release And SAM-531 When Co-Administered', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00745576', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00733785', 'title': 'PK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy Volunteers', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00733785', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00987220', 'title': 'Effect of Aricept on Biomarkers (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 4', 'enrollment': 12, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00987220', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03635879', 'title': 'Medical Food Formulation Pharmacokinetic (PK) Study in Medium Chain Triglycerides', 'status': 'Withdrawn', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03635879', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00468897', 'title': 'A Study To Demonstrate The Bioequivalence Of Rosiglitazone XR (BRL-049653) 8mgs XR Manufactured At Two Different Sites.', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00468897', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00831506', 'title': 'Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00831506', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02005991', 'title': 'A Study To Examine The Distribution Of PF-05212377 In The Brain Of Healthy Volunteer Subjects Using Positron Emission Tomography And A Radioactive Tracer Following Oral Administration Of One Dose Of PF-05212377', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 4, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02005991', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02211079', 'title': 'A Study to Assess Effect of JNJ-54861911 on Pharmacokinetics of Cocktail Representatives for Cytochrome P450 (CYP) 3A4, CYP2B6, CYP2C9, and CYP1A2 Substrates', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02211079', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02534480', 'title': 'Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Young Volunteers (Single-ascending Dose)', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02534480', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02648672', 'title': 'BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02648672', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03545789', 'title': 'Phase 1 Test-retest Evaluation of [18F]MNI-958 PET', 'status': 'Recruiting', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03545789', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00988624', 'title': 'A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine)', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00988624', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02782975', 'title': 'Absolute Bioavailability of a Single, Fixed Subcutaneous Dose of Aducanumab in Healthy Participants', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 28, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02782975', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01221259', 'title': 'A Randomized, Double-blind, Placebo-controlled, Sequential Ascending, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2212 in Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01221259', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01042314', 'title': 'Drug-Drug Interaction Study With Aricept® (Donepezil)', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01042314', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01039194', 'title': 'Drug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER)', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01039194', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00966966', 'title': 'Study Evaluating Potential Interaction Between SAM-531 And Gemfibrozil When Co-Administered', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00966966', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01002079', 'title': 'Drug-Drug Interaction Study With Rifampin', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01002079', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01137799', 'title': 'The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients', 'status': 'Terminated', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 47, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01137799', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00979316', 'title': 'Effect on the Electrocardiographic QT Interval Corrected for Heart Rate (QTc) in Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 62, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00979316', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00788047', 'title': 'A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00788047', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01348737', 'title': 'Assessment of Safety, Tolerability and Blood Concentrations of Single Doses of AZD3839 in Healthy Volunteers', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01348737', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00860275', 'title': 'Drug-Drug Interaction (DDI) w/Ketoconazole or Fluconazole', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00860275', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00593138', 'title': 'Study of Dopamine Transporter Receptor Occupancy With Long-acting Dex-methylphenidate', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 23, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00593138', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00825084', 'title': 'A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00825084', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00827034', 'title': 'A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00827034', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00931073', 'title': 'A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00931073', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00975481', 'title': 'A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00975481', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02040987', 'title': 'AZD3293 Thorough QT Study in Healthy Male Volunteers', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 52, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02040987', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01702467', 'title': 'Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 27, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01702467', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02968875', 'title': \"Alzheimer's Disease and Physiological, Cognitive Function and BDNF Levels of Plasma Adaptation After Exercise Training\", 'status': 'Completed', 'clean_age': '18 Years to 60 Years ', 'phases': 'Not Applicable', 'enrollment': 54, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02968875', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02303158', 'title': 'Relationship Between Protein Biomarkers in Cerebrospinal Fluid and Alzheimer&Apos;s Disease in Patients With Depression', 'status': 'Terminated', 'clean_age': '18 Years to 60 Years ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02303158', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01492322', 'title': 'SPECT Imaging of DAT Genotype', 'status': 'Terminated', 'clean_age': '18 Years to 60 Years ', 'phases': 'Phase 4', 'enrollment': 14, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01492322', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00701532', 'title': 'Brain Imaging Study of the Effects of Modafinil in Cocaine Addiction', 'status': 'Completed', 'clean_age': '18 Years to 65 Years ', 'phases': 'Phase 3', 'enrollment': 29, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00701532', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02710188', 'title': 'Relative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Dose of Prototype Formulation', 'status': 'Completed', 'clean_age': '18 Years to 65 Years ', 'phases': 'Phase 1', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02710188', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03641768', 'title': 'Risk Prediction for Alzheimer Dementia With Brain Imaging and Genetics', 'status': 'Withdrawn', 'clean_age': '18 Years to 65 Years ', 'phases': 'Not Applicable', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03641768', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02439099', 'title': 'Retinoic Acid Homeostasis in Neuropsychiatric Diseases', 'status': 'Recruiting', 'clean_age': '18 Years to 65 Years ', 'phases': 'Phase 4', 'enrollment': 200, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02439099', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00870311', 'title': 'Investigation of Lithium on Signal Transduction, Gene Expression and Brain Myo-Inositol Levels in Manic Patients', 'status': 'Completed', 'clean_age': '18 Years to 65 Years ', 'phases': 'Phase 4', 'enrollment': 28, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00870311', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00726115', 'title': 'Study Evaluating Safety, Tolerability and Pharmacokinetics of Single and Multiple Dose of SAM-531', 'status': 'Completed', 'clean_age': '18 Years to 65 Years ', 'phases': 'Phase 1', 'enrollment': 56, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00726115', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03217396', 'title': 'Biomarkers of Synaptic Damage in Multiple Sclerosis', 'status': 'Recruiting', 'clean_age': '18 Years to 65 Years ', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03217396', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02130661', 'title': 'Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers', 'status': 'Withdrawn', 'clean_age': '18 Years to 65 Years ', 'phases': 'Phase 1', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02130661', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02649985', 'title': \"Microglial Activation Positron Emission Tomography (PET) Brain Imaging in Multiple Sclerosis and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years to 70 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02649985', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02859207', 'title': 'A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 70 Years ', 'phases': 'Phase 1', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02859207', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01622894', 'title': 'Genetics of Mendelian Forms of Young Onset Alzheimer Disease', 'status': 'Unknown status', 'clean_age': '18 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01622894', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03840083', 'title': 'Sleep-dependent Learning in Aging', 'status': 'Recruiting', 'clean_age': '18 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 584, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03840083', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03935568', 'title': 'A Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of PU-AD in Healthy Subjects', 'status': 'Recruiting', 'clean_age': '18 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03935568', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01827982', 'title': 'A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-54861911 in Healthy Volunteers Compared With Placebo', 'status': 'Completed', 'clean_age': '18 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 56, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01827982', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00691340', 'title': \"Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '18 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 0, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00691340', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02570997', 'title': 'Ascending Dose Study of CT1812 in Healthy Volunteers', 'status': 'Completed', 'clean_age': '18 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02570997', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00824590', 'title': 'A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function', 'status': 'Completed', 'clean_age': '18 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00824590', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01421056', 'title': 'Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Open Label Extension (CT04 OLEP)', 'status': 'Completed', 'clean_age': '18 Years to 79 Years ', 'phases': 'Phase 2', 'enrollment': 74, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01421056', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01303744', 'title': 'Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074', 'status': 'Completed', 'clean_age': '18 Years to 79 Years ', 'phases': 'Phase 2', 'enrollment': 96, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01303744', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01602393', 'title': 'Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Prolonged Open Label Extension Phase', 'status': 'Completed', 'clean_age': '18 Years to 79 Years ', 'phases': 'Phase 2', 'enrollment': 51, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01602393', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03071224', 'title': 'Phase 1 Evaluation of [18F]MK-6240 PET as an Imaging Marker for Tau Protein', 'status': 'Recruiting', 'clean_age': '18 Years to 80 Years ', 'phases': 'Early Phase 1', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03071224', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02761707', 'title': 'Biomarkers in Neural Disorders', 'status': 'Completed', 'clean_age': '18 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 54, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02761707', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03859245', 'title': \"Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer's Disease Prevention\", 'status': 'Recruiting', 'clean_age': '18 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03859245', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02820896', 'title': \"A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 74, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02820896', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01826110', 'title': 'PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy Volunteers', 'status': 'Completed', 'clean_age': '18 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01826110', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01760005', 'title': \"Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.\", 'status': 'Recruiting', 'clean_age': '18 Years to 80 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 490, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01760005', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00991419', 'title': 'To Compare Positron Emission Tomography (PET) Measurements of Fibrillar Amyloid Burden', 'status': 'Completed', 'clean_age': '18 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00991419', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02789800', 'title': 'Patient-Centred Innovations for Persons With Multimorbidity - Quebec', 'status': 'Active, not recruiting', 'clean_age': '18 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 1956, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02789800', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02742597', 'title': 'Patient-Centred Innovations for Persons With Multimorbidity - Ontario', 'status': 'Active, not recruiting', 'clean_age': '18 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 1980, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02742597', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03088956', 'title': 'Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD)', 'status': 'Active, not recruiting', 'clean_age': '18 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03088956', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00056524', 'title': 'Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)', 'status': 'Completed', 'clean_age': '18 Years to 80 Years ', 'phases': 'Phase 3', 'enrollment': 600, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00056524', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03352258', 'title': \"Effect of Low Dose Radiotherapy on Brain Amyloidosis in the Treatment of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03352258', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03089918', 'title': 'A Study to Investigate the Regional Brain Kinetics of Brain Drug Transporters Using P-glycoprotein and Breast Cancer Resistance Protein Substrates and by Using the Positron Emission Tomography Ligand 11C-JNJ-63779586 in the Human Brain', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 11, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03089918', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02638519', 'title': \"HP Xenon-129 fMRI of Healthy Volunteers and Participants With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '18 Years to 85 Years ', 'phases': 'Early Phase 1', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02638519', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00959803', 'title': 'Study Of Single Ascending And Multiple Doses Of PF-04447943 In Japanese Subjects.', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00959803', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01339130', 'title': 'Assessment of Social-emotional Functioning in Neurological Diseases', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 177, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01339130', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02621606', 'title': '[11C]MK-6884 Positron Emission Tomography (PET) Tracer Validation Trial (MK-6884-001)', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02621606', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01564706', 'title': 'A Study of 18F-AV-45 in Healthy Volunteers', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 9, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01564706', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00462917', 'title': \"REVEAL III: Risk Evaluation and Education for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 290, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00462917', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01385033', 'title': '[18F]MK-3328 as a Possible Novel Positron Emission Tomography (PET) Tracer for the Detection of Brain Amyloid Plaques (MK-3328-002)', 'status': 'Terminated', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01385033', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03123224', 'title': 'The COACH Project: Combined Online Assistance for Caregiver Health', 'status': 'Recruiting', 'clean_age': '18 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03123224', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03298672', 'title': 'Safety, Tolerability, and Pharmacokinetics Study of NDX-1017', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 88, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03298672', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02129452', 'title': 'Olfactory Neuroepithelial Tissue of Alzheimer Disease', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02129452', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03635047', 'title': 'A Phase I Study for Safety and Tolerability of AL002.', 'status': 'Recruiting', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 67, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03635047', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01659398', 'title': 'Enhanced External Counterpulsation and Its Effects on Vascular Hemodynamics in Cognitively Impaired Patients', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Early Phase 1', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01659398', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03822208', 'title': 'First in Human Study for Safety and Tolerability of AL003.', 'status': 'Recruiting', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 54, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03822208', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01680588', 'title': \"Efficacy and Safety of the PET Imaging Agent [18F]NAV4694 in Subjects With Probable Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01680588', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02793232', 'title': 'Clinical Trial In Healthy Volunteers And Health Elderly Volunteers To Evaluate The Safety, Tolerability And Blood Concentration After Single And Multiple Escalating Oral Doses Of PF-06751979.', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 46, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02793232', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00571025', 'title': \"Risk Evaluation and Education for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 301, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00571025', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02103894', 'title': 'Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02103894', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02509117', 'title': 'First-In-Human Study Of Single And Multiple Ascending Doses Of PF-06751979', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 55, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02509117', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03720548', 'title': \"A Study of LY3372993 in Healthy Participants and Participants With Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03720548', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02562989', 'title': '[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 13, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02562989', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00870974', 'title': 'A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00870974', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03838185', 'title': 'Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147', 'status': 'Recruiting', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 64, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03838185', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00714571', 'title': 'Behavioral and Neuroimaging Changes After Cognitive Rehab in Traumatic Brain Injuries (TBI) and Mild Cognitive Impairment (MCI)', 'status': 'Completed', 'clean_age': '18 Years to 88 Years ', 'phases': 'Phase 1', 'enrollment': 82, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00714571', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01148498', 'title': \"A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's\", 'status': 'Completed', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 55, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01148498', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03435861', 'title': \"Effect of Neflamapimod on Brain Inflammation in Alzheimer's Disease Patients\", 'status': 'Recruiting', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03435861', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03297177', 'title': 'Autologous Stem/Stromal Cells in Neurological Disorders and Disease', 'status': 'Not yet recruiting', 'clean_age': '18 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03297177', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00149175', 'title': 'Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment', 'status': 'Unknown status', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 4000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00149175', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03397667', 'title': 'The Aging Brain ANSWERS Program', 'status': 'Recruiting', 'clean_age': '18 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 400, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03397667', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02681172', 'title': 'Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients With AD', 'status': 'Completed', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 218, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02681172', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00306124', 'title': 'Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment', 'status': 'Unknown status', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00306124', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00029120', 'title': \"Evaluation of Age- and Alzheimer's Disease-Related Memory Disorder\", 'status': 'Completed', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 450, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00029120', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00666445', 'title': \"Improved Diagnosis of Alzheimer's Disease Using the Synchronous Neural Interaction™ Test\", 'status': 'Completed', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00666445', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01461109', 'title': \"Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls\", 'status': 'Completed', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 4, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01461109', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT04045990', 'title': \"Network Modulation in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04045990', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03080051', 'title': 'Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain', 'status': 'Completed', 'clean_age': '18 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03080051', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02767609', 'title': 'Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging', 'status': 'Completed', 'clean_age': '18 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 1, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02767609', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00001480', 'title': 'The Evaluation and Follow-up of Individuals With Memory Disorder', 'status': 'Completed', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 750, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00001480', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02051361', 'title': 'Antiplatelet Therapy Following Stent Implantation', 'status': 'Completed', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 900, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02051361', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00303277', 'title': 'Do HMG CoA Reductase Inhibitors Affect Abeta Levels?', 'status': 'Completed', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 35, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00303277', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02769065', 'title': 'Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants', 'status': 'Terminated', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 179, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02769065', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT01762618', 'title': \"Experimental Study of the Impact of a Group Therapy Psychological Intervention for Caregivers of Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': '18 Years to 95 Years ', 'phases': 'Not Applicable', 'enrollment': 83, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01762618', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00735046', 'title': 'Cognitive Behavioural Therapy of Early Dementia', 'status': 'Completed', 'clean_age': '18 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 200, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00735046', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03971994', 'title': \"Emotion and Attention in Alzheimer's Disease (ATEMMA)\", 'status': 'Recruiting', 'clean_age': '18 Years to 95 Years ', 'phases': 'Not Applicable', 'enrollment': 75, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03971994', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00416078', 'title': \"Online Caregiver Psychoeducation and Support for Alzheimer's\", 'status': 'Completed', 'clean_age': '18 Years to 95 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 53, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00416078', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT03682081', 'title': \"Interventions for Patients With Alzheimer's Disease and Dysphagia\", 'status': 'Not yet recruiting', 'clean_age': '18 Years to 99 Years ', 'phases': 'Early Phase 1', 'enrollment': 76, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03682081', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT02585232', 'title': 'Optimizing Dementia Care', 'status': 'Recruiting', 'clean_age': '19 Years and older ', 'phases': 'Not Applicable', 'enrollment': 68, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02585232', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02695004', 'title': 'Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).', 'status': 'Unknown status', 'clean_age': '19 Years to 50 Years ', 'phases': 'Phase 1', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02695004', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03802162', 'title': 'A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355', 'status': 'Not yet recruiting', 'clean_age': '19 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03802162', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03299062', 'title': 'Smell, Voice and Nasal Swabs as Markers for Neuro-degenerative Disorders', 'status': 'Recruiting', 'clean_age': '19 Years to 89 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03299062', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00927108', 'title': 'Rajavtihi Neuronal Adult Stem Cells Project', 'status': 'Unknown status', 'clean_age': '20 Years and older ', 'phases': 'Phase 2', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00927108', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03969732', 'title': 'Multimodal Biomarkers for Diagnosis and Prognosis in CAA', 'status': 'Recruiting', 'clean_age': '20 Years and older ', 'phases': 'Phase 3', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03969732', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00719394', 'title': 'Study Evaluating Safety of GSI 136 in Young and Elderly Japanese Males', 'status': 'Completed', 'clean_age': '20 Years and older ', 'phases': 'Phase 1', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00719394', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03542656', 'title': 'Application of Amyloid PET in Cerebral Amyloid Angiopathy', 'status': 'Completed', 'clean_age': '20 Years and older ', 'phases': 'Phase 3', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03542656', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00684710', 'title': 'Study Evaluating the Safety, Tolerability and Activity of One Dose of PAZ-417 Given to Healthy Japanese Subjects', 'status': 'Completed', 'clean_age': '20 Years and older ', 'phases': 'Phase 1', 'enrollment': 56, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00684710', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02614131', 'title': \"A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)\", 'status': 'Terminated', 'clean_age': '20 Years and older ', 'phases': 'Phase 1', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02614131', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02323334', 'title': \"A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '20 Years and older ', 'phases': 'Phase 1', 'enrollment': 136, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02323334', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03378037', 'title': 'The Effects of Acupuncture on the Risk of AD After TBI', 'status': 'Recruiting', 'clean_age': '20 Years and older ', 'phases': 'Not Applicable', 'enrollment': 76, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03378037', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02016560', 'title': 'Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects', 'status': 'Completed', 'clean_age': '20 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 383, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02016560', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01859767', 'title': 'Efficacy and Safety of MNI-672 SPECT for Detection/Exclusion of Cerebral B-amyloid in AD Subjects Compared to HVs.', 'status': 'Completed', 'clean_age': '20 Years and older ', 'phases': 'Phase 1', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01859767', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01867372', 'title': \"Early Markers of Alzheimer's Disease: Structural and Functional Brain Changes\", 'status': 'Terminated', 'clean_age': '20 Years and older ', 'phases': 'Phase 4', 'enrollment': 213, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01867372', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01227252', 'title': 'A Safety Study of LY2886721 Multiple Doses in Healthy Subjects', 'status': 'Completed', 'clean_age': '20 Years and older ', 'phases': 'Phase 1', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01227252', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00479349', 'title': 'Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531', 'status': 'Completed', 'clean_age': '20 Years and older ', 'phases': 'Phase 1', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00479349', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00441987', 'title': 'Study Evaluating the Safety and Pharmacokinetics of a Single Dose of GSI-953', 'status': 'Completed', 'clean_age': '20 Years and older ', 'phases': 'Phase 1', 'enrollment': 96, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00441987', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01133405', 'title': 'A Safety Study of LY2886721 Single Doses in Healthy Subjects', 'status': 'Completed', 'clean_age': '20 Years and older ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01133405', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03174938', 'title': 'The Swedish BioFINDER 2 Study', 'status': 'Recruiting', 'clean_age': '20 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 1505, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03174938', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03283449', 'title': 'Tau PET Imaging in Atypical Dementias', 'status': 'Recruiting', 'clean_age': '20 Years to 100 Years ', 'phases': 'Phase 1', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03283449', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT04025801', 'title': 'Heidelberg In Vivo Confocal Microscopy to Evaluate the Ocular Surface Disorders of Healthy and Diseased Individuals', 'status': 'Not yet recruiting', 'clean_age': '20 Years to 40 Years ', 'phases': 'Phase 4', 'enrollment': 400, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04025801', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01057030', 'title': 'Multiple Dose Japanese Bridging Study', 'status': 'Completed', 'clean_age': '20 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01057030', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00479297', 'title': 'Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Japanese Males', 'status': 'Completed', 'clean_age': '20 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00479297', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02820155', 'title': 'Phase I Single and Multiple Escalating Dose Study of RGN1016 in Healthy Male Subjects', 'status': 'Unknown status', 'clean_age': '20 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02820155', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01860625', 'title': 'A Phase I Clinical, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects', 'status': 'Completed', 'clean_age': '20 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01860625', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00480467', 'title': 'Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315 in Healthy Japanese Males', 'status': 'Completed', 'clean_age': '20 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00480467', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02178124', 'title': 'A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects.', 'status': 'Completed', 'clean_age': '20 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02178124', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01297036', 'title': 'Pharmacokinetic Comparisons of Two Donepezil Formulations', 'status': 'Completed', 'clean_age': '20 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01297036', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03584568', 'title': 'Reappraising Intergeneration Relationships in Dementia Caregiving', 'status': 'Recruiting', 'clean_age': '20 Years to 60 Years ', 'phases': 'Not Applicable', 'enrollment': 154, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03584568', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03212599', 'title': 'Disulfiram as a Modulator of Amyloid Precursor Protein-processing', 'status': 'Completed', 'clean_age': '20 Years to 60 Years ', 'phases': 'Phase 4', 'enrollment': 17, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03212599', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00713765', 'title': 'Pharmacokinetic Interaction Between AZD3480 and Donepezil', 'status': 'Terminated', 'clean_age': '20 Years to 60 Years ', 'phases': 'Phase 1', 'enrollment': 33, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00713765', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00838084', 'title': 'A Safety Study of LY2811376 Single Doses in Healthy Subjects', 'status': 'Completed', 'clean_age': '20 Years to 65 Years ', 'phases': 'Phase 1', 'enrollment': 61, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00838084', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01297114', 'title': 'Imaging of Cognition, Learning, and Memory in Aging', 'status': 'Completed', 'clean_age': '20 Years to 70 Years ', 'phases': 'Phase 4', 'enrollment': 294, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01297114', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03052712', 'title': 'Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies', 'status': 'Recruiting', 'clean_age': '20 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 1170, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03052712', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03112096', 'title': \"A Phase I [18F]THK-5351 Positron Emission Tomography Study in Healthy Subjects and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '20 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03112096', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02149017', 'title': 'Phase 1 and Phase 2 Clinical Trials of SNUBH-NM-333(18F)', 'status': 'Terminated', 'clean_age': '20 Years to 80 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02149017', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00548145', 'title': \"The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '20 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00548145', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03389698', 'title': 'Developing Advanced Blood-Brain Barrier Permeability Imaging for Early AD', 'status': 'Recruiting', 'clean_age': '20 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03389698', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03227185', 'title': 'Supporting Episodic Memory With Transcranial Direct Current Stimulation in Healthy Controls and Dementia Patients', 'status': 'Recruiting', 'clean_age': '20 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 110, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03227185', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00692705', 'title': 'Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for β Amyloid', 'status': 'Completed', 'clean_age': '20 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 13, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00692705', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02370524', 'title': \"Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '20 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02370524', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03625128', 'title': \"18F-PM-PBB3 PET Study in Tauopathy Including Alzheimer's Disease, Other Dementias and Normal Controls\", 'status': 'Completed', 'clean_age': '20 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03625128', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02686216', 'title': \"Biodistribution, Pharmacokinetics, and Safety of F-18 THK-5351 PET in Alzheimer's Disease Patients and Healthy Subjects.(Positron Emission Tomograph )\", 'status': 'Completed', 'clean_age': '20 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02686216', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02137460', 'title': \"Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '20 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 920, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02137460', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00094913', 'title': \"PET Changes in Alzheimer's Disease (AD)\", 'status': 'Unknown status', 'clean_age': '20 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 105, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00094913', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01322373', 'title': \"A Study of Alzheimer's Disease Using Magnetoencephalography (MEG) and the Synchronous Neural Interaction™ Test\", 'status': 'Unknown status', 'clean_age': '20 Years to 92 Years ', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01322373', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03587012', 'title': 'Brain Fitness APP for Cognitive Enhancement', 'status': 'Enrolling by invitation', 'clean_age': '20 Years to 95 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03587012', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02343757', 'title': \"Alzheimer's Disease Imaging With PET/MRI - Beta-amyloid\", 'status': 'Unknown status', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02343757', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01020838', 'title': 'Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 3', 'enrollment': 218, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01020838', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00965835', 'title': \"Amyloid Plaque and Tangle Imaging in Alzheimer's Disease and Down Syndrome\", 'status': 'Unknown status', 'clean_age': '21 Years and older ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00965835', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00467766', 'title': 'Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer’s Disease', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00467766', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00759863', 'title': \"LifeZig Personalized Reminiscence Video With Slideshows and Music for Individuals With Alzheimer's and Dementia\", 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 2', 'enrollment': 242, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00759863', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00178165', 'title': 'Coordinating Center for Enhancing ADRD Caregiving', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 1200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00178165', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01886820', 'title': 'A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology', 'status': 'Unknown status', 'clean_age': '21 Years and older ', 'phases': 'Phase 3', 'enrollment': 290, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01886820', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01378195', 'title': 'iCare Stress Management e-Training for Dementia Family Caregivers', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 2', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01378195', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02915939', 'title': 'The Residential Care Transition Module', 'status': 'Recruiting', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02915939', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03665909', 'title': 'A Proactive Health Monitoring Intervention for Dementia Caregivers', 'status': 'Active, not recruiting', 'clean_age': '21 Years and older ', 'phases': 'Phase 3', 'enrollment': 170, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03665909', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03333252', 'title': \"A Non-pharmacological Intervention for Patients With Alzheimer's Disease and Family Caregivers (Care Partners Program)\", 'status': 'Recruiting', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 246, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03333252', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00593372', 'title': \"Treatment of Language and Memory in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 1', 'enrollment': 11, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00593372', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02300584', 'title': 'Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02300584', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00259467', 'title': 'Project TAP: Tailored Activities Project', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 1', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00259467', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00259480', 'title': 'Project ACT: Advancing Caregiving Techniques', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 3', 'enrollment': 272, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00259480', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03218982', 'title': 'Vietnamese Caregiver Intervention Study', 'status': 'Recruiting', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03218982', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00259454', 'title': 'Project COPE:Managing Dementia at Home', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 3', 'enrollment': 278, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00259454', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01465360', 'title': 'Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 4', 'enrollment': 160, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01465360', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02120664', 'title': 'Florbetapir Calibration to the Centiloid Scale', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 1', 'enrollment': 35, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02120664', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03244917', 'title': \"Trial to Reduce Antimicrobial Use In Nursing Home Residents With Alzheimer's Disease and Other Dementias\", 'status': 'Recruiting', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 410, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03244917', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03100617', 'title': \"Alzheimer's Family Caregiver Intervention in Vietnam\", 'status': 'Recruiting', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03100617', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00255866', 'title': 'Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00255866', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02759887', 'title': \"Relationship Between Down Syndrome (DS) and Alzheimer's Disease (AD)\", 'status': 'Unknown status', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02759887', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03282877', 'title': 'iCST Web-application for People With Dementia', 'status': 'Active, not recruiting', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 43, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03282877', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02440646', 'title': 'Natural History of Atherosclerosis in Real-World Patients Underwent Computed Tomography Angiography', 'status': 'Enrolling by invitation', 'clean_age': '21 Years and older ', 'phases': 'Phase 4', 'enrollment': 1080, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02440646', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01005862', 'title': \"Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers\", 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 1', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01005862', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01145482', 'title': 'Mechanisms of Insulin Facilitation of Memory', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01145482', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01892579', 'title': 'Reducing Agitation in People With Dementia: the Customized Activity Trial', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01892579', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02420535', 'title': 'An Innovative Caregiver Tool to Assess and Manage Behavioral Symptoms of Dementia', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 114, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02420535', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00182897', 'title': \"PACT: Providers and Alzheimer's Caregivers Together\", 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00182897', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01550172', 'title': 'Improving Dementia Caregiver Sleep & the Effect on Heart Disease Biomarkers', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01550172', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01188070', 'title': 'Caregiver Stress: Interventions to Promote Health and Wellbeing', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 354, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01188070', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00119561', 'title': 'Testing the Effectiveness of Telephone Support for Dementia Caregivers', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 154, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00119561', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00177489', 'title': 'Coordinating Center for Caregiver Intervention Trial', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 613, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00177489', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01772537', 'title': 'The Effects of Anesthesia on Patients Undergoing Surgery for Repair of a Thoracoabdominal Aneurysm.', 'status': 'Terminated', 'clean_age': '21 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01772537', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02347202', 'title': 'Tools for Distance Delivery of an Evidence-based AD Family Caregiver Intervention', 'status': 'Recruiting', 'clean_age': '21 Years to 125 Years ', 'phases': 'Not Applicable', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02347202', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02741505', 'title': 'Brain Sleep Deprivation MRI Effects (BEDTIME)', 'status': 'Not yet recruiting', 'clean_age': '21 Years to 30 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02741505', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02061878', 'title': 'A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects', 'status': 'Completed', 'clean_age': '21 Years to 50 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02061878', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00765115', 'title': 'A Study of Healthy Subjects to Assess the Effect of LY450139 on Amyloid Beta Peptide Production Rate and or Dose Response.', 'status': 'Completed', 'clean_age': '21 Years to 50 Years ', 'phases': 'Phase 1', 'enrollment': 27, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00765115', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02740634', 'title': \"Molecular and Structural Imaging in Atypical Alzheimer's Disease: A Longitudinal Study\", 'status': 'Recruiting', 'clean_age': '21 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02740634', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03360019', 'title': 'Accurate WiFi-Based Localization of Dementia Patients For Caregiver Support:', 'status': 'Not yet recruiting', 'clean_age': '21 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 187, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03360019', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03393546', 'title': \"Auricular Point Acupressure to Manage Pain in Patients With Alzheimer's Disease and Related Disorders\", 'status': 'Recruiting', 'clean_age': '21 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03393546', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00438724', 'title': \"Couples Coping With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '21 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00438724', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03371420', 'title': 'PET Imaging of Subjects Using 124I-PU-AD', 'status': 'Completed', 'clean_age': '21 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03371420', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00409279', 'title': \"An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '21 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00409279', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00621010', 'title': 'Safety Study of CTS21166 to Treat Alzheimer Disease', 'status': 'Completed', 'clean_age': '22 Years and older ', 'phases': 'Phase 1', 'enrollment': 56, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00621010', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01778946', 'title': 'Nicotine Treatment of Cognitive Decline in Down Syndrome', 'status': 'Recruiting', 'clean_age': '25 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01778946', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02187627', 'title': \"Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Positron Emission Tomography (PET) Imaging of Tau in Healthy and Alzheimer's Disease (AD) Participants\", 'status': 'Completed', 'clean_age': '25 Years and older ', 'phases': 'Phase 1', 'enrollment': 52, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02187627', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02813070', 'title': 'Comparison of PET Amyloid Imaging in Japanese and Western Subjects', 'status': 'Completed', 'clean_age': '25 Years and older ', 'phases': 'Phase 2', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02813070', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00785759', 'title': \"Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers\", 'status': 'Completed', 'clean_age': '25 Years and older ', 'phases': 'Phase 2', 'enrollment': 78, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00785759', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02792179', 'title': \"Evaluation of [18F]RO6958948 as Tracer for Positron Emission Tomography (PET) Imaging of Tau Burden in Alzheimer's Disease Participants\", 'status': 'Completed', 'clean_age': '25 Years and older ', 'phases': 'Phase 1', 'enrollment': 4, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02792179', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00315575', 'title': 'Memory Imaging of Normal Aging', 'status': 'Completed', 'clean_age': '25 Years to 65 Years ', 'phases': 'Phase 4', 'enrollment': 90, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00315575', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02492529', 'title': \"Knowing and Remembering: Cognitive and Neural Influences of Familiarity on Recognition Memory in Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '25 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02492529', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02928211', 'title': 'Aftobetin-HCl and Fluorescence Detection Measured by Sapphire II to Determine the Number and Timing of Administrations', 'status': 'Recruiting', 'clean_age': '25 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 105, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02928211', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02840279', 'title': 'A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects', 'status': 'Completed', 'clean_age': '25 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 77, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02840279', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01775696', 'title': \"Central and Systemic Inflammation in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '30 Years and older ', 'phases': 'Phase 4', 'enrollment': 125, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01775696', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02471833', 'title': 'Health Evaluation in African Americans Using RAS Therapy', 'status': 'Recruiting', 'clean_age': '30 Years and older ', 'phases': 'Phase 1', 'enrollment': 66, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02471833', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00355498', 'title': 'Amyloid Plaque and Tangle Imaging in Aging and Dementia', 'status': 'Completed', 'clean_age': '30 Years and older ', 'phases': 'Phase 4', 'enrollment': 194, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00355498', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03432195', 'title': 'A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) Applied to Different Body Locations', 'status': 'Completed', 'clean_age': '30 Years and older ', 'phases': 'Phase 1', 'enrollment': 66, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03432195', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03259958', 'title': 'A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept®', 'status': 'Completed', 'clean_age': '30 Years and older ', 'phases': 'Phase 1', 'enrollment': 86, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03259958', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01303133', 'title': 'Natural History of Amyloid Deposition in Adults With Down Syndrome', 'status': 'Completed', 'clean_age': '30 Years and older ', 'phases': 'Phase 4', 'enrollment': 81, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01303133', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02754830', 'title': \"A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '30 Years and older ', 'phases': 'Phase 1', 'enrollment': 110, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02754830', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01871610', 'title': 'Amyloid Accumulation After Mild Traumatic Brain Injury', 'status': 'Unknown status', 'clean_age': '30 Years and older ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01871610', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01607476', 'title': 'Bridging Study of C11 Pittsburgh Compound B (PiB) and F18 Flutemetamol Brain Positron Emission Tomography (PET)', 'status': 'Completed', 'clean_age': '30 Years and older ', 'phases': 'Phase 2', 'enrollment': 89, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01607476', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03451591', 'title': 'LACunar Intervention (LACI-2) Trial-2', 'status': 'Recruiting', 'clean_age': '30 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 400, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03451591', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03438604', 'title': 'A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS)', 'status': 'Completed', 'clean_age': '30 Years and older ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03438604', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03618186', 'title': 'Tau PET Imaging in African Americans', 'status': 'Enrolling by invitation', 'clean_age': '30 Years and older ', 'phases': 'Phase 2', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03618186', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00950430', 'title': 'Imaging of Brain Amyloid Plaques in the Aging Population', 'status': 'Enrolling by invitation', 'clean_age': '30 Years to 100 Years ', 'phases': 'Phase 4', 'enrollment': 2500, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00950430', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03371706', 'title': 'Communication Bridge: A Person-centered Internet-based Intervention for Individuals With Primary Progressive Aphasia', 'status': 'Recruiting', 'clean_age': '30 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03371706', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01609335', 'title': \"Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young Adults\", 'status': 'Completed', 'clean_age': '30 Years to 49 Years ', 'phases': 'Phase 1', 'enrollment': 41, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01609335', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00612872', 'title': 'Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects', 'status': 'Terminated', 'clean_age': '30 Years to 50 Years ', 'phases': 'Phase 1', 'enrollment': 46, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00612872', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01924858', 'title': 'A Positron Emission Tomography (PET) Study to Investigate the Brain Biodistribution of 18F GSK2647544 in Healthy Subjects to Determine Its Ability to Cross the Blood-brain-barrier.', 'status': 'Terminated', 'clean_age': '30 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 4, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01924858', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01716897', 'title': 'An Study to Determine the Bioavailability of E2609 Tablets Compared to Capsules and the Effect of Food on Absorption', 'status': 'Completed', 'clean_age': '30 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01716897', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02141971', 'title': 'Down Syndrome Biomarker Initiative (DSBI)', 'status': 'Completed', 'clean_age': '30 Years to 60 Years ', 'phases': 'Phase 4', 'enrollment': 12, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02141971', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01998841', 'title': \"A Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer's Disease (AD), Including a Placebo-Treated Non-Carrier Cohort\", 'status': 'Active, not recruiting', 'clean_age': '30 Years to 60 Years ', 'phases': 'Phase 2', 'enrollment': 252, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01998841', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03977584', 'title': \"Tau Positron Emission Tomography (PET) Longitudinal Substudy Associated With: Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers in the Treatment of Autosomal-Dominant Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '30 Years to 60 Years ', 'phases': 'Phase 2', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03977584', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03901456', 'title': 'Care to Plan: a Tailored Resource for Family Members of Persons With Dementia', 'status': 'Recruiting', 'clean_age': '30 Years to 70 Years ', 'phases': 'Not Applicable', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03901456', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02474251', 'title': 'Brain Sleep Clearance of Amyloid-Beta Peptides', 'status': 'Active, not recruiting', 'clean_age': '30 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02474251', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02612805', 'title': 'The Diabetes and Aquatic Training Study (DATS)', 'status': 'Completed', 'clean_age': '30 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02612805', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01089270', 'title': \"Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives\", 'status': 'Unknown status', 'clean_age': '30 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 80, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01089270', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02397980', 'title': 'Intervention Programs for Decreasing Caregiver Burden in Caregivers of Patients With Dementia', 'status': 'Unknown status', 'clean_age': '30 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02397980', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03388242', 'title': \"Protein and microRNA Markers for Early Detection of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '30 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03388242', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01294540', 'title': 'Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Subjects and an Elderly Cohort', 'status': 'Completed', 'clean_age': '30 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 73, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01294540', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03778151', 'title': 'Repetitive TMS of the Default Mode Network in AD', 'status': 'Recruiting', 'clean_age': '30 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03778151', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT04124029', 'title': \"Contributions of mTBI to Neurodegeneration Due to CTE and Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '30 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 800, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04124029', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00811122', 'title': \"Biodistribution of 11C-PIB PET in Alzheimer's Disease, Frontotemporal Dementia, and Cognitively Normal Elderly\", 'status': 'Unknown status', 'clean_age': '30 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00811122', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01322568', 'title': 'Research on Aging Project in Iceland: Second Stage', 'status': 'Completed', 'clean_age': '32 Years to 60 Years ', 'phases': 'Phase 4', 'enrollment': 5764, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01322568', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01378026', 'title': 'Study of the Role of G72 in Amyotrophic Lateral Sclerosis: Biomarker Discovery and Mechanism Investigation', 'status': 'Unknown status', 'clean_age': '32 Years to 87 Years ', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01378026', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00677885', 'title': 'P-glycoprotein Function in Brain Diseases', 'status': 'Completed', 'clean_age': '35 Years and older ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00677885', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01565330', 'title': \"A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers\", 'status': 'Completed', 'clean_age': '35 Years and older ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01565330', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01565343', 'title': \"A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers\", 'status': 'Completed', 'clean_age': '35 Years and older ', 'phases': 'Phase 1', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01565343', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01565356', 'title': 'Evaluation of PET Scan Timing Relative to AV-45 Injection Time', 'status': 'Completed', 'clean_age': '35 Years and older ', 'phases': 'Not Applicable', 'enrollment': 41, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01565356', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03901261', 'title': \"Cohort Study of Adult Patients With Down Syndrome at Risk of Developing Alzheimer's Disease (TriAL21)\", 'status': 'Recruiting', 'clean_age': '35 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03901261', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00937846', 'title': 'Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study', 'status': 'Completed', 'clean_age': '35 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 4, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00937846', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01153802', 'title': 'An Open Label Positron Emission Tomography Study in Healthy Male Subjects to Investigate Brain DAT and SERT Occupancy,Pharmacokinetics and Safety of Single Oral Doses of GSK1360707, Using 11C- PE2I and 11C-DASB as PET Ligands', 'status': 'Completed', 'clean_age': '35 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01153802', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00777361', 'title': 'Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers', 'status': 'Terminated', 'clean_age': '35 Years to 65 Years ', 'phases': 'Phase 1', 'enrollment': 9, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00777361', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00486044', 'title': \"Evaluating Simvastatin's Potential Role in Therapy\", 'status': 'Completed', 'clean_age': '35 Years to 69 Years ', 'phases': 'Phase 2', 'enrollment': 103, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00486044', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT04080544', 'title': \"Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study\", 'status': 'Not yet recruiting', 'clean_age': '38 Years to 96 Years ', 'phases': 'Phase 2', 'enrollment': 125, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04080544', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01608217', 'title': 'Delta-THC in Dementia', 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01608217', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03631069', 'title': 'Detecting Dementia in the Retina Using Optical Coherence Tomography', 'status': 'Not yet recruiting', 'clean_age': '40 Years and older ', 'phases': 'Phase 4', 'enrollment': 200000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03631069', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02249403', 'title': 'Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type', 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 2', 'enrollment': 362, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02249403', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02675270', 'title': 'Rehabilitation and Prophylaxis of Anomia in Primary Progressive Aphasia', 'status': 'Recruiting', 'clean_age': '40 Years and older ', 'phases': 'Not Applicable', 'enrollment': 85, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02675270', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00253214', 'title': \"Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation\", 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 3', 'enrollment': 973, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00253214', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02249351', 'title': 'Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type', 'status': 'Terminated', 'clean_age': '40 Years and older ', 'phases': 'Phase 2', 'enrollment': 54, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02249351', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00880347', 'title': \"Blood Gene Expression Signature in Patients Diagnosed With Probable Alzheimer's Disease Compared to Patients Suffering From Other Types of Dementia\", 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Not Applicable', 'enrollment': 550, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00880347', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00216593', 'title': \"Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study\", 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 3', 'enrollment': 415, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00216593', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00235716', 'title': \"A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 3', 'enrollment': 613, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00235716', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03279523', 'title': 'F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected', 'status': 'Recruiting', 'clean_age': '40 Years and older ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03279523', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03136679', 'title': \"Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '40 Years and older ', 'phases': 'Phase 4', 'enrollment': 220, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03136679', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01320527', 'title': \"A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 2', 'enrollment': 135, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01320527', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT04073225', 'title': 'Optimizing Cognitive, Environmental, and Neuromotor Stimulation in Traumatic Brain Injury', 'status': 'Not yet recruiting', 'clean_age': '40 Years and older ', 'phases': 'Not Applicable', 'enrollment': 66, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04073225', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00645190', 'title': \"A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 3', 'enrollment': 215, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00645190', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02708485', 'title': \"Effect of Walking on Brain Fuel Consumption in Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Not Applicable', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02708485', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00245206', 'title': 'Side Effects of Newer Antipsychotics in Older Adults', 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 4', 'enrollment': 406, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00245206', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00721383', 'title': 'Telephone Resources and Assistance for Caregivers (TRAC)', 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Not Applicable', 'enrollment': 211, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00721383', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00142324', 'title': 'CALM-AD', 'status': 'Unknown status', 'clean_age': '40 Years and older ', 'phases': 'Phase 4', 'enrollment': 190, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00142324', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02886494', 'title': \"A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia\", 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02886494', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02946710', 'title': \"P75NTR, Diagnostic Biomarker for Alzheimer's Disease: Quantification Study in Cerebrospinal Fluid\", 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02946710', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03811184', 'title': 'Validation of a Smartphone Application for the Assessment of Patients With Mild Cognitive Impairment: MemScreen', 'status': 'Recruiting', 'clean_age': '40 Years and older ', 'phases': 'Phase 4', 'enrollment': 400, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03811184', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00261573', 'title': 'A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia', 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 3', 'enrollment': 593, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00261573', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01478633', 'title': \"Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil\", 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 4', 'enrollment': 102, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01478633', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02467413', 'title': \"BAC in Patient With Alzheimer's Disease or Vascular Dementia\", 'status': 'Withdrawn', 'clean_age': '40 Years and older ', 'phases': 'Phase 2', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02467413', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01194713', 'title': 'Effects of Sleep Deprivation on Cerebrospinal Fluid (CSF) Amyloid-beta (Aβ) Dynamics', 'status': 'Completed', 'clean_age': '40 Years to 60 Years ', 'phases': 'Not Applicable', 'enrollment': 26, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01194713', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03794141', 'title': 'Genetic Information as a Life Style Change Motivator', 'status': 'Active, not recruiting', 'clean_age': '40 Years to 60 Years ', 'phases': 'Not Applicable', 'enrollment': 333, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03794141', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03507257', 'title': \"Longitudinal Early-onset Alzheimer's Disease Study Protocol\", 'status': 'Recruiting', 'clean_age': '40 Years to 64 Years ', 'phases': 'Phase 4', 'enrollment': 600, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03507257', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT04002583', 'title': \"48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '40 Years to 64 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04002583', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02290912', 'title': \"Gray Matters Alzheimer's Disease Prevention Intervention\", 'status': 'Completed', 'clean_age': '40 Years to 64 Years ', 'phases': 'Not Applicable', 'enrollment': 146, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02290912', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02323217', 'title': 'I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers', 'status': 'Completed', 'clean_age': '40 Years to 65 Years ', 'phases': 'Early Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02323217', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00751907', 'title': 'Cerebral and Peripheral Perfusion Pilot Study', 'status': 'Completed', 'clean_age': '40 Years to 65 Years ', 'phases': 'Phase 2', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00751907', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03746366', 'title': '[C-11]PiB PET Imaging in Alcohol Use Disorders', 'status': 'Recruiting', 'clean_age': '40 Years to 65 Years ', 'phases': 'Early Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03746366', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00980785', 'title': \"Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's\", 'status': 'Completed', 'clean_age': '40 Years to 65 Years ', 'phases': 'Phase 4', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00980785', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03240406', 'title': 'Multicultural Healthy Diet to Reduce Cognitive Decline', 'status': 'Recruiting', 'clean_age': '40 Years to 65 Years ', 'phases': 'Not Applicable', 'enrollment': 326, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03240406', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02537938', 'title': 'Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose)', 'status': 'Completed', 'clean_age': '40 Years to 65 Years ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02537938', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03645993', 'title': \"Early Onset Alzheimer's Disease Genomic Study\", 'status': 'Recruiting', 'clean_age': '40 Years to 65 Years ', 'phases': 'Phase 4', 'enrollment': 2, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03645993', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02832921', 'title': 'Cognitive-motor Intervention Using Virtual Reality for Middle-aged Individuals at High Dementia Risk', 'status': 'Recruiting', 'clean_age': '40 Years to 65 Years ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02832921', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02109705', 'title': 'Porphyromonas Gingivalis and Alzheimer`s Disease', 'status': 'Unknown status', 'clean_age': '40 Years to 70 Years ', 'phases': 'Phase 4', 'enrollment': 90, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02109705', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00939822', 'title': \"Statin Effects on Beta-Amyloid and Cerebral Perfusion in Adults at Risk for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years to 72 Years ', 'phases': 'Phase 2', 'enrollment': 88, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00939822', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03865017', 'title': 'A Safety and Tolerability Study of GB301', 'status': 'Not yet recruiting', 'clean_age': '40 Years to 72 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03865017', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01553929', 'title': 'Physical Training and Cognitive Activity on the Mild Cognitive Impairment (MCI) Patient', 'status': 'Terminated', 'clean_age': '40 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01553929', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01147679', 'title': \"Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls\", 'status': 'Unknown status', 'clean_age': '40 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 99, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01147679', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02667496', 'title': \"Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '40 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02667496', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01339195', 'title': 'Post-stroke Cognitive Impairment and Dementia', 'status': 'Completed', 'clean_age': '40 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 1635, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01339195', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00545974', 'title': 'Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia', 'status': 'Completed', 'clean_age': '40 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 81, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00545974', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02656498', 'title': \"[18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease\", 'status': 'Recruiting', 'clean_age': '40 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02656498', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03510572', 'title': 'Evaluation of [18F]PI-2620 as a Potential Positron Emission Computed Tomography Radioligand for Imaging Tau Protein in the Brain', 'status': 'Recruiting', 'clean_age': '40 Years to 80 Years ', 'phases': 'Early Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03510572', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03115814', 'title': \"Deep Brain Stimulation for Treatment of Severe Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '40 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 6, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03115814', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02253043', 'title': \"The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Patients With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '40 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02253043', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00658125', 'title': \"Deep Brain Stimulation (DBS) for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00658125', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01089283', 'title': 'Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients With Different Genetic Characteristics', 'status': 'Unknown status', 'clean_age': '40 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 80, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01089283', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02811653', 'title': \"Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '40 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 155, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02811653', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03381482', 'title': 'Ectosomes, New Biomarkers of Tau Pathology?', 'status': 'Recruiting', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03381482', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00478491', 'title': \"fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 390, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00478491', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03153371', 'title': \"Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks\", 'status': 'Recruiting', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 180, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03153371', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03663387', 'title': \"PET Measures of CSF Clearance in Preclinical Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '40 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 136, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03663387', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00408525', 'title': \"Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 41, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00408525', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01823666', 'title': 'Predicting the Conversion From Mild Cognitive Impairment to Dementia', 'status': 'Completed', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 250, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01823666', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03030586', 'title': 'ADDIA Proof-of-Performance Clinical Study', 'status': 'Recruiting', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 800, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03030586', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03903211', 'title': \"Longitudinal Changes of [18F]PI-2620 Positron Emission Tomography in Subjects With Cognitively Normal, Mild Cognitive Impairment and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03903211', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00153010', 'title': \"An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type\", 'status': 'Completed', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 430, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00153010', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02819700', 'title': 'Evaluation and Characterization of Behavioural Disorders and Dementias by the Behavioural Dysexecutive Syndrome Inventory (BDSI)', 'status': 'Unknown status', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 285, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02819700', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00733863', 'title': \"Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients.\", 'status': 'Completed', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 27, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00733863', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00956410', 'title': \"To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients\", 'status': 'Completed', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00956410', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00795418', 'title': \"Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients\", 'status': 'Completed', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 31, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00795418', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03305809', 'title': \"A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)\", 'status': 'Recruiting', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 340, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03305809', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00432081', 'title': \"Effect of Indomethacin on the Progression of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00432081', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00165724', 'title': \"Alzheimer's Disease Long-term Follow-up Study (ALF Study)\", 'status': 'Completed', 'clean_age': '40 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 114, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00165724', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT02860338', 'title': 'COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE', 'status': 'Completed', 'clean_age': '40 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 900, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02860338', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00065169', 'title': 'Delaying Alzheimer Disease Symptoms With Anti-Inflammatory Drugs', 'status': 'Completed', 'clean_age': '40 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 138, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00065169', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00369603', 'title': \"Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients\", 'status': 'Terminated', 'clean_age': '40 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 4, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00369603', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00702780', 'title': \"Progression Delaying Effect of Escitalopram in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 74, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00702780', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT00267163', 'title': 'Brain Imaging and Mental Disorders of Aging Intervention', 'status': 'Completed', 'clean_age': '40 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 64, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00267163', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03732053', 'title': 'The Effectiveness of Global Postural Reeducation on Alzheimer Disease Patients', 'status': 'Completed', 'clean_age': '40 Years to 95 Years ', 'phases': 'Not Applicable', 'enrollment': 135, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03732053', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01330160', 'title': 'Study of Factors Influencing Post-stroke Dementia', 'status': 'Recruiting', 'clean_age': '40 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 1100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01330160', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT01928420', 'title': \"A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years to 95 Years ', 'phases': 'Phase 2', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01928420', 'age_groups': '18 to 40 years old'}, {'nct_number': 'NCT03116126', 'title': 'Noradrenergic Add-on Therapy With Guanfacine', 'status': 'Recruiting', 'clean_age': '45 Years and older ', 'phases': 'Phase 3', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03116126', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03011723', 'title': 'Tailored Music Therapy for Dementia', 'status': 'Active, not recruiting', 'clean_age': '45 Years and older ', 'phases': 'Not Applicable', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03011723', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00814801', 'title': \"An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Phase 3', 'enrollment': 580, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00814801', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03412604', 'title': 'Effect of Modulating Gamma Oscillations Using tACS', 'status': 'Recruiting', 'clean_age': '45 Years and older ', 'phases': 'Not Applicable', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03412604', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01724151', 'title': 'Effects of Exercise Training in Patients With Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01724151', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01993628', 'title': \"Construction-LBD (Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD))\", 'status': 'Unknown status', 'clean_age': '45 Years and older ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01993628', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02414282', 'title': 'F 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction (IND 123119, Protocol E)', 'status': 'Enrolling by invitation', 'clean_age': '45 Years and older ', 'phases': 'Phase 2', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02414282', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00966017', 'title': 'Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia', 'status': 'Unknown status', 'clean_age': '45 Years and older ', 'phases': 'Phase 4', 'enrollment': 108, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00966017', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01890343', 'title': \"Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.\", 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Phase 2', 'enrollment': 34, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01890343', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01660815', 'title': 'A Study of Florbetapir (18F) in Japanese Healthy Volunteers', 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Phase 1', 'enrollment': 7, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01660815', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01779310', 'title': \"Clinical Pathway for Alzheimer's Disease in China (CPAD)\", 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Phase 4', 'enrollment': 1024, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01779310', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03702907', 'title': 'DC Longitudinal Study on Aging and Specimen Bank', 'status': 'Recruiting', 'clean_age': '45 Years and older ', 'phases': 'Phase 4', 'enrollment': 1000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03702907', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00338117', 'title': \"Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Phase 3', 'enrollment': 554, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00338117', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01315639', 'title': \"New Biomarker for Alzheimer's Disease Diagnostic\", 'status': 'Active, not recruiting', 'clean_age': '45 Years and older ', 'phases': 'Not Applicable', 'enrollment': 1067, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01315639', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02226835', 'title': 'Study of Retinal Findings in People With Signs and Symptoms of Alzheimer s Disease Enrolled in 09-M-0198', 'status': 'Terminated', 'clean_age': '45 Years and older ', 'phases': 'Phase 4', 'enrollment': 33, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02226835', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03851523', 'title': \"Longitudinal Study for the Characterization of the Phases of Subjective Perception of Cognitive Decline and Mild Cognitive Impairment of Alzheimer's Disease.\", 'status': 'Recruiting', 'clean_age': '45 Years and older ', 'phases': 'Phase 4', 'enrollment': 400, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03851523', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01876459', 'title': \"Alpha-synuclein in Cerebrospinal Fluid to Differentiate Alzheimer's Disease From Lewy Body Disease.\", 'status': 'Unknown status', 'clean_age': '45 Years and older ', 'phases': 'Not Applicable', 'enrollment': 265, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01876459', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02213458', 'title': 'Care Ecosystem: Navigating Patients and Families Through Stages of Care', 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Not Applicable', 'enrollment': 780, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02213458', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03880240', 'title': \"Gamma Induction for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '45 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 55, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03880240', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00301574', 'title': \"An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease.\", 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Phase 3', 'enrollment': 398, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00301574', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03290326', 'title': \"tACS for Amyloid-β Reduction in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Not Applicable', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03290326', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00955422', 'title': \"Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Phase 4', 'enrollment': 197, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00955422', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00304629', 'title': \"Long-term Safety and Efficacy of Galantamine in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Phase 3', 'enrollment': 241, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00304629', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01314950', 'title': \"Alzheimer's Disease Multiple Intervention Trial\", 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Not Applicable', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01314950', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03998423', 'title': \"Oral Fecal Microbiota Transplant Feasibility Study in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '45 Years and older ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03998423', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01142336', 'title': 'Effects of Simvastatin on Biomarkers', 'status': 'Completed', 'clean_age': '45 Years to 64 Years ', 'phases': 'Phase 4', 'enrollment': 49, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01142336', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02485730', 'title': \"Early Identification of Markers in Alzheimer's Families / ALFA\", 'status': 'Recruiting', 'clean_age': '45 Years to 64 Years ', 'phases': 'Phase 4', 'enrollment': 400, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02485730', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01723670', 'title': 'Evaluation of Effects of Multiple Dose Regimens of CHF 5074 on Potential Biomarkers of Neurodegeneration in Subjects With Mild Cognitive Impairment', 'status': 'Withdrawn', 'clean_age': '45 Years to 64 Years ', 'phases': 'Phase 2', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01723670', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03411291', 'title': 'Statins in Cerebral Blood Flow and Neuronal Activity--A Pilot Study', 'status': 'Completed', 'clean_age': '45 Years to 65 Years ', 'phases': 'Phase 4', 'enrollment': 18, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03411291', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01777789', 'title': 'The Role of Mid-Life Adiposity in Functional Brain Connectivity', 'status': 'Terminated', 'clean_age': '45 Years to 65 Years ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01777789', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03117829', 'title': 'Study: Diet and Exercise Study to Improve Brain Blood Flow: Blood Flow Improvement Trial', 'status': 'Completed', 'clean_age': '45 Years to 65 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03117829', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02463084', 'title': \"Macronutrient Effects on Alzheimer's Disease (MEAL-2)\", 'status': 'Completed', 'clean_age': '45 Years to 65 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02463084', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03269149', 'title': \"Tango for Alzheimer's Disease Patients' Caregivers\", 'status': 'Recruiting', 'clean_age': '45 Years to 65 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03269149', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02289118', 'title': 'Tau Imaging in Young Onset Dementia', 'status': 'Completed', 'clean_age': '45 Years to 70 Years ', 'phases': 'Phase 4', 'enrollment': 16, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02289118', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03920826', 'title': \"Transcranial Alternating Current Stimulation for Patients With Mild Alzheimer's Disease (TRANSFORM-AD)\", 'status': 'Recruiting', 'clean_age': '45 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03920826', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03352739', 'title': \"Fornix and NbM as Targets of Stimulation In Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '45 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03352739', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02393027', 'title': 'Quantification of Dopamine Active Transporter (DAT) in Humans: Validation of a New Radiophamaceutical, the [18F] LBT-999', 'status': 'Terminated', 'clean_age': '45 Years to 75 Years ', 'phases': 'Early Phase 1', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02393027', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01835717', 'title': 'Study for Cognitive and Genetic Characterization of a 45-65 Years Old Population', 'status': 'Active, not recruiting', 'clean_age': '45 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 2743, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01835717', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02198586', 'title': 'Apoe Impact Study on Brain Structure and Function, in a Population 45 to 75 Years Old', 'status': 'Completed', 'clean_age': '45 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 575, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02198586', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04088643', 'title': \"4Hz Transcranial Alternating Current Stimulation for Patients With Mild Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '45 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04088643', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02685969', 'title': 'Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants', 'status': 'Recruiting', 'clean_age': '45 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 440, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02685969', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02903862', 'title': 'Health-eBrain Study', 'status': 'Withdrawn', 'clean_age': '45 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02903862', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03883633', 'title': 'Reversal of Cognitive Decline (ReCODE) Study', 'status': 'Recruiting', 'clean_age': '45 Years to 76 Years ', 'phases': 'Phase 4', 'enrollment': 30, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03883633', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02772523', 'title': \"Control and Intervention Programme on Alzheimer's Disease Risk Factors\", 'status': 'Active, not recruiting', 'clean_age': '45 Years to 78 Years ', 'phases': 'Not Applicable', 'enrollment': 409, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02772523', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01746498', 'title': 'Therapeutic Effect of Direct Current Stimulation on Cognitive Function of Mild to Moderate Alzheimer Patients', 'status': 'Completed', 'clean_age': '45 Years to 79 Years ', 'phases': 'Not Applicable', 'enrollment': 33, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01746498', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03173846', 'title': \"Multiregional rtfMRI Neurofeedback for the Prevention of Alzheimer's Disease (NPAD)\", 'status': 'Active, not recruiting', 'clean_age': '45 Years to 79 Years ', 'phases': 'Phase 4', 'enrollment': 90, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03173846', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02002819', 'title': \"Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability\", 'status': 'Recruiting', 'clean_age': '45 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02002819', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02384993', 'title': 'aeRobic Exercise and Cognitive Health', 'status': 'Completed', 'clean_age': '45 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02384993', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03699644', 'title': 'Multimodal Ocular Imaging in Neurodegeneration', 'status': 'Recruiting', 'clean_age': '45 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03699644', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03887481', 'title': 'Effects of tDCS on Verbal Short-term Memory in Neurodegenerative Disorders', 'status': 'Recruiting', 'clean_age': '45 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03887481', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01403519', 'title': \"Innovative Biomarkers in Alzheimer's Disease and Frontotemporal Dementia (FTD): Preventative and Personalized\", 'status': 'Unknown status', 'clean_age': '45 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 70, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01403519', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02227953', 'title': \"A Pilot Study of tDCS for Mild to Moderate Alzhemier's Disease\", 'status': 'Unknown status', 'clean_age': '45 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02227953', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03918616', 'title': 'P2X7 Receptor, Inflammation and Neurodegenerative Diseases', 'status': 'Completed', 'clean_age': '45 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03918616', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02119546', 'title': \"Effects of Exercise Training in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02119546', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01608061', 'title': \"ADvance DBS-f in Patients With Mild Probable Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '45 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01608061', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01661673', 'title': \"Safety, Tolerability, Pharmacokinetics of EVP-0962 and Effects of EVP-0962 on Cerebral Spinal Fluid Amyloid Concentrations in Healthy Subjects and in Subjects With Mild Cognitive Impairment or Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 52, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01661673', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01782248', 'title': 'Self-consciousness in Dementia', 'status': 'Recruiting', 'clean_age': '45 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 65, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01782248', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02910739', 'title': 'An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)', 'status': 'Completed', 'clean_age': '45 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02910739', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04052737', 'title': \"PMZ-1620 (Sovateltide) in Mild to Moderate Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '45 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04052737', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00006399', 'title': \"Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00006399', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01559220', 'title': \"Deep Brain Stimulation for the Treatment of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 3, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01559220', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03967535', 'title': 'Connectomics in Psychiatric Classification', 'status': 'Recruiting', 'clean_age': '45 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 30, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03967535', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02380573', 'title': \"Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease\", 'status': 'Suspended', 'clean_age': '45 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 117, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02380573', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00679627', 'title': \"A Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '45 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 2051, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00679627', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00987090', 'title': \"Early-onset and Late-onset Sporadic Alzheimer's Disease (AD)\", 'status': 'Unknown status', 'clean_age': '45 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00987090', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02778971', 'title': 'Implications for Management of PET Amyloid Classification Technology', 'status': 'Recruiting', 'clean_age': '45 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02778971', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02097056', 'title': \"Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 171, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02097056', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00890890', 'title': \"A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '45 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 263, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00890890', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00478205', 'title': \"Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 1467, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00478205', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00104273', 'title': \"Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '45 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 376, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00104273', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02550665', 'title': 'Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23mg', 'status': 'Completed', 'clean_age': '45 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 176, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02550665', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00566501', 'title': \"Open-Label Extension Study of 23 mg Donepezil SR in Patients With Moderate to Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years to 91 Years ', 'phases': 'Phase 3', 'enrollment': 915, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00566501', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00088751', 'title': 'Treatment Study of Frontotemporal Dementia', 'status': 'Completed', 'clean_age': '45 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00088751', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03538574', 'title': 'Mindfulness Meditation and Insomnia in Alzheimer Disease Caregivers', 'status': 'Recruiting', 'clean_age': '45 Years to 95 Years ', 'phases': 'Not Applicable', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03538574', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01047579', 'title': \"A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 51, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01047579', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03038334', 'title': 'Magnesium Sulfate for the Improvement of Cognition in Patients With Alzheimer Disease', 'status': 'Not yet recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03038334', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00556660', 'title': 'Evaluation of [123I] AV51 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00556660', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01152216', 'title': 'An Extension of the CONCERT Protocol (DIM18)', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 672, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01152216', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00217763', 'title': \"European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients\", 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 930, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00217763', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01255046', 'title': 'Study of STA-1 as an Add-on Treatment to Donepezil', 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 136, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01255046', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00857649', 'title': \"Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 369, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00857649', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01504854', 'title': \"Resveratrol for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 119, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01504854', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01594346', 'title': 'Multicenter Vitamin E Trial in Aging Persons With Down Syndrome', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 349, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01594346', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01707719', 'title': \"Isolated Erythrocyte Membrane Susceptibility to Photo-oxidative Stress in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01707719', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00480701', 'title': 'Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheimer Disease', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 26, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00480701', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00606164', 'title': \"Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 9, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00606164', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00104013', 'title': \"Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 1455, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00104013', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00056329', 'title': 'Vitamin E in Aging Persons With Down Syndrome', 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 350, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00056329', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00103649', 'title': \"18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 1306, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00103649', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03019536', 'title': \"A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03019536', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02017340', 'title': \"A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 511, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02017340', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00702143', 'title': \"A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 184, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00702143', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01297140', 'title': 'The PACO Study (\"Personnalité Alzheimer COmportement\")', 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 252, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01297140', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00322153', 'title': \"A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 677, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00322153', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00216502', 'title': \"A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 254, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00216502', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03672201', 'title': 'Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 220, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03672201', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01539031', 'title': \"Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 351, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01539031', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00857233', 'title': \"Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 297, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00857233', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00711139', 'title': 'Long-term Safety and Tolerability of AFFITOPE AD01', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 22, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00711139', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00096473', 'title': \"Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 229, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00096473', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01841125', 'title': \"Escitalopram for the Treatment of Depression in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 84, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01841125', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00829816', 'title': 'Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 46, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00829816', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01696123', 'title': 'Efficacy and Tolerability of MLC601 in Patients With Mild to Moderate Alzheimer Disease Who Were Unable to Tolerate or Failed to Benefit From Treatment With Rivastigmine', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 125, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01696123', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03846492', 'title': 'Targeting Brain Physiology to Treat Neuropsychiatric Symptoms of Dementia Using TMS-EEG and tDCS', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03846492', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03399591', 'title': 'Gait Disorders in Patients With Cognitive Decline', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03399591', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00287248', 'title': 'Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00287248', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02080364', 'title': \"Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 880, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02080364', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03656107', 'title': 'The Cognition and Flow Study', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03656107', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01066546', 'title': \"An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01066546', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02992132', 'title': \"Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 111, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02992132', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04118764', 'title': \"Non-invasive Blood-brain Barrier Opening in Alzheimer's Disease Patients Using Focused Ultrasound\", 'status': 'Not yet recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04118764', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00120874', 'title': \"Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00120874', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03661034', 'title': 'Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03661034', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00216515', 'title': 'The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 102, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00216515', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03118947', 'title': \"A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 79, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03118947', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00088673', 'title': 'Evaluation of 3APS in Patients With Mild to Moderate Alzheimer’s Disease', 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 950, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00088673', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00488670', 'title': \"Escitalopram and Depression in Elderly Alzheimer's Patients\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00488670', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02958670', 'title': 'Imaging Tau Deposition in the Brain of Elderly Subjects', 'status': 'Enrolling by invitation', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02958670', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01962779', 'title': \"Sleep, Aging and Risk for Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 224, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01962779', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02249468', 'title': \"An Exploratory Study to Compare the Differences in Nutritional Status Between Patients With Mild and Moderate Alzheimer's Disease (AD) and Cognitively Intact Healthy People in an Asian Population\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 191, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02249468', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00626210', 'title': 'Modafinil Treatment for Sleep/Wake Disturbances in Older Adults', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 2, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00626210', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03328195', 'title': 'Vielight Neuro RX Gamma - Feasibility Pilot', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03328195', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01019421', 'title': \"Lu AE58054 Added to Donepezil for the Treatment for Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 278, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01019421', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02727699', 'title': 'A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 186, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02727699', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00051909', 'title': \"Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00051909', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01662882', 'title': \"A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01662882', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00829374', 'title': \"Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 1003, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00829374', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01503944', 'title': 'A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01503944', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02663531', 'title': 'Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02663531', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00675623', 'title': \"A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 598, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00675623', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03405662', 'title': \"Impact of Photobiomodulation (PBM) on Biomarkers of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03405662', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02884492', 'title': \"Imaging Tau in Alzheimer's Disease and Normal Aging\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02884492', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00749216', 'title': \"Solanezumab Safety Study in Japanese Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 33, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00749216', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00230568', 'title': \"EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00230568', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00804271', 'title': \"Memantine and Validation of a New Alzheimer's Disease Scale\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 487, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00804271', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00377715', 'title': \"Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 183, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00377715', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00380302', 'title': \"Activity of AVE1625 in Mild to Moderate Alzheimer's Patients.\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 162, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00380302', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01565382', 'title': \"Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01565382', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03926702', 'title': 'Tau Imaging With JNJ067', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03926702', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03424200', 'title': \"Coaching for Cognition in Alzheimer's (COCOA)\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03424200', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00605046', 'title': 'Evaluation of [123I] AV151 and SPECT in Subjects w/ AD in Comparison to Healthy Subjects', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 1, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00605046', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02624778', 'title': \"A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 61, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02624778', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00954538', 'title': 'Safety, Radiation Dosimetry, Biokinetics, and Effectiveness of [18F]MK3328 (MK-3328-001)', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00954538', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00024531', 'title': \"Lipitor as a Treatment for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 98, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00024531', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00285025', 'title': \"Study of the Effect of SR57667B in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 500, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00285025', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00842673', 'title': \"Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 168, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00842673', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00453544', 'title': \"Enhancing Consent for Alzheimer's Research\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 252, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00453544', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01565291', 'title': \"A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly Volunteers\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01565291', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00711321', 'title': 'Long-term Safety and Tolerability of AFFITOPE AD02', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 23, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00711321', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01843075', 'title': \"Evaluating Liraglutide in Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 204, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01843075', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00715858', 'title': \"A Pilot Study of Inflammatory Markers in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00715858', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00692588', 'title': \"MRI to Measure Treatment With Antibiotics in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 58, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00692588', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01723826', 'title': \"A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 360, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01723826', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00285077', 'title': \"Long-Term Safety Extension With SR57667B in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 390, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00285077', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00236431', 'title': 'A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 1063, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00236431', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00622713', 'title': \"A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA)\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 228, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00622713', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00889603', 'title': 'Non-Interventional Study With Aricept® Evess', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 370, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00889603', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00867828', 'title': \"Neptune Krill Oil (NKO™) in Early Stage Alzheimer's Disease (MNEMOSYNE)\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 175, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00867828', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00154635', 'title': 'Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer’s Disease', 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00154635', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00982202', 'title': 'Pioglitazone in Alzheimer Disease', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00982202', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01009255', 'title': \"Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 196, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01009255', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03447613', 'title': 'Retinal Nerve Fiber Layer Thickness and Cerebrospinal Fluid Aβ/Tau', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 86, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03447613', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01420315', 'title': \"The Prevalence of Vitamin D Deficiency in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 502, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01420315', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03744312', 'title': \"Imaging Inflammation in Alzheimer's Disease With 11C-ER176\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03744312', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01992380', 'title': 'A Study of 18F-AV-1451 in Healthy Volunteers and Cognitively Impaired Subjects', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01992380', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00053599', 'title': \"Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 400, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00053599', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01009476', 'title': \"Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 1134, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01009476', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03657745', 'title': \"Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 2000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03657745', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01230853', 'title': 'A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01230853', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02264899', 'title': 'MEMENTO-VAScular COmponents of Dementia', 'status': 'Active, not recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 350, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02264899', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00857506', 'title': 'Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 152, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00857506', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00277810', 'title': \"Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00277810', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01872598', 'title': \"Masitinib in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 721, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01872598', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02646982', 'title': \"Candesartan's Effects on Alzheimer's Disease And Related Biomarkers\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02646982', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02516046', 'title': '18F-AV-1451 Autopsy Study', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 156, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02516046', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00842816', 'title': \"Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 210, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00842816', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02795780', 'title': 'Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 79, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02795780', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00838110', 'title': \"A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 742, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00838110', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01238458', 'title': \"Phase II Study for Amyloid Binding Imaging Study of [18F]AV-45 in Patients With Mild Cognitive Impairment, Alzheimer's Disease and Healthy Volunteers\", 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01238458', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01955161', 'title': \"Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 933, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01955161', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02006654', 'title': \"Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 734, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02006654', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01082965', 'title': \"Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01082965', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02079246', 'title': \"Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 1463, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02079246', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01921972', 'title': \"The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 232, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01921972', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02006641', 'title': \"Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 858, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02006641', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01734395', 'title': \"A Study to Show That the Change of Attention Measure is Correlated With the Changes of Caregiver's Burden After Treatment With Galantamine in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 1882, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01734395', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00236574', 'title': 'A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 974, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00236574', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00469456', 'title': \"Effect of Memantine on Functional Communication in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 265, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00469456', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00843115', 'title': 'Observational Study Of Donepezil In Routine Clinical Practice', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 370, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00843115', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00141661', 'title': \"A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 67, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00141661', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03239561', 'title': \"Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03239561', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03670615', 'title': 'Using Exercise and Electrical Brain Stimulation to Improve Memory in Dementia', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03670615', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00722046', 'title': \"Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 198, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00722046', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00551161', 'title': \"Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00551161', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03402503', 'title': \"Safety, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03402503', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01421420', 'title': \"Alzheimer's Disease Core Center\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 900, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01421420', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00097916', 'title': \"An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 34, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00097916', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03634007', 'title': \"Gene Therapy for APOE4 Homozygote of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03634007', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03295110', 'title': \"Connected Solution of Assistance Dedicated to Caregivers and People With Alzheimer's Disease or Related Diseases\", 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03295110', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00479843', 'title': 'Nutritional Programme for Dementia Elderly Patient', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 946, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00479843', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01481558', 'title': \"Effects of Transcranial Direct Current Stimulation on the Apathy of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01481558', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03666624', 'title': 'Socially Isolated Older Adults Living With Dementia', 'status': 'Not yet recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03666624', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00239759', 'title': \"MIRAGE: Multi-Institutional Research in Alzheimer's Genetic Epidemiology\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 2000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00239759', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04118985', 'title': \"Compensatory Training to Support Brain Healthy Lifestyle Changes in Those at Risk for Alzheimer's Disease\", 'status': 'Enrolling by invitation', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04118985', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03550131', 'title': 'Innovations in Dementia Empowerment and Action', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 225, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03550131', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03307993', 'title': \"Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 3, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03307993', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00657813', 'title': 'Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-amyloid Protein Deposition', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 3, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00657813', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02955706', 'title': \"Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 328, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02955706', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02804789', 'title': \"European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study (LCS)\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 6000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02804789', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03117738', 'title': \"A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03117738', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03454646', 'title': 'Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL)', 'status': 'Not yet recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 1205, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03454646', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03384069', 'title': 'CBT for African Americans With Cognitive Impairment', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03384069', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03430648', 'title': 'Is Tau Protein Linked to Mobility Function?', 'status': 'Enrolling by invitation', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03430648', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01153607', 'title': 'Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy Volunteers', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01153607', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01009359', 'title': 'Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy Volunteers', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01009359', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02854917', 'title': \"Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health Outcome\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02854917', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02987842', 'title': \"Neurofeedback as a Novel Treatment for Mild Cognitive Impairment & Early Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02987842', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03709238', 'title': \"Pain Processing and Pain Reporting in Patients With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03709238', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02654574', 'title': 'Comparison of Two Modes of Administration of the IADL Questionnaire, Assessing the Level of Functional Autonomy of Patients to Carry Out the Tasks of Daily Living: Randomized Controlled Trial Among Patients of a Memory Clinic', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 299, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02654574', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00711204', 'title': \"Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00711204', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01125631', 'title': \"Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01125631', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00561392', 'title': \"Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 208, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00561392', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01066481', 'title': \"A Study Of Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01066481', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00954590', 'title': \"A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 89, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00954590', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00838942', 'title': 'Life From Vision in Alzheimer Disease', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 80, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00838942', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02553928', 'title': 'Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 62, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02553928', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03138018', 'title': \"Aging Stereotypes and Prodromal Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 260, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03138018', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03095417', 'title': 'Improving the Recovery and Outcome Every Day After the ICU', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 344, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03095417', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00703430', 'title': \"Memantine on Aggression and Agitation of Alzheimer's Disease (AD)\", 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00703430', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00403520', 'title': 'Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00403520', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01276353', 'title': \"A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01276353', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01822951', 'title': \"Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)\", 'status': 'Withdrawn', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01822951', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00544453', 'title': 'Evaluation of [123I] MNI-308 and SPECT as a Marker of Beta-amyloid Protein Deposition in AD Subjects Compared to HC', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 2, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00544453', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02051764', 'title': 'Imaging Characteristics of a Follow-up 18F-AV-1451 Scan', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02051764', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03081533', 'title': 'Circle Dance for Family Caregivers of the Elderly With Alzheimer.', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03081533', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00855686', 'title': \"Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 199, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00855686', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00596284', 'title': 'Cognitive Behavior Therapy for Treating Anxiety in People With Dementia', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 34, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00596284', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00884507', 'title': \"A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 389, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00884507', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03022968', 'title': \"Tau Brain Imaging in Typical and Atypical Alzheimer's Disease (AD)\", 'status': 'Active, not recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03022968', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00870519', 'title': 'Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 2, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00870519', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00704782', 'title': \"Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00704782', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00976118', 'title': \"Activity of Masitinib (AB1010) in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 34, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00976118', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01555827', 'title': \"Retinal Neurodegenerative Signs in Alzheimer's Diseases\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01555827', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01554683', 'title': \"Seizure Activity in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01554683', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02916056', 'title': \"2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 298, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02916056', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03991988', 'title': \"Montelukast Therapy on Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03991988', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00130429', 'title': \"Safety and Effect on Memory of PYM50028 in Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00130429', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04114994', 'title': 'Longitudinal Cognitive Assessment by BoCA', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 10000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04114994', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00571064', 'title': \"The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 97, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00571064', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03806478', 'title': \"Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03806478', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00675090', 'title': \"Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 28, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00675090', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02035553', 'title': \"A Study of the Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease Psychosis\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 181, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02035553', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00945672', 'title': \"A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00945672', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01406145', 'title': \"A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of Donepezil\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01406145', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00912288', 'title': \"A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 86, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00912288', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04081285', 'title': \"Epigenetic Biomarkers for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 250, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04081285', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03809351', 'title': \"UAB Alzheimer's Disease Center Core Cohort - Tau Imaging Substudy\", 'status': 'Not yet recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03809351', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03061474', 'title': \"Nicotinamide as an Early Alzheimer's Disease Treatment\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03061474', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00477659', 'title': \"Neural Correlates In Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00477659', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00733642', 'title': \"Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00733642', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00886951', 'title': \"Single Photon Emission Computed Tomography (SPECT) Imaging Study to Develop a Biomarker for Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 2, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00886951', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03044249', 'title': 'A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03044249', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00948766', 'title': \"Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 716, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00948766', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00939783', 'title': \"An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 649, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00939783', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01035164', 'title': \"Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01035164', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00174382', 'title': 'Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 149, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00174382', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00013923', 'title': 'Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00013923', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00017940', 'title': \"Gene Therapy for Alzheimer's Disease Clinical Trial\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00017940', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00074529', 'title': \"Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 512, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00074529', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00605059', 'title': 'Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 3, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00605059', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03168997', 'title': \"Memantine Treatment in Alzheimer's Disease Patients\", 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 222, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03168997', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00423228', 'title': \"Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 228, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00423228', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00334906', 'title': \"Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 75, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00334906', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00240695', 'title': 'A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 724, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00240695', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00630851', 'title': \"A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 249, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00630851', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00439166', 'title': \"Effects of Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal Fluid\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00439166', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00448799', 'title': 'Evaluation of [123I] AV83 and SPECT in Patients With Alzheimer Disease in Comparison to Healthy Controls', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00448799', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03340571', 'title': \"Blood Biomarker of Alzheimer's Disease (AD)\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03340571', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00456417', 'title': 'Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00456417', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00566397', 'title': \"A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 402, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00566397', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03090854', 'title': \"Cholinergic Markers Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03090854', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00164749', 'title': \"A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00164749', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00440050', 'title': \"DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 402, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00440050', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00439010', 'title': 'Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy Subjects', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00439010', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00142805', 'title': \"Ketasyn in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00142805', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02899091', 'title': \"Evaluation of the Safety and Potential Therapeutic Effects After Intravenous Transplantation of CB-AC-02 in Patients With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02899091', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00090116', 'title': \"The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 400, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00090116', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03484143', 'title': 'Neuro RX Gamma - Pivotal Phase', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 228, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03484143', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00244322', 'title': \"Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00244322', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00329082', 'title': \"Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy Volunteers\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00329082', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00495417', 'title': \"Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00495417', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00099710', 'title': \"Curcumin in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 33, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00099710', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03503331', 'title': \"UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03503331', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00073658', 'title': 'Treating Behavioral Disturbances in Individuals With Dementia', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 137, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00073658', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00151398', 'title': \"Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 229, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00151398', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02708186', 'title': 'Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 29, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02708186', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00314912', 'title': \"Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 650, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00314912', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00428389', 'title': \"Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 262, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00428389', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00299988', 'title': \"Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00299988', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02871427', 'title': 'Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02871427', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02265757', 'title': 'Behavioral Interventions to Prevent or Delay Dementia', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 272, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02265757', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02085265', 'title': \"Telmisartan vs. Perindopril in Hypertensive Mild-Moderate Alzheimer's Disease Patients\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02085265', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00862940', 'title': \"A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 277, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00862940', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00895895', 'title': 'Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 526, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00895895', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01538212', 'title': \"Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 55, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01538212', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02918539', 'title': \"Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 317, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02918539', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01926691', 'title': 'Predictors for Poststroke Outcomes: Tel Aviv Brain Acute Stroke Cohort Acute Stroke Cohort (TABASCO)', 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 534, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01926691', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00646269', 'title': \"Efficacy Assessment of Three Non Pharmacological Therapies in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 640, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00646269', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00968097', 'title': 'Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-Amyloid Protein Deposition', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00968097', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00731224', 'title': \"Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 380, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00731224', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00234637', 'title': \"Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 204, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00234637', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03297268', 'title': 'Behavioral and Environmental Sensing and Intervention', 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 24, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03297268', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03160027', 'title': 'Photobiomodulation for Improving Brain Function in Dementia (PBM Dementia)', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03160027', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03489044', 'title': \"An Investigation of Levetiracetam in Alzheimer's Disease\", 'status': 'Enrolling by invitation', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03489044', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03069391', 'title': 'The Interactive Physical and Cognitive Exercise System', 'status': 'Active, not recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 31, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03069391', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04055376', 'title': \"Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04055376', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03939780', 'title': \"Tau Tracer Comparison in Healthy Controls and Alzheimer's Disease Patients\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03939780', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03752463', 'title': \"NMDA Enhancer for the Treatment of Mild Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 100 Years ', 'phases': 'Phase 2', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03752463', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03373604', 'title': \"Imaging Tau in Alzheimer's Disease and Normal Aging\", 'status': 'Enrolling by invitation', 'clean_age': '50 Years to 100 Years ', 'phases': 'Phase 2', 'enrollment': 175, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03373604', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01796314', 'title': \"Impact of Therapeutic Educational Programme on the Alzheimer's Disease Affected Patient's Quality of Life\", 'status': 'Completed', 'clean_age': '50 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 170, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01796314', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02103673', 'title': 'DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of Dementia', 'status': 'Completed', 'clean_age': '50 Years to 100 Years ', 'phases': 'Phase 2', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02103673', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04042922', 'title': \"High Frequency Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04042922', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02825732', 'title': 'MEMORA-Caregiver : Risk Factors of Caregiver Burden Among Patients With Neurocognitive Disorders or Subjective Cognitive Complaint', 'status': 'Completed', 'clean_age': '50 Years to 100 Years ', 'phases': 'Phase 4', 'enrollment': 1300, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02825732', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02957227', 'title': \"Diagnosis of Alzheimer's Disease Using Event Related Potentials\", 'status': 'Recruiting', 'clean_age': '50 Years to 100 Years ', 'phases': 'Phase 4', 'enrollment': 170, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02957227', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03038035', 'title': \"The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study\", 'status': 'Unknown status', 'clean_age': '50 Years to 120 Years ', 'phases': 'Phase 2', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03038035', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00706186', 'title': \"Safety and Feasibility of Sodium Oxybate in Mild Alzheimer's Disease Patients\", 'status': 'Terminated', 'clean_age': '50 Years to 65 Years ', 'phases': 'Phase 4', 'enrollment': 4, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00706186', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00586430', 'title': 'The Impact of Lorazepam on Cognition in APOE e4 Carriers', 'status': 'Completed', 'clean_age': '50 Years to 65 Years ', 'phases': 'Not Applicable', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00586430', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00888056', 'title': \"Chronic Electrical Stimulation of Hypothalamus/Fornix in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 65 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00888056', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00947934', 'title': 'Study of the Brain Stimulation Effect on Memory Impairment in Alzheimer Disease', 'status': 'Unknown status', 'clean_age': '50 Years to 70 Years ', 'phases': 'Not Applicable', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00947934', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02530255', 'title': 'Telomerase Activator and Retinal Amyloid', 'status': 'Completed', 'clean_age': '50 Years to 70 Years ', 'phases': 'Not Applicable', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02530255', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04074837', 'title': 'Phase1a, Dose-escalation Study of NNI-362 in Healthy Aged Volunteers', 'status': 'Recruiting', 'clean_age': '50 Years to 72 Years ', 'phases': 'Phase 1', 'enrollment': 56, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04074837', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03186989', 'title': \"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-MAPTRx in Patients With Mild Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 74 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 44, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03186989', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02719327', 'title': 'Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid', 'status': 'Recruiting', 'clean_age': '50 Years to 75 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02719327', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01297218', 'title': \"The Safety and The Efficacy Evaluation of NEUROSTEM®-AD in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 9, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01297218', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03923569', 'title': \"Epileptiform Activity During REM Sleep in Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03923569', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03790982', 'title': \"Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 75 Years ', 'phases': 'Phase 2', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03790982', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01696591', 'title': 'The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD', 'status': 'Unknown status', 'clean_age': '50 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 14, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01696591', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02835716', 'title': 'Pre-Clinical (Alzheimers) Diagnosis PCD = Optimum Outcomes OO', 'status': 'Recruiting', 'clean_age': '50 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02835716', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04122001', 'title': \"Effects of Electrical Stimulation on Verbal Learning in Typical and Atypical Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04122001', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04042532', 'title': \"Theta-burst Stimulation on Cognitive Function in the Patients With Young-onset Alzheimer's Disease Dementia\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04042532', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01075763', 'title': \"A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 75 Years ', 'phases': 'Phase 2', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01075763', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02340195', 'title': 'Pharmacokinetic Properties of Idalopirdine (Lu AE58054) in Subjects With and Without Impaired Kidney Function', 'status': 'Completed', 'clean_age': '50 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02340195', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03030365', 'title': 'Orientation in AD Patients: PET-MR Study', 'status': 'Not yet recruiting', 'clean_age': '50 Years to 79 Years ', 'phases': 'Phase 4', 'enrollment': 30, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03030365', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02860065', 'title': \"CPC-201 Alzheimer's Disease Type Dementia: PET Study\", 'status': 'Withdrawn', 'clean_age': '50 Years to 79 Years ', 'phases': 'Phase 2', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02860065', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02185053', 'title': \"A Phase II Study of CPC-201 to Treat Alzheimer's Disease Type Dementia\", 'status': 'Completed', 'clean_age': '50 Years to 79 Years ', 'phases': 'Phase 2', 'enrollment': 41, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02185053', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01163825', 'title': 'Encapsulated Cell Biodelivery of Nerve Growth Factor to Alzheimer´s Disease Patients', 'status': 'Unknown status', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01163825', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01001637', 'title': \"Efficacy and Safety of Curcumin Formulation in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 26, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01001637', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01245530', 'title': 'An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 3', 'enrollment': 280, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01245530', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03472183', 'title': 'Exploration of the Enteric Nervous System in Alzheimer Disease', 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03472183', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01334450', 'title': 'Transcranial Magnetic Stimulation (TMS) Treatment for Alzheimer Patients', 'status': 'Unknown status', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01334450', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01309763', 'title': 'Safety and Tolerability of AFFITOPE AD03', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 28, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01309763', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00608946', 'title': 'Treatment With Copper in Patients With Mild Alzheimer´s Dementia', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 68, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00608946', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03875638', 'title': 'Treating Hyperexcitability in AD With Levetiracetam', 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 85, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03875638', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01469351', 'title': 'Identifying Potential Effects of Liraglutide on Degenerative Changes', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 34, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01469351', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01397578', 'title': \"A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 91, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01397578', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03070821', 'title': \"Therapy of Alzheimer's Disease With Neurofeedback\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03070821', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00965588', 'title': \"Study to Evaluate Safety, Tolerability and Immunogenicity of Vaccine (UB 311) in Subjects With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00965588', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00414622', 'title': 'GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer’s Disease', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00414622', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01343966', 'title': \"A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 448, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01343966', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01428453', 'title': \"A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 124, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01428453', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01370954', 'title': 'NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 204, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01370954', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01656525', 'title': 'A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 28, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01656525', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00637442', 'title': 'Continuous Arterial Spin Labeling (CASL) MRI for Monitoring and Prediction of Drug Therapy in Alzheimers Disease (AD)', 'status': 'Unknown status', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00637442', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01568086', 'title': 'Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AD03 Applied During AFF005A', 'status': 'Terminated', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 16, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01568086', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03522129', 'title': \"Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03522129', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02204969', 'title': 'LIWA for Treatment of Alzheimer Patients', 'status': 'Unknown status', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02204969', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02600130', 'title': \"Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02600130', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02841605', 'title': 'Enteric Nervous System in Alzheimer Disease', 'status': 'Unknown status', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 55, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02841605', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03352557', 'title': \"Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 654, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03352557', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00454870', 'title': \"Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00454870', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03939286', 'title': 'Multimodal Imaging Study on Physical Activity in Patients With Alzheimer`s Disease', 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03939286', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02409030', 'title': \"Multi-parameter Diagnostic Blood Test for the Diagnosis of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 700, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02409030', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00087789', 'title': \"CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00087789', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04029623', 'title': \"Partnered Rhythmic Rehabilitation in Prodromal Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 66, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04029623', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00633841', 'title': \"Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00633841', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01887899', 'title': 'Influence of tDCS on Cortical Plasticity in Patients With Dementia of the Alzheimer Type', 'status': 'Unknown status', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01887899', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00100334', 'title': 'Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer’s Disease', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00100334', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01780519', 'title': 'The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 57, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01780519', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02907567', 'title': \"Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02907567', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04082611', 'title': 'The PREVENTION Trial: Precision Recommendations to Optimize Neurocognition', 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04082611', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01701089', 'title': 'A Study of RO4602522 in Patients With Alzheimer Disease and in Healthy Volunteers', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01701089', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00753662', 'title': \"Deep Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00753662', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03290274', 'title': 'Clinical Trial to Evaluate the Efficacy and Security of Deep Brain Stimulation in Alzheimer´s Disease', 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03290274', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03056729', 'title': \"Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03056729', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01979419', 'title': \"Korea Alzheimer's Disease Neuroimaging Initiative\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 500, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01979419', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02874820', 'title': 'I2PETPG - Imidazoline2 Binding Sites in a Group of Participants Diagnosed With AD', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Early Phase 1', 'enrollment': 2, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02874820', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01189084', 'title': \"Observational Study to Monitor Long-term Immunogenicity and Efficacy of UB 311 Vaccine in Subjects With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 14, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01189084', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03943264', 'title': \"A Biomarker-directed Study of XPro1595 in Patients With Mild to Moderate Alzheimer's\", 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03943264', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00100282', 'title': 'Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer’s Disease', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 125, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00100282', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03703856', 'title': \"Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 88, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03703856', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01227564', 'title': \"Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 63, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01227564', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00411580', 'title': \"Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 58, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00411580', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03035851', 'title': \"Aerobic Exercise for Older Adults at Increased Risk of Alzheimer's Disease and Related Dementias\", 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 264, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03035851', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01117818', 'title': \"Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 335, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01117818', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03289143', 'title': \"A Study to Evaluate the Efficacy and Safety of RO7105705 in Patients With Prodromal to Mild Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 457, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03289143', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01966666', 'title': \"A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TPI-287 in Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 82 Years ', 'phases': 'Phase 1', 'enrollment': 33, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01966666', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03319810', 'title': 'Effect of IVIG on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer Disease', 'status': 'Completed', 'clean_age': '50 Years to 84 Years ', 'phases': 'Phase 2', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03319810', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01300728', 'title': 'Study of Intravenous Immunoglobulin in Amnestic Mild Cognitive Impairment', 'status': 'Active, not recruiting', 'clean_age': '50 Years to 84 Years ', 'phases': 'Phase 2', 'enrollment': 52, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01300728', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00134953', 'title': 'Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment', 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00134953', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00099242', 'title': \"Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 1040, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00099242', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02759159', 'title': \"The Study of Mechanism of Alzheimer's Disease Using Acupuncture Based on fMRI\", 'status': 'Unknown status', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02759159', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01117948', 'title': 'Efficacy and Safety of Lornoxicam in Patients With Mild to Moderate Probable Alzheimer´s Disease.', 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 219, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01117948', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01325402', 'title': \"An Open Positron Emission Tomography Study to Assess the Effects of Varying Mass of AZD4694 on Radioligand Binding Parameters in Healthy Volunteers and Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01325402', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00305903', 'title': \"Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00305903', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02537626', 'title': \"An Evaluation of Low Level Laser Light Therapy on Improving the Symptoms of Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02537626', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03090516', 'title': \"Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03090516', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01537757', 'title': 'A Two-Part, Single-Dose Study of the Pharmacokinetics of MK-8931 in Subjects With Renal Insufficiency (MK-8931-009 [P08535])', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01537757', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00151333', 'title': \"Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00151333', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03113812', 'title': \"Repeated Subcutaneous Administration of ABvac40 in Mild to Moderate Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03113812', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00710684', 'title': \"A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 682, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00710684', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00568776', 'title': \"ELND005 in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 353, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00568776', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03819699', 'title': \"Study With Lu AF20513 in Patients With Mild Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Due to AD\", 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 3, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03819699', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03656042', 'title': \"To Evaluate the Efficacy and Safety/Tolerability Profiles of G-CSF in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03656042', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00224497', 'title': \"A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 380, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00224497', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03659643', 'title': 'Mild Cognitive Impairment, Use of qEEG as a Prognostic Marker', 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 300, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03659643', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02054208', 'title': \"Safety and Exploratory Efficacy Study of NEUROSTEM® Versus Placebo in Patients With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02054208', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01547689', 'title': \"Safety and Efficiency of Umbilical Cord-derived Mesenchymal Stem Cells(UC-MSC) in Patients With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01547689', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02984540', 'title': \"Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02984540', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03283059', 'title': \"Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 600, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03283059', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03069014', 'title': 'Study of LM11A-31-BHS in Mild-moderate AD Patients', 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 190, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03069014', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00558402', 'title': 'Meditation or Education for Alzheimer Caregivers', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00558402', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01496170', 'title': \"A Study of the Safety, Tolerability, and Pharmacodynamics of MK-8931 in Participants With Alzheimer's Disease (MK-8931-010 AM1 [P07820 AM1])\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01496170', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00219232', 'title': \"An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 868, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00219232', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03325205', 'title': \"MR Guided tDCS in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03325205', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00069849', 'title': \"A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 64, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00069849', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00649220', 'title': 'Memantine and Antipsychotics Use', 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00649220', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00940589', 'title': 'Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 73, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00940589', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03466177', 'title': \"Multimodal Retinal Imaging in the Detection and Follow-up of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 90, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03466177', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04004767', 'title': 'TRC-PAD Program: In-Clinic Trial-Ready Cohort', 'status': 'Enrolling by invitation', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 2000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04004767', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01179373', 'title': \"Deep Transcranial Magnetic Stimulation for Treatment of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01179373', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03008161', 'title': \"Multiple Dose Safety Study of NPT088 in Patients With Mild to Moderate Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 83, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03008161', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01059877', 'title': 'Efficacy of 1072nm Infrared Stimulation on Executive Functioning in Dementia', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 11, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01059877', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02787746', 'title': \"Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 241, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02787746', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03625401', 'title': \"Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 88, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03625401', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03671889', 'title': \"ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03671889', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03638583', 'title': 'Alzheimer Prevention Trials Webstudy', 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 200000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03638583', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03507790', 'title': \"A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03507790', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02050464', 'title': 'Computational Tools for Early Diagnosis of Memory Disorders', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 126, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02050464', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00838877', 'title': 'Positron Emission Tomography (PET) Study With [18F]AZD4694 and [11C]AZD2184, Candidate PET Ligands for Aβ Amyloid', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 26, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00838877', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03114657', 'title': \"A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 806, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03114657', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03834402', 'title': 'INTERCEPTOR Project: From MCI to Dementia', 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 500, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03834402', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02703636', 'title': \"NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients.\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 118, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02703636', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01548430', 'title': \"A Safety Study of TTP4000 in Subjects With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01548430', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03197740', 'title': \"A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 346, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03197740', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02956486', 'title': \"A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Subjects With Early Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 950, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02956486', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03204604', 'title': 'The Brain Ketone Body Challenge Imaging Study', 'status': 'Withdrawn', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03204604', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00498602', 'title': \"Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00498602', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00960531', 'title': \"A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00960531', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00752232', 'title': \"Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00752232', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02670083', 'title': \"CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 813, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02670083', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02947893', 'title': \"Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02947893', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02875496', 'title': 'Reference Database & Longitudinal Registry of the Normal and Pathological Aging Brain', 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 2000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02875496', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00104442', 'title': \"Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00104442', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01453569', 'title': \"Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 255, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01453569', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01850238', 'title': \"Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01850238', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04040348', 'title': \"Alzheimer's Disease Stem Cells Multiple Infusions\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04040348', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01093664', 'title': 'Safety/Tolerability, Immunological and Clinical Activity of a Boost Immunization With AFFITOPE AD02', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01093664', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00348192', 'title': \"SB-742457 And Donepezil In Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00348192', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01764243', 'title': 'Safety and Efficacy of MT-4666', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 450, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01764243', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02640092', 'title': \"Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02640092', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01054976', 'title': \"The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 99, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01054976', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03748706', 'title': \"PTI-125 for Mild-to-moderate Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03748706', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02221947', 'title': \"Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 9, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02221947', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02322021', 'title': \"Dose-Finding Study To Evaluate the Safety and Tolerability of E2609 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 71, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02322021', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02500784', 'title': \"Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease\", 'status': 'Suspended', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02500784', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01044758', 'title': 'Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 96, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01044758', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03978338', 'title': \"A Study to Evaluate the Efficacy and Safety of Brain Polypeptide Solution in Mild Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03978338', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00112073', 'title': \"AAB-001 in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 234, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00112073', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04079803', 'title': \"PTI-125 for Mild-to-moderate Alzheimer's Disease Patients\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04079803', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03587376', 'title': 'Characterization of T-Cell Response in Participants Previously Treated With JNJ-54861911 (Atabecestat)', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Early Phase 1', 'enrollment': 9, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03587376', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00334568', 'title': 'Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease', 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00334568', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01548287', 'title': \"A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 164, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01548287', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03828747', 'title': \"A Study of RO7105705 in Patients With Moderate Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 260, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03828747', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03919669', 'title': 'A Longitudinal Evaluation of a Radiotracer for Use in Tau Tracking', 'status': 'Enrolling by invitation', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03919669', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02672306', 'title': \"Safety and Exploratory Efficacy Study of UCMSCs in Patients With Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02672306', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00500500', 'title': \"Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00500500', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01715350', 'title': \"Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 151, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01715350', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03514875', 'title': \"Effects of Mitochondrial-targeted Antioxidant on Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03514875', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00455000', 'title': \"A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 37, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00455000', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03130036', 'title': 'Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose Using Positron Emission Tomography (PET) Scanning', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 34, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03130036', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02477800', 'title': \"221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 1605, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02477800', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00397891', 'title': 'Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00397891', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02008513', 'title': 'Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006', 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 194, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02008513', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00607308', 'title': \"A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00607308', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02444637', 'title': 'Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD', 'status': 'Unknown status', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02444637', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02593318', 'title': \"Trial of Oxaloacetate in Alzheimer's Disease (TOAD)\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02593318', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03980730', 'title': \"Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03980730', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02579252', 'title': \"24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 208, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02579252', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01348061', 'title': \"Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 16, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01348061', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00423085', 'title': \"Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 859, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00423085', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03036280', 'title': \"A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Subjects With Early Alzheimer's Disease_\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 950, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03036280', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02484547', 'title': \"221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 1605, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02484547', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02711683', 'title': \"DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02711683', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03867253', 'title': \"Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 33, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03867253', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03739905', 'title': \"ExAblate Blood-Brain Barrier Opening for Treatment of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03739905', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01569516', 'title': \"Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 288, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01569516', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01529619', 'title': \"Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 52, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01529619', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01399125', 'title': \"A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 501, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01399125', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02293915', 'title': \"An Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 818, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02293915', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01953601', 'title': \"Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)\", 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 1454, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01953601', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03422250', 'title': \"Non-invasive Stimulation of Brain Networks and Cognition in Alzheimer's Disease and Frontotemporal Dementia\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 66, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03422250', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01585272', 'title': \"Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 121, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01585272', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01282619', 'title': \"Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 390, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01282619', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01485302', 'title': \"Single and Repeated Dosing Study to Assess the Safety and the Concentration-time Profile of SAR228810 in Alzheimer's Patients\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01485302', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02778438', 'title': 'A Validation Study of the Novel Application of Telehealth in Clinical Drug Development in Subjects With Mild Cognitive Deficits', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 30, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02778438', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01482013', 'title': \"Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 7, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01482013', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03801642', 'title': \"Dapagliflozin In Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03801642', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02406027', 'title': \"An Extension Study to Evaluate the Long-Term Safety and Tolerability of JNJ-54861911 in Participants in the Early Alzheimer's Disease Spectrum\", 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02406027', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03221894', 'title': \"A Retrospective Study to Investigate the Additive Effectiveness of Chinese Herbal Medicine in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 90, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03221894', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00265148', 'title': \"Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00265148', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03119961', 'title': \"Blood Brain Barrier Opening in Alzheimer' Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03119961', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02260674', 'title': \"A Safety and Tolerability Study of JNJ-54861911 in Participants With Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 114, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02260674', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00021723', 'title': \"Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 375, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00021723', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01614886', 'title': 'Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 216, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01614886', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03507192', 'title': 'Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.', 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03507192', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01073228', 'title': \"Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 409, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01073228', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03605667', 'title': \"Study of BHV-4157 in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 292, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03605667', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00959192', 'title': \"Safety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00959192', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00479557', 'title': \"Study Evaluating Safety, Tolerability, And Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 86, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00479557', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03612622', 'title': \"Effect of Theta-Burst Transcranial Magnetic Stimulation (TBS) for Early Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03612622', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01224106', 'title': \"A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 799, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01224106', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00812565', 'title': \"Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 58, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00812565', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00990613', 'title': 'A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00990613', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00708552', 'title': \"Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 576, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00708552', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03752294', 'title': \"A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age.\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03752294', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01350362', 'title': \"Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 306, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01350362', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00506415', 'title': \"Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 1584, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00506415', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03250741', 'title': \"Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 94, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03250741', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03277573', 'title': \"Salsalate in Patients Mild to Moderate Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03277573', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03493282', 'title': 'Effect of CT1812 Treatment on Brain Synaptic Density', 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03493282', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00381238', 'title': \"Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 33, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00381238', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01600859', 'title': \"Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 65, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01600859', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03810794', 'title': \"Clinical Evaluation on the Therapeutic Effect of Acupuncture Treatment for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03810794', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02518412', 'title': 'Transcranial Direct Current Stimulation (tDCS) as a Cognitive Enhancer for Patients With Alzheimers Disease', 'status': 'Unknown status', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02518412', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01948791', 'title': \"16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 222, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01948791', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02580305', 'title': \"SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 563, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02580305', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03639987', 'title': \"A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 500, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03639987', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02585934', 'title': \"Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 1315, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02585934', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03172117', 'title': 'Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial.', 'status': 'Recruiting', 'clean_age': '50 Years to 86 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03172117', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00736775', 'title': \"A Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 86 Years ', 'phases': 'Phase 1', 'enrollment': 56, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00736775', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02586909', 'title': \"12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension\", 'status': 'Terminated', 'clean_age': '50 Years to 86 Years ', 'phases': 'Phase 3', 'enrollment': 1100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02586909', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02031198', 'title': \"18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 86 Years ', 'phases': 'Phase 1', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02031198', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02155946', 'title': 'Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment', 'status': 'Recruiting', 'clean_age': '50 Years to 88 Years ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02155946', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00676143', 'title': 'Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients', 'status': 'Terminated', 'clean_age': '50 Years to 88 Years ', 'phases': 'Phase 3', 'enrollment': 1100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00676143', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00575055', 'title': \"Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)\", 'status': 'Completed', 'clean_age': '50 Years to 88 Years ', 'phases': 'Phase 3', 'enrollment': 1121, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00575055', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00574132', 'title': \"Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)\", 'status': 'Completed', 'clean_age': '50 Years to 88 Years ', 'phases': 'Phase 3', 'enrollment': 1331, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00574132', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01958437', 'title': 'Enhancing Spatial Navigation Using Non-Invasive Brain Stimulation', 'status': 'Completed', 'clean_age': '50 Years to 88 Years ', 'phases': 'Not Applicable', 'enrollment': 44, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01958437', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02262975', 'title': \"A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS)\", 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 4', 'enrollment': 532, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02262975', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02434666', 'title': \"Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07\", 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02434666', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04032626', 'title': 'MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients', 'status': 'Not yet recruiting', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04032626', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00916617', 'title': 'Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab', 'status': 'Terminated', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 62, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00916617', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00818662', 'title': 'A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease', 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 3', 'enrollment': 390, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00818662', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02462161', 'title': 'Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart', 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02462161', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01524887', 'title': 'Phase 3 IGIV, 10% in Alzheimer´s Disease', 'status': 'Terminated', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 3', 'enrollment': 508, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01524887', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03790774', 'title': \"Neurofeedback in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 89 Years ', 'phases': 'Not Applicable', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03790774', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03919162', 'title': 'A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD', 'status': 'Not yet recruiting', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 462, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03919162', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02389413', 'title': \"Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02389413', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01547169', 'title': 'Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days', 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01547169', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02910102', 'title': 'Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia', 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02910102', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00667810', 'title': 'Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients', 'status': 'Terminated', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 3', 'enrollment': 901, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00667810', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01595646', 'title': 'Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)', 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 37, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01595646', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00880555', 'title': 'Semantic Memory, Financial Capacity, and Brain Perfusion in Mild Cognitive Impairment (MCI) (CASL)', 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 4', 'enrollment': 78, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00880555', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02549196', 'title': \"A Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's Type\", 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 28, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02549196', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01193608', 'title': \"Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 1', 'enrollment': 88, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01193608', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01284387', 'title': \"Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 126, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01284387', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01254773', 'title': \"Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 146, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01254773', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00663026', 'title': 'Study Evaluating Bapineuzumab In Alzheimer Disease Subjects', 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 79, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00663026', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01849042', 'title': \"Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 188, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01849042', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00743743', 'title': \"Pilot Study of the Effects of Resveratrol Supplement in Mild-to-moderate Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00743743', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02502253', 'title': 'BDPP Treatment for Mild Cognitive Impairment (MCI) and Prediabetes or Type 2 Diabetes Mellitus (T2DM)', 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02502253', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00684281', 'title': \"Early Diagnosis of Alzheimer's Disease: Clinical, Neuropsychological and Neuroimaging Follow-up of a Cohort of Patients With an Isolated Memory Impairment\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00684281', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03430869', 'title': 'Pathophysiology of Neurodegeneration in Late-life Depression (AV45+THK)', 'status': 'Active, not recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03430869', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02359552', 'title': \"Rasagiline Rescue in Alzheimer's Disease Clinical Trial\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 27, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02359552', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00672945', 'title': \"A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil\", 'status': 'Terminated', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 420, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00672945', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00110552', 'title': \"Effects of Sage on Memory and Mental Performance in Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 111, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00110552', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01782742', 'title': \"Bexarotene Amyloid Treatment for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01782742', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00624026', 'title': 'Memantine - Communication Study', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 107, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00624026', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02503501', 'title': \"Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 49, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02503501', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00973518', 'title': \"Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG)\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 160, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00973518', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03101085', 'title': \"S-Equol in Alzheimer's Disease 2 Trial\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03101085', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00348140', 'title': \"Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 1468, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00348140', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01404169', 'title': \"A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 260, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01404169', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01584440', 'title': \"Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 220, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01584440', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01874418', 'title': \"Biomarker Study to Diagnose Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01874418', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00481520', 'title': \"Study Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00481520', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01940952', 'title': \"Zydena on Cognitive Function of Alzheimer's Disease Patients\", 'status': 'Unknown status', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 210, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01940952', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00688207', 'title': \"Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR)\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00688207', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01600469', 'title': \"NMDA-enhancing Agent for Treatment of Mild Cognitive Impairment and Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 86, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01600469', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03543878', 'title': 'Stimulating Neural Activity to Improve Blood Flow and Reduce Amyloid: Path to Clinical Trials', 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03543878', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03393520', 'title': \"Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 412, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03393520', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01122329', 'title': \"A Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01122329', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01894620', 'title': \"The Effect of rTMS Treatment on Alzheimer's and Sleep Quality\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 11, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01894620', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01876823', 'title': 'Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive Impairment', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01876823', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00800709', 'title': \"Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 26, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00800709', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00678431', 'title': \"Randomized Trial of a Nutritional Supplement in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 27, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00678431', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02094729', 'title': \"A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 26, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02094729', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02524405', 'title': 'BEAM: Brain-Eye Amyloid Memory Study', 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 345, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02524405', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02051608', 'title': 'A Study of Gantenerumab in Participants With Mild Alzheimer Disease', 'status': 'Active, not recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 389, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02051608', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01687153', 'title': 'A Study of Brain Aging in Vietnam War Veterans', 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 420, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01687153', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01436188', 'title': \"A Study to Measure CSF Proteins in Elderly Healthy Volunteers and Volunteers With Mild Cognitive Impairment or Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01436188', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03325556', 'title': 'Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis', 'status': 'Active, not recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 356, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03325556', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00531804', 'title': 'A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00531804', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04065061', 'title': 'Erinacine A-enriched Hericium Erinaceus Mycelia for Improvement of Recognition, Vision, and Functional MRI Alterations', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 68, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04065061', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00810147', 'title': \"A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 209, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00810147', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00348309', 'title': \"Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 1496, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00348309', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02353598', 'title': 'A Study of Crenezumab in Participants With Mild to Moderate Alzheimer Disease', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 77, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02353598', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01864655', 'title': \"Safety and Tolerability of AZD0530 (Saracatinib) in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01864655', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03420807', 'title': 'Retinal Metabolic Imaging of Alzheimer Patient', 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03420807', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00428090', 'title': \"Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 862, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00428090', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02531360', 'title': 'Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 7, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02531360', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02814045', 'title': \"Role of Hypoxia Ans Sleep Fragmentation in Alzheimer's Disease. and Sleep Fragmentation.\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 144, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02814045', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01642420', 'title': 'Non-expensive and Widely Available Tests as Diagnostic Tools in Dementia and Their Ability to Predict Disease Progression', 'status': 'Unknown status', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 115, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01642420', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02442765', 'title': \"Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 410, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02442765', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01767311', 'title': \"A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 800, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01767311', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01677572', 'title': \"Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 197, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01677572', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03503669', 'title': \"Reducing Risk for Alzheimer's Disease in High-Risk Women Through Yogic Meditation Training\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03503669', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03860792', 'title': \"Therapeutic Diets in Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03860792', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01677754', 'title': 'A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 542, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01677754', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02446132', 'title': \"Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 700, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02446132', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01811381', 'title': \"Curcumin and Yoga Therapy for Those at Risk for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01811381', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01094340', 'title': \"Thalidomide for Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01094340', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01681602', 'title': 'Effect of Physical Exercise in Alzheimer Patients', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01681602', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00480870', 'title': \"The Effect of Anticholinesterase Drugs on Sleep in Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 65, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00480870', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03058965', 'title': 'Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03058965', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02560753', 'title': \"Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02560753', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02256306', 'title': 'The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02256306', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03352024', 'title': \"Impact of Hypno-analgesia on Pain During a Lumbar Puncture for Diagnosis of Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03352024', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00663936', 'title': \"Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 373, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00663936', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02521558', 'title': \"Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02521558', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01978548', 'title': \"A Study to Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01978548', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00087724', 'title': \"A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 510, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00087724', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01425957', 'title': 'Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 229, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01425957', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01492374', 'title': \"Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01492374', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01522404', 'title': 'Effects of Atomoxetine in Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 39, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01522404', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01746706', 'title': \"Can the Assessment of the Subhippocampal Region Contribute to the Detection of Early Diagnosis of Alzheimer's Disease? A Validation Study Using PET With Florbetapir (AV-45).\", 'status': 'Unknown status', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01746706', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03443973', 'title': \"Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 760, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03443973', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03441516', 'title': \"Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's Dementia\", 'status': 'Enrolling by invitation', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03441516', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02912936', 'title': 'A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease', 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02912936', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00735800', 'title': 'Telephone Support for Dementia Caregivers', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00735800', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00151502', 'title': 'To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 600, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00151502', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01560585', 'title': \"Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01560585', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02964611', 'title': \"Social Cognition and Personality Changes in Alzheimer's & Parkinson's Disease & Frontotemporal Lobar Degeneration\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02964611', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00814697', 'title': \"Effect of Repetitive Transcranial Magnetic Stimulation on Language in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00814697', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01380288', 'title': \"Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After Rivastigmine\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01380288', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00921297', 'title': \"Cataract Removal and Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 122, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00921297', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00766363', 'title': \"Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 49, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00766363', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02686554', 'title': 'Identification of Proteostasis-related Biomarkers in Alzheimer´s Dementia', 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 200, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02686554', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01025466', 'title': 'Exelon Patch and Combination With Memantine Comparative Trial', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 206, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01025466', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03887455', 'title': \"A Study to Confirm Safety and Efficacy of BAN2401 in Participants With Early Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 1566, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03887455', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02356055', 'title': 'Mass Practice of Activities of Daily Living in Dementia (STOMP)', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02356055', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00693004', 'title': \"Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 236, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00693004', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03444870', 'title': \"Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 760, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03444870', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00257673', 'title': \"Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 183, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00257673', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02442778', 'title': \"Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 522, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02442778', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04100057', 'title': \"Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Dementia\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04100057', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02750306', 'title': \"Safety and Efficacy of Suvorexant (MK-4305) for the Treatment of Insomnia in Participants With Alzheimer's Disease (MK-4305-061)\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 285, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02750306', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01703702', 'title': 'Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 641, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01703702', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01615666', 'title': \"A Composite MR Neuroimaging Marker for Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 0, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01615666', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01369225', 'title': \"Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 52, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01369225', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00083421', 'title': \"Effects of ONO-2506PO in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 647, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00083421', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00580931', 'title': \"Safety Study of Nicotinamide to Treat Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00580931', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03073876', 'title': 'Detecting an Early Response to Donepezil With Measures of Visual Attention', 'status': 'Active, not recruiting', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03073876', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00009217', 'title': \"Treatment of Behavioral Symptoms in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 44, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00009217', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00417482', 'title': \"Antipsychotic Discontinuation in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00417482', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01703117', 'title': \"Riluzole in Mild Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 2', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01703117', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01636596', 'title': \"Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '50 Years to 95 Years ', 'phases': 'Not Applicable', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01636596', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01273272', 'title': \"Cognitive-Behavioral Treatment for Mild Alzheimer's Patients and Their Caregivers\", 'status': 'Completed', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01273272', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00768261', 'title': 'Corticolimbic Degeneration and Treatment of Dementia', 'status': 'Completed', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 39, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00768261', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00013650', 'title': \"Effects of an Anti-Inflammatory Drug in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 1', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00013650', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00255086', 'title': \"The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 3', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00255086', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01772095', 'title': 'ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticE', 'status': 'Completed', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 389, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01772095', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01766336', 'title': \"A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 2', 'enrollment': 296, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01766336', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01735630', 'title': \"Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 2', 'enrollment': 350, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01735630', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04121208', 'title': \"MIcroglial Colony Stimulating Factor-1 Receptor (CSF1R) in Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 99 Years ', 'phases': 'Phase 1', 'enrollment': 54, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04121208', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00911807', 'title': \"Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '51 Years and older ', 'phases': 'Phase 2', 'enrollment': 217, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00911807', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00996918', 'title': 'A Long-Term Safety And Tolerability Study Of Bapineuzumab In Alzheimer Disease Patients', 'status': 'Terminated', 'clean_age': '51 Years and older ', 'phases': 'Phase 3', 'enrollment': 198, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00996918', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01736579', 'title': 'Long-Term Study of IGIV, 10% in Alzheimer´s Disease', 'status': 'Terminated', 'clean_age': '51 Years and older ', 'phases': 'Phase 3', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01736579', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00937352', 'title': \"A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '51 Years and older ', 'phases': 'Phase 3', 'enrollment': 896, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00937352', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01312363', 'title': \"Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients\", 'status': 'Completed', 'clean_age': '51 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 300, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01312363', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00998764', 'title': 'A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients', 'status': 'Terminated', 'clean_age': '51 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 494, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00998764', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00490568', 'title': 'Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers', 'status': 'Terminated', 'clean_age': '51 Years to 91 Years ', 'phases': 'Phase 3', 'enrollment': 1461, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00490568', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00550420', 'title': 'Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers', 'status': 'Terminated', 'clean_age': '51 Years to 91 Years ', 'phases': 'Phase 3', 'enrollment': 331, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00550420', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01238991', 'title': \"Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '52 Years to 87 Years ', 'phases': 'Phase 2', 'enrollment': 53, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01238991', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00385684', 'title': 'Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 11, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00385684', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00013182', 'title': 'Effect of Activity on Sleep of Cognitively-Impaired Veterans', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00013182', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03330353', 'title': 'Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy', 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 56, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03330353', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00012857', 'title': 'Pain Management and Behavioral Outcomes in Patients With Dementia', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 66, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00012857', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01733355', 'title': 'A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807', 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 11, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01733355', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02196545', 'title': \"Physical Activity Training Program for Patients With Alzheimer's Dementia\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02196545', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00249158', 'title': 'A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 344, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00249158', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01058941', 'title': \"Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 67, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01058941', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00249145', 'title': 'A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 349, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00249145', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01264614', 'title': 'Effects of Strengthening Exercise on the Brain for Early Dementia and Normative Older Adults', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01264614', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00242593', 'title': 'Rosiglitazone Effects on Cognition for Adults in Later Life', 'status': 'Unknown status', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00242593', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01723488', 'title': 'A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808', 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01723488', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01068353', 'title': \"Safety and Tolerability of Etanercept in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 41, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01068353', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03556280', 'title': 'Multi-Center Study of Sensory Stimulation to Improve Brain Function', 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03556280', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02908815', 'title': \"Investigating the Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) as a Treatment for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02908815', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00090402', 'title': \"Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 39, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00090402', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03075241', 'title': \"Z-Drugs for Sleep Disorders in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03075241', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01142258', 'title': \"Trazodone for Sleep Disorders in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01142258', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03070535', 'title': \"APOE Genotype and Diet Influences on Alzheimer's Biomarkers\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03070535', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00105547', 'title': \"Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 1600, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00105547', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00253123', 'title': 'A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 626, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00253123', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03330587', 'title': 'Living Alone in Old Age With Cognitive Impairment', 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03330587', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00621647', 'title': 'Seroquel- Agitation Associated With Dementia', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 333, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00621647', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01061489', 'title': 'Sensory-cognitive and Physical Fitness Training in Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 65, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01061489', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01747213', 'title': 'Bisnorcymserine in Healthy Adult Volunteers', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 75, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01747213', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00762411', 'title': \"Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 1111, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00762411', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03821857', 'title': \"Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03821857', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03991195', 'title': 'Intervention of Intestinal Microorganism in Mild Cognitive Impairment', 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03991195', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00357357', 'title': \"European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00357357', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02018913', 'title': 'Blood-brain Barrier Leakage in Dementia. A Dynamic Contrast-enhanced MRI Study', 'status': 'Unknown status', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 140, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02018913', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01802554', 'title': 'Reducing CVD Risk in Caregivers: A Brief Behavioral Activation Intervention', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01802554', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00438568', 'title': 'SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 173, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00438568', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01937221', 'title': \"Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01937221', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02317523', 'title': \"Alzheimer's Caregiver Coping: Mental and Physical Health\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 151, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02317523', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00757939', 'title': \"A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00757939', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01780974', 'title': \"Pilot Study: Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Prevention\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01780974', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03761381', 'title': 'OCT Angiography and NRAI in Dementia', 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03761381', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01183806', 'title': \"Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01183806', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02848404', 'title': 'Therapeutic Efficacy of Categorical Language Fluency Smartphone Game Application', 'status': 'Enrolling by invitation', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02848404', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02541929', 'title': 'Fish Oil Brain Delivery Study', 'status': 'Active, not recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 31, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02541929', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00325728', 'title': \"Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 74, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00325728', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02537496', 'title': \"Enhancing Working Memory in Patients With Early Alzheimer's Disease Through the Use of rTMS\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02537496', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01253122', 'title': 'Comparative Bioavailability in Healthy Elderly Volunteers', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01253122', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02240693', 'title': 'Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 128, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02240693', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01253499', 'title': 'Multiple Dose Study of TRx0037', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 31, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01253499', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03682874', 'title': 'Identifying Novel Aging Targets for Treatment of Delirium', 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 25, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03682874', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03960476', 'title': 'Decision Making and Implementation of Aging-in-Place/Long Term Care Plans Among Older Adults', 'status': 'Not yet recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 700, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03960476', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02359864', 'title': \"Study of Low Dose Whole Brain Irradiation in the Treatment of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02359864', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02337907', 'title': \"BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 329, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02337907', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01867775', 'title': \"Mirtazapine for Sleep Disorders in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01867775', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00420420', 'title': \"MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011)\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 144, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00420420', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00322036', 'title': \"Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's\", 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 800, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00322036', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03140865', 'title': \"Wake Forest Alzheimer's Disease Clinical Core\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 850, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03140865', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03089827', 'title': \"Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease\", 'status': 'Enrolling by invitation', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 300, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03089827', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00777608', 'title': \"A Study to Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimer's Disease (0000-086)(COMPLETED)\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 106, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00777608', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00359944', 'title': \"Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 171, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00359944', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00065689', 'title': \"High Intensity Light Therapy in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 107, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00065689', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01127633', 'title': \"Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 1457, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01127633', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01013610', 'title': \"An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 110, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01013610', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03179501', 'title': \"NP001, Alzheimer's Disease, and Blood Markers of Inflammation\", 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 4, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03179501', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01658722', 'title': 'Retrieval of Patient Information After Discontinuation', 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 169, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01658722', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03748303', 'title': \"Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study\", 'status': 'Not yet recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03748303', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00056225', 'title': \"VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study)\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 340, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00056225', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00254033', 'title': \"Apathy Associated With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00254033', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02351882', 'title': \"Safety and Efficacy of Nabilone in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02351882', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00594568', 'title': \"Effect of LY450139 on the Long Term Progression of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 1537, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00594568', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00083590', 'title': \"Huperzine A in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00083590', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02035982', 'title': \"Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02035982', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01195389', 'title': \"Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01195389', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00739037', 'title': \"Study Evaluating PAZ-417 in Cerebrospinal Fluid in Subjects With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00739037', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03933696', 'title': \"Light, Metabolic Syndrome and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03933696', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00495820', 'title': \"Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00495820', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01313806', 'title': \"Study of Magnetic Fields to Treat Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01313806', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00596024', 'title': \"Lutein and Alzheimer's Disease Study\", 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 3, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00596024', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02788513', 'title': \"BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.\", 'status': 'Active, not recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 611, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02788513', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03777722', 'title': \"Light and the Effect on Metabolic Syndrome and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03777722', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00034762', 'title': \"Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 473, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00034762', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01459016', 'title': \"A Non-drug Methods Study in Participants With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 56, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01459016', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03347084', 'title': \"Deep Brain Stimulation With LIFUP for Mild Cognitive Impairment and Mild Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03347084', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01266525', 'title': \"Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 291, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01266525', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01000870', 'title': 'Safety and Efficacy of Positron Emission Tomography Imaging With MNI-513', 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01000870', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00905372', 'title': \"Effect of LY2062430 on the Progression of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 1000, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00905372', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03082755', 'title': \"Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 136, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03082755', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00392912', 'title': \"Effect of Testosterone Therapy in Men With Alzheimer's Disease and Low Testosterone\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00392912', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01561430', 'title': \"Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01561430', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00362024', 'title': \"MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease (0952-004)(COMPLETED)\", 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00362024', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02817906', 'title': \"ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 177, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02817906', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00183378', 'title': \"Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 132, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00183378', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02221622', 'title': \"Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02221622', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02769000', 'title': \"Low Dose RT to Reduce Cerebral Amyloidosis in Early Alzheimer's\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02769000', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00464334', 'title': 'A Study of V950 in People With Alzheimer Disease (V950-001 AM7)', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 86, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00464334', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00904683', 'title': \"Effect of LY2062430 on the Progression of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 1040, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00904683', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00954369', 'title': 'Exploratory and Safety Study of [F-18]W372', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00954369', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01388478', 'title': \"Safety Study of R(+)Pramipexole to Treat Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01388478', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01617577', 'title': \"Efficacy and Safety of Filgrastim in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01617577', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00205179', 'title': \"Alzheimer's Disease: Potential Benefit of Isoflavones\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00205179', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02702817', 'title': \"Randomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's Dementia\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02702817', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01035138', 'title': \"A Study of Semagacestat for Alzheimer's Patients\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01035138', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00750282', 'title': \"Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 422, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00750282', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01217021', 'title': 'Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01217021', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02972658', 'title': \"A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia\", 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 421, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02972658', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02800395', 'title': 'Influence of Oxidative Stress and Nutrition Biomarkers on the Cognitive Decline Evolution in Alzheimer Disease', 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 350, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02800395', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00191009', 'title': \"Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 124, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00191009', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00380276', 'title': \"Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol\", 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 1000, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00380276', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01128361', 'title': \"Pilot Study of Aerobic Exercise in Early Alzheimer's Disease(AD)\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 76, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01128361', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01329601', 'title': \"Effect of Cognitive Intervention in Alzheimer's Disease (AD) on Functional Cortical Networks in fMRI\", 'status': 'Unknown status', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01329601', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02127476', 'title': \"A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 57, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02127476', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00946530', 'title': \"Light Treatment for Sleep/Wake Disturbances in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 118, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00946530', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03852901', 'title': 'Sodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production', 'status': 'Recruiting', 'clean_age': '55 Years to 100 Years ', 'phases': 'Phase 1', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03852901', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00478166', 'title': \"Posterior Cingulate Function in Persons With Risk Factors for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 65 Years ', 'phases': 'Phase 4', 'enrollment': 206, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00478166', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02460783', 'title': 'Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain Function', 'status': 'Recruiting', 'clean_age': '55 Years to 70 Years ', 'phases': 'Phase 2', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02460783', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02010476', 'title': \"Alzheimer's Disease Biomarkers in Cerebrospinal Fluid in Insulin-resistant Men\", 'status': 'Completed', 'clean_age': '55 Years to 70 Years ', 'phases': 'Phase 4', 'enrollment': 58, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02010476', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03673722', 'title': 'Mediterranean Diet, Exercise and Dementia Risk in UK Adults', 'status': 'Recruiting', 'clean_age': '55 Years to 74 Years ', 'phases': 'Not Applicable', 'enrollment': 108, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03673722', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03577262', 'title': 'A Non-therapeutic Feasibility Study of the Radioligand [11C]-UCB-J for Imaging Synaptic Density', 'status': 'Completed', 'clean_age': '55 Years to 75 Years ', 'phases': 'Early Phase 1', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03577262', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02564692', 'title': \"GeneMatch: A Program of the Alzheimer's Prevention Registry to Match Individuals to Studies Based on Apolipoprotein E (APOE) Genotype\", 'status': 'Active, not recruiting', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 500000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02564692', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03625622', 'title': \"Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 2', 'enrollment': 210, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03625622', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03024944', 'title': 'TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind', 'status': 'Withdrawn', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 2', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03024944', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03706261', 'title': \"Alzheimer's PET Imaging in Racially/Ethnically Diverse Adults\", 'status': 'Recruiting', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03706261', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02180269', 'title': 'A Safety, Tolerability and Pharmacokinetics Study of JNJ-54861911 in Healthy Japanese Male Participants', 'status': 'Completed', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02180269', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02353884', 'title': 'Multi-modality MRI Study on Prediction for Mild Cognitive Impairment Conversion', 'status': 'Completed', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02353884', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03278119', 'title': \"Sleep Aging and Risk for Alzheimer's 2.0\", 'status': 'Recruiting', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 124, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03278119', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03053908', 'title': 'Orexin and Tau Pathology in Cognitively Normal Elderly', 'status': 'Recruiting', 'clean_age': '55 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03053908', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02260700', 'title': 'A Study to Evaluate Bioavailability, Food Effect, Safety and Tolerability of a Solid Dosage Formulation of JNJ-54861911 in Healthy Older Male Participants', 'status': 'Completed', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02260700', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03824197', 'title': \"Auburn University Research on Olive Oil for Alzheimer's Disease (AU-ROOAD)\", 'status': 'Recruiting', 'clean_age': '55 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03824197', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01887535', 'title': 'A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54861911 in Healthy Elderly Participants', 'status': 'Completed', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01887535', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00412048', 'title': \"Functional Magnetic Resonance Imaging - Synthetic Aperture Magnetometry (fMRI-SAM) and Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '55 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00412048', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03375697', 'title': \"A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-63733657 in Healthy Subjects and Subjects With Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03375697', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03417986', 'title': \"Clinical Trial to Explore the the Amyloid Beta Draining Effect of Thiethylperazine (TEP) in Subjects With Newly Diagnosed Early-to-mild Dementia Due to Alzheimer's Disease (AD) in Comparison to Healthy Volunteers\", 'status': 'Active, not recruiting', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 2', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03417986', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03461861', 'title': \"Network-Level Mechanisms for Preclinical Alzheimer's Disease Development\", 'status': 'Recruiting', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03461861', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03354143', 'title': 'Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)', 'status': 'Recruiting', 'clean_age': '55 Years to 79 Years ', 'phases': 'Phase 2', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03354143', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02547818', 'title': \"Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '55 Years to 79 Years ', 'phases': 'Phase 3', 'enrollment': 620, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02547818', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02864303', 'title': \"Use of Saliva for Alzheimer's Disease Diagnosis\", 'status': 'Unknown status', 'clean_age': '55 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02864303', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03823404', 'title': \"GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 573, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03823404', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00876863', 'title': \"Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 49, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00876863', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01120002', 'title': \"Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01120002', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01702480', 'title': 'Effects of Triglycerides on Age-Related Cognitive Function Decline in Older Subjects', 'status': 'Completed', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 116, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01702480', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00459550', 'title': \"A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00459550', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03418688', 'title': 'A Multiple Ascending Dose Study of COR388', 'status': 'Completed', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 33, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03418688', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03862222', 'title': \"Atlas of Retinal Imaging in Alzheimer's Study\", 'status': 'Not yet recruiting', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 330, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03862222', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01965756', 'title': 'Effect of Insulin Sensitizer Metformin on AD Biomarkers', 'status': 'Completed', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01965756', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02833792', 'title': \"Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02833792', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02844855', 'title': 'Memory for Action in Neurological Patients', 'status': 'Recruiting', 'clean_age': '55 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 99, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02844855', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01254448', 'title': \"Multiple Ascending Dose Study of TC-5619 in Healthy Elderly Subjects and Subjects With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01254448', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02707458', 'title': 'Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive Deterioration', 'status': 'Completed', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 23, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02707458', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03151382', 'title': 'A Based on PEEG and PET Study of Anxiolytic Treatment to Improve Cognitive Function in Patients With Alzheimer Disease', 'status': 'Unknown status', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03151382', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01795339', 'title': \"A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients\", 'status': 'Completed', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 47, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01795339', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01072812', 'title': 'Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment', 'status': 'Terminated', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01072812', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01841905', 'title': \"Detection of Disease-Related Changes in Pre-Symptomatic Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01841905', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03461276', 'title': 'Safety and Immunogenicity of Repeated Doses of ABvac40 in Patients With a-MCI or Vm-AD', 'status': 'Recruiting', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03461276', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02063269', 'title': 'Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles', 'status': 'Unknown status', 'clean_age': '55 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02063269', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03093519', 'title': \"A Repeated Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 84 Years ', 'phases': 'Phase 1', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03093519', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02377713', 'title': \"A Single Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease.\", 'status': 'Completed', 'clean_age': '55 Years to 84 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02377713', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01730430', 'title': \"Cerebrospinal Fluid (CSF) Biomarkers Alzheimer's Disease (AD) and Non-AD Dementias\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01730430', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01397539', 'title': \"Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 53, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01397539', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02973971', 'title': 'ADDIA Chronobiological Study', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 24, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02973971', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01429623', 'title': 'A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 210, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01429623', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04049643', 'title': 'Hearing Aid and Individuals With Cognitive Disorders', 'status': 'Not yet recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04049643', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02263235', 'title': 'In Vivo Alzheimer Proteomics', 'status': 'Unknown status', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 110, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02263235', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03721705', 'title': \"Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type\", 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03721705', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03672474', 'title': 'REGEnLIFE RGn530 - Feasibility Pilot', 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 64, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03672474', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03486938', 'title': \"Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 830, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03486938', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01852110', 'title': \"Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012)\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01852110', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00375557', 'title': \"Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia Patients\", 'status': 'Withdrawn', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00375557', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02431468', 'title': \"A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 147, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02431468', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02386306', 'title': \"Study Evaluating Safety, Tolerability, and PK of Multiple Ascending Doses of GC021109 in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 39, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02386306', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02434718', 'title': \"Single and Multiple Ascending Dose Study of Aducanumab (BIIB037) in Japanese Participants With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02434718', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02079909', 'title': \"Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 482, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02079909', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01211782', 'title': 'AC-1204 Long-term Efficacy Response Trial (ALERT Protocol)', 'status': 'Withdrawn', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01211782', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00909285', 'title': 'Effects of Transcranial Magnetic Stimulation (TMS) and Cognitive Training for Alzheimer Patients', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00909285', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02004392', 'title': \"Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 348, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02004392', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00744978', 'title': \"Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 66, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00744978', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01249196', 'title': \"A Confirmatory Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 256, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01249196', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02756858', 'title': \"An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02756858', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04070378', 'title': \"Study of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04070378', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00988598', 'title': \"A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00988598', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01969123', 'title': \"Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 474, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01969123', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01168245', 'title': 'TMS Stimulation and Cognitive Training in Alzheimer Patients', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01168245', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03081546', 'title': \"Cross-Cultural Use of Performance-Based Functional Assessment in Alzheimer's Disease\", 'status': 'Enrolling by invitation', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 80, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03081546', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03901105', 'title': \"Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 205, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03901105', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03817684', 'title': \"Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's Subjects\", 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 255, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03817684', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02064920', 'title': \"Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318)\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02064920', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00930059', 'title': \"A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 198, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00930059', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03531684', 'title': 'Efficacy and Safety of MMFS in Early AD', 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03531684', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02195596', 'title': 'Effects of Exercise on Cognitive Performance of Patients With Alzheimer-type Dementia. Pilot Study.', 'status': 'Unknown status', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02195596', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03757325', 'title': \"Study to Evaluate DNL747 in Subjects With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03757325', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02244541', 'title': \"Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02244541', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02925650', 'title': \"Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02925650', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03560245', 'title': \"A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 108, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03560245', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02573740', 'title': \"Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02573740', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00627848', 'title': \"Rivastigmine in Mild Alzheimer's Disease, FMRI Study\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00627848', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02912169', 'title': \"Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02912169', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01969136', 'title': \"Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 403, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01969136', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03740178', 'title': \"Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)\", 'status': 'Not yet recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03740178', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01561053', 'title': \"A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 347, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01561053', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02327182', 'title': \"Safety Study of MT-4666 in Subjects With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 117, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02327182', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03472664', 'title': \"Brain Energy for Amyloid Transformation in Alzheimer's Disease Study\", 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03472664', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01439555', 'title': \"Endothelial Facilitation in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 11, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01439555', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03706885', 'title': 'Efavirenz for Patients With Mild Cognitive Impairment', 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03706885', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01028911', 'title': \"A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 9, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01028911', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03055741', 'title': \"Study of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil(DRAMA)\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03055741', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03538522', 'title': 'A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831', 'status': 'Not yet recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 156, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03538522', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03959553', 'title': \"GV1001 Subcutaneous(SC) for the Treatment of Moderate Alzheimer's Disease (AD)\", 'status': 'Not yet recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03959553', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03363269', 'title': \"Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 116, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03363269', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02760602', 'title': \"A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 26, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02760602', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02783573', 'title': \"A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 1722, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02783573', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00040443', 'title': 'Efficacy And Safety Of CX516 In Elderly Participants With Mild Cognitive Impairment.', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 175, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00040443', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03184467', 'title': 'Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients', 'status': 'Unknown status', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03184467', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02986932', 'title': \"Blood-Brain-Barrier Opening Using Focused Ultrasound With IV Contrast Agents in Patients With Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02986932', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03456349', 'title': 'Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03456349', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00582855', 'title': 'Effect of AQW051 in Patients With Memory Impairment', 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 54, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00582855', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02246075', 'title': \"Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine\", 'status': 'Withdrawn', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02246075', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02951598', 'title': \"A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)\", 'status': 'Active, not recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 1400, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02951598', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02626572', 'title': \"Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 500, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02626572', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03132272', 'title': \"Immunoadsorption for Treatment of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03132272', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00742417', 'title': 'Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fluid', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00742417', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01374438', 'title': \"3-month Study of MSDC-0160 Effects on Brain Glucose Utilization, Cognition & Safety in Subjects With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 29, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01374438', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03316898', 'title': \"A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03316898', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03402659', 'title': \"Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 161, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03402659', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02931136', 'title': \"Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging\", 'status': 'Not yet recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02931136', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03929302', 'title': 'Brain Energy Metabolism and Sleep in Adults', 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03929302', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02245737', 'title': \"An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 2218, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02245737', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02623764', 'title': 'EEG-cholinergic Index and Clinical Response to Treatment With Cholinesterase Inhibitors', 'status': 'Active, not recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 218, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02623764', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00660088', 'title': 'Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy Elderly', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00660088', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01125683', 'title': \"To Evaluate Effects of AZD1446, Placebo and Donepezil in Patients With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01125683', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02880956', 'title': \"A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 453, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02880956', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01767909', 'title': 'The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 239, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01767909', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01739348', 'title': \"An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 2211, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01739348', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01409915', 'title': \"Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01409915', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04104373', 'title': 'The Ontario Neurodegenerative Disease Research Initiative', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 522, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04104373', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01970150', 'title': \"The Effect of Repeated Transcranial Magnetic Stimulation on Off-line Resting Electroencephalographic Signal in Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01970150', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02279511', 'title': 'ATP in Alzheimer Disease', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02279511', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02778581', 'title': 'Study to Evaluate the Effect of a Vegetal Oil on Cognitive Impairment', 'status': 'Unknown status', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 110, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02778581', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02791191', 'title': \"A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 316, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02791191', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03617497', 'title': 'Prevalence of Epilepsy and Sleep Wake Disorders in Alzheimer Disease', 'status': 'Not yet recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 130, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03617497', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02036645', 'title': \"SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 77, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02036645', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01024660', 'title': 'The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Early Phase 1', 'enrollment': 155, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01024660', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03856359', 'title': \"Trial of Rifaximin in Probable Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03856359', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00243451', 'title': 'Early Detection of Mild Cognitive Impairment in Individual Patients', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 34, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00243451', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00443417', 'title': \"A Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 188, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00443417', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01424436', 'title': \"Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01424436', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02167256', 'title': \"A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 159, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02167256', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01727622', 'title': 'Arterial Spin Labeling (ASL) MRI for Cognitive Decline', 'status': 'Completed', 'clean_age': '55 Years to 89 Years ', 'phases': 'Phase 4', 'enrollment': 102, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01727622', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01482351', 'title': 'Mild Cognitive Impairment and Obstructive Sleep Apnea', 'status': 'Completed', 'clean_age': '55 Years to 89 Years ', 'phases': 'Not Applicable', 'enrollment': 54, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01482351', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03533257', 'title': \"Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03533257', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03620981', 'title': \"Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type\", 'status': 'Recruiting', 'clean_age': '55 Years to 89 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 407, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03620981', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03926520', 'title': \"Electroconvulsive Therapy (ECT) for Agitation in Alzheimer's Dementia (AD)\", 'status': 'Not yet recruiting', 'clean_age': '55 Years to 89 Years ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03926520', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03448445', 'title': \"A Study to Evaluate Alzheimer's Disease Conversion Rate Differences Between High-risk Mild Cognitive Impairment (MCI) and Low-risk MCI in a Real World Setting\", 'status': 'Active, not recruiting', 'clean_age': '55 Years to 89 Years ', 'phases': 'Phase 4', 'enrollment': 201, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03448445', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03724942', 'title': \"Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type\", 'status': 'Recruiting', 'clean_age': '55 Years to 89 Years ', 'phases': 'Phase 3', 'enrollment': 157, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03724942', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02168920', 'title': \"Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type\", 'status': 'Terminated', 'clean_age': '55 Years to 89 Years ', 'phases': 'Phase 3', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02168920', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01922258', 'title': \"Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 270, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01922258', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01883648', 'title': \"Study to Evaluate Coconut Oil for Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01883648', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01862640', 'title': \"Safety and Tolerability Study of Two Fixed-doses of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 433, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01862640', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01908010', 'title': \"Safety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01908010', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00902499', 'title': 'Evolution of Memory Related Activity', 'status': 'Unknown status', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 160, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00902499', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00066157', 'title': \"Alzheimer's Disease: Therapeutic Potential of Estrogen\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00066157', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03702816', 'title': 'The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180)', 'status': 'Enrolling by invitation', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03702816', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04098666', 'title': \"Metformin in Alzheimer's Dementia Prevention\", 'status': 'Not yet recruiting', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 370, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04098666', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01482845', 'title': \"A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01482845', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00809510', 'title': \"A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 Study\", 'status': 'Terminated', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 63, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00809510', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01549834', 'title': \"Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 434, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01549834', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00232570', 'title': \"Quetiapine for the Treatment of Insomnia in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '55 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00232570', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02220738', 'title': \"Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors\", 'status': 'Terminated', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02220738', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01137526', 'title': \"Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 267, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01137526', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00602680', 'title': \"Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 1, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00602680', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00071721', 'title': 'Valproate in Dementia (VALID)', 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 313, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00071721', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00413621', 'title': \"MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00413621', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03912571', 'title': \"Sleep Disordered Breathing and Alzheimer's Disease Biomarkers in Normal Aging and Mild Cognitive Impairment\", 'status': 'Recruiting', 'clean_age': '55 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 95, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03912571', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01047254', 'title': \"Bupropion for the Treatment of Apathy in Alzheimer's Dementia\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 110, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01047254', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01504958', 'title': 'Effects of a Combined Transcranial Magnetic Stimulation (TMS) and Cognitive Training in Alzheimer Patients', 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01504958', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03896698', 'title': \"Feasibility Study of Transcranial Ultrasound Stimulation on Alzheimer's Disease Patients\", 'status': 'Not yet recruiting', 'clean_age': '55 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03896698', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00620191', 'title': 'Metformin in Amnestic Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00620191', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01078636', 'title': \"Alzheimer's Disease Neuroimaging Initiative Grand Opportunity\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 342, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01078636', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00555204', 'title': \"Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 337, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00555204', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00209456', 'title': 'Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia', 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 326, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00209456', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01688128', 'title': 'Efficacy of Ubiquitous SR-based Memory Advancement and Rehabilitation Training (U-SMART)', 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01688128', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01628653', 'title': 'Ubiquitous Spaced Retrieval-based Memory Advancement and Rehabilitation Training', 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01628653', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03630419', 'title': 'Specialized Food Plan Based on Individual Physiological Comprehensive Body Assessments Accompanied With Cellular Repair Therapy to Decrease Inflammation Cognitively Impaired Patients', 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03630419', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00093951', 'title': \"SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 280, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00093951', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00106899', 'title': \"ADNI: Alzheimer's Disease Neuroimaging Initiative\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 818, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00106899', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03548584', 'title': \"A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type\", 'status': 'Recruiting', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 225, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03548584', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00483028', 'title': 'A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI', 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00483028', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00628017', 'title': 'Preliminary Study of Fish Oil and Dementia', 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 46, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00628017', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03954613', 'title': \"Evaluation of the Contribution of Regular Cognitive Exercises to Treatment in Patients With Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 198, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03954613', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01676935', 'title': \"This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 349, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01676935', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01463384', 'title': \"Minocycline in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 13, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01463384', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02843529', 'title': 'Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI)', 'status': 'Enrolling by invitation', 'clean_age': '55 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 900, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02843529', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02854033', 'title': \"Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol\", 'status': 'Recruiting', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 2000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02854033', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01832350', 'title': \"Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01832350', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02471196', 'title': \"Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 308, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02471196', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00065767', 'title': \"Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00065767', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02720445', 'title': 'Memory Improvement Through Nicotine Dosing (MIND) Study', 'status': 'Recruiting', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02720445', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01900665', 'title': \"Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo\", 'status': 'Terminated', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 2129, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01900665', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00257712', 'title': 'SMART: Somatotrophics, Memory, and Aging Research Trial', 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 151, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00257712', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00855868', 'title': \"Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 28, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00855868', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01324518', 'title': \"Safety and Efficacy of ORM-12741 in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01324518', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01690195', 'title': \"Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 343, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01690195', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01099332', 'title': \"Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01099332', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01231971', 'title': \"Alzheimer's Disease Neuroimaging Initiative 2\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 1185, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01231971', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01018875', 'title': \"Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 242, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01018875', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04057807', 'title': \"Peripheral Benzodiazepine Receptors (PBR28) Brain PET Imaging With Lipopolysaccharide Challenge for the Study of Microglia Function in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04057807', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01624389', 'title': \"Establish Taiwan Alzheimer's Disease Neuroimaging Initiative - a Three-year Pilot Study\", 'status': 'Unknown status', 'clean_age': '55 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01624389', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00933608', 'title': \"Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00933608', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03056495', 'title': 'Clinical Trial to Determine Tolerable Dosis of Vorinostat in Patients With Mild Alzheimer Disease', 'status': 'Recruiting', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 44, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03056495', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01527916', 'title': \"Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 438, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01527916', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00948909', 'title': \"Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 274, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00948909', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02190084', 'title': \"Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia\", 'status': 'Completed', 'clean_age': '55 Years to 91 Years ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02190084', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03594123', 'title': \"A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type\", 'status': 'Recruiting', 'clean_age': '55 Years to 91 Years ', 'phases': 'Phase 3', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03594123', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03811847', 'title': 'A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants.', 'status': 'Recruiting', 'clean_age': '55 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03811847', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01951118', 'title': 'Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly', 'status': 'Completed', 'clean_age': '55 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 121, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01951118', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03814382', 'title': \"Acupuncture to Reduce Anxiety in Alzheimer's Disease (AD) and AD Related Dementias\", 'status': 'Recruiting', 'clean_age': '55 Years to 95 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03814382', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00095719', 'title': 'Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia', 'status': 'Completed', 'clean_age': '55 Years to 95 Years ', 'phases': 'Phase 3', 'enrollment': 125, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00095719', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00523666', 'title': \"Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®)\", 'status': 'Unknown status', 'clean_age': '55 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00523666', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00172900', 'title': \"MRS and DTI of White Matter in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '55 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00172900', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04094129', 'title': \"Evaluation of the Effect of Wismemo on Alzheimer's Dementia Patients\", 'status': 'Not yet recruiting', 'clean_age': '55 Years to 95 Years ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04094129', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01845636', 'title': 'Olfactory Deficits in MCI as Predictor of Improved Cognition on Donepezil', 'status': 'Completed', 'clean_age': '55 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 41, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01845636', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01438060', 'title': \"Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type\", 'status': 'Completed', 'clean_age': '55 Years to 95 Years ', 'phases': 'Phase 3', 'enrollment': 232, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01438060', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00192816', 'title': \"Pain Perception in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '55 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00192816', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01119638', 'title': \"Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to Risperidone\", 'status': 'Completed', 'clean_age': '55 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01119638', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00544856', 'title': \"Effects of a Complex Cognitive Training in Mild Cognitive Impairment and Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 95 Years ', 'phases': 'Not Applicable', 'enrollment': 39, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00544856', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01812213', 'title': \"Beta-Amyloid Imaging With [18F]NAV4694 Positron Emission Tomography (PET) in Predicting Progression to Alzheimer's Disease (AD) in Subjects With Mild Cognitive Impairment (MCI)\", 'status': 'Unknown status', 'clean_age': '55 Years to 99 Years ', 'phases': 'Phase 2', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01812213', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00471211', 'title': \"Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '56 Years and older ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00471211', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02648906', 'title': 'A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients', 'status': 'Unknown status', 'clean_age': '56 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 128, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02648906', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03712787', 'title': \"An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD)\", 'status': 'Enrolling by invitation', 'clean_age': '57 Years to 87 Years ', 'phases': 'Phase 2', 'enrollment': 360, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03712787', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03016702', 'title': 'The Cognitive Resilience Study', 'status': 'Completed', 'clean_age': '58 Years to 70 Years ', 'phases': 'Not Applicable', 'enrollment': 29, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03016702', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00239746', 'title': 'BONSAI: Biomarkers of Nonsteroidal Anti-Inflammatories', 'status': 'Unknown status', 'clean_age': '59 Years and older ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00239746', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02187276', 'title': 'The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia', 'status': 'Completed', 'clean_age': '59 Years to 92 Years ', 'phases': 'Phase 4', 'enrollment': 129, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02187276', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02978768', 'title': \"Tai Chi 6-Form Sports Apparatus With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '59 Years to 92 Years ', 'phases': 'Not Applicable', 'enrollment': 67, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02978768', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02007291', 'title': \"Good Rate of Clinical Response to Cholinesterase Inhibitors in Alzheimer's Disease After Three Months of Treatment\", 'status': 'Completed', 'clean_age': '59 Years to 93 Years ', 'phases': 'Phase 4', 'enrollment': 71, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02007291', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00448318', 'title': 'Evaluating the Effects of Music Interventions on Hospitalised People With Dementia', 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00448318', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03672448', 'title': 'The China Longitudinal Aging Study of Cognitive Impairment', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 10000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03672448', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03357328', 'title': 'Therapy Light Rooms for Improved Sleep in Dementia Patients', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03357328', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01315717', 'title': 'Gait and Alzheimer Interaction Tracking (GAIT) Study', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 912, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01315717', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02330510', 'title': 'Amyloid and Glucose PET Imaging in Alzheimer and Vascular Cognitive Impairment Patients With Significant White Matter Disease', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 80, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02330510', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02626377', 'title': 'Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-Comté', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 7604, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02626377', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01839422', 'title': \"Imaging of New Learning in Severe Alzheimer's Disease Patients\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01839422', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03698760', 'title': 'Computerized Olfactory Test - Alzheimer Disease Mild Stage', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03698760', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02959502', 'title': 'Home-Based CR and tDCS to Enhance Cognition in Persons With Mild Cognitive Impairment and Late Life Depression', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02959502', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00693888', 'title': 'Lighthouse Project on Dementia, Ulm, Germany', 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00693888', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00646074', 'title': \"Self- Care TALK Study - Promoting Alzheimer's Disease (AD) Spousal Caregiver Health\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 46, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00646074', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03121950', 'title': 'Movement and Music Intervention for Individuals With Dementia', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03121950', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00997425', 'title': 'Home Evaluation of Exit Barriers in Wandering', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00997425', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02933177', 'title': 'Effectiveness of Flash Mediation Therapy', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 241, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02933177', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02361424', 'title': 'Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD)', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 47, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02361424', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02176629', 'title': \"Usability of Virtual Reality in Subjects With Mild Cognitive Impairment or Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02176629', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02248636', 'title': 'Cholinesterase Inhibitor Discontinuation', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02248636', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01630525', 'title': '\" The Eyes Have it \" : Ocular Saccade Abnormalities in Prodromal Alzheimer\\'s Disease', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 83, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01630525', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01028053', 'title': \"Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 3', 'enrollment': 365, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01028053', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01798199', 'title': 'Vanquishing Apathy Through E-inclusion Using Realistic Virtual Environment Project', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01798199', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00549601', 'title': \"Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 142, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00549601', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02292238', 'title': \"Benfotiamine in Alzheimer's Disease: A Pilot Study\", 'status': 'Active, not recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 76, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02292238', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02294513', 'title': \"Hearing Instruments in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 25, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02294513', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04121858', 'title': \"Brain Safe: Consumer Intervention to Reduce Exposure to Drugs Linked to Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 700, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04121858', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02664584', 'title': 'The Trinity, Ulster and Department of Agriculture Cohort Study', 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 5186, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02664584', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01095718', 'title': 'Comparison of 3 Learning Methods to Improve Independent Activities of Daily Living (IADLs) in Alzheimer Disease', 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01095718', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03548883', 'title': \"Examining Neuroinflammation in AlzHeimer's\", 'status': 'Enrolling by invitation', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 18, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03548883', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00843518', 'title': \"Treatment for Aggression and Agitation in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 132, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00843518', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03185208', 'title': 'Lithium As a Treatment to Prevent Impairment of Cognition in Elders', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03185208', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03799991', 'title': \"Vestibular Therapy in Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03799991', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01478204', 'title': \"A Study to Evaluate Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 925, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01478204', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02386670', 'title': \"Prevention of Alzheimer's Disease With CR Plus tDCS in Mild Cognitive Impairment and Depression (PACt-MD)\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 375, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02386670', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02205710', 'title': 'Adaptive Cognitive Training in Healthy Older Adults', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 99, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02205710', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02518243', 'title': \"Safe & Easy for Alzheimer's Disease and Related Pathologies\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02518243', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03991624', 'title': \"Lack of Decision-making in Patients With Alzheimer's Disease : Functions Involved and the Daily Consequences\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03991624', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00190372', 'title': \"AIDMA: A Psycho-educational Program Designed to Support and Train Carers of Alzheimer's Disease (AD) Patients\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00190372', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03075007', 'title': 'Brain Vascular Disease in Aging and Dementia', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 48, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03075007', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00581867', 'title': \"Memory and Insulin in Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 31, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00581867', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00229333', 'title': 'Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer’s Disease, Vascular Dementia, and Mixed Vascular and Alzheimer’s Dementia', 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00229333', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00368459', 'title': \"Raloxifene for Women With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00368459', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01325259', 'title': \"FluoroAv45 Imaging Research-in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 54, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01325259', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01515982', 'title': 'Physical Exercise as an Additional Treatment for Alzheimer Disease', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01515982', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00231946', 'title': \"ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 3', 'enrollment': 555, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00231946', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00035204', 'title': \"A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 63, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00035204', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00611312', 'title': \"Effects of Delivery Mode of Cognition Intervention in Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00611312', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02702102', 'title': \"Imaging Inflammation in Patients With Parkinson's Disease Dementia or Dementia With Lewy Bodies\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02702102', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00146263', 'title': 'Cognitive Training in the Elderly', 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00146263', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02664571', 'title': 'Florbetaben as an Amyloid Plaque Marker in Elderly Patients With Focal or Disseminated Superficial Hemosiderosis', 'status': 'Not yet recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02664571', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00792662', 'title': 'Improving Function, Quality of Life, Glycemia in Diabetics With Dementia', 'status': 'Withdrawn', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00792662', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01867346', 'title': 'Early Markers of Cognitive Change and Alzheimer s Disease', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 2850, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01867346', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02521818', 'title': 'Dietary Treatments for Cognitive Impairment in Older Adults', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02521818', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00597376', 'title': 'Study of the Effects of Cerefolin NAC on Inflammation Blood Markers in Older Individuals With Memory Complaints', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 104, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00597376', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00062569', 'title': \"Bathing Persons With Alzheimer's Disease aT Home (The BATH Study)\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00062569', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01569997', 'title': 'Impact of Systematic Tracking of Dementia Cases on the Rate of Hospitalization in Emergency Care Units', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 1428, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01569997', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02472899', 'title': \"Biomarker Study for Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02472899', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01409694', 'title': \"Alzheimer's Disease - Input of Vitamin D With mEmantine Assay\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 3', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01409694', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00384423', 'title': \"Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00384423', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03981380', 'title': '11C-PIB PET Study in MESA at Columbia University', 'status': 'Enrolling by invitation', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03981380', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03665831', 'title': 'Deep TMS for Comorbid Depression and Cognitive Impairment in Older Adults', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 28, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03665831', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03846232', 'title': \"Detection of Cerebral Proteinopathy in Alzheimer's Disease Through Magnetic Resonance Imaging\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03846232', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03691428', 'title': 'Stress Reduction Study for Partners of Early Stage Dementia', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03691428', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02361242', 'title': '24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I Completion', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02361242', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02694445', 'title': \"Monetary Cost of Alzheimer's Disease in China\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 2500, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02694445', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01423396', 'title': \"Impact of Controlling Vascular Risk Factors on the Progression of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 406, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01423396', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02051244', 'title': \"Measurement of Retinal Nerve Fiber Layer Thickness - a Biomarker for the Early Detection of Alzheimer's Disease?\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02051244', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03899844', 'title': 'Study to Evaluate Amyloid in Blood and Imaging Related to Dementia', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 1120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03899844', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00182988', 'title': \"Alzheimer's Caregiver Communication Study\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 140, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00182988', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03455569', 'title': \"A Dyadic Sleep Intervention for Alzheimer's Disease Patients and Their Caregivers\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03455569', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03554226', 'title': \"Agitation and Aggressivity in Alzheimer's Disease Patients: A Cohort Study\", 'status': 'Active, not recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 330, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03554226', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01712074', 'title': \"Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil\", 'status': 'Terminated', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 186, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01712074', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02838563', 'title': \"Validation of a Scale of Well-Being Assessment (SIWA) in Patients With Alzheimer's Disease or a Related Disease.\", 'status': 'Terminated', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 135, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02838563', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04019665', 'title': 'Self-screening of Cognitive Impairment in Primary Care', 'status': 'Not yet recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04019665', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01138111', 'title': 'Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 1', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01138111', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01314131', 'title': 'Use of Autobiographical and Interest Assessment for a Better Stimulation of Patients in Nursing Home', 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01314131', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01548053', 'title': 'The Primary Care - Dementia Assessment and Treatment Algorithm', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 55, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01548053', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03866018', 'title': \"Contribution of Physical Activity to Self-esteem and Motivation in Older Adults With Minor to Major Cognitive Disorders Such as Alzheimer's Disease or Related Disorders\", 'status': 'Not yet recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03866018', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02222181', 'title': \"Impact of Pharmacotherapy Management in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 55, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02222181', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02670993', 'title': \"Support by Singing Sessions on Physical and Moral Pain : Assessment of Its Effectiveness in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 59, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02670993', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01021644', 'title': 'Genes, Exercise, Memory and Neurodegeneration', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 73, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01021644', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03313518', 'title': 'Therapeutic Role of Transcranial DCS in Alzheimer', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03313518', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03887923', 'title': 'Vestibular Physical Therapy for People With Alzheimer Disease', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03887923', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03786510', 'title': 'A Study on the Effectiveness of Multidomain Intervention Program for Reducing Risks of Dementia', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03786510', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02831283', 'title': \"Imaging Inflammation in Alzheimer's Disease\", 'status': 'Enrolling by invitation', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02831283', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04012346', 'title': \"Modulation of Cognition and Brain Connectivity by Noninvasive Brain Stimulation in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04012346', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01000038', 'title': 'Wii-fit for Activity, Balance and Gait in Assisted Living', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01000038', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01978353', 'title': 'Memory Training in Patients With Amnestic Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01978353', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01409564', 'title': 'Cilostazol Augmentation Study in Dementia', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 46, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01409564', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01416012', 'title': 'Health Related Quality of Life Effects of Off-the-shelf Computer Gaming in Alzheimer and Related Disorders Populations', 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01416012', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03757910', 'title': 'Brain Imaging in the Diabetes Prevention Program Outcomes Study', 'status': 'Enrolling by invitation', 'clean_age': '60 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03757910', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03638284', 'title': 'Non-invasive Brain Stimulation Using Transcranial Direct Current Stimulation for Neuropsychiatric Symptoms of Dementia', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03638284', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01993836', 'title': 'Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative Care', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 191, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01993836', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01002586', 'title': \"Wii-Fit For Improving Activity, Gait And Balance In Alzheimer's Dementia\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01002586', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00743418', 'title': \"Tracking Technologies for the Analysis of Mobility in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00743418', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02208193', 'title': \"Alzheimer's Disease, Art and Garden\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02208193', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04096261', 'title': \"The Importance of Sleep Quality and the Blood-brain Barrier in Cognitive Disorders and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 132, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04096261', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00165750', 'title': 'Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients', 'status': 'Terminated', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00165750', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01255163', 'title': \"A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 57, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01255163', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02210286', 'title': 'Magnesium L-Threonate for the Enhancement of Learning and Memory in People With Dementia', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02210286', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03644043', 'title': 'Evidence Amyloid Scan EEG Study', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 2000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03644043', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02267057', 'title': 'Efficacy of Pain Treatment on Depression in Patients With Dementia', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 163, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02267057', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03208491', 'title': \"AZ@GAME-Eco: Economic Assessment of Serious Games for the Management of Alzheimer's Disease and Related Disorders\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 136, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03208491', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03676881', 'title': \"Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03676881', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02557464', 'title': \"Identification of Early Markers of Alzheimer's Disease by Using Eye Tracking in Reading.\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02557464', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02021682', 'title': \"CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 58, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02021682', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02005380', 'title': \"Usability Study of Spaced Retrieval Exercise Using Mobile Devices for Alzheimer's Disease Rehabilitation\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02005380', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00476008', 'title': \"Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00476008', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02873546', 'title': \"tDCS Effect on Cognitive Functions From Patients With Alzheimer's Disease or Progressive Primary Aphasia\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 52, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02873546', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04093882', 'title': \"The Relevance of the Blood-brain Barrier to Cognitive Dysfunction and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 132, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04093882', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00499200', 'title': 'Study Evaluating Safety, Tolerability, Pharmacokinetics and 5 HT1A Receptor Occupancy', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 1', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00499200', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02686190', 'title': \"Effects of Light-therapy in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 91, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02686190', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00082602', 'title': \"Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 3', 'enrollment': 83, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00082602', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01329484', 'title': \"Computerized Personal Interventions for Alzheimer's Patients\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 159, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01329484', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00951834', 'title': 'Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00951834', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03962439', 'title': 'Impact of Challenging Engagement on Cognition in Older Adults', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03962439', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03827733', 'title': \"Gut Microbiota and Alzheimer's Diseases\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 200, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03827733', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00000177', 'title': 'Estrogen Hormone Protocol', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 3', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00000177', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02861846', 'title': \"Predictive Value of Biomarkers of the Alzheimer's Disease (AD) in Elderly Patients With New-onset Epilepsy\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02861846', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02840045', 'title': 'Development of a New Neuroimaging Method Aimed to Differentiate Mnesic Abilities of Alzheimer and Depressed Patients', 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02840045', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01434940', 'title': 'Eye Movement Recording as an Early Differential Diagnostic Tool for Alzheimer/Depression', 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 288, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01434940', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00178568', 'title': 'Reducing Caregiver Stress and Sleep Disturbances in Patients With Progressive Dementia', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00178568', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03585907', 'title': 'Feasibility and Efficacy of Dietary Interventions for Older Adults With Subjective Cognitive Decline', 'status': 'Withdrawn', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03585907', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01920672', 'title': 'Disrupted Sleep, Neuroendocrine Status and the Behavioral Symptoms of AD', 'status': 'Completed', 'clean_age': '60 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 82, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01920672', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01661894', 'title': 'Effectiveness of a Brain-Computer Interface Based System for Cognitive Enhancement in the Normal Elderly', 'status': 'Completed', 'clean_age': '60 Years to 70 Years ', 'phases': 'Phase 1', 'enrollment': 82, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01661894', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03131453', 'title': \"A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '60 Years to 75 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 1145, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03131453', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02978729', 'title': 'Telephone Versus Videoconference Communication for Remote Genetic Disclosure in the APOE4 Trial', 'status': 'Enrolling by invitation', 'clean_age': '60 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 3000, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02978729', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04113967', 'title': \"Efficacy of a Biodanza Program in People With Alzheimer's Disease.\", 'status': 'Completed', 'clean_age': '60 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04113967', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03121066', 'title': \"Transcranial Magnetic Stimulation for Alzheimer's Disease Treatment\", 'status': 'Not yet recruiting', 'clean_age': '60 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03121066', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03224988', 'title': 'Bilateral Brain Dynamics in Cognition and Aging', 'status': 'Recruiting', 'clean_age': '60 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03224988', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03959124', 'title': \"Deep Brain Stimulation for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03959124', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03814603', 'title': 'The Sleep Amyloid, Slow WAve Race and Ethnicity Study', 'status': 'Recruiting', 'clean_age': '60 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 210, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03814603', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02087865', 'title': \"Effects of Donepezil HCL on Task-Activated fMRI Brain Activation in Healthy Older Adults at Genetic Risk for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02087865', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02565511', 'title': \"A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '60 Years to 75 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 481, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02565511', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03688126', 'title': 'U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk', 'status': 'Recruiting', 'clean_age': '60 Years to 79 Years ', 'phases': 'Not Applicable', 'enrollment': 2000, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03688126', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01696019', 'title': 'Randomized Trial of Exercise and Social Interaction in a Community-Based Sample of Non-Demented Chinese Elders', 'status': 'Completed', 'clean_age': '60 Years to 79 Years ', 'phases': 'Not Applicable', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01696019', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03943641', 'title': 'Dementia Risk Prediction Model: Development and Validation', 'status': 'Not yet recruiting', 'clean_age': '60 Years to 79 Years ', 'phases': 'Phase 4', 'enrollment': 400000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03943641', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03613844', 'title': 'DHA Brain Delivery Trial', 'status': 'Recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 320, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03613844', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02843906', 'title': 'Cognitive, Morphological and Neurobiological Progressive Aspects in Bipolar Disorders in the Elderly: Toward to a Neurodegenerescence Detection?', 'status': 'Unknown status', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02843906', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02520232', 'title': 'Pathological and Non-pathological Aging, Physical Activity, Genotype and Cognition', 'status': 'Completed', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 139, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02520232', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03978052', 'title': 'Prevention of Cognitive Decline in ApoE4 Carriers With Subjective Cognitive Decline After EGCG and a Multimodal Intervention', 'status': 'Not yet recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03978052', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00205621', 'title': \"Positron Emission Tomography of Amyloid in Alzheimer's Disease\", 'status': 'Suspended', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00205621', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02228187', 'title': 'Brain-Computer Interface System for Training Memory and Attention in Elderly', 'status': 'Completed', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02228187', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03382353', 'title': 'EMuNI Project: Multiple Nonpharmacological Interventions', 'status': 'Active, not recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03382353', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01208675', 'title': 'The Swedish BioFINDER Study', 'status': 'Active, not recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 900, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01208675', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03727360', 'title': \"Exercise for Brain Health in the Fight Against Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 152, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03727360', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03274817', 'title': \"A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol\", 'status': 'Recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 31, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03274817', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02062099', 'title': 'PET Imaging of the Translocator Proteine Ligands (TSPO) With [18 F] DPA-714 Biomarker of NeuroInflammation in Cognitive Decline (NIDECO)', 'status': 'Unknown status', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02062099', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00094939', 'title': 'Predictors of Cognitive Decline in Normal Aging', 'status': 'Unknown status', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 170, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00094939', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00979446', 'title': 'Passport to Brain Wellness in Sedentary Adults', 'status': 'Completed', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 63, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00979446', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03255720', 'title': \"Application of Diffusion Tensor Imaging in Alzheimer's Disease :Quantification of White Matter Micro-structural Changes\", 'status': 'Not yet recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03255720', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03954899', 'title': 'Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in Aging', 'status': 'Recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 230, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03954899', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03370744', 'title': 'Prediction of Cognitive Decline by Neuroimaging Techniques and the Application in Diagnosis and Treatment of Preclinical AD', 'status': 'Recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 300, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03370744', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02273895', 'title': \"The Use of EEG in Alzheimer's Disease, With and Without Scopolamine - A Pilot Study\", 'status': 'Completed', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 29, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02273895', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00687141', 'title': 'Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects', 'status': 'Completed', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 112, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00687141', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01094145', 'title': \"Deep Brain Stimulation (DBS) of the Nucleus Basalis Meynert (NBM) to Treat Cognitive Deficits in Light to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01094145', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04064021', 'title': \"Acupuncture Treatment for Improving Alzheimer's Dementia\", 'status': 'Not yet recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04064021', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03847038', 'title': 'BarcelonaBeta Dementia Prevention Research Clinic: a Study on Risk Factors Disclosure', 'status': 'Recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 425, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03847038', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00094952', 'title': \"Biomarkers and Early Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 80, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00094952', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01055392', 'title': \"Disease-modifying Properties of Lithium in the Neurobiology of Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01055392', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02726906', 'title': 'Lifestyle Enriching Activities for Research in Neuroscience Intervention Trial: LEARNit Study', 'status': 'Recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02726906', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02836054', 'title': 'Study of Degenerescence CSF Hallmarks in Older Bipolar Patients', 'status': 'Recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02836054', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02576639', 'title': 'Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of Age', 'status': 'Completed', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 124, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02576639', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03475446', 'title': 'The Effect of tES on a Cognitive Training', 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03475446', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02377206', 'title': 'Neuroinflammation and Cognitive Decline in Alzheimer Disease', 'status': 'Unknown status', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02377206', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02114372', 'title': 'Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research: Prospective Readiness Cohort Study', 'status': 'Active, not recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 1146, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02114372', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03351452', 'title': 'tES Effects on Associative Memory Performance', 'status': 'Enrolling by invitation', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 74, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03351452', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03900273', 'title': \"Development of Novel Measures for Alzheimer's Disease Prevention Trials\", 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 320, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03900273', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01354691', 'title': \"Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 201, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01354691', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00551772', 'title': 'A Study To Assess The Pharmacokinetics Of SB-742457 Formulated As A Capsule And A Tablet In Healthy Elderly Volunteers.', 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00551772', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01885806', 'title': \"Repetitive Transcranial Magnetic Stimulation for Apathy Treatment in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01885806', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02423200', 'title': \"Clinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02423200', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01466088', 'title': \"Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 386, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01466088', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02089555', 'title': \"African American Alzheimer's Progression Markers - CSF and Neuro-Imaging\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 135, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02089555', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03249688', 'title': \"Multimodal Preventive Trial for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03249688', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03790709', 'title': \"ANAVEX2-73 for Treatment of Early Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 450, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03790709', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01055561', 'title': 'A Study of Acupuncture for Patients With Behavioural and Psychological Symptoms of Dementia', 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01055561', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02363504', 'title': 'The Locus Coeruleus and Memory', 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 70, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02363504', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00948259', 'title': 'Safety Study of a Glycogen Synthase Kinase 3 (GSK3) Inhibitor in Patients With Alzheimer´s Disease', 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00948259', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02991235', 'title': \"Efficacy and Safety of PRJ212 to Improve the Memory of Patients With Mild Severity Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02991235', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02253732', 'title': 'Skeletal Muscle as a Mediator of Exercise Induced Effects on Metabolism & Cognitive Function: Role for Myokines & miRNAs', 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02253732', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03668405', 'title': \"A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients With Alzheimer's Disease (AD)\", 'status': 'Terminated', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03668405', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02569398', 'title': \"An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 596, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02569398', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01039701', 'title': \"4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 99, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01039701', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02608021', 'title': 'Neurotrack Test Validation Protocol', 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 80, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02608021', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02615002', 'title': \"Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)\", 'status': 'Active, not recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 500, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02615002', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03954210', 'title': 'SIESTA: Sleep Intervention to Enhance Cognitive Status and Reduce Beta Amyloid', 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03954210', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00582127', 'title': 'Evaluation of the COGNISION(TM) System as an Event-related Potential (ERP) Collection System.', 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00582127', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02423122', 'title': \"A PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02423122', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02839187', 'title': \"Neuro Imaging and Multimodal Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 59, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02839187', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01481961', 'title': \"Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as add-on Treatment for Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01481961', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03784183', 'title': \"Neuropsychological and Neurophysiological Effects of Cognitive Stimulation in Patients With Alzheimer's Disease and Mild Cognitive Impairment\", 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 126, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03784183', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02913664', 'title': \"Risk Reduction for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 640, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02913664', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02388152', 'title': \"Study to Evaluate the Safety and Tolerability of a New Drug Named Lu AF20513 in Patients With Mild Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02388152', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03367403', 'title': \"A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)\", 'status': 'Active, not recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 266, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03367403', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01428362', 'title': \"VI-1121 for the Treatment Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 61, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01428362', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00117403', 'title': \"Anti-Oxidant Treatment of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 75, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00117403', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03860857', 'title': 'MRI and PET Biomarkers for Cognitive Decline in Older Adults', 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03860857', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01716637', 'title': \"Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01716637', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03020381', 'title': 'Gait as Predictor of Dementia and Falls. The Gait and Brain Cohort Study', 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 400, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03020381', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02305836', 'title': \"Effect of Electroacupuncture Combined With Donepezil for Treating Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 334, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02305836', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00501111', 'title': \"Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 659, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00501111', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03467477', 'title': 'Tau Screening Study in Subjects With Early Symptomatic AD', 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 161, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03467477', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03322462', 'title': 'Tau Screening Study in Patients With Early Symptomatic AD', 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 153, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03322462', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03518073', 'title': \"A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 285, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03518073', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03333837', 'title': 'Improvisational Movement for People With Memory Loss and Their Caregivers', 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03333837', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03270137', 'title': 'Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer Disease', 'status': 'Unknown status', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03270137', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01038726', 'title': 'Effects of Exercise and Cognitive Training on Cognitive Function in Older Adults', 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 108, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01038726', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02350634', 'title': '18F-AV-1451 High Resolution Autopsy Study', 'status': 'Completed', 'clean_age': '60 Years to 89 Years ', 'phases': 'Phase 1', 'enrollment': 3, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02350634', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03359902', 'title': 'Treatment of Mild Cognitive Impairment With Transcutaneous Vagal Nerve Stimulation', 'status': 'Recruiting', 'clean_age': '60 Years to 89 Years ', 'phases': 'Not Applicable', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03359902', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02792257', 'title': \"Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease (AD) (THC-AD)\", 'status': 'Recruiting', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02792257', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04075435', 'title': \"Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Alzheimer's Dementia\", 'status': 'Not yet recruiting', 'clean_age': '60 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04075435', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02263287', 'title': 'LESCOD: \"Lewy Body Screening in Cognitive Disorders\"', 'status': 'Terminated', 'clean_age': '60 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 133, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02263287', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04010175', 'title': \"Digital Cognitive Remote Training in Alzheimer's Disease (MA-EIAD)\", 'status': 'Not yet recruiting', 'clean_age': '60 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 165, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04010175', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03001557', 'title': \"Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia\", 'status': 'Active, not recruiting', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 62, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03001557', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01825317', 'title': 'Effect of NeuroAD on Alzheimer Patients', 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01825317', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01825330', 'title': 'Effect of NeuroAD on the Cognitive Function of Alzheimer Patients', 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 131, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01825330', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01605448', 'title': 'Mindfulness Based Stress Reduction for Adults With Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01605448', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00040378', 'title': \"Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)\", 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 4246, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00040378', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00908999', 'title': \"Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00908999', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00900770', 'title': 'Implications of Amyloid Pathology', 'status': 'Unknown status', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00900770', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00539305', 'title': 'Hormone and Information Processing Study', 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00539305', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00381381', 'title': \"The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 199, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00381381', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00938665', 'title': \"Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.\", 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 204, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00938665', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02772185', 'title': \"Neurostimulation and Cognitive Intervention in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02772185', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02074215', 'title': \"Effect of Exercises Training in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02074215', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03531710', 'title': 'An Extension Study of V203-AD Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UB-311', 'status': 'Active, not recruiting', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 34, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03531710', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03094546', 'title': 'Polyamine-enriched Diet in Elderly Individuals With Subjective Cognitive Decline', 'status': 'Recruiting', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03094546', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03560960', 'title': \"Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '60 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03560960', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03520998', 'title': \"A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03520998', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01819545', 'title': \"The Study of microRNA 107 (miRNA 107) and Beta-amyloid Precursor Protein-cleaving Enzyme 1 (BACE1) Messenger Ribonucleic Acid (mRNA) Gene Expression in Cerebrospinal Fluid and Peripheral Blood of Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 300, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01819545', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02142777', 'title': \"S-Equol in Alzheimer's Disease (SEAD) Trial\", 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02142777', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02166827', 'title': 'Effects of a NeuroAD System, for the Treatment of Alzheimer Disease', 'status': 'Terminated', 'clean_age': '60 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 1, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02166827', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00880412', 'title': \"A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 197, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00880412', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00911690', 'title': 'Establishment of a Bank of Biospecimens for Future Research on Age-related Cognitive Disorders', 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 102, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00911690', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00319891', 'title': \"Computer-Based Training for Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00319891', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02551809', 'title': \"Evaluate the Safety, Tolerability, Immunogenicity and Efficacy of UB-311 in Mild Alzheimer's Disease (AD) Patients\", 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 43, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02551809', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02147652', 'title': 'Personalized Music Therapy and Agitation in Dementia', 'status': 'Enrolling by invitation', 'clean_age': '60 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02147652', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00824967', 'title': 'Non Pharmacological Management of Behavioural Symptoms in Nursing Home', 'status': 'Terminated', 'clean_age': '60 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 306, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00824967', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02769234', 'title': \"EEG/ERP Longitudinal Study in Alzheimer's Disease (AD)\", 'status': 'Unknown status', 'clean_age': '60 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 75, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02769234', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03765762', 'title': \"A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years to 95 Years ', 'phases': 'Phase 2', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03765762', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03300726', 'title': \"Synaptic Injury and Functional Connectivity in Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '60 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 30, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03300726', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01935024', 'title': \"Benefits of Exercise in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years to 95 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01935024', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01454453', 'title': 'Optimisation of Antipsychotic Drug Use in Older People', 'status': 'Terminated', 'clean_age': '60 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 64, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01454453', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02833870', 'title': \"Non-pharmacological Care of Alzheimer's Disease: Benefice of Musical Interventions\", 'status': 'Completed', 'clean_age': '60 Years to 99 Years ', 'phases': 'Not Applicable', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02833870', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00814502', 'title': 'Zolpidem CR and Hospitalized Patients With Dementia', 'status': 'Completed', 'clean_age': '60 Years to 99 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00814502', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00260624', 'title': 'Escitalopram Treatment of Patients With Agitated Dementia', 'status': 'Completed', 'clean_age': '61 Years and older ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00260624', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03537729', 'title': 'Effects of Visual Cues and Education for People Who Live Within Long Term Care Communities to Assist in Wayfinding', 'status': 'Recruiting', 'clean_age': '62 Years and older ', 'phases': 'Not Applicable', 'enrollment': 137, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03537729', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00056628', 'title': \"COGNIShunt® System for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '62 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00056628', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02958930', 'title': \"Safety and Efficacy of Transcranial Electromagnetic Treatment Against Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '63 Years and older ', 'phases': 'Not Applicable', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02958930', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03927040', 'title': \"Transcranial Electromagnetic Treatment Against Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '63 Years to 84 Years ', 'phases': 'Not Applicable', 'enrollment': 7, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03927040', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03313895', 'title': 'The ACT Trial: Effects of Combined Aerobic Exercise and Cognitive Training in MCI', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 128, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03313895', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01847586', 'title': \"Enhancing Neuroplasticity and Frontal Lobe Function in Patients With Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 49, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01847586', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03333096', 'title': 'Assessing Neurovisual Function in Patients With Cognitive Impairment', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03333096', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00831298', 'title': 'Assessment of Sleep Disturbance in Alzheimer Disease', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00831298', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03672279', 'title': 'Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder', 'status': 'Not yet recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03672279', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03462121', 'title': \"A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease\", 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 2', 'enrollment': 81, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03462121', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00814346', 'title': 'Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive Functions', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 2', 'enrollment': 49, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00814346', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00177671', 'title': 'Antidepressant Medication Plus Donepezil for Treating Late-life Depression', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 220, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00177671', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03287765', 'title': 'Evaluating the Relationship Between Tau PET Imaging and CSF Biomarkers of AD (Alzheimer Disease) in Humans', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03287765', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03941119', 'title': 'Evaluating the Impact of VR-therapy on BPSD and QoL of Individuals With Dementia Admitted to Hospital', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03941119', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03403257', 'title': 'Brain Attack Surveillance in Corpus Christi--Cognitive (BASIC-Cognitive)', 'status': 'Enrolling by invitation', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 776, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03403257', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02172612', 'title': 'A Pilot Study to Reduce Inappropriate Anticholinergic Prescribing in the Elderly', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02172612', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00063310', 'title': \"ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 2', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00063310', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03246269', 'title': 'Normative Values for the German Version of the Montreal Cognitive Assessment (MoCA)', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 334, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03246269', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01577394', 'title': 'Oculomotor Testing in the Differential Diagnosis of Dementia', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 3', 'enrollment': 65, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01577394', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02612688', 'title': 'Pragmatic Trial of Video Education in Nursing Homes', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 197692, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02612688', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03175874', 'title': 'Autophagy and Pathological Aging', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03175874', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01773915', 'title': \"New Proteins in Body Fluids as Potential Biomarker for Alzheimer's Disease: a Pilot Study\", 'status': 'Unknown status', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01773915', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03643003', 'title': 'Music Therapy for Persons With Dementia', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03643003', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00488007', 'title': 'Clinical Trial on Alzheimer Disease, Presbycusis and Hearing Aids', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 51, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00488007', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03152630', 'title': 'Research on the Early and Prognosis Diagnosis of Vascular Dementia', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 600, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03152630', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03038282', 'title': 'Effects of Chromium on Insulin Resistance in Alzheimer Disease Patients', 'status': 'Not yet recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03038282', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02434393', 'title': 'Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project', 'status': 'Active, not recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 133, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02434393', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02284906', 'title': 'AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease', 'status': 'Terminated', 'clean_age': '65 Years and older ', 'phases': 'Phase 3', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02284906', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02351453', 'title': 'Patients With Alzheimer Disease, Spouse Carers and Risk of Institutionalization: a Prospective Observational Cohort Study of Dyads (AID Study)', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 207, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02351453', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01329536', 'title': \"The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01329536', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00548951', 'title': 'Alzheimer Patients and the Snoezelen Program', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00548951', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02829801', 'title': 'Evaluation of the Animal Intervention Used as Therapy', 'status': 'Unknown status', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02829801', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03622905', 'title': \"ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 210, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03622905', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04063124', 'title': \"Senolytic Therapy to Modulate Progression of Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04063124', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04102514', 'title': 'A Dyadic Approach for a Remote Physical Activity Intervention in Adults With AD and Their Caregivers', 'status': 'Not yet recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04102514', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01362686', 'title': \"Comparative Research of Alzheimer's Disease Drugs\", 'status': 'Terminated', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01362686', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03256539', 'title': \"Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03256539', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03841539', 'title': 'Nutrition Interventions for Cognitive Enhancement', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03841539', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00388544', 'title': 'Enhancing Quality of Life for Nursing Home Residents', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 2', 'enrollment': 128, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00388544', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00294307', 'title': 'Enhancing Care Coordination: Hospital to Home for Cognitively Impaired Older Adults and Their Caregivers', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 814, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00294307', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00867399', 'title': 'A Safety and Tolerability Study of ABT-126 in Elderly', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00867399', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02196116', 'title': 'Amyloïd Load in Elderly Population: Effect of Cognitive Reserve', 'status': 'Unknown status', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02196116', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00295152', 'title': 'Effects of Community Occupational Therapy in Older Patients With Dementia and Their Caregivers.', 'status': 'Unknown status', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 135, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00295152', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03300180', 'title': \"Caregiver Outcomes of Alzheimer's Disease Screening\", 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 3600, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03300180', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00874939', 'title': \"A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)\", 'status': 'Terminated', 'clean_age': '65 Years and older ', 'phases': 'Phase 1', 'enrollment': 4, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00874939', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03717597', 'title': 'Nonrandomized Evaluation of a Multidimensional Behavioral Intervention', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03717597', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00076440', 'title': \"Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 2', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00076440', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01311492', 'title': \"Exercise Trial for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01311492', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00267124', 'title': 'Brain Aging Project--Kansas University', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 172, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00267124', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03275363', 'title': 'The University of Hong Kong Neurocognitive Disorder Cohort', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 500, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03275363', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04036955', 'title': 'Evaluation of an Innovative Information, Training and Social Support Intervention \"INFOSADEM\" to Principal Caregivers of Dementia Patients Living at Home', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04036955', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01202994', 'title': 'Practice Effects and Amyloid Imaging Using 18F-PIB or Flutemetamol PET and FDG-PET', 'status': 'Active, not recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 2', 'enrollment': 27, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01202994', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01129115', 'title': 'Dose Response Study of Aerobic Exercise in Older Adults', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 101, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01129115', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00547560', 'title': 'Study Evaluating Multiple Doses Of GSI-953 Within The Elderly Population', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 1', 'enrollment': 49, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00547560', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00246896', 'title': 'Care Management for Patients With Alzheimer Disease and Their Family Caregivers', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 220, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00246896', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02000583', 'title': \"Alzheimer's Prevention Through Exercise\", 'status': 'Active, not recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02000583', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03001232', 'title': 'The Effect of Movement-oriented Dementia Care on ADL and QoL of Dementia Patients in Nursing Homes', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 66, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03001232', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01222351', 'title': 'Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172', 'status': 'Active, not recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 161, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01222351', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04044495', 'title': \"Sleep, Rhythms and Risk of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04044495', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03324711', 'title': 'Psychometric Validation of the \"Antillanisée\" Version of the Mini Mental State Examination (MMSEa)', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03324711', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01708304', 'title': \"Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 510, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01708304', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04021888', 'title': \"The Effects of Exercise Program in Alzheimer's Patients With Mild to Moderate Stage Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04021888', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03286608', 'title': 'Polyphenols and Risk of Dementia', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 1329, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03286608', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04095962', 'title': 'Effects of a Multicomponent Exercise Intervention on Physical and Cognitive Function of Older Adults With Dementia', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04095962', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03002142', 'title': 'Auditory Rehabilitation and Cognition in Alzheimer Patients', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 184, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03002142', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03741543', 'title': 'Learning and Coping With Early Stage Dementia', 'status': 'Active, not recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03741543', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02420756', 'title': 'Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 18488, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02420756', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03360552', 'title': \"Evaluating the Effectiveness of a New Way of Organizing Primary Health Care to Improve the Management of Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 320, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03360552', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03723707', 'title': 'Enhanced Quality in Primary Care for Elders With Diabetes and Dementia', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 1000, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03723707', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01400542', 'title': \"Sleep Apnea in Early to Mid-Stage Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 22, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01400542', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03234686', 'title': 'Deferiprone to Delay Dementia (The 3D Study)', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 2', 'enrollment': 171, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03234686', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03581643', 'title': 'Validation of the Montreal Cognitive Assessment in Patients With Mild and Major Neurocognitive Disorder', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 430, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03581643', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01699503', 'title': 'Indiana University Dementia Screening Trial', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 4005, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01699503', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00042172', 'title': 'Treatment for Early Memory Loss', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00042172', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02781220', 'title': 'Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial', 'status': 'Active, not recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 69, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02781220', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03840759', 'title': 'Short-term Effects of an Inpatient Geriatric Consultation Team on Geriatric Syndrome Patients', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 59, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03840759', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03549078', 'title': \"A Multidimensional Behavioral Intervention for Those at Risk for Alzheimer's Dementia\", 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03549078', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02444078', 'title': 'Effects of Exercise on Functional Ability in People With Dementia in Nursing Homes:a Cluster Randomised Controlled Trial', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 140, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02444078', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03638323', 'title': 'Age-related Hearing Loss and Lexical Disorders', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 46, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03638323', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03035201', 'title': 'COcoa Supplement and Multivitamin Outcomes Study for the Mind', 'status': 'Active, not recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 2262, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03035201', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01143350', 'title': \"Non Pharmacological Treatment in Alzheimer's Disease and Associated Disorders\", 'status': 'Terminated', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01143350', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01646723', 'title': 'Volunteers Adding Life in Dementia', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 75, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01646723', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00480220', 'title': \"Specific Care and Assistance Plan for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 1200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00480220', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02719834', 'title': \"Behavioral Expressions in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 4, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02719834', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01049555', 'title': \"Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental Research\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01049555', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01834716', 'title': \"Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01834716', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02502045', 'title': \"Effect of Therapeutic Light on Sleep, Circadian Rhythm, and Global Function in Women With Alzheimer's\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02502045', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02814422', 'title': 'Triglyceride-rich Lipoprotein and Development of Dementia', 'status': 'Unknown status', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 1000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02814422', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02438202', 'title': 'Electroconvulsive Therapy for Treatment of Alzheimer´s Disease', 'status': 'Not yet recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02438202', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02365051', 'title': 'Translation of COPE for Publicly-Funded Home Care Clients and Their Families', 'status': 'Active, not recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 582, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02365051', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03475316', 'title': 'Movement Intervention for Memory Enhancement', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03475316', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01316562', 'title': \"Predictive Value of Cognitive Tests Performed for the Diagnosis of Alzheimer's Disease and Related Disorders\", 'status': 'Unknown status', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 500, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01316562', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01903421', 'title': 'Inhalational Anesthesia and Precipitation of Dementia: is There a Link?', 'status': 'Active, not recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 500, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01903421', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02302482', 'title': 'Predictive Factors and Autonomy Level Change', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 6780, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02302482', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00401167', 'title': \"Memantine for Agitation and Aggression in Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00401167', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00329706', 'title': 'Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 710, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00329706', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03593941', 'title': 'Ageing Gut Brain Interactions', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03593941', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00443014', 'title': 'The Dementia Study in Northern Norway', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 187, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00443014', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02360527', 'title': 'Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s Disease', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 126, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02360527', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00647478', 'title': \"System-IGF-1 Pathway and Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 693, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00647478', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02462291', 'title': \"New Approach for Treatment of Behavioral Disorders in Alzheimer's Disease (Alzheimer's Behavioral and Cognitive Disorders)\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 163, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02462291', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01689948', 'title': \"Alzheimer Disease : Rehabilitation's Intervention at Home\", 'status': 'Terminated', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01689948', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03838952', 'title': 'The Efficacy of Traditional Chinese Herbal Medicine for Dementia', 'status': 'Not yet recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03838952', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02317250', 'title': 'Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II', 'status': 'Withdrawn', 'clean_age': '65 Years and older ', 'phases': 'Phase 3', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02317250', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04073628', 'title': 'The Long-term Impact of a Light Intervention on Sleep and Cognition in Mild Cognitive Impairment', 'status': 'Not yet recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04073628', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03848312', 'title': \"Preventing Alzheimer's Disease With Cognitive Training\", 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 1600, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03848312', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02921672', 'title': 'Feasibility Trial of a Mediterranean Diet Pattern to Prevent Cognitive Decline', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02921672', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00951197', 'title': 'Evaluation of Alteration by Magnetic Resonance Imaging (MRI) in Dementia Among Elderly Subjects', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 318, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00951197', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02709356', 'title': \"Medium Chain Triglycerides and Brain Metabolism in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02709356', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01582919', 'title': 'Neuroimaging Markers of Alzheimer Disease: a Longitudinal Population Study', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 304, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01582919', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01384344', 'title': \"Ecological Assessment of Apathy in Alzheimer's Disease and in Control Subjects: Video Recognition and Actigraphy\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 82, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01384344', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02719938', 'title': 'Triggered Palliative Care for Advanced Dementia', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 62, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02719938', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03466736', 'title': 'Enriching Clinical Trials Requiring Amyloid Positivity With Practice Effects', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 210, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03466736', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02802371', 'title': 'Pharmaceutical Collaborative Care Integrated to a Multidisciplinary Psychosocial Program', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02802371', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00750529', 'title': 'Alzheimer and Sleep', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 1', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00750529', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03984396', 'title': \"Optimal Medication Management in Alzheimer's Disease and Dementia\", 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 3671, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03984396', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03221296', 'title': 'Fall Prevention - Vestibular Rehabilitation', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 29, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03221296', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03565809', 'title': 'Quality of the Management of Diabetes in Elderly People With Dementia in France', 'status': 'Enrolling by invitation', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 87816, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03565809', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02432222', 'title': 'Effects of Visual Arts Training on Dementia', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 23, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02432222', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02846415', 'title': 'Play Intervention for Dementia for Promoting Cognitive Function: A Feasibility Study', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02846415', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02078310', 'title': 'Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 35, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02078310', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01606488', 'title': 'Effects of Brain Beta-Amyloid on Postoperative Cognition', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01606488', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00208819', 'title': 'A Comparison of Two Standard Therapies in the Management of Dementia With Agitation', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00208819', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01815112', 'title': 'Early Diagnosis of Alzheimer-like Dementia: Benefit of MRI and PET Imaging', 'status': 'Terminated', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01815112', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02997982', 'title': \"Feasibility and Effects of Valaciclovir Treatment in Persons With Early Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 2', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02997982', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03046121', 'title': 'A Family-centered Intervention for Acutely-ill Persons With Dementia', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 438, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03046121', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01314638', 'title': 'Study of Adherence and Effects of Balance Exercices (SIEL BLEU Associatio)', 'status': 'Unknown status', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01314638', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01715181', 'title': 'Volunteers Adding Life in Dementia: VALID', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 75, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01715181', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02020356', 'title': \"Music Therapy in Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '65 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 35, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02020356', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03615027', 'title': 'Dementia-specific Intervention of Advance Care Planning', 'status': 'Recruiting', 'clean_age': '65 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03615027', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02849639', 'title': \"The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression\", 'status': 'Recruiting', 'clean_age': '65 Years to 101 Years ', 'phases': 'Early Phase 1', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02849639', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02941289', 'title': \"Visuospatial Attention, Eye Movements and Instrumental Activities of Daily Living (IADLs) in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '65 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 64, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02941289', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03923712', 'title': 'PhysIcal Exercise ,Cerebral, COgnitive and Metabolome in People at Risk of Mild Cognitive Impairment', 'status': 'Recruiting', 'clean_age': '65 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03923712', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00833274', 'title': 'Evaluation of Apathy Using Attentional Reaction Test in Neurodegenerative Diseases', 'status': 'Completed', 'clean_age': '65 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00833274', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02331784', 'title': 'Plasticity-based Adaptive Cognitive Remediation for Alzheimer Disease', 'status': 'Completed', 'clean_age': '65 Years to 79 Years ', 'phases': 'Not Applicable', 'enrollment': 68, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02331784', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02959489', 'title': \"Risk Evaluation and Education for Alzheimer's Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)\", 'status': 'Recruiting', 'clean_age': '65 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 270, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02959489', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02546310', 'title': 'Phase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly Subjects', 'status': 'Completed', 'clean_age': '65 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 54, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02546310', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03928405', 'title': \"Effect of Virtual Reality on Balance and Gait Speed With Alzheimer's Dementia\", 'status': 'Completed', 'clean_age': '65 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03928405', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01931566', 'title': \"Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset\", 'status': 'Terminated', 'clean_age': '65 Years to 83 Years ', 'phases': 'Phase 3', 'enrollment': 3494, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01931566', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02817074', 'title': 'MIND Diet Intervention and Cognitive Decline', 'status': 'Active, not recruiting', 'clean_age': '65 Years to 84 Years ', 'phases': 'Phase 3', 'enrollment': 604, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02817074', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02349191', 'title': \"Omental Transposition Surgery for Mild Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '65 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02349191', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03578991', 'title': \"Diabetes as an Accelerator of Cognitive Impairment and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '65 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 174, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03578991', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02360657', 'title': 'Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer Dementia', 'status': 'Completed', 'clean_age': '65 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02360657', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04009629', 'title': 'Dementia Risk and Dynamic Response to Exercise', 'status': 'Enrolling by invitation', 'clean_age': '65 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04009629', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01467726', 'title': 'Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects', 'status': 'Completed', 'clean_age': '65 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01467726', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02746484', 'title': 'ABILITY - TelerehABILITation: TechnologY-enhanced Multi-domain at Home Continuum of Care Program', 'status': 'Completed', 'clean_age': '65 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02746484', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01893398', 'title': \"Multistimulation Group Therapy for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01893398', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01436045', 'title': 'Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.', 'status': 'Completed', 'clean_age': '65 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01436045', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03361410', 'title': 'Impact of Grape Consumption on Brain Metabolism and Neuropsychological Performance Over 1 Year', 'status': 'Recruiting', 'clean_age': '65 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03361410', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02488720', 'title': 'Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study', 'status': 'Active, not recruiting', 'clean_age': '65 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 500, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02488720', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03890861', 'title': 'Reducing African Americans\\' Alzheimer\\'s Disease Risk Through Exercise (RAATE)\"', 'status': 'Not yet recruiting', 'clean_age': '65 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03890861', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02008357', 'title': 'Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss', 'status': 'Active, not recruiting', 'clean_age': '65 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 1150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02008357', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03378453', 'title': \"Narcolepsy Protect Against Alzheimer's Disease?\", 'status': 'Completed', 'clean_age': '65 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03378453', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01295957', 'title': \"Alzheimer's Disease Reminiscence Quality of Life\", 'status': 'Completed', 'clean_age': '65 Years to 87 Years ', 'phases': 'Phase 4', 'enrollment': 135, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01295957', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03944603', 'title': 'Longitudinal Innate Immunity and Aging Study', 'status': 'Recruiting', 'clean_age': '65 Years to 89 Years ', 'phases': 'Phase 4', 'enrollment': 300, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03944603', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT04018092', 'title': 'The Revitalize Study', 'status': 'Not yet recruiting', 'clean_age': '65 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 168, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04018092', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01713816', 'title': 'Human Brain Antioxidants During Oxidative Stress', 'status': 'Completed', 'clean_age': '65 Years to 89 Years ', 'phases': 'Phase 4', 'enrollment': 52, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01713816', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00403507', 'title': \"Exercise Treatment of Mild-Stage Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 79, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00403507', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03946930', 'title': 'IGF Binding Protein-2 Associated With Cognitive Decline', 'status': 'Recruiting', 'clean_age': '65 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 500, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03946930', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00160147', 'title': \"Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type\", 'status': 'Terminated', 'clean_age': '65 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00160147', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01692977', 'title': \"What Elements of the Design of a Healing Garden Are Used as Landmarks by Patients With Alzheimer's Disease to Locate?\", 'status': 'Completed', 'clean_age': '65 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 77, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01692977', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01669876', 'title': \"Study to Evaluate Dietary Supplementation With a Version of Anatabloc(R) in Subjects With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '65 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 85, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01669876', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00820937', 'title': 'Diagnostic of Lewy Body Dementia by Combining Scintigraphy (SPECT) Using a Specific Transporter and Magnetic Resonance Imaging (MRI)', 'status': 'Completed', 'clean_age': '65 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00820937', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02351388', 'title': \"Transcranial Direct Current Stimulation for Depression in Alzheimer's Disease Patient - Preliminary Research\", 'status': 'Unknown status', 'clean_age': '65 Years to 90 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02351388', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03226522', 'title': 'Addressing Dementia Via Agitation-Centered Evaluation', 'status': 'Recruiting', 'clean_age': '65 Years to 90 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 435, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03226522', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03034746', 'title': 'Impact of Physical Activity on Successful Aging', 'status': 'Completed', 'clean_age': '65 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03034746', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02501876', 'title': \"Type 2 Diabetes Mellitus as Catalyst for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 202, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02501876', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT00190021', 'title': 'Donepezil Treatment of Psychotic Symptoms in Dementia Patients', 'status': 'Unknown status', 'clean_age': '65 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00190021', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03649724', 'title': \"The LUCINDA Trial: LUpron Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer's\", 'status': 'Not yet recruiting', 'clean_age': '65 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03649724', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01729598', 'title': 'Valproic Acid in Subjects With Intact Cognition - Proof of Concept Study', 'status': 'Completed', 'clean_age': '65 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01729598', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02045056', 'title': 'Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease', 'status': 'Completed', 'clean_age': '65 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02045056', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01825577', 'title': 'Exploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia.', 'status': 'Terminated', 'clean_age': '65 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01825577', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01172145', 'title': \"Treatment of Apathy in Alzheimer's Disease With Modafinil\", 'status': 'Completed', 'clean_age': '65 Years to 95 Years ', 'phases': 'Phase 3', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01172145', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT03977025', 'title': 'Alzheimer Biomarkers on CSF of Elderly Patients Undergoing Surgery', 'status': 'Recruiting', 'clean_age': '65 Years to 99 Years ', 'phases': 'Phase 4', 'enrollment': 30, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03977025', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT02963415', 'title': 'Concurrent Aerobic Exercise and Virtual Reality Cognitive Training', 'status': 'Not yet recruiting', 'clean_age': '65 Years to 99 Years ', 'phases': 'Not Applicable', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02963415', 'age_groups': '40 to 65 years old'}, {'nct_number': 'NCT01954550', 'title': \"Effects of Aerobic Exercise for Treating Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '66 Years and older ', 'phases': 'Not Applicable', 'enrollment': 96, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01954550', 'age_groups': '65 and older'}, {'nct_number': 'NCT01741194', 'title': 'AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext', 'status': 'Completed', 'clean_age': '66 Years to 90 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 418, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01741194', 'age_groups': '65 and older'}, {'nct_number': 'NCT01571427', 'title': \"Conversations as a Means to Delay the Onset of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '70 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 83, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01571427', 'age_groups': '65 and older'}, {'nct_number': 'NCT02052947', 'title': 'Co-LEsions in Alzheimer Disease and Related Disorders', 'status': 'Recruiting', 'clean_age': '70 Years and older ', 'phases': 'Not Applicable', 'enrollment': 214, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02052947', 'age_groups': '65 and older'}, {'nct_number': 'NCT00007189', 'title': \"Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)\", 'status': 'Completed', 'clean_age': '70 Years and older ', 'phases': 'Phase 3', 'enrollment': 2625, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00007189', 'age_groups': '65 and older'}, {'nct_number': 'NCT00912886', 'title': \"Pregnenolone Sulfate an Early Marker of the Memory Loss in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '70 Years and older ', 'phases': 'Phase 4', 'enrollment': 90, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00912886', 'age_groups': '65 and older'}, {'nct_number': 'NCT01566071', 'title': 'Ability to Drive of Early Stage Alzheimer Disease', 'status': 'Completed', 'clean_age': '70 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01566071', 'age_groups': '65 and older'}, {'nct_number': 'NCT02529436', 'title': 'Overuse of Antidepressant in Patients With Alzheimer Disease', 'status': 'Completed', 'clean_age': '70 Years and older ', 'phases': 'Phase 4', 'enrollment': 54, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02529436', 'age_groups': '65 and older'}, {'nct_number': 'NCT01231295', 'title': \"Isotopic Imaging for Prodromal Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '70 Years and older ', 'phases': 'Phase 4', 'enrollment': 143, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01231295', 'age_groups': '65 and older'}, {'nct_number': 'NCT00276510', 'title': 'A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints', 'status': 'Completed', 'clean_age': '70 Years and older ', 'phases': 'Phase 4', 'enrollment': 2878, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00276510', 'age_groups': '65 and older'}, {'nct_number': 'NCT03691519', 'title': 'Prevention of Cognitive Decline in Older Adults With Low Dha/Epa Index in Red Blood Cells', 'status': 'Recruiting', 'clean_age': '70 Years and older ', 'phases': 'Phase 3', 'enrollment': 400, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03691519', 'age_groups': '65 and older'}, {'nct_number': 'NCT03129269', 'title': 'Cognitive Function and Prevalence of Amyloid Marker in Frail Older Adults', 'status': 'Recruiting', 'clean_age': '70 Years and older ', 'phases': 'Not Applicable', 'enrollment': 345, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03129269', 'age_groups': '65 and older'}, {'nct_number': 'NCT01192529', 'title': 'Evaluation of a Diet in Patients With Senile Dementia', 'status': 'Unknown status', 'clean_age': '70 Years and older ', 'phases': 'Not Applicable', 'enrollment': 184, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01192529', 'age_groups': '65 and older'}, {'nct_number': 'NCT01345110', 'title': 'A Longitudinal Multidimensional Population Study on Brain Aging', 'status': 'Completed', 'clean_age': '70 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 1321, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01345110', 'age_groups': '65 and older'}, {'nct_number': 'NCT02224326', 'title': 'Vagus Somatosensory Evoked Potentials and Near-infrared Spectroscopy in the Early Diagnosis of Dementia', 'status': 'Active, not recruiting', 'clean_age': '70 Years to 78 Years ', 'phases': 'Phase 4', 'enrollment': 604, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02224326', 'age_groups': '65 and older'}, {'nct_number': 'NCT00099567', 'title': 'Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline', 'status': 'Completed', 'clean_age': '70 Years to 79 Years ', 'phases': 'Phase 4', 'enrollment': 2632, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00099567', 'age_groups': '65 and older'}, {'nct_number': 'NCT03999879', 'title': 'PhosphoRus, Proton Imaging and Amyloid BuRdEn (PREPARE) ON AMYLOID BURDEN AND COGNITION', 'status': 'Recruiting', 'clean_age': '70 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 45, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03999879', 'age_groups': '65 and older'}, {'nct_number': 'NCT01880151', 'title': \"Neuroelectrical Biomarkers for Alzheimer's Disease Stages\", 'status': 'Unknown status', 'clean_age': '70 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01880151', 'age_groups': '65 and older'}, {'nct_number': 'NCT01780896', 'title': 'Relationship Between Vestibular Function and Topographic Memory', 'status': 'Unknown status', 'clean_age': '70 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01780896', 'age_groups': '65 and older'}, {'nct_number': 'NCT03683394', 'title': \"Systematic Multi-domain Alzheimer's Risk Reduction Trial\", 'status': 'Enrolling by invitation', 'clean_age': '70 Years to 89 Years ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03683394', 'age_groups': '65 and older'}, {'nct_number': 'NCT03597360', 'title': \"Low Dose Ionizing Radiation Using CT Scans as a Potential Therapy for Alzheimer's Dementia: A Pilot Study\", 'status': 'Recruiting', 'clean_age': '70 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 3, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03597360', 'age_groups': '65 and older'}, {'nct_number': 'NCT03487380', 'title': \"Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '70 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03487380', 'age_groups': '65 and older'}, {'nct_number': 'NCT00546767', 'title': 'Home-Based Assessment for Alzheimer Disease Prevention', 'status': 'Completed', 'clean_age': '75 Years and older ', 'phases': 'Not Applicable', 'enrollment': 640, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00546767', 'age_groups': '65 and older'}, {'nct_number': 'NCT02041728', 'title': 'The Detection of Early Dementia With the Digital Game Memory', 'status': 'Completed', 'clean_age': '75 Years and older ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02041728', 'age_groups': '65 and older'}, {'nct_number': 'NCT03282097', 'title': \"Decisions About Cancer Screening in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '75 Years and older ', 'phases': 'Not Applicable', 'enrollment': 426, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03282097', 'age_groups': '65 and older'}, {'nct_number': 'NCT00954616', 'title': 'Inappropriate Medications Associated With Anticholinesterase and/or Memantine Treatment in the Elderly', 'status': 'Completed', 'clean_age': '75 Years and older ', 'phases': 'Phase 4', 'enrollment': 636, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00954616', 'age_groups': '65 and older'}, {'nct_number': 'NCT02138682', 'title': 'Validation of DaTscan for Detection of Parkinson Disease Related Disorders', 'status': 'Unknown status', 'clean_age': '75 Years and older ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02138682', 'age_groups': '65 and older'}, {'nct_number': 'NCT01743534', 'title': 'Conservation of Praxis in the Food and Alzheimer Disease', 'status': 'Completed', 'clean_age': '75 Years and older ', 'phases': 'Phase 4', 'enrollment': 32, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01743534', 'age_groups': '65 and older'}, {'nct_number': 'NCT00010803', 'title': 'Ginkgo Biloba Prevention Trial in Older Individuals', 'status': 'Completed', 'clean_age': '75 Years and older ', 'phases': 'Phase 3', 'enrollment': 3069, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00010803', 'age_groups': '65 and older'}, {'nct_number': 'NCT01953705', 'title': 'n-3 PUFA for Vascular Cognitive Aging', 'status': 'Active, not recruiting', 'clean_age': '75 Years and older ', 'phases': 'Phase 2', 'enrollment': 102, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01953705', 'age_groups': '65 and older'}, {'nct_number': 'NCT00034567', 'title': 'Healthy Aging and Memory Study', 'status': 'Completed', 'clean_age': '75 Years and older ', 'phases': 'Phase 4', 'enrollment': 650, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00034567', 'age_groups': '65 and older'}, {'nct_number': 'NCT01417130', 'title': \"Follow-up Study of the Alzheimer's Disease Anti-Inflammatory Prevention Trial\", 'status': 'Unknown status', 'clean_age': '75 Years and older ', 'phases': 'Phase 4', 'enrollment': 1650, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01417130', 'age_groups': '65 and older'}, {'nct_number': 'NCT01570322', 'title': 'Determinants of Quality of Life Related to Health in Alzheimer Disease', 'status': 'Unknown status', 'clean_age': '75 Years and older ', 'phases': 'Phase 4', 'enrollment': 400, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01570322', 'age_groups': '65 and older'}, {'nct_number': 'NCT02578303', 'title': 'Association Between Cerebral Arterial Vascular Flow and Sleep Apnea in Neurodegenerative Alterations', 'status': 'Recruiting', 'clean_age': '75 Years to 120 Years ', 'phases': 'Not Applicable', 'enrollment': 139, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02578303', 'age_groups': '65 and older'}, {'nct_number': 'NCT03981159', 'title': \"Effect of Exercise Training in Alzheimer's Patients\", 'status': 'Completed', 'clean_age': '80 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03981159', 'age_groups': '65 and older'}, {'nct_number': 'NCT03284112', 'title': \"Old SCHOOL Hip-Hop: Improve Alzheimer's Disease Knowledge\", 'status': 'Recruiting', 'clean_age': '9 Years and older ', 'phases': 'Not Applicable', 'enrollment': 6000, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03284112', 'age_groups': 'up to 18 years old'}, {'nct_number': 'NCT00039702', 'title': \"Brain Imaging in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00039702', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT04041895', 'title': \"Detecting Probable Alzheimer's Disease From Speech Using Linguistical Analysis\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04041895', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02878486', 'title': 'Intervention to Reduce Sedentary Time', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02878486', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01525368', 'title': 'Outcome Predictors of a Cognitive Intervention in aMCI', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 110, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01525368', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02158910', 'title': \"A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 2231, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02158910', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00606476', 'title': \"AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 194, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00606476', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03938727', 'title': 'Cardiovascular Risk Factors, Aging and Dementia', 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 500, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03938727', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03408041', 'title': \"Reported Time Between Onset and Diagnosis of Alzheimer's Disease: Correlation With Objective Parameters\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 129, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03408041', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00297414', 'title': 'An Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of Galantamine', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 1083, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00297414', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00202124', 'title': \"Double Blind Study of Trp01 in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00202124', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03485898', 'title': 'Study of Patients Hospitalized in Specialized Cognitive-behavioral Unit (UCC)', 'status': 'Terminated', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 58, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03485898', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00393627', 'title': 'Behavioral Sleep Intervention in Adult Family Homes', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 47, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00393627', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03690193', 'title': \"Feasibility and Efficacy of the Ketogenic Diet in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03690193', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00105105', 'title': \"Mifepristone as Adjunctive Therapy in Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00105105', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01946243', 'title': 'The Feasibility of Florbetapir Quantitation', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 96, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01946243', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00630500', 'title': \"Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 75, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00630500', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01023425', 'title': 'Clinical Trial of Donepezil Between the Naive Group and the Switching Group', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01023425', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01998711', 'title': 'Impact of a Memory Group for Older Adults Reporting Memory Difficulties', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 62, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01998711', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01126099', 'title': \"Prazosin Treatment for Disruptive Agitation in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01126099', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02667665', 'title': 'Verification Study and Reactivity Study for the Validity of QuQu Scale', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 240, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02667665', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02033941', 'title': \"Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD)\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02033941', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03124550', 'title': \"Development of An Exergame for Caregivers of Individuals With Alzheimer's Disease or Related Dementias\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03124550', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01357629', 'title': \"Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 11, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01357629', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03384043', 'title': \"Comparing Smartphone Technology and a Memory Strategy on Improving Prospective Memory in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 52, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03384043', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00287742', 'title': \"A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 3', 'enrollment': 33, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00287742', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02245568', 'title': \"Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)\", 'status': 'Terminated', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 3', 'enrollment': 913, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02245568', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02162251', 'title': \"Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 3482, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02162251', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02260167', 'title': \"Treatment of Alzheimer's and Dementia With the Metabolism, Infections, Nutrition, Drug Elimination (MIND) Protocol\", 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 46, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02260167', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03621839', 'title': \"New CSF Biomarkers for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 50000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03621839', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02192554', 'title': \"Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 450, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02192554', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02350127', 'title': 'Preventing Loss of Independence Through Exercise (PLIE) in Persons With Dementia', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2|Phase 3', 'enrollment': 88, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02350127', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02346201', 'title': 'Apathy in Dementia Methylphenidate Trial 2', 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 3', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02346201', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01225809', 'title': 'AD01 Follow up Extension Visit', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 17, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01225809', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00934050', 'title': \"ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 103, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00934050', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02770482', 'title': \"Amyloid Beta-peptide 1-40 and Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02770482', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00515333', 'title': \"TRx0014 in Patients With Mild or Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 323, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00515333', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00161473', 'title': \"Alzheimer's in Long-Term Care--Treatment for Agitation\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00161473', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00046358', 'title': \"The Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00046358', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00203320', 'title': \"TNF-Alpha Inhibition for Treatment of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00203320', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00203359', 'title': \"TNF-Alpha Inhibition for Treatment of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 1', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00203359', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00105638', 'title': 'Telehealth Education Program for Caregivers of Veterans With Dementia', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00105638', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00866060', 'title': \"Donepezil and Memantine in Moderate to Severe Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 800, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00866060', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02353845', 'title': 'Construction of Diagnosis System for Early AD Based on Multi-Modality MRI Technology', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 297, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02353845', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00297362', 'title': \"A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 344, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00297362', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00001977', 'title': 'The Effect of Acetylcholine on Memory and Attention', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 70, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00001977', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01315704', 'title': \"Alzheimer's Disease and Related Disorders\", 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 700, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01315704', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02029547', 'title': 'Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians', 'status': 'Withdrawn', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02029547', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02107599', 'title': 'The Feasibility of Florbetapir Quantitation in Europe', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 96, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02107599', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02336360', 'title': 'Augmenting 18F-AV-1451 Dosimetry Estimates', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 1', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02336360', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00599469', 'title': \"Far Infrared Treatment for Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 1', 'enrollment': 4, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00599469', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT04004702', 'title': \"Levetiracetam for Alzheimer's Disease Neuropsychiatric Symptoms Related to Epilepsy Trial (LAPSE)\", 'status': 'Not yet recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 65, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04004702', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02013518', 'title': 'Cognitive Behavioural Therapy for Persons With MCI or Mild Dementia', 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02013518', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01198093', 'title': 'Clinical Research Center for Dementia of South Korea (CREDOS)(or CRCD)', 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 800, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01198093', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03901092', 'title': 'A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 PET Scan Interpretation', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 3', 'enrollment': 262, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03901092', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01972204', 'title': 'Intensive Instruction on the Use of Aricept', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 125, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01972204', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02267486', 'title': 'Exploratory Study for the Validity of QuQu Scale', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 972, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02267486', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03611439', 'title': \"Effects of an 8 Component Botanical Supplement on Mild and Moderate Alzheimer's Patients\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03611439', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00105612', 'title': \"Memory Aid for Informed Consent in Alzheimer's Research\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 110, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00105612', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03508024', 'title': \"Patients With Alzheimer's Disease or Related Youth Disease\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 220, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03508024', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00283725', 'title': \"Use of Different Treatment Care Methods in Patients With Dementia Associated With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 573, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00283725', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03349320', 'title': 'Response to Donepezil, Drug Plasma Concentration and the CYP2D6 and APOE Genetic Polymorphisms', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 37, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03349320', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03435705', 'title': 'Maintenance of Occupational Therapy for Patients With Alzheimer', 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03435705', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03718494', 'title': 'The Kronos Early Estrogen Prevention Study (KEEPS)', 'status': 'Enrolling by invitation', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 688, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03718494', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00059410', 'title': \"Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 210, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00059410', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00505167', 'title': \"Memantine Versus Donepezil in Early Stages of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 64, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00505167', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03821844', 'title': \"Music & MEmory: A Pragmatic TRial for Nursing Home Residents With ALzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 1620, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03821844', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03900936', 'title': 'Detecting Dementia Earlier', 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03900936', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02409082', 'title': 'Alzheimers Disease and Neuromarkers in Patients With Acute Hip Fractures', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 400, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02409082', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00211159', 'title': \"OmegAD (Omega-3 and Alzheimer's Disease)\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 204, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00211159', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02129348', 'title': \"Treatment of Psychosis and Agitation in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02129348', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01479855', 'title': 'Multiple Nutritional Deficiencies Causing Dementia of the Alzheimer Type', 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 180, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01479855', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03289377', 'title': 'NRC:Improving Healthcare for Cognitively Impaired Elders and Their Caregivers', 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03289377', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03442322', 'title': 'Optimizing Care for Patients With Dementia', 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03442322', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02247180', 'title': 'Cognitive Rehabilitation in Alzheimer`s Disease', 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02247180', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00299676', 'title': \"An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 61, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00299676', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02051790', 'title': 'Evaluation of Reader Training Processes', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 241, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02051790', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01505504', 'title': 'Mirtazapine in Alzheimer-associated Weight Loss', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 22, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01505504', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00396825', 'title': 'Video-Based Coping Skills Training for Caregivers', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 116, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00396825', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01081743', 'title': 'Effectiveness of Care Management in Alzheimer Patients', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 270, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01081743', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00064870', 'title': \"Alzheimer's Disease Genetics Study\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 3000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00064870', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02248116', 'title': 'Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type', 'status': 'Terminated', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2|Phase 3', 'enrollment': 198, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02248116', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01129596', 'title': \"Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 10238, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01129596', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00001933', 'title': \"Nefiracetam in the Treatment of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00001933', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00470418', 'title': \"Development of NIC5-15 in the Treatment of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00470418', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01029132', 'title': 'Characteristics of Treatment Responders to Galantamine', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 66, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01029132', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00015548', 'title': \"CATIE-Alzheimer's Disease Trial\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 450, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00015548', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00147693', 'title': 'Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach?', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 304, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00147693', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00088387', 'title': \"Effect of Lithium and Divalproex in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 35, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00088387', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01371214', 'title': 'Preventing Loss of Independence Through Exercise (PLIÉ) - Pilot', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01371214', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03472482', 'title': 'Optical Coherence Tomography in Cerebral Amyloidosis', 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 85, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03472482', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02989402', 'title': \"A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 102, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02989402', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02380703', 'title': 'Aggression Prevention Training for Caregivers of Persons With Dementia (APT)', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 228, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02380703', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01870453', 'title': \"Differential Effects of Various Anesthetic Agents on Cognitive Function in Patients With Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 0, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01870453', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT04064164', 'title': 'Speeko for Elderspeak', 'status': 'Not yet recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04064164', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03884023', 'title': 'Effect of REST in the Alzheimer Disease Continuum', 'status': 'Not yet recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 300, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03884023', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00001549', 'title': 'Diagnosis and Natural History Study of Patients With Neurological Conditions', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 600, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00001549', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03773016', 'title': 'Touchscreen Technology and Art for People With Dementia in Care Homes', 'status': 'Enrolling by invitation', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03773016', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01695889', 'title': 'Is There a Relationship Between Previous Exposure to General Anesthesia and the Development of Alzheimer´s Disease?', 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 877, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01695889', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01023867', 'title': \"Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 88, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01023867', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00001917', 'title': \"Brain Imaging in Elderly People and Individuals With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00001917', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01217541', 'title': 'Collaboration Between Department of Old Age Psychiatry and Nursing Homes', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 700, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01217541', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03710642', 'title': \"Prazosin for Agitation in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 186, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03710642', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01023685', 'title': \"To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01023685', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03062449', 'title': 'Phase IIa L-serine Trial for eAD', 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03062449', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02162264', 'title': \"Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 8662, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02162264', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00627029', 'title': 'Evaluation of Programs of Coordinated Care and Disease Management', 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 18277, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00627029', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03378245', 'title': 'Telemedicine-based, Multidisciplinary-team, Intervention to Reduce Unnecessary Hospitalizations', 'status': 'Suspended', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03378245', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00291421', 'title': \"A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 2360, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00291421', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02353949', 'title': 'Investigating the Clinical Consequences of Flutemetamol-PET-scanning', 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 3', 'enrollment': 110, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02353949', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03491150', 'title': \"An Open-Label Crenezumab Study in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 3', 'enrollment': 149, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03491150', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00309725', 'title': \"A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease.\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 3', 'enrollment': 139, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00309725', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01351142', 'title': \"Cytokines and Cognitive Decline in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 133, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01351142', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00391794', 'title': \"Efficacy of Early Stage Alzheimer's Support Groups\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 154, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00391794', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00012831', 'title': 'Nurse Managed Clinic for Dementia Patients and Family Caregivers', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00012831', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00001235', 'title': \"Genetic Studies in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 1500, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00001235', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03656159', 'title': \"Evaluation of a New CBT for People With Alzheimer's Disease and Their Caregivers\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03656159', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00001662', 'title': \"Treatment of Alzheimer's Disease With CX516 (Ampalex)\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00001662', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01574456', 'title': \"Blood-brain Barrier Permeability in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 39, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01574456', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00898807', 'title': \"Citalopram for Agitation in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 3', 'enrollment': 186, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00898807', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00698165', 'title': \"Observational Study on Costs and Caregiver Burden in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 2400, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00698165', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT04103580', 'title': 'Caregiver Speaks: A Technologically Mediated Storytelling Intervention', 'status': 'Not yet recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 468, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04103580', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01609348', 'title': \"Venlafaxine for Depression in Alzheimer's Disease (DIADs-3)\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01609348', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00001972', 'title': 'PET Scan of Brain Metabolism in Relation to Age and Disease', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 123, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00001972', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00684944', 'title': \"Open Label Study of TRx0014 in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 111, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00684944', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03672266', 'title': 'Studies of Brain and Body Interaction', 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03672266', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01251718', 'title': \"Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 894, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01251718', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT00955409', 'title': \"Long Term Extension Study Evaluating Safety, Tolerability and Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00955409', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01354444', 'title': \"Trial of Carvedilol in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'up to 100 Years ', 'phases': 'Phase 4', 'enrollment': 29, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01354444', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT02055092', 'title': 'Young Onset Dementia - the Difficult Diagnosis and the Stressful Life for the Whole Family', 'status': 'Unknown status', 'clean_age': 'up to 69 Years ', 'phases': 'Phase 4', 'enrollment': 250, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02055092', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01097096', 'title': 'Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients', 'status': 'Completed', 'clean_age': 'up to 85 Years ', 'phases': 'Phase 2', 'enrollment': 177, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01097096', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01689233', 'title': \"Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'up to 89 Years ', 'phases': 'Phase 3', 'enrollment': 800, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01689233', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01689246', 'title': \"Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'up to 89 Years ', 'phases': 'Phase 3', 'enrollment': 891, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01689246', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01552265', 'title': 'Shanghai Mild Cognitive Impairment Cohort Study', 'status': 'Completed', 'clean_age': 'up to 90 Years ', 'phases': 'Phase 4', 'enrollment': 400, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01552265', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03863041', 'title': 'Study of Phosphorylated Metabolism Profile as Predictive Biomarker of Cognitive Decline in Memory Complaint.', 'status': 'Recruiting', 'clean_age': 'up to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03863041', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT01626391', 'title': \"Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': 'up to 90 Years ', 'phases': 'Phase 2', 'enrollment': 9, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01626391', 'age_groups': 'Age not specified'}, {'nct_number': 'NCT03446001', 'title': \"Safety and Efficacy of TRx0237 in Subjects With Early Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': 'up to 90 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 375, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03446001', 'age_groups': 'Age not specified'}]\n"
     ]
    }
   ],
   "source": [
    "# conver the dataframe to json\n",
    "json_data = alzheimer_clean.to_dict(orient='records')\n",
    "print(json_data)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'name': 'Alzheimer', 'children': [{'name': 'up to 18 years old', 'children': [{'name': 'Completed', 'children': [{'nct_number': 'NCT00006176', 'title': 'Clinical and Genetic Studies of Familial Presenile Dementia With Neuronal Inclusion Bodies', 'status': 'Completed', 'clean_age': '10 Years and older ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00006176', 'age_groups': 'up to 18 years old', 'name': 'NCT00006176'}, {'nct_number': 'NCT01699711', 'title': 'Normalization of dyrk1A and APP Function as an Approach to Improve Cognitive Performance and Decelerate AD Progression in DS Subjects: Epigallocatechin Gallate as Therapeutic Tool', 'status': 'Completed', 'clean_age': '14 Years to 29 Years ', 'phases': 'Phase 2', 'enrollment': 87, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01699711', 'age_groups': 'up to 18 years old', 'name': 'NCT01699711'}, {'nct_number': 'NCT00165100', 'title': 'Dynamic Area Telethermometry (DAT) as an Imaging Modality in Patients With Cancer', 'status': 'Completed', 'clean_age': '16 Years and older ', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00165100', 'age_groups': 'up to 18 years old', 'name': 'NCT00165100'}, {'nct_number': 'NCT01095744', 'title': \"Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01095744', 'age_groups': 'up to 18 years old', 'name': 'NCT01095744'}, {'nct_number': 'NCT02291783', 'title': 'Phase I, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of an M1 Agonist to Treat Cognitive Impairment', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 108, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02291783', 'age_groups': 'up to 18 years old', 'name': 'NCT02291783'}, {'nct_number': 'NCT02333942', 'title': 'Dementia Signal Development Study of Nautilus NeuroWave TM for the Detection of Dementia', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 41, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02333942', 'age_groups': 'up to 18 years old', 'name': 'NCT02333942'}, {'nct_number': 'NCT02697721', 'title': 'Powerful Tools for Caregivers of Dementia Patients', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02697721', 'age_groups': 'up to 18 years old', 'name': 'NCT02697721'}, {'nct_number': 'NCT01901263', 'title': 'Patients With Behavioural Symptoms and Hospitalized in Cognitive and Behavioural Units', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 306, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01901263', 'age_groups': 'up to 18 years old', 'name': 'NCT01901263'}, {'nct_number': 'NCT00291161', 'title': \"Partners in Dementia Care: A Telephone Care Consultation Intervention Provided to Veterans in Partnership With Local Alzheimer's Association Chapters\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 994, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00291161', 'age_groups': 'up to 18 years old', 'name': 'NCT00291161'}, {'nct_number': 'NCT00908492', 'title': 'Supporting Caregivers of Persons With Dementia: A Pilot Study', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00908492', 'age_groups': 'up to 18 years old', 'name': 'NCT00908492'}, {'nct_number': 'NCT01652222', 'title': 'Experimental Study to Validate the \"Therapeutic Game\" CONEM-BETA', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 101, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01652222', 'age_groups': 'up to 18 years old', 'name': 'NCT01652222'}, {'nct_number': 'NCT03923517', 'title': 'RHAPSODY-plus: Online Counseling for Family Caregivers of Patients With Young Onset Dementia', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03923517', 'age_groups': 'up to 18 years old', 'name': 'NCT03923517'}, {'nct_number': 'NCT01209156', 'title': 'Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological Conditions', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 11, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01209156', 'age_groups': 'up to 18 years old', 'name': 'NCT01209156'}, {'nct_number': 'NCT01723553', 'title': 'Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 27, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01723553', 'age_groups': 'up to 18 years old', 'name': 'NCT01723553'}, {'nct_number': 'NCT00479219', 'title': \"Study Evaluating GSI-953 in Healthy Young and Alzheimer's Patients\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00479219', 'age_groups': 'up to 18 years old', 'name': 'NCT00479219'}, {'nct_number': 'NCT01518374', 'title': 'Clinical Evaluation of Florbetapir F 18 (18F-AV-45)', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 1768, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01518374', 'age_groups': 'up to 18 years old', 'name': 'NCT01518374'}, {'nct_number': 'NCT01550549', 'title': 'Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 151, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01550549', 'age_groups': 'up to 18 years old', 'name': 'NCT01550549'}, {'nct_number': 'NCT02108769', 'title': 'Yogic Breathing Changes Salivary Components', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02108769', 'age_groups': 'up to 18 years old', 'name': 'NCT02108769'}, {'nct_number': 'NCT01190800', 'title': \"Capacity Assessment in Persons With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 400, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01190800', 'age_groups': 'up to 18 years old', 'name': 'NCT01190800'}, {'nct_number': 'NCT00970333', 'title': 'Evaluation of [18F] FEPPA and PET Imaging as a Marker of Inflammation in Subjects With Neurological Conditions', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 3, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00970333', 'age_groups': 'up to 18 years old', 'name': 'NCT00970333'}, {'nct_number': 'NCT00654563', 'title': 'Memory Disorders Registry', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 12, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00654563', 'age_groups': 'up to 18 years old', 'name': 'NCT00654563'}, {'nct_number': 'NCT02063308', 'title': 'Oxaloacetate Pharmacokinetics and Safety', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02063308', 'age_groups': 'up to 18 years old', 'name': 'NCT02063308'}, {'nct_number': 'NCT00857415', 'title': 'Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 3', 'enrollment': 226, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00857415', 'age_groups': 'up to 18 years old', 'name': 'NCT00857415'}, {'nct_number': 'NCT01819714', 'title': \"Sensory Support Care for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 31, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01819714', 'age_groups': 'up to 18 years old', 'name': 'NCT01819714'}, {'nct_number': 'NCT00362284', 'title': \"Comprehensive Support for Alzheimer's Disease Caregivers\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 161, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00362284', 'age_groups': 'up to 18 years old', 'name': 'NCT00362284'}, {'nct_number': 'NCT02968719', 'title': 'A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 107, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02968719', 'age_groups': 'up to 18 years old', 'name': 'NCT02968719'}, {'nct_number': 'NCT00366288', 'title': 'Study Evaluating PAZ-417 in Healthy Young/Elderly', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 56, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00366288', 'age_groups': 'up to 18 years old', 'name': 'NCT00366288'}, {'nct_number': 'NCT01745198', 'title': 'Effect of Cerefolin®/CerefolinNAC® on Biomarker Measurements', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 121, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01745198', 'age_groups': 'up to 18 years old', 'name': 'NCT01745198'}, {'nct_number': 'NCT00480818', 'title': 'Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Young and Elderly Subjects', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00480818', 'age_groups': 'up to 18 years old', 'name': 'NCT00480818'}, {'nct_number': 'NCT02418806', 'title': \"Group Therapy for Caregivers of Alzheimer's Disease Patients in Spanish Elderly Persons Centres\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 231, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02418806', 'age_groups': 'up to 18 years old', 'name': 'NCT02418806'}, {'nct_number': 'NCT01837641', 'title': \"A Study of LY3002813 in Participants With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01837641', 'age_groups': 'up to 18 years old', 'name': 'NCT01837641'}, {'nct_number': 'NCT02563483', 'title': 'Yoga for Family Caregivers of Alzheimers Disease Patient', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 46, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02563483', 'age_groups': 'up to 18 years old', 'name': 'NCT02563483'}, {'nct_number': 'NCT01640275', 'title': 'Markers of Alzheimers Disease After Propofol or Isoflurane Anesthesia', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 105, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01640275', 'age_groups': 'up to 18 years old', 'name': 'NCT01640275'}, {'nct_number': 'NCT00718731', 'title': 'Study GSI-136 in Healthy Young and Healthy Elderly Subjects', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00718731', 'age_groups': 'up to 18 years old', 'name': 'NCT00718731'}, {'nct_number': 'NCT00089882', 'title': \"Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 360, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00089882', 'age_groups': 'up to 18 years old', 'name': 'NCT00089882'}, {'nct_number': 'NCT01079819', 'title': 'Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-708163', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01079819', 'age_groups': 'up to 18 years old', 'name': 'NCT01079819'}, {'nct_number': 'NCT01447719', 'title': 'Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 3', 'enrollment': 110, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01447719', 'age_groups': 'up to 18 years old', 'name': 'NCT01447719'}, {'nct_number': 'NCT01454115', 'title': 'Study to Evaluate the Safety, Pharmacokinetics and Tolerability of BMS-708163', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 116, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01454115', 'age_groups': 'up to 18 years old', 'name': 'NCT01454115'}, {'nct_number': 'NCT01268020', 'title': 'Evaluation of [18F] FMH3 and PET as a Marker of Histamine-3 Receptor Activity in Subjects With AD Compared w/ HC', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01268020', 'age_groups': 'up to 18 years old', 'name': 'NCT01268020'}, {'nct_number': 'NCT01565369', 'title': 'Evaluation of Physician Training Methods to Read Florbetapir-PET Scans', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 35, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01565369', 'age_groups': 'up to 18 years old', 'name': 'NCT01565369'}, {'nct_number': 'NCT00366483', 'title': 'Study Evaluating the Safety of Lecozotan SR in Healthy Young and Elderly Subjects', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00366483', 'age_groups': 'up to 18 years old', 'name': 'NCT00366483'}, {'nct_number': 'NCT01089582', 'title': \"Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 628, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01089582', 'age_groups': 'up to 18 years old', 'name': 'NCT01089582'}, {'nct_number': 'NCT03049501', 'title': 'Caring for the Caregiver Network', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 244, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03049501', 'age_groups': 'up to 18 years old', 'name': 'NCT03049501'}, {'nct_number': 'NCT01117181', 'title': 'Apathy in Dementia Methylphenidate Trial (ADMET)', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01117181', 'age_groups': 'up to 18 years old', 'name': 'NCT01117181'}, {'nct_number': 'NCT03994237', 'title': 'Accompanying ALZHEIMER CAREGIVER', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 45, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03994237', 'age_groups': 'up to 18 years old', 'name': 'NCT03994237'}, {'nct_number': 'NCT02489110', 'title': 'Webnovela for Hispanic Dementia Family Caregivers', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02489110', 'age_groups': 'up to 18 years old', 'name': 'NCT02489110'}, {'nct_number': 'NCT01450891', 'title': \"Health Technology Assessment of Diagnostic Approaches in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 304, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01450891', 'age_groups': 'up to 18 years old', 'name': 'NCT01450891'}, {'nct_number': 'NCT02271685', 'title': 'Sound Estimation and Accuracy Task', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 600, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02271685', 'age_groups': 'up to 18 years old', 'name': 'NCT02271685'}, {'nct_number': 'NCT01672827', 'title': 'Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]Flutemetamol Positron Emission Tomography (PET) Images', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 3', 'enrollment': 276, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01672827', 'age_groups': 'up to 18 years old', 'name': 'NCT01672827'}, {'nct_number': 'NCT02556502', 'title': \"18F-Florbetaben PET Amyloid Imaging in Case of Intermediate CSF Biology for the Diagnosis of Alzheimer's Disease : a Pilot Study\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02556502', 'age_groups': 'up to 18 years old', 'name': 'NCT02556502'}, {'nct_number': 'NCT00407576', 'title': 'PET Imaging of Brain Amyloid Using [11C]MeS-IMPY', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00407576', 'age_groups': 'up to 18 years old', 'name': 'NCT00407576'}, {'nct_number': 'NCT02403752', 'title': 'Paired Integrative Home Exercise for Seniors With Dementia and Their Caregivers (PairedPLIE)', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02403752', 'age_groups': 'up to 18 years old', 'name': 'NCT02403752'}, {'nct_number': 'NCT01434667', 'title': \"Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IV\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 146, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01434667', 'age_groups': 'up to 18 years old', 'name': 'NCT01434667'}, {'nct_number': 'NCT02278354', 'title': 'Tau Imaging in Professional Fighters', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02278354', 'age_groups': 'up to 18 years old', 'name': 'NCT02278354'}, {'nct_number': 'NCT02221661', 'title': 'Performance of AclarusDx® a Blood-Based Transcriptomic Test for AD, in French Patients Newly Referred to a Memory Center', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 606, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02221661', 'age_groups': 'up to 18 years old', 'name': 'NCT02221661'}, {'nct_number': 'NCT02392468', 'title': \"Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 61, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02392468', 'age_groups': 'up to 18 years old', 'name': 'NCT02392468'}, {'nct_number': 'NCT03076307', 'title': \"DAT SPECT and Procedural Motor Skills in Parkinson's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 9, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03076307', 'age_groups': 'up to 18 years old', 'name': 'NCT03076307'}, {'nct_number': 'NCT00253227', 'title': \"A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 3', 'enrollment': 387, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00253227', 'age_groups': 'up to 18 years old', 'name': 'NCT00253227'}, {'nct_number': 'NCT02750982', 'title': 'Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02750982', 'age_groups': 'up to 18 years old', 'name': 'NCT02750982'}, {'nct_number': 'NCT00253188', 'title': \"A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 3', 'enrollment': 653, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00253188', 'age_groups': 'up to 18 years old', 'name': 'NCT00253188'}, {'nct_number': 'NCT01565434', 'title': 'Erythrocyte Complement Receptor 1 and Alzheimer Disease', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01565434', 'age_groups': 'up to 18 years old', 'name': 'NCT01565434'}, {'nct_number': 'NCT00253201', 'title': \"A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 3', 'enrollment': 636, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00253201', 'age_groups': 'up to 18 years old', 'name': 'NCT00253201'}, {'nct_number': 'NCT01366027', 'title': 'PRISM Registry: Pseudobulbar Affect Registry Series', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 5290, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01366027', 'age_groups': 'up to 18 years old', 'name': 'NCT01366027'}, {'nct_number': 'NCT00145132', 'title': 'Beta-CIT-SPECT and Neurophysiology in Depression', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00145132', 'age_groups': 'up to 18 years old', 'name': 'NCT00145132'}, {'nct_number': 'NCT03623542', 'title': 'Adverse Drug Reactions in Older Subjects', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 293, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03623542', 'age_groups': 'up to 18 years old', 'name': 'NCT03623542'}, {'nct_number': 'NCT01867359', 'title': 'The Genetic Characterization of Dementia', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 87, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01867359', 'age_groups': 'up to 18 years old', 'name': 'NCT01867359'}, {'nct_number': 'NCT00321971', 'title': 'Prevention of Depression in Spouses of People With Cognitive Impairment', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 73, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00321971', 'age_groups': 'up to 18 years old', 'name': 'NCT00321971'}, {'nct_number': 'NCT00878059', 'title': \"Alzheimer's Family Research\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 165, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00878059', 'age_groups': 'up to 18 years old', 'name': 'NCT00878059'}, {'nct_number': 'NCT00249080', 'title': 'Magnetic Resonance Imaging (MRI) of Brain Iron in Neurodegenerative Disease', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 182, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00249080', 'age_groups': 'up to 18 years old', 'name': 'NCT00249080'}, {'nct_number': 'NCT01807026', 'title': \"A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01807026', 'age_groups': 'up to 18 years old', 'name': 'NCT01807026'}, {'nct_number': 'NCT01078168', 'title': 'Alzheimer`s Disease Acitretin Medication', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01078168', 'age_groups': 'up to 18 years old', 'name': 'NCT01078168'}, {'nct_number': 'NCT00086138', 'title': \"Depression in Alzheimer's Disease-2\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 131, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00086138', 'age_groups': 'up to 18 years old', 'name': 'NCT00086138'}, {'nct_number': 'NCT01550718', 'title': 'Two Interventions for Early Stage Dementia: A Comparative Efficacy Trial', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 152, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01550718', 'age_groups': 'up to 18 years old', 'name': 'NCT01550718'}, {'nct_number': 'NCT03417219', 'title': 'Mobile Tablet Education to Advance Caregiver Health', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03417219', 'age_groups': 'up to 18 years old', 'name': 'NCT03417219'}, {'nct_number': 'NCT01430286', 'title': \"Web-based Psycho-Educational Program to Support Carers of Alzheimer's Patients\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 49, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01430286', 'age_groups': 'up to 18 years old', 'name': 'NCT01430286'}, {'nct_number': 'NCT02428387', 'title': 'Evaluation of \"My Tools 4 Care\" for Family Caregivers of Persons With Dementia', 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 199, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02428387', 'age_groups': 'up to 18 years old', 'name': 'NCT02428387'}, {'nct_number': 'NCT01513967', 'title': \"A Randomized SAD and MAD Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01513967', 'age_groups': 'up to 18 years old', 'name': 'NCT01513967'}, {'nct_number': 'NCT00459355', 'title': \"Home Safety Clinical Trial for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 254, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00459355', 'age_groups': 'up to 18 years old', 'name': 'NCT00459355'}, {'nct_number': 'NCT02309723', 'title': 'Influence of Beta Amyloid Imaging on Care of Patients Cognitive Complaints.', 'status': 'Completed', 'clean_age': '18 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 315, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02309723', 'age_groups': 'up to 18 years old', 'name': 'NCT02309723'}, {'nct_number': 'NCT01592552', 'title': \"A Biospecimen and Clinical Data Study on Patients With Alzheimer's, Multiple Sclerosis, Parkinson's, and Huntington's, for Drug & Biomarker Discovery\", 'status': 'Completed', 'clean_age': '18 Years to 100 Years ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01592552', 'age_groups': 'up to 18 years old', 'name': 'NCT01592552'}, {'nct_number': 'NCT03134963', 'title': 'Cerebral Haemodynamic Changes During Cognitive Testing: A fTCD Study', 'status': 'Completed', 'clean_age': '18 Years to 100 Years ', 'phases': 'Phase 4', 'enrollment': 51, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03134963', 'age_groups': 'up to 18 years old', 'name': 'NCT03134963'}, {'nct_number': 'NCT02453763', 'title': 'In Vivo Imaging of Therapeutic Electric Current Flow', 'status': 'Completed', 'clean_age': '18 Years to 30 Years ', 'phases': 'Phase 4', 'enrollment': 17, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02453763', 'age_groups': 'up to 18 years old', 'name': 'NCT02453763'}, {'nct_number': 'NCT01487395', 'title': 'Prediction of Cognitive Properties of New Drug Candidates for Neurodegenerative Diseases in Early Clinical Development', 'status': 'Completed', 'clean_age': '18 Years to 30 Years ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01487395', 'age_groups': 'up to 18 years old', 'name': 'NCT01487395'}, {'nct_number': 'NCT00592943', 'title': 'PET Study Examining the Dopaminergic Activity of Armodafinil in Adults', 'status': 'Completed', 'clean_age': '18 Years to 35 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00592943', 'age_groups': 'up to 18 years old', 'name': 'NCT00592943'}, {'nct_number': 'NCT03711825', 'title': 'Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules Containing Memantine Hydrochloride in Healthy Adults', 'status': 'Completed', 'clean_age': '18 Years to 40 Years ', 'phases': 'Early Phase 1', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03711825', 'age_groups': 'up to 18 years old', 'name': 'NCT03711825'}, {'nct_number': 'NCT01325662', 'title': 'A Study to Evaluate the Use of an Indwelling Catheter to Obtain Cerebrospinal Fluid (CSF) by Low-rate Continuous Sampling (MK-0000-211)', 'status': 'Completed', 'clean_age': '18 Years to 40 Years ', 'phases': 'Phase 4', 'enrollment': 11, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01325662', 'age_groups': 'up to 18 years old', 'name': 'NCT01325662'}, {'nct_number': 'NCT01258452', 'title': 'Study to Evaluate the Effects of Food Ingestion on the Pharmacokinetics of CHF 5074 in Healthy Young Male Subjects', 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01258452', 'age_groups': 'up to 18 years old', 'name': 'NCT01258452'}, {'nct_number': 'NCT00954252', 'title': 'Safety, Pharmacokinetics and Pharmacodynamics Study of Treatment With CHF 5074 in Healthy Young Male Subjects', 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 84, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00954252', 'age_groups': 'up to 18 years old', 'name': 'NCT00954252'}, {'nct_number': 'NCT00479700', 'title': 'Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00479700', 'age_groups': 'up to 18 years old', 'name': 'NCT00479700'}, {'nct_number': 'NCT01203384', 'title': 'Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of CHF5074 in Healthy Young Male Subjects', 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01203384', 'age_groups': 'up to 18 years old', 'name': 'NCT01203384'}, {'nct_number': 'NCT00726726', 'title': \"Drug Interaction Study With a Potential Alzheimer's Disease Compound\", 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00726726', 'age_groups': 'up to 18 years old', 'name': 'NCT00726726'}, {'nct_number': 'NCT00689637', 'title': 'Drug Interaction Study Between AZD3480 and Warfarin', 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 26, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00689637', 'age_groups': 'up to 18 years old', 'name': 'NCT00689637'}, {'nct_number': 'NCT00901498', 'title': \"Relative Bioavailability Study of Four Experimental Formulations for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00901498', 'age_groups': 'up to 18 years old', 'name': 'NCT00901498'}, {'nct_number': 'NCT00689559', 'title': 'Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 52, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00689559', 'age_groups': 'up to 18 years old', 'name': 'NCT00689559'}, {'nct_number': 'NCT02051335', 'title': 'Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults', 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 27, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02051335', 'age_groups': 'up to 18 years old', 'name': 'NCT02051335'}, {'nct_number': 'NCT03944460', 'title': 'SAD Phase I Study (First-in-human) to Investigate Contraloid Acetate', 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03944460', 'age_groups': 'up to 18 years old', 'name': 'NCT03944460'}, {'nct_number': 'NCT03955380', 'title': 'MAD Phase I Study to Investigate Contraloid Acetate', 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03955380', 'age_groups': 'up to 18 years old', 'name': 'NCT03955380'}, {'nct_number': 'NCT00479440', 'title': 'Study Evaluating the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-315 in Healthy Adults', 'status': 'Completed', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 56, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00479440', 'age_groups': 'up to 18 years old', 'name': 'NCT00479440'}, {'nct_number': 'NCT00906191', 'title': 'Study Evaluating How Quickly And To What Extent The 14-Carbon-SAM-531 Is Absorbed/Converted/Eliminated In Male Subjects', 'status': 'Completed', 'clean_age': '18 Years to 50 Years ', 'phases': 'Phase 1', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00906191', 'age_groups': 'up to 18 years old', 'name': 'NCT00906191'}, {'nct_number': 'NCT00452504', 'title': 'Single Ascending Dose Study of SRA-444 in Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 50 Years ', 'phases': 'Phase 1', 'enrollment': 64, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00452504', 'age_groups': 'up to 18 years old', 'name': 'NCT00452504'}, {'nct_number': 'NCT00519298', 'title': 'Study Evaluating Effects of SAM-531 on Sleep Electroencephalogram (EEG) and Quantitative Wake EEG in Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 50 Years ', 'phases': 'Phase 1', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00519298', 'age_groups': 'up to 18 years old', 'name': 'NCT00519298'}, {'nct_number': 'NCT00959881', 'title': 'Study Evaluating The Coadministration of Begacestat And Donepezil', 'status': 'Completed', 'clean_age': '18 Years to 50 Years ', 'phases': 'Phase 1', 'enrollment': 47, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00959881', 'age_groups': 'up to 18 years old', 'name': 'NCT00959881'}, {'nct_number': 'NCT00494962', 'title': 'Study Comparing Lecozotan SR Two 5-mg Tablets Vs. Lecozotan SR One 10-mg Tablet in Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 50 Years ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00494962', 'age_groups': 'up to 18 years old', 'name': 'NCT00494962'}, {'nct_number': 'NCT02126514', 'title': 'A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02126514', 'age_groups': 'up to 18 years old', 'name': 'NCT02126514'}, {'nct_number': 'NCT03030105', 'title': 'Study to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy Volunteers', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03030105', 'age_groups': 'up to 18 years old', 'name': 'NCT03030105'}, {'nct_number': 'NCT02197884', 'title': 'A Study to Assess Effects of Clarithromycin on Pharmacokinetics of JNJ-54861911 in Healthy Male Participants', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 13, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02197884', 'age_groups': 'up to 18 years old', 'name': 'NCT02197884'}, {'nct_number': 'NCT03551769', 'title': 'Pharmacokinetics of Tricaprilin Including Food Effect on Ketone Body Production', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03551769', 'age_groups': 'up to 18 years old', 'name': 'NCT03551769'}, {'nct_number': 'NCT00692510', 'title': 'Drug Interaction Study Between AZD3480 and Cytochrome P450', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00692510', 'age_groups': 'up to 18 years old', 'name': 'NCT00692510'}, {'nct_number': 'NCT00745576', 'title': 'Study Evaluating The Potential Interaction Between Verapamil Immediate Release And SAM-531 When Co-Administered', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00745576', 'age_groups': 'up to 18 years old', 'name': 'NCT00745576'}, {'nct_number': 'NCT00733785', 'title': 'PK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy Volunteers', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00733785', 'age_groups': 'up to 18 years old', 'name': 'NCT00733785'}, {'nct_number': 'NCT00987220', 'title': 'Effect of Aricept on Biomarkers (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 4', 'enrollment': 12, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00987220', 'age_groups': 'up to 18 years old', 'name': 'NCT00987220'}, {'nct_number': 'NCT00468897', 'title': 'A Study To Demonstrate The Bioequivalence Of Rosiglitazone XR (BRL-049653) 8mgs XR Manufactured At Two Different Sites.', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00468897', 'age_groups': 'up to 18 years old', 'name': 'NCT00468897'}, {'nct_number': 'NCT00831506', 'title': 'Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00831506', 'age_groups': 'up to 18 years old', 'name': 'NCT00831506'}, {'nct_number': 'NCT02005991', 'title': 'A Study To Examine The Distribution Of PF-05212377 In The Brain Of Healthy Volunteer Subjects Using Positron Emission Tomography And A Radioactive Tracer Following Oral Administration Of One Dose Of PF-05212377', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 4, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02005991', 'age_groups': 'up to 18 years old', 'name': 'NCT02005991'}, {'nct_number': 'NCT02211079', 'title': 'A Study to Assess Effect of JNJ-54861911 on Pharmacokinetics of Cocktail Representatives for Cytochrome P450 (CYP) 3A4, CYP2B6, CYP2C9, and CYP1A2 Substrates', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02211079', 'age_groups': 'up to 18 years old', 'name': 'NCT02211079'}, {'nct_number': 'NCT02534480', 'title': 'Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Young Volunteers (Single-ascending Dose)', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02534480', 'age_groups': 'up to 18 years old', 'name': 'NCT02534480'}, {'nct_number': 'NCT02648672', 'title': 'BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02648672', 'age_groups': 'up to 18 years old', 'name': 'NCT02648672'}, {'nct_number': 'NCT00988624', 'title': 'A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine)', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00988624', 'age_groups': 'up to 18 years old', 'name': 'NCT00988624'}, {'nct_number': 'NCT02782975', 'title': 'Absolute Bioavailability of a Single, Fixed Subcutaneous Dose of Aducanumab in Healthy Participants', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 28, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02782975', 'age_groups': 'up to 18 years old', 'name': 'NCT02782975'}, {'nct_number': 'NCT01221259', 'title': 'A Randomized, Double-blind, Placebo-controlled, Sequential Ascending, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2212 in Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01221259', 'age_groups': 'up to 18 years old', 'name': 'NCT01221259'}, {'nct_number': 'NCT01042314', 'title': 'Drug-Drug Interaction Study With Aricept® (Donepezil)', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01042314', 'age_groups': 'up to 18 years old', 'name': 'NCT01042314'}, {'nct_number': 'NCT01039194', 'title': 'Drug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER)', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01039194', 'age_groups': 'up to 18 years old', 'name': 'NCT01039194'}, {'nct_number': 'NCT00966966', 'title': 'Study Evaluating Potential Interaction Between SAM-531 And Gemfibrozil When Co-Administered', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00966966', 'age_groups': 'up to 18 years old', 'name': 'NCT00966966'}, {'nct_number': 'NCT01002079', 'title': 'Drug-Drug Interaction Study With Rifampin', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01002079', 'age_groups': 'up to 18 years old', 'name': 'NCT01002079'}, {'nct_number': 'NCT00979316', 'title': 'Effect on the Electrocardiographic QT Interval Corrected for Heart Rate (QTc) in Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 62, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00979316', 'age_groups': 'up to 18 years old', 'name': 'NCT00979316'}, {'nct_number': 'NCT00788047', 'title': 'A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00788047', 'age_groups': 'up to 18 years old', 'name': 'NCT00788047'}, {'nct_number': 'NCT01348737', 'title': 'Assessment of Safety, Tolerability and Blood Concentrations of Single Doses of AZD3839 in Healthy Volunteers', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01348737', 'age_groups': 'up to 18 years old', 'name': 'NCT01348737'}, {'nct_number': 'NCT00860275', 'title': 'Drug-Drug Interaction (DDI) w/Ketoconazole or Fluconazole', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00860275', 'age_groups': 'up to 18 years old', 'name': 'NCT00860275'}, {'nct_number': 'NCT00593138', 'title': 'Study of Dopamine Transporter Receptor Occupancy With Long-acting Dex-methylphenidate', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 23, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00593138', 'age_groups': 'up to 18 years old', 'name': 'NCT00593138'}, {'nct_number': 'NCT00825084', 'title': 'A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00825084', 'age_groups': 'up to 18 years old', 'name': 'NCT00825084'}, {'nct_number': 'NCT00827034', 'title': 'A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00827034', 'age_groups': 'up to 18 years old', 'name': 'NCT00827034'}, {'nct_number': 'NCT00931073', 'title': 'A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00931073', 'age_groups': 'up to 18 years old', 'name': 'NCT00931073'}, {'nct_number': 'NCT00975481', 'title': 'A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00975481', 'age_groups': 'up to 18 years old', 'name': 'NCT00975481'}, {'nct_number': 'NCT02040987', 'title': 'AZD3293 Thorough QT Study in Healthy Male Volunteers', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 52, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02040987', 'age_groups': 'up to 18 years old', 'name': 'NCT02040987'}, {'nct_number': 'NCT01702467', 'title': 'Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers', 'status': 'Completed', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 27, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01702467', 'age_groups': 'up to 18 years old', 'name': 'NCT01702467'}, {'nct_number': 'NCT02968875', 'title': \"Alzheimer's Disease and Physiological, Cognitive Function and BDNF Levels of Plasma Adaptation After Exercise Training\", 'status': 'Completed', 'clean_age': '18 Years to 60 Years ', 'phases': 'Not Applicable', 'enrollment': 54, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02968875', 'age_groups': 'up to 18 years old', 'name': 'NCT02968875'}, {'nct_number': 'NCT00701532', 'title': 'Brain Imaging Study of the Effects of Modafinil in Cocaine Addiction', 'status': 'Completed', 'clean_age': '18 Years to 65 Years ', 'phases': 'Phase 3', 'enrollment': 29, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00701532', 'age_groups': 'up to 18 years old', 'name': 'NCT00701532'}, {'nct_number': 'NCT02710188', 'title': 'Relative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Dose of Prototype Formulation', 'status': 'Completed', 'clean_age': '18 Years to 65 Years ', 'phases': 'Phase 1', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02710188', 'age_groups': 'up to 18 years old', 'name': 'NCT02710188'}, {'nct_number': 'NCT00870311', 'title': 'Investigation of Lithium on Signal Transduction, Gene Expression and Brain Myo-Inositol Levels in Manic Patients', 'status': 'Completed', 'clean_age': '18 Years to 65 Years ', 'phases': 'Phase 4', 'enrollment': 28, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00870311', 'age_groups': 'up to 18 years old', 'name': 'NCT00870311'}, {'nct_number': 'NCT00726115', 'title': 'Study Evaluating Safety, Tolerability and Pharmacokinetics of Single and Multiple Dose of SAM-531', 'status': 'Completed', 'clean_age': '18 Years to 65 Years ', 'phases': 'Phase 1', 'enrollment': 56, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00726115', 'age_groups': 'up to 18 years old', 'name': 'NCT00726115'}, {'nct_number': 'NCT02859207', 'title': 'A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 70 Years ', 'phases': 'Phase 1', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02859207', 'age_groups': 'up to 18 years old', 'name': 'NCT02859207'}, {'nct_number': 'NCT01827982', 'title': 'A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-54861911 in Healthy Volunteers Compared With Placebo', 'status': 'Completed', 'clean_age': '18 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 56, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01827982', 'age_groups': 'up to 18 years old', 'name': 'NCT01827982'}, {'nct_number': 'NCT02570997', 'title': 'Ascending Dose Study of CT1812 in Healthy Volunteers', 'status': 'Completed', 'clean_age': '18 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02570997', 'age_groups': 'up to 18 years old', 'name': 'NCT02570997'}, {'nct_number': 'NCT00824590', 'title': 'A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function', 'status': 'Completed', 'clean_age': '18 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00824590', 'age_groups': 'up to 18 years old', 'name': 'NCT00824590'}, {'nct_number': 'NCT01421056', 'title': 'Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Open Label Extension (CT04 OLEP)', 'status': 'Completed', 'clean_age': '18 Years to 79 Years ', 'phases': 'Phase 2', 'enrollment': 74, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01421056', 'age_groups': 'up to 18 years old', 'name': 'NCT01421056'}, {'nct_number': 'NCT01303744', 'title': 'Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074', 'status': 'Completed', 'clean_age': '18 Years to 79 Years ', 'phases': 'Phase 2', 'enrollment': 96, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01303744', 'age_groups': 'up to 18 years old', 'name': 'NCT01303744'}, {'nct_number': 'NCT01602393', 'title': 'Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Prolonged Open Label Extension Phase', 'status': 'Completed', 'clean_age': '18 Years to 79 Years ', 'phases': 'Phase 2', 'enrollment': 51, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01602393', 'age_groups': 'up to 18 years old', 'name': 'NCT01602393'}, {'nct_number': 'NCT02761707', 'title': 'Biomarkers in Neural Disorders', 'status': 'Completed', 'clean_age': '18 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 54, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02761707', 'age_groups': 'up to 18 years old', 'name': 'NCT02761707'}, {'nct_number': 'NCT02820896', 'title': \"A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 74, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02820896', 'age_groups': 'up to 18 years old', 'name': 'NCT02820896'}, {'nct_number': 'NCT01826110', 'title': 'PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy Volunteers', 'status': 'Completed', 'clean_age': '18 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01826110', 'age_groups': 'up to 18 years old', 'name': 'NCT01826110'}, {'nct_number': 'NCT00991419', 'title': 'To Compare Positron Emission Tomography (PET) Measurements of Fibrillar Amyloid Burden', 'status': 'Completed', 'clean_age': '18 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00991419', 'age_groups': 'up to 18 years old', 'name': 'NCT00991419'}, {'nct_number': 'NCT00056524', 'title': 'Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)', 'status': 'Completed', 'clean_age': '18 Years to 80 Years ', 'phases': 'Phase 3', 'enrollment': 600, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00056524', 'age_groups': 'up to 18 years old', 'name': 'NCT00056524'}, {'nct_number': 'NCT03089918', 'title': 'A Study to Investigate the Regional Brain Kinetics of Brain Drug Transporters Using P-glycoprotein and Breast Cancer Resistance Protein Substrates and by Using the Positron Emission Tomography Ligand 11C-JNJ-63779586 in the Human Brain', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 11, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03089918', 'age_groups': 'up to 18 years old', 'name': 'NCT03089918'}, {'nct_number': 'NCT00959803', 'title': 'Study Of Single Ascending And Multiple Doses Of PF-04447943 In Japanese Subjects.', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00959803', 'age_groups': 'up to 18 years old', 'name': 'NCT00959803'}, {'nct_number': 'NCT01339130', 'title': 'Assessment of Social-emotional Functioning in Neurological Diseases', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 177, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01339130', 'age_groups': 'up to 18 years old', 'name': 'NCT01339130'}, {'nct_number': 'NCT02621606', 'title': '[11C]MK-6884 Positron Emission Tomography (PET) Tracer Validation Trial (MK-6884-001)', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02621606', 'age_groups': 'up to 18 years old', 'name': 'NCT02621606'}, {'nct_number': 'NCT01564706', 'title': 'A Study of 18F-AV-45 in Healthy Volunteers', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 9, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01564706', 'age_groups': 'up to 18 years old', 'name': 'NCT01564706'}, {'nct_number': 'NCT00462917', 'title': \"REVEAL III: Risk Evaluation and Education for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 290, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00462917', 'age_groups': 'up to 18 years old', 'name': 'NCT00462917'}, {'nct_number': 'NCT03298672', 'title': 'Safety, Tolerability, and Pharmacokinetics Study of NDX-1017', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 88, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03298672', 'age_groups': 'up to 18 years old', 'name': 'NCT03298672'}, {'nct_number': 'NCT02129452', 'title': 'Olfactory Neuroepithelial Tissue of Alzheimer Disease', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02129452', 'age_groups': 'up to 18 years old', 'name': 'NCT02129452'}, {'nct_number': 'NCT01659398', 'title': 'Enhanced External Counterpulsation and Its Effects on Vascular Hemodynamics in Cognitively Impaired Patients', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Early Phase 1', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01659398', 'age_groups': 'up to 18 years old', 'name': 'NCT01659398'}, {'nct_number': 'NCT02793232', 'title': 'Clinical Trial In Healthy Volunteers And Health Elderly Volunteers To Evaluate The Safety, Tolerability And Blood Concentration After Single And Multiple Escalating Oral Doses Of PF-06751979.', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 46, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02793232', 'age_groups': 'up to 18 years old', 'name': 'NCT02793232'}, {'nct_number': 'NCT00571025', 'title': \"Risk Evaluation and Education for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 301, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00571025', 'age_groups': 'up to 18 years old', 'name': 'NCT00571025'}, {'nct_number': 'NCT02103894', 'title': 'Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02103894', 'age_groups': 'up to 18 years old', 'name': 'NCT02103894'}, {'nct_number': 'NCT02509117', 'title': 'First-In-Human Study Of Single And Multiple Ascending Doses Of PF-06751979', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 55, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02509117', 'age_groups': 'up to 18 years old', 'name': 'NCT02509117'}, {'nct_number': 'NCT03720548', 'title': \"A Study of LY3372993 in Healthy Participants and Participants With Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03720548', 'age_groups': 'up to 18 years old', 'name': 'NCT03720548'}, {'nct_number': 'NCT02562989', 'title': '[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 13, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02562989', 'age_groups': 'up to 18 years old', 'name': 'NCT02562989'}, {'nct_number': 'NCT00870974', 'title': 'A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions', 'status': 'Completed', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00870974', 'age_groups': 'up to 18 years old', 'name': 'NCT00870974'}, {'nct_number': 'NCT00714571', 'title': 'Behavioral and Neuroimaging Changes After Cognitive Rehab in Traumatic Brain Injuries (TBI) and Mild Cognitive Impairment (MCI)', 'status': 'Completed', 'clean_age': '18 Years to 88 Years ', 'phases': 'Phase 1', 'enrollment': 82, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00714571', 'age_groups': 'up to 18 years old', 'name': 'NCT00714571'}, {'nct_number': 'NCT01148498', 'title': \"A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's\", 'status': 'Completed', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 55, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01148498', 'age_groups': 'up to 18 years old', 'name': 'NCT01148498'}, {'nct_number': 'NCT02681172', 'title': 'Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients With AD', 'status': 'Completed', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 218, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02681172', 'age_groups': 'up to 18 years old', 'name': 'NCT02681172'}, {'nct_number': 'NCT00029120', 'title': \"Evaluation of Age- and Alzheimer's Disease-Related Memory Disorder\", 'status': 'Completed', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 450, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00029120', 'age_groups': 'up to 18 years old', 'name': 'NCT00029120'}, {'nct_number': 'NCT00666445', 'title': \"Improved Diagnosis of Alzheimer's Disease Using the Synchronous Neural Interaction™ Test\", 'status': 'Completed', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00666445', 'age_groups': 'up to 18 years old', 'name': 'NCT00666445'}, {'nct_number': 'NCT01461109', 'title': \"Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls\", 'status': 'Completed', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 4, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01461109', 'age_groups': 'up to 18 years old', 'name': 'NCT01461109'}, {'nct_number': 'NCT03080051', 'title': 'Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain', 'status': 'Completed', 'clean_age': '18 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03080051', 'age_groups': 'up to 18 years old', 'name': 'NCT03080051'}, {'nct_number': 'NCT02767609', 'title': 'Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging', 'status': 'Completed', 'clean_age': '18 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 1, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02767609', 'age_groups': 'up to 18 years old', 'name': 'NCT02767609'}, {'nct_number': 'NCT00001480', 'title': 'The Evaluation and Follow-up of Individuals With Memory Disorder', 'status': 'Completed', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 750, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00001480', 'age_groups': 'up to 18 years old', 'name': 'NCT00001480'}, {'nct_number': 'NCT02051361', 'title': 'Antiplatelet Therapy Following Stent Implantation', 'status': 'Completed', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 900, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02051361', 'age_groups': 'up to 18 years old', 'name': 'NCT02051361'}, {'nct_number': 'NCT00303277', 'title': 'Do HMG CoA Reductase Inhibitors Affect Abeta Levels?', 'status': 'Completed', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 35, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00303277', 'age_groups': 'up to 18 years old', 'name': 'NCT00303277'}, {'nct_number': 'NCT01762618', 'title': \"Experimental Study of the Impact of a Group Therapy Psychological Intervention for Caregivers of Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': '18 Years to 95 Years ', 'phases': 'Not Applicable', 'enrollment': 83, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01762618', 'age_groups': 'up to 18 years old', 'name': 'NCT01762618'}, {'nct_number': 'NCT00735046', 'title': 'Cognitive Behavioural Therapy of Early Dementia', 'status': 'Completed', 'clean_age': '18 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 200, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00735046', 'age_groups': 'up to 18 years old', 'name': 'NCT00735046'}, {'nct_number': 'NCT00416078', 'title': \"Online Caregiver Psychoeducation and Support for Alzheimer's\", 'status': 'Completed', 'clean_age': '18 Years to 95 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 53, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00416078', 'age_groups': 'up to 18 years old', 'name': 'NCT00416078'}]}, {'name': 'Unknown status', 'children': [{'nct_number': 'NCT01682915', 'title': 'Structural and Functional Connectivity of Frontostriatal and Frontoparietal Networks as Endophenotypes of ADHD', 'status': 'Unknown status', 'clean_age': '12 Years to 20 Years ', 'phases': 'Phase 4', 'enrollment': 240, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01682915', 'age_groups': 'up to 18 years old', 'name': 'NCT01682915'}, {'nct_number': 'NCT01476228', 'title': 'EEG Objectification in Neuropsychiatry', 'status': 'Unknown status', 'clean_age': '15 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01476228', 'age_groups': 'up to 18 years old', 'name': 'NCT01476228'}, {'nct_number': 'NCT01128725', 'title': \"Truncated and Extended Forms of Amyloid Beta Peptides in Alzheimer's Disease: Genesis, Toxicity and Identification as Biological Markers\", 'status': 'Unknown status', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01128725', 'age_groups': 'up to 18 years old', 'name': 'NCT01128725'}, {'nct_number': 'NCT02299154', 'title': 'Memory Problems Perceptions Among Patients and Accompaniers During Diagnosis Process :', 'status': 'Unknown status', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02299154', 'age_groups': 'up to 18 years old', 'name': 'NCT02299154'}, {'nct_number': 'NCT00192998', 'title': 'The Serotonergic Transmitter System in Dementia and Affective Disorders', 'status': 'Unknown status', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00192998', 'age_groups': 'up to 18 years old', 'name': 'NCT00192998'}, {'nct_number': 'NCT03308032', 'title': 'Self-Directed Online Training for Chinese Caregivers', 'status': 'Unknown status', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03308032', 'age_groups': 'up to 18 years old', 'name': 'NCT03308032'}, {'nct_number': 'NCT01700556', 'title': 'A Trial to Support Caregivers of Patients With Dementia in Italy: the UP-TECH Project', 'status': 'Unknown status', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 900, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01700556', 'age_groups': 'up to 18 years old', 'name': 'NCT01700556'}, {'nct_number': 'NCT02522091', 'title': \"Cerebral Substrates of Prospective Memory in Young and Its Disruption in Normal Aging and in Alzheimer's Disease: A Study in Anatomical MRI, Diffusion Tensor MRI and Functional MRI\", 'status': 'Unknown status', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 178, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02522091', 'age_groups': 'up to 18 years old', 'name': 'NCT02522091'}, {'nct_number': 'NCT01639586', 'title': 'Comparison for the Patient With Alzheimer Disease the Impact of Three Different Groups of Patient Care', 'status': 'Unknown status', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 360, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01639586', 'age_groups': 'up to 18 years old', 'name': 'NCT01639586'}, {'nct_number': 'NCT02868905', 'title': \"Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in Women\", 'status': 'Unknown status', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02868905', 'age_groups': 'up to 18 years old', 'name': 'NCT02868905'}, {'nct_number': 'NCT01638884', 'title': 'Prospective Memory Imaging', 'status': 'Unknown status', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 118, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01638884', 'age_groups': 'up to 18 years old', 'name': 'NCT01638884'}, {'nct_number': 'NCT02685787', 'title': \"Early Counseling and Support for Alzheimer's Disease Caregivers\", 'status': 'Unknown status', 'clean_age': '18 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 230, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02685787', 'age_groups': 'up to 18 years old', 'name': 'NCT02685787'}, {'nct_number': 'NCT01622894', 'title': 'Genetics of Mendelian Forms of Young Onset Alzheimer Disease', 'status': 'Unknown status', 'clean_age': '18 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01622894', 'age_groups': 'up to 18 years old', 'name': 'NCT01622894'}, {'nct_number': 'NCT02638519', 'title': \"HP Xenon-129 fMRI of Healthy Volunteers and Participants With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '18 Years to 85 Years ', 'phases': 'Early Phase 1', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02638519', 'age_groups': 'up to 18 years old', 'name': 'NCT02638519'}, {'nct_number': 'NCT01680588', 'title': \"Efficacy and Safety of the PET Imaging Agent [18F]NAV4694 in Subjects With Probable Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01680588', 'age_groups': 'up to 18 years old', 'name': 'NCT01680588'}, {'nct_number': 'NCT00149175', 'title': 'Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment', 'status': 'Unknown status', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 4000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00149175', 'age_groups': 'up to 18 years old', 'name': 'NCT00149175'}, {'nct_number': 'NCT00306124', 'title': 'Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment', 'status': 'Unknown status', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00306124', 'age_groups': 'up to 18 years old', 'name': 'NCT00306124'}]}, {'name': 'Recruiting', 'children': [{'nct_number': 'NCT03149380', 'title': \"Effectiveness of Alzheimer's Universe (Www.AlzU.Org) on Knowledge and Behavior\", 'status': 'Recruiting', 'clean_age': '14 Years and older ', 'phases': 'Not Applicable', 'enrollment': 10000, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03149380', 'age_groups': 'up to 18 years old', 'name': 'NCT03149380'}, {'nct_number': 'NCT03902548', 'title': \"Initial Investigation of [18F]P16-129 in Alzheimer's Disease Patients and Healthy Volunteers\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03902548', 'age_groups': 'up to 18 years old', 'name': 'NCT03902548'}, {'nct_number': 'NCT03602391', 'title': 'The Senior Companion Program Plus', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03602391', 'age_groups': 'up to 18 years old', 'name': 'NCT03602391'}, {'nct_number': 'NCT03942341', 'title': \"Sleep in Adults With Down Syndrome and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 90, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03942341', 'age_groups': 'up to 18 years old', 'name': 'NCT03942341'}, {'nct_number': 'NCT02134041', 'title': 'Amyloid Accumulation After Mild Traumatic Brain Injury', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02134041', 'age_groups': 'up to 18 years old', 'name': 'NCT02134041'}, {'nct_number': 'NCT03858283', 'title': 'Mindfulness for Alzheimer Caregivers', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 145, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03858283', 'age_groups': 'up to 18 years old', 'name': 'NCT03858283'}, {'nct_number': 'NCT01982578', 'title': \"Genistein as a Possible Treatment for Alzheimer's Disease.\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01982578', 'age_groups': 'up to 18 years old', 'name': 'NCT01982578'}, {'nct_number': 'NCT03444181', 'title': 'ALzheimer and MUsic THerapy: Effects of Music Lessons on Brain Plasticity, Mood, and Quality of Life in Alzheimer Patients', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 135, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03444181', 'age_groups': 'up to 18 years old', 'name': 'NCT03444181'}, {'nct_number': 'NCT03019757', 'title': \"Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 76, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03019757', 'age_groups': 'up to 18 years old', 'name': 'NCT03019757'}, {'nct_number': 'NCT03288363', 'title': \"Transcranial Direct Current Stimulation and Early Alzheimer's Disease (tDCS-AD)\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03288363', 'age_groups': 'up to 18 years old', 'name': 'NCT03288363'}, {'nct_number': 'NCT02576821', 'title': \"Hippocampal Sclerosis and Amnesia Not Due to Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 140, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02576821', 'age_groups': 'up to 18 years old', 'name': 'NCT02576821'}, {'nct_number': 'NCT02690896', 'title': 'Caregiver Burden and Depression: Caring for Those Who Care for Others', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02690896', 'age_groups': 'up to 18 years old', 'name': 'NCT02690896'}, {'nct_number': 'NCT03144921', 'title': 'EPIC: An Intervention for Early-stage AD Dyads', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 320, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03144921', 'age_groups': 'up to 18 years old', 'name': 'NCT03144921'}, {'nct_number': 'NCT02951559', 'title': 'SOLFAMU Study of Nasal Brushing Collected OLFActory MUcosa Samples in the Diagnosis of Human Encephalopathies', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02951559', 'age_groups': 'up to 18 years old', 'name': 'NCT02951559'}, {'nct_number': 'NCT03828383', 'title': 'In-Home Technology for Dementia Caregivers', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03828383', 'age_groups': 'up to 18 years old', 'name': 'NCT03828383'}, {'nct_number': 'NCT03342326', 'title': \"Lexical Priming by Music in Alzheimer's Disease and Healthy Aging\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 78, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03342326', 'age_groups': 'up to 18 years old', 'name': 'NCT03342326'}, {'nct_number': 'NCT03653156', 'title': 'China Cognition and Aging Study', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 25000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03653156', 'age_groups': 'up to 18 years old', 'name': 'NCT03653156'}, {'nct_number': 'NCT03031184', 'title': 'Study of Mirtazapine for Agitation in Dementia', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 3', 'enrollment': 222, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03031184', 'age_groups': 'up to 18 years old', 'name': 'NCT03031184'}, {'nct_number': 'NCT02278367', 'title': 'Clinical Evaluation of 18F-AV-1451', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02278367', 'age_groups': 'up to 18 years old', 'name': 'NCT02278367'}, {'nct_number': 'NCT02612376', 'title': \"Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 800, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02612376', 'age_groups': 'up to 18 years old', 'name': 'NCT02612376'}, {'nct_number': 'NCT03047694', 'title': \"A Lexico-semantic Program on Tactile Tablet for Patients With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03047694', 'age_groups': 'up to 18 years old', 'name': 'NCT03047694'}, {'nct_number': 'NCT04099823', 'title': 'MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04099823', 'age_groups': 'up to 18 years old', 'name': 'NCT04099823'}, {'nct_number': 'NCT04077450', 'title': \"HRVB on Alzheimer's Disease Caregivers\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04077450', 'age_groups': 'up to 18 years old', 'name': 'NCT04077450'}, {'nct_number': 'NCT02414178', 'title': \"F 18 T807 Tau PET Imaging in Dominantly Inherited Alzheimer's Network (DIAN Project)\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 130, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02414178', 'age_groups': 'up to 18 years old', 'name': 'NCT02414178'}, {'nct_number': 'NCT02362880', 'title': \"Study of Genetic Alzheimer's Disease Mutation Carriers in Preclinical Stages of the Disease 18F-Florbetaben Positron Emission Tomography Study\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02362880', 'age_groups': 'up to 18 years old', 'name': 'NCT02362880'}, {'nct_number': 'NCT03770182', 'title': 'Brain Stimulation for Neurological Patients', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03770182', 'age_groups': 'up to 18 years old', 'name': 'NCT03770182'}, {'nct_number': 'NCT03033875', 'title': 'Testing Tele-Savvy, an On-line Psychoeducation Program for Dementia Family Caregivers', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 270, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03033875', 'age_groups': 'up to 18 years old', 'name': 'NCT03033875'}, {'nct_number': 'NCT00869817', 'title': 'Dominantly Inherited Alzheimer Network (DIAN)', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 700, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00869817', 'age_groups': 'up to 18 years old', 'name': 'NCT00869817'}, {'nct_number': 'NCT03233646', 'title': \"OCTA in Mild Cognitive Impairment and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 1000, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03233646', 'age_groups': 'up to 18 years old', 'name': 'NCT03233646'}, {'nct_number': 'NCT03938870', 'title': \"CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03938870', 'age_groups': 'up to 18 years old', 'name': 'NCT03938870'}, {'nct_number': 'NCT03786471', 'title': 'D-CARE - The Dementia Care Study: A Pragmatic Clinical Trial of Health System-Based Versus Community-Based Dementia Care', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 2150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03786471', 'age_groups': 'up to 18 years old', 'name': 'NCT03786471'}, {'nct_number': 'NCT03311711', 'title': 'Two-Phased Study of SPIRIT in Mild Dementia', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 264, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03311711', 'age_groups': 'up to 18 years old', 'name': 'NCT03311711'}, {'nct_number': 'NCT01638949', 'title': \"Multi-modal Neuroimaging in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 295, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01638949', 'age_groups': 'up to 18 years old', 'name': 'NCT01638949'}, {'nct_number': 'NCT04104659', 'title': 'Study of Tau Imaging With the Use of [18F]MK-6240 Tracer', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04104659', 'age_groups': 'up to 18 years old', 'name': 'NCT04104659'}, {'nct_number': 'NCT02014246', 'title': 'Genetic Characterization of Movement Disorders and Dementias', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 12000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02014246', 'age_groups': 'up to 18 years old', 'name': 'NCT02014246'}, {'nct_number': 'NCT03945968', 'title': 'The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 16000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03945968', 'age_groups': 'up to 18 years old', 'name': 'NCT03945968'}, {'nct_number': 'NCT03724136', 'title': \"Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03724136', 'age_groups': 'up to 18 years old', 'name': 'NCT03724136'}, {'nct_number': 'NCT03734289', 'title': 'Improving Family Quality of Life Through Training to Reduce Care-Resistant Behaviors by People With AD and TBI', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03734289', 'age_groups': 'up to 18 years old', 'name': 'NCT03734289'}, {'nct_number': 'NCT02494531', 'title': \"Illiteracy and Vulnerability to Alzheimer's Disease: Evaluation of Amyloid Pathology by PET Imaging\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02494531', 'age_groups': 'up to 18 years old', 'name': 'NCT02494531'}, {'nct_number': 'NCT03592563', 'title': 'CUHK Brain Health Longitudinal Study', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 5000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03592563', 'age_groups': 'up to 18 years old', 'name': 'NCT03592563'}, {'nct_number': 'NCT03506672', 'title': 'Assessing the Effectiveness of an Approach for Vocal Behaviors in Older People Living in Nursing Homes', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 324, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03506672', 'age_groups': 'up to 18 years old', 'name': 'NCT03506672'}, {'nct_number': 'NCT03657732', 'title': \"The Chinese Familial Alzheimer's Network\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 10000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03657732', 'age_groups': 'up to 18 years old', 'name': 'NCT03657732'}, {'nct_number': 'NCT03628404', 'title': \"Defining the Genetic Etiology of Alzheimer's Disease in the Faroe Islands\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 1000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03628404', 'age_groups': 'up to 18 years old', 'name': 'NCT03628404'}, {'nct_number': 'NCT00874783', 'title': 'Development of iPS From Donated Somatic Cells of Patients With Neurological Diseases', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00874783', 'age_groups': 'up to 18 years old', 'name': 'NCT00874783'}, {'nct_number': 'NCT03098459', 'title': 'Illuminating Neuropsychological Dysfunction and Systemic Inflammatory Mechanisms Gleaned After Hospitalization in Trauma-ICU Study', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 900, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03098459', 'age_groups': 'up to 18 years old', 'name': 'NCT03098459'}, {'nct_number': 'NCT02402426', 'title': 'Brain Health Registry', 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 100000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02402426', 'age_groups': 'up to 18 years old', 'name': 'NCT02402426'}, {'nct_number': 'NCT01353430', 'title': \"Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)\", 'status': 'Recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01353430', 'age_groups': 'up to 18 years old', 'name': 'NCT01353430'}, {'nct_number': 'NCT03864965', 'title': 'Advance Care Planning in Cognitive Disorders Clinic', 'status': 'Recruiting', 'clean_age': '18 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03864965', 'age_groups': 'up to 18 years old', 'name': 'NCT03864965'}, {'nct_number': 'NCT03282916', 'title': \"Anti-viral Therapy in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years to 105 Years ', 'phases': 'Phase 2', 'enrollment': 130, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03282916', 'age_groups': 'up to 18 years old', 'name': 'NCT03282916'}, {'nct_number': 'NCT03108846', 'title': \"Escitalopram for Agitation in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years to 109 Years ', 'phases': 'Phase 3', 'enrollment': 392, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03108846', 'age_groups': 'up to 18 years old', 'name': 'NCT03108846'}, {'nct_number': 'NCT03682185', 'title': 'The Healthy Patterns Study', 'status': 'Recruiting', 'clean_age': '18 Years to 110 Years ', 'phases': 'Phase 3', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03682185', 'age_groups': 'up to 18 years old', 'name': 'NCT03682185'}, {'nct_number': 'NCT02022943', 'title': \"Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies\", 'status': 'Recruiting', 'clean_age': '18 Years to 110 Years ', 'phases': 'Phase 4', 'enrollment': 500000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02022943', 'age_groups': 'up to 18 years old', 'name': 'NCT02022943'}, {'nct_number': 'NCT03653871', 'title': 'Caregiver Study Dr. Phillips', 'status': 'Recruiting', 'clean_age': '18 Years to 115 Years ', 'phases': 'Not Applicable', 'enrollment': 210, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03653871', 'age_groups': 'up to 18 years old', 'name': 'NCT03653871'}, {'nct_number': 'NCT01498263', 'title': 'Inherited Diseases, Caregiving, and Social Networks', 'status': 'Recruiting', 'clean_age': '18 Years to 118 Years ', 'phases': 'Phase 4', 'enrollment': 3300, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01498263', 'age_groups': 'up to 18 years old', 'name': 'NCT01498263'}, {'nct_number': 'NCT02681822', 'title': 'Multi-center Imaging Genetics Studies in China', 'status': 'Recruiting', 'clean_age': '18 Years to 30 Years ', 'phases': 'Phase 4', 'enrollment': 10000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02681822', 'age_groups': 'up to 18 years old', 'name': 'NCT02681822'}, {'nct_number': 'NCT02899403', 'title': 'Neurophysiological Correlates of Cognitive Tasks in Healthy Volunteers -WP3 P003', 'status': 'Recruiting', 'clean_age': '18 Years to 30 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02899403', 'age_groups': 'up to 18 years old', 'name': 'NCT02899403'}, {'nct_number': 'NCT02288000', 'title': 'Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases', 'status': 'Recruiting', 'clean_age': '18 Years to 30 Years ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02288000', 'age_groups': 'up to 18 years old', 'name': 'NCT02288000'}, {'nct_number': 'NCT02891343', 'title': 'Effect of Hypoxia on Cognitive Assessment and Cerebral Activity in Healthy Volunteers', 'status': 'Recruiting', 'clean_age': '18 Years to 30 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02891343', 'age_groups': 'up to 18 years old', 'name': 'NCT02891343'}, {'nct_number': 'NCT04023994', 'title': 'A Single Ascending Dose Study to Investigate the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Intravenously Administered RO7126209 in Healthy Participants', 'status': 'Recruiting', 'clean_age': '18 Years to 40 Years ', 'phases': 'Phase 1', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04023994', 'age_groups': 'up to 18 years old', 'name': 'NCT04023994'}, {'nct_number': 'NCT03971123', 'title': 'Study to Compare the Pharmacokinetics of Two Formulations of Tricaprilin and a Placebo on Ketone Body Production', 'status': 'Recruiting', 'clean_age': '18 Years to 50 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03971123', 'age_groups': 'up to 18 years old', 'name': 'NCT03971123'}, {'nct_number': 'NCT03587649', 'title': 'Evaluation of [18F]MNI-1126 as an Imaging Marker for Synaptic Density Loss', 'status': 'Recruiting', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03587649', 'age_groups': 'up to 18 years old', 'name': 'NCT03587649'}, {'nct_number': 'NCT03545789', 'title': 'Phase 1 Test-retest Evaluation of [18F]MNI-958 PET', 'status': 'Recruiting', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03545789', 'age_groups': 'up to 18 years old', 'name': 'NCT03545789'}, {'nct_number': 'NCT02439099', 'title': 'Retinoic Acid Homeostasis in Neuropsychiatric Diseases', 'status': 'Recruiting', 'clean_age': '18 Years to 65 Years ', 'phases': 'Phase 4', 'enrollment': 200, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02439099', 'age_groups': 'up to 18 years old', 'name': 'NCT02439099'}, {'nct_number': 'NCT03217396', 'title': 'Biomarkers of Synaptic Damage in Multiple Sclerosis', 'status': 'Recruiting', 'clean_age': '18 Years to 65 Years ', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03217396', 'age_groups': 'up to 18 years old', 'name': 'NCT03217396'}, {'nct_number': 'NCT02649985', 'title': \"Microglial Activation Positron Emission Tomography (PET) Brain Imaging in Multiple Sclerosis and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years to 70 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02649985', 'age_groups': 'up to 18 years old', 'name': 'NCT02649985'}, {'nct_number': 'NCT03840083', 'title': 'Sleep-dependent Learning in Aging', 'status': 'Recruiting', 'clean_age': '18 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 584, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03840083', 'age_groups': 'up to 18 years old', 'name': 'NCT03840083'}, {'nct_number': 'NCT03935568', 'title': 'A Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of PU-AD in Healthy Subjects', 'status': 'Recruiting', 'clean_age': '18 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03935568', 'age_groups': 'up to 18 years old', 'name': 'NCT03935568'}, {'nct_number': 'NCT03071224', 'title': 'Phase 1 Evaluation of [18F]MK-6240 PET as an Imaging Marker for Tau Protein', 'status': 'Recruiting', 'clean_age': '18 Years to 80 Years ', 'phases': 'Early Phase 1', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03071224', 'age_groups': 'up to 18 years old', 'name': 'NCT03071224'}, {'nct_number': 'NCT03859245', 'title': \"Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer's Disease Prevention\", 'status': 'Recruiting', 'clean_age': '18 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03859245', 'age_groups': 'up to 18 years old', 'name': 'NCT03859245'}, {'nct_number': 'NCT01760005', 'title': \"Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.\", 'status': 'Recruiting', 'clean_age': '18 Years to 80 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 490, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01760005', 'age_groups': 'up to 18 years old', 'name': 'NCT01760005'}, {'nct_number': 'NCT03352258', 'title': \"Effect of Low Dose Radiotherapy on Brain Amyloidosis in the Treatment of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03352258', 'age_groups': 'up to 18 years old', 'name': 'NCT03352258'}, {'nct_number': 'NCT03123224', 'title': 'The COACH Project: Combined Online Assistance for Caregiver Health', 'status': 'Recruiting', 'clean_age': '18 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03123224', 'age_groups': 'up to 18 years old', 'name': 'NCT03123224'}, {'nct_number': 'NCT03635047', 'title': 'A Phase I Study for Safety and Tolerability of AL002.', 'status': 'Recruiting', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 67, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03635047', 'age_groups': 'up to 18 years old', 'name': 'NCT03635047'}, {'nct_number': 'NCT03822208', 'title': 'First in Human Study for Safety and Tolerability of AL003.', 'status': 'Recruiting', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 54, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03822208', 'age_groups': 'up to 18 years old', 'name': 'NCT03822208'}, {'nct_number': 'NCT03838185', 'title': 'Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147', 'status': 'Recruiting', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 64, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03838185', 'age_groups': 'up to 18 years old', 'name': 'NCT03838185'}, {'nct_number': 'NCT03435861', 'title': \"Effect of Neflamapimod on Brain Inflammation in Alzheimer's Disease Patients\", 'status': 'Recruiting', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03435861', 'age_groups': 'up to 18 years old', 'name': 'NCT03435861'}, {'nct_number': 'NCT03397667', 'title': 'The Aging Brain ANSWERS Program', 'status': 'Recruiting', 'clean_age': '18 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 400, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03397667', 'age_groups': 'up to 18 years old', 'name': 'NCT03397667'}, {'nct_number': 'NCT04045990', 'title': \"Network Modulation in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '18 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04045990', 'age_groups': 'up to 18 years old', 'name': 'NCT04045990'}, {'nct_number': 'NCT03971994', 'title': \"Emotion and Attention in Alzheimer's Disease (ATEMMA)\", 'status': 'Recruiting', 'clean_age': '18 Years to 95 Years ', 'phases': 'Not Applicable', 'enrollment': 75, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03971994', 'age_groups': 'up to 18 years old', 'name': 'NCT03971994'}, {'nct_number': 'NCT03284112', 'title': \"Old SCHOOL Hip-Hop: Improve Alzheimer's Disease Knowledge\", 'status': 'Recruiting', 'clean_age': '9 Years and older ', 'phases': 'Not Applicable', 'enrollment': 6000, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03284112', 'age_groups': 'up to 18 years old', 'name': 'NCT03284112'}]}, {'name': 'Terminated', 'children': [{'nct_number': 'NCT00978536', 'title': 'A Monocenter, Cross-sectional Study to Compare Different Type of Cognitive Impairment in Multiple Sclerosis Patients and Cerebrospinal Fluid Biomarkers (Beta Amyloid, Total Tau Protein and Tau-phosphorylated Protein).', 'status': 'Terminated', 'clean_age': '17 Years to 66 Years ', 'phases': 'Not Applicable', 'enrollment': 29, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00978536', 'age_groups': 'up to 18 years old', 'name': 'NCT00978536'}, {'nct_number': 'NCT00795730', 'title': 'Multiple Dose Study Evaluating the Safety and Tolerability of NSA-789', 'status': 'Terminated', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 56, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00795730', 'age_groups': 'up to 18 years old', 'name': 'NCT00795730'}, {'nct_number': 'NCT00001178', 'title': 'Brain Study of Patients With Frontal Lobe Dementia and Parkinsonian Disorders', 'status': 'Terminated', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 597, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00001178', 'age_groups': 'up to 18 years old', 'name': 'NCT00001178'}, {'nct_number': 'NCT01028209', 'title': 'Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions', 'status': 'Terminated', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01028209', 'age_groups': 'up to 18 years old', 'name': 'NCT01028209'}, {'nct_number': 'NCT00474552', 'title': 'Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315', 'status': 'Terminated', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 56, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00474552', 'age_groups': 'up to 18 years old', 'name': 'NCT00474552'}, {'nct_number': 'NCT01181921', 'title': \"The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 1, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01181921', 'age_groups': 'up to 18 years old', 'name': 'NCT01181921'}, {'nct_number': 'NCT01978327', 'title': 'GSK2647544 RD, DDI in Healthy Young and Elderly Volunteers', 'status': 'Terminated', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01978327', 'age_groups': 'up to 18 years old', 'name': 'NCT01978327'}, {'nct_number': 'NCT03387267', 'title': 'Videofluoroscopic Swallowing Study (VFSS)', 'status': 'Terminated', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 442, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03387267', 'age_groups': 'up to 18 years old', 'name': 'NCT03387267'}, {'nct_number': 'NCT03185182', 'title': 'Diagnostic Imaging for Clear Cell Renal Cell Carcinoma', 'status': 'Terminated', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03185182', 'age_groups': 'up to 18 years old', 'name': 'NCT03185182'}, {'nct_number': 'NCT00459693', 'title': 'PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)', 'status': 'Terminated', 'clean_age': '18 Years to 50 Years ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00459693', 'age_groups': 'up to 18 years old', 'name': 'NCT00459693'}, {'nct_number': 'NCT01137799', 'title': 'The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients', 'status': 'Terminated', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 47, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01137799', 'age_groups': 'up to 18 years old', 'name': 'NCT01137799'}, {'nct_number': 'NCT02303158', 'title': 'Relationship Between Protein Biomarkers in Cerebrospinal Fluid and Alzheimer&Apos;s Disease in Patients With Depression', 'status': 'Terminated', 'clean_age': '18 Years to 60 Years ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02303158', 'age_groups': 'up to 18 years old', 'name': 'NCT02303158'}, {'nct_number': 'NCT01492322', 'title': 'SPECT Imaging of DAT Genotype', 'status': 'Terminated', 'clean_age': '18 Years to 60 Years ', 'phases': 'Phase 4', 'enrollment': 14, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01492322', 'age_groups': 'up to 18 years old', 'name': 'NCT01492322'}, {'nct_number': 'NCT01385033', 'title': '[18F]MK-3328 as a Possible Novel Positron Emission Tomography (PET) Tracer for the Detection of Brain Amyloid Plaques (MK-3328-002)', 'status': 'Terminated', 'clean_age': '18 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01385033', 'age_groups': 'up to 18 years old', 'name': 'NCT01385033'}, {'nct_number': 'NCT02769065', 'title': 'Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants', 'status': 'Terminated', 'clean_age': '18 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 179, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02769065', 'age_groups': 'up to 18 years old', 'name': 'NCT02769065'}]}, {'name': 'Not yet recruiting', 'children': [{'nct_number': 'NCT04117178', 'title': 'Monitoring Anti-Dementia Drugs by Serum Levels', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 110, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04117178', 'age_groups': 'up to 18 years old', 'name': 'NCT04117178'}, {'nct_number': 'NCT04058886', 'title': 'Telephone-delivered Mindfulness Intervention for African American Dementia Caregivers', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04058886', 'age_groups': 'up to 18 years old', 'name': 'NCT04058886'}, {'nct_number': 'NCT03119259', 'title': 'iCare-AD: A Mobile Health Application for Caregivers of Patients With Dementia.', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 448, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03119259', 'age_groups': 'up to 18 years old', 'name': 'NCT03119259'}, {'nct_number': 'NCT03715855', 'title': 'Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03715855', 'age_groups': 'up to 18 years old', 'name': 'NCT03715855'}, {'nct_number': 'NCT03721042', 'title': 'Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03721042', 'age_groups': 'up to 18 years old', 'name': 'NCT03721042'}, {'nct_number': 'NCT04111211', 'title': 'Long-term Follow-up of Cognitive and Functional Evolutions of Persons With Isolated Cognitive Complaints or Mild Cognitive Deficits', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 2000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04111211', 'age_groups': 'up to 18 years old', 'name': 'NCT04111211'}, {'nct_number': 'NCT04123314', 'title': \"Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04123314', 'age_groups': 'up to 18 years old', 'name': 'NCT04123314'}, {'nct_number': 'NCT03654911', 'title': \"Sustainable Method for Alzheimer's Prediction\", 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03654911', 'age_groups': 'up to 18 years old', 'name': 'NCT03654911'}, {'nct_number': 'NCT04100889', 'title': \"A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04100889', 'age_groups': 'up to 18 years old', 'name': 'NCT04100889'}, {'nct_number': 'NCT03816228', 'title': 'Imaging of Brain Structural/Functional Connectivity and Amyloid and Tau Lesions in APOE4 Carriers.', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03816228', 'age_groups': 'up to 18 years old', 'name': 'NCT03816228'}, {'nct_number': 'NCT03323502', 'title': \"Aligning Patient Preferences: a Role Offering Alzheimer's Patients, Caregivers, and Healthcare Providers Education and Support\", 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 22650, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03323502', 'age_groups': 'up to 18 years old', 'name': 'NCT03323502'}, {'nct_number': 'NCT03987464', 'title': 'Platform-based Mild Cognitive Impairment (MCI) Trial', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03987464', 'age_groups': 'up to 18 years old', 'name': 'NCT03987464'}, {'nct_number': 'NCT04055532', 'title': 'Biomarkers in Neurodegenerative Diseases', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 200, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04055532', 'age_groups': 'up to 18 years old', 'name': 'NCT04055532'}, {'nct_number': 'NCT03909347', 'title': 'PLAN: Dementia Literacy Education and Navigation for Korean Elders With Probable Dementia and Their Caregivers', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 288, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03909347', 'age_groups': 'up to 18 years old', 'name': 'NCT03909347'}, {'nct_number': 'NCT04048759', 'title': \"The Promotion of Physical Activity for the Prevention of Alzheimer's Disease in Adults With Down Syndrome\", 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04048759', 'age_groups': 'up to 18 years old', 'name': 'NCT04048759'}, {'nct_number': 'NCT03899298', 'title': 'Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 1', 'enrollment': 5000, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03899298', 'age_groups': 'up to 18 years old', 'name': 'NCT03899298'}, {'nct_number': 'NCT04037501', 'title': 'Effectiveness of a Care Management System to Reduce Unmet Needs of Informal Caregivers of People With Dementia', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 504, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04037501', 'age_groups': 'up to 18 years old', 'name': 'NCT04037501'}, {'nct_number': 'NCT03907748', 'title': 'Home-based Family Caregiver-delivered Music and Reading Interventions for People With Dementia', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 990, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03907748', 'age_groups': 'up to 18 years old', 'name': 'NCT03907748'}, {'nct_number': 'NCT03650816', 'title': \"Cerebrovascular Reactivity in Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 48, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03650816', 'age_groups': 'up to 18 years old', 'name': 'NCT03650816'}, {'nct_number': 'NCT04113577', 'title': 'COgilus Remediation in Alzheimer Patients (CORA)', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04113577', 'age_groups': 'up to 18 years old', 'name': 'NCT04113577'}, {'nct_number': 'NCT03894254', 'title': 'Predictive Factors of Autonomy Loss in Real-life Cohort', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 5250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03894254', 'age_groups': 'up to 18 years old', 'name': 'NCT03894254'}, {'nct_number': 'NCT03610698', 'title': 'Life Enhancing Activities for Family Caregivers (LEAF 2.0)', 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 500, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03610698', 'age_groups': 'up to 18 years old', 'name': 'NCT03610698'}, {'nct_number': 'NCT04044131', 'title': \"Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients\", 'status': 'Not yet recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04044131', 'age_groups': 'up to 18 years old', 'name': 'NCT04044131'}, {'nct_number': 'NCT03448601', 'title': \"Alzheimer's Disease and Precision Medicine Research With American Indian and Alaska Native People\", 'status': 'Not yet recruiting', 'clean_age': '18 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 3000, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03448601', 'age_groups': 'up to 18 years old', 'name': 'NCT03448601'}, {'nct_number': 'NCT03932812', 'title': 'Building a Bridge (BAB) Between Clinical and Community Care', 'status': 'Not yet recruiting', 'clean_age': '18 Years to 110 Years ', 'phases': 'Not Applicable', 'enrollment': 106, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03932812', 'age_groups': 'up to 18 years old', 'name': 'NCT03932812'}, {'nct_number': 'NCT03896711', 'title': 'MEMORI Corps: Activity-based Companion Care for Dementia', 'status': 'Not yet recruiting', 'clean_age': '18 Years to 115 Years ', 'phases': 'Not Applicable', 'enrollment': 560, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03896711', 'age_groups': 'up to 18 years old', 'name': 'NCT03896711'}, {'nct_number': 'NCT03297177', 'title': 'Autologous Stem/Stromal Cells in Neurological Disorders and Disease', 'status': 'Not yet recruiting', 'clean_age': '18 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03297177', 'age_groups': 'up to 18 years old', 'name': 'NCT03297177'}, {'nct_number': 'NCT03682081', 'title': \"Interventions for Patients With Alzheimer's Disease and Dysphagia\", 'status': 'Not yet recruiting', 'clean_age': '18 Years to 99 Years ', 'phases': 'Early Phase 1', 'enrollment': 76, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03682081', 'age_groups': 'up to 18 years old', 'name': 'NCT03682081'}]}, {'name': 'Active, not recruiting', 'children': [{'nct_number': 'NCT03687710', 'title': \"The Comparative Effectiveness Dementia & Alzheimer's Registry\", 'status': 'Active, not recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 1000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03687710', 'age_groups': 'up to 18 years old', 'name': 'NCT03687710'}, {'nct_number': 'NCT01554202', 'title': \"Multi-modal Neuroimaging in Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 295, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01554202', 'age_groups': 'up to 18 years old', 'name': 'NCT01554202'}, {'nct_number': 'NCT01926249', 'title': \"A Cohort of Outpatients From French Research Memory Centers in Order to Improve Knowledge on Alzheimer's Disease and Related Disorders\", 'status': 'Active, not recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 2300, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01926249', 'age_groups': 'up to 18 years old', 'name': 'NCT01926249'}, {'nct_number': 'NCT02205424', 'title': 'Cognition And Neocortical Volume After Stroke', 'status': 'Active, not recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 175, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02205424', 'age_groups': 'up to 18 years old', 'name': 'NCT02205424'}, {'nct_number': 'NCT02164643', 'title': 'Longitudinal Study of Brain Amyloid imaGing in MEMENTO', 'status': 'Active, not recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 3', 'enrollment': 448, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02164643', 'age_groups': 'up to 18 years old', 'name': 'NCT02164643'}, {'nct_number': 'NCT01334749', 'title': 'Observational Study on Determinants of Dementia After Stroke', 'status': 'Active, not recruiting', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 736, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01334749', 'age_groups': 'up to 18 years old', 'name': 'NCT01334749'}, {'nct_number': 'NCT03698695', 'title': 'A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers', 'status': 'Active, not recruiting', 'clean_age': '18 Years to 40 Years ', 'phases': 'Phase 1', 'enrollment': 152, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03698695', 'age_groups': 'up to 18 years old', 'name': 'NCT03698695'}, {'nct_number': 'NCT02789800', 'title': 'Patient-Centred Innovations for Persons With Multimorbidity - Quebec', 'status': 'Active, not recruiting', 'clean_age': '18 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 1956, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02789800', 'age_groups': 'up to 18 years old', 'name': 'NCT02789800'}, {'nct_number': 'NCT02742597', 'title': 'Patient-Centred Innovations for Persons With Multimorbidity - Ontario', 'status': 'Active, not recruiting', 'clean_age': '18 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 1980, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02742597', 'age_groups': 'up to 18 years old', 'name': 'NCT02742597'}, {'nct_number': 'NCT03088956', 'title': 'Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD)', 'status': 'Active, not recruiting', 'clean_age': '18 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03088956', 'age_groups': 'up to 18 years old', 'name': 'NCT03088956'}]}, {'name': 'Enrolling by invitation', 'children': [{'nct_number': 'NCT00585572', 'title': 'Wisconsin Brain Donor Program', 'status': 'Enrolling by invitation', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 500, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00585572', 'age_groups': 'up to 18 years old', 'name': 'NCT00585572'}, {'nct_number': 'NCT03667924', 'title': 'Utilizing Senior Companions to Enhance Dementia Care', 'status': 'Enrolling by invitation', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03667924', 'age_groups': 'up to 18 years old', 'name': 'NCT03667924'}, {'nct_number': 'NCT02752750', 'title': \"Longitudinal Quantitative Susceptibility Mapping (QSM) in Alzheimer 's Disease\", 'status': 'Enrolling by invitation', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02752750', 'age_groups': 'up to 18 years old', 'name': 'NCT02752750'}, {'nct_number': 'NCT02414347', 'title': \"F 18 T807 Tau PET Imaging of Alzheimer's Disease\", 'status': 'Enrolling by invitation', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02414347', 'age_groups': 'up to 18 years old', 'name': 'NCT02414347'}, {'nct_number': 'NCT02650843', 'title': 'Non-motor Symptoms and Brain Dopamine Transporter Binding', 'status': 'Enrolling by invitation', 'clean_age': '18 Years to 100 Years ', 'phases': 'Phase 4', 'enrollment': 1000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02650843', 'age_groups': 'up to 18 years old', 'name': 'NCT02650843'}]}, {'name': 'Withdrawn', 'children': [{'nct_number': 'NCT02506374', 'title': 'Development of Therapeutic Intervention for Sleep in Alzheimer/Caregiver Dyads', 'status': 'Withdrawn', 'clean_age': '18 Years and older ', 'phases': 'Phase 4', 'enrollment': 0, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02506374', 'age_groups': 'up to 18 years old', 'name': 'NCT02506374'}, {'nct_number': 'NCT02707978', 'title': 'F 18 T807 Tau PET Imaging of Frontotemporal Dementia (FTD)', 'status': 'Withdrawn', 'clean_age': '18 Years and older ', 'phases': 'Phase 2', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02707978', 'age_groups': 'up to 18 years old', 'name': 'NCT02707978'}, {'nct_number': 'NCT02319681', 'title': \"Reminiscence, Anxiety and Early Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '18 Years and older ', 'phases': 'Not Applicable', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02319681', 'age_groups': 'up to 18 years old', 'name': 'NCT02319681'}, {'nct_number': 'NCT00884533', 'title': 'QTc Study of Rosi XR in Healthy Volunteers', 'status': 'Withdrawn', 'clean_age': '18 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00884533', 'age_groups': 'up to 18 years old', 'name': 'NCT00884533'}, {'nct_number': 'NCT03635879', 'title': 'Medical Food Formulation Pharmacokinetic (PK) Study in Medium Chain Triglycerides', 'status': 'Withdrawn', 'clean_age': '18 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03635879', 'age_groups': 'up to 18 years old', 'name': 'NCT03635879'}, {'nct_number': 'NCT03641768', 'title': 'Risk Prediction for Alzheimer Dementia With Brain Imaging and Genetics', 'status': 'Withdrawn', 'clean_age': '18 Years to 65 Years ', 'phases': 'Not Applicable', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03641768', 'age_groups': 'up to 18 years old', 'name': 'NCT03641768'}, {'nct_number': 'NCT02130661', 'title': 'Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers', 'status': 'Withdrawn', 'clean_age': '18 Years to 65 Years ', 'phases': 'Phase 1', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02130661', 'age_groups': 'up to 18 years old', 'name': 'NCT02130661'}, {'nct_number': 'NCT00691340', 'title': \"Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '18 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 0, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00691340', 'age_groups': 'up to 18 years old', 'name': 'NCT00691340'}]}, {'name': 'Suspended', 'children': []}]}, {'name': '18 to 40 years old', 'children': [{'name': 'Completed', 'children': [{'nct_number': 'NCT00719394', 'title': 'Study Evaluating Safety of GSI 136 in Young and Elderly Japanese Males', 'status': 'Completed', 'clean_age': '20 Years and older ', 'phases': 'Phase 1', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00719394', 'age_groups': '18 to 40 years old', 'name': 'NCT00719394'}, {'nct_number': 'NCT03542656', 'title': 'Application of Amyloid PET in Cerebral Amyloid Angiopathy', 'status': 'Completed', 'clean_age': '20 Years and older ', 'phases': 'Phase 3', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03542656', 'age_groups': '18 to 40 years old', 'name': 'NCT03542656'}, {'nct_number': 'NCT00684710', 'title': 'Study Evaluating the Safety, Tolerability and Activity of One Dose of PAZ-417 Given to Healthy Japanese Subjects', 'status': 'Completed', 'clean_age': '20 Years and older ', 'phases': 'Phase 1', 'enrollment': 56, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00684710', 'age_groups': '18 to 40 years old', 'name': 'NCT00684710'}, {'nct_number': 'NCT02323334', 'title': \"A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '20 Years and older ', 'phases': 'Phase 1', 'enrollment': 136, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02323334', 'age_groups': '18 to 40 years old', 'name': 'NCT02323334'}, {'nct_number': 'NCT02016560', 'title': 'Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects', 'status': 'Completed', 'clean_age': '20 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 383, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02016560', 'age_groups': '18 to 40 years old', 'name': 'NCT02016560'}, {'nct_number': 'NCT01859767', 'title': 'Efficacy and Safety of MNI-672 SPECT for Detection/Exclusion of Cerebral B-amyloid in AD Subjects Compared to HVs.', 'status': 'Completed', 'clean_age': '20 Years and older ', 'phases': 'Phase 1', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01859767', 'age_groups': '18 to 40 years old', 'name': 'NCT01859767'}, {'nct_number': 'NCT01227252', 'title': 'A Safety Study of LY2886721 Multiple Doses in Healthy Subjects', 'status': 'Completed', 'clean_age': '20 Years and older ', 'phases': 'Phase 1', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01227252', 'age_groups': '18 to 40 years old', 'name': 'NCT01227252'}, {'nct_number': 'NCT00479349', 'title': 'Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531', 'status': 'Completed', 'clean_age': '20 Years and older ', 'phases': 'Phase 1', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00479349', 'age_groups': '18 to 40 years old', 'name': 'NCT00479349'}, {'nct_number': 'NCT00441987', 'title': 'Study Evaluating the Safety and Pharmacokinetics of a Single Dose of GSI-953', 'status': 'Completed', 'clean_age': '20 Years and older ', 'phases': 'Phase 1', 'enrollment': 96, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00441987', 'age_groups': '18 to 40 years old', 'name': 'NCT00441987'}, {'nct_number': 'NCT01133405', 'title': 'A Safety Study of LY2886721 Single Doses in Healthy Subjects', 'status': 'Completed', 'clean_age': '20 Years and older ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01133405', 'age_groups': '18 to 40 years old', 'name': 'NCT01133405'}, {'nct_number': 'NCT01057030', 'title': 'Multiple Dose Japanese Bridging Study', 'status': 'Completed', 'clean_age': '20 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01057030', 'age_groups': '18 to 40 years old', 'name': 'NCT01057030'}, {'nct_number': 'NCT00479297', 'title': 'Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Japanese Males', 'status': 'Completed', 'clean_age': '20 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00479297', 'age_groups': '18 to 40 years old', 'name': 'NCT00479297'}, {'nct_number': 'NCT01860625', 'title': 'A Phase I Clinical, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects', 'status': 'Completed', 'clean_age': '20 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01860625', 'age_groups': '18 to 40 years old', 'name': 'NCT01860625'}, {'nct_number': 'NCT00480467', 'title': 'Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315 in Healthy Japanese Males', 'status': 'Completed', 'clean_age': '20 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00480467', 'age_groups': '18 to 40 years old', 'name': 'NCT00480467'}, {'nct_number': 'NCT02178124', 'title': 'A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects.', 'status': 'Completed', 'clean_age': '20 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02178124', 'age_groups': '18 to 40 years old', 'name': 'NCT02178124'}, {'nct_number': 'NCT01297036', 'title': 'Pharmacokinetic Comparisons of Two Donepezil Formulations', 'status': 'Completed', 'clean_age': '20 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01297036', 'age_groups': '18 to 40 years old', 'name': 'NCT01297036'}, {'nct_number': 'NCT03212599', 'title': 'Disulfiram as a Modulator of Amyloid Precursor Protein-processing', 'status': 'Completed', 'clean_age': '20 Years to 60 Years ', 'phases': 'Phase 4', 'enrollment': 17, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03212599', 'age_groups': '18 to 40 years old', 'name': 'NCT03212599'}, {'nct_number': 'NCT00838084', 'title': 'A Safety Study of LY2811376 Single Doses in Healthy Subjects', 'status': 'Completed', 'clean_age': '20 Years to 65 Years ', 'phases': 'Phase 1', 'enrollment': 61, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00838084', 'age_groups': '18 to 40 years old', 'name': 'NCT00838084'}, {'nct_number': 'NCT01297114', 'title': 'Imaging of Cognition, Learning, and Memory in Aging', 'status': 'Completed', 'clean_age': '20 Years to 70 Years ', 'phases': 'Phase 4', 'enrollment': 294, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01297114', 'age_groups': '18 to 40 years old', 'name': 'NCT01297114'}, {'nct_number': 'NCT00692705', 'title': 'Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for β Amyloid', 'status': 'Completed', 'clean_age': '20 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 13, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00692705', 'age_groups': '18 to 40 years old', 'name': 'NCT00692705'}, {'nct_number': 'NCT02370524', 'title': \"Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '20 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02370524', 'age_groups': '18 to 40 years old', 'name': 'NCT02370524'}, {'nct_number': 'NCT03625128', 'title': \"18F-PM-PBB3 PET Study in Tauopathy Including Alzheimer's Disease, Other Dementias and Normal Controls\", 'status': 'Completed', 'clean_age': '20 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03625128', 'age_groups': '18 to 40 years old', 'name': 'NCT03625128'}, {'nct_number': 'NCT02686216', 'title': \"Biodistribution, Pharmacokinetics, and Safety of F-18 THK-5351 PET in Alzheimer's Disease Patients and Healthy Subjects.(Positron Emission Tomograph )\", 'status': 'Completed', 'clean_age': '20 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02686216', 'age_groups': '18 to 40 years old', 'name': 'NCT02686216'}, {'nct_number': 'NCT01020838', 'title': 'Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 3', 'enrollment': 218, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01020838', 'age_groups': '18 to 40 years old', 'name': 'NCT01020838'}, {'nct_number': 'NCT00467766', 'title': 'Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer’s Disease', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00467766', 'age_groups': '18 to 40 years old', 'name': 'NCT00467766'}, {'nct_number': 'NCT00759863', 'title': \"LifeZig Personalized Reminiscence Video With Slideshows and Music for Individuals With Alzheimer's and Dementia\", 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 2', 'enrollment': 242, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00759863', 'age_groups': '18 to 40 years old', 'name': 'NCT00759863'}, {'nct_number': 'NCT00178165', 'title': 'Coordinating Center for Enhancing ADRD Caregiving', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 1200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00178165', 'age_groups': '18 to 40 years old', 'name': 'NCT00178165'}, {'nct_number': 'NCT01378195', 'title': 'iCare Stress Management e-Training for Dementia Family Caregivers', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 2', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01378195', 'age_groups': '18 to 40 years old', 'name': 'NCT01378195'}, {'nct_number': 'NCT00593372', 'title': \"Treatment of Language and Memory in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 1', 'enrollment': 11, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00593372', 'age_groups': '18 to 40 years old', 'name': 'NCT00593372'}, {'nct_number': 'NCT02300584', 'title': 'Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02300584', 'age_groups': '18 to 40 years old', 'name': 'NCT02300584'}, {'nct_number': 'NCT00259467', 'title': 'Project TAP: Tailored Activities Project', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 1', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00259467', 'age_groups': '18 to 40 years old', 'name': 'NCT00259467'}, {'nct_number': 'NCT00259480', 'title': 'Project ACT: Advancing Caregiving Techniques', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 3', 'enrollment': 272, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00259480', 'age_groups': '18 to 40 years old', 'name': 'NCT00259480'}, {'nct_number': 'NCT00259454', 'title': 'Project COPE:Managing Dementia at Home', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 3', 'enrollment': 278, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00259454', 'age_groups': '18 to 40 years old', 'name': 'NCT00259454'}, {'nct_number': 'NCT01465360', 'title': 'Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 4', 'enrollment': 160, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01465360', 'age_groups': '18 to 40 years old', 'name': 'NCT01465360'}, {'nct_number': 'NCT02120664', 'title': 'Florbetapir Calibration to the Centiloid Scale', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 1', 'enrollment': 35, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02120664', 'age_groups': '18 to 40 years old', 'name': 'NCT02120664'}, {'nct_number': 'NCT00255866', 'title': 'Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00255866', 'age_groups': '18 to 40 years old', 'name': 'NCT00255866'}, {'nct_number': 'NCT01005862', 'title': \"Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers\", 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Phase 1', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01005862', 'age_groups': '18 to 40 years old', 'name': 'NCT01005862'}, {'nct_number': 'NCT01145482', 'title': 'Mechanisms of Insulin Facilitation of Memory', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01145482', 'age_groups': '18 to 40 years old', 'name': 'NCT01145482'}, {'nct_number': 'NCT01892579', 'title': 'Reducing Agitation in People With Dementia: the Customized Activity Trial', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01892579', 'age_groups': '18 to 40 years old', 'name': 'NCT01892579'}, {'nct_number': 'NCT02420535', 'title': 'An Innovative Caregiver Tool to Assess and Manage Behavioral Symptoms of Dementia', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 114, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02420535', 'age_groups': '18 to 40 years old', 'name': 'NCT02420535'}, {'nct_number': 'NCT00182897', 'title': \"PACT: Providers and Alzheimer's Caregivers Together\", 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00182897', 'age_groups': '18 to 40 years old', 'name': 'NCT00182897'}, {'nct_number': 'NCT01550172', 'title': 'Improving Dementia Caregiver Sleep & the Effect on Heart Disease Biomarkers', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01550172', 'age_groups': '18 to 40 years old', 'name': 'NCT01550172'}, {'nct_number': 'NCT01188070', 'title': 'Caregiver Stress: Interventions to Promote Health and Wellbeing', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 354, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01188070', 'age_groups': '18 to 40 years old', 'name': 'NCT01188070'}, {'nct_number': 'NCT00119561', 'title': 'Testing the Effectiveness of Telephone Support for Dementia Caregivers', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 154, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00119561', 'age_groups': '18 to 40 years old', 'name': 'NCT00119561'}, {'nct_number': 'NCT00177489', 'title': 'Coordinating Center for Caregiver Intervention Trial', 'status': 'Completed', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 613, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00177489', 'age_groups': '18 to 40 years old', 'name': 'NCT00177489'}, {'nct_number': 'NCT02061878', 'title': 'A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects', 'status': 'Completed', 'clean_age': '21 Years to 50 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02061878', 'age_groups': '18 to 40 years old', 'name': 'NCT02061878'}, {'nct_number': 'NCT00765115', 'title': 'A Study of Healthy Subjects to Assess the Effect of LY450139 on Amyloid Beta Peptide Production Rate and or Dose Response.', 'status': 'Completed', 'clean_age': '21 Years to 50 Years ', 'phases': 'Phase 1', 'enrollment': 27, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00765115', 'age_groups': '18 to 40 years old', 'name': 'NCT00765115'}, {'nct_number': 'NCT03371420', 'title': 'PET Imaging of Subjects Using 124I-PU-AD', 'status': 'Completed', 'clean_age': '21 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03371420', 'age_groups': '18 to 40 years old', 'name': 'NCT03371420'}, {'nct_number': 'NCT00621010', 'title': 'Safety Study of CTS21166 to Treat Alzheimer Disease', 'status': 'Completed', 'clean_age': '22 Years and older ', 'phases': 'Phase 1', 'enrollment': 56, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00621010', 'age_groups': '18 to 40 years old', 'name': 'NCT00621010'}, {'nct_number': 'NCT02187627', 'title': \"Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Positron Emission Tomography (PET) Imaging of Tau in Healthy and Alzheimer's Disease (AD) Participants\", 'status': 'Completed', 'clean_age': '25 Years and older ', 'phases': 'Phase 1', 'enrollment': 52, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02187627', 'age_groups': '18 to 40 years old', 'name': 'NCT02187627'}, {'nct_number': 'NCT02813070', 'title': 'Comparison of PET Amyloid Imaging in Japanese and Western Subjects', 'status': 'Completed', 'clean_age': '25 Years and older ', 'phases': 'Phase 2', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02813070', 'age_groups': '18 to 40 years old', 'name': 'NCT02813070'}, {'nct_number': 'NCT00785759', 'title': \"Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers\", 'status': 'Completed', 'clean_age': '25 Years and older ', 'phases': 'Phase 2', 'enrollment': 78, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00785759', 'age_groups': '18 to 40 years old', 'name': 'NCT00785759'}, {'nct_number': 'NCT02792179', 'title': \"Evaluation of [18F]RO6958948 as Tracer for Positron Emission Tomography (PET) Imaging of Tau Burden in Alzheimer's Disease Participants\", 'status': 'Completed', 'clean_age': '25 Years and older ', 'phases': 'Phase 1', 'enrollment': 4, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02792179', 'age_groups': '18 to 40 years old', 'name': 'NCT02792179'}, {'nct_number': 'NCT00315575', 'title': 'Memory Imaging of Normal Aging', 'status': 'Completed', 'clean_age': '25 Years to 65 Years ', 'phases': 'Phase 4', 'enrollment': 90, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00315575', 'age_groups': '18 to 40 years old', 'name': 'NCT00315575'}, {'nct_number': 'NCT02492529', 'title': \"Knowing and Remembering: Cognitive and Neural Influences of Familiarity on Recognition Memory in Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '25 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02492529', 'age_groups': '18 to 40 years old', 'name': 'NCT02492529'}, {'nct_number': 'NCT02840279', 'title': 'A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects', 'status': 'Completed', 'clean_age': '25 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 77, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02840279', 'age_groups': '18 to 40 years old', 'name': 'NCT02840279'}, {'nct_number': 'NCT01775696', 'title': \"Central and Systemic Inflammation in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '30 Years and older ', 'phases': 'Phase 4', 'enrollment': 125, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01775696', 'age_groups': '18 to 40 years old', 'name': 'NCT01775696'}, {'nct_number': 'NCT00355498', 'title': 'Amyloid Plaque and Tangle Imaging in Aging and Dementia', 'status': 'Completed', 'clean_age': '30 Years and older ', 'phases': 'Phase 4', 'enrollment': 194, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00355498', 'age_groups': '18 to 40 years old', 'name': 'NCT00355498'}, {'nct_number': 'NCT03432195', 'title': 'A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) Applied to Different Body Locations', 'status': 'Completed', 'clean_age': '30 Years and older ', 'phases': 'Phase 1', 'enrollment': 66, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03432195', 'age_groups': '18 to 40 years old', 'name': 'NCT03432195'}, {'nct_number': 'NCT03259958', 'title': 'A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept®', 'status': 'Completed', 'clean_age': '30 Years and older ', 'phases': 'Phase 1', 'enrollment': 86, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03259958', 'age_groups': '18 to 40 years old', 'name': 'NCT03259958'}, {'nct_number': 'NCT01303133', 'title': 'Natural History of Amyloid Deposition in Adults With Down Syndrome', 'status': 'Completed', 'clean_age': '30 Years and older ', 'phases': 'Phase 4', 'enrollment': 81, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01303133', 'age_groups': '18 to 40 years old', 'name': 'NCT01303133'}, {'nct_number': 'NCT02754830', 'title': \"A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '30 Years and older ', 'phases': 'Phase 1', 'enrollment': 110, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02754830', 'age_groups': '18 to 40 years old', 'name': 'NCT02754830'}, {'nct_number': 'NCT01607476', 'title': 'Bridging Study of C11 Pittsburgh Compound B (PiB) and F18 Flutemetamol Brain Positron Emission Tomography (PET)', 'status': 'Completed', 'clean_age': '30 Years and older ', 'phases': 'Phase 2', 'enrollment': 89, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01607476', 'age_groups': '18 to 40 years old', 'name': 'NCT01607476'}, {'nct_number': 'NCT03438604', 'title': 'A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS)', 'status': 'Completed', 'clean_age': '30 Years and older ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03438604', 'age_groups': '18 to 40 years old', 'name': 'NCT03438604'}, {'nct_number': 'NCT01609335', 'title': \"Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young Adults\", 'status': 'Completed', 'clean_age': '30 Years to 49 Years ', 'phases': 'Phase 1', 'enrollment': 41, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01609335', 'age_groups': '18 to 40 years old', 'name': 'NCT01609335'}, {'nct_number': 'NCT01716897', 'title': 'An Study to Determine the Bioavailability of E2609 Tablets Compared to Capsules and the Effect of Food on Absorption', 'status': 'Completed', 'clean_age': '30 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01716897', 'age_groups': '18 to 40 years old', 'name': 'NCT01716897'}, {'nct_number': 'NCT02141971', 'title': 'Down Syndrome Biomarker Initiative (DSBI)', 'status': 'Completed', 'clean_age': '30 Years to 60 Years ', 'phases': 'Phase 4', 'enrollment': 12, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02141971', 'age_groups': '18 to 40 years old', 'name': 'NCT02141971'}, {'nct_number': 'NCT02612805', 'title': 'The Diabetes and Aquatic Training Study (DATS)', 'status': 'Completed', 'clean_age': '30 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02612805', 'age_groups': '18 to 40 years old', 'name': 'NCT02612805'}, {'nct_number': 'NCT01294540', 'title': 'Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Subjects and an Elderly Cohort', 'status': 'Completed', 'clean_age': '30 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 73, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01294540', 'age_groups': '18 to 40 years old', 'name': 'NCT01294540'}, {'nct_number': 'NCT01322568', 'title': 'Research on Aging Project in Iceland: Second Stage', 'status': 'Completed', 'clean_age': '32 Years to 60 Years ', 'phases': 'Phase 4', 'enrollment': 5764, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01322568', 'age_groups': '18 to 40 years old', 'name': 'NCT01322568'}, {'nct_number': 'NCT00677885', 'title': 'P-glycoprotein Function in Brain Diseases', 'status': 'Completed', 'clean_age': '35 Years and older ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00677885', 'age_groups': '18 to 40 years old', 'name': 'NCT00677885'}, {'nct_number': 'NCT01565330', 'title': \"A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers\", 'status': 'Completed', 'clean_age': '35 Years and older ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01565330', 'age_groups': '18 to 40 years old', 'name': 'NCT01565330'}, {'nct_number': 'NCT01565343', 'title': \"A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers\", 'status': 'Completed', 'clean_age': '35 Years and older ', 'phases': 'Phase 1', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01565343', 'age_groups': '18 to 40 years old', 'name': 'NCT01565343'}, {'nct_number': 'NCT01565356', 'title': 'Evaluation of PET Scan Timing Relative to AV-45 Injection Time', 'status': 'Completed', 'clean_age': '35 Years and older ', 'phases': 'Not Applicable', 'enrollment': 41, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01565356', 'age_groups': '18 to 40 years old', 'name': 'NCT01565356'}, {'nct_number': 'NCT00937846', 'title': 'Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study', 'status': 'Completed', 'clean_age': '35 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 4, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00937846', 'age_groups': '18 to 40 years old', 'name': 'NCT00937846'}, {'nct_number': 'NCT01153802', 'title': 'An Open Label Positron Emission Tomography Study in Healthy Male Subjects to Investigate Brain DAT and SERT Occupancy,Pharmacokinetics and Safety of Single Oral Doses of GSK1360707, Using 11C- PE2I and 11C-DASB as PET Ligands', 'status': 'Completed', 'clean_age': '35 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01153802', 'age_groups': '18 to 40 years old', 'name': 'NCT01153802'}, {'nct_number': 'NCT00486044', 'title': \"Evaluating Simvastatin's Potential Role in Therapy\", 'status': 'Completed', 'clean_age': '35 Years to 69 Years ', 'phases': 'Phase 2', 'enrollment': 103, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00486044', 'age_groups': '18 to 40 years old', 'name': 'NCT00486044'}, {'nct_number': 'NCT01608217', 'title': 'Delta-THC in Dementia', 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01608217', 'age_groups': '18 to 40 years old', 'name': 'NCT01608217'}, {'nct_number': 'NCT02249403', 'title': 'Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type', 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 2', 'enrollment': 362, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02249403', 'age_groups': '18 to 40 years old', 'name': 'NCT02249403'}, {'nct_number': 'NCT00253214', 'title': \"Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation\", 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 3', 'enrollment': 973, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00253214', 'age_groups': '18 to 40 years old', 'name': 'NCT00253214'}, {'nct_number': 'NCT00880347', 'title': \"Blood Gene Expression Signature in Patients Diagnosed With Probable Alzheimer's Disease Compared to Patients Suffering From Other Types of Dementia\", 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Not Applicable', 'enrollment': 550, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00880347', 'age_groups': '18 to 40 years old', 'name': 'NCT00880347'}, {'nct_number': 'NCT00216593', 'title': \"Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study\", 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 3', 'enrollment': 415, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00216593', 'age_groups': '18 to 40 years old', 'name': 'NCT00216593'}, {'nct_number': 'NCT00235716', 'title': \"A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 3', 'enrollment': 613, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00235716', 'age_groups': '18 to 40 years old', 'name': 'NCT00235716'}, {'nct_number': 'NCT01320527', 'title': \"A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 2', 'enrollment': 135, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01320527', 'age_groups': '18 to 40 years old', 'name': 'NCT01320527'}, {'nct_number': 'NCT00645190', 'title': \"A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 3', 'enrollment': 215, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00645190', 'age_groups': '18 to 40 years old', 'name': 'NCT00645190'}, {'nct_number': 'NCT02708485', 'title': \"Effect of Walking on Brain Fuel Consumption in Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Not Applicable', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02708485', 'age_groups': '18 to 40 years old', 'name': 'NCT02708485'}, {'nct_number': 'NCT00245206', 'title': 'Side Effects of Newer Antipsychotics in Older Adults', 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 4', 'enrollment': 406, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00245206', 'age_groups': '18 to 40 years old', 'name': 'NCT00245206'}, {'nct_number': 'NCT00721383', 'title': 'Telephone Resources and Assistance for Caregivers (TRAC)', 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Not Applicable', 'enrollment': 211, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00721383', 'age_groups': '18 to 40 years old', 'name': 'NCT00721383'}, {'nct_number': 'NCT02886494', 'title': \"A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia\", 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02886494', 'age_groups': '18 to 40 years old', 'name': 'NCT02886494'}, {'nct_number': 'NCT02946710', 'title': \"P75NTR, Diagnostic Biomarker for Alzheimer's Disease: Quantification Study in Cerebrospinal Fluid\", 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02946710', 'age_groups': '18 to 40 years old', 'name': 'NCT02946710'}, {'nct_number': 'NCT00261573', 'title': 'A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia', 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 3', 'enrollment': 593, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00261573', 'age_groups': '18 to 40 years old', 'name': 'NCT00261573'}, {'nct_number': 'NCT01478633', 'title': \"Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil\", 'status': 'Completed', 'clean_age': '40 Years and older ', 'phases': 'Phase 4', 'enrollment': 102, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01478633', 'age_groups': '18 to 40 years old', 'name': 'NCT01478633'}, {'nct_number': 'NCT01194713', 'title': 'Effects of Sleep Deprivation on Cerebrospinal Fluid (CSF) Amyloid-beta (Aβ) Dynamics', 'status': 'Completed', 'clean_age': '40 Years to 60 Years ', 'phases': 'Not Applicable', 'enrollment': 26, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01194713', 'age_groups': '18 to 40 years old', 'name': 'NCT01194713'}, {'nct_number': 'NCT02290912', 'title': \"Gray Matters Alzheimer's Disease Prevention Intervention\", 'status': 'Completed', 'clean_age': '40 Years to 64 Years ', 'phases': 'Not Applicable', 'enrollment': 146, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02290912', 'age_groups': '18 to 40 years old', 'name': 'NCT02290912'}, {'nct_number': 'NCT02323217', 'title': 'I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers', 'status': 'Completed', 'clean_age': '40 Years to 65 Years ', 'phases': 'Early Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02323217', 'age_groups': '18 to 40 years old', 'name': 'NCT02323217'}, {'nct_number': 'NCT00751907', 'title': 'Cerebral and Peripheral Perfusion Pilot Study', 'status': 'Completed', 'clean_age': '40 Years to 65 Years ', 'phases': 'Phase 2', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00751907', 'age_groups': '18 to 40 years old', 'name': 'NCT00751907'}, {'nct_number': 'NCT00980785', 'title': \"Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's\", 'status': 'Completed', 'clean_age': '40 Years to 65 Years ', 'phases': 'Phase 4', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00980785', 'age_groups': '18 to 40 years old', 'name': 'NCT00980785'}, {'nct_number': 'NCT02537938', 'title': 'Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose)', 'status': 'Completed', 'clean_age': '40 Years to 65 Years ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02537938', 'age_groups': '18 to 40 years old', 'name': 'NCT02537938'}, {'nct_number': 'NCT00939822', 'title': \"Statin Effects on Beta-Amyloid and Cerebral Perfusion in Adults at Risk for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years to 72 Years ', 'phases': 'Phase 2', 'enrollment': 88, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00939822', 'age_groups': '18 to 40 years old', 'name': 'NCT00939822'}, {'nct_number': 'NCT01339195', 'title': 'Post-stroke Cognitive Impairment and Dementia', 'status': 'Completed', 'clean_age': '40 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 1635, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01339195', 'age_groups': '18 to 40 years old', 'name': 'NCT01339195'}, {'nct_number': 'NCT00545974', 'title': 'Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia', 'status': 'Completed', 'clean_age': '40 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 81, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00545974', 'age_groups': '18 to 40 years old', 'name': 'NCT00545974'}, {'nct_number': 'NCT00658125', 'title': \"Deep Brain Stimulation (DBS) for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00658125', 'age_groups': '18 to 40 years old', 'name': 'NCT00658125'}, {'nct_number': 'NCT00478491', 'title': \"fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 390, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00478491', 'age_groups': '18 to 40 years old', 'name': 'NCT00478491'}, {'nct_number': 'NCT00408525', 'title': \"Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 41, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00408525', 'age_groups': '18 to 40 years old', 'name': 'NCT00408525'}, {'nct_number': 'NCT01823666', 'title': 'Predicting the Conversion From Mild Cognitive Impairment to Dementia', 'status': 'Completed', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 250, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01823666', 'age_groups': '18 to 40 years old', 'name': 'NCT01823666'}, {'nct_number': 'NCT00153010', 'title': \"An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type\", 'status': 'Completed', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 430, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00153010', 'age_groups': '18 to 40 years old', 'name': 'NCT00153010'}, {'nct_number': 'NCT00733863', 'title': \"Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients.\", 'status': 'Completed', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 27, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00733863', 'age_groups': '18 to 40 years old', 'name': 'NCT00733863'}, {'nct_number': 'NCT00956410', 'title': \"To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients\", 'status': 'Completed', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00956410', 'age_groups': '18 to 40 years old', 'name': 'NCT00956410'}, {'nct_number': 'NCT00795418', 'title': \"Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients\", 'status': 'Completed', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 31, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00795418', 'age_groups': '18 to 40 years old', 'name': 'NCT00795418'}, {'nct_number': 'NCT00432081', 'title': \"Effect of Indomethacin on the Progression of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00432081', 'age_groups': '18 to 40 years old', 'name': 'NCT00432081'}, {'nct_number': 'NCT00165724', 'title': \"Alzheimer's Disease Long-term Follow-up Study (ALF Study)\", 'status': 'Completed', 'clean_age': '40 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 114, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00165724', 'age_groups': '18 to 40 years old', 'name': 'NCT00165724'}, {'nct_number': 'NCT02860338', 'title': 'COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE', 'status': 'Completed', 'clean_age': '40 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 900, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02860338', 'age_groups': '18 to 40 years old', 'name': 'NCT02860338'}, {'nct_number': 'NCT00065169', 'title': 'Delaying Alzheimer Disease Symptoms With Anti-Inflammatory Drugs', 'status': 'Completed', 'clean_age': '40 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 138, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00065169', 'age_groups': '18 to 40 years old', 'name': 'NCT00065169'}, {'nct_number': 'NCT00702780', 'title': \"Progression Delaying Effect of Escitalopram in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 74, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00702780', 'age_groups': '18 to 40 years old', 'name': 'NCT00702780'}, {'nct_number': 'NCT00267163', 'title': 'Brain Imaging and Mental Disorders of Aging Intervention', 'status': 'Completed', 'clean_age': '40 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 64, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00267163', 'age_groups': '18 to 40 years old', 'name': 'NCT00267163'}, {'nct_number': 'NCT03732053', 'title': 'The Effectiveness of Global Postural Reeducation on Alzheimer Disease Patients', 'status': 'Completed', 'clean_age': '40 Years to 95 Years ', 'phases': 'Not Applicable', 'enrollment': 135, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03732053', 'age_groups': '18 to 40 years old', 'name': 'NCT03732053'}, {'nct_number': 'NCT01928420', 'title': \"A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '40 Years to 95 Years ', 'phases': 'Phase 2', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01928420', 'age_groups': '18 to 40 years old', 'name': 'NCT01928420'}]}, {'name': 'Unknown status', 'children': [{'nct_number': 'NCT02695004', 'title': 'Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).', 'status': 'Unknown status', 'clean_age': '19 Years to 50 Years ', 'phases': 'Phase 1', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02695004', 'age_groups': '18 to 40 years old', 'name': 'NCT02695004'}, {'nct_number': 'NCT00927108', 'title': 'Rajavtihi Neuronal Adult Stem Cells Project', 'status': 'Unknown status', 'clean_age': '20 Years and older ', 'phases': 'Phase 2', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00927108', 'age_groups': '18 to 40 years old', 'name': 'NCT00927108'}, {'nct_number': 'NCT02820155', 'title': 'Phase I Single and Multiple Escalating Dose Study of RGN1016 in Healthy Male Subjects', 'status': 'Unknown status', 'clean_age': '20 Years to 45 Years ', 'phases': 'Phase 1', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02820155', 'age_groups': '18 to 40 years old', 'name': 'NCT02820155'}, {'nct_number': 'NCT00094913', 'title': \"PET Changes in Alzheimer's Disease (AD)\", 'status': 'Unknown status', 'clean_age': '20 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 105, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00094913', 'age_groups': '18 to 40 years old', 'name': 'NCT00094913'}, {'nct_number': 'NCT01322373', 'title': \"A Study of Alzheimer's Disease Using Magnetoencephalography (MEG) and the Synchronous Neural Interaction™ Test\", 'status': 'Unknown status', 'clean_age': '20 Years to 92 Years ', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01322373', 'age_groups': '18 to 40 years old', 'name': 'NCT01322373'}, {'nct_number': 'NCT02343757', 'title': \"Alzheimer's Disease Imaging With PET/MRI - Beta-amyloid\", 'status': 'Unknown status', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02343757', 'age_groups': '18 to 40 years old', 'name': 'NCT02343757'}, {'nct_number': 'NCT00965835', 'title': \"Amyloid Plaque and Tangle Imaging in Alzheimer's Disease and Down Syndrome\", 'status': 'Unknown status', 'clean_age': '21 Years and older ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00965835', 'age_groups': '18 to 40 years old', 'name': 'NCT00965835'}, {'nct_number': 'NCT01886820', 'title': 'A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology', 'status': 'Unknown status', 'clean_age': '21 Years and older ', 'phases': 'Phase 3', 'enrollment': 290, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01886820', 'age_groups': '18 to 40 years old', 'name': 'NCT01886820'}, {'nct_number': 'NCT02759887', 'title': \"Relationship Between Down Syndrome (DS) and Alzheimer's Disease (AD)\", 'status': 'Unknown status', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02759887', 'age_groups': '18 to 40 years old', 'name': 'NCT02759887'}, {'nct_number': 'NCT00438724', 'title': \"Couples Coping With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '21 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00438724', 'age_groups': '18 to 40 years old', 'name': 'NCT00438724'}, {'nct_number': 'NCT00409279', 'title': \"An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '21 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00409279', 'age_groups': '18 to 40 years old', 'name': 'NCT00409279'}, {'nct_number': 'NCT01871610', 'title': 'Amyloid Accumulation After Mild Traumatic Brain Injury', 'status': 'Unknown status', 'clean_age': '30 Years and older ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01871610', 'age_groups': '18 to 40 years old', 'name': 'NCT01871610'}, {'nct_number': 'NCT01089270', 'title': \"Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives\", 'status': 'Unknown status', 'clean_age': '30 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 80, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01089270', 'age_groups': '18 to 40 years old', 'name': 'NCT01089270'}, {'nct_number': 'NCT02397980', 'title': 'Intervention Programs for Decreasing Caregiver Burden in Caregivers of Patients With Dementia', 'status': 'Unknown status', 'clean_age': '30 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02397980', 'age_groups': '18 to 40 years old', 'name': 'NCT02397980'}, {'nct_number': 'NCT00811122', 'title': \"Biodistribution of 11C-PIB PET in Alzheimer's Disease, Frontotemporal Dementia, and Cognitively Normal Elderly\", 'status': 'Unknown status', 'clean_age': '30 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00811122', 'age_groups': '18 to 40 years old', 'name': 'NCT00811122'}, {'nct_number': 'NCT01378026', 'title': 'Study of the Role of G72 in Amyotrophic Lateral Sclerosis: Biomarker Discovery and Mechanism Investigation', 'status': 'Unknown status', 'clean_age': '32 Years to 87 Years ', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01378026', 'age_groups': '18 to 40 years old', 'name': 'NCT01378026'}, {'nct_number': 'NCT00142324', 'title': 'CALM-AD', 'status': 'Unknown status', 'clean_age': '40 Years and older ', 'phases': 'Phase 4', 'enrollment': 190, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00142324', 'age_groups': '18 to 40 years old', 'name': 'NCT00142324'}, {'nct_number': 'NCT02109705', 'title': 'Porphyromonas Gingivalis and Alzheimer`s Disease', 'status': 'Unknown status', 'clean_age': '40 Years to 70 Years ', 'phases': 'Phase 4', 'enrollment': 90, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02109705', 'age_groups': '18 to 40 years old', 'name': 'NCT02109705'}, {'nct_number': 'NCT01147679', 'title': \"Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls\", 'status': 'Unknown status', 'clean_age': '40 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 99, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01147679', 'age_groups': '18 to 40 years old', 'name': 'NCT01147679'}, {'nct_number': 'NCT03115814', 'title': \"Deep Brain Stimulation for Treatment of Severe Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '40 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 6, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03115814', 'age_groups': '18 to 40 years old', 'name': 'NCT03115814'}, {'nct_number': 'NCT02253043', 'title': \"The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Patients With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '40 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02253043', 'age_groups': '18 to 40 years old', 'name': 'NCT02253043'}, {'nct_number': 'NCT01089283', 'title': 'Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients With Different Genetic Characteristics', 'status': 'Unknown status', 'clean_age': '40 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 80, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01089283', 'age_groups': '18 to 40 years old', 'name': 'NCT01089283'}, {'nct_number': 'NCT02819700', 'title': 'Evaluation and Characterization of Behavioural Disorders and Dementias by the Behavioural Dysexecutive Syndrome Inventory (BDSI)', 'status': 'Unknown status', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 285, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02819700', 'age_groups': '18 to 40 years old', 'name': 'NCT02819700'}]}, {'name': 'Recruiting', 'children': [{'nct_number': 'NCT02585232', 'title': 'Optimizing Dementia Care', 'status': 'Recruiting', 'clean_age': '19 Years and older ', 'phases': 'Not Applicable', 'enrollment': 68, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02585232', 'age_groups': '18 to 40 years old', 'name': 'NCT02585232'}, {'nct_number': 'NCT03299062', 'title': 'Smell, Voice and Nasal Swabs as Markers for Neuro-degenerative Disorders', 'status': 'Recruiting', 'clean_age': '19 Years to 89 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03299062', 'age_groups': '18 to 40 years old', 'name': 'NCT03299062'}, {'nct_number': 'NCT03969732', 'title': 'Multimodal Biomarkers for Diagnosis and Prognosis in CAA', 'status': 'Recruiting', 'clean_age': '20 Years and older ', 'phases': 'Phase 3', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03969732', 'age_groups': '18 to 40 years old', 'name': 'NCT03969732'}, {'nct_number': 'NCT03378037', 'title': 'The Effects of Acupuncture on the Risk of AD After TBI', 'status': 'Recruiting', 'clean_age': '20 Years and older ', 'phases': 'Not Applicable', 'enrollment': 76, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03378037', 'age_groups': '18 to 40 years old', 'name': 'NCT03378037'}, {'nct_number': 'NCT03174938', 'title': 'The Swedish BioFINDER 2 Study', 'status': 'Recruiting', 'clean_age': '20 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 1505, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03174938', 'age_groups': '18 to 40 years old', 'name': 'NCT03174938'}, {'nct_number': 'NCT03283449', 'title': 'Tau PET Imaging in Atypical Dementias', 'status': 'Recruiting', 'clean_age': '20 Years to 100 Years ', 'phases': 'Phase 1', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03283449', 'age_groups': '18 to 40 years old', 'name': 'NCT03283449'}, {'nct_number': 'NCT03584568', 'title': 'Reappraising Intergeneration Relationships in Dementia Caregiving', 'status': 'Recruiting', 'clean_age': '20 Years to 60 Years ', 'phases': 'Not Applicable', 'enrollment': 154, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03584568', 'age_groups': '18 to 40 years old', 'name': 'NCT03584568'}, {'nct_number': 'NCT03052712', 'title': 'Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies', 'status': 'Recruiting', 'clean_age': '20 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 1170, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03052712', 'age_groups': '18 to 40 years old', 'name': 'NCT03052712'}, {'nct_number': 'NCT03112096', 'title': \"A Phase I [18F]THK-5351 Positron Emission Tomography Study in Healthy Subjects and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '20 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03112096', 'age_groups': '18 to 40 years old', 'name': 'NCT03112096'}, {'nct_number': 'NCT03389698', 'title': 'Developing Advanced Blood-Brain Barrier Permeability Imaging for Early AD', 'status': 'Recruiting', 'clean_age': '20 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03389698', 'age_groups': '18 to 40 years old', 'name': 'NCT03389698'}, {'nct_number': 'NCT03227185', 'title': 'Supporting Episodic Memory With Transcranial Direct Current Stimulation in Healthy Controls and Dementia Patients', 'status': 'Recruiting', 'clean_age': '20 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 110, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03227185', 'age_groups': '18 to 40 years old', 'name': 'NCT03227185'}, {'nct_number': 'NCT02915939', 'title': 'The Residential Care Transition Module', 'status': 'Recruiting', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02915939', 'age_groups': '18 to 40 years old', 'name': 'NCT02915939'}, {'nct_number': 'NCT03333252', 'title': \"A Non-pharmacological Intervention for Patients With Alzheimer's Disease and Family Caregivers (Care Partners Program)\", 'status': 'Recruiting', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 246, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03333252', 'age_groups': '18 to 40 years old', 'name': 'NCT03333252'}, {'nct_number': 'NCT03218982', 'title': 'Vietnamese Caregiver Intervention Study', 'status': 'Recruiting', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03218982', 'age_groups': '18 to 40 years old', 'name': 'NCT03218982'}, {'nct_number': 'NCT03244917', 'title': \"Trial to Reduce Antimicrobial Use In Nursing Home Residents With Alzheimer's Disease and Other Dementias\", 'status': 'Recruiting', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 410, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03244917', 'age_groups': '18 to 40 years old', 'name': 'NCT03244917'}, {'nct_number': 'NCT03100617', 'title': \"Alzheimer's Family Caregiver Intervention in Vietnam\", 'status': 'Recruiting', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03100617', 'age_groups': '18 to 40 years old', 'name': 'NCT03100617'}, {'nct_number': 'NCT02347202', 'title': 'Tools for Distance Delivery of an Evidence-based AD Family Caregiver Intervention', 'status': 'Recruiting', 'clean_age': '21 Years to 125 Years ', 'phases': 'Not Applicable', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02347202', 'age_groups': '18 to 40 years old', 'name': 'NCT02347202'}, {'nct_number': 'NCT02740634', 'title': \"Molecular and Structural Imaging in Atypical Alzheimer's Disease: A Longitudinal Study\", 'status': 'Recruiting', 'clean_age': '21 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02740634', 'age_groups': '18 to 40 years old', 'name': 'NCT02740634'}, {'nct_number': 'NCT03393546', 'title': \"Auricular Point Acupressure to Manage Pain in Patients With Alzheimer's Disease and Related Disorders\", 'status': 'Recruiting', 'clean_age': '21 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03393546', 'age_groups': '18 to 40 years old', 'name': 'NCT03393546'}, {'nct_number': 'NCT01778946', 'title': 'Nicotine Treatment of Cognitive Decline in Down Syndrome', 'status': 'Recruiting', 'clean_age': '25 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01778946', 'age_groups': '18 to 40 years old', 'name': 'NCT01778946'}, {'nct_number': 'NCT02928211', 'title': 'Aftobetin-HCl and Fluorescence Detection Measured by Sapphire II to Determine the Number and Timing of Administrations', 'status': 'Recruiting', 'clean_age': '25 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 105, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02928211', 'age_groups': '18 to 40 years old', 'name': 'NCT02928211'}, {'nct_number': 'NCT02471833', 'title': 'Health Evaluation in African Americans Using RAS Therapy', 'status': 'Recruiting', 'clean_age': '30 Years and older ', 'phases': 'Phase 1', 'enrollment': 66, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02471833', 'age_groups': '18 to 40 years old', 'name': 'NCT02471833'}, {'nct_number': 'NCT03451591', 'title': 'LACunar Intervention (LACI-2) Trial-2', 'status': 'Recruiting', 'clean_age': '30 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 400, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03451591', 'age_groups': '18 to 40 years old', 'name': 'NCT03451591'}, {'nct_number': 'NCT03371706', 'title': 'Communication Bridge: A Person-centered Internet-based Intervention for Individuals With Primary Progressive Aphasia', 'status': 'Recruiting', 'clean_age': '30 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03371706', 'age_groups': '18 to 40 years old', 'name': 'NCT03371706'}, {'nct_number': 'NCT03901456', 'title': 'Care to Plan: a Tailored Resource for Family Members of Persons With Dementia', 'status': 'Recruiting', 'clean_age': '30 Years to 70 Years ', 'phases': 'Not Applicable', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03901456', 'age_groups': '18 to 40 years old', 'name': 'NCT03901456'}, {'nct_number': 'NCT03388242', 'title': \"Protein and microRNA Markers for Early Detection of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '30 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03388242', 'age_groups': '18 to 40 years old', 'name': 'NCT03388242'}, {'nct_number': 'NCT03778151', 'title': 'Repetitive TMS of the Default Mode Network in AD', 'status': 'Recruiting', 'clean_age': '30 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03778151', 'age_groups': '18 to 40 years old', 'name': 'NCT03778151'}, {'nct_number': 'NCT03901261', 'title': \"Cohort Study of Adult Patients With Down Syndrome at Risk of Developing Alzheimer's Disease (TriAL21)\", 'status': 'Recruiting', 'clean_age': '35 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03901261', 'age_groups': '18 to 40 years old', 'name': 'NCT03901261'}, {'nct_number': 'NCT02675270', 'title': 'Rehabilitation and Prophylaxis of Anomia in Primary Progressive Aphasia', 'status': 'Recruiting', 'clean_age': '40 Years and older ', 'phases': 'Not Applicable', 'enrollment': 85, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02675270', 'age_groups': '18 to 40 years old', 'name': 'NCT02675270'}, {'nct_number': 'NCT03279523', 'title': 'F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected', 'status': 'Recruiting', 'clean_age': '40 Years and older ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03279523', 'age_groups': '18 to 40 years old', 'name': 'NCT03279523'}, {'nct_number': 'NCT03136679', 'title': \"Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '40 Years and older ', 'phases': 'Phase 4', 'enrollment': 220, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03136679', 'age_groups': '18 to 40 years old', 'name': 'NCT03136679'}, {'nct_number': 'NCT03811184', 'title': 'Validation of a Smartphone Application for the Assessment of Patients With Mild Cognitive Impairment: MemScreen', 'status': 'Recruiting', 'clean_age': '40 Years and older ', 'phases': 'Phase 4', 'enrollment': 400, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03811184', 'age_groups': '18 to 40 years old', 'name': 'NCT03811184'}, {'nct_number': 'NCT03507257', 'title': \"Longitudinal Early-onset Alzheimer's Disease Study Protocol\", 'status': 'Recruiting', 'clean_age': '40 Years to 64 Years ', 'phases': 'Phase 4', 'enrollment': 600, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03507257', 'age_groups': '18 to 40 years old', 'name': 'NCT03507257'}, {'nct_number': 'NCT03746366', 'title': '[C-11]PiB PET Imaging in Alcohol Use Disorders', 'status': 'Recruiting', 'clean_age': '40 Years to 65 Years ', 'phases': 'Early Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03746366', 'age_groups': '18 to 40 years old', 'name': 'NCT03746366'}, {'nct_number': 'NCT03240406', 'title': 'Multicultural Healthy Diet to Reduce Cognitive Decline', 'status': 'Recruiting', 'clean_age': '40 Years to 65 Years ', 'phases': 'Not Applicable', 'enrollment': 326, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03240406', 'age_groups': '18 to 40 years old', 'name': 'NCT03240406'}, {'nct_number': 'NCT03645993', 'title': \"Early Onset Alzheimer's Disease Genomic Study\", 'status': 'Recruiting', 'clean_age': '40 Years to 65 Years ', 'phases': 'Phase 4', 'enrollment': 2, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03645993', 'age_groups': '18 to 40 years old', 'name': 'NCT03645993'}, {'nct_number': 'NCT02832921', 'title': 'Cognitive-motor Intervention Using Virtual Reality for Middle-aged Individuals at High Dementia Risk', 'status': 'Recruiting', 'clean_age': '40 Years to 65 Years ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02832921', 'age_groups': '18 to 40 years old', 'name': 'NCT02832921'}, {'nct_number': 'NCT02656498', 'title': \"[18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease\", 'status': 'Recruiting', 'clean_age': '40 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02656498', 'age_groups': '18 to 40 years old', 'name': 'NCT02656498'}, {'nct_number': 'NCT03510572', 'title': 'Evaluation of [18F]PI-2620 as a Potential Positron Emission Computed Tomography Radioligand for Imaging Tau Protein in the Brain', 'status': 'Recruiting', 'clean_age': '40 Years to 80 Years ', 'phases': 'Early Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03510572', 'age_groups': '18 to 40 years old', 'name': 'NCT03510572'}, {'nct_number': 'NCT02811653', 'title': \"Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '40 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 155, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02811653', 'age_groups': '18 to 40 years old', 'name': 'NCT02811653'}, {'nct_number': 'NCT03381482', 'title': 'Ectosomes, New Biomarkers of Tau Pathology?', 'status': 'Recruiting', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03381482', 'age_groups': '18 to 40 years old', 'name': 'NCT03381482'}, {'nct_number': 'NCT03153371', 'title': \"Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks\", 'status': 'Recruiting', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 180, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03153371', 'age_groups': '18 to 40 years old', 'name': 'NCT03153371'}, {'nct_number': 'NCT03663387', 'title': \"PET Measures of CSF Clearance in Preclinical Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '40 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 136, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03663387', 'age_groups': '18 to 40 years old', 'name': 'NCT03663387'}, {'nct_number': 'NCT03030586', 'title': 'ADDIA Proof-of-Performance Clinical Study', 'status': 'Recruiting', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 800, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03030586', 'age_groups': '18 to 40 years old', 'name': 'NCT03030586'}, {'nct_number': 'NCT03903211', 'title': \"Longitudinal Changes of [18F]PI-2620 Positron Emission Tomography in Subjects With Cognitively Normal, Mild Cognitive Impairment and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03903211', 'age_groups': '18 to 40 years old', 'name': 'NCT03903211'}, {'nct_number': 'NCT03305809', 'title': \"A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)\", 'status': 'Recruiting', 'clean_age': '40 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 340, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03305809', 'age_groups': '18 to 40 years old', 'name': 'NCT03305809'}, {'nct_number': 'NCT01330160', 'title': 'Study of Factors Influencing Post-stroke Dementia', 'status': 'Recruiting', 'clean_age': '40 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 1100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01330160', 'age_groups': '18 to 40 years old', 'name': 'NCT01330160'}]}, {'name': 'Terminated', 'children': [{'nct_number': 'NCT02614131', 'title': \"A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)\", 'status': 'Terminated', 'clean_age': '20 Years and older ', 'phases': 'Phase 1', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02614131', 'age_groups': '18 to 40 years old', 'name': 'NCT02614131'}, {'nct_number': 'NCT01867372', 'title': \"Early Markers of Alzheimer's Disease: Structural and Functional Brain Changes\", 'status': 'Terminated', 'clean_age': '20 Years and older ', 'phases': 'Phase 4', 'enrollment': 213, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01867372', 'age_groups': '18 to 40 years old', 'name': 'NCT01867372'}, {'nct_number': 'NCT00713765', 'title': 'Pharmacokinetic Interaction Between AZD3480 and Donepezil', 'status': 'Terminated', 'clean_age': '20 Years to 60 Years ', 'phases': 'Phase 1', 'enrollment': 33, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00713765', 'age_groups': '18 to 40 years old', 'name': 'NCT00713765'}, {'nct_number': 'NCT02149017', 'title': 'Phase 1 and Phase 2 Clinical Trials of SNUBH-NM-333(18F)', 'status': 'Terminated', 'clean_age': '20 Years to 80 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02149017', 'age_groups': '18 to 40 years old', 'name': 'NCT02149017'}, {'nct_number': 'NCT00548145', 'title': \"The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '20 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00548145', 'age_groups': '18 to 40 years old', 'name': 'NCT00548145'}, {'nct_number': 'NCT01772537', 'title': 'The Effects of Anesthesia on Patients Undergoing Surgery for Repair of a Thoracoabdominal Aneurysm.', 'status': 'Terminated', 'clean_age': '21 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01772537', 'age_groups': '18 to 40 years old', 'name': 'NCT01772537'}, {'nct_number': 'NCT00612872', 'title': 'Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects', 'status': 'Terminated', 'clean_age': '30 Years to 50 Years ', 'phases': 'Phase 1', 'enrollment': 46, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00612872', 'age_groups': '18 to 40 years old', 'name': 'NCT00612872'}, {'nct_number': 'NCT01924858', 'title': 'A Positron Emission Tomography (PET) Study to Investigate the Brain Biodistribution of 18F GSK2647544 in Healthy Subjects to Determine Its Ability to Cross the Blood-brain-barrier.', 'status': 'Terminated', 'clean_age': '30 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 4, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01924858', 'age_groups': '18 to 40 years old', 'name': 'NCT01924858'}, {'nct_number': 'NCT00777361', 'title': 'Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers', 'status': 'Terminated', 'clean_age': '35 Years to 65 Years ', 'phases': 'Phase 1', 'enrollment': 9, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00777361', 'age_groups': '18 to 40 years old', 'name': 'NCT00777361'}, {'nct_number': 'NCT02249351', 'title': 'Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type', 'status': 'Terminated', 'clean_age': '40 Years and older ', 'phases': 'Phase 2', 'enrollment': 54, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02249351', 'age_groups': '18 to 40 years old', 'name': 'NCT02249351'}, {'nct_number': 'NCT01553929', 'title': 'Physical Training and Cognitive Activity on the Mild Cognitive Impairment (MCI) Patient', 'status': 'Terminated', 'clean_age': '40 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01553929', 'age_groups': '18 to 40 years old', 'name': 'NCT01553929'}, {'nct_number': 'NCT00369603', 'title': \"Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients\", 'status': 'Terminated', 'clean_age': '40 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 4, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00369603', 'age_groups': '18 to 40 years old', 'name': 'NCT00369603'}]}, {'name': 'Not yet recruiting', 'children': [{'nct_number': 'NCT03802162', 'title': 'A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355', 'status': 'Not yet recruiting', 'clean_age': '19 Years to 55 Years ', 'phases': 'Phase 1', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03802162', 'age_groups': '18 to 40 years old', 'name': 'NCT03802162'}, {'nct_number': 'NCT04025801', 'title': 'Heidelberg In Vivo Confocal Microscopy to Evaluate the Ocular Surface Disorders of Healthy and Diseased Individuals', 'status': 'Not yet recruiting', 'clean_age': '20 Years to 40 Years ', 'phases': 'Phase 4', 'enrollment': 400, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04025801', 'age_groups': '18 to 40 years old', 'name': 'NCT04025801'}, {'nct_number': 'NCT02741505', 'title': 'Brain Sleep Deprivation MRI Effects (BEDTIME)', 'status': 'Not yet recruiting', 'clean_age': '21 Years to 30 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02741505', 'age_groups': '18 to 40 years old', 'name': 'NCT02741505'}, {'nct_number': 'NCT03360019', 'title': 'Accurate WiFi-Based Localization of Dementia Patients For Caregiver Support:', 'status': 'Not yet recruiting', 'clean_age': '21 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 187, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03360019', 'age_groups': '18 to 40 years old', 'name': 'NCT03360019'}, {'nct_number': 'NCT03977584', 'title': \"Tau Positron Emission Tomography (PET) Longitudinal Substudy Associated With: Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers in the Treatment of Autosomal-Dominant Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '30 Years to 60 Years ', 'phases': 'Phase 2', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03977584', 'age_groups': '18 to 40 years old', 'name': 'NCT03977584'}, {'nct_number': 'NCT04124029', 'title': \"Contributions of mTBI to Neurodegeneration Due to CTE and Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '30 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 800, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04124029', 'age_groups': '18 to 40 years old', 'name': 'NCT04124029'}, {'nct_number': 'NCT04080544', 'title': \"Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study\", 'status': 'Not yet recruiting', 'clean_age': '38 Years to 96 Years ', 'phases': 'Phase 2', 'enrollment': 125, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04080544', 'age_groups': '18 to 40 years old', 'name': 'NCT04080544'}, {'nct_number': 'NCT03631069', 'title': 'Detecting Dementia in the Retina Using Optical Coherence Tomography', 'status': 'Not yet recruiting', 'clean_age': '40 Years and older ', 'phases': 'Phase 4', 'enrollment': 200000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03631069', 'age_groups': '18 to 40 years old', 'name': 'NCT03631069'}, {'nct_number': 'NCT04073225', 'title': 'Optimizing Cognitive, Environmental, and Neuromotor Stimulation in Traumatic Brain Injury', 'status': 'Not yet recruiting', 'clean_age': '40 Years and older ', 'phases': 'Not Applicable', 'enrollment': 66, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04073225', 'age_groups': '18 to 40 years old', 'name': 'NCT04073225'}, {'nct_number': 'NCT04002583', 'title': \"48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '40 Years to 64 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04002583', 'age_groups': '18 to 40 years old', 'name': 'NCT04002583'}, {'nct_number': 'NCT03865017', 'title': 'A Safety and Tolerability Study of GB301', 'status': 'Not yet recruiting', 'clean_age': '40 Years to 72 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03865017', 'age_groups': '18 to 40 years old', 'name': 'NCT03865017'}]}, {'name': 'Active, not recruiting', 'children': [{'nct_number': 'NCT02137460', 'title': \"Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '20 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 920, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02137460', 'age_groups': '18 to 40 years old', 'name': 'NCT02137460'}, {'nct_number': 'NCT03665909', 'title': 'A Proactive Health Monitoring Intervention for Dementia Caregivers', 'status': 'Active, not recruiting', 'clean_age': '21 Years and older ', 'phases': 'Phase 3', 'enrollment': 170, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03665909', 'age_groups': '18 to 40 years old', 'name': 'NCT03665909'}, {'nct_number': 'NCT03282877', 'title': 'iCST Web-application for People With Dementia', 'status': 'Active, not recruiting', 'clean_age': '21 Years and older ', 'phases': 'Not Applicable', 'enrollment': 43, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03282877', 'age_groups': '18 to 40 years old', 'name': 'NCT03282877'}, {'nct_number': 'NCT01998841', 'title': \"A Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer's Disease (AD), Including a Placebo-Treated Non-Carrier Cohort\", 'status': 'Active, not recruiting', 'clean_age': '30 Years to 60 Years ', 'phases': 'Phase 2', 'enrollment': 252, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01998841', 'age_groups': '18 to 40 years old', 'name': 'NCT01998841'}, {'nct_number': 'NCT02474251', 'title': 'Brain Sleep Clearance of Amyloid-Beta Peptides', 'status': 'Active, not recruiting', 'clean_age': '30 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02474251', 'age_groups': '18 to 40 years old', 'name': 'NCT02474251'}, {'nct_number': 'NCT03794141', 'title': 'Genetic Information as a Life Style Change Motivator', 'status': 'Active, not recruiting', 'clean_age': '40 Years to 60 Years ', 'phases': 'Not Applicable', 'enrollment': 333, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03794141', 'age_groups': '18 to 40 years old', 'name': 'NCT03794141'}]}, {'name': 'Enrolling by invitation', 'children': [{'nct_number': 'NCT03587012', 'title': 'Brain Fitness APP for Cognitive Enhancement', 'status': 'Enrolling by invitation', 'clean_age': '20 Years to 95 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03587012', 'age_groups': '18 to 40 years old', 'name': 'NCT03587012'}, {'nct_number': 'NCT02440646', 'title': 'Natural History of Atherosclerosis in Real-World Patients Underwent Computed Tomography Angiography', 'status': 'Enrolling by invitation', 'clean_age': '21 Years and older ', 'phases': 'Phase 4', 'enrollment': 1080, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02440646', 'age_groups': '18 to 40 years old', 'name': 'NCT02440646'}, {'nct_number': 'NCT03618186', 'title': 'Tau PET Imaging in African Americans', 'status': 'Enrolling by invitation', 'clean_age': '30 Years and older ', 'phases': 'Phase 2', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03618186', 'age_groups': '18 to 40 years old', 'name': 'NCT03618186'}, {'nct_number': 'NCT00950430', 'title': 'Imaging of Brain Amyloid Plaques in the Aging Population', 'status': 'Enrolling by invitation', 'clean_age': '30 Years to 100 Years ', 'phases': 'Phase 4', 'enrollment': 2500, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00950430', 'age_groups': '18 to 40 years old', 'name': 'NCT00950430'}]}, {'name': 'Withdrawn', 'children': [{'nct_number': 'NCT02467413', 'title': \"BAC in Patient With Alzheimer's Disease or Vascular Dementia\", 'status': 'Withdrawn', 'clean_age': '40 Years and older ', 'phases': 'Phase 2', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02467413', 'age_groups': '18 to 40 years old', 'name': 'NCT02467413'}, {'nct_number': 'NCT02667496', 'title': \"Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '40 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02667496', 'age_groups': '18 to 40 years old', 'name': 'NCT02667496'}]}, {'name': 'Suspended', 'children': []}]}, {'name': '40 to 65 years old', 'children': [{'name': 'Completed', 'children': [{'nct_number': 'NCT00814801', 'title': \"An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Phase 3', 'enrollment': 580, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00814801', 'age_groups': '40 to 65 years old', 'name': 'NCT00814801'}, {'nct_number': 'NCT01724151', 'title': 'Effects of Exercise Training in Patients With Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01724151', 'age_groups': '40 to 65 years old', 'name': 'NCT01724151'}, {'nct_number': 'NCT01890343', 'title': \"Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.\", 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Phase 2', 'enrollment': 34, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01890343', 'age_groups': '40 to 65 years old', 'name': 'NCT01890343'}, {'nct_number': 'NCT01660815', 'title': 'A Study of Florbetapir (18F) in Japanese Healthy Volunteers', 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Phase 1', 'enrollment': 7, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01660815', 'age_groups': '40 to 65 years old', 'name': 'NCT01660815'}, {'nct_number': 'NCT01779310', 'title': \"Clinical Pathway for Alzheimer's Disease in China (CPAD)\", 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Phase 4', 'enrollment': 1024, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01779310', 'age_groups': '40 to 65 years old', 'name': 'NCT01779310'}, {'nct_number': 'NCT00338117', 'title': \"Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Phase 3', 'enrollment': 554, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00338117', 'age_groups': '40 to 65 years old', 'name': 'NCT00338117'}, {'nct_number': 'NCT02213458', 'title': 'Care Ecosystem: Navigating Patients and Families Through Stages of Care', 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Not Applicable', 'enrollment': 780, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02213458', 'age_groups': '40 to 65 years old', 'name': 'NCT02213458'}, {'nct_number': 'NCT00301574', 'title': \"An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease.\", 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Phase 3', 'enrollment': 398, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00301574', 'age_groups': '40 to 65 years old', 'name': 'NCT00301574'}, {'nct_number': 'NCT03290326', 'title': \"tACS for Amyloid-β Reduction in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Not Applicable', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03290326', 'age_groups': '40 to 65 years old', 'name': 'NCT03290326'}, {'nct_number': 'NCT00955422', 'title': \"Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Phase 4', 'enrollment': 197, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00955422', 'age_groups': '40 to 65 years old', 'name': 'NCT00955422'}, {'nct_number': 'NCT00304629', 'title': \"Long-term Safety and Efficacy of Galantamine in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Phase 3', 'enrollment': 241, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00304629', 'age_groups': '40 to 65 years old', 'name': 'NCT00304629'}, {'nct_number': 'NCT01314950', 'title': \"Alzheimer's Disease Multiple Intervention Trial\", 'status': 'Completed', 'clean_age': '45 Years and older ', 'phases': 'Not Applicable', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01314950', 'age_groups': '40 to 65 years old', 'name': 'NCT01314950'}, {'nct_number': 'NCT01142336', 'title': 'Effects of Simvastatin on Biomarkers', 'status': 'Completed', 'clean_age': '45 Years to 64 Years ', 'phases': 'Phase 4', 'enrollment': 49, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01142336', 'age_groups': '40 to 65 years old', 'name': 'NCT01142336'}, {'nct_number': 'NCT03411291', 'title': 'Statins in Cerebral Blood Flow and Neuronal Activity--A Pilot Study', 'status': 'Completed', 'clean_age': '45 Years to 65 Years ', 'phases': 'Phase 4', 'enrollment': 18, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03411291', 'age_groups': '40 to 65 years old', 'name': 'NCT03411291'}, {'nct_number': 'NCT03117829', 'title': 'Study: Diet and Exercise Study to Improve Brain Blood Flow: Blood Flow Improvement Trial', 'status': 'Completed', 'clean_age': '45 Years to 65 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03117829', 'age_groups': '40 to 65 years old', 'name': 'NCT03117829'}, {'nct_number': 'NCT02463084', 'title': \"Macronutrient Effects on Alzheimer's Disease (MEAL-2)\", 'status': 'Completed', 'clean_age': '45 Years to 65 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02463084', 'age_groups': '40 to 65 years old', 'name': 'NCT02463084'}, {'nct_number': 'NCT02289118', 'title': 'Tau Imaging in Young Onset Dementia', 'status': 'Completed', 'clean_age': '45 Years to 70 Years ', 'phases': 'Phase 4', 'enrollment': 16, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02289118', 'age_groups': '40 to 65 years old', 'name': 'NCT02289118'}, {'nct_number': 'NCT02198586', 'title': 'Apoe Impact Study on Brain Structure and Function, in a Population 45 to 75 Years Old', 'status': 'Completed', 'clean_age': '45 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 575, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02198586', 'age_groups': '40 to 65 years old', 'name': 'NCT02198586'}, {'nct_number': 'NCT01746498', 'title': 'Therapeutic Effect of Direct Current Stimulation on Cognitive Function of Mild to Moderate Alzheimer Patients', 'status': 'Completed', 'clean_age': '45 Years to 79 Years ', 'phases': 'Not Applicable', 'enrollment': 33, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01746498', 'age_groups': '40 to 65 years old', 'name': 'NCT01746498'}, {'nct_number': 'NCT02384993', 'title': 'aeRobic Exercise and Cognitive Health', 'status': 'Completed', 'clean_age': '45 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02384993', 'age_groups': '40 to 65 years old', 'name': 'NCT02384993'}, {'nct_number': 'NCT03918616', 'title': 'P2X7 Receptor, Inflammation and Neurodegenerative Diseases', 'status': 'Completed', 'clean_age': '45 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03918616', 'age_groups': '40 to 65 years old', 'name': 'NCT03918616'}, {'nct_number': 'NCT02119546', 'title': \"Effects of Exercise Training in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02119546', 'age_groups': '40 to 65 years old', 'name': 'NCT02119546'}, {'nct_number': 'NCT01661673', 'title': \"Safety, Tolerability, Pharmacokinetics of EVP-0962 and Effects of EVP-0962 on Cerebral Spinal Fluid Amyloid Concentrations in Healthy Subjects and in Subjects With Mild Cognitive Impairment or Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 52, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01661673', 'age_groups': '40 to 65 years old', 'name': 'NCT01661673'}, {'nct_number': 'NCT02910739', 'title': 'An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)', 'status': 'Completed', 'clean_age': '45 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02910739', 'age_groups': '40 to 65 years old', 'name': 'NCT02910739'}, {'nct_number': 'NCT00006399', 'title': \"Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00006399', 'age_groups': '40 to 65 years old', 'name': 'NCT00006399'}, {'nct_number': 'NCT01559220', 'title': \"Deep Brain Stimulation for the Treatment of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 3, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01559220', 'age_groups': '40 to 65 years old', 'name': 'NCT01559220'}, {'nct_number': 'NCT02097056', 'title': \"Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 171, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02097056', 'age_groups': '40 to 65 years old', 'name': 'NCT02097056'}, {'nct_number': 'NCT00478205', 'title': \"Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 1467, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00478205', 'age_groups': '40 to 65 years old', 'name': 'NCT00478205'}, {'nct_number': 'NCT00104273', 'title': \"Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '45 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 376, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00104273', 'age_groups': '40 to 65 years old', 'name': 'NCT00104273'}, {'nct_number': 'NCT02550665', 'title': 'Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23mg', 'status': 'Completed', 'clean_age': '45 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 176, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02550665', 'age_groups': '40 to 65 years old', 'name': 'NCT02550665'}, {'nct_number': 'NCT00566501', 'title': \"Open-Label Extension Study of 23 mg Donepezil SR in Patients With Moderate to Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '45 Years to 91 Years ', 'phases': 'Phase 3', 'enrollment': 915, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00566501', 'age_groups': '40 to 65 years old', 'name': 'NCT00566501'}, {'nct_number': 'NCT00088751', 'title': 'Treatment Study of Frontotemporal Dementia', 'status': 'Completed', 'clean_age': '45 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00088751', 'age_groups': '40 to 65 years old', 'name': 'NCT00088751'}, {'nct_number': 'NCT01047579', 'title': \"A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 51, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01047579', 'age_groups': '40 to 65 years old', 'name': 'NCT01047579'}, {'nct_number': 'NCT00556660', 'title': 'Evaluation of [123I] AV51 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00556660', 'age_groups': '40 to 65 years old', 'name': 'NCT00556660'}, {'nct_number': 'NCT01504854', 'title': \"Resveratrol for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 119, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01504854', 'age_groups': '40 to 65 years old', 'name': 'NCT01504854'}, {'nct_number': 'NCT01594346', 'title': 'Multicenter Vitamin E Trial in Aging Persons With Down Syndrome', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 349, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01594346', 'age_groups': '40 to 65 years old', 'name': 'NCT01594346'}, {'nct_number': 'NCT00480701', 'title': 'Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheimer Disease', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 26, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00480701', 'age_groups': '40 to 65 years old', 'name': 'NCT00480701'}, {'nct_number': 'NCT00104013', 'title': \"Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 1455, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00104013', 'age_groups': '40 to 65 years old', 'name': 'NCT00104013'}, {'nct_number': 'NCT00103649', 'title': \"18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 1306, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00103649', 'age_groups': '40 to 65 years old', 'name': 'NCT00103649'}, {'nct_number': 'NCT03019536', 'title': \"A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03019536', 'age_groups': '40 to 65 years old', 'name': 'NCT03019536'}, {'nct_number': 'NCT02017340', 'title': \"A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 511, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02017340', 'age_groups': '40 to 65 years old', 'name': 'NCT02017340'}, {'nct_number': 'NCT00702143', 'title': \"A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 184, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00702143', 'age_groups': '40 to 65 years old', 'name': 'NCT00702143'}, {'nct_number': 'NCT00322153', 'title': \"A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 677, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00322153', 'age_groups': '40 to 65 years old', 'name': 'NCT00322153'}, {'nct_number': 'NCT00216502', 'title': \"A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 254, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00216502', 'age_groups': '40 to 65 years old', 'name': 'NCT00216502'}, {'nct_number': 'NCT01539031', 'title': \"Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 351, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01539031', 'age_groups': '40 to 65 years old', 'name': 'NCT01539031'}, {'nct_number': 'NCT00711139', 'title': 'Long-term Safety and Tolerability of AFFITOPE AD01', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 22, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00711139', 'age_groups': '40 to 65 years old', 'name': 'NCT00711139'}, {'nct_number': 'NCT00096473', 'title': \"Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 229, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00096473', 'age_groups': '40 to 65 years old', 'name': 'NCT00096473'}, {'nct_number': 'NCT01841125', 'title': \"Escitalopram for the Treatment of Depression in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 84, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01841125', 'age_groups': '40 to 65 years old', 'name': 'NCT01841125'}, {'nct_number': 'NCT00829816', 'title': 'Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 46, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00829816', 'age_groups': '40 to 65 years old', 'name': 'NCT00829816'}, {'nct_number': 'NCT01696123', 'title': 'Efficacy and Tolerability of MLC601 in Patients With Mild to Moderate Alzheimer Disease Who Were Unable to Tolerate or Failed to Benefit From Treatment With Rivastigmine', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 125, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01696123', 'age_groups': '40 to 65 years old', 'name': 'NCT01696123'}, {'nct_number': 'NCT00287248', 'title': 'Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00287248', 'age_groups': '40 to 65 years old', 'name': 'NCT00287248'}, {'nct_number': 'NCT00120874', 'title': \"Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00120874', 'age_groups': '40 to 65 years old', 'name': 'NCT00120874'}, {'nct_number': 'NCT00216515', 'title': 'The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 102, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00216515', 'age_groups': '40 to 65 years old', 'name': 'NCT00216515'}, {'nct_number': 'NCT03118947', 'title': \"A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 79, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03118947', 'age_groups': '40 to 65 years old', 'name': 'NCT03118947'}, {'nct_number': 'NCT01019421', 'title': \"Lu AE58054 Added to Donepezil for the Treatment for Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 278, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01019421', 'age_groups': '40 to 65 years old', 'name': 'NCT01019421'}, {'nct_number': 'NCT02727699', 'title': 'A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 186, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02727699', 'age_groups': '40 to 65 years old', 'name': 'NCT02727699'}, {'nct_number': 'NCT00051909', 'title': \"Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00051909', 'age_groups': '40 to 65 years old', 'name': 'NCT00051909'}, {'nct_number': 'NCT01662882', 'title': \"A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01662882', 'age_groups': '40 to 65 years old', 'name': 'NCT01662882'}, {'nct_number': 'NCT00829374', 'title': \"Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 1003, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00829374', 'age_groups': '40 to 65 years old', 'name': 'NCT00829374'}, {'nct_number': 'NCT01503944', 'title': 'A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01503944', 'age_groups': '40 to 65 years old', 'name': 'NCT01503944'}, {'nct_number': 'NCT00675623', 'title': \"A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 598, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00675623', 'age_groups': '40 to 65 years old', 'name': 'NCT00675623'}, {'nct_number': 'NCT00749216', 'title': \"Solanezumab Safety Study in Japanese Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 33, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00749216', 'age_groups': '40 to 65 years old', 'name': 'NCT00749216'}, {'nct_number': 'NCT00230568', 'title': \"EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00230568', 'age_groups': '40 to 65 years old', 'name': 'NCT00230568'}, {'nct_number': 'NCT00804271', 'title': \"Memantine and Validation of a New Alzheimer's Disease Scale\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 487, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00804271', 'age_groups': '40 to 65 years old', 'name': 'NCT00804271'}, {'nct_number': 'NCT00377715', 'title': \"Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 183, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00377715', 'age_groups': '40 to 65 years old', 'name': 'NCT00377715'}, {'nct_number': 'NCT00380302', 'title': \"Activity of AVE1625 in Mild to Moderate Alzheimer's Patients.\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 162, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00380302', 'age_groups': '40 to 65 years old', 'name': 'NCT00380302'}, {'nct_number': 'NCT01565382', 'title': \"Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01565382', 'age_groups': '40 to 65 years old', 'name': 'NCT01565382'}, {'nct_number': 'NCT02624778', 'title': \"A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 61, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02624778', 'age_groups': '40 to 65 years old', 'name': 'NCT02624778'}, {'nct_number': 'NCT00954538', 'title': 'Safety, Radiation Dosimetry, Biokinetics, and Effectiveness of [18F]MK3328 (MK-3328-001)', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00954538', 'age_groups': '40 to 65 years old', 'name': 'NCT00954538'}, {'nct_number': 'NCT00024531', 'title': \"Lipitor as a Treatment for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 98, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00024531', 'age_groups': '40 to 65 years old', 'name': 'NCT00024531'}, {'nct_number': 'NCT00285025', 'title': \"Study of the Effect of SR57667B in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 500, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00285025', 'age_groups': '40 to 65 years old', 'name': 'NCT00285025'}, {'nct_number': 'NCT00842673', 'title': \"Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 168, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00842673', 'age_groups': '40 to 65 years old', 'name': 'NCT00842673'}, {'nct_number': 'NCT00453544', 'title': \"Enhancing Consent for Alzheimer's Research\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 252, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00453544', 'age_groups': '40 to 65 years old', 'name': 'NCT00453544'}, {'nct_number': 'NCT01565291', 'title': \"A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly Volunteers\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01565291', 'age_groups': '40 to 65 years old', 'name': 'NCT01565291'}, {'nct_number': 'NCT00711321', 'title': 'Long-term Safety and Tolerability of AFFITOPE AD02', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 23, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00711321', 'age_groups': '40 to 65 years old', 'name': 'NCT00711321'}, {'nct_number': 'NCT00692588', 'title': \"MRI to Measure Treatment With Antibiotics in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 58, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00692588', 'age_groups': '40 to 65 years old', 'name': 'NCT00692588'}, {'nct_number': 'NCT01723826', 'title': \"A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 360, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01723826', 'age_groups': '40 to 65 years old', 'name': 'NCT01723826'}, {'nct_number': 'NCT00285077', 'title': \"Long-Term Safety Extension With SR57667B in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 390, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00285077', 'age_groups': '40 to 65 years old', 'name': 'NCT00285077'}, {'nct_number': 'NCT00236431', 'title': 'A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 1063, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00236431', 'age_groups': '40 to 65 years old', 'name': 'NCT00236431'}, {'nct_number': 'NCT00622713', 'title': \"A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA)\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 228, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00622713', 'age_groups': '40 to 65 years old', 'name': 'NCT00622713'}, {'nct_number': 'NCT00889603', 'title': 'Non-Interventional Study With Aricept® Evess', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 370, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00889603', 'age_groups': '40 to 65 years old', 'name': 'NCT00889603'}, {'nct_number': 'NCT00867828', 'title': \"Neptune Krill Oil (NKO™) in Early Stage Alzheimer's Disease (MNEMOSYNE)\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 175, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00867828', 'age_groups': '40 to 65 years old', 'name': 'NCT00867828'}, {'nct_number': 'NCT00982202', 'title': 'Pioglitazone in Alzheimer Disease', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00982202', 'age_groups': '40 to 65 years old', 'name': 'NCT00982202'}, {'nct_number': 'NCT01009255', 'title': \"Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 196, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01009255', 'age_groups': '40 to 65 years old', 'name': 'NCT01009255'}, {'nct_number': 'NCT03447613', 'title': 'Retinal Nerve Fiber Layer Thickness and Cerebrospinal Fluid Aβ/Tau', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 86, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03447613', 'age_groups': '40 to 65 years old', 'name': 'NCT03447613'}, {'nct_number': 'NCT01420315', 'title': \"The Prevalence of Vitamin D Deficiency in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 502, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01420315', 'age_groups': '40 to 65 years old', 'name': 'NCT01420315'}, {'nct_number': 'NCT01992380', 'title': 'A Study of 18F-AV-1451 in Healthy Volunteers and Cognitively Impaired Subjects', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01992380', 'age_groups': '40 to 65 years old', 'name': 'NCT01992380'}, {'nct_number': 'NCT00053599', 'title': \"Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 400, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00053599', 'age_groups': '40 to 65 years old', 'name': 'NCT00053599'}, {'nct_number': 'NCT01009476', 'title': \"Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 1134, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01009476', 'age_groups': '40 to 65 years old', 'name': 'NCT01009476'}, {'nct_number': 'NCT01230853', 'title': 'A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01230853', 'age_groups': '40 to 65 years old', 'name': 'NCT01230853'}, {'nct_number': 'NCT00857506', 'title': 'Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 152, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00857506', 'age_groups': '40 to 65 years old', 'name': 'NCT00857506'}, {'nct_number': 'NCT00277810', 'title': \"Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00277810', 'age_groups': '40 to 65 years old', 'name': 'NCT00277810'}, {'nct_number': 'NCT02516046', 'title': '18F-AV-1451 Autopsy Study', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 156, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02516046', 'age_groups': '40 to 65 years old', 'name': 'NCT02516046'}, {'nct_number': 'NCT00842816', 'title': \"Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 210, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00842816', 'age_groups': '40 to 65 years old', 'name': 'NCT00842816'}, {'nct_number': 'NCT02795780', 'title': 'Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 79, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02795780', 'age_groups': '40 to 65 years old', 'name': 'NCT02795780'}, {'nct_number': 'NCT00838110', 'title': \"A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 742, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00838110', 'age_groups': '40 to 65 years old', 'name': 'NCT00838110'}, {'nct_number': 'NCT01955161', 'title': \"Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 933, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01955161', 'age_groups': '40 to 65 years old', 'name': 'NCT01955161'}, {'nct_number': 'NCT02006654', 'title': \"Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 734, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02006654', 'age_groups': '40 to 65 years old', 'name': 'NCT02006654'}, {'nct_number': 'NCT02079246', 'title': \"Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 1463, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02079246', 'age_groups': '40 to 65 years old', 'name': 'NCT02079246'}, {'nct_number': 'NCT01921972', 'title': \"The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 232, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01921972', 'age_groups': '40 to 65 years old', 'name': 'NCT01921972'}, {'nct_number': 'NCT02006641', 'title': \"Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 858, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02006641', 'age_groups': '40 to 65 years old', 'name': 'NCT02006641'}, {'nct_number': 'NCT01734395', 'title': \"A Study to Show That the Change of Attention Measure is Correlated With the Changes of Caregiver's Burden After Treatment With Galantamine in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 1882, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01734395', 'age_groups': '40 to 65 years old', 'name': 'NCT01734395'}, {'nct_number': 'NCT00236574', 'title': 'A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 974, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00236574', 'age_groups': '40 to 65 years old', 'name': 'NCT00236574'}, {'nct_number': 'NCT00469456', 'title': \"Effect of Memantine on Functional Communication in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 265, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00469456', 'age_groups': '40 to 65 years old', 'name': 'NCT00469456'}, {'nct_number': 'NCT00141661', 'title': \"A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 67, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00141661', 'age_groups': '40 to 65 years old', 'name': 'NCT00141661'}, {'nct_number': 'NCT03239561', 'title': \"Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03239561', 'age_groups': '40 to 65 years old', 'name': 'NCT03239561'}, {'nct_number': 'NCT00722046', 'title': \"Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 198, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00722046', 'age_groups': '40 to 65 years old', 'name': 'NCT00722046'}, {'nct_number': 'NCT00551161', 'title': \"Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00551161', 'age_groups': '40 to 65 years old', 'name': 'NCT00551161'}, {'nct_number': 'NCT00097916', 'title': \"An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 34, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00097916', 'age_groups': '40 to 65 years old', 'name': 'NCT00097916'}, {'nct_number': 'NCT00479843', 'title': 'Nutritional Programme for Dementia Elderly Patient', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 946, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00479843', 'age_groups': '40 to 65 years old', 'name': 'NCT00479843'}, {'nct_number': 'NCT01481558', 'title': \"Effects of Transcranial Direct Current Stimulation on the Apathy of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01481558', 'age_groups': '40 to 65 years old', 'name': 'NCT01481558'}, {'nct_number': 'NCT00239759', 'title': \"MIRAGE: Multi-Institutional Research in Alzheimer's Genetic Epidemiology\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 2000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00239759', 'age_groups': '40 to 65 years old', 'name': 'NCT00239759'}, {'nct_number': 'NCT01153607', 'title': 'Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy Volunteers', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01153607', 'age_groups': '40 to 65 years old', 'name': 'NCT01153607'}, {'nct_number': 'NCT01009359', 'title': 'Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy Volunteers', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01009359', 'age_groups': '40 to 65 years old', 'name': 'NCT01009359'}, {'nct_number': 'NCT02854917', 'title': \"Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health Outcome\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02854917', 'age_groups': '40 to 65 years old', 'name': 'NCT02854917'}, {'nct_number': 'NCT02654574', 'title': 'Comparison of Two Modes of Administration of the IADL Questionnaire, Assessing the Level of Functional Autonomy of Patients to Carry Out the Tasks of Daily Living: Randomized Controlled Trial Among Patients of a Memory Clinic', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 299, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02654574', 'age_groups': '40 to 65 years old', 'name': 'NCT02654574'}, {'nct_number': 'NCT01125631', 'title': \"Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01125631', 'age_groups': '40 to 65 years old', 'name': 'NCT01125631'}, {'nct_number': 'NCT00561392', 'title': \"Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 208, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00561392', 'age_groups': '40 to 65 years old', 'name': 'NCT00561392'}, {'nct_number': 'NCT00838942', 'title': 'Life From Vision in Alzheimer Disease', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 80, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00838942', 'age_groups': '40 to 65 years old', 'name': 'NCT00838942'}, {'nct_number': 'NCT02553928', 'title': 'Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 62, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02553928', 'age_groups': '40 to 65 years old', 'name': 'NCT02553928'}, {'nct_number': 'NCT00403520', 'title': 'Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00403520', 'age_groups': '40 to 65 years old', 'name': 'NCT00403520'}, {'nct_number': 'NCT01276353', 'title': \"A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01276353', 'age_groups': '40 to 65 years old', 'name': 'NCT01276353'}, {'nct_number': 'NCT02051764', 'title': 'Imaging Characteristics of a Follow-up 18F-AV-1451 Scan', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02051764', 'age_groups': '40 to 65 years old', 'name': 'NCT02051764'}, {'nct_number': 'NCT00855686', 'title': \"Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 199, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00855686', 'age_groups': '40 to 65 years old', 'name': 'NCT00855686'}, {'nct_number': 'NCT00596284', 'title': 'Cognitive Behavior Therapy for Treating Anxiety in People With Dementia', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 34, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00596284', 'age_groups': '40 to 65 years old', 'name': 'NCT00596284'}, {'nct_number': 'NCT00884507', 'title': \"A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 389, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00884507', 'age_groups': '40 to 65 years old', 'name': 'NCT00884507'}, {'nct_number': 'NCT00976118', 'title': \"Activity of Masitinib (AB1010) in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 34, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00976118', 'age_groups': '40 to 65 years old', 'name': 'NCT00976118'}, {'nct_number': 'NCT01555827', 'title': \"Retinal Neurodegenerative Signs in Alzheimer's Diseases\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01555827', 'age_groups': '40 to 65 years old', 'name': 'NCT01555827'}, {'nct_number': 'NCT01554683', 'title': \"Seizure Activity in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01554683', 'age_groups': '40 to 65 years old', 'name': 'NCT01554683'}, {'nct_number': 'NCT00130429', 'title': \"Safety and Effect on Memory of PYM50028 in Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00130429', 'age_groups': '40 to 65 years old', 'name': 'NCT00130429'}, {'nct_number': 'NCT00571064', 'title': \"The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 97, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00571064', 'age_groups': '40 to 65 years old', 'name': 'NCT00571064'}, {'nct_number': 'NCT00675090', 'title': \"Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 28, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00675090', 'age_groups': '40 to 65 years old', 'name': 'NCT00675090'}, {'nct_number': 'NCT02035553', 'title': \"A Study of the Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease Psychosis\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 181, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02035553', 'age_groups': '40 to 65 years old', 'name': 'NCT02035553'}, {'nct_number': 'NCT00945672', 'title': \"A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00945672', 'age_groups': '40 to 65 years old', 'name': 'NCT00945672'}, {'nct_number': 'NCT01406145', 'title': \"A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of Donepezil\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01406145', 'age_groups': '40 to 65 years old', 'name': 'NCT01406145'}, {'nct_number': 'NCT00477659', 'title': \"Neural Correlates In Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00477659', 'age_groups': '40 to 65 years old', 'name': 'NCT00477659'}, {'nct_number': 'NCT00733642', 'title': \"Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00733642', 'age_groups': '40 to 65 years old', 'name': 'NCT00733642'}, {'nct_number': 'NCT00948766', 'title': \"Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 716, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00948766', 'age_groups': '40 to 65 years old', 'name': 'NCT00948766'}, {'nct_number': 'NCT01035164', 'title': \"Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01035164', 'age_groups': '40 to 65 years old', 'name': 'NCT01035164'}, {'nct_number': 'NCT00013923', 'title': 'Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00013923', 'age_groups': '40 to 65 years old', 'name': 'NCT00013923'}, {'nct_number': 'NCT00017940', 'title': \"Gene Therapy for Alzheimer's Disease Clinical Trial\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00017940', 'age_groups': '40 to 65 years old', 'name': 'NCT00017940'}, {'nct_number': 'NCT00074529', 'title': \"Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 512, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00074529', 'age_groups': '40 to 65 years old', 'name': 'NCT00074529'}, {'nct_number': 'NCT00423228', 'title': \"Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 228, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00423228', 'age_groups': '40 to 65 years old', 'name': 'NCT00423228'}, {'nct_number': 'NCT00334906', 'title': \"Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 75, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00334906', 'age_groups': '40 to 65 years old', 'name': 'NCT00334906'}, {'nct_number': 'NCT00240695', 'title': 'A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 724, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00240695', 'age_groups': '40 to 65 years old', 'name': 'NCT00240695'}, {'nct_number': 'NCT00630851', 'title': \"A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 249, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00630851', 'age_groups': '40 to 65 years old', 'name': 'NCT00630851'}, {'nct_number': 'NCT00439166', 'title': \"Effects of Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal Fluid\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00439166', 'age_groups': '40 to 65 years old', 'name': 'NCT00439166'}, {'nct_number': 'NCT00448799', 'title': 'Evaluation of [123I] AV83 and SPECT in Patients With Alzheimer Disease in Comparison to Healthy Controls', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00448799', 'age_groups': '40 to 65 years old', 'name': 'NCT00448799'}, {'nct_number': 'NCT00456417', 'title': 'Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00456417', 'age_groups': '40 to 65 years old', 'name': 'NCT00456417'}, {'nct_number': 'NCT00566397', 'title': \"A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 402, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00566397', 'age_groups': '40 to 65 years old', 'name': 'NCT00566397'}, {'nct_number': 'NCT00164749', 'title': \"A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00164749', 'age_groups': '40 to 65 years old', 'name': 'NCT00164749'}, {'nct_number': 'NCT00440050', 'title': \"DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 402, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00440050', 'age_groups': '40 to 65 years old', 'name': 'NCT00440050'}, {'nct_number': 'NCT00439010', 'title': 'Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy Subjects', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00439010', 'age_groups': '40 to 65 years old', 'name': 'NCT00439010'}, {'nct_number': 'NCT00142805', 'title': \"Ketasyn in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00142805', 'age_groups': '40 to 65 years old', 'name': 'NCT00142805'}, {'nct_number': 'NCT00090116', 'title': \"The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 400, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00090116', 'age_groups': '40 to 65 years old', 'name': 'NCT00090116'}, {'nct_number': 'NCT00244322', 'title': \"Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00244322', 'age_groups': '40 to 65 years old', 'name': 'NCT00244322'}, {'nct_number': 'NCT00329082', 'title': \"Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy Volunteers\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00329082', 'age_groups': '40 to 65 years old', 'name': 'NCT00329082'}, {'nct_number': 'NCT00495417', 'title': \"Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00495417', 'age_groups': '40 to 65 years old', 'name': 'NCT00495417'}, {'nct_number': 'NCT00099710', 'title': \"Curcumin in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 33, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00099710', 'age_groups': '40 to 65 years old', 'name': 'NCT00099710'}, {'nct_number': 'NCT00073658', 'title': 'Treating Behavioral Disturbances in Individuals With Dementia', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 137, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00073658', 'age_groups': '40 to 65 years old', 'name': 'NCT00073658'}, {'nct_number': 'NCT00151398', 'title': \"Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 229, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00151398', 'age_groups': '40 to 65 years old', 'name': 'NCT00151398'}, {'nct_number': 'NCT02708186', 'title': 'Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 29, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02708186', 'age_groups': '40 to 65 years old', 'name': 'NCT02708186'}, {'nct_number': 'NCT00428389', 'title': \"Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 262, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00428389', 'age_groups': '40 to 65 years old', 'name': 'NCT00428389'}, {'nct_number': 'NCT00299988', 'title': \"Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00299988', 'age_groups': '40 to 65 years old', 'name': 'NCT00299988'}, {'nct_number': 'NCT02265757', 'title': 'Behavioral Interventions to Prevent or Delay Dementia', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 272, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02265757', 'age_groups': '40 to 65 years old', 'name': 'NCT02265757'}, {'nct_number': 'NCT00862940', 'title': \"A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 277, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00862940', 'age_groups': '40 to 65 years old', 'name': 'NCT00862940'}, {'nct_number': 'NCT01538212', 'title': \"Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 55, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01538212', 'age_groups': '40 to 65 years old', 'name': 'NCT01538212'}, {'nct_number': 'NCT02918539', 'title': \"Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 317, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02918539', 'age_groups': '40 to 65 years old', 'name': 'NCT02918539'}, {'nct_number': 'NCT00646269', 'title': \"Efficacy Assessment of Three Non Pharmacological Therapies in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 640, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00646269', 'age_groups': '40 to 65 years old', 'name': 'NCT00646269'}, {'nct_number': 'NCT00731224', 'title': \"Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 380, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00731224', 'age_groups': '40 to 65 years old', 'name': 'NCT00731224'}, {'nct_number': 'NCT00234637', 'title': \"Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment\", 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 204, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00234637', 'age_groups': '40 to 65 years old', 'name': 'NCT00234637'}, {'nct_number': 'NCT03160027', 'title': 'Photobiomodulation for Improving Brain Function in Dementia (PBM Dementia)', 'status': 'Completed', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03160027', 'age_groups': '40 to 65 years old', 'name': 'NCT03160027'}, {'nct_number': 'NCT01796314', 'title': \"Impact of Therapeutic Educational Programme on the Alzheimer's Disease Affected Patient's Quality of Life\", 'status': 'Completed', 'clean_age': '50 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 170, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01796314', 'age_groups': '40 to 65 years old', 'name': 'NCT01796314'}, {'nct_number': 'NCT02103673', 'title': 'DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of Dementia', 'status': 'Completed', 'clean_age': '50 Years to 100 Years ', 'phases': 'Phase 2', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02103673', 'age_groups': '40 to 65 years old', 'name': 'NCT02103673'}, {'nct_number': 'NCT02825732', 'title': 'MEMORA-Caregiver : Risk Factors of Caregiver Burden Among Patients With Neurocognitive Disorders or Subjective Cognitive Complaint', 'status': 'Completed', 'clean_age': '50 Years to 100 Years ', 'phases': 'Phase 4', 'enrollment': 1300, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02825732', 'age_groups': '40 to 65 years old', 'name': 'NCT02825732'}, {'nct_number': 'NCT00586430', 'title': 'The Impact of Lorazepam on Cognition in APOE e4 Carriers', 'status': 'Completed', 'clean_age': '50 Years to 65 Years ', 'phases': 'Not Applicable', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00586430', 'age_groups': '40 to 65 years old', 'name': 'NCT00586430'}, {'nct_number': 'NCT02530255', 'title': 'Telomerase Activator and Retinal Amyloid', 'status': 'Completed', 'clean_age': '50 Years to 70 Years ', 'phases': 'Not Applicable', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02530255', 'age_groups': '40 to 65 years old', 'name': 'NCT02530255'}, {'nct_number': 'NCT01297218', 'title': \"The Safety and The Efficacy Evaluation of NEUROSTEM®-AD in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 9, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01297218', 'age_groups': '40 to 65 years old', 'name': 'NCT01297218'}, {'nct_number': 'NCT01075763', 'title': \"A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 75 Years ', 'phases': 'Phase 2', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01075763', 'age_groups': '40 to 65 years old', 'name': 'NCT01075763'}, {'nct_number': 'NCT02340195', 'title': 'Pharmacokinetic Properties of Idalopirdine (Lu AE58054) in Subjects With and Without Impaired Kidney Function', 'status': 'Completed', 'clean_age': '50 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02340195', 'age_groups': '40 to 65 years old', 'name': 'NCT02340195'}, {'nct_number': 'NCT02185053', 'title': \"A Phase II Study of CPC-201 to Treat Alzheimer's Disease Type Dementia\", 'status': 'Completed', 'clean_age': '50 Years to 79 Years ', 'phases': 'Phase 2', 'enrollment': 41, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02185053', 'age_groups': '40 to 65 years old', 'name': 'NCT02185053'}, {'nct_number': 'NCT01245530', 'title': 'An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 3', 'enrollment': 280, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01245530', 'age_groups': '40 to 65 years old', 'name': 'NCT01245530'}, {'nct_number': 'NCT01309763', 'title': 'Safety and Tolerability of AFFITOPE AD03', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 28, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01309763', 'age_groups': '40 to 65 years old', 'name': 'NCT01309763'}, {'nct_number': 'NCT00608946', 'title': 'Treatment With Copper in Patients With Mild Alzheimer´s Dementia', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 68, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00608946', 'age_groups': '40 to 65 years old', 'name': 'NCT00608946'}, {'nct_number': 'NCT01469351', 'title': 'Identifying Potential Effects of Liraglutide on Degenerative Changes', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 34, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01469351', 'age_groups': '40 to 65 years old', 'name': 'NCT01469351'}, {'nct_number': 'NCT01397578', 'title': \"A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 91, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01397578', 'age_groups': '40 to 65 years old', 'name': 'NCT01397578'}, {'nct_number': 'NCT03070821', 'title': \"Therapy of Alzheimer's Disease With Neurofeedback\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03070821', 'age_groups': '40 to 65 years old', 'name': 'NCT03070821'}, {'nct_number': 'NCT00965588', 'title': \"Study to Evaluate Safety, Tolerability and Immunogenicity of Vaccine (UB 311) in Subjects With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00965588', 'age_groups': '40 to 65 years old', 'name': 'NCT00965588'}, {'nct_number': 'NCT00414622', 'title': 'GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer’s Disease', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00414622', 'age_groups': '40 to 65 years old', 'name': 'NCT00414622'}, {'nct_number': 'NCT01343966', 'title': \"A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 448, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01343966', 'age_groups': '40 to 65 years old', 'name': 'NCT01343966'}, {'nct_number': 'NCT01428453', 'title': \"A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 124, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01428453', 'age_groups': '40 to 65 years old', 'name': 'NCT01428453'}, {'nct_number': 'NCT01370954', 'title': 'NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 204, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01370954', 'age_groups': '40 to 65 years old', 'name': 'NCT01370954'}, {'nct_number': 'NCT01656525', 'title': 'A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 28, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01656525', 'age_groups': '40 to 65 years old', 'name': 'NCT01656525'}, {'nct_number': 'NCT00454870', 'title': \"Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00454870', 'age_groups': '40 to 65 years old', 'name': 'NCT00454870'}, {'nct_number': 'NCT02409030', 'title': \"Multi-parameter Diagnostic Blood Test for the Diagnosis of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 700, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02409030', 'age_groups': '40 to 65 years old', 'name': 'NCT02409030'}, {'nct_number': 'NCT00087789', 'title': \"CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00087789', 'age_groups': '40 to 65 years old', 'name': 'NCT00087789'}, {'nct_number': 'NCT00633841', 'title': \"Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00633841', 'age_groups': '40 to 65 years old', 'name': 'NCT00633841'}, {'nct_number': 'NCT00100334', 'title': 'Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer’s Disease', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00100334', 'age_groups': '40 to 65 years old', 'name': 'NCT00100334'}, {'nct_number': 'NCT01780519', 'title': 'The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 57, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01780519', 'age_groups': '40 to 65 years old', 'name': 'NCT01780519'}, {'nct_number': 'NCT02907567', 'title': \"Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02907567', 'age_groups': '40 to 65 years old', 'name': 'NCT02907567'}, {'nct_number': 'NCT01701089', 'title': 'A Study of RO4602522 in Patients With Alzheimer Disease and in Healthy Volunteers', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01701089', 'age_groups': '40 to 65 years old', 'name': 'NCT01701089'}, {'nct_number': 'NCT02874820', 'title': 'I2PETPG - Imidazoline2 Binding Sites in a Group of Participants Diagnosed With AD', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Early Phase 1', 'enrollment': 2, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02874820', 'age_groups': '40 to 65 years old', 'name': 'NCT02874820'}, {'nct_number': 'NCT01189084', 'title': \"Observational Study to Monitor Long-term Immunogenicity and Efficacy of UB 311 Vaccine in Subjects With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 14, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01189084', 'age_groups': '40 to 65 years old', 'name': 'NCT01189084'}, {'nct_number': 'NCT00100282', 'title': 'Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer’s Disease', 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 125, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00100282', 'age_groups': '40 to 65 years old', 'name': 'NCT00100282'}, {'nct_number': 'NCT01227564', 'title': \"Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 63, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01227564', 'age_groups': '40 to 65 years old', 'name': 'NCT01227564'}, {'nct_number': 'NCT00411580', 'title': \"Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 58, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00411580', 'age_groups': '40 to 65 years old', 'name': 'NCT00411580'}, {'nct_number': 'NCT01117818', 'title': \"Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 335, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01117818', 'age_groups': '40 to 65 years old', 'name': 'NCT01117818'}, {'nct_number': 'NCT03319810', 'title': 'Effect of IVIG on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer Disease', 'status': 'Completed', 'clean_age': '50 Years to 84 Years ', 'phases': 'Phase 2', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03319810', 'age_groups': '40 to 65 years old', 'name': 'NCT03319810'}, {'nct_number': 'NCT00099242', 'title': \"Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 1040, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00099242', 'age_groups': '40 to 65 years old', 'name': 'NCT00099242'}, {'nct_number': 'NCT01325402', 'title': \"An Open Positron Emission Tomography Study to Assess the Effects of Varying Mass of AZD4694 on Radioligand Binding Parameters in Healthy Volunteers and Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01325402', 'age_groups': '40 to 65 years old', 'name': 'NCT01325402'}, {'nct_number': 'NCT00305903', 'title': \"Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00305903', 'age_groups': '40 to 65 years old', 'name': 'NCT00305903'}, {'nct_number': 'NCT01537757', 'title': 'A Two-Part, Single-Dose Study of the Pharmacokinetics of MK-8931 in Subjects With Renal Insufficiency (MK-8931-009 [P08535])', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01537757', 'age_groups': '40 to 65 years old', 'name': 'NCT01537757'}, {'nct_number': 'NCT00151333', 'title': \"Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00151333', 'age_groups': '40 to 65 years old', 'name': 'NCT00151333'}, {'nct_number': 'NCT03113812', 'title': \"Repeated Subcutaneous Administration of ABvac40 in Mild to Moderate Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03113812', 'age_groups': '40 to 65 years old', 'name': 'NCT03113812'}, {'nct_number': 'NCT00710684', 'title': \"A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 682, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00710684', 'age_groups': '40 to 65 years old', 'name': 'NCT00710684'}, {'nct_number': 'NCT00568776', 'title': \"ELND005 in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 353, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00568776', 'age_groups': '40 to 65 years old', 'name': 'NCT00568776'}, {'nct_number': 'NCT03656042', 'title': \"To Evaluate the Efficacy and Safety/Tolerability Profiles of G-CSF in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03656042', 'age_groups': '40 to 65 years old', 'name': 'NCT03656042'}, {'nct_number': 'NCT00224497', 'title': \"A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 380, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00224497', 'age_groups': '40 to 65 years old', 'name': 'NCT00224497'}, {'nct_number': 'NCT02984540', 'title': \"Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02984540', 'age_groups': '40 to 65 years old', 'name': 'NCT02984540'}, {'nct_number': 'NCT00558402', 'title': 'Meditation or Education for Alzheimer Caregivers', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00558402', 'age_groups': '40 to 65 years old', 'name': 'NCT00558402'}, {'nct_number': 'NCT01496170', 'title': \"A Study of the Safety, Tolerability, and Pharmacodynamics of MK-8931 in Participants With Alzheimer's Disease (MK-8931-010 AM1 [P07820 AM1])\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01496170', 'age_groups': '40 to 65 years old', 'name': 'NCT01496170'}, {'nct_number': 'NCT00219232', 'title': \"An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 868, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00219232', 'age_groups': '40 to 65 years old', 'name': 'NCT00219232'}, {'nct_number': 'NCT00940589', 'title': 'Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 73, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00940589', 'age_groups': '40 to 65 years old', 'name': 'NCT00940589'}, {'nct_number': 'NCT01179373', 'title': \"Deep Transcranial Magnetic Stimulation for Treatment of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01179373', 'age_groups': '40 to 65 years old', 'name': 'NCT01179373'}, {'nct_number': 'NCT03008161', 'title': \"Multiple Dose Safety Study of NPT088 in Patients With Mild to Moderate Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 83, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03008161', 'age_groups': '40 to 65 years old', 'name': 'NCT03008161'}, {'nct_number': 'NCT01059877', 'title': 'Efficacy of 1072nm Infrared Stimulation on Executive Functioning in Dementia', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 11, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01059877', 'age_groups': '40 to 65 years old', 'name': 'NCT01059877'}, {'nct_number': 'NCT02787746', 'title': \"Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 241, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02787746', 'age_groups': '40 to 65 years old', 'name': 'NCT02787746'}, {'nct_number': 'NCT02050464', 'title': 'Computational Tools for Early Diagnosis of Memory Disorders', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 126, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02050464', 'age_groups': '40 to 65 years old', 'name': 'NCT02050464'}, {'nct_number': 'NCT00838877', 'title': 'Positron Emission Tomography (PET) Study With [18F]AZD4694 and [11C]AZD2184, Candidate PET Ligands for Aβ Amyloid', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 26, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00838877', 'age_groups': '40 to 65 years old', 'name': 'NCT00838877'}, {'nct_number': 'NCT03114657', 'title': \"A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 806, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03114657', 'age_groups': '40 to 65 years old', 'name': 'NCT03114657'}, {'nct_number': 'NCT02703636', 'title': \"NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients.\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 118, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02703636', 'age_groups': '40 to 65 years old', 'name': 'NCT02703636'}, {'nct_number': 'NCT01548430', 'title': \"A Safety Study of TTP4000 in Subjects With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01548430', 'age_groups': '40 to 65 years old', 'name': 'NCT01548430'}, {'nct_number': 'NCT00498602', 'title': \"Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00498602', 'age_groups': '40 to 65 years old', 'name': 'NCT00498602'}, {'nct_number': 'NCT00752232', 'title': \"Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00752232', 'age_groups': '40 to 65 years old', 'name': 'NCT00752232'}, {'nct_number': 'NCT02670083', 'title': \"CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 813, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02670083', 'age_groups': '40 to 65 years old', 'name': 'NCT02670083'}, {'nct_number': 'NCT00104442', 'title': \"Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00104442', 'age_groups': '40 to 65 years old', 'name': 'NCT00104442'}, {'nct_number': 'NCT01453569', 'title': \"Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 255, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01453569', 'age_groups': '40 to 65 years old', 'name': 'NCT01453569'}, {'nct_number': 'NCT01850238', 'title': \"Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01850238', 'age_groups': '40 to 65 years old', 'name': 'NCT01850238'}, {'nct_number': 'NCT01093664', 'title': 'Safety/Tolerability, Immunological and Clinical Activity of a Boost Immunization With AFFITOPE AD02', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01093664', 'age_groups': '40 to 65 years old', 'name': 'NCT01093664'}, {'nct_number': 'NCT00348192', 'title': \"SB-742457 And Donepezil In Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00348192', 'age_groups': '40 to 65 years old', 'name': 'NCT00348192'}, {'nct_number': 'NCT01764243', 'title': 'Safety and Efficacy of MT-4666', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 450, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01764243', 'age_groups': '40 to 65 years old', 'name': 'NCT01764243'}, {'nct_number': 'NCT01054976', 'title': \"The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 99, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01054976', 'age_groups': '40 to 65 years old', 'name': 'NCT01054976'}, {'nct_number': 'NCT03748706', 'title': \"PTI-125 for Mild-to-moderate Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03748706', 'age_groups': '40 to 65 years old', 'name': 'NCT03748706'}, {'nct_number': 'NCT01044758', 'title': 'Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 96, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01044758', 'age_groups': '40 to 65 years old', 'name': 'NCT01044758'}, {'nct_number': 'NCT00112073', 'title': \"AAB-001 in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 234, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00112073', 'age_groups': '40 to 65 years old', 'name': 'NCT00112073'}, {'nct_number': 'NCT03587376', 'title': 'Characterization of T-Cell Response in Participants Previously Treated With JNJ-54861911 (Atabecestat)', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Early Phase 1', 'enrollment': 9, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03587376', 'age_groups': '40 to 65 years old', 'name': 'NCT03587376'}, {'nct_number': 'NCT01548287', 'title': \"A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 164, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01548287', 'age_groups': '40 to 65 years old', 'name': 'NCT01548287'}, {'nct_number': 'NCT01715350', 'title': \"Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 151, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01715350', 'age_groups': '40 to 65 years old', 'name': 'NCT01715350'}, {'nct_number': 'NCT00455000', 'title': \"A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 37, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00455000', 'age_groups': '40 to 65 years old', 'name': 'NCT00455000'}, {'nct_number': 'NCT03130036', 'title': 'Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose Using Positron Emission Tomography (PET) Scanning', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 34, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03130036', 'age_groups': '40 to 65 years old', 'name': 'NCT03130036'}, {'nct_number': 'NCT00397891', 'title': 'Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00397891', 'age_groups': '40 to 65 years old', 'name': 'NCT00397891'}, {'nct_number': 'NCT00607308', 'title': \"A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00607308', 'age_groups': '40 to 65 years old', 'name': 'NCT00607308'}, {'nct_number': 'NCT02593318', 'title': \"Trial of Oxaloacetate in Alzheimer's Disease (TOAD)\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02593318', 'age_groups': '40 to 65 years old', 'name': 'NCT02593318'}, {'nct_number': 'NCT01348061', 'title': \"Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 16, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01348061', 'age_groups': '40 to 65 years old', 'name': 'NCT01348061'}, {'nct_number': 'NCT00423085', 'title': \"Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 859, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00423085', 'age_groups': '40 to 65 years old', 'name': 'NCT00423085'}, {'nct_number': 'NCT01529619', 'title': \"Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 52, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01529619', 'age_groups': '40 to 65 years old', 'name': 'NCT01529619'}, {'nct_number': 'NCT01399125', 'title': \"A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 501, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01399125', 'age_groups': '40 to 65 years old', 'name': 'NCT01399125'}, {'nct_number': 'NCT02293915', 'title': \"An Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 818, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02293915', 'age_groups': '40 to 65 years old', 'name': 'NCT02293915'}, {'nct_number': 'NCT03422250', 'title': \"Non-invasive Stimulation of Brain Networks and Cognition in Alzheimer's Disease and Frontotemporal Dementia\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 66, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03422250', 'age_groups': '40 to 65 years old', 'name': 'NCT03422250'}, {'nct_number': 'NCT01585272', 'title': \"Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 121, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01585272', 'age_groups': '40 to 65 years old', 'name': 'NCT01585272'}, {'nct_number': 'NCT01485302', 'title': \"Single and Repeated Dosing Study to Assess the Safety and the Concentration-time Profile of SAR228810 in Alzheimer's Patients\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01485302', 'age_groups': '40 to 65 years old', 'name': 'NCT01485302'}, {'nct_number': 'NCT02778438', 'title': 'A Validation Study of the Novel Application of Telehealth in Clinical Drug Development in Subjects With Mild Cognitive Deficits', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 30, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02778438', 'age_groups': '40 to 65 years old', 'name': 'NCT02778438'}, {'nct_number': 'NCT00265148', 'title': \"Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00265148', 'age_groups': '40 to 65 years old', 'name': 'NCT00265148'}, {'nct_number': 'NCT02260674', 'title': \"A Safety and Tolerability Study of JNJ-54861911 in Participants With Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 114, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02260674', 'age_groups': '40 to 65 years old', 'name': 'NCT02260674'}, {'nct_number': 'NCT01614886', 'title': 'Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 216, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01614886', 'age_groups': '40 to 65 years old', 'name': 'NCT01614886'}, {'nct_number': 'NCT01073228', 'title': \"Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 409, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01073228', 'age_groups': '40 to 65 years old', 'name': 'NCT01073228'}, {'nct_number': 'NCT00959192', 'title': \"Safety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00959192', 'age_groups': '40 to 65 years old', 'name': 'NCT00959192'}, {'nct_number': 'NCT00479557', 'title': \"Study Evaluating Safety, Tolerability, And Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 86, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00479557', 'age_groups': '40 to 65 years old', 'name': 'NCT00479557'}, {'nct_number': 'NCT00812565', 'title': \"Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 58, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00812565', 'age_groups': '40 to 65 years old', 'name': 'NCT00812565'}, {'nct_number': 'NCT00990613', 'title': 'A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin', 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00990613', 'age_groups': '40 to 65 years old', 'name': 'NCT00990613'}, {'nct_number': 'NCT00708552', 'title': \"Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 576, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00708552', 'age_groups': '40 to 65 years old', 'name': 'NCT00708552'}, {'nct_number': 'NCT01350362', 'title': \"Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 306, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01350362', 'age_groups': '40 to 65 years old', 'name': 'NCT01350362'}, {'nct_number': 'NCT00506415', 'title': \"Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 1584, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00506415', 'age_groups': '40 to 65 years old', 'name': 'NCT00506415'}, {'nct_number': 'NCT03250741', 'title': \"Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 94, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03250741', 'age_groups': '40 to 65 years old', 'name': 'NCT03250741'}, {'nct_number': 'NCT00381238', 'title': \"Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 33, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00381238', 'age_groups': '40 to 65 years old', 'name': 'NCT00381238'}, {'nct_number': 'NCT01600859', 'title': \"Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 65, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01600859', 'age_groups': '40 to 65 years old', 'name': 'NCT01600859'}, {'nct_number': 'NCT01948791', 'title': \"16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 222, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01948791', 'age_groups': '40 to 65 years old', 'name': 'NCT01948791'}, {'nct_number': 'NCT02585934', 'title': \"Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study\", 'status': 'Completed', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 1315, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02585934', 'age_groups': '40 to 65 years old', 'name': 'NCT02585934'}, {'nct_number': 'NCT00736775', 'title': \"A Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 86 Years ', 'phases': 'Phase 1', 'enrollment': 56, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00736775', 'age_groups': '40 to 65 years old', 'name': 'NCT00736775'}, {'nct_number': 'NCT02031198', 'title': \"18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 86 Years ', 'phases': 'Phase 1', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02031198', 'age_groups': '40 to 65 years old', 'name': 'NCT02031198'}, {'nct_number': 'NCT00575055', 'title': \"Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)\", 'status': 'Completed', 'clean_age': '50 Years to 88 Years ', 'phases': 'Phase 3', 'enrollment': 1121, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00575055', 'age_groups': '40 to 65 years old', 'name': 'NCT00575055'}, {'nct_number': 'NCT00574132', 'title': \"Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)\", 'status': 'Completed', 'clean_age': '50 Years to 88 Years ', 'phases': 'Phase 3', 'enrollment': 1331, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00574132', 'age_groups': '40 to 65 years old', 'name': 'NCT00574132'}, {'nct_number': 'NCT01958437', 'title': 'Enhancing Spatial Navigation Using Non-Invasive Brain Stimulation', 'status': 'Completed', 'clean_age': '50 Years to 88 Years ', 'phases': 'Not Applicable', 'enrollment': 44, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01958437', 'age_groups': '40 to 65 years old', 'name': 'NCT01958437'}, {'nct_number': 'NCT02262975', 'title': \"A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS)\", 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 4', 'enrollment': 532, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02262975', 'age_groups': '40 to 65 years old', 'name': 'NCT02262975'}, {'nct_number': 'NCT02434666', 'title': \"Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07\", 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02434666', 'age_groups': '40 to 65 years old', 'name': 'NCT02434666'}, {'nct_number': 'NCT00818662', 'title': 'A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease', 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 3', 'enrollment': 390, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00818662', 'age_groups': '40 to 65 years old', 'name': 'NCT00818662'}, {'nct_number': 'NCT02462161', 'title': 'Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart', 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02462161', 'age_groups': '40 to 65 years old', 'name': 'NCT02462161'}, {'nct_number': 'NCT02389413', 'title': \"Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02389413', 'age_groups': '40 to 65 years old', 'name': 'NCT02389413'}, {'nct_number': 'NCT01547169', 'title': 'Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days', 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01547169', 'age_groups': '40 to 65 years old', 'name': 'NCT01547169'}, {'nct_number': 'NCT02910102', 'title': 'Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia', 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02910102', 'age_groups': '40 to 65 years old', 'name': 'NCT02910102'}, {'nct_number': 'NCT01595646', 'title': 'Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)', 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 37, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01595646', 'age_groups': '40 to 65 years old', 'name': 'NCT01595646'}, {'nct_number': 'NCT00880555', 'title': 'Semantic Memory, Financial Capacity, and Brain Perfusion in Mild Cognitive Impairment (MCI) (CASL)', 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 4', 'enrollment': 78, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00880555', 'age_groups': '40 to 65 years old', 'name': 'NCT00880555'}, {'nct_number': 'NCT02549196', 'title': \"A Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's Type\", 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 28, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02549196', 'age_groups': '40 to 65 years old', 'name': 'NCT02549196'}, {'nct_number': 'NCT01193608', 'title': \"Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 1', 'enrollment': 88, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01193608', 'age_groups': '40 to 65 years old', 'name': 'NCT01193608'}, {'nct_number': 'NCT01284387', 'title': \"Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 126, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01284387', 'age_groups': '40 to 65 years old', 'name': 'NCT01284387'}, {'nct_number': 'NCT01254773', 'title': \"Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 146, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01254773', 'age_groups': '40 to 65 years old', 'name': 'NCT01254773'}, {'nct_number': 'NCT00663026', 'title': 'Study Evaluating Bapineuzumab In Alzheimer Disease Subjects', 'status': 'Completed', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 79, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00663026', 'age_groups': '40 to 65 years old', 'name': 'NCT00663026'}, {'nct_number': 'NCT00684281', 'title': \"Early Diagnosis of Alzheimer's Disease: Clinical, Neuropsychological and Neuroimaging Follow-up of a Cohort of Patients With an Isolated Memory Impairment\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00684281', 'age_groups': '40 to 65 years old', 'name': 'NCT00684281'}, {'nct_number': 'NCT02359552', 'title': \"Rasagiline Rescue in Alzheimer's Disease Clinical Trial\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 27, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02359552', 'age_groups': '40 to 65 years old', 'name': 'NCT02359552'}, {'nct_number': 'NCT00110552', 'title': \"Effects of Sage on Memory and Mental Performance in Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 111, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00110552', 'age_groups': '40 to 65 years old', 'name': 'NCT00110552'}, {'nct_number': 'NCT01782742', 'title': \"Bexarotene Amyloid Treatment for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01782742', 'age_groups': '40 to 65 years old', 'name': 'NCT01782742'}, {'nct_number': 'NCT00624026', 'title': 'Memantine - Communication Study', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 107, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00624026', 'age_groups': '40 to 65 years old', 'name': 'NCT00624026'}, {'nct_number': 'NCT00973518', 'title': \"Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG)\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 160, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00973518', 'age_groups': '40 to 65 years old', 'name': 'NCT00973518'}, {'nct_number': 'NCT00348140', 'title': \"Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 1468, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00348140', 'age_groups': '40 to 65 years old', 'name': 'NCT00348140'}, {'nct_number': 'NCT01404169', 'title': \"A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 260, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01404169', 'age_groups': '40 to 65 years old', 'name': 'NCT01404169'}, {'nct_number': 'NCT01584440', 'title': \"Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 220, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01584440', 'age_groups': '40 to 65 years old', 'name': 'NCT01584440'}, {'nct_number': 'NCT00481520', 'title': \"Study Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00481520', 'age_groups': '40 to 65 years old', 'name': 'NCT00481520'}, {'nct_number': 'NCT00688207', 'title': \"Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR)\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00688207', 'age_groups': '40 to 65 years old', 'name': 'NCT00688207'}, {'nct_number': 'NCT01600469', 'title': \"NMDA-enhancing Agent for Treatment of Mild Cognitive Impairment and Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 86, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01600469', 'age_groups': '40 to 65 years old', 'name': 'NCT01600469'}, {'nct_number': 'NCT01122329', 'title': \"A Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01122329', 'age_groups': '40 to 65 years old', 'name': 'NCT01122329'}, {'nct_number': 'NCT01894620', 'title': \"The Effect of rTMS Treatment on Alzheimer's and Sleep Quality\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 11, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01894620', 'age_groups': '40 to 65 years old', 'name': 'NCT01894620'}, {'nct_number': 'NCT01876823', 'title': 'Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive Impairment', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01876823', 'age_groups': '40 to 65 years old', 'name': 'NCT01876823'}, {'nct_number': 'NCT00800709', 'title': \"Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 26, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00800709', 'age_groups': '40 to 65 years old', 'name': 'NCT00800709'}, {'nct_number': 'NCT00678431', 'title': \"Randomized Trial of a Nutritional Supplement in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 27, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00678431', 'age_groups': '40 to 65 years old', 'name': 'NCT00678431'}, {'nct_number': 'NCT02094729', 'title': \"A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 26, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02094729', 'age_groups': '40 to 65 years old', 'name': 'NCT02094729'}, {'nct_number': 'NCT01436188', 'title': \"A Study to Measure CSF Proteins in Elderly Healthy Volunteers and Volunteers With Mild Cognitive Impairment or Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01436188', 'age_groups': '40 to 65 years old', 'name': 'NCT01436188'}, {'nct_number': 'NCT00531804', 'title': 'A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00531804', 'age_groups': '40 to 65 years old', 'name': 'NCT00531804'}, {'nct_number': 'NCT04065061', 'title': 'Erinacine A-enriched Hericium Erinaceus Mycelia for Improvement of Recognition, Vision, and Functional MRI Alterations', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 68, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04065061', 'age_groups': '40 to 65 years old', 'name': 'NCT04065061'}, {'nct_number': 'NCT00810147', 'title': \"A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 209, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00810147', 'age_groups': '40 to 65 years old', 'name': 'NCT00810147'}, {'nct_number': 'NCT00348309', 'title': \"Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 1496, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00348309', 'age_groups': '40 to 65 years old', 'name': 'NCT00348309'}, {'nct_number': 'NCT02353598', 'title': 'A Study of Crenezumab in Participants With Mild to Moderate Alzheimer Disease', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 77, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02353598', 'age_groups': '40 to 65 years old', 'name': 'NCT02353598'}, {'nct_number': 'NCT01864655', 'title': \"Safety and Tolerability of AZD0530 (Saracatinib) in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01864655', 'age_groups': '40 to 65 years old', 'name': 'NCT01864655'}, {'nct_number': 'NCT00428090', 'title': \"Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 862, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00428090', 'age_groups': '40 to 65 years old', 'name': 'NCT00428090'}, {'nct_number': 'NCT02531360', 'title': 'Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 7, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02531360', 'age_groups': '40 to 65 years old', 'name': 'NCT02531360'}, {'nct_number': 'NCT02442765', 'title': \"Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 410, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02442765', 'age_groups': '40 to 65 years old', 'name': 'NCT02442765'}, {'nct_number': 'NCT01677754', 'title': 'A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 542, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01677754', 'age_groups': '40 to 65 years old', 'name': 'NCT01677754'}, {'nct_number': 'NCT01681602', 'title': 'Effect of Physical Exercise in Alzheimer Patients', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01681602', 'age_groups': '40 to 65 years old', 'name': 'NCT01681602'}, {'nct_number': 'NCT00480870', 'title': \"The Effect of Anticholinesterase Drugs on Sleep in Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 65, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00480870', 'age_groups': '40 to 65 years old', 'name': 'NCT00480870'}, {'nct_number': 'NCT03058965', 'title': 'Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03058965', 'age_groups': '40 to 65 years old', 'name': 'NCT03058965'}, {'nct_number': 'NCT02560753', 'title': \"Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02560753', 'age_groups': '40 to 65 years old', 'name': 'NCT02560753'}, {'nct_number': 'NCT02256306', 'title': 'The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02256306', 'age_groups': '40 to 65 years old', 'name': 'NCT02256306'}, {'nct_number': 'NCT00663936', 'title': \"Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 373, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00663936', 'age_groups': '40 to 65 years old', 'name': 'NCT00663936'}, {'nct_number': 'NCT01978548', 'title': \"A Study to Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01978548', 'age_groups': '40 to 65 years old', 'name': 'NCT01978548'}, {'nct_number': 'NCT01425957', 'title': 'Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 229, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01425957', 'age_groups': '40 to 65 years old', 'name': 'NCT01425957'}, {'nct_number': 'NCT01492374', 'title': \"Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01492374', 'age_groups': '40 to 65 years old', 'name': 'NCT01492374'}, {'nct_number': 'NCT01522404', 'title': 'Effects of Atomoxetine in Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 39, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01522404', 'age_groups': '40 to 65 years old', 'name': 'NCT01522404'}, {'nct_number': 'NCT00735800', 'title': 'Telephone Support for Dementia Caregivers', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00735800', 'age_groups': '40 to 65 years old', 'name': 'NCT00735800'}, {'nct_number': 'NCT00151502', 'title': 'To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 600, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00151502', 'age_groups': '40 to 65 years old', 'name': 'NCT00151502'}, {'nct_number': 'NCT00814697', 'title': \"Effect of Repetitive Transcranial Magnetic Stimulation on Language in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00814697', 'age_groups': '40 to 65 years old', 'name': 'NCT00814697'}, {'nct_number': 'NCT01380288', 'title': \"Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After Rivastigmine\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01380288', 'age_groups': '40 to 65 years old', 'name': 'NCT01380288'}, {'nct_number': 'NCT00921297', 'title': \"Cataract Removal and Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 122, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00921297', 'age_groups': '40 to 65 years old', 'name': 'NCT00921297'}, {'nct_number': 'NCT00766363', 'title': \"Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 49, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00766363', 'age_groups': '40 to 65 years old', 'name': 'NCT00766363'}, {'nct_number': 'NCT01025466', 'title': 'Exelon Patch and Combination With Memantine Comparative Trial', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 206, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01025466', 'age_groups': '40 to 65 years old', 'name': 'NCT01025466'}, {'nct_number': 'NCT02356055', 'title': 'Mass Practice of Activities of Daily Living in Dementia (STOMP)', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02356055', 'age_groups': '40 to 65 years old', 'name': 'NCT02356055'}, {'nct_number': 'NCT00257673', 'title': \"Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 183, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00257673', 'age_groups': '40 to 65 years old', 'name': 'NCT00257673'}, {'nct_number': 'NCT02442778', 'title': \"Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 522, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02442778', 'age_groups': '40 to 65 years old', 'name': 'NCT02442778'}, {'nct_number': 'NCT02750306', 'title': \"Safety and Efficacy of Suvorexant (MK-4305) for the Treatment of Insomnia in Participants With Alzheimer's Disease (MK-4305-061)\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 285, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02750306', 'age_groups': '40 to 65 years old', 'name': 'NCT02750306'}, {'nct_number': 'NCT01703702', 'title': 'Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline', 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 641, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01703702', 'age_groups': '40 to 65 years old', 'name': 'NCT01703702'}, {'nct_number': 'NCT01369225', 'title': \"Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 52, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01369225', 'age_groups': '40 to 65 years old', 'name': 'NCT01369225'}, {'nct_number': 'NCT00083421', 'title': \"Effects of ONO-2506PO in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 647, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00083421', 'age_groups': '40 to 65 years old', 'name': 'NCT00083421'}, {'nct_number': 'NCT00580931', 'title': \"Safety Study of Nicotinamide to Treat Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00580931', 'age_groups': '40 to 65 years old', 'name': 'NCT00580931'}, {'nct_number': 'NCT00009217', 'title': \"Treatment of Behavioral Symptoms in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 44, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00009217', 'age_groups': '40 to 65 years old', 'name': 'NCT00009217'}, {'nct_number': 'NCT00417482', 'title': \"Antipsychotic Discontinuation in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00417482', 'age_groups': '40 to 65 years old', 'name': 'NCT00417482'}, {'nct_number': 'NCT01273272', 'title': \"Cognitive-Behavioral Treatment for Mild Alzheimer's Patients and Their Caregivers\", 'status': 'Completed', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01273272', 'age_groups': '40 to 65 years old', 'name': 'NCT01273272'}, {'nct_number': 'NCT00768261', 'title': 'Corticolimbic Degeneration and Treatment of Dementia', 'status': 'Completed', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 39, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00768261', 'age_groups': '40 to 65 years old', 'name': 'NCT00768261'}, {'nct_number': 'NCT00013650', 'title': \"Effects of an Anti-Inflammatory Drug in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 1', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00013650', 'age_groups': '40 to 65 years old', 'name': 'NCT00013650'}, {'nct_number': 'NCT00255086', 'title': \"The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 3', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00255086', 'age_groups': '40 to 65 years old', 'name': 'NCT00255086'}, {'nct_number': 'NCT01772095', 'title': 'ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticE', 'status': 'Completed', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 389, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01772095', 'age_groups': '40 to 65 years old', 'name': 'NCT01772095'}, {'nct_number': 'NCT01735630', 'title': \"Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 2', 'enrollment': 350, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01735630', 'age_groups': '40 to 65 years old', 'name': 'NCT01735630'}, {'nct_number': 'NCT00911807', 'title': \"Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '51 Years and older ', 'phases': 'Phase 2', 'enrollment': 217, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00911807', 'age_groups': '40 to 65 years old', 'name': 'NCT00911807'}, {'nct_number': 'NCT01312363', 'title': \"Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients\", 'status': 'Completed', 'clean_age': '51 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 300, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01312363', 'age_groups': '40 to 65 years old', 'name': 'NCT01312363'}, {'nct_number': 'NCT00385684', 'title': 'Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 11, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00385684', 'age_groups': '40 to 65 years old', 'name': 'NCT00385684'}, {'nct_number': 'NCT00013182', 'title': 'Effect of Activity on Sleep of Cognitively-Impaired Veterans', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00013182', 'age_groups': '40 to 65 years old', 'name': 'NCT00013182'}, {'nct_number': 'NCT00012857', 'title': 'Pain Management and Behavioral Outcomes in Patients With Dementia', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 66, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00012857', 'age_groups': '40 to 65 years old', 'name': 'NCT00012857'}, {'nct_number': 'NCT02196545', 'title': \"Physical Activity Training Program for Patients With Alzheimer's Dementia\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02196545', 'age_groups': '40 to 65 years old', 'name': 'NCT02196545'}, {'nct_number': 'NCT00249158', 'title': 'A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 344, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00249158', 'age_groups': '40 to 65 years old', 'name': 'NCT00249158'}, {'nct_number': 'NCT01058941', 'title': \"Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 67, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01058941', 'age_groups': '40 to 65 years old', 'name': 'NCT01058941'}, {'nct_number': 'NCT00249145', 'title': 'A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 349, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00249145', 'age_groups': '40 to 65 years old', 'name': 'NCT00249145'}, {'nct_number': 'NCT01264614', 'title': 'Effects of Strengthening Exercise on the Brain for Early Dementia and Normative Older Adults', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01264614', 'age_groups': '40 to 65 years old', 'name': 'NCT01264614'}, {'nct_number': 'NCT01068353', 'title': \"Safety and Tolerability of Etanercept in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 41, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01068353', 'age_groups': '40 to 65 years old', 'name': 'NCT01068353'}, {'nct_number': 'NCT00090402', 'title': \"Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 39, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00090402', 'age_groups': '40 to 65 years old', 'name': 'NCT00090402'}, {'nct_number': 'NCT01142258', 'title': \"Trazodone for Sleep Disorders in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01142258', 'age_groups': '40 to 65 years old', 'name': 'NCT01142258'}, {'nct_number': 'NCT00105547', 'title': \"Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 1600, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00105547', 'age_groups': '40 to 65 years old', 'name': 'NCT00105547'}, {'nct_number': 'NCT00253123', 'title': 'A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 626, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00253123', 'age_groups': '40 to 65 years old', 'name': 'NCT00253123'}, {'nct_number': 'NCT00621647', 'title': 'Seroquel- Agitation Associated With Dementia', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 333, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00621647', 'age_groups': '40 to 65 years old', 'name': 'NCT00621647'}, {'nct_number': 'NCT01061489', 'title': 'Sensory-cognitive and Physical Fitness Training in Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 65, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01061489', 'age_groups': '40 to 65 years old', 'name': 'NCT01061489'}, {'nct_number': 'NCT01747213', 'title': 'Bisnorcymserine in Healthy Adult Volunteers', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 75, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01747213', 'age_groups': '40 to 65 years old', 'name': 'NCT01747213'}, {'nct_number': 'NCT00762411', 'title': \"Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 1111, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00762411', 'age_groups': '40 to 65 years old', 'name': 'NCT00762411'}, {'nct_number': 'NCT00357357', 'title': \"European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00357357', 'age_groups': '40 to 65 years old', 'name': 'NCT00357357'}, {'nct_number': 'NCT01802554', 'title': 'Reducing CVD Risk in Caregivers: A Brief Behavioral Activation Intervention', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01802554', 'age_groups': '40 to 65 years old', 'name': 'NCT01802554'}, {'nct_number': 'NCT00438568', 'title': 'SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 173, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00438568', 'age_groups': '40 to 65 years old', 'name': 'NCT00438568'}, {'nct_number': 'NCT01937221', 'title': \"Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01937221', 'age_groups': '40 to 65 years old', 'name': 'NCT01937221'}, {'nct_number': 'NCT02317523', 'title': \"Alzheimer's Caregiver Coping: Mental and Physical Health\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 151, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02317523', 'age_groups': '40 to 65 years old', 'name': 'NCT02317523'}, {'nct_number': 'NCT00757939', 'title': \"A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00757939', 'age_groups': '40 to 65 years old', 'name': 'NCT00757939'}, {'nct_number': 'NCT01780974', 'title': \"Pilot Study: Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Prevention\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01780974', 'age_groups': '40 to 65 years old', 'name': 'NCT01780974'}, {'nct_number': 'NCT01183806', 'title': \"Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01183806', 'age_groups': '40 to 65 years old', 'name': 'NCT01183806'}, {'nct_number': 'NCT00325728', 'title': \"Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 74, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00325728', 'age_groups': '40 to 65 years old', 'name': 'NCT00325728'}, {'nct_number': 'NCT02537496', 'title': \"Enhancing Working Memory in Patients With Early Alzheimer's Disease Through the Use of rTMS\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02537496', 'age_groups': '40 to 65 years old', 'name': 'NCT02537496'}, {'nct_number': 'NCT01253122', 'title': 'Comparative Bioavailability in Healthy Elderly Volunteers', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01253122', 'age_groups': '40 to 65 years old', 'name': 'NCT01253122'}, {'nct_number': 'NCT02240693', 'title': 'Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 128, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02240693', 'age_groups': '40 to 65 years old', 'name': 'NCT02240693'}, {'nct_number': 'NCT01253499', 'title': 'Multiple Dose Study of TRx0037', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 31, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01253499', 'age_groups': '40 to 65 years old', 'name': 'NCT01253499'}, {'nct_number': 'NCT02337907', 'title': \"BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 329, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02337907', 'age_groups': '40 to 65 years old', 'name': 'NCT02337907'}, {'nct_number': 'NCT00420420', 'title': \"MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011)\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 144, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00420420', 'age_groups': '40 to 65 years old', 'name': 'NCT00420420'}, {'nct_number': 'NCT00777608', 'title': \"A Study to Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimer's Disease (0000-086)(COMPLETED)\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 106, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00777608', 'age_groups': '40 to 65 years old', 'name': 'NCT00777608'}, {'nct_number': 'NCT00359944', 'title': \"Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 171, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00359944', 'age_groups': '40 to 65 years old', 'name': 'NCT00359944'}, {'nct_number': 'NCT00065689', 'title': \"High Intensity Light Therapy in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 107, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00065689', 'age_groups': '40 to 65 years old', 'name': 'NCT00065689'}, {'nct_number': 'NCT01013610', 'title': \"An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 110, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01013610', 'age_groups': '40 to 65 years old', 'name': 'NCT01013610'}, {'nct_number': 'NCT00056225', 'title': \"VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study)\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 340, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00056225', 'age_groups': '40 to 65 years old', 'name': 'NCT00056225'}, {'nct_number': 'NCT00254033', 'title': \"Apathy Associated With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00254033', 'age_groups': '40 to 65 years old', 'name': 'NCT00254033'}, {'nct_number': 'NCT02351882', 'title': \"Safety and Efficacy of Nabilone in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02351882', 'age_groups': '40 to 65 years old', 'name': 'NCT02351882'}, {'nct_number': 'NCT00594568', 'title': \"Effect of LY450139 on the Long Term Progression of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 1537, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00594568', 'age_groups': '40 to 65 years old', 'name': 'NCT00594568'}, {'nct_number': 'NCT00083590', 'title': \"Huperzine A in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00083590', 'age_groups': '40 to 65 years old', 'name': 'NCT00083590'}, {'nct_number': 'NCT02035982', 'title': \"Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02035982', 'age_groups': '40 to 65 years old', 'name': 'NCT02035982'}, {'nct_number': 'NCT00495820', 'title': \"Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00495820', 'age_groups': '40 to 65 years old', 'name': 'NCT00495820'}, {'nct_number': 'NCT00034762', 'title': \"Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 473, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00034762', 'age_groups': '40 to 65 years old', 'name': 'NCT00034762'}, {'nct_number': 'NCT01459016', 'title': \"A Non-drug Methods Study in Participants With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 56, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01459016', 'age_groups': '40 to 65 years old', 'name': 'NCT01459016'}, {'nct_number': 'NCT01266525', 'title': \"Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 291, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01266525', 'age_groups': '40 to 65 years old', 'name': 'NCT01266525'}, {'nct_number': 'NCT00905372', 'title': \"Effect of LY2062430 on the Progression of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 1000, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00905372', 'age_groups': '40 to 65 years old', 'name': 'NCT00905372'}, {'nct_number': 'NCT00392912', 'title': \"Effect of Testosterone Therapy in Men With Alzheimer's Disease and Low Testosterone\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00392912', 'age_groups': '40 to 65 years old', 'name': 'NCT00392912'}, {'nct_number': 'NCT00183378', 'title': \"Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 132, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00183378', 'age_groups': '40 to 65 years old', 'name': 'NCT00183378'}, {'nct_number': 'NCT02221622', 'title': \"Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02221622', 'age_groups': '40 to 65 years old', 'name': 'NCT02221622'}, {'nct_number': 'NCT00464334', 'title': 'A Study of V950 in People With Alzheimer Disease (V950-001 AM7)', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 86, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00464334', 'age_groups': '40 to 65 years old', 'name': 'NCT00464334'}, {'nct_number': 'NCT00904683', 'title': \"Effect of LY2062430 on the Progression of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 1040, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00904683', 'age_groups': '40 to 65 years old', 'name': 'NCT00904683'}, {'nct_number': 'NCT00954369', 'title': 'Exploratory and Safety Study of [F-18]W372', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00954369', 'age_groups': '40 to 65 years old', 'name': 'NCT00954369'}, {'nct_number': 'NCT01388478', 'title': \"Safety Study of R(+)Pramipexole to Treat Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01388478', 'age_groups': '40 to 65 years old', 'name': 'NCT01388478'}, {'nct_number': 'NCT01617577', 'title': \"Efficacy and Safety of Filgrastim in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01617577', 'age_groups': '40 to 65 years old', 'name': 'NCT01617577'}, {'nct_number': 'NCT00205179', 'title': \"Alzheimer's Disease: Potential Benefit of Isoflavones\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00205179', 'age_groups': '40 to 65 years old', 'name': 'NCT00205179'}, {'nct_number': 'NCT02702817', 'title': \"Randomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's Dementia\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02702817', 'age_groups': '40 to 65 years old', 'name': 'NCT02702817'}, {'nct_number': 'NCT01035138', 'title': \"A Study of Semagacestat for Alzheimer's Patients\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01035138', 'age_groups': '40 to 65 years old', 'name': 'NCT01035138'}, {'nct_number': 'NCT00750282', 'title': \"Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 422, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00750282', 'age_groups': '40 to 65 years old', 'name': 'NCT00750282'}, {'nct_number': 'NCT01217021', 'title': 'Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558', 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01217021', 'age_groups': '40 to 65 years old', 'name': 'NCT01217021'}, {'nct_number': 'NCT00191009', 'title': \"Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 124, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00191009', 'age_groups': '40 to 65 years old', 'name': 'NCT00191009'}, {'nct_number': 'NCT01128361', 'title': \"Pilot Study of Aerobic Exercise in Early Alzheimer's Disease(AD)\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 76, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01128361', 'age_groups': '40 to 65 years old', 'name': 'NCT01128361'}, {'nct_number': 'NCT02127476', 'title': \"A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 57, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02127476', 'age_groups': '40 to 65 years old', 'name': 'NCT02127476'}, {'nct_number': 'NCT00946530', 'title': \"Light Treatment for Sleep/Wake Disturbances in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 118, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00946530', 'age_groups': '40 to 65 years old', 'name': 'NCT00946530'}, {'nct_number': 'NCT00478166', 'title': \"Posterior Cingulate Function in Persons With Risk Factors for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 65 Years ', 'phases': 'Phase 4', 'enrollment': 206, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00478166', 'age_groups': '40 to 65 years old', 'name': 'NCT00478166'}, {'nct_number': 'NCT02010476', 'title': \"Alzheimer's Disease Biomarkers in Cerebrospinal Fluid in Insulin-resistant Men\", 'status': 'Completed', 'clean_age': '55 Years to 70 Years ', 'phases': 'Phase 4', 'enrollment': 58, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02010476', 'age_groups': '40 to 65 years old', 'name': 'NCT02010476'}, {'nct_number': 'NCT03577262', 'title': 'A Non-therapeutic Feasibility Study of the Radioligand [11C]-UCB-J for Imaging Synaptic Density', 'status': 'Completed', 'clean_age': '55 Years to 75 Years ', 'phases': 'Early Phase 1', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03577262', 'age_groups': '40 to 65 years old', 'name': 'NCT03577262'}, {'nct_number': 'NCT02180269', 'title': 'A Safety, Tolerability and Pharmacokinetics Study of JNJ-54861911 in Healthy Japanese Male Participants', 'status': 'Completed', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02180269', 'age_groups': '40 to 65 years old', 'name': 'NCT02180269'}, {'nct_number': 'NCT02353884', 'title': 'Multi-modality MRI Study on Prediction for Mild Cognitive Impairment Conversion', 'status': 'Completed', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02353884', 'age_groups': '40 to 65 years old', 'name': 'NCT02353884'}, {'nct_number': 'NCT02260700', 'title': 'A Study to Evaluate Bioavailability, Food Effect, Safety and Tolerability of a Solid Dosage Formulation of JNJ-54861911 in Healthy Older Male Participants', 'status': 'Completed', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02260700', 'age_groups': '40 to 65 years old', 'name': 'NCT02260700'}, {'nct_number': 'NCT01887535', 'title': 'A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54861911 in Healthy Elderly Participants', 'status': 'Completed', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01887535', 'age_groups': '40 to 65 years old', 'name': 'NCT01887535'}, {'nct_number': 'NCT00876863', 'title': \"Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 49, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00876863', 'age_groups': '40 to 65 years old', 'name': 'NCT00876863'}, {'nct_number': 'NCT01702480', 'title': 'Effects of Triglycerides on Age-Related Cognitive Function Decline in Older Subjects', 'status': 'Completed', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 116, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01702480', 'age_groups': '40 to 65 years old', 'name': 'NCT01702480'}, {'nct_number': 'NCT00459550', 'title': \"A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00459550', 'age_groups': '40 to 65 years old', 'name': 'NCT00459550'}, {'nct_number': 'NCT03418688', 'title': 'A Multiple Ascending Dose Study of COR388', 'status': 'Completed', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 33, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03418688', 'age_groups': '40 to 65 years old', 'name': 'NCT03418688'}, {'nct_number': 'NCT01965756', 'title': 'Effect of Insulin Sensitizer Metformin on AD Biomarkers', 'status': 'Completed', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01965756', 'age_groups': '40 to 65 years old', 'name': 'NCT01965756'}, {'nct_number': 'NCT01254448', 'title': \"Multiple Ascending Dose Study of TC-5619 in Healthy Elderly Subjects and Subjects With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01254448', 'age_groups': '40 to 65 years old', 'name': 'NCT01254448'}, {'nct_number': 'NCT02707458', 'title': 'Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive Deterioration', 'status': 'Completed', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 23, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02707458', 'age_groups': '40 to 65 years old', 'name': 'NCT02707458'}, {'nct_number': 'NCT01795339', 'title': \"A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients\", 'status': 'Completed', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 47, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01795339', 'age_groups': '40 to 65 years old', 'name': 'NCT01795339'}, {'nct_number': 'NCT03093519', 'title': \"A Repeated Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 84 Years ', 'phases': 'Phase 1', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03093519', 'age_groups': '40 to 65 years old', 'name': 'NCT03093519'}, {'nct_number': 'NCT02377713', 'title': \"A Single Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease.\", 'status': 'Completed', 'clean_age': '55 Years to 84 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02377713', 'age_groups': '40 to 65 years old', 'name': 'NCT02377713'}, {'nct_number': 'NCT01730430', 'title': \"Cerebrospinal Fluid (CSF) Biomarkers Alzheimer's Disease (AD) and Non-AD Dementias\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01730430', 'age_groups': '40 to 65 years old', 'name': 'NCT01730430'}, {'nct_number': 'NCT01397539', 'title': \"Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 53, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01397539', 'age_groups': '40 to 65 years old', 'name': 'NCT01397539'}, {'nct_number': 'NCT02973971', 'title': 'ADDIA Chronobiological Study', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 24, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02973971', 'age_groups': '40 to 65 years old', 'name': 'NCT02973971'}, {'nct_number': 'NCT01429623', 'title': 'A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 210, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01429623', 'age_groups': '40 to 65 years old', 'name': 'NCT01429623'}, {'nct_number': 'NCT02431468', 'title': \"A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 147, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02431468', 'age_groups': '40 to 65 years old', 'name': 'NCT02431468'}, {'nct_number': 'NCT02386306', 'title': \"Study Evaluating Safety, Tolerability, and PK of Multiple Ascending Doses of GC021109 in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 39, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02386306', 'age_groups': '40 to 65 years old', 'name': 'NCT02386306'}, {'nct_number': 'NCT02434718', 'title': \"Single and Multiple Ascending Dose Study of Aducanumab (BIIB037) in Japanese Participants With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02434718', 'age_groups': '40 to 65 years old', 'name': 'NCT02434718'}, {'nct_number': 'NCT02079909', 'title': \"Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 482, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02079909', 'age_groups': '40 to 65 years old', 'name': 'NCT02079909'}, {'nct_number': 'NCT00909285', 'title': 'Effects of Transcranial Magnetic Stimulation (TMS) and Cognitive Training for Alzheimer Patients', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00909285', 'age_groups': '40 to 65 years old', 'name': 'NCT00909285'}, {'nct_number': 'NCT00744978', 'title': \"Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 66, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00744978', 'age_groups': '40 to 65 years old', 'name': 'NCT00744978'}, {'nct_number': 'NCT01249196', 'title': \"A Confirmatory Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 256, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01249196', 'age_groups': '40 to 65 years old', 'name': 'NCT01249196'}, {'nct_number': 'NCT00988598', 'title': \"A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00988598', 'age_groups': '40 to 65 years old', 'name': 'NCT00988598'}, {'nct_number': 'NCT01168245', 'title': 'TMS Stimulation and Cognitive Training in Alzheimer Patients', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01168245', 'age_groups': '40 to 65 years old', 'name': 'NCT01168245'}, {'nct_number': 'NCT03901105', 'title': \"Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 205, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03901105', 'age_groups': '40 to 65 years old', 'name': 'NCT03901105'}, {'nct_number': 'NCT02064920', 'title': \"Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318)\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02064920', 'age_groups': '40 to 65 years old', 'name': 'NCT02064920'}, {'nct_number': 'NCT00930059', 'title': \"A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 198, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00930059', 'age_groups': '40 to 65 years old', 'name': 'NCT00930059'}, {'nct_number': 'NCT02244541', 'title': \"Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02244541', 'age_groups': '40 to 65 years old', 'name': 'NCT02244541'}, {'nct_number': 'NCT03560245', 'title': \"A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 108, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03560245', 'age_groups': '40 to 65 years old', 'name': 'NCT03560245'}, {'nct_number': 'NCT00627848', 'title': \"Rivastigmine in Mild Alzheimer's Disease, FMRI Study\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00627848', 'age_groups': '40 to 65 years old', 'name': 'NCT00627848'}, {'nct_number': 'NCT01561053', 'title': \"A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 347, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01561053', 'age_groups': '40 to 65 years old', 'name': 'NCT01561053'}, {'nct_number': 'NCT01439555', 'title': \"Endothelial Facilitation in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 11, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01439555', 'age_groups': '40 to 65 years old', 'name': 'NCT01439555'}, {'nct_number': 'NCT03055741', 'title': \"Study of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil(DRAMA)\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03055741', 'age_groups': '40 to 65 years old', 'name': 'NCT03055741'}, {'nct_number': 'NCT03363269', 'title': \"Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 116, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03363269', 'age_groups': '40 to 65 years old', 'name': 'NCT03363269'}, {'nct_number': 'NCT00040443', 'title': 'Efficacy And Safety Of CX516 In Elderly Participants With Mild Cognitive Impairment.', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 175, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00040443', 'age_groups': '40 to 65 years old', 'name': 'NCT00040443'}, {'nct_number': 'NCT02986932', 'title': \"Blood-Brain-Barrier Opening Using Focused Ultrasound With IV Contrast Agents in Patients With Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02986932', 'age_groups': '40 to 65 years old', 'name': 'NCT02986932'}, {'nct_number': 'NCT03456349', 'title': 'Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03456349', 'age_groups': '40 to 65 years old', 'name': 'NCT03456349'}, {'nct_number': 'NCT02626572', 'title': \"Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 500, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02626572', 'age_groups': '40 to 65 years old', 'name': 'NCT02626572'}, {'nct_number': 'NCT00742417', 'title': 'Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fluid', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00742417', 'age_groups': '40 to 65 years old', 'name': 'NCT00742417'}, {'nct_number': 'NCT01374438', 'title': \"3-month Study of MSDC-0160 Effects on Brain Glucose Utilization, Cognition & Safety in Subjects With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 29, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01374438', 'age_groups': '40 to 65 years old', 'name': 'NCT01374438'}, {'nct_number': 'NCT03402659', 'title': \"Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 161, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03402659', 'age_groups': '40 to 65 years old', 'name': 'NCT03402659'}, {'nct_number': 'NCT00660088', 'title': 'Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy Elderly', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00660088', 'age_groups': '40 to 65 years old', 'name': 'NCT00660088'}, {'nct_number': 'NCT01767909', 'title': 'The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 239, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01767909', 'age_groups': '40 to 65 years old', 'name': 'NCT01767909'}, {'nct_number': 'NCT04104373', 'title': 'The Ontario Neurodegenerative Disease Research Initiative', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 522, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04104373', 'age_groups': '40 to 65 years old', 'name': 'NCT04104373'}, {'nct_number': 'NCT02279511', 'title': 'ATP in Alzheimer Disease', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02279511', 'age_groups': '40 to 65 years old', 'name': 'NCT02279511'}, {'nct_number': 'NCT02036645', 'title': \"SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 77, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02036645', 'age_groups': '40 to 65 years old', 'name': 'NCT02036645'}, {'nct_number': 'NCT01024660', 'title': 'The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Early Phase 1', 'enrollment': 155, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01024660', 'age_groups': '40 to 65 years old', 'name': 'NCT01024660'}, {'nct_number': 'NCT00243451', 'title': 'Early Detection of Mild Cognitive Impairment in Individual Patients', 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 34, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00243451', 'age_groups': '40 to 65 years old', 'name': 'NCT00243451'}, {'nct_number': 'NCT00443417', 'title': \"A Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 188, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00443417', 'age_groups': '40 to 65 years old', 'name': 'NCT00443417'}, {'nct_number': 'NCT01424436', 'title': \"Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01424436', 'age_groups': '40 to 65 years old', 'name': 'NCT01424436'}, {'nct_number': 'NCT02167256', 'title': \"A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 159, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02167256', 'age_groups': '40 to 65 years old', 'name': 'NCT02167256'}, {'nct_number': 'NCT01727622', 'title': 'Arterial Spin Labeling (ASL) MRI for Cognitive Decline', 'status': 'Completed', 'clean_age': '55 Years to 89 Years ', 'phases': 'Phase 4', 'enrollment': 102, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01727622', 'age_groups': '40 to 65 years old', 'name': 'NCT01727622'}, {'nct_number': 'NCT01482351', 'title': 'Mild Cognitive Impairment and Obstructive Sleep Apnea', 'status': 'Completed', 'clean_age': '55 Years to 89 Years ', 'phases': 'Not Applicable', 'enrollment': 54, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01482351', 'age_groups': '40 to 65 years old', 'name': 'NCT01482351'}, {'nct_number': 'NCT01922258', 'title': \"Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 270, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01922258', 'age_groups': '40 to 65 years old', 'name': 'NCT01922258'}, {'nct_number': 'NCT01862640', 'title': \"Safety and Tolerability Study of Two Fixed-doses of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 433, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01862640', 'age_groups': '40 to 65 years old', 'name': 'NCT01862640'}, {'nct_number': 'NCT01908010', 'title': \"Safety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01908010', 'age_groups': '40 to 65 years old', 'name': 'NCT01908010'}, {'nct_number': 'NCT00066157', 'title': \"Alzheimer's Disease: Therapeutic Potential of Estrogen\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00066157', 'age_groups': '40 to 65 years old', 'name': 'NCT00066157'}, {'nct_number': 'NCT01482845', 'title': \"A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01482845', 'age_groups': '40 to 65 years old', 'name': 'NCT01482845'}, {'nct_number': 'NCT01549834', 'title': \"Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 434, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01549834', 'age_groups': '40 to 65 years old', 'name': 'NCT01549834'}, {'nct_number': 'NCT01137526', 'title': \"Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 267, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01137526', 'age_groups': '40 to 65 years old', 'name': 'NCT01137526'}, {'nct_number': 'NCT00071721', 'title': 'Valproate in Dementia (VALID)', 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 313, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00071721', 'age_groups': '40 to 65 years old', 'name': 'NCT00071721'}, {'nct_number': 'NCT00413621', 'title': \"MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00413621', 'age_groups': '40 to 65 years old', 'name': 'NCT00413621'}, {'nct_number': 'NCT01047254', 'title': \"Bupropion for the Treatment of Apathy in Alzheimer's Dementia\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 110, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01047254', 'age_groups': '40 to 65 years old', 'name': 'NCT01047254'}, {'nct_number': 'NCT01504958', 'title': 'Effects of a Combined Transcranial Magnetic Stimulation (TMS) and Cognitive Training in Alzheimer Patients', 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01504958', 'age_groups': '40 to 65 years old', 'name': 'NCT01504958'}, {'nct_number': 'NCT00620191', 'title': 'Metformin in Amnestic Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00620191', 'age_groups': '40 to 65 years old', 'name': 'NCT00620191'}, {'nct_number': 'NCT01078636', 'title': \"Alzheimer's Disease Neuroimaging Initiative Grand Opportunity\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 342, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01078636', 'age_groups': '40 to 65 years old', 'name': 'NCT01078636'}, {'nct_number': 'NCT00209456', 'title': 'Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia', 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 326, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00209456', 'age_groups': '40 to 65 years old', 'name': 'NCT00209456'}, {'nct_number': 'NCT01688128', 'title': 'Efficacy of Ubiquitous SR-based Memory Advancement and Rehabilitation Training (U-SMART)', 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01688128', 'age_groups': '40 to 65 years old', 'name': 'NCT01688128'}, {'nct_number': 'NCT01628653', 'title': 'Ubiquitous Spaced Retrieval-based Memory Advancement and Rehabilitation Training', 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01628653', 'age_groups': '40 to 65 years old', 'name': 'NCT01628653'}, {'nct_number': 'NCT03630419', 'title': 'Specialized Food Plan Based on Individual Physiological Comprehensive Body Assessments Accompanied With Cellular Repair Therapy to Decrease Inflammation Cognitively Impaired Patients', 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03630419', 'age_groups': '40 to 65 years old', 'name': 'NCT03630419'}, {'nct_number': 'NCT00093951', 'title': \"SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 280, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00093951', 'age_groups': '40 to 65 years old', 'name': 'NCT00093951'}, {'nct_number': 'NCT00106899', 'title': \"ADNI: Alzheimer's Disease Neuroimaging Initiative\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 818, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00106899', 'age_groups': '40 to 65 years old', 'name': 'NCT00106899'}, {'nct_number': 'NCT00483028', 'title': 'A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI', 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00483028', 'age_groups': '40 to 65 years old', 'name': 'NCT00483028'}, {'nct_number': 'NCT00628017', 'title': 'Preliminary Study of Fish Oil and Dementia', 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 46, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00628017', 'age_groups': '40 to 65 years old', 'name': 'NCT00628017'}, {'nct_number': 'NCT01463384', 'title': \"Minocycline in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 13, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01463384', 'age_groups': '40 to 65 years old', 'name': 'NCT01463384'}, {'nct_number': 'NCT02471196', 'title': \"Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 308, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02471196', 'age_groups': '40 to 65 years old', 'name': 'NCT02471196'}, {'nct_number': 'NCT00065767', 'title': \"Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00065767', 'age_groups': '40 to 65 years old', 'name': 'NCT00065767'}, {'nct_number': 'NCT00257712', 'title': 'SMART: Somatotrophics, Memory, and Aging Research Trial', 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 151, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00257712', 'age_groups': '40 to 65 years old', 'name': 'NCT00257712'}, {'nct_number': 'NCT00855868', 'title': \"Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 28, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00855868', 'age_groups': '40 to 65 years old', 'name': 'NCT00855868'}, {'nct_number': 'NCT01324518', 'title': \"Safety and Efficacy of ORM-12741 in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01324518', 'age_groups': '40 to 65 years old', 'name': 'NCT01324518'}, {'nct_number': 'NCT01231971', 'title': \"Alzheimer's Disease Neuroimaging Initiative 2\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 1185, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01231971', 'age_groups': '40 to 65 years old', 'name': 'NCT01231971'}, {'nct_number': 'NCT01018875', 'title': \"Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 242, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01018875', 'age_groups': '40 to 65 years old', 'name': 'NCT01018875'}, {'nct_number': 'NCT00933608', 'title': \"Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00933608', 'age_groups': '40 to 65 years old', 'name': 'NCT00933608'}, {'nct_number': 'NCT01527916', 'title': \"Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 438, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01527916', 'age_groups': '40 to 65 years old', 'name': 'NCT01527916'}, {'nct_number': 'NCT00948909', 'title': \"Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 274, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00948909', 'age_groups': '40 to 65 years old', 'name': 'NCT00948909'}, {'nct_number': 'NCT02190084', 'title': \"Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia\", 'status': 'Completed', 'clean_age': '55 Years to 91 Years ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02190084', 'age_groups': '40 to 65 years old', 'name': 'NCT02190084'}, {'nct_number': 'NCT01951118', 'title': 'Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly', 'status': 'Completed', 'clean_age': '55 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 121, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01951118', 'age_groups': '40 to 65 years old', 'name': 'NCT01951118'}, {'nct_number': 'NCT00095719', 'title': 'Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia', 'status': 'Completed', 'clean_age': '55 Years to 95 Years ', 'phases': 'Phase 3', 'enrollment': 125, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00095719', 'age_groups': '40 to 65 years old', 'name': 'NCT00095719'}, {'nct_number': 'NCT01845636', 'title': 'Olfactory Deficits in MCI as Predictor of Improved Cognition on Donepezil', 'status': 'Completed', 'clean_age': '55 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 41, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01845636', 'age_groups': '40 to 65 years old', 'name': 'NCT01845636'}, {'nct_number': 'NCT01438060', 'title': \"Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type\", 'status': 'Completed', 'clean_age': '55 Years to 95 Years ', 'phases': 'Phase 3', 'enrollment': 232, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01438060', 'age_groups': '40 to 65 years old', 'name': 'NCT01438060'}, {'nct_number': 'NCT01119638', 'title': \"Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to Risperidone\", 'status': 'Completed', 'clean_age': '55 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01119638', 'age_groups': '40 to 65 years old', 'name': 'NCT01119638'}, {'nct_number': 'NCT00544856', 'title': \"Effects of a Complex Cognitive Training in Mild Cognitive Impairment and Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '55 Years to 95 Years ', 'phases': 'Not Applicable', 'enrollment': 39, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00544856', 'age_groups': '40 to 65 years old', 'name': 'NCT00544856'}, {'nct_number': 'NCT00471211', 'title': \"Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '56 Years and older ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00471211', 'age_groups': '40 to 65 years old', 'name': 'NCT00471211'}, {'nct_number': 'NCT03016702', 'title': 'The Cognitive Resilience Study', 'status': 'Completed', 'clean_age': '58 Years to 70 Years ', 'phases': 'Not Applicable', 'enrollment': 29, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03016702', 'age_groups': '40 to 65 years old', 'name': 'NCT03016702'}, {'nct_number': 'NCT02187276', 'title': 'The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia', 'status': 'Completed', 'clean_age': '59 Years to 92 Years ', 'phases': 'Phase 4', 'enrollment': 129, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02187276', 'age_groups': '40 to 65 years old', 'name': 'NCT02187276'}, {'nct_number': 'NCT02978768', 'title': \"Tai Chi 6-Form Sports Apparatus With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '59 Years to 92 Years ', 'phases': 'Not Applicable', 'enrollment': 67, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02978768', 'age_groups': '40 to 65 years old', 'name': 'NCT02978768'}, {'nct_number': 'NCT02007291', 'title': \"Good Rate of Clinical Response to Cholinesterase Inhibitors in Alzheimer's Disease After Three Months of Treatment\", 'status': 'Completed', 'clean_age': '59 Years to 93 Years ', 'phases': 'Phase 4', 'enrollment': 71, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02007291', 'age_groups': '40 to 65 years old', 'name': 'NCT02007291'}, {'nct_number': 'NCT03357328', 'title': 'Therapy Light Rooms for Improved Sleep in Dementia Patients', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03357328', 'age_groups': '40 to 65 years old', 'name': 'NCT03357328'}, {'nct_number': 'NCT01315717', 'title': 'Gait and Alzheimer Interaction Tracking (GAIT) Study', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 912, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01315717', 'age_groups': '40 to 65 years old', 'name': 'NCT01315717'}, {'nct_number': 'NCT00646074', 'title': \"Self- Care TALK Study - Promoting Alzheimer's Disease (AD) Spousal Caregiver Health\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 46, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00646074', 'age_groups': '40 to 65 years old', 'name': 'NCT00646074'}, {'nct_number': 'NCT03121950', 'title': 'Movement and Music Intervention for Individuals With Dementia', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03121950', 'age_groups': '40 to 65 years old', 'name': 'NCT03121950'}, {'nct_number': 'NCT00997425', 'title': 'Home Evaluation of Exit Barriers in Wandering', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00997425', 'age_groups': '40 to 65 years old', 'name': 'NCT00997425'}, {'nct_number': 'NCT02933177', 'title': 'Effectiveness of Flash Mediation Therapy', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 241, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02933177', 'age_groups': '40 to 65 years old', 'name': 'NCT02933177'}, {'nct_number': 'NCT02361424', 'title': 'Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD)', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 47, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02361424', 'age_groups': '40 to 65 years old', 'name': 'NCT02361424'}, {'nct_number': 'NCT02176629', 'title': \"Usability of Virtual Reality in Subjects With Mild Cognitive Impairment or Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02176629', 'age_groups': '40 to 65 years old', 'name': 'NCT02176629'}, {'nct_number': 'NCT02248636', 'title': 'Cholinesterase Inhibitor Discontinuation', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02248636', 'age_groups': '40 to 65 years old', 'name': 'NCT02248636'}, {'nct_number': 'NCT01630525', 'title': '\" The Eyes Have it \" : Ocular Saccade Abnormalities in Prodromal Alzheimer\\'s Disease', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 83, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01630525', 'age_groups': '40 to 65 years old', 'name': 'NCT01630525'}, {'nct_number': 'NCT01028053', 'title': \"Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 3', 'enrollment': 365, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01028053', 'age_groups': '40 to 65 years old', 'name': 'NCT01028053'}, {'nct_number': 'NCT01798199', 'title': 'Vanquishing Apathy Through E-inclusion Using Realistic Virtual Environment Project', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01798199', 'age_groups': '40 to 65 years old', 'name': 'NCT01798199'}, {'nct_number': 'NCT00549601', 'title': \"Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 142, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00549601', 'age_groups': '40 to 65 years old', 'name': 'NCT00549601'}, {'nct_number': 'NCT02294513', 'title': \"Hearing Instruments in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 25, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02294513', 'age_groups': '40 to 65 years old', 'name': 'NCT02294513'}, {'nct_number': 'NCT00843518', 'title': \"Treatment for Aggression and Agitation in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 132, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00843518', 'age_groups': '40 to 65 years old', 'name': 'NCT00843518'}, {'nct_number': 'NCT01478204', 'title': \"A Study to Evaluate Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 925, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01478204', 'age_groups': '40 to 65 years old', 'name': 'NCT01478204'}, {'nct_number': 'NCT02205710', 'title': 'Adaptive Cognitive Training in Healthy Older Adults', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 99, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02205710', 'age_groups': '40 to 65 years old', 'name': 'NCT02205710'}, {'nct_number': 'NCT00190372', 'title': \"AIDMA: A Psycho-educational Program Designed to Support and Train Carers of Alzheimer's Disease (AD) Patients\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00190372', 'age_groups': '40 to 65 years old', 'name': 'NCT00190372'}, {'nct_number': 'NCT03075007', 'title': 'Brain Vascular Disease in Aging and Dementia', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 48, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03075007', 'age_groups': '40 to 65 years old', 'name': 'NCT03075007'}, {'nct_number': 'NCT00581867', 'title': \"Memory and Insulin in Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 31, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00581867', 'age_groups': '40 to 65 years old', 'name': 'NCT00581867'}, {'nct_number': 'NCT00368459', 'title': \"Raloxifene for Women With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00368459', 'age_groups': '40 to 65 years old', 'name': 'NCT00368459'}, {'nct_number': 'NCT01325259', 'title': \"FluoroAv45 Imaging Research-in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 54, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01325259', 'age_groups': '40 to 65 years old', 'name': 'NCT01325259'}, {'nct_number': 'NCT01515982', 'title': 'Physical Exercise as an Additional Treatment for Alzheimer Disease', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01515982', 'age_groups': '40 to 65 years old', 'name': 'NCT01515982'}, {'nct_number': 'NCT00231946', 'title': \"ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 3', 'enrollment': 555, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00231946', 'age_groups': '40 to 65 years old', 'name': 'NCT00231946'}, {'nct_number': 'NCT00035204', 'title': \"A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 63, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00035204', 'age_groups': '40 to 65 years old', 'name': 'NCT00035204'}, {'nct_number': 'NCT00611312', 'title': \"Effects of Delivery Mode of Cognition Intervention in Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00611312', 'age_groups': '40 to 65 years old', 'name': 'NCT00611312'}, {'nct_number': 'NCT02702102', 'title': \"Imaging Inflammation in Patients With Parkinson's Disease Dementia or Dementia With Lewy Bodies\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02702102', 'age_groups': '40 to 65 years old', 'name': 'NCT02702102'}, {'nct_number': 'NCT01867346', 'title': 'Early Markers of Cognitive Change and Alzheimer s Disease', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 2850, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01867346', 'age_groups': '40 to 65 years old', 'name': 'NCT01867346'}, {'nct_number': 'NCT02521818', 'title': 'Dietary Treatments for Cognitive Impairment in Older Adults', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02521818', 'age_groups': '40 to 65 years old', 'name': 'NCT02521818'}, {'nct_number': 'NCT00597376', 'title': 'Study of the Effects of Cerefolin NAC on Inflammation Blood Markers in Older Individuals With Memory Complaints', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 104, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00597376', 'age_groups': '40 to 65 years old', 'name': 'NCT00597376'}, {'nct_number': 'NCT00062569', 'title': \"Bathing Persons With Alzheimer's Disease aT Home (The BATH Study)\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00062569', 'age_groups': '40 to 65 years old', 'name': 'NCT00062569'}, {'nct_number': 'NCT01569997', 'title': 'Impact of Systematic Tracking of Dementia Cases on the Rate of Hospitalization in Emergency Care Units', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 1428, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01569997', 'age_groups': '40 to 65 years old', 'name': 'NCT01569997'}, {'nct_number': 'NCT01409694', 'title': \"Alzheimer's Disease - Input of Vitamin D With mEmantine Assay\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 3', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01409694', 'age_groups': '40 to 65 years old', 'name': 'NCT01409694'}, {'nct_number': 'NCT00384423', 'title': \"Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00384423', 'age_groups': '40 to 65 years old', 'name': 'NCT00384423'}, {'nct_number': 'NCT02361242', 'title': '24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I Completion', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02361242', 'age_groups': '40 to 65 years old', 'name': 'NCT02361242'}, {'nct_number': 'NCT00182988', 'title': \"Alzheimer's Caregiver Communication Study\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 140, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00182988', 'age_groups': '40 to 65 years old', 'name': 'NCT00182988'}, {'nct_number': 'NCT01138111', 'title': 'Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 1', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01138111', 'age_groups': '40 to 65 years old', 'name': 'NCT01138111'}, {'nct_number': 'NCT01548053', 'title': 'The Primary Care - Dementia Assessment and Treatment Algorithm', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 55, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01548053', 'age_groups': '40 to 65 years old', 'name': 'NCT01548053'}, {'nct_number': 'NCT02222181', 'title': \"Impact of Pharmacotherapy Management in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 55, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02222181', 'age_groups': '40 to 65 years old', 'name': 'NCT02222181'}, {'nct_number': 'NCT02670993', 'title': \"Support by Singing Sessions on Physical and Moral Pain : Assessment of Its Effectiveness in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 59, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02670993', 'age_groups': '40 to 65 years old', 'name': 'NCT02670993'}, {'nct_number': 'NCT01021644', 'title': 'Genes, Exercise, Memory and Neurodegeneration', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 73, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01021644', 'age_groups': '40 to 65 years old', 'name': 'NCT01021644'}, {'nct_number': 'NCT03313518', 'title': 'Therapeutic Role of Transcranial DCS in Alzheimer', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03313518', 'age_groups': '40 to 65 years old', 'name': 'NCT03313518'}, {'nct_number': 'NCT03786510', 'title': 'A Study on the Effectiveness of Multidomain Intervention Program for Reducing Risks of Dementia', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03786510', 'age_groups': '40 to 65 years old', 'name': 'NCT03786510'}, {'nct_number': 'NCT01000038', 'title': 'Wii-fit for Activity, Balance and Gait in Assisted Living', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01000038', 'age_groups': '40 to 65 years old', 'name': 'NCT01000038'}, {'nct_number': 'NCT01978353', 'title': 'Memory Training in Patients With Amnestic Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01978353', 'age_groups': '40 to 65 years old', 'name': 'NCT01978353'}, {'nct_number': 'NCT01409564', 'title': 'Cilostazol Augmentation Study in Dementia', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 46, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01409564', 'age_groups': '40 to 65 years old', 'name': 'NCT01409564'}, {'nct_number': 'NCT01993836', 'title': 'Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative Care', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 191, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01993836', 'age_groups': '40 to 65 years old', 'name': 'NCT01993836'}, {'nct_number': 'NCT01002586', 'title': \"Wii-Fit For Improving Activity, Gait And Balance In Alzheimer's Dementia\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01002586', 'age_groups': '40 to 65 years old', 'name': 'NCT01002586'}, {'nct_number': 'NCT02210286', 'title': 'Magnesium L-Threonate for the Enhancement of Learning and Memory in People With Dementia', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02210286', 'age_groups': '40 to 65 years old', 'name': 'NCT02210286'}, {'nct_number': 'NCT02267057', 'title': 'Efficacy of Pain Treatment on Depression in Patients With Dementia', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 163, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02267057', 'age_groups': '40 to 65 years old', 'name': 'NCT02267057'}, {'nct_number': 'NCT02021682', 'title': \"CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 58, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02021682', 'age_groups': '40 to 65 years old', 'name': 'NCT02021682'}, {'nct_number': 'NCT02005380', 'title': \"Usability Study of Spaced Retrieval Exercise Using Mobile Devices for Alzheimer's Disease Rehabilitation\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02005380', 'age_groups': '40 to 65 years old', 'name': 'NCT02005380'}, {'nct_number': 'NCT00476008', 'title': \"Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00476008', 'age_groups': '40 to 65 years old', 'name': 'NCT00476008'}, {'nct_number': 'NCT00499200', 'title': 'Study Evaluating Safety, Tolerability, Pharmacokinetics and 5 HT1A Receptor Occupancy', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 1', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00499200', 'age_groups': '40 to 65 years old', 'name': 'NCT00499200'}, {'nct_number': 'NCT02686190', 'title': \"Effects of Light-therapy in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 91, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02686190', 'age_groups': '40 to 65 years old', 'name': 'NCT02686190'}, {'nct_number': 'NCT00082602', 'title': \"Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 3', 'enrollment': 83, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00082602', 'age_groups': '40 to 65 years old', 'name': 'NCT00082602'}, {'nct_number': 'NCT00951834', 'title': 'Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00951834', 'age_groups': '40 to 65 years old', 'name': 'NCT00951834'}, {'nct_number': 'NCT00000177', 'title': 'Estrogen Hormone Protocol', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 3', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00000177', 'age_groups': '40 to 65 years old', 'name': 'NCT00000177'}, {'nct_number': 'NCT00178568', 'title': 'Reducing Caregiver Stress and Sleep Disturbances in Patients With Progressive Dementia', 'status': 'Completed', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00178568', 'age_groups': '40 to 65 years old', 'name': 'NCT00178568'}, {'nct_number': 'NCT01920672', 'title': 'Disrupted Sleep, Neuroendocrine Status and the Behavioral Symptoms of AD', 'status': 'Completed', 'clean_age': '60 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 82, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01920672', 'age_groups': '40 to 65 years old', 'name': 'NCT01920672'}, {'nct_number': 'NCT01661894', 'title': 'Effectiveness of a Brain-Computer Interface Based System for Cognitive Enhancement in the Normal Elderly', 'status': 'Completed', 'clean_age': '60 Years to 70 Years ', 'phases': 'Phase 1', 'enrollment': 82, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01661894', 'age_groups': '40 to 65 years old', 'name': 'NCT01661894'}, {'nct_number': 'NCT04113967', 'title': \"Efficacy of a Biodanza Program in People With Alzheimer's Disease.\", 'status': 'Completed', 'clean_age': '60 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04113967', 'age_groups': '40 to 65 years old', 'name': 'NCT04113967'}, {'nct_number': 'NCT01696019', 'title': 'Randomized Trial of Exercise and Social Interaction in a Community-Based Sample of Non-Demented Chinese Elders', 'status': 'Completed', 'clean_age': '60 Years to 79 Years ', 'phases': 'Not Applicable', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01696019', 'age_groups': '40 to 65 years old', 'name': 'NCT01696019'}, {'nct_number': 'NCT02520232', 'title': 'Pathological and Non-pathological Aging, Physical Activity, Genotype and Cognition', 'status': 'Completed', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 139, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02520232', 'age_groups': '40 to 65 years old', 'name': 'NCT02520232'}, {'nct_number': 'NCT02228187', 'title': 'Brain-Computer Interface System for Training Memory and Attention in Elderly', 'status': 'Completed', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02228187', 'age_groups': '40 to 65 years old', 'name': 'NCT02228187'}, {'nct_number': 'NCT00979446', 'title': 'Passport to Brain Wellness in Sedentary Adults', 'status': 'Completed', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 63, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00979446', 'age_groups': '40 to 65 years old', 'name': 'NCT00979446'}, {'nct_number': 'NCT02273895', 'title': \"The Use of EEG in Alzheimer's Disease, With and Without Scopolamine - A Pilot Study\", 'status': 'Completed', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 29, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02273895', 'age_groups': '40 to 65 years old', 'name': 'NCT02273895'}, {'nct_number': 'NCT00687141', 'title': 'Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects', 'status': 'Completed', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 112, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00687141', 'age_groups': '40 to 65 years old', 'name': 'NCT00687141'}, {'nct_number': 'NCT01094145', 'title': \"Deep Brain Stimulation (DBS) of the Nucleus Basalis Meynert (NBM) to Treat Cognitive Deficits in Light to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01094145', 'age_groups': '40 to 65 years old', 'name': 'NCT01094145'}, {'nct_number': 'NCT02576639', 'title': 'Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of Age', 'status': 'Completed', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 124, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02576639', 'age_groups': '40 to 65 years old', 'name': 'NCT02576639'}, {'nct_number': 'NCT01354691', 'title': \"Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 201, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01354691', 'age_groups': '40 to 65 years old', 'name': 'NCT01354691'}, {'nct_number': 'NCT00551772', 'title': 'A Study To Assess The Pharmacokinetics Of SB-742457 Formulated As A Capsule And A Tablet In Healthy Elderly Volunteers.', 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00551772', 'age_groups': '40 to 65 years old', 'name': 'NCT00551772'}, {'nct_number': 'NCT02423200', 'title': \"Clinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02423200', 'age_groups': '40 to 65 years old', 'name': 'NCT02423200'}, {'nct_number': 'NCT01466088', 'title': \"Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 386, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01466088', 'age_groups': '40 to 65 years old', 'name': 'NCT01466088'}, {'nct_number': 'NCT02089555', 'title': \"African American Alzheimer's Progression Markers - CSF and Neuro-Imaging\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 135, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02089555', 'age_groups': '40 to 65 years old', 'name': 'NCT02089555'}, {'nct_number': 'NCT01055561', 'title': 'A Study of Acupuncture for Patients With Behavioural and Psychological Symptoms of Dementia', 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01055561', 'age_groups': '40 to 65 years old', 'name': 'NCT01055561'}, {'nct_number': 'NCT00948259', 'title': 'Safety Study of a Glycogen Synthase Kinase 3 (GSK3) Inhibitor in Patients With Alzheimer´s Disease', 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00948259', 'age_groups': '40 to 65 years old', 'name': 'NCT00948259'}, {'nct_number': 'NCT02253732', 'title': 'Skeletal Muscle as a Mediator of Exercise Induced Effects on Metabolism & Cognitive Function: Role for Myokines & miRNAs', 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02253732', 'age_groups': '40 to 65 years old', 'name': 'NCT02253732'}, {'nct_number': 'NCT02569398', 'title': \"An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 596, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02569398', 'age_groups': '40 to 65 years old', 'name': 'NCT02569398'}, {'nct_number': 'NCT01039701', 'title': \"4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 99, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01039701', 'age_groups': '40 to 65 years old', 'name': 'NCT01039701'}, {'nct_number': 'NCT00582127', 'title': 'Evaluation of the COGNISION(TM) System as an Event-related Potential (ERP) Collection System.', 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00582127', 'age_groups': '40 to 65 years old', 'name': 'NCT00582127'}, {'nct_number': 'NCT02423122', 'title': \"A PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02423122', 'age_groups': '40 to 65 years old', 'name': 'NCT02423122'}, {'nct_number': 'NCT02839187', 'title': \"Neuro Imaging and Multimodal Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 59, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02839187', 'age_groups': '40 to 65 years old', 'name': 'NCT02839187'}, {'nct_number': 'NCT01481961', 'title': \"Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as add-on Treatment for Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01481961', 'age_groups': '40 to 65 years old', 'name': 'NCT01481961'}, {'nct_number': 'NCT01428362', 'title': \"VI-1121 for the Treatment Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 61, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01428362', 'age_groups': '40 to 65 years old', 'name': 'NCT01428362'}, {'nct_number': 'NCT00117403', 'title': \"Anti-Oxidant Treatment of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 75, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00117403', 'age_groups': '40 to 65 years old', 'name': 'NCT00117403'}, {'nct_number': 'NCT01716637', 'title': \"Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01716637', 'age_groups': '40 to 65 years old', 'name': 'NCT01716637'}, {'nct_number': 'NCT00501111', 'title': \"Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 659, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00501111', 'age_groups': '40 to 65 years old', 'name': 'NCT00501111'}, {'nct_number': 'NCT03467477', 'title': 'Tau Screening Study in Subjects With Early Symptomatic AD', 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 161, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03467477', 'age_groups': '40 to 65 years old', 'name': 'NCT03467477'}, {'nct_number': 'NCT03322462', 'title': 'Tau Screening Study in Patients With Early Symptomatic AD', 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 153, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03322462', 'age_groups': '40 to 65 years old', 'name': 'NCT03322462'}, {'nct_number': 'NCT01038726', 'title': 'Effects of Exercise and Cognitive Training on Cognitive Function in Older Adults', 'status': 'Completed', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 108, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01038726', 'age_groups': '40 to 65 years old', 'name': 'NCT01038726'}, {'nct_number': 'NCT02350634', 'title': '18F-AV-1451 High Resolution Autopsy Study', 'status': 'Completed', 'clean_age': '60 Years to 89 Years ', 'phases': 'Phase 1', 'enrollment': 3, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02350634', 'age_groups': '40 to 65 years old', 'name': 'NCT02350634'}, {'nct_number': 'NCT01825317', 'title': 'Effect of NeuroAD on Alzheimer Patients', 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01825317', 'age_groups': '40 to 65 years old', 'name': 'NCT01825317'}, {'nct_number': 'NCT01825330', 'title': 'Effect of NeuroAD on the Cognitive Function of Alzheimer Patients', 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 131, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01825330', 'age_groups': '40 to 65 years old', 'name': 'NCT01825330'}, {'nct_number': 'NCT01605448', 'title': 'Mindfulness Based Stress Reduction for Adults With Mild Cognitive Impairment', 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01605448', 'age_groups': '40 to 65 years old', 'name': 'NCT01605448'}, {'nct_number': 'NCT00040378', 'title': \"Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)\", 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 4246, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00040378', 'age_groups': '40 to 65 years old', 'name': 'NCT00040378'}, {'nct_number': 'NCT00908999', 'title': \"Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)\", 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00908999', 'age_groups': '40 to 65 years old', 'name': 'NCT00908999'}, {'nct_number': 'NCT00539305', 'title': 'Hormone and Information Processing Study', 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00539305', 'age_groups': '40 to 65 years old', 'name': 'NCT00539305'}, {'nct_number': 'NCT00381381', 'title': \"The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 199, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00381381', 'age_groups': '40 to 65 years old', 'name': 'NCT00381381'}, {'nct_number': 'NCT00938665', 'title': \"Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.\", 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 204, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00938665', 'age_groups': '40 to 65 years old', 'name': 'NCT00938665'}, {'nct_number': 'NCT02074215', 'title': \"Effect of Exercises Training in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02074215', 'age_groups': '40 to 65 years old', 'name': 'NCT02074215'}, {'nct_number': 'NCT03520998', 'title': \"A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03520998', 'age_groups': '40 to 65 years old', 'name': 'NCT03520998'}, {'nct_number': 'NCT02142777', 'title': \"S-Equol in Alzheimer's Disease (SEAD) Trial\", 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02142777', 'age_groups': '40 to 65 years old', 'name': 'NCT02142777'}, {'nct_number': 'NCT00880412', 'title': \"A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 197, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00880412', 'age_groups': '40 to 65 years old', 'name': 'NCT00880412'}, {'nct_number': 'NCT00911690', 'title': 'Establishment of a Bank of Biospecimens for Future Research on Age-related Cognitive Disorders', 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 102, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00911690', 'age_groups': '40 to 65 years old', 'name': 'NCT00911690'}, {'nct_number': 'NCT00319891', 'title': \"Computer-Based Training for Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00319891', 'age_groups': '40 to 65 years old', 'name': 'NCT00319891'}, {'nct_number': 'NCT02551809', 'title': \"Evaluate the Safety, Tolerability, Immunogenicity and Efficacy of UB-311 in Mild Alzheimer's Disease (AD) Patients\", 'status': 'Completed', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 43, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02551809', 'age_groups': '40 to 65 years old', 'name': 'NCT02551809'}, {'nct_number': 'NCT02833870', 'title': \"Non-pharmacological Care of Alzheimer's Disease: Benefice of Musical Interventions\", 'status': 'Completed', 'clean_age': '60 Years to 99 Years ', 'phases': 'Not Applicable', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02833870', 'age_groups': '40 to 65 years old', 'name': 'NCT02833870'}, {'nct_number': 'NCT00814502', 'title': 'Zolpidem CR and Hospitalized Patients With Dementia', 'status': 'Completed', 'clean_age': '60 Years to 99 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00814502', 'age_groups': '40 to 65 years old', 'name': 'NCT00814502'}, {'nct_number': 'NCT00260624', 'title': 'Escitalopram Treatment of Patients With Agitated Dementia', 'status': 'Completed', 'clean_age': '61 Years and older ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00260624', 'age_groups': '40 to 65 years old', 'name': 'NCT00260624'}, {'nct_number': 'NCT00056628', 'title': \"COGNIShunt® System for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '62 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00056628', 'age_groups': '40 to 65 years old', 'name': 'NCT00056628'}, {'nct_number': 'NCT02958930', 'title': \"Safety and Efficacy of Transcranial Electromagnetic Treatment Against Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '63 Years and older ', 'phases': 'Not Applicable', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02958930', 'age_groups': '40 to 65 years old', 'name': 'NCT02958930'}, {'nct_number': 'NCT01847586', 'title': \"Enhancing Neuroplasticity and Frontal Lobe Function in Patients With Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 49, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01847586', 'age_groups': '40 to 65 years old', 'name': 'NCT01847586'}, {'nct_number': 'NCT00831298', 'title': 'Assessment of Sleep Disturbance in Alzheimer Disease', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00831298', 'age_groups': '40 to 65 years old', 'name': 'NCT00831298'}, {'nct_number': 'NCT00814346', 'title': 'Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive Functions', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 2', 'enrollment': 49, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00814346', 'age_groups': '40 to 65 years old', 'name': 'NCT00814346'}, {'nct_number': 'NCT00177671', 'title': 'Antidepressant Medication Plus Donepezil for Treating Late-life Depression', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 220, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00177671', 'age_groups': '40 to 65 years old', 'name': 'NCT00177671'}, {'nct_number': 'NCT02172612', 'title': 'A Pilot Study to Reduce Inappropriate Anticholinergic Prescribing in the Elderly', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02172612', 'age_groups': '40 to 65 years old', 'name': 'NCT02172612'}, {'nct_number': 'NCT00063310', 'title': \"ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 2', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00063310', 'age_groups': '40 to 65 years old', 'name': 'NCT00063310'}, {'nct_number': 'NCT03246269', 'title': 'Normative Values for the German Version of the Montreal Cognitive Assessment (MoCA)', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 334, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03246269', 'age_groups': '40 to 65 years old', 'name': 'NCT03246269'}, {'nct_number': 'NCT01577394', 'title': 'Oculomotor Testing in the Differential Diagnosis of Dementia', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 3', 'enrollment': 65, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01577394', 'age_groups': '40 to 65 years old', 'name': 'NCT01577394'}, {'nct_number': 'NCT02612688', 'title': 'Pragmatic Trial of Video Education in Nursing Homes', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 197692, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02612688', 'age_groups': '40 to 65 years old', 'name': 'NCT02612688'}, {'nct_number': 'NCT03643003', 'title': 'Music Therapy for Persons With Dementia', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03643003', 'age_groups': '40 to 65 years old', 'name': 'NCT03643003'}, {'nct_number': 'NCT00488007', 'title': 'Clinical Trial on Alzheimer Disease, Presbycusis and Hearing Aids', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 51, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00488007', 'age_groups': '40 to 65 years old', 'name': 'NCT00488007'}, {'nct_number': 'NCT02351453', 'title': 'Patients With Alzheimer Disease, Spouse Carers and Risk of Institutionalization: a Prospective Observational Cohort Study of Dyads (AID Study)', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 207, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02351453', 'age_groups': '40 to 65 years old', 'name': 'NCT02351453'}, {'nct_number': 'NCT01329536', 'title': \"The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01329536', 'age_groups': '40 to 65 years old', 'name': 'NCT01329536'}, {'nct_number': 'NCT00548951', 'title': 'Alzheimer Patients and the Snoezelen Program', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00548951', 'age_groups': '40 to 65 years old', 'name': 'NCT00548951'}, {'nct_number': 'NCT00388544', 'title': 'Enhancing Quality of Life for Nursing Home Residents', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 2', 'enrollment': 128, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00388544', 'age_groups': '40 to 65 years old', 'name': 'NCT00388544'}, {'nct_number': 'NCT00294307', 'title': 'Enhancing Care Coordination: Hospital to Home for Cognitively Impaired Older Adults and Their Caregivers', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 814, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00294307', 'age_groups': '40 to 65 years old', 'name': 'NCT00294307'}, {'nct_number': 'NCT00867399', 'title': 'A Safety and Tolerability Study of ABT-126 in Elderly', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00867399', 'age_groups': '40 to 65 years old', 'name': 'NCT00867399'}, {'nct_number': 'NCT00076440', 'title': \"Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 2', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00076440', 'age_groups': '40 to 65 years old', 'name': 'NCT00076440'}, {'nct_number': 'NCT01311492', 'title': \"Exercise Trial for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01311492', 'age_groups': '40 to 65 years old', 'name': 'NCT01311492'}, {'nct_number': 'NCT00267124', 'title': 'Brain Aging Project--Kansas University', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 172, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00267124', 'age_groups': '40 to 65 years old', 'name': 'NCT00267124'}, {'nct_number': 'NCT04036955', 'title': 'Evaluation of an Innovative Information, Training and Social Support Intervention \"INFOSADEM\" to Principal Caregivers of Dementia Patients Living at Home', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04036955', 'age_groups': '40 to 65 years old', 'name': 'NCT04036955'}, {'nct_number': 'NCT01129115', 'title': 'Dose Response Study of Aerobic Exercise in Older Adults', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 101, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01129115', 'age_groups': '40 to 65 years old', 'name': 'NCT01129115'}, {'nct_number': 'NCT00547560', 'title': 'Study Evaluating Multiple Doses Of GSI-953 Within The Elderly Population', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 1', 'enrollment': 49, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00547560', 'age_groups': '40 to 65 years old', 'name': 'NCT00547560'}, {'nct_number': 'NCT00246896', 'title': 'Care Management for Patients With Alzheimer Disease and Their Family Caregivers', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 220, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00246896', 'age_groups': '40 to 65 years old', 'name': 'NCT00246896'}, {'nct_number': 'NCT03001232', 'title': 'The Effect of Movement-oriented Dementia Care on ADL and QoL of Dementia Patients in Nursing Homes', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 66, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03001232', 'age_groups': '40 to 65 years old', 'name': 'NCT03001232'}, {'nct_number': 'NCT01708304', 'title': \"Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 510, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01708304', 'age_groups': '40 to 65 years old', 'name': 'NCT01708304'}, {'nct_number': 'NCT03286608', 'title': 'Polyphenols and Risk of Dementia', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 1329, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03286608', 'age_groups': '40 to 65 years old', 'name': 'NCT03286608'}, {'nct_number': 'NCT02420756', 'title': 'Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 18488, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02420756', 'age_groups': '40 to 65 years old', 'name': 'NCT02420756'}, {'nct_number': 'NCT03581643', 'title': 'Validation of the Montreal Cognitive Assessment in Patients With Mild and Major Neurocognitive Disorder', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 430, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03581643', 'age_groups': '40 to 65 years old', 'name': 'NCT03581643'}, {'nct_number': 'NCT01699503', 'title': 'Indiana University Dementia Screening Trial', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 4005, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01699503', 'age_groups': '40 to 65 years old', 'name': 'NCT01699503'}, {'nct_number': 'NCT00042172', 'title': 'Treatment for Early Memory Loss', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00042172', 'age_groups': '40 to 65 years old', 'name': 'NCT00042172'}, {'nct_number': 'NCT03840759', 'title': 'Short-term Effects of an Inpatient Geriatric Consultation Team on Geriatric Syndrome Patients', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 59, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03840759', 'age_groups': '40 to 65 years old', 'name': 'NCT03840759'}, {'nct_number': 'NCT02444078', 'title': 'Effects of Exercise on Functional Ability in People With Dementia in Nursing Homes:a Cluster Randomised Controlled Trial', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 140, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02444078', 'age_groups': '40 to 65 years old', 'name': 'NCT02444078'}, {'nct_number': 'NCT03638323', 'title': 'Age-related Hearing Loss and Lexical Disorders', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 46, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03638323', 'age_groups': '40 to 65 years old', 'name': 'NCT03638323'}, {'nct_number': 'NCT01646723', 'title': 'Volunteers Adding Life in Dementia', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 75, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01646723', 'age_groups': '40 to 65 years old', 'name': 'NCT01646723'}, {'nct_number': 'NCT00480220', 'title': \"Specific Care and Assistance Plan for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 1200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00480220', 'age_groups': '40 to 65 years old', 'name': 'NCT00480220'}, {'nct_number': 'NCT02719834', 'title': \"Behavioral Expressions in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 4, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02719834', 'age_groups': '40 to 65 years old', 'name': 'NCT02719834'}, {'nct_number': 'NCT01049555', 'title': \"Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental Research\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01049555', 'age_groups': '40 to 65 years old', 'name': 'NCT01049555'}, {'nct_number': 'NCT01834716', 'title': \"Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01834716', 'age_groups': '40 to 65 years old', 'name': 'NCT01834716'}, {'nct_number': 'NCT02502045', 'title': \"Effect of Therapeutic Light on Sleep, Circadian Rhythm, and Global Function in Women With Alzheimer's\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02502045', 'age_groups': '40 to 65 years old', 'name': 'NCT02502045'}, {'nct_number': 'NCT00401167', 'title': \"Memantine for Agitation and Aggression in Severe Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00401167', 'age_groups': '40 to 65 years old', 'name': 'NCT00401167'}, {'nct_number': 'NCT00329706', 'title': 'Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 710, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00329706', 'age_groups': '40 to 65 years old', 'name': 'NCT00329706'}, {'nct_number': 'NCT00443014', 'title': 'The Dementia Study in Northern Norway', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 187, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00443014', 'age_groups': '40 to 65 years old', 'name': 'NCT00443014'}, {'nct_number': 'NCT02360527', 'title': 'Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s Disease', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 126, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02360527', 'age_groups': '40 to 65 years old', 'name': 'NCT02360527'}, {'nct_number': 'NCT00647478', 'title': \"System-IGF-1 Pathway and Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 693, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00647478', 'age_groups': '40 to 65 years old', 'name': 'NCT00647478'}, {'nct_number': 'NCT02462291', 'title': \"New Approach for Treatment of Behavioral Disorders in Alzheimer's Disease (Alzheimer's Behavioral and Cognitive Disorders)\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 163, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02462291', 'age_groups': '40 to 65 years old', 'name': 'NCT02462291'}, {'nct_number': 'NCT02921672', 'title': 'Feasibility Trial of a Mediterranean Diet Pattern to Prevent Cognitive Decline', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02921672', 'age_groups': '40 to 65 years old', 'name': 'NCT02921672'}, {'nct_number': 'NCT00951197', 'title': 'Evaluation of Alteration by Magnetic Resonance Imaging (MRI) in Dementia Among Elderly Subjects', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 318, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00951197', 'age_groups': '40 to 65 years old', 'name': 'NCT00951197'}, {'nct_number': 'NCT02709356', 'title': \"Medium Chain Triglycerides and Brain Metabolism in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02709356', 'age_groups': '40 to 65 years old', 'name': 'NCT02709356'}, {'nct_number': 'NCT01582919', 'title': 'Neuroimaging Markers of Alzheimer Disease: a Longitudinal Population Study', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 304, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01582919', 'age_groups': '40 to 65 years old', 'name': 'NCT01582919'}, {'nct_number': 'NCT01384344', 'title': \"Ecological Assessment of Apathy in Alzheimer's Disease and in Control Subjects: Video Recognition and Actigraphy\", 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 82, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01384344', 'age_groups': '40 to 65 years old', 'name': 'NCT01384344'}, {'nct_number': 'NCT02719938', 'title': 'Triggered Palliative Care for Advanced Dementia', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 62, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02719938', 'age_groups': '40 to 65 years old', 'name': 'NCT02719938'}, {'nct_number': 'NCT00750529', 'title': 'Alzheimer and Sleep', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 1', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00750529', 'age_groups': '40 to 65 years old', 'name': 'NCT00750529'}, {'nct_number': 'NCT03221296', 'title': 'Fall Prevention - Vestibular Rehabilitation', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 29, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03221296', 'age_groups': '40 to 65 years old', 'name': 'NCT03221296'}, {'nct_number': 'NCT02432222', 'title': 'Effects of Visual Arts Training on Dementia', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 23, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02432222', 'age_groups': '40 to 65 years old', 'name': 'NCT02432222'}, {'nct_number': 'NCT02846415', 'title': 'Play Intervention for Dementia for Promoting Cognitive Function: A Feasibility Study', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02846415', 'age_groups': '40 to 65 years old', 'name': 'NCT02846415'}, {'nct_number': 'NCT02078310', 'title': 'Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 35, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02078310', 'age_groups': '40 to 65 years old', 'name': 'NCT02078310'}, {'nct_number': 'NCT00208819', 'title': 'A Comparison of Two Standard Therapies in the Management of Dementia With Agitation', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00208819', 'age_groups': '40 to 65 years old', 'name': 'NCT00208819'}, {'nct_number': 'NCT01715181', 'title': 'Volunteers Adding Life in Dementia: VALID', 'status': 'Completed', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 75, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01715181', 'age_groups': '40 to 65 years old', 'name': 'NCT01715181'}, {'nct_number': 'NCT00833274', 'title': 'Evaluation of Apathy Using Attentional Reaction Test in Neurodegenerative Diseases', 'status': 'Completed', 'clean_age': '65 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00833274', 'age_groups': '40 to 65 years old', 'name': 'NCT00833274'}, {'nct_number': 'NCT02331784', 'title': 'Plasticity-based Adaptive Cognitive Remediation for Alzheimer Disease', 'status': 'Completed', 'clean_age': '65 Years to 79 Years ', 'phases': 'Not Applicable', 'enrollment': 68, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02331784', 'age_groups': '40 to 65 years old', 'name': 'NCT02331784'}, {'nct_number': 'NCT02546310', 'title': 'Phase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly Subjects', 'status': 'Completed', 'clean_age': '65 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 54, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02546310', 'age_groups': '40 to 65 years old', 'name': 'NCT02546310'}, {'nct_number': 'NCT03928405', 'title': \"Effect of Virtual Reality on Balance and Gait Speed With Alzheimer's Dementia\", 'status': 'Completed', 'clean_age': '65 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03928405', 'age_groups': '40 to 65 years old', 'name': 'NCT03928405'}, {'nct_number': 'NCT02360657', 'title': 'Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer Dementia', 'status': 'Completed', 'clean_age': '65 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02360657', 'age_groups': '40 to 65 years old', 'name': 'NCT02360657'}, {'nct_number': 'NCT01467726', 'title': 'Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects', 'status': 'Completed', 'clean_age': '65 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01467726', 'age_groups': '40 to 65 years old', 'name': 'NCT01467726'}, {'nct_number': 'NCT02746484', 'title': 'ABILITY - TelerehABILITation: TechnologY-enhanced Multi-domain at Home Continuum of Care Program', 'status': 'Completed', 'clean_age': '65 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02746484', 'age_groups': '40 to 65 years old', 'name': 'NCT02746484'}, {'nct_number': 'NCT01893398', 'title': \"Multistimulation Group Therapy for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01893398', 'age_groups': '40 to 65 years old', 'name': 'NCT01893398'}, {'nct_number': 'NCT01436045', 'title': 'Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.', 'status': 'Completed', 'clean_age': '65 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01436045', 'age_groups': '40 to 65 years old', 'name': 'NCT01436045'}, {'nct_number': 'NCT03378453', 'title': \"Narcolepsy Protect Against Alzheimer's Disease?\", 'status': 'Completed', 'clean_age': '65 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 38, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03378453', 'age_groups': '40 to 65 years old', 'name': 'NCT03378453'}, {'nct_number': 'NCT01295957', 'title': \"Alzheimer's Disease Reminiscence Quality of Life\", 'status': 'Completed', 'clean_age': '65 Years to 87 Years ', 'phases': 'Phase 4', 'enrollment': 135, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01295957', 'age_groups': '40 to 65 years old', 'name': 'NCT01295957'}, {'nct_number': 'NCT01713816', 'title': 'Human Brain Antioxidants During Oxidative Stress', 'status': 'Completed', 'clean_age': '65 Years to 89 Years ', 'phases': 'Phase 4', 'enrollment': 52, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01713816', 'age_groups': '40 to 65 years old', 'name': 'NCT01713816'}, {'nct_number': 'NCT00403507', 'title': \"Exercise Treatment of Mild-Stage Probable Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 79, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00403507', 'age_groups': '40 to 65 years old', 'name': 'NCT00403507'}, {'nct_number': 'NCT01692977', 'title': \"What Elements of the Design of a Healing Garden Are Used as Landmarks by Patients With Alzheimer's Disease to Locate?\", 'status': 'Completed', 'clean_age': '65 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 77, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01692977', 'age_groups': '40 to 65 years old', 'name': 'NCT01692977'}, {'nct_number': 'NCT00820937', 'title': 'Diagnostic of Lewy Body Dementia by Combining Scintigraphy (SPECT) Using a Specific Transporter and Magnetic Resonance Imaging (MRI)', 'status': 'Completed', 'clean_age': '65 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00820937', 'age_groups': '40 to 65 years old', 'name': 'NCT00820937'}, {'nct_number': 'NCT03034746', 'title': 'Impact of Physical Activity on Successful Aging', 'status': 'Completed', 'clean_age': '65 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03034746', 'age_groups': '40 to 65 years old', 'name': 'NCT03034746'}, {'nct_number': 'NCT02501876', 'title': \"Type 2 Diabetes Mellitus as Catalyst for Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '65 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 202, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02501876', 'age_groups': '40 to 65 years old', 'name': 'NCT02501876'}, {'nct_number': 'NCT01729598', 'title': 'Valproic Acid in Subjects With Intact Cognition - Proof of Concept Study', 'status': 'Completed', 'clean_age': '65 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01729598', 'age_groups': '40 to 65 years old', 'name': 'NCT01729598'}, {'nct_number': 'NCT02045056', 'title': 'Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease', 'status': 'Completed', 'clean_age': '65 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02045056', 'age_groups': '40 to 65 years old', 'name': 'NCT02045056'}, {'nct_number': 'NCT01172145', 'title': \"Treatment of Apathy in Alzheimer's Disease With Modafinil\", 'status': 'Completed', 'clean_age': '65 Years to 95 Years ', 'phases': 'Phase 3', 'enrollment': 22, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01172145', 'age_groups': '40 to 65 years old', 'name': 'NCT01172145'}]}, {'name': 'Unknown status', 'children': [{'nct_number': 'NCT01993628', 'title': \"Construction-LBD (Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD))\", 'status': 'Unknown status', 'clean_age': '45 Years and older ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01993628', 'age_groups': '40 to 65 years old', 'name': 'NCT01993628'}, {'nct_number': 'NCT00966017', 'title': 'Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia', 'status': 'Unknown status', 'clean_age': '45 Years and older ', 'phases': 'Phase 4', 'enrollment': 108, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00966017', 'age_groups': '40 to 65 years old', 'name': 'NCT00966017'}, {'nct_number': 'NCT01876459', 'title': \"Alpha-synuclein in Cerebrospinal Fluid to Differentiate Alzheimer's Disease From Lewy Body Disease.\", 'status': 'Unknown status', 'clean_age': '45 Years and older ', 'phases': 'Not Applicable', 'enrollment': 265, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01876459', 'age_groups': '40 to 65 years old', 'name': 'NCT01876459'}, {'nct_number': 'NCT01403519', 'title': \"Innovative Biomarkers in Alzheimer's Disease and Frontotemporal Dementia (FTD): Preventative and Personalized\", 'status': 'Unknown status', 'clean_age': '45 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 70, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01403519', 'age_groups': '40 to 65 years old', 'name': 'NCT01403519'}, {'nct_number': 'NCT02227953', 'title': \"A Pilot Study of tDCS for Mild to Moderate Alzhemier's Disease\", 'status': 'Unknown status', 'clean_age': '45 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02227953', 'age_groups': '40 to 65 years old', 'name': 'NCT02227953'}, {'nct_number': 'NCT01608061', 'title': \"ADvance DBS-f in Patients With Mild Probable Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '45 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01608061', 'age_groups': '40 to 65 years old', 'name': 'NCT01608061'}, {'nct_number': 'NCT00987090', 'title': \"Early-onset and Late-onset Sporadic Alzheimer's Disease (AD)\", 'status': 'Unknown status', 'clean_age': '45 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00987090', 'age_groups': '40 to 65 years old', 'name': 'NCT00987090'}, {'nct_number': 'NCT00217763', 'title': \"European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients\", 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 930, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00217763', 'age_groups': '40 to 65 years old', 'name': 'NCT00217763'}, {'nct_number': 'NCT01255046', 'title': 'Study of STA-1 as an Add-on Treatment to Donepezil', 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 136, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01255046', 'age_groups': '40 to 65 years old', 'name': 'NCT01255046'}, {'nct_number': 'NCT00606164', 'title': \"Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 9, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00606164', 'age_groups': '40 to 65 years old', 'name': 'NCT00606164'}, {'nct_number': 'NCT00056329', 'title': 'Vitamin E in Aging Persons With Down Syndrome', 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 350, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00056329', 'age_groups': '40 to 65 years old', 'name': 'NCT00056329'}, {'nct_number': 'NCT01297140', 'title': 'The PACO Study (\"Personnalité Alzheimer COmportement\")', 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 252, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01297140', 'age_groups': '40 to 65 years old', 'name': 'NCT01297140'}, {'nct_number': 'NCT00088673', 'title': 'Evaluation of 3APS in Patients With Mild to Moderate Alzheimer’s Disease', 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 950, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00088673', 'age_groups': '40 to 65 years old', 'name': 'NCT00088673'}, {'nct_number': 'NCT00715858', 'title': \"A Pilot Study of Inflammatory Markers in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00715858', 'age_groups': '40 to 65 years old', 'name': 'NCT00715858'}, {'nct_number': 'NCT00154635', 'title': 'Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer’s Disease', 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00154635', 'age_groups': '40 to 65 years old', 'name': 'NCT00154635'}, {'nct_number': 'NCT01238458', 'title': \"Phase II Study for Amyloid Binding Imaging Study of [18F]AV-45 in Patients With Mild Cognitive Impairment, Alzheimer's Disease and Healthy Volunteers\", 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01238458', 'age_groups': '40 to 65 years old', 'name': 'NCT01238458'}, {'nct_number': 'NCT03295110', 'title': \"Connected Solution of Assistance Dedicated to Caregivers and People With Alzheimer's Disease or Related Diseases\", 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03295110', 'age_groups': '40 to 65 years old', 'name': 'NCT03295110'}, {'nct_number': 'NCT02955706', 'title': \"Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 328, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02955706', 'age_groups': '40 to 65 years old', 'name': 'NCT02955706'}, {'nct_number': 'NCT02987842', 'title': \"Neurofeedback as a Novel Treatment for Mild Cognitive Impairment & Early Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02987842', 'age_groups': '40 to 65 years old', 'name': 'NCT02987842'}, {'nct_number': 'NCT00703430', 'title': \"Memantine on Aggression and Agitation of Alzheimer's Disease (AD)\", 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00703430', 'age_groups': '40 to 65 years old', 'name': 'NCT00703430'}, {'nct_number': 'NCT03168997', 'title': \"Memantine Treatment in Alzheimer's Disease Patients\", 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 222, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03168997', 'age_groups': '40 to 65 years old', 'name': 'NCT03168997'}, {'nct_number': 'NCT00314912', 'title': \"Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 650, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00314912', 'age_groups': '40 to 65 years old', 'name': 'NCT00314912'}, {'nct_number': 'NCT01926691', 'title': 'Predictors for Poststroke Outcomes: Tel Aviv Brain Acute Stroke Cohort Acute Stroke Cohort (TABASCO)', 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 534, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01926691', 'age_groups': '40 to 65 years old', 'name': 'NCT01926691'}, {'nct_number': 'NCT03297268', 'title': 'Behavioral and Environmental Sensing and Intervention', 'status': 'Unknown status', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 24, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03297268', 'age_groups': '40 to 65 years old', 'name': 'NCT03297268'}, {'nct_number': 'NCT03038035', 'title': \"The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study\", 'status': 'Unknown status', 'clean_age': '50 Years to 120 Years ', 'phases': 'Phase 2', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03038035', 'age_groups': '40 to 65 years old', 'name': 'NCT03038035'}, {'nct_number': 'NCT00888056', 'title': \"Chronic Electrical Stimulation of Hypothalamus/Fornix in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 65 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00888056', 'age_groups': '40 to 65 years old', 'name': 'NCT00888056'}, {'nct_number': 'NCT00947934', 'title': 'Study of the Brain Stimulation Effect on Memory Impairment in Alzheimer Disease', 'status': 'Unknown status', 'clean_age': '50 Years to 70 Years ', 'phases': 'Not Applicable', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00947934', 'age_groups': '40 to 65 years old', 'name': 'NCT00947934'}, {'nct_number': 'NCT01696591', 'title': 'The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD', 'status': 'Unknown status', 'clean_age': '50 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 14, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01696591', 'age_groups': '40 to 65 years old', 'name': 'NCT01696591'}, {'nct_number': 'NCT01163825', 'title': 'Encapsulated Cell Biodelivery of Nerve Growth Factor to Alzheimer´s Disease Patients', 'status': 'Unknown status', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01163825', 'age_groups': '40 to 65 years old', 'name': 'NCT01163825'}, {'nct_number': 'NCT01001637', 'title': \"Efficacy and Safety of Curcumin Formulation in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 26, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01001637', 'age_groups': '40 to 65 years old', 'name': 'NCT01001637'}, {'nct_number': 'NCT01334450', 'title': 'Transcranial Magnetic Stimulation (TMS) Treatment for Alzheimer Patients', 'status': 'Unknown status', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01334450', 'age_groups': '40 to 65 years old', 'name': 'NCT01334450'}, {'nct_number': 'NCT00637442', 'title': 'Continuous Arterial Spin Labeling (CASL) MRI for Monitoring and Prediction of Drug Therapy in Alzheimers Disease (AD)', 'status': 'Unknown status', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00637442', 'age_groups': '40 to 65 years old', 'name': 'NCT00637442'}, {'nct_number': 'NCT02204969', 'title': 'LIWA for Treatment of Alzheimer Patients', 'status': 'Unknown status', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02204969', 'age_groups': '40 to 65 years old', 'name': 'NCT02204969'}, {'nct_number': 'NCT02841605', 'title': 'Enteric Nervous System in Alzheimer Disease', 'status': 'Unknown status', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 55, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02841605', 'age_groups': '40 to 65 years old', 'name': 'NCT02841605'}, {'nct_number': 'NCT01887899', 'title': 'Influence of tDCS on Cortical Plasticity in Patients With Dementia of the Alzheimer Type', 'status': 'Unknown status', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01887899', 'age_groups': '40 to 65 years old', 'name': 'NCT01887899'}, {'nct_number': 'NCT00753662', 'title': \"Deep Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00753662', 'age_groups': '40 to 65 years old', 'name': 'NCT00753662'}, {'nct_number': 'NCT02759159', 'title': \"The Study of Mechanism of Alzheimer's Disease Using Acupuncture Based on fMRI\", 'status': 'Unknown status', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02759159', 'age_groups': '40 to 65 years old', 'name': 'NCT02759159'}, {'nct_number': 'NCT01547689', 'title': \"Safety and Efficiency of Umbilical Cord-derived Mesenchymal Stem Cells(UC-MSC) in Patients With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01547689', 'age_groups': '40 to 65 years old', 'name': 'NCT01547689'}, {'nct_number': 'NCT02444637', 'title': 'Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD', 'status': 'Unknown status', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02444637', 'age_groups': '40 to 65 years old', 'name': 'NCT02444637'}, {'nct_number': 'NCT02579252', 'title': \"24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 208, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02579252', 'age_groups': '40 to 65 years old', 'name': 'NCT02579252'}, {'nct_number': 'NCT01569516', 'title': \"Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 288, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01569516', 'age_groups': '40 to 65 years old', 'name': 'NCT01569516'}, {'nct_number': 'NCT01282619', 'title': \"Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 390, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01282619', 'age_groups': '40 to 65 years old', 'name': 'NCT01282619'}, {'nct_number': 'NCT03221894', 'title': \"A Retrospective Study to Investigate the Additive Effectiveness of Chinese Herbal Medicine in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 90, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03221894', 'age_groups': '40 to 65 years old', 'name': 'NCT03221894'}, {'nct_number': 'NCT03119961', 'title': \"Blood Brain Barrier Opening in Alzheimer' Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03119961', 'age_groups': '40 to 65 years old', 'name': 'NCT03119961'}, {'nct_number': 'NCT02518412', 'title': 'Transcranial Direct Current Stimulation (tDCS) as a Cognitive Enhancer for Patients With Alzheimers Disease', 'status': 'Unknown status', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02518412', 'age_groups': '40 to 65 years old', 'name': 'NCT02518412'}, {'nct_number': 'NCT01849042', 'title': \"Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 188, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01849042', 'age_groups': '40 to 65 years old', 'name': 'NCT01849042'}, {'nct_number': 'NCT01874418', 'title': \"Biomarker Study to Diagnose Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01874418', 'age_groups': '40 to 65 years old', 'name': 'NCT01874418'}, {'nct_number': 'NCT01940952', 'title': \"Zydena on Cognitive Function of Alzheimer's Disease Patients\", 'status': 'Unknown status', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 210, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01940952', 'age_groups': '40 to 65 years old', 'name': 'NCT01940952'}, {'nct_number': 'NCT01642420', 'title': 'Non-expensive and Widely Available Tests as Diagnostic Tools in Dementia and Their Ability to Predict Disease Progression', 'status': 'Unknown status', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 115, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01642420', 'age_groups': '40 to 65 years old', 'name': 'NCT01642420'}, {'nct_number': 'NCT01094340', 'title': \"Thalidomide for Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01094340', 'age_groups': '40 to 65 years old', 'name': 'NCT01094340'}, {'nct_number': 'NCT01746706', 'title': \"Can the Assessment of the Subhippocampal Region Contribute to the Detection of Early Diagnosis of Alzheimer's Disease? A Validation Study Using PET With Florbetapir (AV-45).\", 'status': 'Unknown status', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01746706', 'age_groups': '40 to 65 years old', 'name': 'NCT01746706'}, {'nct_number': 'NCT00242593', 'title': 'Rosiglitazone Effects on Cognition for Adults in Later Life', 'status': 'Unknown status', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00242593', 'age_groups': '40 to 65 years old', 'name': 'NCT00242593'}, {'nct_number': 'NCT02018913', 'title': 'Blood-brain Barrier Leakage in Dementia. A Dynamic Contrast-enhanced MRI Study', 'status': 'Unknown status', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 140, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02018913', 'age_groups': '40 to 65 years old', 'name': 'NCT02018913'}, {'nct_number': 'NCT01867775', 'title': \"Mirtazapine for Sleep Disorders in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01867775', 'age_groups': '40 to 65 years old', 'name': 'NCT01867775'}, {'nct_number': 'NCT01195389', 'title': \"Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01195389', 'age_groups': '40 to 65 years old', 'name': 'NCT01195389'}, {'nct_number': 'NCT01329601', 'title': \"Effect of Cognitive Intervention in Alzheimer's Disease (AD) on Functional Cortical Networks in fMRI\", 'status': 'Unknown status', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01329601', 'age_groups': '40 to 65 years old', 'name': 'NCT01329601'}, {'nct_number': 'NCT02864303', 'title': \"Use of Saliva for Alzheimer's Disease Diagnosis\", 'status': 'Unknown status', 'clean_age': '55 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02864303', 'age_groups': '40 to 65 years old', 'name': 'NCT02864303'}, {'nct_number': 'NCT01120002', 'title': \"Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01120002', 'age_groups': '40 to 65 years old', 'name': 'NCT01120002'}, {'nct_number': 'NCT03151382', 'title': 'A Based on PEEG and PET Study of Anxiolytic Treatment to Improve Cognitive Function in Patients With Alzheimer Disease', 'status': 'Unknown status', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03151382', 'age_groups': '40 to 65 years old', 'name': 'NCT03151382'}, {'nct_number': 'NCT01841905', 'title': \"Detection of Disease-Related Changes in Pre-Symptomatic Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01841905', 'age_groups': '40 to 65 years old', 'name': 'NCT01841905'}, {'nct_number': 'NCT02063269', 'title': 'Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles', 'status': 'Unknown status', 'clean_age': '55 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02063269', 'age_groups': '40 to 65 years old', 'name': 'NCT02063269'}, {'nct_number': 'NCT02263235', 'title': 'In Vivo Alzheimer Proteomics', 'status': 'Unknown status', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 110, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02263235', 'age_groups': '40 to 65 years old', 'name': 'NCT02263235'}, {'nct_number': 'NCT02195596', 'title': 'Effects of Exercise on Cognitive Performance of Patients With Alzheimer-type Dementia. Pilot Study.', 'status': 'Unknown status', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02195596', 'age_groups': '40 to 65 years old', 'name': 'NCT02195596'}, {'nct_number': 'NCT03184467', 'title': 'Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients', 'status': 'Unknown status', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03184467', 'age_groups': '40 to 65 years old', 'name': 'NCT03184467'}, {'nct_number': 'NCT02778581', 'title': 'Study to Evaluate the Effect of a Vegetal Oil on Cognitive Impairment', 'status': 'Unknown status', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 110, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02778581', 'age_groups': '40 to 65 years old', 'name': 'NCT02778581'}, {'nct_number': 'NCT00902499', 'title': 'Evolution of Memory Related Activity', 'status': 'Unknown status', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 160, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00902499', 'age_groups': '40 to 65 years old', 'name': 'NCT00902499'}, {'nct_number': 'NCT00232570', 'title': \"Quetiapine for the Treatment of Insomnia in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '55 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00232570', 'age_groups': '40 to 65 years old', 'name': 'NCT00232570'}, {'nct_number': 'NCT01832350', 'title': \"Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01832350', 'age_groups': '40 to 65 years old', 'name': 'NCT01832350'}, {'nct_number': 'NCT01099332', 'title': \"Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01099332', 'age_groups': '40 to 65 years old', 'name': 'NCT01099332'}, {'nct_number': 'NCT01624389', 'title': \"Establish Taiwan Alzheimer's Disease Neuroimaging Initiative - a Three-year Pilot Study\", 'status': 'Unknown status', 'clean_age': '55 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01624389', 'age_groups': '40 to 65 years old', 'name': 'NCT01624389'}, {'nct_number': 'NCT00523666', 'title': \"Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®)\", 'status': 'Unknown status', 'clean_age': '55 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00523666', 'age_groups': '40 to 65 years old', 'name': 'NCT00523666'}, {'nct_number': 'NCT00172900', 'title': \"MRS and DTI of White Matter in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '55 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00172900', 'age_groups': '40 to 65 years old', 'name': 'NCT00172900'}, {'nct_number': 'NCT00192816', 'title': \"Pain Perception in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '55 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00192816', 'age_groups': '40 to 65 years old', 'name': 'NCT00192816'}, {'nct_number': 'NCT01812213', 'title': \"Beta-Amyloid Imaging With [18F]NAV4694 Positron Emission Tomography (PET) in Predicting Progression to Alzheimer's Disease (AD) in Subjects With Mild Cognitive Impairment (MCI)\", 'status': 'Unknown status', 'clean_age': '55 Years to 99 Years ', 'phases': 'Phase 2', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01812213', 'age_groups': '40 to 65 years old', 'name': 'NCT01812213'}, {'nct_number': 'NCT02648906', 'title': 'A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients', 'status': 'Unknown status', 'clean_age': '56 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 128, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02648906', 'age_groups': '40 to 65 years old', 'name': 'NCT02648906'}, {'nct_number': 'NCT00239746', 'title': 'BONSAI: Biomarkers of Nonsteroidal Anti-Inflammatories', 'status': 'Unknown status', 'clean_age': '59 Years and older ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00239746', 'age_groups': '40 to 65 years old', 'name': 'NCT00239746'}, {'nct_number': 'NCT00448318', 'title': 'Evaluating the Effects of Music Interventions on Hospitalised People With Dementia', 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00448318', 'age_groups': '40 to 65 years old', 'name': 'NCT00448318'}, {'nct_number': 'NCT01839422', 'title': \"Imaging of New Learning in Severe Alzheimer's Disease Patients\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01839422', 'age_groups': '40 to 65 years old', 'name': 'NCT01839422'}, {'nct_number': 'NCT00693888', 'title': 'Lighthouse Project on Dementia, Ulm, Germany', 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00693888', 'age_groups': '40 to 65 years old', 'name': 'NCT00693888'}, {'nct_number': 'NCT02664584', 'title': 'The Trinity, Ulster and Department of Agriculture Cohort Study', 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 5186, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02664584', 'age_groups': '40 to 65 years old', 'name': 'NCT02664584'}, {'nct_number': 'NCT01095718', 'title': 'Comparison of 3 Learning Methods to Improve Independent Activities of Daily Living (IADLs) in Alzheimer Disease', 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01095718', 'age_groups': '40 to 65 years old', 'name': 'NCT01095718'}, {'nct_number': 'NCT02518243', 'title': \"Safe & Easy for Alzheimer's Disease and Related Pathologies\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02518243', 'age_groups': '40 to 65 years old', 'name': 'NCT02518243'}, {'nct_number': 'NCT00229333', 'title': 'Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer’s Disease, Vascular Dementia, and Mixed Vascular and Alzheimer’s Dementia', 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00229333', 'age_groups': '40 to 65 years old', 'name': 'NCT00229333'}, {'nct_number': 'NCT00146263', 'title': 'Cognitive Training in the Elderly', 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00146263', 'age_groups': '40 to 65 years old', 'name': 'NCT00146263'}, {'nct_number': 'NCT02472899', 'title': \"Biomarker Study for Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02472899', 'age_groups': '40 to 65 years old', 'name': 'NCT02472899'}, {'nct_number': 'NCT02694445', 'title': \"Monetary Cost of Alzheimer's Disease in China\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 2500, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02694445', 'age_groups': '40 to 65 years old', 'name': 'NCT02694445'}, {'nct_number': 'NCT02051244', 'title': \"Measurement of Retinal Nerve Fiber Layer Thickness - a Biomarker for the Early Detection of Alzheimer's Disease?\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02051244', 'age_groups': '40 to 65 years old', 'name': 'NCT02051244'}, {'nct_number': 'NCT01314131', 'title': 'Use of Autobiographical and Interest Assessment for a Better Stimulation of Patients in Nursing Home', 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01314131', 'age_groups': '40 to 65 years old', 'name': 'NCT01314131'}, {'nct_number': 'NCT01416012', 'title': 'Health Related Quality of Life Effects of Off-the-shelf Computer Gaming in Alzheimer and Related Disorders Populations', 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01416012', 'age_groups': '40 to 65 years old', 'name': 'NCT01416012'}, {'nct_number': 'NCT00743418', 'title': \"Tracking Technologies for the Analysis of Mobility in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00743418', 'age_groups': '40 to 65 years old', 'name': 'NCT00743418'}, {'nct_number': 'NCT02208193', 'title': \"Alzheimer's Disease, Art and Garden\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02208193', 'age_groups': '40 to 65 years old', 'name': 'NCT02208193'}, {'nct_number': 'NCT03208491', 'title': \"AZ@GAME-Eco: Economic Assessment of Serious Games for the Management of Alzheimer's Disease and Related Disorders\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 136, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03208491', 'age_groups': '40 to 65 years old', 'name': 'NCT03208491'}, {'nct_number': 'NCT02557464', 'title': \"Identification of Early Markers of Alzheimer's Disease by Using Eye Tracking in Reading.\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02557464', 'age_groups': '40 to 65 years old', 'name': 'NCT02557464'}, {'nct_number': 'NCT02873546', 'title': \"tDCS Effect on Cognitive Functions From Patients With Alzheimer's Disease or Progressive Primary Aphasia\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 52, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02873546', 'age_groups': '40 to 65 years old', 'name': 'NCT02873546'}, {'nct_number': 'NCT01329484', 'title': \"Computerized Personal Interventions for Alzheimer's Patients\", 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 159, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01329484', 'age_groups': '40 to 65 years old', 'name': 'NCT01329484'}, {'nct_number': 'NCT02840045', 'title': 'Development of a New Neuroimaging Method Aimed to Differentiate Mnesic Abilities of Alzheimer and Depressed Patients', 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02840045', 'age_groups': '40 to 65 years old', 'name': 'NCT02840045'}, {'nct_number': 'NCT01434940', 'title': 'Eye Movement Recording as an Early Differential Diagnostic Tool for Alzheimer/Depression', 'status': 'Unknown status', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 288, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01434940', 'age_groups': '40 to 65 years old', 'name': 'NCT01434940'}, {'nct_number': 'NCT02843906', 'title': 'Cognitive, Morphological and Neurobiological Progressive Aspects in Bipolar Disorders in the Elderly: Toward to a Neurodegenerescence Detection?', 'status': 'Unknown status', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02843906', 'age_groups': '40 to 65 years old', 'name': 'NCT02843906'}, {'nct_number': 'NCT02062099', 'title': 'PET Imaging of the Translocator Proteine Ligands (TSPO) With [18 F] DPA-714 Biomarker of NeuroInflammation in Cognitive Decline (NIDECO)', 'status': 'Unknown status', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02062099', 'age_groups': '40 to 65 years old', 'name': 'NCT02062099'}, {'nct_number': 'NCT00094939', 'title': 'Predictors of Cognitive Decline in Normal Aging', 'status': 'Unknown status', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 170, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00094939', 'age_groups': '40 to 65 years old', 'name': 'NCT00094939'}, {'nct_number': 'NCT00094952', 'title': \"Biomarkers and Early Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 80, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00094952', 'age_groups': '40 to 65 years old', 'name': 'NCT00094952'}, {'nct_number': 'NCT01055392', 'title': \"Disease-modifying Properties of Lithium in the Neurobiology of Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01055392', 'age_groups': '40 to 65 years old', 'name': 'NCT01055392'}, {'nct_number': 'NCT02377206', 'title': 'Neuroinflammation and Cognitive Decline in Alzheimer Disease', 'status': 'Unknown status', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02377206', 'age_groups': '40 to 65 years old', 'name': 'NCT02377206'}, {'nct_number': 'NCT01885806', 'title': \"Repetitive Transcranial Magnetic Stimulation for Apathy Treatment in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01885806', 'age_groups': '40 to 65 years old', 'name': 'NCT01885806'}, {'nct_number': 'NCT03270137', 'title': 'Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer Disease', 'status': 'Unknown status', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03270137', 'age_groups': '40 to 65 years old', 'name': 'NCT03270137'}, {'nct_number': 'NCT00900770', 'title': 'Implications of Amyloid Pathology', 'status': 'Unknown status', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00900770', 'age_groups': '40 to 65 years old', 'name': 'NCT00900770'}, {'nct_number': 'NCT02772185', 'title': \"Neurostimulation and Cognitive Intervention in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02772185', 'age_groups': '40 to 65 years old', 'name': 'NCT02772185'}, {'nct_number': 'NCT01819545', 'title': \"The Study of microRNA 107 (miRNA 107) and Beta-amyloid Precursor Protein-cleaving Enzyme 1 (BACE1) Messenger Ribonucleic Acid (mRNA) Gene Expression in Cerebrospinal Fluid and Peripheral Blood of Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 300, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01819545', 'age_groups': '40 to 65 years old', 'name': 'NCT01819545'}, {'nct_number': 'NCT02769234', 'title': \"EEG/ERP Longitudinal Study in Alzheimer's Disease (AD)\", 'status': 'Unknown status', 'clean_age': '60 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 75, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02769234', 'age_groups': '40 to 65 years old', 'name': 'NCT02769234'}, {'nct_number': 'NCT01773915', 'title': \"New Proteins in Body Fluids as Potential Biomarker for Alzheimer's Disease: a Pilot Study\", 'status': 'Unknown status', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01773915', 'age_groups': '40 to 65 years old', 'name': 'NCT01773915'}, {'nct_number': 'NCT02829801', 'title': 'Evaluation of the Animal Intervention Used as Therapy', 'status': 'Unknown status', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02829801', 'age_groups': '40 to 65 years old', 'name': 'NCT02829801'}, {'nct_number': 'NCT02196116', 'title': 'Amyloïd Load in Elderly Population: Effect of Cognitive Reserve', 'status': 'Unknown status', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02196116', 'age_groups': '40 to 65 years old', 'name': 'NCT02196116'}, {'nct_number': 'NCT00295152', 'title': 'Effects of Community Occupational Therapy in Older Patients With Dementia and Their Caregivers.', 'status': 'Unknown status', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 135, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00295152', 'age_groups': '40 to 65 years old', 'name': 'NCT00295152'}, {'nct_number': 'NCT02814422', 'title': 'Triglyceride-rich Lipoprotein and Development of Dementia', 'status': 'Unknown status', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 1000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02814422', 'age_groups': '40 to 65 years old', 'name': 'NCT02814422'}, {'nct_number': 'NCT01316562', 'title': \"Predictive Value of Cognitive Tests Performed for the Diagnosis of Alzheimer's Disease and Related Disorders\", 'status': 'Unknown status', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 500, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01316562', 'age_groups': '40 to 65 years old', 'name': 'NCT01316562'}, {'nct_number': 'NCT01314638', 'title': 'Study of Adherence and Effects of Balance Exercices (SIEL BLEU Associatio)', 'status': 'Unknown status', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01314638', 'age_groups': '40 to 65 years old', 'name': 'NCT01314638'}, {'nct_number': 'NCT02941289', 'title': \"Visuospatial Attention, Eye Movements and Instrumental Activities of Daily Living (IADLs) in Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '65 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 64, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02941289', 'age_groups': '40 to 65 years old', 'name': 'NCT02941289'}, {'nct_number': 'NCT02349191', 'title': \"Omental Transposition Surgery for Mild Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': '65 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02349191', 'age_groups': '40 to 65 years old', 'name': 'NCT02349191'}, {'nct_number': 'NCT02351388', 'title': \"Transcranial Direct Current Stimulation for Depression in Alzheimer's Disease Patient - Preliminary Research\", 'status': 'Unknown status', 'clean_age': '65 Years to 90 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02351388', 'age_groups': '40 to 65 years old', 'name': 'NCT02351388'}, {'nct_number': 'NCT00190021', 'title': 'Donepezil Treatment of Psychotic Symptoms in Dementia Patients', 'status': 'Unknown status', 'clean_age': '65 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00190021', 'age_groups': '40 to 65 years old', 'name': 'NCT00190021'}]}, {'name': 'Recruiting', 'children': [{'nct_number': 'NCT03116126', 'title': 'Noradrenergic Add-on Therapy With Guanfacine', 'status': 'Recruiting', 'clean_age': '45 Years and older ', 'phases': 'Phase 3', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03116126', 'age_groups': '40 to 65 years old', 'name': 'NCT03116126'}, {'nct_number': 'NCT03412604', 'title': 'Effect of Modulating Gamma Oscillations Using tACS', 'status': 'Recruiting', 'clean_age': '45 Years and older ', 'phases': 'Not Applicable', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03412604', 'age_groups': '40 to 65 years old', 'name': 'NCT03412604'}, {'nct_number': 'NCT03702907', 'title': 'DC Longitudinal Study on Aging and Specimen Bank', 'status': 'Recruiting', 'clean_age': '45 Years and older ', 'phases': 'Phase 4', 'enrollment': 1000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03702907', 'age_groups': '40 to 65 years old', 'name': 'NCT03702907'}, {'nct_number': 'NCT03851523', 'title': \"Longitudinal Study for the Characterization of the Phases of Subjective Perception of Cognitive Decline and Mild Cognitive Impairment of Alzheimer's Disease.\", 'status': 'Recruiting', 'clean_age': '45 Years and older ', 'phases': 'Phase 4', 'enrollment': 400, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03851523', 'age_groups': '40 to 65 years old', 'name': 'NCT03851523'}, {'nct_number': 'NCT03880240', 'title': \"Gamma Induction for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '45 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 55, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03880240', 'age_groups': '40 to 65 years old', 'name': 'NCT03880240'}, {'nct_number': 'NCT03998423', 'title': \"Oral Fecal Microbiota Transplant Feasibility Study in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '45 Years and older ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03998423', 'age_groups': '40 to 65 years old', 'name': 'NCT03998423'}, {'nct_number': 'NCT02485730', 'title': \"Early Identification of Markers in Alzheimer's Families / ALFA\", 'status': 'Recruiting', 'clean_age': '45 Years to 64 Years ', 'phases': 'Phase 4', 'enrollment': 400, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02485730', 'age_groups': '40 to 65 years old', 'name': 'NCT02485730'}, {'nct_number': 'NCT03269149', 'title': \"Tango for Alzheimer's Disease Patients' Caregivers\", 'status': 'Recruiting', 'clean_age': '45 Years to 65 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03269149', 'age_groups': '40 to 65 years old', 'name': 'NCT03269149'}, {'nct_number': 'NCT03920826', 'title': \"Transcranial Alternating Current Stimulation for Patients With Mild Alzheimer's Disease (TRANSFORM-AD)\", 'status': 'Recruiting', 'clean_age': '45 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03920826', 'age_groups': '40 to 65 years old', 'name': 'NCT03920826'}, {'nct_number': 'NCT03352739', 'title': \"Fornix and NbM as Targets of Stimulation In Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '45 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03352739', 'age_groups': '40 to 65 years old', 'name': 'NCT03352739'}, {'nct_number': 'NCT02685969', 'title': 'Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants', 'status': 'Recruiting', 'clean_age': '45 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 440, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02685969', 'age_groups': '40 to 65 years old', 'name': 'NCT02685969'}, {'nct_number': 'NCT03883633', 'title': 'Reversal of Cognitive Decline (ReCODE) Study', 'status': 'Recruiting', 'clean_age': '45 Years to 76 Years ', 'phases': 'Phase 4', 'enrollment': 30, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03883633', 'age_groups': '40 to 65 years old', 'name': 'NCT03883633'}, {'nct_number': 'NCT02002819', 'title': \"Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability\", 'status': 'Recruiting', 'clean_age': '45 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02002819', 'age_groups': '40 to 65 years old', 'name': 'NCT02002819'}, {'nct_number': 'NCT03699644', 'title': 'Multimodal Ocular Imaging in Neurodegeneration', 'status': 'Recruiting', 'clean_age': '45 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03699644', 'age_groups': '40 to 65 years old', 'name': 'NCT03699644'}, {'nct_number': 'NCT03887481', 'title': 'Effects of tDCS on Verbal Short-term Memory in Neurodegenerative Disorders', 'status': 'Recruiting', 'clean_age': '45 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03887481', 'age_groups': '40 to 65 years old', 'name': 'NCT03887481'}, {'nct_number': 'NCT01782248', 'title': 'Self-consciousness in Dementia', 'status': 'Recruiting', 'clean_age': '45 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 65, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01782248', 'age_groups': '40 to 65 years old', 'name': 'NCT01782248'}, {'nct_number': 'NCT04052737', 'title': \"PMZ-1620 (Sovateltide) in Mild to Moderate Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '45 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04052737', 'age_groups': '40 to 65 years old', 'name': 'NCT04052737'}, {'nct_number': 'NCT03967535', 'title': 'Connectomics in Psychiatric Classification', 'status': 'Recruiting', 'clean_age': '45 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 30, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03967535', 'age_groups': '40 to 65 years old', 'name': 'NCT03967535'}, {'nct_number': 'NCT02778971', 'title': 'Implications for Management of PET Amyloid Classification Technology', 'status': 'Recruiting', 'clean_age': '45 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02778971', 'age_groups': '40 to 65 years old', 'name': 'NCT02778971'}, {'nct_number': 'NCT03538574', 'title': 'Mindfulness Meditation and Insomnia in Alzheimer Disease Caregivers', 'status': 'Recruiting', 'clean_age': '45 Years to 95 Years ', 'phases': 'Not Applicable', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03538574', 'age_groups': '40 to 65 years old', 'name': 'NCT03538574'}, {'nct_number': 'NCT01707719', 'title': \"Isolated Erythrocyte Membrane Susceptibility to Photo-oxidative Stress in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01707719', 'age_groups': '40 to 65 years old', 'name': 'NCT01707719'}, {'nct_number': 'NCT03672201', 'title': 'Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 220, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03672201', 'age_groups': '40 to 65 years old', 'name': 'NCT03672201'}, {'nct_number': 'NCT03846492', 'title': 'Targeting Brain Physiology to Treat Neuropsychiatric Symptoms of Dementia Using TMS-EEG and tDCS', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03846492', 'age_groups': '40 to 65 years old', 'name': 'NCT03846492'}, {'nct_number': 'NCT03399591', 'title': 'Gait Disorders in Patients With Cognitive Decline', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03399591', 'age_groups': '40 to 65 years old', 'name': 'NCT03399591'}, {'nct_number': 'NCT03656107', 'title': 'The Cognition and Flow Study', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03656107', 'age_groups': '40 to 65 years old', 'name': 'NCT03656107'}, {'nct_number': 'NCT03661034', 'title': 'Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03661034', 'age_groups': '40 to 65 years old', 'name': 'NCT03661034'}, {'nct_number': 'NCT03328195', 'title': 'Vielight Neuro RX Gamma - Feasibility Pilot', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03328195', 'age_groups': '40 to 65 years old', 'name': 'NCT03328195'}, {'nct_number': 'NCT02663531', 'title': 'Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02663531', 'age_groups': '40 to 65 years old', 'name': 'NCT02663531'}, {'nct_number': 'NCT03405662', 'title': \"Impact of Photobiomodulation (PBM) on Biomarkers of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03405662', 'age_groups': '40 to 65 years old', 'name': 'NCT03405662'}, {'nct_number': 'NCT03926702', 'title': 'Tau Imaging With JNJ067', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03926702', 'age_groups': '40 to 65 years old', 'name': 'NCT03926702'}, {'nct_number': 'NCT03424200', 'title': \"Coaching for Cognition in Alzheimer's (COCOA)\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03424200', 'age_groups': '40 to 65 years old', 'name': 'NCT03424200'}, {'nct_number': 'NCT03744312', 'title': \"Imaging Inflammation in Alzheimer's Disease With 11C-ER176\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03744312', 'age_groups': '40 to 65 years old', 'name': 'NCT03744312'}, {'nct_number': 'NCT03657745', 'title': \"Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 2000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03657745', 'age_groups': '40 to 65 years old', 'name': 'NCT03657745'}, {'nct_number': 'NCT02646982', 'title': \"Candesartan's Effects on Alzheimer's Disease And Related Biomarkers\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02646982', 'age_groups': '40 to 65 years old', 'name': 'NCT02646982'}, {'nct_number': 'NCT03670615', 'title': 'Using Exercise and Electrical Brain Stimulation to Improve Memory in Dementia', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03670615', 'age_groups': '40 to 65 years old', 'name': 'NCT03670615'}, {'nct_number': 'NCT03402503', 'title': \"Safety, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03402503', 'age_groups': '40 to 65 years old', 'name': 'NCT03402503'}, {'nct_number': 'NCT01421420', 'title': \"Alzheimer's Disease Core Center\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 900, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01421420', 'age_groups': '40 to 65 years old', 'name': 'NCT01421420'}, {'nct_number': 'NCT03634007', 'title': \"Gene Therapy for APOE4 Homozygote of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03634007', 'age_groups': '40 to 65 years old', 'name': 'NCT03634007'}, {'nct_number': 'NCT03550131', 'title': 'Innovations in Dementia Empowerment and Action', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 225, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03550131', 'age_groups': '40 to 65 years old', 'name': 'NCT03550131'}, {'nct_number': 'NCT02804789', 'title': \"European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study (LCS)\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 6000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02804789', 'age_groups': '40 to 65 years old', 'name': 'NCT02804789'}, {'nct_number': 'NCT03384069', 'title': 'CBT for African Americans With Cognitive Impairment', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03384069', 'age_groups': '40 to 65 years old', 'name': 'NCT03384069'}, {'nct_number': 'NCT03709238', 'title': \"Pain Processing and Pain Reporting in Patients With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03709238', 'age_groups': '40 to 65 years old', 'name': 'NCT03709238'}, {'nct_number': 'NCT03138018', 'title': \"Aging Stereotypes and Prodromal Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 260, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03138018', 'age_groups': '40 to 65 years old', 'name': 'NCT03138018'}, {'nct_number': 'NCT03095417', 'title': 'Improving the Recovery and Outcome Every Day After the ICU', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 344, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03095417', 'age_groups': '40 to 65 years old', 'name': 'NCT03095417'}, {'nct_number': 'NCT03081533', 'title': 'Circle Dance for Family Caregivers of the Elderly With Alzheimer.', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03081533', 'age_groups': '40 to 65 years old', 'name': 'NCT03081533'}, {'nct_number': 'NCT03991988', 'title': \"Montelukast Therapy on Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03991988', 'age_groups': '40 to 65 years old', 'name': 'NCT03991988'}, {'nct_number': 'NCT04114994', 'title': 'Longitudinal Cognitive Assessment by BoCA', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 10000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04114994', 'age_groups': '40 to 65 years old', 'name': 'NCT04114994'}, {'nct_number': 'NCT04081285', 'title': \"Epigenetic Biomarkers for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 250, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04081285', 'age_groups': '40 to 65 years old', 'name': 'NCT04081285'}, {'nct_number': 'NCT03061474', 'title': \"Nicotinamide as an Early Alzheimer's Disease Treatment\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03061474', 'age_groups': '40 to 65 years old', 'name': 'NCT03061474'}, {'nct_number': 'NCT03044249', 'title': 'A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03044249', 'age_groups': '40 to 65 years old', 'name': 'NCT03044249'}, {'nct_number': 'NCT03340571', 'title': \"Blood Biomarker of Alzheimer's Disease (AD)\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03340571', 'age_groups': '40 to 65 years old', 'name': 'NCT03340571'}, {'nct_number': 'NCT03090854', 'title': \"Cholinergic Markers Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03090854', 'age_groups': '40 to 65 years old', 'name': 'NCT03090854'}, {'nct_number': 'NCT02899091', 'title': \"Evaluation of the Safety and Potential Therapeutic Effects After Intravenous Transplantation of CB-AC-02 in Patients With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02899091', 'age_groups': '40 to 65 years old', 'name': 'NCT02899091'}, {'nct_number': 'NCT03484143', 'title': 'Neuro RX Gamma - Pivotal Phase', 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 228, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03484143', 'age_groups': '40 to 65 years old', 'name': 'NCT03484143'}, {'nct_number': 'NCT03503331', 'title': \"UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03503331', 'age_groups': '40 to 65 years old', 'name': 'NCT03503331'}, {'nct_number': 'NCT02085265', 'title': \"Telmisartan vs. Perindopril in Hypertensive Mild-Moderate Alzheimer's Disease Patients\", 'status': 'Recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02085265', 'age_groups': '40 to 65 years old', 'name': 'NCT02085265'}, {'nct_number': 'NCT04055376', 'title': \"Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04055376', 'age_groups': '40 to 65 years old', 'name': 'NCT04055376'}, {'nct_number': 'NCT03752463', 'title': \"NMDA Enhancer for the Treatment of Mild Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 100 Years ', 'phases': 'Phase 2', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03752463', 'age_groups': '40 to 65 years old', 'name': 'NCT03752463'}, {'nct_number': 'NCT04042922', 'title': \"High Frequency Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04042922', 'age_groups': '40 to 65 years old', 'name': 'NCT04042922'}, {'nct_number': 'NCT02957227', 'title': \"Diagnosis of Alzheimer's Disease Using Event Related Potentials\", 'status': 'Recruiting', 'clean_age': '50 Years to 100 Years ', 'phases': 'Phase 4', 'enrollment': 170, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02957227', 'age_groups': '40 to 65 years old', 'name': 'NCT02957227'}, {'nct_number': 'NCT04074837', 'title': 'Phase1a, Dose-escalation Study of NNI-362 in Healthy Aged Volunteers', 'status': 'Recruiting', 'clean_age': '50 Years to 72 Years ', 'phases': 'Phase 1', 'enrollment': 56, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04074837', 'age_groups': '40 to 65 years old', 'name': 'NCT04074837'}, {'nct_number': 'NCT03186989', 'title': \"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-MAPTRx in Patients With Mild Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 74 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 44, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03186989', 'age_groups': '40 to 65 years old', 'name': 'NCT03186989'}, {'nct_number': 'NCT02719327', 'title': 'Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid', 'status': 'Recruiting', 'clean_age': '50 Years to 75 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02719327', 'age_groups': '40 to 65 years old', 'name': 'NCT02719327'}, {'nct_number': 'NCT02835716', 'title': 'Pre-Clinical (Alzheimers) Diagnosis PCD = Optimum Outcomes OO', 'status': 'Recruiting', 'clean_age': '50 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02835716', 'age_groups': '40 to 65 years old', 'name': 'NCT02835716'}, {'nct_number': 'NCT03472183', 'title': 'Exploration of the Enteric Nervous System in Alzheimer Disease', 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03472183', 'age_groups': '40 to 65 years old', 'name': 'NCT03472183'}, {'nct_number': 'NCT03875638', 'title': 'Treating Hyperexcitability in AD With Levetiracetam', 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 85, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03875638', 'age_groups': '40 to 65 years old', 'name': 'NCT03875638'}, {'nct_number': 'NCT03522129', 'title': \"Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03522129', 'age_groups': '40 to 65 years old', 'name': 'NCT03522129'}, {'nct_number': 'NCT02600130', 'title': \"Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02600130', 'age_groups': '40 to 65 years old', 'name': 'NCT02600130'}, {'nct_number': 'NCT03939286', 'title': 'Multimodal Imaging Study on Physical Activity in Patients With Alzheimer`s Disease', 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03939286', 'age_groups': '40 to 65 years old', 'name': 'NCT03939286'}, {'nct_number': 'NCT04082611', 'title': 'The PREVENTION Trial: Precision Recommendations to Optimize Neurocognition', 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04082611', 'age_groups': '40 to 65 years old', 'name': 'NCT04082611'}, {'nct_number': 'NCT03290274', 'title': 'Clinical Trial to Evaluate the Efficacy and Security of Deep Brain Stimulation in Alzheimer´s Disease', 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03290274', 'age_groups': '40 to 65 years old', 'name': 'NCT03290274'}, {'nct_number': 'NCT03056729', 'title': \"Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03056729', 'age_groups': '40 to 65 years old', 'name': 'NCT03056729'}, {'nct_number': 'NCT03943264', 'title': \"A Biomarker-directed Study of XPro1595 in Patients With Mild to Moderate Alzheimer's\", 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03943264', 'age_groups': '40 to 65 years old', 'name': 'NCT03943264'}, {'nct_number': 'NCT03703856', 'title': \"Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 88, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03703856', 'age_groups': '40 to 65 years old', 'name': 'NCT03703856'}, {'nct_number': 'NCT03035851', 'title': \"Aerobic Exercise for Older Adults at Increased Risk of Alzheimer's Disease and Related Dementias\", 'status': 'Recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 264, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03035851', 'age_groups': '40 to 65 years old', 'name': 'NCT03035851'}, {'nct_number': 'NCT03090516', 'title': \"Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03090516', 'age_groups': '40 to 65 years old', 'name': 'NCT03090516'}, {'nct_number': 'NCT03659643', 'title': 'Mild Cognitive Impairment, Use of qEEG as a Prognostic Marker', 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 300, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03659643', 'age_groups': '40 to 65 years old', 'name': 'NCT03659643'}, {'nct_number': 'NCT02054208', 'title': \"Safety and Exploratory Efficacy Study of NEUROSTEM® Versus Placebo in Patients With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02054208', 'age_groups': '40 to 65 years old', 'name': 'NCT02054208'}, {'nct_number': 'NCT03283059', 'title': \"Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 600, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03283059', 'age_groups': '40 to 65 years old', 'name': 'NCT03283059'}, {'nct_number': 'NCT03069014', 'title': 'Study of LM11A-31-BHS in Mild-moderate AD Patients', 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 190, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03069014', 'age_groups': '40 to 65 years old', 'name': 'NCT03069014'}, {'nct_number': 'NCT03325205', 'title': \"MR Guided tDCS in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03325205', 'age_groups': '40 to 65 years old', 'name': 'NCT03325205'}, {'nct_number': 'NCT03466177', 'title': \"Multimodal Retinal Imaging in the Detection and Follow-up of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 90, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03466177', 'age_groups': '40 to 65 years old', 'name': 'NCT03466177'}, {'nct_number': 'NCT03625401', 'title': \"Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 88, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03625401', 'age_groups': '40 to 65 years old', 'name': 'NCT03625401'}, {'nct_number': 'NCT03671889', 'title': \"ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03671889', 'age_groups': '40 to 65 years old', 'name': 'NCT03671889'}, {'nct_number': 'NCT03638583', 'title': 'Alzheimer Prevention Trials Webstudy', 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 200000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03638583', 'age_groups': '40 to 65 years old', 'name': 'NCT03638583'}, {'nct_number': 'NCT03507790', 'title': \"A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03507790', 'age_groups': '40 to 65 years old', 'name': 'NCT03507790'}, {'nct_number': 'NCT03834402', 'title': 'INTERCEPTOR Project: From MCI to Dementia', 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 500, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03834402', 'age_groups': '40 to 65 years old', 'name': 'NCT03834402'}, {'nct_number': 'NCT03197740', 'title': \"A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 346, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03197740', 'age_groups': '40 to 65 years old', 'name': 'NCT03197740'}, {'nct_number': 'NCT02875496', 'title': 'Reference Database & Longitudinal Registry of the Normal and Pathological Aging Brain', 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 2000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02875496', 'age_groups': '40 to 65 years old', 'name': 'NCT02875496'}, {'nct_number': 'NCT04040348', 'title': \"Alzheimer's Disease Stem Cells Multiple Infusions\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04040348', 'age_groups': '40 to 65 years old', 'name': 'NCT04040348'}, {'nct_number': 'NCT04079803', 'title': \"PTI-125 for Mild-to-moderate Alzheimer's Disease Patients\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04079803', 'age_groups': '40 to 65 years old', 'name': 'NCT04079803'}, {'nct_number': 'NCT03828747', 'title': \"A Study of RO7105705 in Patients With Moderate Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 260, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03828747', 'age_groups': '40 to 65 years old', 'name': 'NCT03828747'}, {'nct_number': 'NCT03980730', 'title': \"Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03980730', 'age_groups': '40 to 65 years old', 'name': 'NCT03980730'}, {'nct_number': 'NCT02711683', 'title': \"DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02711683', 'age_groups': '40 to 65 years old', 'name': 'NCT02711683'}, {'nct_number': 'NCT03867253', 'title': \"Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 33, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03867253', 'age_groups': '40 to 65 years old', 'name': 'NCT03867253'}, {'nct_number': 'NCT03739905', 'title': \"ExAblate Blood-Brain Barrier Opening for Treatment of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03739905', 'age_groups': '40 to 65 years old', 'name': 'NCT03739905'}, {'nct_number': 'NCT03801642', 'title': \"Dapagliflozin In Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03801642', 'age_groups': '40 to 65 years old', 'name': 'NCT03801642'}, {'nct_number': 'NCT03507192', 'title': 'Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.', 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03507192', 'age_groups': '40 to 65 years old', 'name': 'NCT03507192'}, {'nct_number': 'NCT03605667', 'title': \"Study of BHV-4157 in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 292, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03605667', 'age_groups': '40 to 65 years old', 'name': 'NCT03605667'}, {'nct_number': 'NCT03612622', 'title': \"Effect of Theta-Burst Transcranial Magnetic Stimulation (TBS) for Early Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03612622', 'age_groups': '40 to 65 years old', 'name': 'NCT03612622'}, {'nct_number': 'NCT03277573', 'title': \"Salsalate in Patients Mild to Moderate Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03277573', 'age_groups': '40 to 65 years old', 'name': 'NCT03277573'}, {'nct_number': 'NCT03493282', 'title': 'Effect of CT1812 Treatment on Brain Synaptic Density', 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03493282', 'age_groups': '40 to 65 years old', 'name': 'NCT03493282'}, {'nct_number': 'NCT03810794', 'title': \"Clinical Evaluation on the Therapeutic Effect of Acupuncture Treatment for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03810794', 'age_groups': '40 to 65 years old', 'name': 'NCT03810794'}, {'nct_number': 'NCT03172117', 'title': 'Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial.', 'status': 'Recruiting', 'clean_age': '50 Years to 86 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03172117', 'age_groups': '40 to 65 years old', 'name': 'NCT03172117'}, {'nct_number': 'NCT02155946', 'title': 'Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment', 'status': 'Recruiting', 'clean_age': '50 Years to 88 Years ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02155946', 'age_groups': '40 to 65 years old', 'name': 'NCT02155946'}, {'nct_number': 'NCT03790774', 'title': \"Neurofeedback in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 89 Years ', 'phases': 'Not Applicable', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03790774', 'age_groups': '40 to 65 years old', 'name': 'NCT03790774'}, {'nct_number': 'NCT02502253', 'title': 'BDPP Treatment for Mild Cognitive Impairment (MCI) and Prediabetes or Type 2 Diabetes Mellitus (T2DM)', 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02502253', 'age_groups': '40 to 65 years old', 'name': 'NCT02502253'}, {'nct_number': 'NCT03101085', 'title': \"S-Equol in Alzheimer's Disease 2 Trial\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03101085', 'age_groups': '40 to 65 years old', 'name': 'NCT03101085'}, {'nct_number': 'NCT03543878', 'title': 'Stimulating Neural Activity to Improve Blood Flow and Reduce Amyloid: Path to Clinical Trials', 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03543878', 'age_groups': '40 to 65 years old', 'name': 'NCT03543878'}, {'nct_number': 'NCT03393520', 'title': \"Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 412, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03393520', 'age_groups': '40 to 65 years old', 'name': 'NCT03393520'}, {'nct_number': 'NCT02524405', 'title': 'BEAM: Brain-Eye Amyloid Memory Study', 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 345, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02524405', 'age_groups': '40 to 65 years old', 'name': 'NCT02524405'}, {'nct_number': 'NCT01687153', 'title': 'A Study of Brain Aging in Vietnam War Veterans', 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 420, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01687153', 'age_groups': '40 to 65 years old', 'name': 'NCT01687153'}, {'nct_number': 'NCT03420807', 'title': 'Retinal Metabolic Imaging of Alzheimer Patient', 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03420807', 'age_groups': '40 to 65 years old', 'name': 'NCT03420807'}, {'nct_number': 'NCT02814045', 'title': \"Role of Hypoxia Ans Sleep Fragmentation in Alzheimer's Disease. and Sleep Fragmentation.\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 144, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02814045', 'age_groups': '40 to 65 years old', 'name': 'NCT02814045'}, {'nct_number': 'NCT03503669', 'title': \"Reducing Risk for Alzheimer's Disease in High-Risk Women Through Yogic Meditation Training\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03503669', 'age_groups': '40 to 65 years old', 'name': 'NCT03503669'}, {'nct_number': 'NCT02446132', 'title': \"Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 700, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02446132', 'age_groups': '40 to 65 years old', 'name': 'NCT02446132'}, {'nct_number': 'NCT01811381', 'title': \"Curcumin and Yoga Therapy for Those at Risk for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01811381', 'age_groups': '40 to 65 years old', 'name': 'NCT01811381'}, {'nct_number': 'NCT02521558', 'title': \"Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02521558', 'age_groups': '40 to 65 years old', 'name': 'NCT02521558'}, {'nct_number': 'NCT03443973', 'title': \"Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 760, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03443973', 'age_groups': '40 to 65 years old', 'name': 'NCT03443973'}, {'nct_number': 'NCT02912936', 'title': 'A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease', 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02912936', 'age_groups': '40 to 65 years old', 'name': 'NCT02912936'}, {'nct_number': 'NCT02964611', 'title': \"Social Cognition and Personality Changes in Alzheimer's & Parkinson's Disease & Frontotemporal Lobar Degeneration\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02964611', 'age_groups': '40 to 65 years old', 'name': 'NCT02964611'}, {'nct_number': 'NCT02686554', 'title': 'Identification of Proteostasis-related Biomarkers in Alzheimer´s Dementia', 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 200, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02686554', 'age_groups': '40 to 65 years old', 'name': 'NCT02686554'}, {'nct_number': 'NCT03887455', 'title': \"A Study to Confirm Safety and Efficacy of BAN2401 in Participants With Early Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 1566, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03887455', 'age_groups': '40 to 65 years old', 'name': 'NCT03887455'}, {'nct_number': 'NCT03444870', 'title': \"Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)\", 'status': 'Recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 760, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03444870', 'age_groups': '40 to 65 years old', 'name': 'NCT03444870'}, {'nct_number': 'NCT01703117', 'title': \"Riluzole in Mild Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 2', 'enrollment': 48, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01703117', 'age_groups': '40 to 65 years old', 'name': 'NCT01703117'}, {'nct_number': 'NCT03330353', 'title': 'Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy', 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 56, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03330353', 'age_groups': '40 to 65 years old', 'name': 'NCT03330353'}, {'nct_number': 'NCT03556280', 'title': 'Multi-Center Study of Sensory Stimulation to Improve Brain Function', 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03556280', 'age_groups': '40 to 65 years old', 'name': 'NCT03556280'}, {'nct_number': 'NCT02908815', 'title': \"Investigating the Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) as a Treatment for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02908815', 'age_groups': '40 to 65 years old', 'name': 'NCT02908815'}, {'nct_number': 'NCT03075241', 'title': \"Z-Drugs for Sleep Disorders in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03075241', 'age_groups': '40 to 65 years old', 'name': 'NCT03075241'}, {'nct_number': 'NCT03070535', 'title': \"APOE Genotype and Diet Influences on Alzheimer's Biomarkers\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03070535', 'age_groups': '40 to 65 years old', 'name': 'NCT03070535'}, {'nct_number': 'NCT03330587', 'title': 'Living Alone in Old Age With Cognitive Impairment', 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03330587', 'age_groups': '40 to 65 years old', 'name': 'NCT03330587'}, {'nct_number': 'NCT03821857', 'title': \"Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03821857', 'age_groups': '40 to 65 years old', 'name': 'NCT03821857'}, {'nct_number': 'NCT03991195', 'title': 'Intervention of Intestinal Microorganism in Mild Cognitive Impairment', 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03991195', 'age_groups': '40 to 65 years old', 'name': 'NCT03991195'}, {'nct_number': 'NCT03761381', 'title': 'OCT Angiography and NRAI in Dementia', 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03761381', 'age_groups': '40 to 65 years old', 'name': 'NCT03761381'}, {'nct_number': 'NCT03682874', 'title': 'Identifying Novel Aging Targets for Treatment of Delirium', 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 25, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03682874', 'age_groups': '40 to 65 years old', 'name': 'NCT03682874'}, {'nct_number': 'NCT02359864', 'title': \"Study of Low Dose Whole Brain Irradiation in the Treatment of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02359864', 'age_groups': '40 to 65 years old', 'name': 'NCT02359864'}, {'nct_number': 'NCT03140865', 'title': \"Wake Forest Alzheimer's Disease Clinical Core\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 850, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03140865', 'age_groups': '40 to 65 years old', 'name': 'NCT03140865'}, {'nct_number': 'NCT03933696', 'title': \"Light, Metabolic Syndrome and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03933696', 'age_groups': '40 to 65 years old', 'name': 'NCT03933696'}, {'nct_number': 'NCT03777722', 'title': \"Light and the Effect on Metabolic Syndrome and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03777722', 'age_groups': '40 to 65 years old', 'name': 'NCT03777722'}, {'nct_number': 'NCT03347084', 'title': \"Deep Brain Stimulation With LIFUP for Mild Cognitive Impairment and Mild Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03347084', 'age_groups': '40 to 65 years old', 'name': 'NCT03347084'}, {'nct_number': 'NCT03082755', 'title': \"Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 136, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03082755', 'age_groups': '40 to 65 years old', 'name': 'NCT03082755'}, {'nct_number': 'NCT02769000', 'title': \"Low Dose RT to Reduce Cerebral Amyloidosis in Early Alzheimer's\", 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02769000', 'age_groups': '40 to 65 years old', 'name': 'NCT02769000'}, {'nct_number': 'NCT02800395', 'title': 'Influence of Oxidative Stress and Nutrition Biomarkers on the Cognitive Decline Evolution in Alzheimer Disease', 'status': 'Recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 350, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02800395', 'age_groups': '40 to 65 years old', 'name': 'NCT02800395'}, {'nct_number': 'NCT03852901', 'title': 'Sodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production', 'status': 'Recruiting', 'clean_age': '55 Years to 100 Years ', 'phases': 'Phase 1', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03852901', 'age_groups': '40 to 65 years old', 'name': 'NCT03852901'}, {'nct_number': 'NCT02460783', 'title': 'Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain Function', 'status': 'Recruiting', 'clean_age': '55 Years to 70 Years ', 'phases': 'Phase 2', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02460783', 'age_groups': '40 to 65 years old', 'name': 'NCT02460783'}, {'nct_number': 'NCT03673722', 'title': 'Mediterranean Diet, Exercise and Dementia Risk in UK Adults', 'status': 'Recruiting', 'clean_age': '55 Years to 74 Years ', 'phases': 'Not Applicable', 'enrollment': 108, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03673722', 'age_groups': '40 to 65 years old', 'name': 'NCT03673722'}, {'nct_number': 'NCT03625622', 'title': \"Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 2', 'enrollment': 210, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03625622', 'age_groups': '40 to 65 years old', 'name': 'NCT03625622'}, {'nct_number': 'NCT03706261', 'title': \"Alzheimer's PET Imaging in Racially/Ethnically Diverse Adults\", 'status': 'Recruiting', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03706261', 'age_groups': '40 to 65 years old', 'name': 'NCT03706261'}, {'nct_number': 'NCT03278119', 'title': \"Sleep Aging and Risk for Alzheimer's 2.0\", 'status': 'Recruiting', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 124, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03278119', 'age_groups': '40 to 65 years old', 'name': 'NCT03278119'}, {'nct_number': 'NCT03053908', 'title': 'Orexin and Tau Pathology in Cognitively Normal Elderly', 'status': 'Recruiting', 'clean_age': '55 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03053908', 'age_groups': '40 to 65 years old', 'name': 'NCT03053908'}, {'nct_number': 'NCT03824197', 'title': \"Auburn University Research on Olive Oil for Alzheimer's Disease (AU-ROOAD)\", 'status': 'Recruiting', 'clean_age': '55 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03824197', 'age_groups': '40 to 65 years old', 'name': 'NCT03824197'}, {'nct_number': 'NCT03461861', 'title': \"Network-Level Mechanisms for Preclinical Alzheimer's Disease Development\", 'status': 'Recruiting', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03461861', 'age_groups': '40 to 65 years old', 'name': 'NCT03461861'}, {'nct_number': 'NCT03354143', 'title': 'Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)', 'status': 'Recruiting', 'clean_age': '55 Years to 79 Years ', 'phases': 'Phase 2', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03354143', 'age_groups': '40 to 65 years old', 'name': 'NCT03354143'}, {'nct_number': 'NCT03823404', 'title': \"GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 573, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03823404', 'age_groups': '40 to 65 years old', 'name': 'NCT03823404'}, {'nct_number': 'NCT02833792', 'title': \"Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02833792', 'age_groups': '40 to 65 years old', 'name': 'NCT02833792'}, {'nct_number': 'NCT02844855', 'title': 'Memory for Action in Neurological Patients', 'status': 'Recruiting', 'clean_age': '55 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 99, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02844855', 'age_groups': '40 to 65 years old', 'name': 'NCT02844855'}, {'nct_number': 'NCT03461276', 'title': 'Safety and Immunogenicity of Repeated Doses of ABvac40 in Patients With a-MCI or Vm-AD', 'status': 'Recruiting', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03461276', 'age_groups': '40 to 65 years old', 'name': 'NCT03461276'}, {'nct_number': 'NCT03721705', 'title': \"Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type\", 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03721705', 'age_groups': '40 to 65 years old', 'name': 'NCT03721705'}, {'nct_number': 'NCT03672474', 'title': 'REGEnLIFE RGn530 - Feasibility Pilot', 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 64, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03672474', 'age_groups': '40 to 65 years old', 'name': 'NCT03672474'}, {'nct_number': 'NCT03486938', 'title': \"Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 830, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03486938', 'age_groups': '40 to 65 years old', 'name': 'NCT03486938'}, {'nct_number': 'NCT03817684', 'title': \"Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's Subjects\", 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 255, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03817684', 'age_groups': '40 to 65 years old', 'name': 'NCT03817684'}, {'nct_number': 'NCT03531684', 'title': 'Efficacy and Safety of MMFS in Early AD', 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03531684', 'age_groups': '40 to 65 years old', 'name': 'NCT03531684'}, {'nct_number': 'NCT03757325', 'title': \"Study to Evaluate DNL747 in Subjects With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03757325', 'age_groups': '40 to 65 years old', 'name': 'NCT03757325'}, {'nct_number': 'NCT02925650', 'title': \"Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02925650', 'age_groups': '40 to 65 years old', 'name': 'NCT02925650'}, {'nct_number': 'NCT03472664', 'title': \"Brain Energy for Amyloid Transformation in Alzheimer's Disease Study\", 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03472664', 'age_groups': '40 to 65 years old', 'name': 'NCT03472664'}, {'nct_number': 'NCT03706885', 'title': 'Efavirenz for Patients With Mild Cognitive Impairment', 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03706885', 'age_groups': '40 to 65 years old', 'name': 'NCT03706885'}, {'nct_number': 'NCT03132272', 'title': \"Immunoadsorption for Treatment of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03132272', 'age_groups': '40 to 65 years old', 'name': 'NCT03132272'}, {'nct_number': 'NCT03929302', 'title': 'Brain Energy Metabolism and Sleep in Adults', 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03929302', 'age_groups': '40 to 65 years old', 'name': 'NCT03929302'}, {'nct_number': 'NCT03856359', 'title': \"Trial of Rifaximin in Probable Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03856359', 'age_groups': '40 to 65 years old', 'name': 'NCT03856359'}, {'nct_number': 'NCT03533257', 'title': \"Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03533257', 'age_groups': '40 to 65 years old', 'name': 'NCT03533257'}, {'nct_number': 'NCT03620981', 'title': \"Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type\", 'status': 'Recruiting', 'clean_age': '55 Years to 89 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 407, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03620981', 'age_groups': '40 to 65 years old', 'name': 'NCT03620981'}, {'nct_number': 'NCT03724942', 'title': \"Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type\", 'status': 'Recruiting', 'clean_age': '55 Years to 89 Years ', 'phases': 'Phase 3', 'enrollment': 157, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03724942', 'age_groups': '40 to 65 years old', 'name': 'NCT03724942'}, {'nct_number': 'NCT03912571', 'title': \"Sleep Disordered Breathing and Alzheimer's Disease Biomarkers in Normal Aging and Mild Cognitive Impairment\", 'status': 'Recruiting', 'clean_age': '55 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 95, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03912571', 'age_groups': '40 to 65 years old', 'name': 'NCT03912571'}, {'nct_number': 'NCT03548584', 'title': \"A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type\", 'status': 'Recruiting', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 225, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03548584', 'age_groups': '40 to 65 years old', 'name': 'NCT03548584'}, {'nct_number': 'NCT02854033', 'title': \"Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol\", 'status': 'Recruiting', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 2000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02854033', 'age_groups': '40 to 65 years old', 'name': 'NCT02854033'}, {'nct_number': 'NCT02720445', 'title': 'Memory Improvement Through Nicotine Dosing (MIND) Study', 'status': 'Recruiting', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02720445', 'age_groups': '40 to 65 years old', 'name': 'NCT02720445'}, {'nct_number': 'NCT04057807', 'title': \"Peripheral Benzodiazepine Receptors (PBR28) Brain PET Imaging With Lipopolysaccharide Challenge for the Study of Microglia Function in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '55 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04057807', 'age_groups': '40 to 65 years old', 'name': 'NCT04057807'}, {'nct_number': 'NCT03056495', 'title': 'Clinical Trial to Determine Tolerable Dosis of Vorinostat in Patients With Mild Alzheimer Disease', 'status': 'Recruiting', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 44, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03056495', 'age_groups': '40 to 65 years old', 'name': 'NCT03056495'}, {'nct_number': 'NCT03594123', 'title': \"A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type\", 'status': 'Recruiting', 'clean_age': '55 Years to 91 Years ', 'phases': 'Phase 3', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03594123', 'age_groups': '40 to 65 years old', 'name': 'NCT03594123'}, {'nct_number': 'NCT03811847', 'title': 'A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants.', 'status': 'Recruiting', 'clean_age': '55 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03811847', 'age_groups': '40 to 65 years old', 'name': 'NCT03811847'}, {'nct_number': 'NCT03814382', 'title': \"Acupuncture to Reduce Anxiety in Alzheimer's Disease (AD) and AD Related Dementias\", 'status': 'Recruiting', 'clean_age': '55 Years to 95 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03814382', 'age_groups': '40 to 65 years old', 'name': 'NCT03814382'}, {'nct_number': 'NCT03672448', 'title': 'The China Longitudinal Aging Study of Cognitive Impairment', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 10000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03672448', 'age_groups': '40 to 65 years old', 'name': 'NCT03672448'}, {'nct_number': 'NCT02330510', 'title': 'Amyloid and Glucose PET Imaging in Alzheimer and Vascular Cognitive Impairment Patients With Significant White Matter Disease', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 80, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02330510', 'age_groups': '40 to 65 years old', 'name': 'NCT02330510'}, {'nct_number': 'NCT02626377', 'title': 'Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-Comté', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 7604, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02626377', 'age_groups': '40 to 65 years old', 'name': 'NCT02626377'}, {'nct_number': 'NCT03698760', 'title': 'Computerized Olfactory Test - Alzheimer Disease Mild Stage', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03698760', 'age_groups': '40 to 65 years old', 'name': 'NCT03698760'}, {'nct_number': 'NCT02959502', 'title': 'Home-Based CR and tDCS to Enhance Cognition in Persons With Mild Cognitive Impairment and Late Life Depression', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02959502', 'age_groups': '40 to 65 years old', 'name': 'NCT02959502'}, {'nct_number': 'NCT04121858', 'title': \"Brain Safe: Consumer Intervention to Reduce Exposure to Drugs Linked to Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 700, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04121858', 'age_groups': '40 to 65 years old', 'name': 'NCT04121858'}, {'nct_number': 'NCT03185208', 'title': 'Lithium As a Treatment to Prevent Impairment of Cognition in Elders', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03185208', 'age_groups': '40 to 65 years old', 'name': 'NCT03185208'}, {'nct_number': 'NCT02386670', 'title': \"Prevention of Alzheimer's Disease With CR Plus tDCS in Mild Cognitive Impairment and Depression (PACt-MD)\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 375, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02386670', 'age_groups': '40 to 65 years old', 'name': 'NCT02386670'}, {'nct_number': 'NCT03991624', 'title': \"Lack of Decision-making in Patients With Alzheimer's Disease : Functions Involved and the Daily Consequences\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03991624', 'age_groups': '40 to 65 years old', 'name': 'NCT03991624'}, {'nct_number': 'NCT03665831', 'title': 'Deep TMS for Comorbid Depression and Cognitive Impairment in Older Adults', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 28, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03665831', 'age_groups': '40 to 65 years old', 'name': 'NCT03665831'}, {'nct_number': 'NCT03846232', 'title': \"Detection of Cerebral Proteinopathy in Alzheimer's Disease Through Magnetic Resonance Imaging\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03846232', 'age_groups': '40 to 65 years old', 'name': 'NCT03846232'}, {'nct_number': 'NCT03691428', 'title': 'Stress Reduction Study for Partners of Early Stage Dementia', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03691428', 'age_groups': '40 to 65 years old', 'name': 'NCT03691428'}, {'nct_number': 'NCT01423396', 'title': \"Impact of Controlling Vascular Risk Factors on the Progression of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 406, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01423396', 'age_groups': '40 to 65 years old', 'name': 'NCT01423396'}, {'nct_number': 'NCT03899844', 'title': 'Study to Evaluate Amyloid in Blood and Imaging Related to Dementia', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 1120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03899844', 'age_groups': '40 to 65 years old', 'name': 'NCT03899844'}, {'nct_number': 'NCT03455569', 'title': \"A Dyadic Sleep Intervention for Alzheimer's Disease Patients and Their Caregivers\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03455569', 'age_groups': '40 to 65 years old', 'name': 'NCT03455569'}, {'nct_number': 'NCT03887923', 'title': 'Vestibular Physical Therapy for People With Alzheimer Disease', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03887923', 'age_groups': '40 to 65 years old', 'name': 'NCT03887923'}, {'nct_number': 'NCT04012346', 'title': \"Modulation of Cognition and Brain Connectivity by Noninvasive Brain Stimulation in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04012346', 'age_groups': '40 to 65 years old', 'name': 'NCT04012346'}, {'nct_number': 'NCT03638284', 'title': 'Non-invasive Brain Stimulation Using Transcranial Direct Current Stimulation for Neuropsychiatric Symptoms of Dementia', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03638284', 'age_groups': '40 to 65 years old', 'name': 'NCT03638284'}, {'nct_number': 'NCT04096261', 'title': \"The Importance of Sleep Quality and the Blood-brain Barrier in Cognitive Disorders and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 132, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04096261', 'age_groups': '40 to 65 years old', 'name': 'NCT04096261'}, {'nct_number': 'NCT03644043', 'title': 'Evidence Amyloid Scan EEG Study', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 2000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03644043', 'age_groups': '40 to 65 years old', 'name': 'NCT03644043'}, {'nct_number': 'NCT03676881', 'title': \"Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03676881', 'age_groups': '40 to 65 years old', 'name': 'NCT03676881'}, {'nct_number': 'NCT04093882', 'title': \"The Relevance of the Blood-brain Barrier to Cognitive Dysfunction and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 132, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04093882', 'age_groups': '40 to 65 years old', 'name': 'NCT04093882'}, {'nct_number': 'NCT03962439', 'title': 'Impact of Challenging Engagement on Cognition in Older Adults', 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03962439', 'age_groups': '40 to 65 years old', 'name': 'NCT03962439'}, {'nct_number': 'NCT03827733', 'title': \"Gut Microbiota and Alzheimer's Diseases\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 200, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03827733', 'age_groups': '40 to 65 years old', 'name': 'NCT03827733'}, {'nct_number': 'NCT02861846', 'title': \"Predictive Value of Biomarkers of the Alzheimer's Disease (AD) in Elderly Patients With New-onset Epilepsy\", 'status': 'Recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02861846', 'age_groups': '40 to 65 years old', 'name': 'NCT02861846'}, {'nct_number': 'NCT03224988', 'title': 'Bilateral Brain Dynamics in Cognition and Aging', 'status': 'Recruiting', 'clean_age': '60 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03224988', 'age_groups': '40 to 65 years old', 'name': 'NCT03224988'}, {'nct_number': 'NCT03959124', 'title': \"Deep Brain Stimulation for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03959124', 'age_groups': '40 to 65 years old', 'name': 'NCT03959124'}, {'nct_number': 'NCT03814603', 'title': 'The Sleep Amyloid, Slow WAve Race and Ethnicity Study', 'status': 'Recruiting', 'clean_age': '60 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 210, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03814603', 'age_groups': '40 to 65 years old', 'name': 'NCT03814603'}, {'nct_number': 'NCT02087865', 'title': \"Effects of Donepezil HCL on Task-Activated fMRI Brain Activation in Healthy Older Adults at Genetic Risk for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02087865', 'age_groups': '40 to 65 years old', 'name': 'NCT02087865'}, {'nct_number': 'NCT03688126', 'title': 'U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk', 'status': 'Recruiting', 'clean_age': '60 Years to 79 Years ', 'phases': 'Not Applicable', 'enrollment': 2000, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03688126', 'age_groups': '40 to 65 years old', 'name': 'NCT03688126'}, {'nct_number': 'NCT03613844', 'title': 'DHA Brain Delivery Trial', 'status': 'Recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 320, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03613844', 'age_groups': '40 to 65 years old', 'name': 'NCT03613844'}, {'nct_number': 'NCT03727360', 'title': \"Exercise for Brain Health in the Fight Against Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 152, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03727360', 'age_groups': '40 to 65 years old', 'name': 'NCT03727360'}, {'nct_number': 'NCT03274817', 'title': \"A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol\", 'status': 'Recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 31, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03274817', 'age_groups': '40 to 65 years old', 'name': 'NCT03274817'}, {'nct_number': 'NCT03954899', 'title': 'Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in Aging', 'status': 'Recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 230, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03954899', 'age_groups': '40 to 65 years old', 'name': 'NCT03954899'}, {'nct_number': 'NCT03370744', 'title': 'Prediction of Cognitive Decline by Neuroimaging Techniques and the Application in Diagnosis and Treatment of Preclinical AD', 'status': 'Recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 300, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03370744', 'age_groups': '40 to 65 years old', 'name': 'NCT03370744'}, {'nct_number': 'NCT03847038', 'title': 'BarcelonaBeta Dementia Prevention Research Clinic: a Study on Risk Factors Disclosure', 'status': 'Recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 425, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03847038', 'age_groups': '40 to 65 years old', 'name': 'NCT03847038'}, {'nct_number': 'NCT02726906', 'title': 'Lifestyle Enriching Activities for Research in Neuroscience Intervention Trial: LEARNit Study', 'status': 'Recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02726906', 'age_groups': '40 to 65 years old', 'name': 'NCT02726906'}, {'nct_number': 'NCT02836054', 'title': 'Study of Degenerescence CSF Hallmarks in Older Bipolar Patients', 'status': 'Recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02836054', 'age_groups': '40 to 65 years old', 'name': 'NCT02836054'}, {'nct_number': 'NCT03475446', 'title': 'The Effect of tES on a Cognitive Training', 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 180, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03475446', 'age_groups': '40 to 65 years old', 'name': 'NCT03475446'}, {'nct_number': 'NCT03900273', 'title': \"Development of Novel Measures for Alzheimer's Disease Prevention Trials\", 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 320, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03900273', 'age_groups': '40 to 65 years old', 'name': 'NCT03900273'}, {'nct_number': 'NCT03249688', 'title': \"Multimodal Preventive Trial for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03249688', 'age_groups': '40 to 65 years old', 'name': 'NCT03249688'}, {'nct_number': 'NCT03790709', 'title': \"ANAVEX2-73 for Treatment of Early Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 450, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03790709', 'age_groups': '40 to 65 years old', 'name': 'NCT03790709'}, {'nct_number': 'NCT02363504', 'title': 'The Locus Coeruleus and Memory', 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 70, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02363504', 'age_groups': '40 to 65 years old', 'name': 'NCT02363504'}, {'nct_number': 'NCT02608021', 'title': 'Neurotrack Test Validation Protocol', 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 80, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02608021', 'age_groups': '40 to 65 years old', 'name': 'NCT02608021'}, {'nct_number': 'NCT03954210', 'title': 'SIESTA: Sleep Intervention to Enhance Cognitive Status and Reduce Beta Amyloid', 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03954210', 'age_groups': '40 to 65 years old', 'name': 'NCT03954210'}, {'nct_number': 'NCT03784183', 'title': \"Neuropsychological and Neurophysiological Effects of Cognitive Stimulation in Patients With Alzheimer's Disease and Mild Cognitive Impairment\", 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 126, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03784183', 'age_groups': '40 to 65 years old', 'name': 'NCT03784183'}, {'nct_number': 'NCT02913664', 'title': \"Risk Reduction for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 640, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02913664', 'age_groups': '40 to 65 years old', 'name': 'NCT02913664'}, {'nct_number': 'NCT03860857', 'title': 'MRI and PET Biomarkers for Cognitive Decline in Older Adults', 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03860857', 'age_groups': '40 to 65 years old', 'name': 'NCT03860857'}, {'nct_number': 'NCT03020381', 'title': 'Gait as Predictor of Dementia and Falls. The Gait and Brain Cohort Study', 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 400, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03020381', 'age_groups': '40 to 65 years old', 'name': 'NCT03020381'}, {'nct_number': 'NCT02305836', 'title': \"Effect of Electroacupuncture Combined With Donepezil for Treating Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 334, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02305836', 'age_groups': '40 to 65 years old', 'name': 'NCT02305836'}, {'nct_number': 'NCT03333837', 'title': 'Improvisational Movement for People With Memory Loss and Their Caregivers', 'status': 'Recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03333837', 'age_groups': '40 to 65 years old', 'name': 'NCT03333837'}, {'nct_number': 'NCT03359902', 'title': 'Treatment of Mild Cognitive Impairment With Transcutaneous Vagal Nerve Stimulation', 'status': 'Recruiting', 'clean_age': '60 Years to 89 Years ', 'phases': 'Not Applicable', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03359902', 'age_groups': '40 to 65 years old', 'name': 'NCT03359902'}, {'nct_number': 'NCT02792257', 'title': \"Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease (AD) (THC-AD)\", 'status': 'Recruiting', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02792257', 'age_groups': '40 to 65 years old', 'name': 'NCT02792257'}, {'nct_number': 'NCT03094546', 'title': 'Polyamine-enriched Diet in Elderly Individuals With Subjective Cognitive Decline', 'status': 'Recruiting', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03094546', 'age_groups': '40 to 65 years old', 'name': 'NCT03094546'}, {'nct_number': 'NCT03765762', 'title': \"A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years to 95 Years ', 'phases': 'Phase 2', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03765762', 'age_groups': '40 to 65 years old', 'name': 'NCT03765762'}, {'nct_number': 'NCT01935024', 'title': \"Benefits of Exercise in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '60 Years to 95 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01935024', 'age_groups': '40 to 65 years old', 'name': 'NCT01935024'}, {'nct_number': 'NCT03537729', 'title': 'Effects of Visual Cues and Education for People Who Live Within Long Term Care Communities to Assist in Wayfinding', 'status': 'Recruiting', 'clean_age': '62 Years and older ', 'phases': 'Not Applicable', 'enrollment': 137, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03537729', 'age_groups': '40 to 65 years old', 'name': 'NCT03537729'}, {'nct_number': 'NCT03313895', 'title': 'The ACT Trial: Effects of Combined Aerobic Exercise and Cognitive Training in MCI', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 128, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03313895', 'age_groups': '40 to 65 years old', 'name': 'NCT03313895'}, {'nct_number': 'NCT03333096', 'title': 'Assessing Neurovisual Function in Patients With Cognitive Impairment', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03333096', 'age_groups': '40 to 65 years old', 'name': 'NCT03333096'}, {'nct_number': 'NCT03462121', 'title': \"A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease\", 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 2', 'enrollment': 81, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03462121', 'age_groups': '40 to 65 years old', 'name': 'NCT03462121'}, {'nct_number': 'NCT03287765', 'title': 'Evaluating the Relationship Between Tau PET Imaging and CSF Biomarkers of AD (Alzheimer Disease) in Humans', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03287765', 'age_groups': '40 to 65 years old', 'name': 'NCT03287765'}, {'nct_number': 'NCT03941119', 'title': 'Evaluating the Impact of VR-therapy on BPSD and QoL of Individuals With Dementia Admitted to Hospital', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03941119', 'age_groups': '40 to 65 years old', 'name': 'NCT03941119'}, {'nct_number': 'NCT03175874', 'title': 'Autophagy and Pathological Aging', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03175874', 'age_groups': '40 to 65 years old', 'name': 'NCT03175874'}, {'nct_number': 'NCT03152630', 'title': 'Research on the Early and Prognosis Diagnosis of Vascular Dementia', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 600, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03152630', 'age_groups': '40 to 65 years old', 'name': 'NCT03152630'}, {'nct_number': 'NCT03622905', 'title': \"ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 210, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03622905', 'age_groups': '40 to 65 years old', 'name': 'NCT03622905'}, {'nct_number': 'NCT03841539', 'title': 'Nutrition Interventions for Cognitive Enhancement', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03841539', 'age_groups': '40 to 65 years old', 'name': 'NCT03841539'}, {'nct_number': 'NCT03300180', 'title': \"Caregiver Outcomes of Alzheimer's Disease Screening\", 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 3600, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03300180', 'age_groups': '40 to 65 years old', 'name': 'NCT03300180'}, {'nct_number': 'NCT03717597', 'title': 'Nonrandomized Evaluation of a Multidimensional Behavioral Intervention', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03717597', 'age_groups': '40 to 65 years old', 'name': 'NCT03717597'}, {'nct_number': 'NCT03275363', 'title': 'The University of Hong Kong Neurocognitive Disorder Cohort', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 500, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03275363', 'age_groups': '40 to 65 years old', 'name': 'NCT03275363'}, {'nct_number': 'NCT04044495', 'title': \"Sleep, Rhythms and Risk of Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04044495', 'age_groups': '40 to 65 years old', 'name': 'NCT04044495'}, {'nct_number': 'NCT03324711', 'title': 'Psychometric Validation of the \"Antillanisée\" Version of the Mini Mental State Examination (MMSEa)', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03324711', 'age_groups': '40 to 65 years old', 'name': 'NCT03324711'}, {'nct_number': 'NCT04095962', 'title': 'Effects of a Multicomponent Exercise Intervention on Physical and Cognitive Function of Older Adults With Dementia', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04095962', 'age_groups': '40 to 65 years old', 'name': 'NCT04095962'}, {'nct_number': 'NCT03002142', 'title': 'Auditory Rehabilitation and Cognition in Alzheimer Patients', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 184, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03002142', 'age_groups': '40 to 65 years old', 'name': 'NCT03002142'}, {'nct_number': 'NCT03723707', 'title': 'Enhanced Quality in Primary Care for Elders With Diabetes and Dementia', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 1000, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03723707', 'age_groups': '40 to 65 years old', 'name': 'NCT03723707'}, {'nct_number': 'NCT03234686', 'title': 'Deferiprone to Delay Dementia (The 3D Study)', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 2', 'enrollment': 171, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03234686', 'age_groups': '40 to 65 years old', 'name': 'NCT03234686'}, {'nct_number': 'NCT03549078', 'title': \"A Multidimensional Behavioral Intervention for Those at Risk for Alzheimer's Dementia\", 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03549078', 'age_groups': '40 to 65 years old', 'name': 'NCT03549078'}, {'nct_number': 'NCT03475316', 'title': 'Movement Intervention for Memory Enhancement', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03475316', 'age_groups': '40 to 65 years old', 'name': 'NCT03475316'}, {'nct_number': 'NCT02302482', 'title': 'Predictive Factors and Autonomy Level Change', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 6780, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02302482', 'age_groups': '40 to 65 years old', 'name': 'NCT02302482'}, {'nct_number': 'NCT03593941', 'title': 'Ageing Gut Brain Interactions', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03593941', 'age_groups': '40 to 65 years old', 'name': 'NCT03593941'}, {'nct_number': 'NCT03848312', 'title': \"Preventing Alzheimer's Disease With Cognitive Training\", 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 1600, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03848312', 'age_groups': '40 to 65 years old', 'name': 'NCT03848312'}, {'nct_number': 'NCT03466736', 'title': 'Enriching Clinical Trials Requiring Amyloid Positivity With Practice Effects', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 210, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03466736', 'age_groups': '40 to 65 years old', 'name': 'NCT03466736'}, {'nct_number': 'NCT02802371', 'title': 'Pharmaceutical Collaborative Care Integrated to a Multidisciplinary Psychosocial Program', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02802371', 'age_groups': '40 to 65 years old', 'name': 'NCT02802371'}, {'nct_number': 'NCT03984396', 'title': \"Optimal Medication Management in Alzheimer's Disease and Dementia\", 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 3671, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03984396', 'age_groups': '40 to 65 years old', 'name': 'NCT03984396'}, {'nct_number': 'NCT01606488', 'title': 'Effects of Brain Beta-Amyloid on Postoperative Cognition', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01606488', 'age_groups': '40 to 65 years old', 'name': 'NCT01606488'}, {'nct_number': 'NCT02997982', 'title': \"Feasibility and Effects of Valaciclovir Treatment in Persons With Early Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 2', 'enrollment': 36, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02997982', 'age_groups': '40 to 65 years old', 'name': 'NCT02997982'}, {'nct_number': 'NCT03046121', 'title': 'A Family-centered Intervention for Acutely-ill Persons With Dementia', 'status': 'Recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 438, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03046121', 'age_groups': '40 to 65 years old', 'name': 'NCT03046121'}, {'nct_number': 'NCT03615027', 'title': 'Dementia-specific Intervention of Advance Care Planning', 'status': 'Recruiting', 'clean_age': '65 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03615027', 'age_groups': '40 to 65 years old', 'name': 'NCT03615027'}, {'nct_number': 'NCT02849639', 'title': \"The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression\", 'status': 'Recruiting', 'clean_age': '65 Years to 101 Years ', 'phases': 'Early Phase 1', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02849639', 'age_groups': '40 to 65 years old', 'name': 'NCT02849639'}, {'nct_number': 'NCT03923712', 'title': 'PhysIcal Exercise ,Cerebral, COgnitive and Metabolome in People at Risk of Mild Cognitive Impairment', 'status': 'Recruiting', 'clean_age': '65 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03923712', 'age_groups': '40 to 65 years old', 'name': 'NCT03923712'}, {'nct_number': 'NCT02959489', 'title': \"Risk Evaluation and Education for Alzheimer's Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)\", 'status': 'Recruiting', 'clean_age': '65 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 270, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02959489', 'age_groups': '40 to 65 years old', 'name': 'NCT02959489'}, {'nct_number': 'NCT03578991', 'title': \"Diabetes as an Accelerator of Cognitive Impairment and Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '65 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 174, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03578991', 'age_groups': '40 to 65 years old', 'name': 'NCT03578991'}, {'nct_number': 'NCT03361410', 'title': 'Impact of Grape Consumption on Brain Metabolism and Neuropsychological Performance Over 1 Year', 'status': 'Recruiting', 'clean_age': '65 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03361410', 'age_groups': '40 to 65 years old', 'name': 'NCT03361410'}, {'nct_number': 'NCT03944603', 'title': 'Longitudinal Innate Immunity and Aging Study', 'status': 'Recruiting', 'clean_age': '65 Years to 89 Years ', 'phases': 'Phase 4', 'enrollment': 300, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03944603', 'age_groups': '40 to 65 years old', 'name': 'NCT03944603'}, {'nct_number': 'NCT03946930', 'title': 'IGF Binding Protein-2 Associated With Cognitive Decline', 'status': 'Recruiting', 'clean_age': '65 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 500, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03946930', 'age_groups': '40 to 65 years old', 'name': 'NCT03946930'}, {'nct_number': 'NCT03226522', 'title': 'Addressing Dementia Via Agitation-Centered Evaluation', 'status': 'Recruiting', 'clean_age': '65 Years to 90 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 435, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03226522', 'age_groups': '40 to 65 years old', 'name': 'NCT03226522'}, {'nct_number': 'NCT03977025', 'title': 'Alzheimer Biomarkers on CSF of Elderly Patients Undergoing Surgery', 'status': 'Recruiting', 'clean_age': '65 Years to 99 Years ', 'phases': 'Phase 4', 'enrollment': 30, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03977025', 'age_groups': '40 to 65 years old', 'name': 'NCT03977025'}]}, {'name': 'Terminated', 'children': [{'nct_number': 'NCT02226835', 'title': 'Study of Retinal Findings in People With Signs and Symptoms of Alzheimer s Disease Enrolled in 09-M-0198', 'status': 'Terminated', 'clean_age': '45 Years and older ', 'phases': 'Phase 4', 'enrollment': 33, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02226835', 'age_groups': '40 to 65 years old', 'name': 'NCT02226835'}, {'nct_number': 'NCT01777789', 'title': 'The Role of Mid-Life Adiposity in Functional Brain Connectivity', 'status': 'Terminated', 'clean_age': '45 Years to 65 Years ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01777789', 'age_groups': '40 to 65 years old', 'name': 'NCT01777789'}, {'nct_number': 'NCT02393027', 'title': 'Quantification of Dopamine Active Transporter (DAT) in Humans: Validation of a New Radiophamaceutical, the [18F] LBT-999', 'status': 'Terminated', 'clean_age': '45 Years to 75 Years ', 'phases': 'Early Phase 1', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02393027', 'age_groups': '40 to 65 years old', 'name': 'NCT02393027'}, {'nct_number': 'NCT00679627', 'title': \"A Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '45 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 2051, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00679627', 'age_groups': '40 to 65 years old', 'name': 'NCT00679627'}, {'nct_number': 'NCT00890890', 'title': \"A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '45 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 263, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00890890', 'age_groups': '40 to 65 years old', 'name': 'NCT00890890'}, {'nct_number': 'NCT01152216', 'title': 'An Extension of the CONCERT Protocol (DIM18)', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 672, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01152216', 'age_groups': '40 to 65 years old', 'name': 'NCT01152216'}, {'nct_number': 'NCT00857649', 'title': \"Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 369, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00857649', 'age_groups': '40 to 65 years old', 'name': 'NCT00857649'}, {'nct_number': 'NCT00857233', 'title': \"Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 297, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00857233', 'age_groups': '40 to 65 years old', 'name': 'NCT00857233'}, {'nct_number': 'NCT02080364', 'title': \"Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 880, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02080364', 'age_groups': '40 to 65 years old', 'name': 'NCT02080364'}, {'nct_number': 'NCT01066546', 'title': \"An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01066546', 'age_groups': '40 to 65 years old', 'name': 'NCT01066546'}, {'nct_number': 'NCT02992132', 'title': \"Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 111, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02992132', 'age_groups': '40 to 65 years old', 'name': 'NCT02992132'}, {'nct_number': 'NCT00488670', 'title': \"Escitalopram and Depression in Elderly Alzheimer's Patients\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00488670', 'age_groups': '40 to 65 years old', 'name': 'NCT00488670'}, {'nct_number': 'NCT02249468', 'title': \"An Exploratory Study to Compare the Differences in Nutritional Status Between Patients With Mild and Moderate Alzheimer's Disease (AD) and Cognitively Intact Healthy People in an Asian Population\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 191, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02249468', 'age_groups': '40 to 65 years old', 'name': 'NCT02249468'}, {'nct_number': 'NCT00626210', 'title': 'Modafinil Treatment for Sleep/Wake Disturbances in Older Adults', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 2, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00626210', 'age_groups': '40 to 65 years old', 'name': 'NCT00626210'}, {'nct_number': 'NCT02884492', 'title': \"Imaging Tau in Alzheimer's Disease and Normal Aging\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02884492', 'age_groups': '40 to 65 years old', 'name': 'NCT02884492'}, {'nct_number': 'NCT00605046', 'title': 'Evaluation of [123I] AV151 and SPECT in Subjects w/ AD in Comparison to Healthy Subjects', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 1, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00605046', 'age_groups': '40 to 65 years old', 'name': 'NCT00605046'}, {'nct_number': 'NCT01082965', 'title': \"Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01082965', 'age_groups': '40 to 65 years old', 'name': 'NCT01082965'}, {'nct_number': 'NCT00843115', 'title': 'Observational Study Of Donepezil In Routine Clinical Practice', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 370, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00843115', 'age_groups': '40 to 65 years old', 'name': 'NCT00843115'}, {'nct_number': 'NCT03307993', 'title': \"Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 3, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03307993', 'age_groups': '40 to 65 years old', 'name': 'NCT03307993'}, {'nct_number': 'NCT00657813', 'title': 'Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-amyloid Protein Deposition', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 3, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00657813', 'age_groups': '40 to 65 years old', 'name': 'NCT00657813'}, {'nct_number': 'NCT00954590', 'title': \"A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 89, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00954590', 'age_groups': '40 to 65 years old', 'name': 'NCT00954590'}, {'nct_number': 'NCT00544453', 'title': 'Evaluation of [123I] MNI-308 and SPECT as a Marker of Beta-amyloid Protein Deposition in AD Subjects Compared to HC', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 2, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00544453', 'age_groups': '40 to 65 years old', 'name': 'NCT00544453'}, {'nct_number': 'NCT00870519', 'title': 'Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 2, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00870519', 'age_groups': '40 to 65 years old', 'name': 'NCT00870519'}, {'nct_number': 'NCT00704782', 'title': \"Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00704782', 'age_groups': '40 to 65 years old', 'name': 'NCT00704782'}, {'nct_number': 'NCT02916056', 'title': \"2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 298, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02916056', 'age_groups': '40 to 65 years old', 'name': 'NCT02916056'}, {'nct_number': 'NCT00912288', 'title': \"A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 86, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00912288', 'age_groups': '40 to 65 years old', 'name': 'NCT00912288'}, {'nct_number': 'NCT00886951', 'title': \"Single Photon Emission Computed Tomography (SPECT) Imaging Study to Develop a Biomarker for Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 2, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00886951', 'age_groups': '40 to 65 years old', 'name': 'NCT00886951'}, {'nct_number': 'NCT00939783', 'title': \"An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 649, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00939783', 'age_groups': '40 to 65 years old', 'name': 'NCT00939783'}, {'nct_number': 'NCT00174382', 'title': 'Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 149, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00174382', 'age_groups': '40 to 65 years old', 'name': 'NCT00174382'}, {'nct_number': 'NCT00605059', 'title': 'Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 3, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00605059', 'age_groups': '40 to 65 years old', 'name': 'NCT00605059'}, {'nct_number': 'NCT02871427', 'title': 'Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02871427', 'age_groups': '40 to 65 years old', 'name': 'NCT02871427'}, {'nct_number': 'NCT00895895', 'title': 'Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 526, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00895895', 'age_groups': '40 to 65 years old', 'name': 'NCT00895895'}, {'nct_number': 'NCT00968097', 'title': 'Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-Amyloid Protein Deposition', 'status': 'Terminated', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00968097', 'age_groups': '40 to 65 years old', 'name': 'NCT00968097'}, {'nct_number': 'NCT00706186', 'title': \"Safety and Feasibility of Sodium Oxybate in Mild Alzheimer's Disease Patients\", 'status': 'Terminated', 'clean_age': '50 Years to 65 Years ', 'phases': 'Phase 4', 'enrollment': 4, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00706186', 'age_groups': '40 to 65 years old', 'name': 'NCT00706186'}, {'nct_number': 'NCT01568086', 'title': 'Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AD03 Applied During AFF005A', 'status': 'Terminated', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 16, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01568086', 'age_groups': '40 to 65 years old', 'name': 'NCT01568086'}, {'nct_number': 'NCT00134953', 'title': 'Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment', 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00134953', 'age_groups': '40 to 65 years old', 'name': 'NCT00134953'}, {'nct_number': 'NCT01117948', 'title': 'Efficacy and Safety of Lornoxicam in Patients With Mild to Moderate Probable Alzheimer´s Disease.', 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 219, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01117948', 'age_groups': '40 to 65 years old', 'name': 'NCT01117948'}, {'nct_number': 'NCT03819699', 'title': \"Study With Lu AF20513 in Patients With Mild Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Due to AD\", 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 3, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03819699', 'age_groups': '40 to 65 years old', 'name': 'NCT03819699'}, {'nct_number': 'NCT00069849', 'title': \"A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 64, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00069849', 'age_groups': '40 to 65 years old', 'name': 'NCT00069849'}, {'nct_number': 'NCT00649220', 'title': 'Memantine and Antipsychotics Use', 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00649220', 'age_groups': '40 to 65 years old', 'name': 'NCT00649220'}, {'nct_number': 'NCT00960531', 'title': \"A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00960531', 'age_groups': '40 to 65 years old', 'name': 'NCT00960531'}, {'nct_number': 'NCT02221947', 'title': \"Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 9, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02221947', 'age_groups': '40 to 65 years old', 'name': 'NCT02221947'}, {'nct_number': 'NCT00334568', 'title': 'Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease', 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00334568', 'age_groups': '40 to 65 years old', 'name': 'NCT00334568'}, {'nct_number': 'NCT00500500', 'title': \"Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00500500', 'age_groups': '40 to 65 years old', 'name': 'NCT00500500'}, {'nct_number': 'NCT02008513', 'title': 'Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006', 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 194, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02008513', 'age_groups': '40 to 65 years old', 'name': 'NCT02008513'}, {'nct_number': 'NCT01953601', 'title': \"Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)\", 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 1454, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01953601', 'age_groups': '40 to 65 years old', 'name': 'NCT01953601'}, {'nct_number': 'NCT01482013', 'title': \"Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 7, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01482013', 'age_groups': '40 to 65 years old', 'name': 'NCT01482013'}, {'nct_number': 'NCT02406027', 'title': \"An Extension Study to Evaluate the Long-Term Safety and Tolerability of JNJ-54861911 in Participants in the Early Alzheimer's Disease Spectrum\", 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02406027', 'age_groups': '40 to 65 years old', 'name': 'NCT02406027'}, {'nct_number': 'NCT00021723', 'title': \"Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 375, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00021723', 'age_groups': '40 to 65 years old', 'name': 'NCT00021723'}, {'nct_number': 'NCT02586909', 'title': \"12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension\", 'status': 'Terminated', 'clean_age': '50 Years to 86 Years ', 'phases': 'Phase 3', 'enrollment': 1100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02586909', 'age_groups': '40 to 65 years old', 'name': 'NCT02586909'}, {'nct_number': 'NCT00676143', 'title': 'Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients', 'status': 'Terminated', 'clean_age': '50 Years to 88 Years ', 'phases': 'Phase 3', 'enrollment': 1100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00676143', 'age_groups': '40 to 65 years old', 'name': 'NCT00676143'}, {'nct_number': 'NCT00916617', 'title': 'Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab', 'status': 'Terminated', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 62, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00916617', 'age_groups': '40 to 65 years old', 'name': 'NCT00916617'}, {'nct_number': 'NCT01524887', 'title': 'Phase 3 IGIV, 10% in Alzheimer´s Disease', 'status': 'Terminated', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 3', 'enrollment': 508, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01524887', 'age_groups': '40 to 65 years old', 'name': 'NCT01524887'}, {'nct_number': 'NCT00667810', 'title': 'Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients', 'status': 'Terminated', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 3', 'enrollment': 901, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00667810', 'age_groups': '40 to 65 years old', 'name': 'NCT00667810'}, {'nct_number': 'NCT00672945', 'title': \"A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil\", 'status': 'Terminated', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 420, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00672945', 'age_groups': '40 to 65 years old', 'name': 'NCT00672945'}, {'nct_number': 'NCT01677572', 'title': \"Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 197, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01677572', 'age_groups': '40 to 65 years old', 'name': 'NCT01677572'}, {'nct_number': 'NCT00087724', 'title': \"A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 510, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00087724', 'age_groups': '40 to 65 years old', 'name': 'NCT00087724'}, {'nct_number': 'NCT01560585', 'title': \"Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01560585', 'age_groups': '40 to 65 years old', 'name': 'NCT01560585'}, {'nct_number': 'NCT00693004', 'title': \"Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 236, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00693004', 'age_groups': '40 to 65 years old', 'name': 'NCT00693004'}, {'nct_number': 'NCT01766336', 'title': \"A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 2', 'enrollment': 296, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01766336', 'age_groups': '40 to 65 years old', 'name': 'NCT01766336'}, {'nct_number': 'NCT00996918', 'title': 'A Long-Term Safety And Tolerability Study Of Bapineuzumab In Alzheimer Disease Patients', 'status': 'Terminated', 'clean_age': '51 Years and older ', 'phases': 'Phase 3', 'enrollment': 198, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00996918', 'age_groups': '40 to 65 years old', 'name': 'NCT00996918'}, {'nct_number': 'NCT01736579', 'title': 'Long-Term Study of IGIV, 10% in Alzheimer´s Disease', 'status': 'Terminated', 'clean_age': '51 Years and older ', 'phases': 'Phase 3', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01736579', 'age_groups': '40 to 65 years old', 'name': 'NCT01736579'}, {'nct_number': 'NCT00937352', 'title': \"A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '51 Years and older ', 'phases': 'Phase 3', 'enrollment': 896, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00937352', 'age_groups': '40 to 65 years old', 'name': 'NCT00937352'}, {'nct_number': 'NCT00998764', 'title': 'A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients', 'status': 'Terminated', 'clean_age': '51 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 494, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00998764', 'age_groups': '40 to 65 years old', 'name': 'NCT00998764'}, {'nct_number': 'NCT00490568', 'title': 'Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers', 'status': 'Terminated', 'clean_age': '51 Years to 91 Years ', 'phases': 'Phase 3', 'enrollment': 1461, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00490568', 'age_groups': '40 to 65 years old', 'name': 'NCT00490568'}, {'nct_number': 'NCT00550420', 'title': 'Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers', 'status': 'Terminated', 'clean_age': '51 Years to 91 Years ', 'phases': 'Phase 3', 'enrollment': 331, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00550420', 'age_groups': '40 to 65 years old', 'name': 'NCT00550420'}, {'nct_number': 'NCT01238991', 'title': \"Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '52 Years to 87 Years ', 'phases': 'Phase 2', 'enrollment': 53, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01238991', 'age_groups': '40 to 65 years old', 'name': 'NCT01238991'}, {'nct_number': 'NCT01733355', 'title': 'A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807', 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 11, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01733355', 'age_groups': '40 to 65 years old', 'name': 'NCT01733355'}, {'nct_number': 'NCT01723488', 'title': 'A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808', 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01723488', 'age_groups': '40 to 65 years old', 'name': 'NCT01723488'}, {'nct_number': 'NCT00322036', 'title': \"Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's\", 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 800, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00322036', 'age_groups': '40 to 65 years old', 'name': 'NCT00322036'}, {'nct_number': 'NCT01127633', 'title': \"Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 1457, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01127633', 'age_groups': '40 to 65 years old', 'name': 'NCT01127633'}, {'nct_number': 'NCT03179501', 'title': \"NP001, Alzheimer's Disease, and Blood Markers of Inflammation\", 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 4, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03179501', 'age_groups': '40 to 65 years old', 'name': 'NCT03179501'}, {'nct_number': 'NCT01658722', 'title': 'Retrieval of Patient Information After Discontinuation', 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 169, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01658722', 'age_groups': '40 to 65 years old', 'name': 'NCT01658722'}, {'nct_number': 'NCT00739037', 'title': \"Study Evaluating PAZ-417 in Cerebrospinal Fluid in Subjects With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00739037', 'age_groups': '40 to 65 years old', 'name': 'NCT00739037'}, {'nct_number': 'NCT00596024', 'title': \"Lutein and Alzheimer's Disease Study\", 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 3, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00596024', 'age_groups': '40 to 65 years old', 'name': 'NCT00596024'}, {'nct_number': 'NCT01000870', 'title': 'Safety and Efficacy of Positron Emission Tomography Imaging With MNI-513', 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01000870', 'age_groups': '40 to 65 years old', 'name': 'NCT01000870'}, {'nct_number': 'NCT01561430', 'title': \"Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01561430', 'age_groups': '40 to 65 years old', 'name': 'NCT01561430'}, {'nct_number': 'NCT00362024', 'title': \"MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease (0952-004)(COMPLETED)\", 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00362024', 'age_groups': '40 to 65 years old', 'name': 'NCT00362024'}, {'nct_number': 'NCT02817906', 'title': \"ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 177, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02817906', 'age_groups': '40 to 65 years old', 'name': 'NCT02817906'}, {'nct_number': 'NCT02972658', 'title': \"A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia\", 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 421, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02972658', 'age_groups': '40 to 65 years old', 'name': 'NCT02972658'}, {'nct_number': 'NCT00380276', 'title': \"Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol\", 'status': 'Terminated', 'clean_age': '55 Years and older ', 'phases': 'Phase 3', 'enrollment': 1000, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00380276', 'age_groups': '40 to 65 years old', 'name': 'NCT00380276'}, {'nct_number': 'NCT01072812', 'title': 'Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment', 'status': 'Terminated', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01072812', 'age_groups': '40 to 65 years old', 'name': 'NCT01072812'}, {'nct_number': 'NCT01852110', 'title': \"Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012)\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01852110', 'age_groups': '40 to 65 years old', 'name': 'NCT01852110'}, {'nct_number': 'NCT02004392', 'title': \"Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 348, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02004392', 'age_groups': '40 to 65 years old', 'name': 'NCT02004392'}, {'nct_number': 'NCT01969123', 'title': \"Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 474, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01969123', 'age_groups': '40 to 65 years old', 'name': 'NCT01969123'}, {'nct_number': 'NCT02573740', 'title': \"Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 8, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02573740', 'age_groups': '40 to 65 years old', 'name': 'NCT02573740'}, {'nct_number': 'NCT01969136', 'title': \"Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 403, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01969136', 'age_groups': '40 to 65 years old', 'name': 'NCT01969136'}, {'nct_number': 'NCT02327182', 'title': \"Safety Study of MT-4666 in Subjects With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 117, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02327182', 'age_groups': '40 to 65 years old', 'name': 'NCT02327182'}, {'nct_number': 'NCT01028911', 'title': \"A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 9, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01028911', 'age_groups': '40 to 65 years old', 'name': 'NCT01028911'}, {'nct_number': 'NCT02760602', 'title': \"A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 26, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02760602', 'age_groups': '40 to 65 years old', 'name': 'NCT02760602'}, {'nct_number': 'NCT02783573', 'title': \"A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 1722, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02783573', 'age_groups': '40 to 65 years old', 'name': 'NCT02783573'}, {'nct_number': 'NCT00582855', 'title': 'Effect of AQW051 in Patients With Memory Impairment', 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 54, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00582855', 'age_groups': '40 to 65 years old', 'name': 'NCT00582855'}, {'nct_number': 'NCT02245737', 'title': \"An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 2218, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02245737', 'age_groups': '40 to 65 years old', 'name': 'NCT02245737'}, {'nct_number': 'NCT01125683', 'title': \"To Evaluate Effects of AZD1446, Placebo and Donepezil in Patients With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01125683', 'age_groups': '40 to 65 years old', 'name': 'NCT01125683'}, {'nct_number': 'NCT01739348', 'title': \"An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 2211, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01739348', 'age_groups': '40 to 65 years old', 'name': 'NCT01739348'}, {'nct_number': 'NCT01970150', 'title': \"The Effect of Repeated Transcranial Magnetic Stimulation on Off-line Resting Electroencephalographic Signal in Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01970150', 'age_groups': '40 to 65 years old', 'name': 'NCT01970150'}, {'nct_number': 'NCT02791191', 'title': \"A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia\", 'status': 'Terminated', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 316, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02791191', 'age_groups': '40 to 65 years old', 'name': 'NCT02791191'}, {'nct_number': 'NCT02168920', 'title': \"Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type\", 'status': 'Terminated', 'clean_age': '55 Years to 89 Years ', 'phases': 'Phase 3', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02168920', 'age_groups': '40 to 65 years old', 'name': 'NCT02168920'}, {'nct_number': 'NCT01883648', 'title': \"Study to Evaluate Coconut Oil for Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01883648', 'age_groups': '40 to 65 years old', 'name': 'NCT01883648'}, {'nct_number': 'NCT00809510', 'title': \"A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 Study\", 'status': 'Terminated', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 63, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00809510', 'age_groups': '40 to 65 years old', 'name': 'NCT00809510'}, {'nct_number': 'NCT02220738', 'title': \"Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors\", 'status': 'Terminated', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 1', 'enrollment': 19, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02220738', 'age_groups': '40 to 65 years old', 'name': 'NCT02220738'}, {'nct_number': 'NCT00602680', 'title': \"Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 1, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00602680', 'age_groups': '40 to 65 years old', 'name': 'NCT00602680'}, {'nct_number': 'NCT00555204', 'title': \"Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 337, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00555204', 'age_groups': '40 to 65 years old', 'name': 'NCT00555204'}, {'nct_number': 'NCT01676935', 'title': \"This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 349, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01676935', 'age_groups': '40 to 65 years old', 'name': 'NCT01676935'}, {'nct_number': 'NCT01900665', 'title': \"Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo\", 'status': 'Terminated', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 2129, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01900665', 'age_groups': '40 to 65 years old', 'name': 'NCT01900665'}, {'nct_number': 'NCT01690195', 'title': \"Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 343, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01690195', 'age_groups': '40 to 65 years old', 'name': 'NCT01690195'}, {'nct_number': 'NCT01712074', 'title': \"Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil\", 'status': 'Terminated', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 186, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01712074', 'age_groups': '40 to 65 years old', 'name': 'NCT01712074'}, {'nct_number': 'NCT02838563', 'title': \"Validation of a Scale of Well-Being Assessment (SIWA) in Patients With Alzheimer's Disease or a Related Disease.\", 'status': 'Terminated', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 135, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02838563', 'age_groups': '40 to 65 years old', 'name': 'NCT02838563'}, {'nct_number': 'NCT00165750', 'title': 'Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients', 'status': 'Terminated', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00165750', 'age_groups': '40 to 65 years old', 'name': 'NCT00165750'}, {'nct_number': 'NCT01255163', 'title': \"A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 57, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01255163', 'age_groups': '40 to 65 years old', 'name': 'NCT01255163'}, {'nct_number': 'NCT03668405', 'title': \"A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients With Alzheimer's Disease (AD)\", 'status': 'Terminated', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 18, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03668405', 'age_groups': '40 to 65 years old', 'name': 'NCT03668405'}, {'nct_number': 'NCT02388152', 'title': \"Study to Evaluate the Safety and Tolerability of a New Drug Named Lu AF20513 in Patients With Mild Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02388152', 'age_groups': '40 to 65 years old', 'name': 'NCT02388152'}, {'nct_number': 'NCT02263287', 'title': 'LESCOD: \"Lewy Body Screening in Cognitive Disorders\"', 'status': 'Terminated', 'clean_age': '60 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 133, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02263287', 'age_groups': '40 to 65 years old', 'name': 'NCT02263287'}, {'nct_number': 'NCT02166827', 'title': 'Effects of a NeuroAD System, for the Treatment of Alzheimer Disease', 'status': 'Terminated', 'clean_age': '60 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 1, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02166827', 'age_groups': '40 to 65 years old', 'name': 'NCT02166827'}, {'nct_number': 'NCT00824967', 'title': 'Non Pharmacological Management of Behavioural Symptoms in Nursing Home', 'status': 'Terminated', 'clean_age': '60 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 306, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00824967', 'age_groups': '40 to 65 years old', 'name': 'NCT00824967'}, {'nct_number': 'NCT01454453', 'title': 'Optimisation of Antipsychotic Drug Use in Older People', 'status': 'Terminated', 'clean_age': '60 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 64, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01454453', 'age_groups': '40 to 65 years old', 'name': 'NCT01454453'}, {'nct_number': 'NCT02284906', 'title': 'AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease', 'status': 'Terminated', 'clean_age': '65 Years and older ', 'phases': 'Phase 3', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02284906', 'age_groups': '40 to 65 years old', 'name': 'NCT02284906'}, {'nct_number': 'NCT01362686', 'title': \"Comparative Research of Alzheimer's Disease Drugs\", 'status': 'Terminated', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01362686', 'age_groups': '40 to 65 years old', 'name': 'NCT01362686'}, {'nct_number': 'NCT00874939', 'title': \"A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)\", 'status': 'Terminated', 'clean_age': '65 Years and older ', 'phases': 'Phase 1', 'enrollment': 4, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00874939', 'age_groups': '40 to 65 years old', 'name': 'NCT00874939'}, {'nct_number': 'NCT01400542', 'title': \"Sleep Apnea in Early to Mid-Stage Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 22, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01400542', 'age_groups': '40 to 65 years old', 'name': 'NCT01400542'}, {'nct_number': 'NCT01143350', 'title': \"Non Pharmacological Treatment in Alzheimer's Disease and Associated Disorders\", 'status': 'Terminated', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01143350', 'age_groups': '40 to 65 years old', 'name': 'NCT01143350'}, {'nct_number': 'NCT01689948', 'title': \"Alzheimer Disease : Rehabilitation's Intervention at Home\", 'status': 'Terminated', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01689948', 'age_groups': '40 to 65 years old', 'name': 'NCT01689948'}, {'nct_number': 'NCT01815112', 'title': 'Early Diagnosis of Alzheimer-like Dementia: Benefit of MRI and PET Imaging', 'status': 'Terminated', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01815112', 'age_groups': '40 to 65 years old', 'name': 'NCT01815112'}, {'nct_number': 'NCT02020356', 'title': \"Music Therapy in Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '65 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 35, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02020356', 'age_groups': '40 to 65 years old', 'name': 'NCT02020356'}, {'nct_number': 'NCT01931566', 'title': \"Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset\", 'status': 'Terminated', 'clean_age': '65 Years to 83 Years ', 'phases': 'Phase 3', 'enrollment': 3494, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01931566', 'age_groups': '40 to 65 years old', 'name': 'NCT01931566'}, {'nct_number': 'NCT00160147', 'title': \"Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type\", 'status': 'Terminated', 'clean_age': '65 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00160147', 'age_groups': '40 to 65 years old', 'name': 'NCT00160147'}, {'nct_number': 'NCT01669876', 'title': \"Study to Evaluate Dietary Supplementation With a Version of Anatabloc(R) in Subjects With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': '65 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 85, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01669876', 'age_groups': '40 to 65 years old', 'name': 'NCT01669876'}, {'nct_number': 'NCT01825577', 'title': 'Exploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia.', 'status': 'Terminated', 'clean_age': '65 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01825577', 'age_groups': '40 to 65 years old', 'name': 'NCT01825577'}]}, {'name': 'Not yet recruiting', 'children': [{'nct_number': 'NCT04088643', 'title': \"4Hz Transcranial Alternating Current Stimulation for Patients With Mild Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '45 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04088643', 'age_groups': '40 to 65 years old', 'name': 'NCT04088643'}, {'nct_number': 'NCT03038334', 'title': 'Magnesium Sulfate for the Improvement of Cognition in Patients With Alzheimer Disease', 'status': 'Not yet recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03038334', 'age_groups': '40 to 65 years old', 'name': 'NCT03038334'}, {'nct_number': 'NCT04118764', 'title': \"Non-invasive Blood-brain Barrier Opening in Alzheimer's Disease Patients Using Focused Ultrasound\", 'status': 'Not yet recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04118764', 'age_groups': '40 to 65 years old', 'name': 'NCT04118764'}, {'nct_number': 'NCT03666624', 'title': 'Socially Isolated Older Adults Living With Dementia', 'status': 'Not yet recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03666624', 'age_groups': '40 to 65 years old', 'name': 'NCT03666624'}, {'nct_number': 'NCT03454646', 'title': 'Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL)', 'status': 'Not yet recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 1205, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03454646', 'age_groups': '40 to 65 years old', 'name': 'NCT03454646'}, {'nct_number': 'NCT03806478', 'title': \"Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03806478', 'age_groups': '40 to 65 years old', 'name': 'NCT03806478'}, {'nct_number': 'NCT03809351', 'title': \"UAB Alzheimer's Disease Center Core Cohort - Tau Imaging Substudy\", 'status': 'Not yet recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 1', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03809351', 'age_groups': '40 to 65 years old', 'name': 'NCT03809351'}, {'nct_number': 'NCT03939780', 'title': \"Tau Tracer Comparison in Healthy Controls and Alzheimer's Disease Patients\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 100 Years ', 'phases': 'Not Applicable', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03939780', 'age_groups': '40 to 65 years old', 'name': 'NCT03939780'}, {'nct_number': 'NCT03923569', 'title': \"Epileptiform Activity During REM Sleep in Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03923569', 'age_groups': '40 to 65 years old', 'name': 'NCT03923569'}, {'nct_number': 'NCT04122001', 'title': \"Effects of Electrical Stimulation on Verbal Learning in Typical and Atypical Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04122001', 'age_groups': '40 to 65 years old', 'name': 'NCT04122001'}, {'nct_number': 'NCT04042532', 'title': \"Theta-burst Stimulation on Cognitive Function in the Patients With Young-onset Alzheimer's Disease Dementia\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04042532', 'age_groups': '40 to 65 years old', 'name': 'NCT04042532'}, {'nct_number': 'NCT03030365', 'title': 'Orientation in AD Patients: PET-MR Study', 'status': 'Not yet recruiting', 'clean_age': '50 Years to 79 Years ', 'phases': 'Phase 4', 'enrollment': 30, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03030365', 'age_groups': '40 to 65 years old', 'name': 'NCT03030365'}, {'nct_number': 'NCT04029623', 'title': \"Partnered Rhythmic Rehabilitation in Prodromal Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 66, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04029623', 'age_groups': '40 to 65 years old', 'name': 'NCT04029623'}, {'nct_number': 'NCT02537626', 'title': \"An Evaluation of Low Level Laser Light Therapy on Improving the Symptoms of Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02537626', 'age_groups': '40 to 65 years old', 'name': 'NCT02537626'}, {'nct_number': 'NCT03978338', 'title': \"A Study to Evaluate the Efficacy and Safety of Brain Polypeptide Solution in Mild Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03978338', 'age_groups': '40 to 65 years old', 'name': 'NCT03978338'}, {'nct_number': 'NCT03514875', 'title': \"Effects of Mitochondrial-targeted Antioxidant on Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03514875', 'age_groups': '40 to 65 years old', 'name': 'NCT03514875'}, {'nct_number': 'NCT03752294', 'title': \"A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age.\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03752294', 'age_groups': '40 to 65 years old', 'name': 'NCT03752294'}, {'nct_number': 'NCT04032626', 'title': 'MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients', 'status': 'Not yet recruiting', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04032626', 'age_groups': '40 to 65 years old', 'name': 'NCT04032626'}, {'nct_number': 'NCT03919162', 'title': 'A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD', 'status': 'Not yet recruiting', 'clean_age': '50 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 462, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03919162', 'age_groups': '40 to 65 years old', 'name': 'NCT03919162'}, {'nct_number': 'NCT03860792', 'title': \"Therapeutic Diets in Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03860792', 'age_groups': '40 to 65 years old', 'name': 'NCT03860792'}, {'nct_number': 'NCT03352024', 'title': \"Impact of Hypno-analgesia on Pain During a Lumbar Puncture for Diagnosis of Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03352024', 'age_groups': '40 to 65 years old', 'name': 'NCT03352024'}, {'nct_number': 'NCT04100057', 'title': \"Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Dementia\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04100057', 'age_groups': '40 to 65 years old', 'name': 'NCT04100057'}, {'nct_number': 'NCT04121208', 'title': \"MIcroglial Colony Stimulating Factor-1 Receptor (CSF1R) in Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '50 Years to 99 Years ', 'phases': 'Phase 1', 'enrollment': 54, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04121208', 'age_groups': '40 to 65 years old', 'name': 'NCT04121208'}, {'nct_number': 'NCT03960476', 'title': 'Decision Making and Implementation of Aging-in-Place/Long Term Care Plans Among Older Adults', 'status': 'Not yet recruiting', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 700, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03960476', 'age_groups': '40 to 65 years old', 'name': 'NCT03960476'}, {'nct_number': 'NCT03748303', 'title': \"Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study\", 'status': 'Not yet recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03748303', 'age_groups': '40 to 65 years old', 'name': 'NCT03748303'}, {'nct_number': 'NCT03862222', 'title': \"Atlas of Retinal Imaging in Alzheimer's Study\", 'status': 'Not yet recruiting', 'clean_age': '55 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 330, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03862222', 'age_groups': '40 to 65 years old', 'name': 'NCT03862222'}, {'nct_number': 'NCT04049643', 'title': 'Hearing Aid and Individuals With Cognitive Disorders', 'status': 'Not yet recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04049643', 'age_groups': '40 to 65 years old', 'name': 'NCT04049643'}, {'nct_number': 'NCT04070378', 'title': \"Study of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04070378', 'age_groups': '40 to 65 years old', 'name': 'NCT04070378'}, {'nct_number': 'NCT03740178', 'title': \"Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)\", 'status': 'Not yet recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03740178', 'age_groups': '40 to 65 years old', 'name': 'NCT03740178'}, {'nct_number': 'NCT03538522', 'title': 'A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831', 'status': 'Not yet recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 156, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03538522', 'age_groups': '40 to 65 years old', 'name': 'NCT03538522'}, {'nct_number': 'NCT03959553', 'title': \"GV1001 Subcutaneous(SC) for the Treatment of Moderate Alzheimer's Disease (AD)\", 'status': 'Not yet recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03959553', 'age_groups': '40 to 65 years old', 'name': 'NCT03959553'}, {'nct_number': 'NCT02931136', 'title': \"Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging\", 'status': 'Not yet recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02931136', 'age_groups': '40 to 65 years old', 'name': 'NCT02931136'}, {'nct_number': 'NCT03617497', 'title': 'Prevalence of Epilepsy and Sleep Wake Disorders in Alzheimer Disease', 'status': 'Not yet recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 130, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03617497', 'age_groups': '40 to 65 years old', 'name': 'NCT03617497'}, {'nct_number': 'NCT03926520', 'title': \"Electroconvulsive Therapy (ECT) for Agitation in Alzheimer's Dementia (AD)\", 'status': 'Not yet recruiting', 'clean_age': '55 Years to 89 Years ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03926520', 'age_groups': '40 to 65 years old', 'name': 'NCT03926520'}, {'nct_number': 'NCT04098666', 'title': \"Metformin in Alzheimer's Dementia Prevention\", 'status': 'Not yet recruiting', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 370, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04098666', 'age_groups': '40 to 65 years old', 'name': 'NCT04098666'}, {'nct_number': 'NCT03896698', 'title': \"Feasibility Study of Transcranial Ultrasound Stimulation on Alzheimer's Disease Patients\", 'status': 'Not yet recruiting', 'clean_age': '55 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03896698', 'age_groups': '40 to 65 years old', 'name': 'NCT03896698'}, {'nct_number': 'NCT03954613', 'title': \"Evaluation of the Contribution of Regular Cognitive Exercises to Treatment in Patients With Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 198, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03954613', 'age_groups': '40 to 65 years old', 'name': 'NCT03954613'}, {'nct_number': 'NCT04094129', 'title': \"Evaluation of the Effect of Wismemo on Alzheimer's Dementia Patients\", 'status': 'Not yet recruiting', 'clean_age': '55 Years to 95 Years ', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04094129', 'age_groups': '40 to 65 years old', 'name': 'NCT04094129'}, {'nct_number': 'NCT03799991', 'title': \"Vestibular Therapy in Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03799991', 'age_groups': '40 to 65 years old', 'name': 'NCT03799991'}, {'nct_number': 'NCT02664571', 'title': 'Florbetaben as an Amyloid Plaque Marker in Elderly Patients With Focal or Disseminated Superficial Hemosiderosis', 'status': 'Not yet recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02664571', 'age_groups': '40 to 65 years old', 'name': 'NCT02664571'}, {'nct_number': 'NCT04019665', 'title': 'Self-screening of Cognitive Impairment in Primary Care', 'status': 'Not yet recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04019665', 'age_groups': '40 to 65 years old', 'name': 'NCT04019665'}, {'nct_number': 'NCT03866018', 'title': \"Contribution of Physical Activity to Self-esteem and Motivation in Older Adults With Minor to Major Cognitive Disorders Such as Alzheimer's Disease or Related Disorders\", 'status': 'Not yet recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03866018', 'age_groups': '40 to 65 years old', 'name': 'NCT03866018'}, {'nct_number': 'NCT03121066', 'title': \"Transcranial Magnetic Stimulation for Alzheimer's Disease Treatment\", 'status': 'Not yet recruiting', 'clean_age': '60 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 45, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03121066', 'age_groups': '40 to 65 years old', 'name': 'NCT03121066'}, {'nct_number': 'NCT03943641', 'title': 'Dementia Risk Prediction Model: Development and Validation', 'status': 'Not yet recruiting', 'clean_age': '60 Years to 79 Years ', 'phases': 'Phase 4', 'enrollment': 400000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03943641', 'age_groups': '40 to 65 years old', 'name': 'NCT03943641'}, {'nct_number': 'NCT03978052', 'title': 'Prevention of Cognitive Decline in ApoE4 Carriers With Subjective Cognitive Decline After EGCG and a Multimodal Intervention', 'status': 'Not yet recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03978052', 'age_groups': '40 to 65 years old', 'name': 'NCT03978052'}, {'nct_number': 'NCT03255720', 'title': \"Application of Diffusion Tensor Imaging in Alzheimer's Disease :Quantification of White Matter Micro-structural Changes\", 'status': 'Not yet recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03255720', 'age_groups': '40 to 65 years old', 'name': 'NCT03255720'}, {'nct_number': 'NCT04064021', 'title': \"Acupuncture Treatment for Improving Alzheimer's Dementia\", 'status': 'Not yet recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04064021', 'age_groups': '40 to 65 years old', 'name': 'NCT04064021'}, {'nct_number': 'NCT04075435', 'title': \"Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Alzheimer's Dementia\", 'status': 'Not yet recruiting', 'clean_age': '60 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04075435', 'age_groups': '40 to 65 years old', 'name': 'NCT04075435'}, {'nct_number': 'NCT04010175', 'title': \"Digital Cognitive Remote Training in Alzheimer's Disease (MA-EIAD)\", 'status': 'Not yet recruiting', 'clean_age': '60 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 165, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04010175', 'age_groups': '40 to 65 years old', 'name': 'NCT04010175'}, {'nct_number': 'NCT03560960', 'title': \"Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '60 Years to 90 Years ', 'phases': 'Early Phase 1', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03560960', 'age_groups': '40 to 65 years old', 'name': 'NCT03560960'}, {'nct_number': 'NCT03672279', 'title': 'Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder', 'status': 'Not yet recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03672279', 'age_groups': '40 to 65 years old', 'name': 'NCT03672279'}, {'nct_number': 'NCT03038282', 'title': 'Effects of Chromium on Insulin Resistance in Alzheimer Disease Patients', 'status': 'Not yet recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03038282', 'age_groups': '40 to 65 years old', 'name': 'NCT03038282'}, {'nct_number': 'NCT04063124', 'title': \"Senolytic Therapy to Modulate Progression of Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04063124', 'age_groups': '40 to 65 years old', 'name': 'NCT04063124'}, {'nct_number': 'NCT04102514', 'title': 'A Dyadic Approach for a Remote Physical Activity Intervention in Adults With AD and Their Caregivers', 'status': 'Not yet recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04102514', 'age_groups': '40 to 65 years old', 'name': 'NCT04102514'}, {'nct_number': 'NCT03256539', 'title': \"Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03256539', 'age_groups': '40 to 65 years old', 'name': 'NCT03256539'}, {'nct_number': 'NCT03360552', 'title': \"Evaluating the Effectiveness of a New Way of Organizing Primary Health Care to Improve the Management of Alzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 320, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03360552', 'age_groups': '40 to 65 years old', 'name': 'NCT03360552'}, {'nct_number': 'NCT02438202', 'title': 'Electroconvulsive Therapy for Treatment of Alzheimer´s Disease', 'status': 'Not yet recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02438202', 'age_groups': '40 to 65 years old', 'name': 'NCT02438202'}, {'nct_number': 'NCT03838952', 'title': 'The Efficacy of Traditional Chinese Herbal Medicine for Dementia', 'status': 'Not yet recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03838952', 'age_groups': '40 to 65 years old', 'name': 'NCT03838952'}, {'nct_number': 'NCT04073628', 'title': 'The Long-term Impact of a Light Intervention on Sleep and Cognition in Mild Cognitive Impairment', 'status': 'Not yet recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04073628', 'age_groups': '40 to 65 years old', 'name': 'NCT04073628'}, {'nct_number': 'NCT03890861', 'title': 'Reducing African Americans\\' Alzheimer\\'s Disease Risk Through Exercise (RAATE)\"', 'status': 'Not yet recruiting', 'clean_age': '65 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03890861', 'age_groups': '40 to 65 years old', 'name': 'NCT03890861'}, {'nct_number': 'NCT04018092', 'title': 'The Revitalize Study', 'status': 'Not yet recruiting', 'clean_age': '65 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 168, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04018092', 'age_groups': '40 to 65 years old', 'name': 'NCT04018092'}, {'nct_number': 'NCT03649724', 'title': \"The LUCINDA Trial: LUpron Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer's\", 'status': 'Not yet recruiting', 'clean_age': '65 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03649724', 'age_groups': '40 to 65 years old', 'name': 'NCT03649724'}, {'nct_number': 'NCT02963415', 'title': 'Concurrent Aerobic Exercise and Virtual Reality Cognitive Training', 'status': 'Not yet recruiting', 'clean_age': '65 Years to 99 Years ', 'phases': 'Not Applicable', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02963415', 'age_groups': '40 to 65 years old', 'name': 'NCT02963415'}]}, {'name': 'Active, not recruiting', 'children': [{'nct_number': 'NCT03011723', 'title': 'Tailored Music Therapy for Dementia', 'status': 'Active, not recruiting', 'clean_age': '45 Years and older ', 'phases': 'Not Applicable', 'enrollment': 10, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03011723', 'age_groups': '40 to 65 years old', 'name': 'NCT03011723'}, {'nct_number': 'NCT01315639', 'title': \"New Biomarker for Alzheimer's Disease Diagnostic\", 'status': 'Active, not recruiting', 'clean_age': '45 Years and older ', 'phases': 'Not Applicable', 'enrollment': 1067, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01315639', 'age_groups': '40 to 65 years old', 'name': 'NCT01315639'}, {'nct_number': 'NCT01835717', 'title': 'Study for Cognitive and Genetic Characterization of a 45-65 Years Old Population', 'status': 'Active, not recruiting', 'clean_age': '45 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 2743, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01835717', 'age_groups': '40 to 65 years old', 'name': 'NCT01835717'}, {'nct_number': 'NCT02772523', 'title': \"Control and Intervention Programme on Alzheimer's Disease Risk Factors\", 'status': 'Active, not recruiting', 'clean_age': '45 Years to 78 Years ', 'phases': 'Not Applicable', 'enrollment': 409, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02772523', 'age_groups': '40 to 65 years old', 'name': 'NCT02772523'}, {'nct_number': 'NCT03173846', 'title': \"Multiregional rtfMRI Neurofeedback for the Prevention of Alzheimer's Disease (NPAD)\", 'status': 'Active, not recruiting', 'clean_age': '45 Years to 79 Years ', 'phases': 'Phase 4', 'enrollment': 90, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03173846', 'age_groups': '40 to 65 years old', 'name': 'NCT03173846'}, {'nct_number': 'NCT01962779', 'title': \"Sleep, Aging and Risk for Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 224, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01962779', 'age_groups': '40 to 65 years old', 'name': 'NCT01962779'}, {'nct_number': 'NCT01843075', 'title': \"Evaluating Liraglutide in Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 204, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01843075', 'age_groups': '40 to 65 years old', 'name': 'NCT01843075'}, {'nct_number': 'NCT02264899', 'title': 'MEMENTO-VAScular COmponents of Dementia', 'status': 'Active, not recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 350, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02264899', 'age_groups': '40 to 65 years old', 'name': 'NCT02264899'}, {'nct_number': 'NCT01872598', 'title': \"Masitinib in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 3', 'enrollment': 721, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01872598', 'age_groups': '40 to 65 years old', 'name': 'NCT01872598'}, {'nct_number': 'NCT03117738', 'title': \"A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 1|Phase 2', 'enrollment': 21, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03117738', 'age_groups': '40 to 65 years old', 'name': 'NCT03117738'}, {'nct_number': 'NCT03022968', 'title': \"Tau Brain Imaging in Typical and Atypical Alzheimer's Disease (AD)\", 'status': 'Active, not recruiting', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 17, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03022968', 'age_groups': '40 to 65 years old', 'name': 'NCT03022968'}, {'nct_number': 'NCT03069391', 'title': 'The Interactive Physical and Cognitive Exercise System', 'status': 'Active, not recruiting', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 31, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03069391', 'age_groups': '40 to 65 years old', 'name': 'NCT03069391'}, {'nct_number': 'NCT03790982', 'title': \"Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 75 Years ', 'phases': 'Phase 2', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03790982', 'age_groups': '40 to 65 years old', 'name': 'NCT03790982'}, {'nct_number': 'NCT03352557', 'title': \"Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 654, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03352557', 'age_groups': '40 to 65 years old', 'name': 'NCT03352557'}, {'nct_number': 'NCT01979419', 'title': \"Korea Alzheimer's Disease Neuroimaging Initiative\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 500, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01979419', 'age_groups': '40 to 65 years old', 'name': 'NCT01979419'}, {'nct_number': 'NCT03289143', 'title': \"A Study to Evaluate the Efficacy and Safety of RO7105705 in Patients With Prodromal to Mild Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 80 Years ', 'phases': 'Phase 2', 'enrollment': 457, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03289143', 'age_groups': '40 to 65 years old', 'name': 'NCT03289143'}, {'nct_number': 'NCT01966666', 'title': \"A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TPI-287 in Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 82 Years ', 'phases': 'Phase 1', 'enrollment': 33, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01966666', 'age_groups': '40 to 65 years old', 'name': 'NCT01966666'}, {'nct_number': 'NCT01300728', 'title': 'Study of Intravenous Immunoglobulin in Amnestic Mild Cognitive Impairment', 'status': 'Active, not recruiting', 'clean_age': '50 Years to 84 Years ', 'phases': 'Phase 2', 'enrollment': 52, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01300728', 'age_groups': '40 to 65 years old', 'name': 'NCT01300728'}, {'nct_number': 'NCT02956486', 'title': \"A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Subjects With Early Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 950, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02956486', 'age_groups': '40 to 65 years old', 'name': 'NCT02956486'}, {'nct_number': 'NCT02947893', 'title': \"Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02947893', 'age_groups': '40 to 65 years old', 'name': 'NCT02947893'}, {'nct_number': 'NCT02640092', 'title': \"Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02640092', 'age_groups': '40 to 65 years old', 'name': 'NCT02640092'}, {'nct_number': 'NCT02322021', 'title': \"Dose-Finding Study To Evaluate the Safety and Tolerability of E2609 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 71, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02322021', 'age_groups': '40 to 65 years old', 'name': 'NCT02322021'}, {'nct_number': 'NCT02672306', 'title': \"Safety and Exploratory Efficacy Study of UCMSCs in Patients With Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 16, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02672306', 'age_groups': '40 to 65 years old', 'name': 'NCT02672306'}, {'nct_number': 'NCT02477800', 'title': \"221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 1605, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02477800', 'age_groups': '40 to 65 years old', 'name': 'NCT02477800'}, {'nct_number': 'NCT03036280', 'title': \"A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Subjects With Early Alzheimer's Disease_\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 950, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03036280', 'age_groups': '40 to 65 years old', 'name': 'NCT03036280'}, {'nct_number': 'NCT02484547', 'title': \"221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 1605, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02484547', 'age_groups': '40 to 65 years old', 'name': 'NCT02484547'}, {'nct_number': 'NCT01224106', 'title': \"A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 799, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01224106', 'age_groups': '40 to 65 years old', 'name': 'NCT01224106'}, {'nct_number': 'NCT02580305', 'title': \"SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 563, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02580305', 'age_groups': '40 to 65 years old', 'name': 'NCT02580305'}, {'nct_number': 'NCT03639987', 'title': \"A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 500, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03639987', 'age_groups': '40 to 65 years old', 'name': 'NCT03639987'}, {'nct_number': 'NCT03430869', 'title': 'Pathophysiology of Neurodegeneration in Late-life Depression (AV45+THK)', 'status': 'Active, not recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03430869', 'age_groups': '40 to 65 years old', 'name': 'NCT03430869'}, {'nct_number': 'NCT02503501', 'title': \"Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 49, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02503501', 'age_groups': '40 to 65 years old', 'name': 'NCT02503501'}, {'nct_number': 'NCT02051608', 'title': 'A Study of Gantenerumab in Participants With Mild Alzheimer Disease', 'status': 'Active, not recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 389, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02051608', 'age_groups': '40 to 65 years old', 'name': 'NCT02051608'}, {'nct_number': 'NCT03325556', 'title': 'Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis', 'status': 'Active, not recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 356, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03325556', 'age_groups': '40 to 65 years old', 'name': 'NCT03325556'}, {'nct_number': 'NCT01767311', 'title': \"A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 800, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01767311', 'age_groups': '40 to 65 years old', 'name': 'NCT01767311'}, {'nct_number': 'NCT03073876', 'title': 'Detecting an Early Response to Donepezil With Measures of Visual Attention', 'status': 'Active, not recruiting', 'clean_age': '50 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03073876', 'age_groups': '40 to 65 years old', 'name': 'NCT03073876'}, {'nct_number': 'NCT02541929', 'title': 'Fish Oil Brain Delivery Study', 'status': 'Active, not recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 2|Phase 3', 'enrollment': 31, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02541929', 'age_groups': '40 to 65 years old', 'name': 'NCT02541929'}, {'nct_number': 'NCT02788513', 'title': \"BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.\", 'status': 'Active, not recruiting', 'clean_age': '55 Years and older ', 'phases': 'Phase 2', 'enrollment': 611, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02788513', 'age_groups': '40 to 65 years old', 'name': 'NCT02788513'}, {'nct_number': 'NCT02564692', 'title': \"GeneMatch: A Program of the Alzheimer's Prevention Registry to Match Individuals to Studies Based on Apolipoprotein E (APOE) Genotype\", 'status': 'Active, not recruiting', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 500000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02564692', 'age_groups': '40 to 65 years old', 'name': 'NCT02564692'}, {'nct_number': 'NCT03375697', 'title': \"A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-63733657 in Healthy Subjects and Subjects With Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 1', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03375697', 'age_groups': '40 to 65 years old', 'name': 'NCT03375697'}, {'nct_number': 'NCT03417986', 'title': \"Clinical Trial to Explore the the Amyloid Beta Draining Effect of Thiethylperazine (TEP) in Subjects With Newly Diagnosed Early-to-mild Dementia Due to Alzheimer's Disease (AD) in Comparison to Healthy Volunteers\", 'status': 'Active, not recruiting', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 2', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03417986', 'age_groups': '40 to 65 years old', 'name': 'NCT03417986'}, {'nct_number': 'NCT02547818', 'title': \"Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '55 Years to 79 Years ', 'phases': 'Phase 3', 'enrollment': 620, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02547818', 'age_groups': '40 to 65 years old', 'name': 'NCT02547818'}, {'nct_number': 'NCT02756858', 'title': \"An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 32, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02756858', 'age_groups': '40 to 65 years old', 'name': 'NCT02756858'}, {'nct_number': 'NCT02951598', 'title': \"A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)\", 'status': 'Active, not recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 1400, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02951598', 'age_groups': '40 to 65 years old', 'name': 'NCT02951598'}, {'nct_number': 'NCT02623764', 'title': 'EEG-cholinergic Index and Clinical Response to Treatment With Cholinesterase Inhibitors', 'status': 'Active, not recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 218, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02623764', 'age_groups': '40 to 65 years old', 'name': 'NCT02623764'}, {'nct_number': 'NCT02880956', 'title': \"A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 453, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02880956', 'age_groups': '40 to 65 years old', 'name': 'NCT02880956'}, {'nct_number': 'NCT01409915', 'title': \"Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01409915', 'age_groups': '40 to 65 years old', 'name': 'NCT01409915'}, {'nct_number': 'NCT03448445', 'title': \"A Study to Evaluate Alzheimer's Disease Conversion Rate Differences Between High-risk Mild Cognitive Impairment (MCI) and Low-risk MCI in a Real World Setting\", 'status': 'Active, not recruiting', 'clean_age': '55 Years to 89 Years ', 'phases': 'Phase 4', 'enrollment': 201, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03448445', 'age_groups': '40 to 65 years old', 'name': 'NCT03448445'}, {'nct_number': 'NCT02292238', 'title': \"Benfotiamine in Alzheimer's Disease: A Pilot Study\", 'status': 'Active, not recruiting', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 76, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02292238', 'age_groups': '40 to 65 years old', 'name': 'NCT02292238'}, {'nct_number': 'NCT03554226', 'title': \"Agitation and Aggressivity in Alzheimer's Disease Patients: A Cohort Study\", 'status': 'Active, not recruiting', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 330, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03554226', 'age_groups': '40 to 65 years old', 'name': 'NCT03554226'}, {'nct_number': 'NCT03131453', 'title': \"A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '60 Years to 75 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 1145, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03131453', 'age_groups': '40 to 65 years old', 'name': 'NCT03131453'}, {'nct_number': 'NCT02565511', 'title': \"A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '60 Years to 75 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 481, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02565511', 'age_groups': '40 to 65 years old', 'name': 'NCT02565511'}, {'nct_number': 'NCT03382353', 'title': 'EMuNI Project: Multiple Nonpharmacological Interventions', 'status': 'Active, not recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Not Applicable', 'enrollment': 120, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03382353', 'age_groups': '40 to 65 years old', 'name': 'NCT03382353'}, {'nct_number': 'NCT01208675', 'title': 'The Swedish BioFINDER Study', 'status': 'Active, not recruiting', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 4', 'enrollment': 900, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01208675', 'age_groups': '40 to 65 years old', 'name': 'NCT01208675'}, {'nct_number': 'NCT02114372', 'title': 'Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research: Prospective Readiness Cohort Study', 'status': 'Active, not recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 1146, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02114372', 'age_groups': '40 to 65 years old', 'name': 'NCT02114372'}, {'nct_number': 'NCT02991235', 'title': \"Efficacy and Safety of PRJ212 to Improve the Memory of Patients With Mild Severity Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02991235', 'age_groups': '40 to 65 years old', 'name': 'NCT02991235'}, {'nct_number': 'NCT02615002', 'title': \"Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)\", 'status': 'Active, not recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 500, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02615002', 'age_groups': '40 to 65 years old', 'name': 'NCT02615002'}, {'nct_number': 'NCT03367403', 'title': \"A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)\", 'status': 'Active, not recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 266, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03367403', 'age_groups': '40 to 65 years old', 'name': 'NCT03367403'}, {'nct_number': 'NCT03518073', 'title': \"A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '60 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 285, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03518073', 'age_groups': '40 to 65 years old', 'name': 'NCT03518073'}, {'nct_number': 'NCT03001557', 'title': \"Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia\", 'status': 'Active, not recruiting', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 62, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03001557', 'age_groups': '40 to 65 years old', 'name': 'NCT03001557'}, {'nct_number': 'NCT03531710', 'title': 'An Extension Study of V203-AD Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UB-311', 'status': 'Active, not recruiting', 'clean_age': '60 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 34, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03531710', 'age_groups': '40 to 65 years old', 'name': 'NCT03531710'}, {'nct_number': 'NCT03300726', 'title': \"Synaptic Injury and Functional Connectivity in Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '60 Years to 95 Years ', 'phases': 'Phase 4', 'enrollment': 30, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03300726', 'age_groups': '40 to 65 years old', 'name': 'NCT03300726'}, {'nct_number': 'NCT03927040', 'title': \"Transcranial Electromagnetic Treatment Against Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '63 Years to 84 Years ', 'phases': 'Not Applicable', 'enrollment': 7, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03927040', 'age_groups': '40 to 65 years old', 'name': 'NCT03927040'}, {'nct_number': 'NCT02434393', 'title': 'Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project', 'status': 'Active, not recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 133, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02434393', 'age_groups': '40 to 65 years old', 'name': 'NCT02434393'}, {'nct_number': 'NCT01202994', 'title': 'Practice Effects and Amyloid Imaging Using 18F-PIB or Flutemetamol PET and FDG-PET', 'status': 'Active, not recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 2', 'enrollment': 27, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01202994', 'age_groups': '40 to 65 years old', 'name': 'NCT01202994'}, {'nct_number': 'NCT02000583', 'title': \"Alzheimer's Prevention Through Exercise\", 'status': 'Active, not recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02000583', 'age_groups': '40 to 65 years old', 'name': 'NCT02000583'}, {'nct_number': 'NCT01222351', 'title': 'Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172', 'status': 'Active, not recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 161, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01222351', 'age_groups': '40 to 65 years old', 'name': 'NCT01222351'}, {'nct_number': 'NCT04021888', 'title': \"The Effects of Exercise Program in Alzheimer's Patients With Mild to Moderate Stage Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04021888', 'age_groups': '40 to 65 years old', 'name': 'NCT04021888'}, {'nct_number': 'NCT03741543', 'title': 'Learning and Coping With Early Stage Dementia', 'status': 'Active, not recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03741543', 'age_groups': '40 to 65 years old', 'name': 'NCT03741543'}, {'nct_number': 'NCT02781220', 'title': 'Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial', 'status': 'Active, not recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 69, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02781220', 'age_groups': '40 to 65 years old', 'name': 'NCT02781220'}, {'nct_number': 'NCT03035201', 'title': 'COcoa Supplement and Multivitamin Outcomes Study for the Mind', 'status': 'Active, not recruiting', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 2262, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03035201', 'age_groups': '40 to 65 years old', 'name': 'NCT03035201'}, {'nct_number': 'NCT02365051', 'title': 'Translation of COPE for Publicly-Funded Home Care Clients and Their Families', 'status': 'Active, not recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 582, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02365051', 'age_groups': '40 to 65 years old', 'name': 'NCT02365051'}, {'nct_number': 'NCT01903421', 'title': 'Inhalational Anesthesia and Precipitation of Dementia: is There a Link?', 'status': 'Active, not recruiting', 'clean_age': '65 Years and older ', 'phases': 'Not Applicable', 'enrollment': 500, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01903421', 'age_groups': '40 to 65 years old', 'name': 'NCT01903421'}, {'nct_number': 'NCT02817074', 'title': 'MIND Diet Intervention and Cognitive Decline', 'status': 'Active, not recruiting', 'clean_age': '65 Years to 84 Years ', 'phases': 'Phase 3', 'enrollment': 604, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02817074', 'age_groups': '40 to 65 years old', 'name': 'NCT02817074'}, {'nct_number': 'NCT02488720', 'title': 'Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study', 'status': 'Active, not recruiting', 'clean_age': '65 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 500, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02488720', 'age_groups': '40 to 65 years old', 'name': 'NCT02488720'}, {'nct_number': 'NCT02008357', 'title': 'Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss', 'status': 'Active, not recruiting', 'clean_age': '65 Years to 85 Years ', 'phases': 'Phase 3', 'enrollment': 1150, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02008357', 'age_groups': '40 to 65 years old', 'name': 'NCT02008357'}]}, {'name': 'Enrolling by invitation', 'children': [{'nct_number': 'NCT02414282', 'title': 'F 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction (IND 123119, Protocol E)', 'status': 'Enrolling by invitation', 'clean_age': '45 Years and older ', 'phases': 'Phase 2', 'enrollment': 25, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02414282', 'age_groups': '40 to 65 years old', 'name': 'NCT02414282'}, {'nct_number': 'NCT02958670', 'title': 'Imaging Tau Deposition in the Brain of Elderly Subjects', 'status': 'Enrolling by invitation', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02958670', 'age_groups': '40 to 65 years old', 'name': 'NCT02958670'}, {'nct_number': 'NCT04118985', 'title': \"Compensatory Training to Support Brain Healthy Lifestyle Changes in Those at Risk for Alzheimer's Disease\", 'status': 'Enrolling by invitation', 'clean_age': '50 Years and older ', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04118985', 'age_groups': '40 to 65 years old', 'name': 'NCT04118985'}, {'nct_number': 'NCT03430648', 'title': 'Is Tau Protein Linked to Mobility Function?', 'status': 'Enrolling by invitation', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 60, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03430648', 'age_groups': '40 to 65 years old', 'name': 'NCT03430648'}, {'nct_number': 'NCT03489044', 'title': \"An Investigation of Levetiracetam in Alzheimer's Disease\", 'status': 'Enrolling by invitation', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03489044', 'age_groups': '40 to 65 years old', 'name': 'NCT03489044'}, {'nct_number': 'NCT03373604', 'title': \"Imaging Tau in Alzheimer's Disease and Normal Aging\", 'status': 'Enrolling by invitation', 'clean_age': '50 Years to 100 Years ', 'phases': 'Phase 2', 'enrollment': 175, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03373604', 'age_groups': '40 to 65 years old', 'name': 'NCT03373604'}, {'nct_number': 'NCT04004767', 'title': 'TRC-PAD Program: In-Clinic Trial-Ready Cohort', 'status': 'Enrolling by invitation', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 2000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04004767', 'age_groups': '40 to 65 years old', 'name': 'NCT04004767'}, {'nct_number': 'NCT03919669', 'title': 'A Longitudinal Evaluation of a Radiotracer for Use in Tau Tracking', 'status': 'Enrolling by invitation', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 42, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03919669', 'age_groups': '40 to 65 years old', 'name': 'NCT03919669'}, {'nct_number': 'NCT03441516', 'title': \"Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's Dementia\", 'status': 'Enrolling by invitation', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03441516', 'age_groups': '40 to 65 years old', 'name': 'NCT03441516'}, {'nct_number': 'NCT02848404', 'title': 'Therapeutic Efficacy of Categorical Language Fluency Smartphone Game Application', 'status': 'Enrolling by invitation', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02848404', 'age_groups': '40 to 65 years old', 'name': 'NCT02848404'}, {'nct_number': 'NCT03089827', 'title': \"Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease\", 'status': 'Enrolling by invitation', 'clean_age': '55 Years and older ', 'phases': 'Phase 4', 'enrollment': 300, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03089827', 'age_groups': '40 to 65 years old', 'name': 'NCT03089827'}, {'nct_number': 'NCT03081546', 'title': \"Cross-Cultural Use of Performance-Based Functional Assessment in Alzheimer's Disease\", 'status': 'Enrolling by invitation', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 80, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03081546', 'age_groups': '40 to 65 years old', 'name': 'NCT03081546'}, {'nct_number': 'NCT03702816', 'title': 'The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180)', 'status': 'Enrolling by invitation', 'clean_age': '55 Years to 90 Years ', 'phases': 'Phase 2', 'enrollment': 70, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03702816', 'age_groups': '40 to 65 years old', 'name': 'NCT03702816'}, {'nct_number': 'NCT02843529', 'title': 'Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI)', 'status': 'Enrolling by invitation', 'clean_age': '55 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 900, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02843529', 'age_groups': '40 to 65 years old', 'name': 'NCT02843529'}, {'nct_number': 'NCT03712787', 'title': \"An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD)\", 'status': 'Enrolling by invitation', 'clean_age': '57 Years to 87 Years ', 'phases': 'Phase 2', 'enrollment': 360, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03712787', 'age_groups': '40 to 65 years old', 'name': 'NCT03712787'}, {'nct_number': 'NCT03548883', 'title': \"Examining Neuroinflammation in AlzHeimer's\", 'status': 'Enrolling by invitation', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 18, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03548883', 'age_groups': '40 to 65 years old', 'name': 'NCT03548883'}, {'nct_number': 'NCT03981380', 'title': '11C-PIB PET Study in MESA at Columbia University', 'status': 'Enrolling by invitation', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 250, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03981380', 'age_groups': '40 to 65 years old', 'name': 'NCT03981380'}, {'nct_number': 'NCT02831283', 'title': \"Imaging Inflammation in Alzheimer's Disease\", 'status': 'Enrolling by invitation', 'clean_age': '60 Years and older ', 'phases': 'Phase 2', 'enrollment': 100, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02831283', 'age_groups': '40 to 65 years old', 'name': 'NCT02831283'}, {'nct_number': 'NCT03757910', 'title': 'Brain Imaging in the Diabetes Prevention Program Outcomes Study', 'status': 'Enrolling by invitation', 'clean_age': '60 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03757910', 'age_groups': '40 to 65 years old', 'name': 'NCT03757910'}, {'nct_number': 'NCT02978729', 'title': 'Telephone Versus Videoconference Communication for Remote Genetic Disclosure in the APOE4 Trial', 'status': 'Enrolling by invitation', 'clean_age': '60 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 3000, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02978729', 'age_groups': '40 to 65 years old', 'name': 'NCT02978729'}, {'nct_number': 'NCT03351452', 'title': 'tES Effects on Associative Memory Performance', 'status': 'Enrolling by invitation', 'clean_age': '60 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 74, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03351452', 'age_groups': '40 to 65 years old', 'name': 'NCT03351452'}, {'nct_number': 'NCT02147652', 'title': 'Personalized Music Therapy and Agitation in Dementia', 'status': 'Enrolling by invitation', 'clean_age': '60 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02147652', 'age_groups': '40 to 65 years old', 'name': 'NCT02147652'}, {'nct_number': 'NCT03403257', 'title': 'Brain Attack Surveillance in Corpus Christi--Cognitive (BASIC-Cognitive)', 'status': 'Enrolling by invitation', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 776, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03403257', 'age_groups': '40 to 65 years old', 'name': 'NCT03403257'}, {'nct_number': 'NCT03565809', 'title': 'Quality of the Management of Diabetes in Elderly People With Dementia in France', 'status': 'Enrolling by invitation', 'clean_age': '65 Years and older ', 'phases': 'Phase 4', 'enrollment': 87816, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03565809', 'age_groups': '40 to 65 years old', 'name': 'NCT03565809'}, {'nct_number': 'NCT04009629', 'title': 'Dementia Risk and Dynamic Response to Exercise', 'status': 'Enrolling by invitation', 'clean_age': '65 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04009629', 'age_groups': '40 to 65 years old', 'name': 'NCT04009629'}]}, {'name': 'Withdrawn', 'children': [{'nct_number': 'NCT01723670', 'title': 'Evaluation of Effects of Multiple Dose Regimens of CHF 5074 on Potential Biomarkers of Neurodegeneration in Subjects With Mild Cognitive Impairment', 'status': 'Withdrawn', 'clean_age': '45 Years to 64 Years ', 'phases': 'Phase 2', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01723670', 'age_groups': '40 to 65 years old', 'name': 'NCT01723670'}, {'nct_number': 'NCT02903862', 'title': 'Health-eBrain Study', 'status': 'Withdrawn', 'clean_age': '45 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02903862', 'age_groups': '40 to 65 years old', 'name': 'NCT02903862'}, {'nct_number': 'NCT00711204', 'title': \"Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00711204', 'age_groups': '40 to 65 years old', 'name': 'NCT00711204'}, {'nct_number': 'NCT01066481', 'title': \"A Study Of Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '50 Years and older ', 'phases': 'Phase 2', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01066481', 'age_groups': '40 to 65 years old', 'name': 'NCT01066481'}, {'nct_number': 'NCT01822951', 'title': \"Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)\", 'status': 'Withdrawn', 'clean_age': '50 Years and older ', 'phases': 'Phase 4', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01822951', 'age_groups': '40 to 65 years old', 'name': 'NCT01822951'}, {'nct_number': 'NCT02860065', 'title': \"CPC-201 Alzheimer's Disease Type Dementia: PET Study\", 'status': 'Withdrawn', 'clean_age': '50 Years to 79 Years ', 'phases': 'Phase 2', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02860065', 'age_groups': '40 to 65 years old', 'name': 'NCT02860065'}, {'nct_number': 'NCT03204604', 'title': 'The Brain Ketone Body Challenge Imaging Study', 'status': 'Withdrawn', 'clean_age': '50 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03204604', 'age_groups': '40 to 65 years old', 'name': 'NCT03204604'}, {'nct_number': 'NCT00743743', 'title': \"Pilot Study of the Effects of Resveratrol Supplement in Mild-to-moderate Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 3', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00743743', 'age_groups': '40 to 65 years old', 'name': 'NCT00743743'}, {'nct_number': 'NCT01615666', 'title': \"A Composite MR Neuroimaging Marker for Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '50 Years to 90 Years ', 'phases': 'Phase 4', 'enrollment': 0, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01615666', 'age_groups': '40 to 65 years old', 'name': 'NCT01615666'}, {'nct_number': 'NCT01636596', 'title': \"Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '50 Years to 95 Years ', 'phases': 'Not Applicable', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01636596', 'age_groups': '40 to 65 years old', 'name': 'NCT01636596'}, {'nct_number': 'NCT01313806', 'title': \"Study of Magnetic Fields to Treat Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '55 Years and older ', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01313806', 'age_groups': '40 to 65 years old', 'name': 'NCT01313806'}, {'nct_number': 'NCT03024944', 'title': 'TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind', 'status': 'Withdrawn', 'clean_age': '55 Years to 75 Years ', 'phases': 'Phase 2', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03024944', 'age_groups': '40 to 65 years old', 'name': 'NCT03024944'}, {'nct_number': 'NCT00412048', 'title': \"Functional Magnetic Resonance Imaging - Synthetic Aperture Magnetometry (fMRI-SAM) and Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '55 Years to 75 Years ', 'phases': 'Not Applicable', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00412048', 'age_groups': '40 to 65 years old', 'name': 'NCT00412048'}, {'nct_number': 'NCT00375557', 'title': \"Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia Patients\", 'status': 'Withdrawn', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00375557', 'age_groups': '40 to 65 years old', 'name': 'NCT00375557'}, {'nct_number': 'NCT01211782', 'title': 'AC-1204 Long-term Efficacy Response Trial (ALERT Protocol)', 'status': 'Withdrawn', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01211782', 'age_groups': '40 to 65 years old', 'name': 'NCT01211782'}, {'nct_number': 'NCT02912169', 'title': \"Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1|Phase 2', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02912169', 'age_groups': '40 to 65 years old', 'name': 'NCT02912169'}, {'nct_number': 'NCT02246075', 'title': \"Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine\", 'status': 'Withdrawn', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02246075', 'age_groups': '40 to 65 years old', 'name': 'NCT02246075'}, {'nct_number': 'NCT03316898', 'title': \"A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': '55 Years to 85 Years ', 'phases': 'Phase 1', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03316898', 'age_groups': '40 to 65 years old', 'name': 'NCT03316898'}, {'nct_number': 'NCT00792662', 'title': 'Improving Function, Quality of Life, Glycemia in Diabetics With Dementia', 'status': 'Withdrawn', 'clean_age': '60 Years and older ', 'phases': 'Phase 4', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00792662', 'age_groups': '40 to 65 years old', 'name': 'NCT00792662'}, {'nct_number': 'NCT03585907', 'title': 'Feasibility and Efficacy of Dietary Interventions for Older Adults With Subjective Cognitive Decline', 'status': 'Withdrawn', 'clean_age': '60 Years and older ', 'phases': 'Not Applicable', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03585907', 'age_groups': '40 to 65 years old', 'name': 'NCT03585907'}, {'nct_number': 'NCT02317250', 'title': 'Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II', 'status': 'Withdrawn', 'clean_age': '65 Years and older ', 'phases': 'Phase 3', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02317250', 'age_groups': '40 to 65 years old', 'name': 'NCT02317250'}]}, {'name': 'Suspended', 'children': [{'nct_number': 'NCT02380573', 'title': \"Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease\", 'status': 'Suspended', 'clean_age': '45 Years to 89 Years ', 'phases': 'Phase 2', 'enrollment': 117, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02380573', 'age_groups': '40 to 65 years old', 'name': 'NCT02380573'}, {'nct_number': 'NCT02500784', 'title': \"Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease\", 'status': 'Suspended', 'clean_age': '50 Years to 85 Years ', 'phases': 'Phase 2', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02500784', 'age_groups': '40 to 65 years old', 'name': 'NCT02500784'}, {'nct_number': 'NCT00205621', 'title': \"Positron Emission Tomography of Amyloid in Alzheimer's Disease\", 'status': 'Suspended', 'clean_age': '60 Years to 80 Years ', 'phases': 'Phase 1', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00205621', 'age_groups': '40 to 65 years old', 'name': 'NCT00205621'}]}]}, {'name': '65 and older', 'children': [{'name': 'Completed', 'children': [{'nct_number': 'NCT01741194', 'title': 'AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext', 'status': 'Completed', 'clean_age': '66 Years to 90 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 418, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01741194', 'age_groups': '65 and older', 'name': 'NCT01741194'}, {'nct_number': 'NCT01571427', 'title': \"Conversations as a Means to Delay the Onset of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '70 Years and older ', 'phases': 'Early Phase 1', 'enrollment': 83, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01571427', 'age_groups': '65 and older', 'name': 'NCT01571427'}, {'nct_number': 'NCT00007189', 'title': \"Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)\", 'status': 'Completed', 'clean_age': '70 Years and older ', 'phases': 'Phase 3', 'enrollment': 2625, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00007189', 'age_groups': '65 and older', 'name': 'NCT00007189'}, {'nct_number': 'NCT00912886', 'title': \"Pregnenolone Sulfate an Early Marker of the Memory Loss in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '70 Years and older ', 'phases': 'Phase 4', 'enrollment': 90, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00912886', 'age_groups': '65 and older', 'name': 'NCT00912886'}, {'nct_number': 'NCT01566071', 'title': 'Ability to Drive of Early Stage Alzheimer Disease', 'status': 'Completed', 'clean_age': '70 Years and older ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01566071', 'age_groups': '65 and older', 'name': 'NCT01566071'}, {'nct_number': 'NCT02529436', 'title': 'Overuse of Antidepressant in Patients With Alzheimer Disease', 'status': 'Completed', 'clean_age': '70 Years and older ', 'phases': 'Phase 4', 'enrollment': 54, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02529436', 'age_groups': '65 and older', 'name': 'NCT02529436'}, {'nct_number': 'NCT01231295', 'title': \"Isotopic Imaging for Prodromal Alzheimer's Disease\", 'status': 'Completed', 'clean_age': '70 Years and older ', 'phases': 'Phase 4', 'enrollment': 143, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01231295', 'age_groups': '65 and older', 'name': 'NCT01231295'}, {'nct_number': 'NCT00276510', 'title': 'A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints', 'status': 'Completed', 'clean_age': '70 Years and older ', 'phases': 'Phase 4', 'enrollment': 2878, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00276510', 'age_groups': '65 and older', 'name': 'NCT00276510'}, {'nct_number': 'NCT01345110', 'title': 'A Longitudinal Multidimensional Population Study on Brain Aging', 'status': 'Completed', 'clean_age': '70 Years to 75 Years ', 'phases': 'Phase 4', 'enrollment': 1321, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01345110', 'age_groups': '65 and older', 'name': 'NCT01345110'}, {'nct_number': 'NCT00099567', 'title': 'Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline', 'status': 'Completed', 'clean_age': '70 Years to 79 Years ', 'phases': 'Phase 4', 'enrollment': 2632, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00099567', 'age_groups': '65 and older', 'name': 'NCT00099567'}, {'nct_number': 'NCT00546767', 'title': 'Home-Based Assessment for Alzheimer Disease Prevention', 'status': 'Completed', 'clean_age': '75 Years and older ', 'phases': 'Not Applicable', 'enrollment': 640, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00546767', 'age_groups': '65 and older', 'name': 'NCT00546767'}, {'nct_number': 'NCT02041728', 'title': 'The Detection of Early Dementia With the Digital Game Memory', 'status': 'Completed', 'clean_age': '75 Years and older ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02041728', 'age_groups': '65 and older', 'name': 'NCT02041728'}, {'nct_number': 'NCT00954616', 'title': 'Inappropriate Medications Associated With Anticholinesterase and/or Memantine Treatment in the Elderly', 'status': 'Completed', 'clean_age': '75 Years and older ', 'phases': 'Phase 4', 'enrollment': 636, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00954616', 'age_groups': '65 and older', 'name': 'NCT00954616'}, {'nct_number': 'NCT01743534', 'title': 'Conservation of Praxis in the Food and Alzheimer Disease', 'status': 'Completed', 'clean_age': '75 Years and older ', 'phases': 'Phase 4', 'enrollment': 32, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01743534', 'age_groups': '65 and older', 'name': 'NCT01743534'}, {'nct_number': 'NCT00010803', 'title': 'Ginkgo Biloba Prevention Trial in Older Individuals', 'status': 'Completed', 'clean_age': '75 Years and older ', 'phases': 'Phase 3', 'enrollment': 3069, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00010803', 'age_groups': '65 and older', 'name': 'NCT00010803'}, {'nct_number': 'NCT00034567', 'title': 'Healthy Aging and Memory Study', 'status': 'Completed', 'clean_age': '75 Years and older ', 'phases': 'Phase 4', 'enrollment': 650, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00034567', 'age_groups': '65 and older', 'name': 'NCT00034567'}, {'nct_number': 'NCT03981159', 'title': \"Effect of Exercise Training in Alzheimer's Patients\", 'status': 'Completed', 'clean_age': '80 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03981159', 'age_groups': '65 and older', 'name': 'NCT03981159'}]}, {'name': 'Unknown status', 'children': [{'nct_number': 'NCT01192529', 'title': 'Evaluation of a Diet in Patients With Senile Dementia', 'status': 'Unknown status', 'clean_age': '70 Years and older ', 'phases': 'Not Applicable', 'enrollment': 184, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01192529', 'age_groups': '65 and older', 'name': 'NCT01192529'}, {'nct_number': 'NCT01880151', 'title': \"Neuroelectrical Biomarkers for Alzheimer's Disease Stages\", 'status': 'Unknown status', 'clean_age': '70 Years to 85 Years ', 'phases': 'Not Applicable', 'enrollment': 90, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01880151', 'age_groups': '65 and older', 'name': 'NCT01880151'}, {'nct_number': 'NCT01780896', 'title': 'Relationship Between Vestibular Function and Topographic Memory', 'status': 'Unknown status', 'clean_age': '70 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01780896', 'age_groups': '65 and older', 'name': 'NCT01780896'}, {'nct_number': 'NCT02138682', 'title': 'Validation of DaTscan for Detection of Parkinson Disease Related Disorders', 'status': 'Unknown status', 'clean_age': '75 Years and older ', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02138682', 'age_groups': '65 and older', 'name': 'NCT02138682'}, {'nct_number': 'NCT01417130', 'title': \"Follow-up Study of the Alzheimer's Disease Anti-Inflammatory Prevention Trial\", 'status': 'Unknown status', 'clean_age': '75 Years and older ', 'phases': 'Phase 4', 'enrollment': 1650, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01417130', 'age_groups': '65 and older', 'name': 'NCT01417130'}, {'nct_number': 'NCT01570322', 'title': 'Determinants of Quality of Life Related to Health in Alzheimer Disease', 'status': 'Unknown status', 'clean_age': '75 Years and older ', 'phases': 'Phase 4', 'enrollment': 400, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01570322', 'age_groups': '65 and older', 'name': 'NCT01570322'}]}, {'name': 'Recruiting', 'children': [{'nct_number': 'NCT02052947', 'title': 'Co-LEsions in Alzheimer Disease and Related Disorders', 'status': 'Recruiting', 'clean_age': '70 Years and older ', 'phases': 'Not Applicable', 'enrollment': 214, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02052947', 'age_groups': '65 and older', 'name': 'NCT02052947'}, {'nct_number': 'NCT03691519', 'title': 'Prevention of Cognitive Decline in Older Adults With Low Dha/Epa Index in Red Blood Cells', 'status': 'Recruiting', 'clean_age': '70 Years and older ', 'phases': 'Phase 3', 'enrollment': 400, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03691519', 'age_groups': '65 and older', 'name': 'NCT03691519'}, {'nct_number': 'NCT03129269', 'title': 'Cognitive Function and Prevalence of Amyloid Marker in Frail Older Adults', 'status': 'Recruiting', 'clean_age': '70 Years and older ', 'phases': 'Not Applicable', 'enrollment': 345, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03129269', 'age_groups': '65 and older', 'name': 'NCT03129269'}, {'nct_number': 'NCT03999879', 'title': 'PhosphoRus, Proton Imaging and Amyloid BuRdEn (PREPARE) ON AMYLOID BURDEN AND COGNITION', 'status': 'Recruiting', 'clean_age': '70 Years to 85 Years ', 'phases': 'Phase 4', 'enrollment': 45, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03999879', 'age_groups': '65 and older', 'name': 'NCT03999879'}, {'nct_number': 'NCT03597360', 'title': \"Low Dose Ionizing Radiation Using CT Scans as a Potential Therapy for Alzheimer's Dementia: A Pilot Study\", 'status': 'Recruiting', 'clean_age': '70 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 3, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03597360', 'age_groups': '65 and older', 'name': 'NCT03597360'}, {'nct_number': 'NCT03487380', 'title': \"Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '70 Years to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 300, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03487380', 'age_groups': '65 and older', 'name': 'NCT03487380'}, {'nct_number': 'NCT03282097', 'title': \"Decisions About Cancer Screening in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': '75 Years and older ', 'phases': 'Not Applicable', 'enrollment': 426, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03282097', 'age_groups': '65 and older', 'name': 'NCT03282097'}, {'nct_number': 'NCT02578303', 'title': 'Association Between Cerebral Arterial Vascular Flow and Sleep Apnea in Neurodegenerative Alterations', 'status': 'Recruiting', 'clean_age': '75 Years to 120 Years ', 'phases': 'Not Applicable', 'enrollment': 139, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02578303', 'age_groups': '65 and older', 'name': 'NCT02578303'}]}, {'name': 'Terminated', 'children': []}, {'name': 'Not yet recruiting', 'children': []}, {'name': 'Active, not recruiting', 'children': [{'nct_number': 'NCT01954550', 'title': \"Effects of Aerobic Exercise for Treating Alzheimer's Disease\", 'status': 'Active, not recruiting', 'clean_age': '66 Years and older ', 'phases': 'Not Applicable', 'enrollment': 96, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01954550', 'age_groups': '65 and older', 'name': 'NCT01954550'}, {'nct_number': 'NCT02224326', 'title': 'Vagus Somatosensory Evoked Potentials and Near-infrared Spectroscopy in the Early Diagnosis of Dementia', 'status': 'Active, not recruiting', 'clean_age': '70 Years to 78 Years ', 'phases': 'Phase 4', 'enrollment': 604, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02224326', 'age_groups': '65 and older', 'name': 'NCT02224326'}, {'nct_number': 'NCT01953705', 'title': 'n-3 PUFA for Vascular Cognitive Aging', 'status': 'Active, not recruiting', 'clean_age': '75 Years and older ', 'phases': 'Phase 2', 'enrollment': 102, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01953705', 'age_groups': '65 and older', 'name': 'NCT01953705'}]}, {'name': 'Enrolling by invitation', 'children': [{'nct_number': 'NCT03683394', 'title': \"Systematic Multi-domain Alzheimer's Risk Reduction Trial\", 'status': 'Enrolling by invitation', 'clean_age': '70 Years to 89 Years ', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03683394', 'age_groups': '65 and older', 'name': 'NCT03683394'}]}, {'name': 'Withdrawn', 'children': []}, {'name': 'Suspended', 'children': []}]}, {'name': 'Age not specified', 'children': [{'name': 'Completed', 'children': [{'nct_number': 'NCT00039702', 'title': \"Brain Imaging in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 40, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00039702', 'age_groups': 'Age not specified', 'name': 'NCT00039702'}, {'nct_number': 'NCT02878486', 'title': 'Intervention to Reduce Sedentary Time', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02878486', 'age_groups': 'Age not specified', 'name': 'NCT02878486'}, {'nct_number': 'NCT01525368', 'title': 'Outcome Predictors of a Cognitive Intervention in aMCI', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 110, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01525368', 'age_groups': 'Age not specified', 'name': 'NCT01525368'}, {'nct_number': 'NCT02158910', 'title': \"A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 2231, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02158910', 'age_groups': 'Age not specified', 'name': 'NCT02158910'}, {'nct_number': 'NCT03408041', 'title': \"Reported Time Between Onset and Diagnosis of Alzheimer's Disease: Correlation With Objective Parameters\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 129, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03408041', 'age_groups': 'Age not specified', 'name': 'NCT03408041'}, {'nct_number': 'NCT00297414', 'title': 'An Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of Galantamine', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 1083, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00297414', 'age_groups': 'Age not specified', 'name': 'NCT00297414'}, {'nct_number': 'NCT00202124', 'title': \"Double Blind Study of Trp01 in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00202124', 'age_groups': 'Age not specified', 'name': 'NCT00202124'}, {'nct_number': 'NCT00393627', 'title': 'Behavioral Sleep Intervention in Adult Family Homes', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 47, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00393627', 'age_groups': 'Age not specified', 'name': 'NCT00393627'}, {'nct_number': 'NCT03690193', 'title': \"Feasibility and Efficacy of the Ketogenic Diet in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03690193', 'age_groups': 'Age not specified', 'name': 'NCT03690193'}, {'nct_number': 'NCT01946243', 'title': 'The Feasibility of Florbetapir Quantitation', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 96, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01946243', 'age_groups': 'Age not specified', 'name': 'NCT01946243'}, {'nct_number': 'NCT00630500', 'title': \"Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 75, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00630500', 'age_groups': 'Age not specified', 'name': 'NCT00630500'}, {'nct_number': 'NCT01023425', 'title': 'Clinical Trial of Donepezil Between the Naive Group and the Switching Group', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 72, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01023425', 'age_groups': 'Age not specified', 'name': 'NCT01023425'}, {'nct_number': 'NCT01998711', 'title': 'Impact of a Memory Group for Older Adults Reporting Memory Difficulties', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 62, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01998711', 'age_groups': 'Age not specified', 'name': 'NCT01998711'}, {'nct_number': 'NCT01126099', 'title': \"Prazosin Treatment for Disruptive Agitation in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01126099', 'age_groups': 'Age not specified', 'name': 'NCT01126099'}, {'nct_number': 'NCT02667665', 'title': 'Verification Study and Reactivity Study for the Validity of QuQu Scale', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 240, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02667665', 'age_groups': 'Age not specified', 'name': 'NCT02667665'}, {'nct_number': 'NCT02162251', 'title': \"Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 3482, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02162251', 'age_groups': 'Age not specified', 'name': 'NCT02162251'}, {'nct_number': 'NCT02192554', 'title': \"Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 450, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02192554', 'age_groups': 'Age not specified', 'name': 'NCT02192554'}, {'nct_number': 'NCT02350127', 'title': 'Preventing Loss of Independence Through Exercise (PLIE) in Persons With Dementia', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2|Phase 3', 'enrollment': 88, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02350127', 'age_groups': 'Age not specified', 'name': 'NCT02350127'}, {'nct_number': 'NCT01225809', 'title': 'AD01 Follow up Extension Visit', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 17, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01225809', 'age_groups': 'Age not specified', 'name': 'NCT01225809'}, {'nct_number': 'NCT00934050', 'title': \"ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 103, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00934050', 'age_groups': 'Age not specified', 'name': 'NCT00934050'}, {'nct_number': 'NCT00515333', 'title': \"TRx0014 in Patients With Mild or Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 323, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00515333', 'age_groups': 'Age not specified', 'name': 'NCT00515333'}, {'nct_number': 'NCT00161473', 'title': \"Alzheimer's in Long-Term Care--Treatment for Agitation\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00161473', 'age_groups': 'Age not specified', 'name': 'NCT00161473'}, {'nct_number': 'NCT00046358', 'title': \"The Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00046358', 'age_groups': 'Age not specified', 'name': 'NCT00046358'}, {'nct_number': 'NCT00203320', 'title': \"TNF-Alpha Inhibition for Treatment of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 1', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00203320', 'age_groups': 'Age not specified', 'name': 'NCT00203320'}, {'nct_number': 'NCT00203359', 'title': \"TNF-Alpha Inhibition for Treatment of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 1', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00203359', 'age_groups': 'Age not specified', 'name': 'NCT00203359'}, {'nct_number': 'NCT00105638', 'title': 'Telehealth Education Program for Caregivers of Veterans With Dementia', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00105638', 'age_groups': 'Age not specified', 'name': 'NCT00105638'}, {'nct_number': 'NCT02353845', 'title': 'Construction of Diagnosis System for Early AD Based on Multi-Modality MRI Technology', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 297, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02353845', 'age_groups': 'Age not specified', 'name': 'NCT02353845'}, {'nct_number': 'NCT00297362', 'title': \"A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 344, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00297362', 'age_groups': 'Age not specified', 'name': 'NCT00297362'}, {'nct_number': 'NCT00001977', 'title': 'The Effect of Acetylcholine on Memory and Attention', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 70, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00001977', 'age_groups': 'Age not specified', 'name': 'NCT00001977'}, {'nct_number': 'NCT02107599', 'title': 'The Feasibility of Florbetapir Quantitation in Europe', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 96, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02107599', 'age_groups': 'Age not specified', 'name': 'NCT02107599'}, {'nct_number': 'NCT02336360', 'title': 'Augmenting 18F-AV-1451 Dosimetry Estimates', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 1', 'enrollment': 6, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02336360', 'age_groups': 'Age not specified', 'name': 'NCT02336360'}, {'nct_number': 'NCT03901092', 'title': 'A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 PET Scan Interpretation', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 3', 'enrollment': 262, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03901092', 'age_groups': 'Age not specified', 'name': 'NCT03901092'}, {'nct_number': 'NCT01972204', 'title': 'Intensive Instruction on the Use of Aricept', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 125, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01972204', 'age_groups': 'Age not specified', 'name': 'NCT01972204'}, {'nct_number': 'NCT02267486', 'title': 'Exploratory Study for the Validity of QuQu Scale', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 972, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02267486', 'age_groups': 'Age not specified', 'name': 'NCT02267486'}, {'nct_number': 'NCT03611439', 'title': \"Effects of an 8 Component Botanical Supplement on Mild and Moderate Alzheimer's Patients\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03611439', 'age_groups': 'Age not specified', 'name': 'NCT03611439'}, {'nct_number': 'NCT00105612', 'title': \"Memory Aid for Informed Consent in Alzheimer's Research\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 110, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00105612', 'age_groups': 'Age not specified', 'name': 'NCT00105612'}, {'nct_number': 'NCT00283725', 'title': \"Use of Different Treatment Care Methods in Patients With Dementia Associated With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 573, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00283725', 'age_groups': 'Age not specified', 'name': 'NCT00283725'}, {'nct_number': 'NCT03349320', 'title': 'Response to Donepezil, Drug Plasma Concentration and the CYP2D6 and APOE Genetic Polymorphisms', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 37, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03349320', 'age_groups': 'Age not specified', 'name': 'NCT03349320'}, {'nct_number': 'NCT00059410', 'title': \"Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 210, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00059410', 'age_groups': 'Age not specified', 'name': 'NCT00059410'}, {'nct_number': 'NCT00505167', 'title': \"Memantine Versus Donepezil in Early Stages of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 64, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00505167', 'age_groups': 'Age not specified', 'name': 'NCT00505167'}, {'nct_number': 'NCT02409082', 'title': 'Alzheimers Disease and Neuromarkers in Patients With Acute Hip Fractures', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 400, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02409082', 'age_groups': 'Age not specified', 'name': 'NCT02409082'}, {'nct_number': 'NCT00211159', 'title': \"OmegAD (Omega-3 and Alzheimer's Disease)\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 204, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00211159', 'age_groups': 'Age not specified', 'name': 'NCT00211159'}, {'nct_number': 'NCT00299676', 'title': \"An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 61, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00299676', 'age_groups': 'Age not specified', 'name': 'NCT00299676'}, {'nct_number': 'NCT02051790', 'title': 'Evaluation of Reader Training Processes', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 241, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02051790', 'age_groups': 'Age not specified', 'name': 'NCT02051790'}, {'nct_number': 'NCT01505504', 'title': 'Mirtazapine in Alzheimer-associated Weight Loss', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 22, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01505504', 'age_groups': 'Age not specified', 'name': 'NCT01505504'}, {'nct_number': 'NCT00396825', 'title': 'Video-Based Coping Skills Training for Caregivers', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 116, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00396825', 'age_groups': 'Age not specified', 'name': 'NCT00396825'}, {'nct_number': 'NCT01081743', 'title': 'Effectiveness of Care Management in Alzheimer Patients', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 270, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01081743', 'age_groups': 'Age not specified', 'name': 'NCT01081743'}, {'nct_number': 'NCT01129596', 'title': \"Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 10238, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01129596', 'age_groups': 'Age not specified', 'name': 'NCT01129596'}, {'nct_number': 'NCT00001933', 'title': \"Nefiracetam in the Treatment of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00001933', 'age_groups': 'Age not specified', 'name': 'NCT00001933'}, {'nct_number': 'NCT00470418', 'title': \"Development of NIC5-15 in the Treatment of Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 15, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00470418', 'age_groups': 'Age not specified', 'name': 'NCT00470418'}, {'nct_number': 'NCT01029132', 'title': 'Characteristics of Treatment Responders to Galantamine', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 66, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01029132', 'age_groups': 'Age not specified', 'name': 'NCT01029132'}, {'nct_number': 'NCT00015548', 'title': \"CATIE-Alzheimer's Disease Trial\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 450, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00015548', 'age_groups': 'Age not specified', 'name': 'NCT00015548'}, {'nct_number': 'NCT00147693', 'title': 'Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach?', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 304, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00147693', 'age_groups': 'Age not specified', 'name': 'NCT00147693'}, {'nct_number': 'NCT00088387', 'title': \"Effect of Lithium and Divalproex in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 35, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00088387', 'age_groups': 'Age not specified', 'name': 'NCT00088387'}, {'nct_number': 'NCT01371214', 'title': 'Preventing Loss of Independence Through Exercise (PLIÉ) - Pilot', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 1', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01371214', 'age_groups': 'Age not specified', 'name': 'NCT01371214'}, {'nct_number': 'NCT02380703', 'title': 'Aggression Prevention Training for Caregivers of Persons With Dementia (APT)', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 228, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02380703', 'age_groups': 'Age not specified', 'name': 'NCT02380703'}, {'nct_number': 'NCT00001549', 'title': 'Diagnosis and Natural History Study of Patients With Neurological Conditions', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 600, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00001549', 'age_groups': 'Age not specified', 'name': 'NCT00001549'}, {'nct_number': 'NCT01023867', 'title': \"Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 88, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01023867', 'age_groups': 'Age not specified', 'name': 'NCT01023867'}, {'nct_number': 'NCT00001917', 'title': \"Brain Imaging in Elderly People and Individuals With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 150, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00001917', 'age_groups': 'Age not specified', 'name': 'NCT00001917'}, {'nct_number': 'NCT01217541', 'title': 'Collaboration Between Department of Old Age Psychiatry and Nursing Homes', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 700, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01217541', 'age_groups': 'Age not specified', 'name': 'NCT01217541'}, {'nct_number': 'NCT01023685', 'title': \"To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 24, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01023685', 'age_groups': 'Age not specified', 'name': 'NCT01023685'}, {'nct_number': 'NCT02162264', 'title': \"Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 8662, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02162264', 'age_groups': 'Age not specified', 'name': 'NCT02162264'}, {'nct_number': 'NCT00291421', 'title': \"A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 2360, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00291421', 'age_groups': 'Age not specified', 'name': 'NCT00291421'}, {'nct_number': 'NCT03491150', 'title': \"An Open-Label Crenezumab Study in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 3', 'enrollment': 149, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03491150', 'age_groups': 'Age not specified', 'name': 'NCT03491150'}, {'nct_number': 'NCT00309725', 'title': \"A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease.\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 3', 'enrollment': 139, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00309725', 'age_groups': 'Age not specified', 'name': 'NCT00309725'}, {'nct_number': 'NCT01351142', 'title': \"Cytokines and Cognitive Decline in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 133, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01351142', 'age_groups': 'Age not specified', 'name': 'NCT01351142'}, {'nct_number': 'NCT00391794', 'title': \"Efficacy of Early Stage Alzheimer's Support Groups\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 154, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00391794', 'age_groups': 'Age not specified', 'name': 'NCT00391794'}, {'nct_number': 'NCT00012831', 'title': 'Nurse Managed Clinic for Dementia Patients and Family Caregivers', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 120, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00012831', 'age_groups': 'Age not specified', 'name': 'NCT00012831'}, {'nct_number': 'NCT00001235', 'title': \"Genetic Studies in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 1500, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00001235', 'age_groups': 'Age not specified', 'name': 'NCT00001235'}, {'nct_number': 'NCT00001662', 'title': \"Treatment of Alzheimer's Disease With CX516 (Ampalex)\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00001662', 'age_groups': 'Age not specified', 'name': 'NCT00001662'}, {'nct_number': 'NCT01574456', 'title': \"Blood-brain Barrier Permeability in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 39, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01574456', 'age_groups': 'Age not specified', 'name': 'NCT01574456'}, {'nct_number': 'NCT00898807', 'title': \"Citalopram for Agitation in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 3', 'enrollment': 186, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00898807', 'age_groups': 'Age not specified', 'name': 'NCT00898807'}, {'nct_number': 'NCT00698165', 'title': \"Observational Study on Costs and Caregiver Burden in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 2400, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00698165', 'age_groups': 'Age not specified', 'name': 'NCT00698165'}, {'nct_number': 'NCT01609348', 'title': \"Venlafaxine for Depression in Alzheimer's Disease (DIADs-3)\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 5, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01609348', 'age_groups': 'Age not specified', 'name': 'NCT01609348'}, {'nct_number': 'NCT00001972', 'title': 'PET Scan of Brain Metabolism in Relation to Age and Disease', 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 123, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00001972', 'age_groups': 'Age not specified', 'name': 'NCT00001972'}, {'nct_number': 'NCT00684944', 'title': \"Open Label Study of TRx0014 in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 111, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00684944', 'age_groups': 'Age not specified', 'name': 'NCT00684944'}, {'nct_number': 'NCT01251718', 'title': \"Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 894, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01251718', 'age_groups': 'Age not specified', 'name': 'NCT01251718'}, {'nct_number': 'NCT00955409', 'title': \"Long Term Extension Study Evaluating Safety, Tolerability and Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00955409', 'age_groups': 'Age not specified', 'name': 'NCT00955409'}, {'nct_number': 'NCT01354444', 'title': \"Trial of Carvedilol in Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'up to 100 Years ', 'phases': 'Phase 4', 'enrollment': 29, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01354444', 'age_groups': 'Age not specified', 'name': 'NCT01354444'}, {'nct_number': 'NCT01097096', 'title': 'Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients', 'status': 'Completed', 'clean_age': 'up to 85 Years ', 'phases': 'Phase 2', 'enrollment': 177, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01097096', 'age_groups': 'Age not specified', 'name': 'NCT01097096'}, {'nct_number': 'NCT01689233', 'title': \"Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'up to 89 Years ', 'phases': 'Phase 3', 'enrollment': 800, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01689233', 'age_groups': 'Age not specified', 'name': 'NCT01689233'}, {'nct_number': 'NCT01689246', 'title': \"Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease\", 'status': 'Completed', 'clean_age': 'up to 89 Years ', 'phases': 'Phase 3', 'enrollment': 891, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01689246', 'age_groups': 'Age not specified', 'name': 'NCT01689246'}, {'nct_number': 'NCT01552265', 'title': 'Shanghai Mild Cognitive Impairment Cohort Study', 'status': 'Completed', 'clean_age': 'up to 90 Years ', 'phases': 'Phase 4', 'enrollment': 400, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01552265', 'age_groups': 'Age not specified', 'name': 'NCT01552265'}]}, {'name': 'Unknown status', 'children': [{'nct_number': 'NCT02260167', 'title': \"Treatment of Alzheimer's and Dementia With the Metabolism, Infections, Nutrition, Drug Elimination (MIND) Protocol\", 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 46, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02260167', 'age_groups': 'Age not specified', 'name': 'NCT02260167'}, {'nct_number': 'NCT02770482', 'title': \"Amyloid Beta-peptide 1-40 and Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02770482', 'age_groups': 'Age not specified', 'name': 'NCT02770482'}, {'nct_number': 'NCT00866060', 'title': \"Donepezil and Memantine in Moderate to Severe Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 800, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00866060', 'age_groups': 'Age not specified', 'name': 'NCT00866060'}, {'nct_number': 'NCT01315704', 'title': \"Alzheimer's Disease and Related Disorders\", 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 700, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01315704', 'age_groups': 'Age not specified', 'name': 'NCT01315704'}, {'nct_number': 'NCT00599469', 'title': \"Far Infrared Treatment for Alzheimer's Disease\", 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 1', 'enrollment': 4, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00599469', 'age_groups': 'Age not specified', 'name': 'NCT00599469'}, {'nct_number': 'NCT02013518', 'title': 'Cognitive Behavioural Therapy for Persons With MCI or Mild Dementia', 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02013518', 'age_groups': 'Age not specified', 'name': 'NCT02013518'}, {'nct_number': 'NCT01198093', 'title': 'Clinical Research Center for Dementia of South Korea (CREDOS)(or CRCD)', 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 800, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01198093', 'age_groups': 'Age not specified', 'name': 'NCT01198093'}, {'nct_number': 'NCT01479855', 'title': 'Multiple Nutritional Deficiencies Causing Dementia of the Alzheimer Type', 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 180, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01479855', 'age_groups': 'Age not specified', 'name': 'NCT01479855'}, {'nct_number': 'NCT02247180', 'title': 'Cognitive Rehabilitation in Alzheimer`s Disease', 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 14, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02247180', 'age_groups': 'Age not specified', 'name': 'NCT02247180'}, {'nct_number': 'NCT01695889', 'title': 'Is There a Relationship Between Previous Exposure to General Anesthesia and the Development of Alzheimer´s Disease?', 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 877, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01695889', 'age_groups': 'Age not specified', 'name': 'NCT01695889'}, {'nct_number': 'NCT00627029', 'title': 'Evaluation of Programs of Coordinated Care and Disease Management', 'status': 'Unknown status', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 18277, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00627029', 'age_groups': 'Age not specified', 'name': 'NCT00627029'}, {'nct_number': 'NCT02055092', 'title': 'Young Onset Dementia - the Difficult Diagnosis and the Stressful Life for the Whole Family', 'status': 'Unknown status', 'clean_age': 'up to 69 Years ', 'phases': 'Phase 4', 'enrollment': 250, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT02055092', 'age_groups': 'Age not specified', 'name': 'NCT02055092'}]}, {'name': 'Recruiting', 'children': [{'nct_number': 'NCT04041895', 'title': \"Detecting Probable Alzheimer's Disease From Speech Using Linguistical Analysis\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT04041895', 'age_groups': 'Age not specified', 'name': 'NCT04041895'}, {'nct_number': 'NCT03938727', 'title': 'Cardiovascular Risk Factors, Aging and Dementia', 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 500, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03938727', 'age_groups': 'Age not specified', 'name': 'NCT03938727'}, {'nct_number': 'NCT02033941', 'title': \"Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD)\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02033941', 'age_groups': 'Age not specified', 'name': 'NCT02033941'}, {'nct_number': 'NCT03124550', 'title': \"Development of An Exergame for Caregivers of Individuals With Alzheimer's Disease or Related Dementias\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 20, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03124550', 'age_groups': 'Age not specified', 'name': 'NCT03124550'}, {'nct_number': 'NCT03384043', 'title': \"Comparing Smartphone Technology and a Memory Strategy on Improving Prospective Memory in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 52, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03384043', 'age_groups': 'Age not specified', 'name': 'NCT03384043'}, {'nct_number': 'NCT03621839', 'title': \"New CSF Biomarkers for Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 50000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03621839', 'age_groups': 'Age not specified', 'name': 'NCT03621839'}, {'nct_number': 'NCT02346201', 'title': 'Apathy in Dementia Methylphenidate Trial 2', 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 3', 'enrollment': 200, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02346201', 'age_groups': 'Age not specified', 'name': 'NCT02346201'}, {'nct_number': 'NCT03508024', 'title': \"Patients With Alzheimer's Disease or Related Youth Disease\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 220, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03508024', 'age_groups': 'Age not specified', 'name': 'NCT03508024'}, {'nct_number': 'NCT03435705', 'title': 'Maintenance of Occupational Therapy for Patients With Alzheimer', 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 240, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03435705', 'age_groups': 'Age not specified', 'name': 'NCT03435705'}, {'nct_number': 'NCT03900936', 'title': 'Detecting Dementia Earlier', 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 20, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03900936', 'age_groups': 'Age not specified', 'name': 'NCT03900936'}, {'nct_number': 'NCT02129348', 'title': \"Treatment of Psychosis and Agitation in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02129348', 'age_groups': 'Age not specified', 'name': 'NCT02129348'}, {'nct_number': 'NCT03289377', 'title': 'NRC:Improving Healthcare for Cognitively Impaired Elders and Their Caregivers', 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 50, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03289377', 'age_groups': 'Age not specified', 'name': 'NCT03289377'}, {'nct_number': 'NCT03442322', 'title': 'Optimizing Care for Patients With Dementia', 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03442322', 'age_groups': 'Age not specified', 'name': 'NCT03442322'}, {'nct_number': 'NCT00064870', 'title': \"Alzheimer's Disease Genetics Study\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 3000, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT00064870', 'age_groups': 'Age not specified', 'name': 'NCT00064870'}, {'nct_number': 'NCT03472482', 'title': 'Optical Coherence Tomography in Cerebral Amyloidosis', 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 85, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03472482', 'age_groups': 'Age not specified', 'name': 'NCT03472482'}, {'nct_number': 'NCT02989402', 'title': \"A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 102, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02989402', 'age_groups': 'Age not specified', 'name': 'NCT02989402'}, {'nct_number': 'NCT03710642', 'title': \"Prazosin for Agitation in Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 186, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03710642', 'age_groups': 'Age not specified', 'name': 'NCT03710642'}, {'nct_number': 'NCT03062449', 'title': 'Phase IIa L-serine Trial for eAD', 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03062449', 'age_groups': 'Age not specified', 'name': 'NCT03062449'}, {'nct_number': 'NCT02353949', 'title': 'Investigating the Clinical Consequences of Flutemetamol-PET-scanning', 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 3', 'enrollment': 110, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02353949', 'age_groups': 'Age not specified', 'name': 'NCT02353949'}, {'nct_number': 'NCT03656159', 'title': \"Evaluation of a New CBT for People With Alzheimer's Disease and Their Caregivers\", 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 30, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03656159', 'age_groups': 'Age not specified', 'name': 'NCT03656159'}, {'nct_number': 'NCT03672266', 'title': 'Studies of Brain and Body Interaction', 'status': 'Recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 100, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03672266', 'age_groups': 'Age not specified', 'name': 'NCT03672266'}, {'nct_number': 'NCT03863041', 'title': 'Study of Phosphorylated Metabolism Profile as Predictive Biomarker of Cognitive Decline in Memory Complaint.', 'status': 'Recruiting', 'clean_age': 'up to 90 Years ', 'phases': 'Not Applicable', 'enrollment': 60, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03863041', 'age_groups': 'Age not specified', 'name': 'NCT03863041'}, {'nct_number': 'NCT03446001', 'title': \"Safety and Efficacy of TRx0237 in Subjects With Early Alzheimer's Disease\", 'status': 'Recruiting', 'clean_age': 'up to 90 Years ', 'phases': 'Phase 2|Phase 3', 'enrollment': 375, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03446001', 'age_groups': 'Age not specified', 'name': 'NCT03446001'}]}, {'name': 'Terminated', 'children': [{'nct_number': 'NCT00606476', 'title': \"AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 194, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00606476', 'age_groups': 'Age not specified', 'name': 'NCT00606476'}, {'nct_number': 'NCT03485898', 'title': 'Study of Patients Hospitalized in Specialized Cognitive-behavioral Unit (UCC)', 'status': 'Terminated', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 58, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03485898', 'age_groups': 'Age not specified', 'name': 'NCT03485898'}, {'nct_number': 'NCT00105105', 'title': \"Mifepristone as Adjunctive Therapy in Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 160, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00105105', 'age_groups': 'Age not specified', 'name': 'NCT00105105'}, {'nct_number': 'NCT01357629', 'title': \"Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 11, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01357629', 'age_groups': 'Age not specified', 'name': 'NCT01357629'}, {'nct_number': 'NCT00287742', 'title': \"A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 3', 'enrollment': 33, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT00287742', 'age_groups': 'Age not specified', 'name': 'NCT00287742'}, {'nct_number': 'NCT02245568', 'title': \"Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)\", 'status': 'Terminated', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 3', 'enrollment': 913, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02245568', 'age_groups': 'Age not specified', 'name': 'NCT02245568'}, {'nct_number': 'NCT02248116', 'title': 'Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type', 'status': 'Terminated', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2|Phase 3', 'enrollment': 198, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02248116', 'age_groups': 'Age not specified', 'name': 'NCT02248116'}, {'nct_number': 'NCT01626391', 'title': \"Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease\", 'status': 'Terminated', 'clean_age': 'up to 90 Years ', 'phases': 'Phase 2', 'enrollment': 9, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT01626391', 'age_groups': 'Age not specified', 'name': 'NCT01626391'}]}, {'name': 'Not yet recruiting', 'children': [{'nct_number': 'NCT04004702', 'title': \"Levetiracetam for Alzheimer's Disease Neuropsychiatric Symptoms Related to Epilepsy Trial (LAPSE)\", 'status': 'Not yet recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 2', 'enrollment': 65, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04004702', 'age_groups': 'Age not specified', 'name': 'NCT04004702'}, {'nct_number': 'NCT03821844', 'title': \"Music & MEmory: A Pragmatic TRial for Nursing Home Residents With ALzheimer's Disease\", 'status': 'Not yet recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 1620, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03821844', 'age_groups': 'Age not specified', 'name': 'NCT03821844'}, {'nct_number': 'NCT04064164', 'title': 'Speeko for Elderspeak', 'status': 'Not yet recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 80, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04064164', 'age_groups': 'Age not specified', 'name': 'NCT04064164'}, {'nct_number': 'NCT03884023', 'title': 'Effect of REST in the Alzheimer Disease Continuum', 'status': 'Not yet recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 300, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT03884023', 'age_groups': 'Age not specified', 'name': 'NCT03884023'}, {'nct_number': 'NCT04103580', 'title': 'Caregiver Speaks: A Technologically Mediated Storytelling Intervention', 'status': 'Not yet recruiting', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 468, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT04103580', 'age_groups': 'Age not specified', 'name': 'NCT04103580'}]}, {'name': 'Active, not recruiting', 'children': []}, {'name': 'Enrolling by invitation', 'children': [{'nct_number': 'NCT03718494', 'title': 'The Kronos Early Estrogen Prevention Study (KEEPS)', 'status': 'Enrolling by invitation', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 688, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03718494', 'age_groups': 'Age not specified', 'name': 'NCT03718494'}, {'nct_number': 'NCT03773016', 'title': 'Touchscreen Technology and Art for People With Dementia in Care Homes', 'status': 'Enrolling by invitation', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 12, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03773016', 'age_groups': 'Age not specified', 'name': 'NCT03773016'}]}, {'name': 'Withdrawn', 'children': [{'nct_number': 'NCT02029547', 'title': 'Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians', 'status': 'Withdrawn', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 0, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT02029547', 'age_groups': 'Age not specified', 'name': 'NCT02029547'}, {'nct_number': 'NCT01870453', 'title': \"Differential Effects of Various Anesthetic Agents on Cognitive Function in Patients With Alzheimer's Disease\", 'status': 'Withdrawn', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Phase 4', 'enrollment': 0, 'study_type': 'Observational', 'url': 'https://ClinicalTrials.gov/show/NCT01870453', 'age_groups': 'Age not specified', 'name': 'NCT01870453'}]}, {'name': 'Suspended', 'children': [{'nct_number': 'NCT03378245', 'title': 'Telemedicine-based, Multidisciplinary-team, Intervention to Reduce Unnecessary Hospitalizations', 'status': 'Suspended', 'clean_age': 'Child, Adult, Older Adult', 'phases': 'Not Applicable', 'enrollment': 40, 'study_type': 'Interventional', 'url': 'https://ClinicalTrials.gov/show/NCT03378245', 'age_groups': 'Age not specified', 'name': 'NCT03378245'}]}]}]}\n"
     ]
    }
   ],
   "source": [
    "# nest the json\n",
    "    \n",
    "formatted = {'name': 'Alzheimer', 'children': []}\n",
    "age_groups = []\n",
    "status = []\n",
    "\n",
    "for d in json_data:\n",
    "    d['name'] = d['nct_number']\n",
    "\n",
    "    # locate and append unique age_groups values to the age_groups list\n",
    "    if d['age_groups'] not in age_groups:\n",
    "        age_groups.append(d['age_groups'])\n",
    "\n",
    "        # append structure for the nested json (formatted dict)\n",
    "        formatted['children'].append({'name': d['age_groups'], 'children': []})\n",
    "\n",
    "for d in json_data:\n",
    "    if d['status'] not in status:\n",
    "        # locate and append unique statuses to the status list\n",
    "        status.append(d['status'])\n",
    "\n",
    "        for age in formatted['children']:\n",
    "            # append the status values to the 'children' key in the formatted dict\n",
    "            age['children'].append({'name': d['status'], 'children': []})\n",
    "\n",
    "    for age in formatted['children']:\n",
    "        # for Observational studies only (group by study type)\n",
    "        if d['study_type'] == 'Observational' and age['name'] == d['age_groups']:\n",
    "            for s in status:\n",
    "                # check that current data point has a specific status\n",
    "                if s == d['status']:\n",
    "                    for f in age['children']:\n",
    "                        # add data to unique status group\n",
    "                        if f['name'] == s:\n",
    "                            f['children'].append(d)                   \n",
    "                            \n",
    "        # for Interventional studies only (group by study type)                    \n",
    "        if d['study_type'] == 'Interventional' and age['name'] == d['age_groups']:\n",
    "            for s in status:\n",
    "                # check that current data point has a specific status\n",
    "                if s == d['status']:\n",
    "                    for f in age['children']:\n",
    "                        # add data to unique status group\n",
    "                        if f['name'] == s:\n",
    "                            f['children'].append(d)\n",
    "\n",
    "print(formatted)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [],
   "source": [
    "# # export the nested json\n",
    "# with open (r'clean_data/alzheimer.json', 'w') as json_file:\n",
    "#     json.dump(formatted, json_file)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [],
   "source": [
    "# # export the nested json\n",
    "# with open (r'clean_data/alzheimer2.json', 'w') as json_file:\n",
    "#     json.dump(formatted, json_file)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [],
   "source": [
    "# alzheimer.to_csv(r'clean_data/alzheimer.csv', index=False)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
